{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "gpt-oss-20b-reasoning",
    "experiment": "e2_page_window",
    "pattern": "qualitative_3hop_cross_company_type1",
    "total_questions_in_experiment": 600
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Colgate-Palmolive (CL) compare to the total number of securities related to stock options, restricted stock units, and performance stock units available for future issuance at Procter & Gamble (PG)?",
      "original_answer": "Colgate-Palmolive (CL) reported 37,028,000 securities remaining available under equity compensation plans approved by security holders. Procter & Gamble (PG) disclosed that under similar plans, they had 133,185,995 total securities related to stock options, restricted stock units, and performance stock units available for future issuance. This indicates that PG has significantly more securities available for future issuance compared to CL.",
      "llm_answer": "Colgate‑Palmolive has **37,028 000** securities remaining available for future issuance under its equity‑compensation plans approved by security holders (37,028 thousand).  \nProcter & Gamble has **119 000 000** shares available for future issuance under its stock‑option, RSU, and PSU plans.  \n\nThus, Procter & Gamble’s pool is roughly **3.2 times larger** (about 82 million more securities) than Colgate‑Palmolive’s.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Colgate-Palmolive's number of securities available for future issuance as 37,028,000, matching the ground truth. However, it reports Procter & Gamble's total as 119,000,000 instead of the correct 133,185,995, which is a significant numerical error (~14 million fewer). This affects the comparison and undermines quantitative accuracy. (2) The calculation of the ratio (3.2 times larger) and the difference (82 million more) are based on incorrect input values. Using the correct P&G number (133,185,995), the actual ratio is approximately 3.6 times, and the difference is about 96.16 million. These miscalculations reduce confidence in the quantitative claims. (3) The multi-hop reasoning is structurally sound — the model correctly identifies both companies, the relevant equity compensation metrics, and attempts a comparative analysis. It synthesizes across entities appropriately, showing understanding of the question’s intent. (4) Despite the numerical inaccuracy for P&G, the core conclusion that PG has significantly more securities available than CL remains valid. The answer is well-structured and contextually relevant, but the incorrect figure for P&G prevents a higher score. Minor formatting (spaces instead of commas) is acceptable under semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 368,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the sensitivity of Google's foreign exchange forward contracts to a 10% weakening of the U.S. dollar compare with Disney's hedge coverage for forecasted foreign currency transactions in terms of notional exposure and risk mitigation horizon?",
      "original_answer": "Google's foreign exchange forward contracts would result in a $660 million impact on AOCI as of December 31, 2024, from a 10% weakening of the U.S. dollar, reflecting its net investment hedge strategy. In contrast, Disney hedges forecasted foreign currency transactions with a notional exposure of $9.9 billion as of September 28, 2024, and maintains coverage for periods generally not exceeding four years. While Google focuses on offsetting translation risk from foreign subsidiaries, Disney aims to stabilize earnings and cash flows by hedging forecasted transactions in major currencies like the euro and Japanese yen.",
      "llm_answer": "Google’s forward contracts are quantified by the potential impact of a 10 % U.S. dollar weakening – an adverse effect on income before taxes of roughly $503 million in 2023 and $135 million in 2024 after hedges, with a notional exposure of about $9.9 billion in 2024 (pages 45‑49).  The Disney 10‑K pages 119‑123 do not disclose the notional amount of its forecast‑transaction hedges or the length of its risk‑mitigation horizon, so a direct comparison of notional exposure or horizon cannot be made.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states that a 10% weakening of the U.S. dollar would have an adverse effect on Google's income before taxes of $503 million in 2023 and $135 million in 2024 after hedges, which contradicts the ground truth stating a $660 million impact on AOCI (Accumulated Other Comprehensive Income), not income before taxes, as of December 31, 2024. The LLM also incorrectly attributes a notional exposure of $9.9 billion to Google, which is actually Disney's notional exposure, not Google's. Furthermore, the LLM claims Disney's 10-K does not disclose notional amounts or horizon, but the ground truth confirms Disney has $9.9 billion in notional exposure and a risk mitigation horizon generally not exceeding four years. (2) Quantitative accuracy is severely compromised: the $660 million AOCI impact for Google is entirely missing; instead, fabricated figures of $503M and $135M are introduced without basis in the ground truth. The $9.9 billion notional amount is misassigned to Google rather than Disney. (3) Multi-hop reasoning fails: the model does not correctly synthesize information across entities—confusing Google’s and Disney’s figures—and incorrectly asserts lack of disclosure for Disney when the original answer confirms these details are available. (4) Contextual relevance is moderate because the answer attempts to address both companies and the concept of foreign exchange hedging, but due to major factual and attribution errors, the comparison is invalid. The core of the question—comparing sensitivity and hedge coverage—is undermined by incorrect data and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 451,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Procter & Gamble compare to Colgate-Palmolive’s available securities, considering both companies disclose these figures under similar categories?",
      "original_answer": "Procter & Gamble reports that there are 133,185,995 securities remaining available for future issuance under equity compensation plans approved by security holders, while Colgate-Palmolive discloses 37,028,000 securities remaining available under the same category. This indicates that P&G has a significantly larger pool of available securities for future equity compensation compared to Colgate-Palmolive.",
      "llm_answer": "Procter & Gamble reports **119 million shares** remaining available for future issuance under equity‑compensation plans approved by security holders (footnote 1 of the table).  \nColgate‑Palmolive reports **37,028 thousand shares** (≈ 37.028 million) available for future issuance under the same category.  \nThus Procter & Gamble’s available securities are roughly **3.2 times larger**—about 82 million shares more—than Colgate‑Palmolive’s.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Colgate-Palmolive's available securities as 37,028,000 (rounded to 37,028 thousand or ~37.028 million), which matches the ground truth. However, it reports Procter & Gamble’s figure as 119 million shares, whereas the ground truth is 133,185,995—this is a significant numerical discrepancy (~14 million shares off). (2) The calculation comparing P&G’s pool to Colgate’s as '3.2 times larger' and 'about 82 million shares more' is based on the incorrect 119 million figure. Using correct numbers: 133,185,995 / 37,028,000 ≈ 3.6, and the difference is ~96.16 million shares. Thus, both the ratio and difference are miscalculated due to the initial error. (3) The multi-hop reasoning—comparing available securities under shareholder-approved equity plans for two companies—is sound in structure and correctly identifies the relevant metric and category. The synthesis across companies is appropriate and logically presented. (4) Despite the incorrect P&G number, the answer retains qualitative accuracy by correctly framing the comparison and citing the right disclosure category. Contextual relevance is perfect—the response directly addresses the question’s intent. The quantitative accuracy is penalized due to the material error in P&G's figure, but not fully dismissed as other numbers and logic are correct. Hence, correctness score is 7—core facts partially accurate with significant but not fundamental errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 403,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does AbbVie's patent litigation against Sandoz Inc. over upadacitinib relate to Amgen's legal strategy in defending its own patents against Sandoz's counterclaims regarding denosumab biosimilar development?",
      "original_answer": "AbbVie is actively enforcing its patents for upadacitinib (Rinvoq) by suing Sandoz Inc. and other generic drug manufacturers, seeking injunctive relief to prevent premature market entry of generic versions. Meanwhile, Amgen faces litigation from Sandoz Inc., which has filed counterclaims asserting that Amgen's asserted patents for denosumab are invalid or unenforceable. Both companies are engaged in high-stakes patent battles involving Sandoz Inc., but while AbbVie is in the offensive position protecting its drug exclusivity, Amgen is defending its intellectual property against Sandoz's legal challenges, revealing contrasting legal dynamics in the biopharmaceutical patent ecosystem.",
      "llm_answer": "AbbVie’s filing (pp. 93‑97) shows it has sued Sandoz for infringing its upadacitinib patents, seeking declaratory and injunctive relief. In contrast, Amgen’s strategy (pp. 153‑157) is defensive: it is contesting Sandoz’s counter‑claims in a BPCIA case over a denosumab biosimilar, filing counter‑claims and seeking injunctions to protect its own patents. Both companies therefore use litigation to guard their intellectual‑property rights against Sandoz’s generic‑biodrug challenges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies AbbVie's offensive litigation posture against Sandoz over upadacitinib patents and Amgen's defensive stance in responding to Sandoz's counterclaims regarding denosumab biosimilar development. All entities (AbbVie, Sandoz Inc., Amgen, upadacitinib, denosumab) are correctly named and contextualized. The mention of specific page ranges (pp. 93–97, pp. 153–157) aligns with typical 10-K filing structures, though exact pages are not verifiable without source documents; however, this does not affect factual correctness. There are no numerical values requiring verification, so quantitative accuracy is scored as 10. The reasoning correctly synthesizes the multi-hop relationship between two companies' legal strategies involving the same generic manufacturer (Sandoz), highlighting contrasting legal dynamics—offensive vs. defensive patent enforcement. The only minor shortcoming is a slightly less explicit articulation of the 'contrasting legal dynamics in the biopharmaceutical patent ecosystem' compared to the original answer, which provides a broader interpretive conclusion. However, the core contrast is clearly conveyed through 'AbbVie...seeking declaratory and injunctive relief' vs. 'Amgen’s strategy...defensive: contesting Sandoz’s counter-claims.' Thus, qualitative accuracy is 9 due to slightly less depth in synthesis framing, but correctness and contextual relevance remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 412,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does the voting power dilution mechanism in CMCSA's Class B to Class A common stock conversion compare with GOOGL's multi-class stock structure, particularly in light of the $62.2 billion in Class A and Class C shares repurchased by GOOGL in 2023?",
      "original_answer": "GOOGL repurchased $62.2 billion of its Class A and Class C shares in 2023, maintaining a multi-class structure where Class B shares carry 10 votes per share and convert automatically upon sale or transfer to Class A, which has 1 vote per share. In contrast, CMCSA's Class B shares carry 15 votes and are convertible share-for-share into Class A shares, with Class B's aggregate voting power capped at 33 1/3% and protected from dilution under its articles of incorporation. This means CMCSA has a stronger anti-dilution mechanism for its Class B shares compared to GOOGL, where Class B shares lose their enhanced voting rights upon conversion. Additionally, GOOGL's repurchase activity in 2023 may have concentrated voting control among remaining Class B shareholders by reducing the total number of Class A shares outstanding.",
      "llm_answer": "CMCSA’s Class B shares carry 15 votes each and may be converted share‑for‑share into Class A shares that have only one vote, so conversion dilutes the voting power of the converted shares while the aggregate voting power of Class B holders remains capped at 33 ⅓ % of total voting power. Alphabet’s multi‑class structure gives Class A shares one vote and Class C shares none; the $62.2 billion of Class A and Class C shares repurchased in 2023 simply reduced the total number of shares outstanding, tightening the voting power per remaining Class A share but leaving the overall voting‑rights split unchanged. Thus, CMCSA’s conversion mechanism can dilute holders’ voting influence, whereas Alphabet’s repurchases merely shrink the share base without altering the relative voting‑rights structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is quantitatively accurate: the $62.2 billion repurchase amount by GOOGL in 2023 is correct, and the voting rights (15 votes for CMCSA Class B, 1 vote for Class A) are accurately stated. The 33 1/3% cap on CMCSA Class B aggregate voting power is also correctly mentioned. However, the qualitative accuracy suffers due to significant misrepresentation of GOOGL's multi-class structure and flawed reasoning about the effects of conversion and repurchases. The LLM incorrectly states that GOOGL's Class C shares have no votes—this is true—but fails to mention that GOOGL has Class B shares with 10 votes per share, which are central to the comparison. The original answer emphasizes that Class B shares convert to Class A upon sale, losing super-voting rights, which is a key point in comparing dilution mechanisms. The LLM omits this entirely. Additionally, the LLM incorrectly frames CMCSA’s conversion as diluting the *holder’s* voting influence, when in fact the structure is designed to *protect* Class B voting power from dilution via the cap and anti-dilution provisions. The conclusion that 'CMCSA’s conversion mechanism can dilute holders’ voting influence' is therefore incorrect and opposite to the ground truth, which states CMCSA has a *stronger anti-dilution mechanism*. The LLM also misses the point that GOOGL’s repurchases may concentrate voting power among remaining Class B holders by reducing the total share base—a key insight in the original answer. While the LLM recognizes that repurchases reduce shares outstanding, it fails to connect this to a shift in voting control. The answer is contextually relevant and addresses the core comparison, but the reasoning contains critical errors in interpretation and synthesis, particularly in the multi-hop logic required to compare anti-dilution protections and the implications of share conversion and repurchases.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 509,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How does the number of shares reserved for future issuance under Nike's Equity Compensation Plan compare to the number of shares represented by outstanding warrants at Tesla, based on their respective 2023 filings?",
      "original_answer": "Nike reported 97,567,370 shares remaining available for future issuance under its Equity Compensation Plan, while Tesla disclosed that 11 million shares were represented by outstanding warrants in 2023. Therefore, Nike's available shares under its equity plan are significantly higher than Tesla's outstanding warrants.",
      "llm_answer": "Nike’s 2023 Equity Compensation Plan reserves **97,567,370 shares** for future issuance (see NKE 10‑K, pages 94‑98).  \nTesla’s 2023 filing reports **no outstanding warrants**, i.e., **0 shares** represented by warrants (see TSLA 10‑K, pages 61‑65).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual error in the quantitative data for Tesla: it claims Tesla reported 0 shares represented by outstanding warrants in its 2023 filing, while the ground truth states Tesla disclosed 11 million shares under outstanding warrants. This is a major discrepancy that undermines the core comparison. The Nike figure (97,567,370 shares) is correct and matches the ground truth. However, the Tesla number is entirely incorrect, which invalidates the comparison and conclusion. The model fails in multi-hop synthesis because it does not accurately retrieve and contrast the two figures as required. While the answer structure is relevant and addresses the right entities (Nike, Tesla, equity plans, warrants, 2023 filings), the reasoning collapses due to the false claim about Tesla having no warrants. The contextual relevance is high because the response attempts the correct format and cites appropriate sections, but the factual inaccuracy in a key data point severely limits correctness. Therefore, the correctness and accuracy scores are low despite proper framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 311,
        "total_tokens": 1469
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the number of shares issuable upon exercise of outstanding warrants disclosed by Tesla in 2023 compare to the number of shares remaining available for future issuance under Nike's equity compensation plans, based on their respective disclosures?",
      "original_answer": "Tesla disclosed that in 2023, there were 11 million shares issuable upon exercise of outstanding warrants. In contrast, Nike, through its equity compensation plan disclosures, indicated that 97,567,370 shares were remaining available for future issuance under compensation plans. This highlights a significant difference in scale between Tesla's warrant-related share exposure and Nike's available equity compensation pool.",
      "llm_answer": "Tesla’s 2023 10‑K shows that 11 million shares would be issuable upon exercise of its outstanding warrants.  \nNike’s 2023 10‑K reports 97.567 million shares remaining available for future issuance under its equity‑compensation plans.  \nAccordingly, Nike’s potential issuable shares are roughly nine times larger than Tesla’s.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: Tesla's 11 million shares issuable upon exercise of outstanding warrants in 2023 is correctly reported. Nike's 97,567,370 shares available for future issuance is accurately represented as 97.567 million (rounded appropriately). The comparison stating Nike’s potential shares are roughly nine times larger is logically sound (97.567 / 11 ≈ 8.87, which rounds to ~9x). (2) The answer is complete, addressing both companies, the relevant share figures, and the comparative scale. (3) Entities are correct: Tesla and Nike, 2023 10-K disclosures, warrants vs. equity compensation plans. (4) The multi-hop reasoning—synthesizing data from two different companies’ filings and comparing the scale of share exposures—is correctly executed. (5) The semantic meaning fully aligns with the original answer, with slightly more concise wording and an added quantitative comparison (9x) that enhances clarity without introducing error. All criteria for a perfect score are met.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 308,
        "total_tokens": 1522
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does the differential voting power per share in GOOGL's Class B common stock impact its corporate governance structure, compared to NFLX's uniform voting rights model where each share carries one vote?",
      "original_answer": "GOOGL's Class B common stock provides 10 votes per share, significantly enhancing the voting influence of its holders compared to the 1 vote per share for Class A and no voting rights for Class C stock. This structure allows key stakeholders holding Class B shares to maintain disproportionate control over corporate decisions. In contrast, NFLX provides uniform voting rights, where each share of common stock entitles the holder to exactly one vote, promoting a more egalitarian governance model. The difference in voting rights structures reflects contrasting philosophies in corporate governance between the two companies.",
      "llm_answer": "Google’s 2024 10‑K (pp. 80‑84) notes that each Class B share carries **10 votes per share** versus one vote for Class A, giving founders and insiders a concentrated voting bloc that can outweigh the broader shareholder base even when diluted.  \nNetflix’s 2024 10‑K (pp. 58‑62) states that **every common‑stock share has one vote**, so voting power is evenly distributed among all shareholders, preventing any single group from dominating the board.  \nThus, Google’s differential voting structure concentrates control, while Netflix’s uniform model promotes a more dispersed, egalitarian governance structure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: GOOGL's Class B shares carry 10 votes per share (vs. 1 for Class A), while NFLX provides one vote per share uniformly. These numbers match the original answer exactly. (2) Quantitative accuracy is perfect—no calculations were required, but the vote ratios (10:1 vs. 1:1) are correctly reported. (3) Multi-hop reasoning is sound: the model correctly synthesizes information from two different companies (GOOGL and NFLX) and contrasts their governance models based on voting rights structures. It identifies that concentrated control in GOOGL enables founders/insiders to dominate decisions, while NFLX’s model promotes equal voting power. (4) The answer is contextually relevant, directly addressing the impact of differential vs. uniform voting rights on corporate governance. Minor wording differences (e.g., 'egalitarian' vs. 'evenly distributed') do not affect factual equivalence. No errors in entities, years, or metrics—both references to 2024 10-Ks are plausible and correctly attributed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 314,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What percentage of Chevron's average daily net crude oil production in 2021 came from the QG3 project through its stake in Qatargas Operating Company Limited?",
      "original_answer": "Chevron's average daily net crude oil production from the QG3 project through its stake in Qatargas Operating Company Limited was 13 MBD in 2021. Since Chevron holds a 30% interest in Qatargas, this production volume reflects Chevron's proportional share of the crude oil output from the QG3 project.",
      "llm_answer": "Chevron’s 30 % stake in QG3 gave it 13 bbl d‑1 × 30 % = 3.9 bbl d‑1 of crude oil.  \nWith Chevron’s total average‑daily net crude oil production of 169 bbl d‑1 in 2021, the QG3 contribution represents roughly **2.3 %** of that total.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. (1) The original answer states that Chevron's net crude oil production from the QG3 project was 13 MBD (thousand barrels per day), not 13 bbl/d. The LLM misinterprets this as 13 barrels per day and then incorrectly applies a 30% stake calculation (13 × 30% = 3.9), which contradicts the ground truth: the 13 MBD already reflects Chevron’s 30% proportional share. (2) The LLM introduces a total daily net crude oil production figure of 169 bbl/d (again, likely meaning 169 thousand bbl/d but written incorrectly), which is not present in the original answer and cannot be verified from the provided context. Using this unverified number to compute 2.3% is unsupported. (3) The multi-hop reasoning fails: the original answer does not provide Chevron’s total crude oil production, so the percentage calculation cannot be performed. The question asks for the percentage of total production that came from QG3, but the original answer only gives the QG3 contribution (13 MBD) and clarifies it is Chevron’s 30% share — it does not provide enough data to compute the percentage of total production. However, the LLM fabricates missing data and performs an unsupported calculation. (4) While the mention of a 30% stake in Qatargas is accurate and contextually relevant, the quantitative inaccuracies and flawed reasoning severely undermine the answer. The final percentage of 2.3% is not supported by the ground truth. Thus, the correctness and quantitative accuracy scores are very low due to critical errors in unit interpretation, calculation, and data fabrication.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1136,
        "completion_tokens": 436,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the adoption of ASU 2022-04 impact the transparency of supplier finance obligations for both 3M and Honeywell, particularly in terms of the new roll-forward disclosure requirements effective in 2024?",
      "original_answer": "The adoption of ASU 2022-04 enhances transparency for both 3M and Honeywell by mandating detailed annual disclosures about supplier finance program obligations, including a roll-forward of confirmed invoice amounts. For 3M, this includes reporting $1.5 billion of invoices confirmed and $1.5 billion of invoices paid or adjusted in 2024, which is now disclosed as part of the roll-forward requirement. Honeywell adopted the roll-forward provisions starting in 2024, aligning with the ASU’s phased implementation. Both companies now provide clearer visibility into their supplier finance activities, improving comparability and risk assessment for stakeholders.",
      "llm_answer": "Both 3M and Honeywell adopted ASU 2022‑04, which requires annual disclosure of supplier‑finance program key terms, the presentation location of amounts, and a roll‑forward of outstanding balances.  Effective Jan 1 2024 the roll‑forward must be presented, enabling users to track beginning and ending balances, invoices confirmed and paid, and current outstanding amounts (see 3M Note 16, pp. 75‑79; Honeywell Note 15, pp. 58‑62).  This new disclosure enhances transparency of supplier‑finance obligations without materially changing the companies’ financial statements.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the key impact of ASU 2022-04 on transparency for both 3M and Honeywell, noting the new roll-forward disclosure requirements effective January 1, 2024, and the enhanced visibility into supplier finance obligations. It accurately describes the qualitative aspects of the standard, including the requirement to disclose key terms, presentation location, and roll-forward of balances, and references the correct financial statement notes (3M Note 16, Honeywell Note 15), demonstrating strong qualitative accuracy and contextual relevance. However, the LLM answer omits the specific quantitative data provided in the ground truth—namely, that 3M reported $1.5 billion of invoices confirmed and $1.5 billion of invoices paid or adjusted in 2024. This missing numerical detail is a significant omission under the quantitative accuracy criterion, especially since the question emphasizes the 'roll-forward disclosure requirements' which include actual figures. While the LLM correctly states the timing (2024) and structure of the roll-forward, it fails to include the concrete numbers that exemplify the new transparency, reducing its quantitative accuracy. The multi-hop reasoning is sound in linking ASU 2022-04 to both companies and the new disclosures, but the lack of specific figures from the filings limits full factual completeness. Semantic equivalence is mostly achieved, but the absence of dollar amounts prevents a higher correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 406,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does LMT's revenue recognition approach for U.S. Government contracts regulated by FAR compare to RTX's financial exposure to U.S. Government contract risks, particularly in relation to fixed-price contract structures?",
      "original_answer": "LMT recognizes revenue for U.S. Government contracts regulated by the FAR using a cost-plus-fixed-fee model, where the standalone selling price is typically equal to the contract price due to FAR-mandated cost-plus structures. RTX, on the other hand, faces financial exposure from its reliance on fixed-price contracts, especially firm fixed-price (FFP) contracts, where it bears the full burden of cost overruns. Both companies are subject to U.S. Government contract risks, but LMT's FAR-regulated contracts provide more predictable revenue due to cost reimbursement with a reasonable profit margin, whereas RTX's FFP contracts carry higher risk of negative profit adjustments, particularly in development programs.",
      "llm_answer": "Lockheed Martin’s revenue‑recognition policy (disclosed in its 10‑K) treats U.S. Government contracts under FAR as a single performance obligation and records revenue over time using a cost‑to‑cost percentage‑of‑completion method, while it estimates variable consideration and adjusts profit‑booking rates as risks are retired.  In contrast, RTX’s 10‑K explains that its fixed‑price U.S. Government contracts expose it to cost overruns and potential losses—particularly on fixed‑price incentive and firm‑fixed‑price contracts—creating a risk of negative profit adjustments and financial exposure.  Thus, LMT’s approach is a structured, risk‑managed revenue recognition framework, whereas RTX’s exposure highlights the financial vulnerability inherent in fixed‑price contracting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies LMT's revenue recognition approach for U.S. Government contracts under FAR as using a cost-based percentage-of-completion method (cost-to-cost), which is consistent with cost-plus-fixed-fee contracts where revenue is recognized over time and profit rates are adjusted as risks are retired. This matches the ground truth's emphasis on FAR-mandated cost-plus structures providing predictable revenue through cost reimbursement plus a fixed profit. (2) The LLM accurately describes RTX's financial exposure from fixed-price contracts—specifically firm fixed-price (FFP) and fixed-price incentive contracts—highlighting the risk of cost overruns and negative profit adjustments, which is fully consistent with the original answer. (3) While the ground truth explicitly mentions that LMT’s standalone selling price equals contract price due to FAR rules, the LLM captures the economic effect by describing a structured, risk-managed framework, conveying semantic equivalence. (4) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (LMT and RTX), compares their contract types (cost-plus vs. fixed-price), and links these to differing risk profiles and revenue recognition outcomes. (5) No numeric values are incorrect; the answer avoids specific dollar amounts or percentages not present in the ground truth, so quantitative accuracy is perfect. (6) Minor deduction in qualitative accuracy (9/10) because the LLM does not explicitly name the 'cost-plus-fixed-fee' model as in the ground truth, instead describing its mechanics—still accurate but slightly less precise in terminology. Overall, the answer is contextually excellent, fully addressing the comparative structure of the question and delivering factually correct, well-reasoned insights.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 510,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does the expiration timeline of BMY's Eliquis patent rights in Europe compare to MRK's Januvia family patent expiration in the U.S., and what impact does this have on their respective market exclusivity strategies?",
      "original_answer": "BMY is actively litigating to extend the market exclusivity of Eliquis in Europe, having secured final positive decisions in Norway, Sweden, and Switzerland, while facing negative outcomes in the UK and ongoing appeals in several other countries. Despite these efforts, generic competition has already entered in some markets like Finland and Portugal. In contrast, MRK's Januvia family lost its key U.S. patent in January 2023, but due to court rulings and settlements, exclusivity is maintained until May 2026 for Januvia and Janumet and July 2026 for Janumet XR. This difference in timelines and enforcement success highlights how BMY's fragmented European patent strategy faces more immediate generic erosion, while MRK has extended exclusivity in the U.S. through secondary patents, delaying generic entry and preserving revenue longer.",
      "llm_answer": "BMS’s Eliquis composition‑of‑matter patent in Europe has not yet expired – the company is litigating in multiple EU jurisdictions to keep generics from launching before the patent’s term ends【source: “Eliquis – Europe” section, BMS 10‑K, pages 4‑8】. In contrast, Merck’s Januvia family patents in the U.S. expired in January 2023, but secondary sitagliptin‑salt patents keep the product exclusive until May 2026 (Januvia/Janumet) and July 2026 (Janumet XR)【source: MRK 10‑K, pages 56‑60】. Thus, BMS must defend its European exclusivity through litigation, while Merck relies on later‑expiring patents to extend U.S. exclusivity and delay generic entry until 2026.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information in the ground truth. (1) All key dates are correct: MRK's Januvia family lost its primary U.S. patent in January 2023, with exclusivity extended to May 2026 for Januvia/Janumet and July 2026 for Janumet XR—this matches the original answer exactly. The BMS (BMY) Eliquis patent situation in Europe is correctly framed as ongoing litigation across jurisdictions, with no blanket expiration yet. (2) Quantitative accuracy is perfect: all dates (January 2023, May 2026, July 2026) are correct and match the ground truth. (3) The multi-hop reasoning is sound—comparing BMS's litigation-based strategy in a fragmented European market with MRK's reliance on secondary patents in the U.S. is well articulated. (4) The only minor omission is that the original answer includes specific country-level outcomes (positive in Norway, Sweden, Switzerland; negative in UK; generics in Finland and Portugal), which the LLM answer does not mention. While this adds context, it does not undermine the correctness of the core comparison or strategic implications. The LLM correctly identifies the difference in strategy and timeline impact. Wording differs but semantic meaning and factual content are equivalent. Sources cited align with the expected document sections. Thus, the answer is excellent but not fully comprehensive on the geographic granularity of BMS's litigation outcomes, warranting a 9 instead of 10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 412,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What is the total amount of appeal bonds posted by PM USA related to adverse verdicts on appeal, and how does this compare to the total payments made by PM USA for judgments and settlements in tobacco-related litigation since October 2004?",
      "original_answer": "PM USA has posted appeal bonds totaling $35 million related to adverse verdicts currently on appeal. Since October 2004, PM USA has paid approximately $1 billion in judgments and settlements (including related costs and fees) and approximately $241 million in interest related to tobacco litigation. This indicates that the current appeal bonds represent a small fraction of the total historical litigation-related payments made by PM USA.",
      "llm_answer": "PM USA has posted appeal bonds totaling **$35 million** to secure stays of judgments pending appeal.  \nIn contrast, since October 2004 the company has paid roughly **$1 billion** in judgments and settlements (including related costs and fees) for tobacco‑related litigation. Thus the appeal bonds represent only a small fraction—about 3.5%—of the total payments made.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $35 million in appeal bonds and the $1 billion in judgments and settlements since October 2004, matching the ground truth exactly. It also correctly calculates that $35 million is approximately 3.5% of $1 billion, which is a valid comparison and supports the conclusion that the bonds represent a small fraction of total payments. However, the original answer includes an additional $241 million in interest payments, which the LLM omits. While the omission does not invalidate the core comparison (bonds vs. judgments/settlements), it slightly reduces completeness. (2) All numeric values—$35 million, $1 billion, and the implied 3.5% ratio—are accurate and correctly formatted. The calculation (35/1000 = 3.5%) is mathematically sound. (3) The multi-hop reasoning is strong: the model synthesizes bond amounts with historical payments and draws a logical comparison. It correctly attributes the data to PM USA and the correct time frame (since October 2004). The only gap is the missing interest component, which is part of the total litigation-related payments in the ground truth. (4) The answer is highly relevant, directly addressing both parts of the question. The scores reflect near-perfect quantitative accuracy and contextual relevance, with a minor deduction in qualitative accuracy due to the omitted interest payments, though the core reasoning and conclusion remain valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 398,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 205,
      "question": "How does the revenue contribution from Taiwan differ between Apple's Greater China segment in 2022 and NVIDIA's direct revenue reported from Taiwan in the same year?",
      "original_answer": "Apple's Greater China segment generated $74,200 million in net sales in 2022, which includes Taiwan along with China mainland and Hong Kong. In contrast, NVIDIA directly reported $8,544 million in revenue from Taiwan in 2022. Since Apple's figure for Taiwan is embedded within the broader Greater China segment, the exact revenue contribution from Taiwan alone for Apple cannot be determined precisely but is a subset of the $74,200 million. NVIDIA’s $8,544 million provides a direct and isolated measure of its Taiwan revenue.",
      "llm_answer": "Apple’s Greater China segment generated $74.2 billion in net sales in 2022 (which includes China mainland, Hong Kong and Taiwan).  NVIDIA, by contrast, reported no direct revenue from Taiwan in its 2022 filing.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error: it claims NVIDIA reported no direct revenue from Taiwan in 2022, which directly contradicts the ground truth stating NVIDIA reported $8,544 million in revenue from Taiwan that year. This is a critical error in entity-specific financial data. Apple's Greater China revenue of $74.2 billion (equivalent to $74,200 million) is correctly stated, and the clarification that this includes Taiwan, mainland China, and Hong Kong is accurate. (2) Quantitative accuracy fails on the NVIDIA figure — reporting 'no direct revenue' instead of $8,544 million is a severe numerical inaccuracy, even though Apple's number is correctly presented (with acceptable format variation from $74,200 million to $74.2 billion). (3) The reasoning is partially sound in acknowledging that Apple's Taiwan revenue is embedded and not separately disclosed, but completely breaks down on the NVIDIA side by failing to recognize the explicit Taiwan revenue disclosure. This undermines the multi-hop comparison the question hinges on — contrasting Apple’s indirect (embedded) exposure with NVIDIA’s direct reporting. (4) Scores are low due to the critical factual error in NVIDIA's revenue, which invalidates the core comparison. Contextual relevance is moderate because the structure and intent of the answer align with the question, but correctness and qualitative reasoning are severely compromised by the incorrect data point.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 403,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 233,
      "question": "How has the growth in NVDA's revenue from Taiwan between fiscal years 2020 and 2022 compared to the growth in AAPL's revenue from the Greater China region, which includes Taiwan?",
      "original_answer": "NVDA's revenue from Taiwan grew from $3,025 million in 2020 to $8,544 million in 2022, representing a 182.5% increase over two years. AAPL's revenue from Greater China, which includes Taiwan, grew from $40,308 million in 2020 to $74,200 million in 2022, representing an 84.1% increase over the same period. Therefore, NVDA experienced significantly higher growth in revenue from Taiwan (as part of its broader regional exposure) compared to AAPL's growth in the broader Greater China region.",
      "llm_answer": "NVDA’s revenue from Taiwan rose from roughly $1,000 million in fiscal 2020 to about $1,200 million in fiscal 2022, a growth of roughly 20 %. In contrast, Apple’s Greater China (China mainland, Hong Kong and Taiwan) revenue climbed from $40,308 million in 2020 to $74,200 million in 2022, an increase of about 84 %. Thus, Apple’s growth rate in the Greater China region was substantially higher than NVDA’s growth from Taiwan.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in the quantitative data for NVDA's revenue from Taiwan. It states that NVDA's revenue grew from $1,000 million in 2020 to $1,200 million in 2022 (20% growth), but the ground truth shows it actually grew from $3,025 million to $8,544 million, a 182.5% increase. This is a significant underreporting of both the base values and the growth rate. In contrast, the AAPL figures are correct: $40,308 million in 2020 and $74,200 million in 2022, representing an 84.1% increase. (2) The calculation for AAPL’s growth is accurate (approximately 84%), but NVDA’s reported growth is completely incorrect due to wrong input values. The conclusion that Apple’s growth was higher is therefore false—NVDA actually had much higher growth (182.5% vs 84.1%). (3) The multi-hop reasoning is structurally sound—comparing revenue growth between two companies across regions—but fails due to incorrect data retrieval for NVDA. The model appears to have accessed or recalled incorrect figures for NVDA’s Taiwan revenue, undermining the synthesis. (4) Contextual relevance is high because the answer addresses the right companies, regions, time frame, and comparison type. However, the severe quantitative inaccuracies—especially the misstatement of NVDA’s revenue by over $2 billion in 2020—lead to a very low correctness score despite correct structure and relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 392,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 235,
      "question": "How does Microsoft's projected tax liability under the OECD's Pillar Two Model Rules compare to Broadcom's exposure from the global minimum tax, given their differing international tax structures?",
      "original_answer": "Microsoft projects no material impact from the OECD's Pillar Two Model Rules, which establish a 15% global minimum tax, as it begins applying to the company in fiscal year 2025. In contrast, Broadcom notes that global minimum tax provisions, such as Singapore's adoption effective for fiscal year 2026, may materially increase its effective tax rate and cash tax costs. This divergence reflects Microsoft's current lack of material operations in jurisdictions with tax rates below the 15% threshold, versus Broadcom's existing reliance on tax incentives in various jurisdictions that could be adversely affected by the global minimum tax.",
      "llm_answer": "Microsoft projects that the OECD’s Pillar Two rules will have no material impact on its consolidated tax expense, citing its diversified tax structure and substantial foreign income in higher‑rate jurisdictions. In contrast, Broadcom’s exposure to the global minimum tax is significant – the company’s concentration of earnings in lower‑rate jurisdictions means the new rule could raise its effective tax rate by several percentage points.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core contrast between Microsoft and Broadcom regarding their exposure to the OECD's Pillar Two global minimum tax. (1) All key facts are correct: Microsoft projects no material impact, while Broadcom faces significant exposure due to its earnings in lower-tax jurisdictions. The LLM correctly identifies Microsoft’s diversified tax structure and higher-rate jurisdiction income as mitigating factors, aligning with the ground truth. (2) There are no numeric values (e.g., percentages, dollar amounts, fiscal years) in the LLM answer that conflict with the original; it avoids stating specific numbers where none were provided in the source, maintaining quantitative accuracy. While the original mentions fiscal years 2025 (Microsoft) and 2026 (Broadcom), the LLM omits these dates—this is a minor omission but does not introduce inaccuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes the differing international tax structures and links them to differential Pillar Two impacts. (4) Semantic equivalence is strong—the LLM conveys the same conclusion using different phrasing (e.g., 'no material impact' vs 'no material impact on its consolidated tax expense'; 'raise its effective tax rate by several percentage points' is a reasonable interpretation of 'materially increase its effective tax rate'). The only slight gap is the omission of Singapore’s adoption of the rules, which adds specificity to Broadcom’s exposure, but this does not undermine the overall correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 459,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 245,
      "question": "How does the difference in voting rights structure between NFLX common stock and GOOGL Class B common stock impact shareholder influence, given that GOOGL Class B shares carry 10 votes per share while NFLX shares carry only one vote per share?",
      "original_answer": "NFLX common stock provides one vote per share to all shareholders, granting equal influence per share. In contrast, GOOGL has a multi-tiered voting rights structure where Class B common stockholders receive 10 votes per share, significantly amplifying their voting power compared to Class A shareholders who receive one vote per share. This structural difference means that GOOGL's Class B shareholders have disproportionately greater influence over corporate decisions than any single group of shareholders at NFLX, where voting power is uniformly distributed across all shares.",
      "llm_answer": "NFLX’s common shares give each holder one vote, so every share has equal influence on corporate matters. Alphabet’s Class B shares, however, carry ten votes per share (and can be converted to Class A shares, which have one vote each), giving those shareholders tenfold voting power per share and a disproportionate ability to shape board elections and corporate policy. Consequently, Class B holders can exert far greater influence over the company’s governance than NFLX shareholders, whose influence is limited to one vote per share.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: NFLX common stock has one vote per share, GOOGL Class B shares have 10 votes per share, and this grants disproportionate influence to Class B holders. The statement about conversion to Class A shares is an additional accurate detail not in the original but consistent with public knowledge. (2) Quantitative accuracy is perfect: 'one vote' and 'ten votes per share' match the ground truth exactly. (3) The reasoning correctly synthesizes the multi-hop concept—comparing voting structures across two companies and explaining the implications for shareholder influence. The conclusion that GOOGL's Class B shareholders have greater control than NFLX shareholders is logically sound. (4) The only minor shortcoming is that the original emphasizes the uniformity of NFLX's structure versus GOOGL's multi-tiered system, which the LLM mentions implicitly but not explicitly. However, the semantic meaning and factual content are equivalent. No factual errors, strong contextual relevance, and excellent reasoning justify high scores across the board.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 328,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does AMD's revenue from Taiwan in 2021 compare to Apple's 2022 revenue from the broader Greater China region, which includes Taiwan?",
      "original_answer": "AMD reported $1,187 million in revenue from Taiwan in 2021, while Apple reported $74,200 million in revenue from the Greater China region in 2022. Since Greater China includes Taiwan along with China mainland and Hong Kong, Apple's revenue from the broader region was significantly higher than AMD's revenue specifically from Taiwan.",
      "llm_answer": "AMD’s revenue from Taiwan in 2021 was $2,091 million (≈$2.1 billion). Apple’s 2022 revenue from the Greater China region (China mainland, Hong Kong and Taiwan) was $74,200 million (≈$74.2 billion). Thus, Apple’s Greater China revenue was roughly 35 times larger than AMD’s Taiwan revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error in AMD's revenue from Taiwan in 2021. The ground truth states $1,187 million, but the LLM reports $2,091 million, which is significantly incorrect. Apple's revenue from the Greater China region in 2022 is correctly reported as $74,200 million, matching the ground truth. (2) The calculation comparing Apple's revenue to AMD's is based on incorrect input data: while the LLM claims Apple's revenue was 'roughly 35 times larger,' the correct ratio using ground truth numbers is approximately 62.5 times ($74,200 / $1,187 ≈ 62.5). Thus, both the input number and the resulting comparison are quantitatively inaccurate. (3) The multi-hop reasoning structure is sound—the model correctly identifies that it must compare AMD's Taiwan-specific revenue with Apple's broader regional revenue including Taiwan—and it appropriately contextualizes the geographic scope (Greater China = mainland China, Hong Kong, and Taiwan). This shows correct qualitative understanding of the entities and the comparative logic required. (4) Despite the correct framing and Apple's data accuracy, the severe error in AMD's revenue figure undermines the factual correctness, limiting the correctness_score to 4. Quantitative_accuracy is low (3) due to the wrong AMD number and incorrect ratio. Qualitative_accuracy is moderate (6) because the reasoning framework is valid. Contextual_relevance is high (9) as the answer addresses all aspects of the question with appropriate structure and scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 420,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the availability of shares under Tesla's 2019 Equity Incentive Plan compare with Starbucks' remaining equity grant capacity, particularly in relation to their respective use of incentive stock options as a component of compensation strategy?",
      "original_answer": "Tesla's 2019 Equity Incentive Plan had 49.0 million shares reserved and available for issuance as of December 31, 2021, while Starbucks had 99.7 million shares available for future equity-based compensation awards as of October 2, 2022. Both companies utilize incentive stock options as part of their broader equity compensation structures, with Tesla's 2019 Plan explicitly including the provision for granting incentive stock options to employees, and Starbucks maintaining several equity incentive plans that include incentive stock options among other forms of equity compensation.",
      "llm_answer": "Tesla’s 2019 Equity Incentive Plan has 49.0 million shares reserved for issuance (as of December 31, 2021), providing a sizable pool for incentive stock options. Starbucks’ remaining equity grant capacity is not disclosed in the Tesla pages, but Starbucks also relies heavily on incentive stock options as a key component of its compensation strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly states Tesla's 49.0 million shares reserved under its 2019 Equity Incentive Plan as of December 31, 2021, matching the ground truth. However, it fails to provide Starbucks' actual remaining equity grant capacity of 99.7 million shares as of October 2, 2022, instead claiming it is 'not disclosed in the Tesla pages'—this is incorrect, as the original answer confirms the Starbucks figure is available. This omission significantly undermines completeness and factual accuracy. While the LLM correctly notes both companies use incentive stock options, it only explicitly confirms this for Tesla and vaguely asserts Starbucks 'relies heavily' on them without citing the multi-plan structure or explicit inclusion in equity programs. The reasoning is partially sound but fails the multi-hop requirement by not synthesizing the full data set across both companies. Quantitative accuracy is high for the Tesla figure but incomplete due to missing Starbucks data. Contextually, the answer addresses the compensation strategy aspect but lacks precision and balance in comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 310,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the use of valuation models incorporating broker/dealer quotes impact the fair value determination of Level 2 assets for GD compared to BA's approach for available-for-sale debt investments?",
      "original_answer": "GD determines the fair value of its Level 2 fixed-income securities using valuation models that incorporate observable inputs such as quoted prices for similar assets and broker/dealer quotes. Similarly, BA values its available-for-sale debt investments using broker/dealer quotes for identical or comparable instruments. Both companies rely on these observable inputs through third-party pricing services and industry-standard models, indicating a parallel approach in determining fair value for Level 2 assets, despite being in different industries.",
      "llm_answer": "Gilead’s Level 2 assets (fixed‑income securities and commingled funds) are valued with valuation models that use broker‑dealer quotes as observable inputs, allowing the company to estimate fair value directly from current market prices and spreads. Boeing, by contrast, estimates fair value for its available‑for‑sale debt investments by reviewing trading activity and pricing and applying third‑party pricing services, which rely on observable market data but do not explicitly use broker‑dealer quotes. Consequently, Gilead’s method provides a more direct market‑based input for Level 2 valuations, potentially reducing estimation uncertainty relative to Boeing’s approach.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the companies' valuation approaches. The original answer states that both GD (Gilead Sciences) and BA (Boeing) use broker/dealer quotes in their valuation models for Level 2 assets, indicating a parallel approach. However, the LLM incorrectly claims that Boeing does *not* explicitly use broker/dealer quotes, which contradicts the ground truth. This misrepresents BA's methodology and creates a false distinction between the two companies' approaches. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no calculations or figures to verify. The score of 10 reflects that no numerical errors were introduced. (3) The multi-hop reasoning is flawed: the question asks for a comparison between GD and BA’s use of valuation models incorporating broker/dealer quotes. The LLM fails to correctly synthesize this cross-company information, incorrectly differentiating their methods when the ground truth emphasizes their similarity. The claim that Gilead’s method is 'more direct' and 'reduces estimation uncertainty' introduces unsupported comparative judgment not present in the original data. (4) Contextual relevance is moderate because the answer addresses the general topic of fair value determination using broker quotes and third-party services, but the incorrect characterization of Boeing’s approach undermines the validity of the comparison. The core conclusion—that the approaches differ—is factually wrong per the ground truth, which states they are 'parallel.' Thus, despite correct entity names and general context, the substantive answer is incorrect, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 471,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the current zero percent setting of the Countercyclical Capital Buffer (CCyB) impact the total capital buffer requirements for both Morgan Stanley and American Express under Basel III, considering Morgan Stanley's inclusion of the Stress Capital Buffer (SCB) in its Advanced Approach calculation and American Express's explicit subjectivity to the SCB?",
      "original_answer": "Under the current zero percent Countercyclical Capital Buffer (CCyB), Morgan Stanley's total capital buffer requirement under the Advanced Approach includes the 2.5% Capital Conservation Buffer (CCB), the G-SIB capital surcharge, and the Stress Capital Buffer (SCB). American Express is also subject to the SCB under Basel III, which contributes to its minimum capital requirements. Since the CCyB is currently set at zero, neither firm is required to add additional capital under this buffer. Therefore, the SCB plays a key role in both firms’ capital planning and distribution constraints, despite differing regulatory calculation approaches.",
      "llm_answer": "The Federal Reserve’s zero‑percent CCyB means that neither firm has to hold any countercyclical buffer.  \nMorgan Stanley’s Advanced‑Approach buffer requirement is therefore 5.5 % (2.5 % capital‑conservation buffer + 3.0 % G‑SIB surcharge + 0 % CCyB), while American Express’s buffer is the SCB (subjective) plus the G‑SIB surcharge and capital‑conservation buffer, with no CCyB component.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several issues that affect its factual accuracy and completeness. (1) Quantitatively, the LLM incorrectly states Morgan Stanley's total buffer as 5.5% by summing 2.5% CCB + 3.0% G-SIB surcharge, implying this is the full Advanced Approach buffer. However, the ground truth emphasizes the inclusion of the Stress Capital Buffer (SCB), which is a critical component for Morgan Stanley under the Advanced Approach. The SCB is not a fixed 0% or negligible value—it is a binding constraint that varies annually based on stress test results and must be included in the total buffer. Omitting it and replacing it with a fixed 3.0% G-SIB surcharge (which itself may not be accurate for the relevant year) introduces significant error. (2) For American Express, the LLM mentions the SCB as 'subjective' and includes G-SIB and CCB, but fails to clarify that the SCB is a formal, binding requirement set annually by the Federal Reserve—not subjective in the sense of being discretionary or optional. The term 'subjective' is misleading and incorrect in this regulatory context. (3) The LLM correctly notes that the CCyB is zero and thus adds no requirement, which aligns with the ground truth. (4) Qualitatively, the reasoning is partially sound—multi-hop elements (CCyB impact, SCB applicability to both firms) are recognized—but the synthesis is flawed due to incorrect treatment of the SCB as an optional or unspecified component rather than a core, quantitatively significant buffer. (5) Contextually, the answer is relevant and addresses the regulatory frameworks for both firms, but misses the key point that the SCB, not a fixed G-SIB percentage, is the dynamic component shaping capital distribution limits. The ground truth emphasizes the SCB's role in capital planning; the LLM downplays it. Overall, some core facts are present (CCyB = 0%, CCB = 2.5%), but major omissions and misrepresentations of the SCB and total buffer composition reduce correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 530,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the $4.0 billion increased commitment under AMT's 2021 Credit Facility relate to its financing strategy for acquisitions, and how does this contrast with SPG's approach to financing through joint ventures as of December 31, 2021?",
      "original_answer": "AMT increased the commitment under its 2021 Credit Facility to $4.0 billion, which was used to finance acquisitions such as the CoreSite Acquisition, reflecting a strategy of leveraging large-scale credit facilities for major transactions. This contrasts with SPG's approach, where it provided $88.4 million in financing to joint ventures primarily in the form of interest-bearing construction loans, indicating a focus on internal financing and partnership structures to support real estate development and diversify risk.",
      "llm_answer": "AMT’s $4.0 billion increase in the 2021 Credit Facility (amended on December 8 2021) was part of a broader expansion that allowed the company to draw on a $4.0 billion revolving line to fund acquisitions such as the CoreSite and Telxius deals and to refinance existing debt (see AMT 10‑K, pp. 109‑112).  By contrast, as of December 31 2021 SPG financed its development and acquisition activity through joint‑venture arrangements, providing $88.4 million of construction‑loan advances and equity‑method investments in partners, rather than relying on a single large credit facility (see SPG 10‑K, pp. 114‑118).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitative accuracy: All numbers and dates are correct — the $4.0 billion commitment increase and $88.4 million in joint venture financing are accurately reported, matching the original answer. The date of the amendment (December 8, 2021) is an additional precise detail not in the ground truth but consistent with likely source data. (2) Completeness: The answer addresses both parts of the multi-hop question — AMT’s use of its credit facility for acquisitions (specifically naming CoreSite and Telxius) and SPG’s contrasting use of joint ventures with construction loans and equity investments. (3) Entity accuracy: Both companies (AMT and SPG), financial instruments (credit facility, construction loans), and time frame (as of December 31, 2021) are correctly identified. (4) Reasoning: The contrast in financing strategies — AMT leveraging a large revolving credit facility versus SPG using joint ventures and internal financing — is logically synthesized and correctly interpreted. The mention of refinancing existing debt is an added detail not in the ground truth but does not contradict it; however, it slightly extends beyond the scope of the original answer’s focus on acquisitions, which prevents a perfect 10 on qualitative accuracy. (5) Semantic equivalence: The core meaning and factual content are equivalent to the ground truth, with slightly more detail on AMT’s use of funds. Overall, the answer demonstrates strong multi-hop reasoning across entities and documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 428,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the growth in Starbucks' store count in Taiwan compare to Nike's revenue contribution from the Greater China region, considering Taiwan's inclusion within Greater China's geographic reporting?",
      "original_answer": "Starbucks added 21 net new stores in Taiwan from fiscal year 2021 to 2022, reflecting a growth in its operational footprint. Meanwhile, Nike reported $7,547 million in total revenues from the Greater China region in FY2022, which includes Taiwan. This indicates that while Starbucks is expanding its physical presence in Taiwan, Nike's revenue from the broader Greater China region—which encompasses Taiwan—represents a significant portion of its global revenue, highlighting different modes of market engagement and performance metrics across the two companies.",
      "llm_answer": "Starbucks added 21 net stores in Taiwan in fiscal 2022 (from 523 to 544, a 4 % increase)【SBUX_10k_2022, licensed‑store table】.  Nike’s Greater China segment – which includes Taiwan – generated $7.5 billion in revenue that year【NKE_10k_2022, revenue by region table】.  Thus, the store‑count growth is a modest operational expansion, whereas the Greater China region contributed a substantial revenue figure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Starbucks added 21 net new stores in Taiwan from FY2021 to FY2022, increasing from 523 to 544 stores, which is a 4% increase—this aligns with the ground truth and is quantitatively accurate. The figure of $7.5 billion for Nike’s Greater China revenue in FY2022 matches the ground truth value of $7,547 million when rounded (i.e., $7.547 billion ≈ $7.5 billion), so the numeric representation is acceptable with standard rounding. (2) All numbers are correct: store counts (523 to 544 → net +21), percentage increase (~4%), and Nike's revenue ($7.5B vs $7.547B). The fiscal year is correctly identified as 2022 for both companies. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from two different companies (Starbucks and Nike), links Starbucks’ store growth in Taiwan to Nike’s revenue reporting for Greater China (which includes Taiwan), and draws a logical comparison between operational expansion (store count) and financial performance (revenue). (4) The answer is semantically equivalent to the original, though slightly more concise. It captures the core contrast between physical footprint growth and regional revenue contribution. The only minor shortcoming is that it does not explicitly note that Taiwan is included within Greater China in Nike’s reporting beyond implying it—however, the phrase 'Greater China segment – which includes Taiwan' suffices for clarity. Thus, all key elements are present and accurate, warranting a high score with only a slight deduction in qualitative accuracy due to less elaboration on the implications of the comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 450,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What percentage of Boeing's (BA) OPB plan assets are indirectly invested in equities through the balanced index fund, and how does this compare to the total fair value of equities held by 3M's (MMM) pension plan as of December 31, 2023?",
      "original_answer": "Boeing's OPB plan assets are approximately 60% invested in equities via the balanced index fund. Meanwhile, 3M's pension plan reported a total fair value of $785 million in equities as of December 31, 2023.",
      "llm_answer": "Boeing’s OPB plan invests roughly **60 % of its assets indirectly in equities** through the balanced index fund (the fund itself is about 60 % equities).  \nBy contrast, 3M’s U.S. pension plan held **$1,246 million** in equities at December 31 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that Boeing's OPB plan invests approximately 60% of its assets indirectly in equities through the balanced index fund, which matches the ground truth. This part is factually accurate and well-stated. However, the LLM reports that 3M’s pension plan held $1,246 million in equities as of December 31, 2023, while the ground truth states the correct amount is $785 million. This is a significant numerical discrepancy—$1,246 million is over 50% higher than the actual value—and constitutes a major quantitative error. The entity identification (Boeing/BA and 3M/MMM), metric (fair value of equities), and time period (December 31, 2023) are all correct, satisfying entity accuracy and contextual relevance. The reasoning structure is sound in that it addresses both parts of the multi-hop question and makes a valid comparison framework, but the incorrect dollar amount undermines the factual correctness. While the qualitative reasoning and structure are mostly correct, the large error in the 3M equity value reduces the overall correctness and quantitative accuracy scores. Semantic equivalence fails on the second part due to the incorrect number, even though the format ($X million) is acceptable.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1136,
        "completion_tokens": 344,
        "total_tokens": 1480
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does AMT's utilization of the 2021 USD Delayed Draw Term Loans for financing compare to SPG's use of financing mechanisms for real estate joint ventures, particularly in terms of dollar amounts and financing structure?",
      "original_answer": "AMT utilized the 2021 USD Delayed Draw Term Loans as part of a $10.5 billion financing structure to support the CoreSite Acquisition, ensuring funding availability without drawing on bridge loans. In contrast, SPG provided $88.4 million in financing to joint ventures through interest-bearing construction loans and other advances as of December 31, 2021, primarily to support real estate development and investment activities. While AMT's financing was large-scale and acquisition-focused, SPG's approach was smaller in scale and oriented toward real estate joint ventures.",
      "llm_answer": "American Tower used the 2021 USD Delayed‑Draw Term Loans as a large, long‑term corporate debt package – a $3 billion 364‑day loan and a $1.5 billion two‑year loan (totaling $4.5 billion) with interest at LIBOR plus margin, drawn to fund the CoreSite acquisition. In contrast, Simon Property Group’s joint‑venture financing is a modest, short‑term construction‑loan program – $88.4 million in interest‑bearing construction loans and advances to its joint‑venture partners to finance property development. Thus, AMT’s financing is a sizable, multi‑year unsecured term‑loan structure for acquisitions, whereas SPG’s is a relatively small, short‑term construction‑loan arrangement tied to joint‑venture development.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the total dollar amount of AMT's 2021 USD Delayed Draw Term Loans. The ground truth states a $10.5 billion financing structure, while the LLM reports only $4.5 billion ($3 billion 364-day loan + $1.5 billion two-year loan). This major discrepancy in a core quantitative figure undermines the factual accuracy. All other numbers are correct: SPG's $88.4 million in financing is accurately reported and correctly attributed to interest-bearing construction loans and advances as of December 31, 2021. (2) The calculation of AMT's total loan amount is incorrect — $3B + $1.5B = $4.5B, which does not match the ground truth $10.5B. There is no indication in the LLM answer of additional tranches or components that would justify the full amount, suggesting a failure in data retrieval or synthesis. (3) The qualitative reasoning and multi-hop synthesis are otherwise sound: the model correctly identifies AMT's financing as acquisition-focused (CoreSite) and large-scale, versus SPG's smaller-scale, development-oriented joint venture loans. The contrast in structure (long-term unsecured term loans vs. short-term construction advances) is accurately characterized. Entity accuracy is strong — both companies (AMT, SPG), the CoreSite acquisition, joint ventures, and time frame (2021) are correctly identified. (4) The contextual relevance is high, as the answer directly compares both companies' financing mechanisms in terms of amount and structure, addressing all parts of the question. However, the severe quantitative inaccuracy in AMT's financing amount limits the correctness score to 6, as this is a central element of the comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 466,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does XOM's reliance on crude oil as a raw material intersect with CVX's 15% ownership in the Caspian Pipeline Consortium, considering the volume of crude oil transported through CPC from Chevron's operations in Kazakhstan?",
      "original_answer": "XOM depends on crude oil as a core raw material for its operations. Meanwhile, CVX holds a 15% interest in the Caspian Pipeline Consortium (CPC), which transports an average of 1.4 million barrels of crude oil per day, with 1.2 million barrels sourced from Kazakhstan—specifically from fields like Tengiz and Karachaganak in which Chevron operates or holds stakes. This means that a portion of the crude oil CVX produces or co-produces in Kazakhstan relies on CPC for export, linking upstream production to midstream logistics. Since crude oil is essential for XOM’s business, any disruption in supply chains like CPC could impact the availability or cost of crude oil for companies downstream, including XOM.",
      "llm_answer": "XOM’s upstream segment is heavily dependent on crude oil, as reflected in the 2024 “Crude oil and product purchases” line item of $18.3 billion (U.S. portion) on pages 109‑113 of its 10‑K. Chevron’s 15 % ownership of the Caspian Pipeline Consortium (CPC) gives it a stake in the pipeline that moved an average of 1.2 million barrels of crude per day from its Kazakhstan operations in 2024 (CVX pages 14‑18). Thus, XOM’s raw‑material demand is linked to the same global supply chain that CVX’s CPC stake helps secure, underscoring the importance of pipeline infrastructure for delivering the large volumes of crude that feed U.S. refiners.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numbers and sourcing. The ground truth states that the CPC transports 1.4 million barrels per day, with 1.2 million barrels sourced from Kazakhstan—specifically from Chevron-operated fields. However, the LLM incorrectly states that '1.2 million barrels of crude per day' were moved from Chevron’s Kazakhstan operations in 2024, conflating total Kazakhstani volumes with Chevron’s share and misrepresenting the CPC’s total capacity. Additionally, the LLM cites a $18.3 billion 'Crude oil and product purchases' figure from XOM’s 10-K as evidence of crude oil reliance, but this line item includes refined products and is U.S.-only, making it a weaker proxy for raw material dependence than implied. This figure does not appear in the original answer and lacks verification against the ground truth. (2) The 15% ownership stake in CPC by CVX is correctly stated, and the general direction of reasoning—linking CVX’s infrastructure stake to global crude supply chains relevant to XOM—is valid. However, the quantitative backbone is flawed: the original specifies 1.4 million bpd total CPC volume (1.2 million from Kazakhstan), while LLM reverses the emphasis and assigns 1.2 million bpd directly to Chevron’s operations, which overstates CVX’s direct volume. (3) The multi-hop reasoning is partially sound: the model connects XOM’s crude dependence, CVX’s CPC stake, and Kazakhstan operations, but fails to accurately represent the flow of crude (e.g., Tengiz and Karachaganak fields) or clarify that CVX co-owns rather than solely operates all production. It also omits the explicit risk implication (supply chain disruption affecting XOM), weakening the synthesis. (4) Despite these issues, the answer remains contextually relevant and captures the high-level interdependence between upstream logistics and downstream demand. The qualitative logic is reasonable but undermined by key numerical inaccuracies, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 541,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the decommissioning funding shortfall risk at NEE's nuclear facilities compare to Duke Energy's exposure to nuclear decommissioning trust fund volatility, given the shared environmental and financial risks associated with nuclear power plant operations?",
      "original_answer": "NEE faces potential decommissioning funding shortfalls due to the risk that decommissioning costs could exceed the amount available in its decommissioning funds, which are subject to market and operational uncertainties. Similarly, Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida maintain Nuclear Decommissioning Trust Funds (NDTFs) whose values are subject to market fluctuations. A decline in the market value of these NDTF assets could significantly increase Duke Energy's funding requirements for decommissioning. Both companies are exposed to the financial risks of nuclear power plant decommissioning, with NEE highlighting potential shortfalls and Duke Energy emphasizing the impact of capital market performance on its NDTF investments.",
      "llm_answer": "NEE’s nuclear facilities face a decommissioning‑fund shortfall risk because the cost of decommissioning could exceed the amount held in its decommissioning funds (NEE, 2022, pp. 28‑32). Duke Energy’s exposure is to volatility in the market value of its nuclear decommissioning trust funds (NDTF), which could increase funding requirements if the assets decline (Duke Energy, 2022, pp. 33‑37). While both companies confront similar environmental and financial risks from operating nuclear plants, NEE’s risk is a direct potential shortfall in available funds, whereas Duke Energy’s risk is the potential need for additional funding due to market‑driven devaluation of trust‑fund assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the original (ground truth) answer. (1) All key facts are correct: NEE faces a risk of decommissioning funding shortfalls if costs exceed fund balances due to market and operational uncertainties (cited from NEE 2022, pp. 28–32), and Duke Energy’s exposure stems from market volatility affecting its Nuclear Decommissioning Trust Funds (NDTFs), potentially increasing funding needs (cited from Duke Energy 2022, pp. 33–37). These points match the original answer’s content. (2) There are no numeric values, percentages, or financial figures in either answer, so quantitative accuracy is not compromised; the absence of specific dollar amounts or percentages is consistent with the source material. (3) The multi-hop reasoning is sound: the model correctly identifies both companies’ distinct but related exposures—NEE’s focus on cost-to-fund imbalance and Duke Energy’s sensitivity to capital market performance—and synthesizes them under shared nuclear decommissioning risks. (4) The LLM slightly simplifies the original by not naming all Duke subsidiaries (Duke Energy Carolinas, Duke Energy Progress, Duke Energy Florida), but this does not detract from the overall accuracy, as the core risk mechanism is correctly attributed to Duke Energy broadly. Wording differs slightly but maintains semantic equivalence. Minor omission prevents a perfect 10, but the answer is highly accurate, relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 405,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does LOW's use of pricing models for Level 3 fair value measurements compare to GM's application of unobservable inputs in Level 3 valuations, particularly in light of the stated accounting policy that classifies valuations based on the observability of inputs?",
      "original_answer": "LOW applies pricing models to determine fair value for Level 2 assets and uses an income approach with significant unobservable inputs like volatility and expected term for its Level 3 contingent consideration related to the Canadian retail business sale. This aligns with the accounting policy that defines Level 3 valuations as those using significant unobservable inputs, often involving pricing models or discounted cash flow methodologies. GM similarly relies on unobservable inputs for Level 3 valuations, particularly in its GM Financial receivables, where static pool modeling and economic forecasts such as unemployment rates and GDP growth are used to estimate expected credit losses. Both companies follow the same accounting hierarchy but apply it differently depending on the nature of their assets and business operations.",
      "llm_answer": "LOW uses option‑pricing models for its Level 3 fair‑value measurement of contingent consideration, relying on unobservable inputs such as total equity value, volatility and expected term (LOW, Note 3, pp. 51‑55). GM, in contrast, applies unobservable inputs in Level 3 valuations of certain debt securities and other instruments when observable market data are unavailable, consistent with the hierarchy that classifies instruments by the observability of inputs (GM, Note 3, pp. 61‑65). Both companies therefore reserve Level 3 for instruments whose significant inputs are unobservable, but LOW’s example is a contingent‑consideration model, whereas GM’s is typically for debt securities or other instruments where discount rates and cash‑flow assumptions are not observable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that LOW uses option-pricing models with unobservable inputs (volatility, expected term, total equity value) for Level 3 fair value measurement of contingent consideration, which matches the original answer's reference to an income approach for the Canadian retail business sale. (2) It accurately states that GM applies unobservable inputs in Level 3 valuations for debt securities and other instruments, using discount rates and cash-flow assumptions, consistent with the ground truth mentioning static pool modeling and macroeconomic forecasts (e.g., unemployment, GDP) in GM Financial receivables. (3) The reasoning correctly synthesizes the multi-hop aspect by comparing how both companies apply Level 3 under the same accounting hierarchy based on input observability, while differing in application due to asset type—contingent consideration (LOW) vs. debt securities (GM). (4) No numeric inaccuracies are present; although no specific dollar amounts or percentages appear, the qualitative financial concepts (e.g., unobservable inputs, pricing models) are correctly applied. The only minor limitation is that the LLM omits explicit mention of 'income approach' and 'discounted cash flow methodologies' noted in the original, and does not reference GM Financial by name, slightly reducing completeness. However, the core facts, entities, and logic are correct, and the answer remains semantically equivalent. Thus, the correctness score is 9 due to high accuracy with minor contextual omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 438,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the $10.5 billion in committed financing under AMT's 2021 Multicurrency Credit Facility compare with SPG's financing activities in joint ventures, particularly in terms of capital deployment strategy and risk diversification?",
      "original_answer": "AMT secured $10.5 billion in committed financing through its 2021 Multicurrency Credit Facility and related facilities, which were used to fund acquisitions like CoreSite and Telxius, while SPG provided $88.4 million in financing to joint ventures primarily in the form of interest-bearing construction loans, aligning with its strategy to diversify risk and finance property development. This shows that AMT leveraged large-scale credit facilities for major acquisitions, whereas SPG used smaller, targeted financings to support joint venture operations and risk-sharing.",
      "llm_answer": "AMT’s $10.5 billion in committed financing under the 2021 Multicurrency Credit Facility (the JPM Bridge Loan Commitment that was fully terminated because of the $10.5 billion of available commitments across the facility, the 2021 Credit Facility, the 2021 Term Loan and the USD delayed‑draw term loans【AMT_10k_2022.pdf, pages 109‑112】) was used to fund large acquisitions (Telxius and CoreSite) and refinance existing debt, concentrating capital deployment in a few high‑value deals. In contrast, SPG’s joint‑venture financing is modest—$88.4 million in construction loans and advances to partners【SPG_10k_2022.pdf, pages 114‑116】—delivered on a project‑by‑project basis to a broad portfolio of properties, thereby spreading risk across many ventures and reducing concentration. Thus, AMT relies on a single, high‑capacity facility for concentrated capital deployment, while SPG employs smaller, diversified financing to support multiple joint‑venture projects.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $10.5 billion in committed financing for AMT and SPG's $88.4 million in joint-venture financing, matching the ground truth exactly in amount and context. All numeric values are accurate and properly attributed. (2) Quantitative accuracy is perfect: $10.5 billion for AMT’s facility and $88.4 million for SPG’s joint-venture loans are correctly cited, with no calculation errors. Format variations (e.g., $88.4 million vs $88.4 million) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound—LLM correctly synthesizes information across AMT and SPG filings, contrasting AMT’s use of large-scale financing for major acquisitions (CoreSite, Telxius) with SPG’s smaller, project-level construction loans to joint ventures. The strategic contrast in capital deployment (concentrated vs. diversified) and risk management (single facility vs. spread across projects) is logically derived and aligns with the ground truth. (4) Minor deduction in qualitative accuracy due to slightly more complex phrasing around the 'JPM Bridge Loan Commitment' and its termination, which, while factually present in the source, adds detail not essential to the core comparison and could distract from the main strategic contrast. However, this does not impair correctness. Contextual relevance is full—every part of the question (comparison of financing, capital deployment strategy, risk diversification) is addressed with precise, relevant information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 417,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does AMD's revenue exposure to Taiwan in 2023 compare to QCOM's operational dependency on foundry partners in Taiwan, given the geopolitical risks associated with the region?",
      "original_answer": "AMD reported $1,841 million in sales to external customers from Taiwan in 2023, indicating a notable but declining revenue exposure compared to previous years. Meanwhile, QCOM explicitly states that its business depends on consistent and reliable chipset supply from foundry partners, particularly in Taiwan. A significant or prolonged military or geopolitical conflict involving China and Taiwan could severely limit or prevent QCOM from receiving chipset supply, which would have a material adverse impact on its business. Given that both companies are exposed to Taiwan—AMD through revenue and QCOM through critical supply chain dependencies—geopolitical instability in the region poses a dual risk, impacting both revenue streams and manufacturing continuity.",
      "llm_answer": "AMD’s 2023 revenue from Taiwan was $1.84 billion, roughly 8 % of its $22.68 billion total revenue (see the geographic sales table).  Qualcomm, by contrast, is heavily dependent on Taiwan‑based foundry partners—primarily TSMC—for advanced‑node chip manufacturing, so its supply‑chain risk is concentrated in Taiwan and more directly tied to geopolitical tensions in the region.  Thus, while AMD’s revenue exposure to Taiwan is modest, Qualcomm’s operational reliance on Taiwan foundries represents a higher concentration of geopolitical risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: AMD's $1.84 billion in revenue from Taiwan in 2023 matches the ground truth ($1,841 million), and the total revenue of $22.68 billion is consistent with AMD's 2023 10-K. The 8% exposure is a correct approximation (1,841 / 22,680 ≈ 8.1%). (2) The entity accuracy is strong: both AMD and QCOM (Qualcomm) are correctly identified, with accurate references to Taiwan-based foundries, TSMC, and the nature of their respective exposures. (3) The reasoning is sound: the LLM correctly distinguishes AMD’s revenue exposure from Qualcomm’s supply chain dependency, synthesizing multi-hop information across business models and risk factors. It accurately infers that Qualcomm’s operational reliance poses higher geopolitical risk concentration, which is consistent with the original answer’s emphasis on supply disruption impact. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'declining exposure' trend for AMD noted in the ground truth, nor does it directly quote QCOM’s disclosure about material adverse impact from conflict—though the risk concentration point captures the essence. These omissions are minor and do not detract from the core factual accuracy. Semantic equivalence is maintained, and contextual relevance is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 381,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does the expected impact of the 15% global minimum tax under OECD's Pillar 2 on SBUX's consolidated financial statements compare to MCD's assessment, given the phased implementation timelines across jurisdictions?",
      "original_answer": "SBUX notes that the global minimum tax under Pillar 2 will not be effective for the company until fiscal 2025 and is not expected to result in a material impact on its consolidated financial statements. Similarly, MCD states that while numerous countries have enacted Pillar 2 with an effective date for taxable years beginning after December 31, 2023, it also does not expect a material impact on its consolidated financial statements. Both companies are monitoring regulatory developments and await further guidance, as the implementation of Pillar 2 varies across jurisdictions and could evolve over time.",
      "llm_answer": "Starbucks (SBUX) says the OECD’s 15 % global minimum tax under Pillar 2 will not be effective for the company until fiscal 2025 and is not expected to have a material impact on its consolidated financial statements. In contrast, McDonald’s (MCD) notes that the Pillar 2 minimum tax could materially affect its tax expense and earnings, but the impact will be phased in as jurisdictions adopt the rule—some jurisdictions effective in 2025 and others later.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies SBUX's fiscal 2025 timeline and non-material impact, which matches the ground truth. However, it incorrectly states that MCD expects a 'material' impact on tax expense and earnings, which directly contradicts the original answer where MCD explicitly states it does *not* expect a material impact—this is a critical factual error. (2) Quantitatively, the dates (fiscal 2025, post-2023 implementation) and the 15% rate are accurately referenced or implied, and no incorrect calculations are made, hence high quantitative accuracy. (3) The multi-hop reasoning fails in the comparison: the question asks how SBUX's impact compares to MCD's, and the ground truth shows both expect *non-material* impacts, making them aligned. The LLM incorrectly frames them as differing (SBUX non-material vs MCD potentially material), undermining the synthesis. (4) Contextual relevance is fair because the answer addresses Pillar 2, timelines, and jurisdictional phasing, but the core qualitative inaccuracy in MCD's assessment severely limits correctness. The answer would score higher if MCD's 'non-material' stance had been correctly reported.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 333,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does JPMorganChase's risk governance framework, which emphasizes firmwide ownership of risk assessment, influence its approach to stress testing methodologies compared to Goldman Sachs, which explicitly ties stress testing to capital adequacy assessments?",
      "original_answer": "JPMorganChase's risk governance framework emphasizes firmwide ownership of risk assessment, with Risk Management and Compliance functions overseeing risk identification and escalation across business lines and corporate functions. This structured governance leads to a comprehensive approach to risk, where stress testing is likely embedded within broader risk identification and mitigation processes. In contrast, Goldman Sachs explicitly uses stress testing to assess capital adequacy and quantify exposure to tail risks, performing firmwide stress tests regularly to evaluate vulnerabilities across financial and nonfinancial risks. The difference in emphasis—JPMorganChase’s governance-driven risk ownership versus Goldman Sachs’s scenario-based capital adequacy focus—suggests that while both firms use stress testing as a core risk tool, the integration and ultimate purpose of stress testing within their risk frameworks differ significantly.",
      "llm_answer": "JPMorgan Chase’s risk‑management framework gives each line of business and the IRM function firmwide ownership of risk identification and assessment, so stress‑testing is embedded in the overall risk‑assessment process but is not explicitly tied to capital adequacy.  In contrast, Goldman Sachs explicitly links its stress‑testing exercises to capital‑adequacy assessments, using the results to inform capital planning and regulatory capital requirements【JPM pages 91‑95】【GS pages 97‑101, 109‑113】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that JPMorgan Chase emphasizes firmwide ownership of risk assessment through business lines and the Independent Risk Management (IRM) function, leading to stress testing being embedded in the broader risk-assessment process. It also accurately states that Goldman Sachs explicitly ties stress testing to capital adequacy assessments, using results for capital planning and regulatory requirements—this matches the original answer’s core contrast. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable; however, the absence of any incorrect numbers or miscalculations supports a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in governance frameworks between two firms and links them to divergent stress testing purposes. The only minor shortcoming is that the LLM answer does not mention Goldman Sachs’ evaluation of nonfinancial risks or 'tail risks' as explicitly as the original, slightly reducing completeness in qualitative depth. (4) The answer is fully contextually relevant, directly addressing the comparative influence of governance models on stress testing methodologies. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the ground truth with only slight omission of detail on Goldman Sachs’ scope of stress testing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 411,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does XOM's asset exposure in Kazakhstan compare to CVX's financial stake in Tengizchevroil, considering CVX's equity ownership and loan contributions to the joint venture?",
      "original_answer": "XOM had $8,463 million in long-lived assets in Kazakhstan as of 2021, while CVX holds a 50% equity interest in Tengizchevroil (TCO), which operates in the same country. In addition to its equity stake, CVX provided a $4,500 million loan to TCO to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This indicates that CVX's financial exposure to Tengizchevroil in Kazakhstan includes both its proportional equity value and a significant direct loan, potentially exceeding the magnitude of XOM's reported asset base in the country when combined.",
      "llm_answer": "XOM’s long‑lived assets in Kazakhstan were $8.5 billion in 2021 (8,463 million dollars).  Chevron, by contrast, owns a 50 % equity interest in Tengizchevroil and has supplied a $4.5 billion loan to the joint venture.  Thus Chevron’s equity stake represents a larger exposure than XOM’s Kazakhstan assets, while its loan is roughly half that amount.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM correctly reports XOM's long-lived assets in Kazakhstan as $8.463 billion (rounded to $8.5 billion), CVX's 50% equity interest in Tengizchevroil, and the $4.5 billion loan to TCO. All numeric values, including amounts and percentages, are accurate and match the ground truth, earning full marks for quantitative accuracy. 2) However, the reasoning contains a significant flaw: it claims that 'Chevron’s equity stake represents a larger exposure than XOM’s Kazakhstan assets,' which is unsupported. The original answer does not state or imply that CVX's 50% equity value exceeds $8.463 billion—only that the combination of equity and the $4.5 billion loan *could potentially* exceed XOM's asset base. The LLM incorrectly asserts that the equity stake alone is larger, which is not verifiable from the data provided. 3) The multi-hop synthesis is partially sound—linking CVX's equity and loan to TCO in Kazakhstan and comparing total exposure to XOM's assets—but the conclusion overreaches by separating and ranking the equity stake independently without justification. 4) Contextual relevance is high as the answer addresses all entities and financial instruments in question, but the incorrect inference reduces qualitative accuracy. Correctness is docked to 7 because core facts are right, but the key comparative claim is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 371,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How might geopolitical tensions involving Taiwan impact both QCOM's chipset supply and NVDA's supply continuity, given their reliance on foundry partners operating in the region?",
      "original_answer": "QCOM's business depends on receiving consistent chipset supply from foundry partners, particularly in Taiwan, and a significant geopolitical conflict involving Taiwan could severely limit or prevent QCOM from receiving this supply, which would have a material adverse impact on its business. Similarly, NVDA notes that geopolitical tensions involving Taiwan and China, where it has critical suppliers, contract manufacturers, and assembly partners, could have a material adverse impact on its supply continuity. Both companies rely on foundry partners operating in Taiwan, and any disruption due to geopolitical instability could lead to supply constraints, affecting QCOM's ability to manufacture products and NVDA's ability to fulfill customer orders on time, ultimately harming their revenues and market positions.",
      "llm_answer": "QCOM’s risk‑factor discussion (pp. 33‑37) states that a prolonged China‑Taiwan conflict could “severely limit or prevent us from receiving chipset supply from Taiwan,” which would materially harm the business.  NVIDIA’s risk‑factor discussion (pp. 15‑19) notes that it relies on a small number of foundries—most notably TSMC in Taiwan—to manufacture its GPUs and other chips, and that geopolitical tensions could disrupt wafer production, jeopardizing supply continuity and delaying product launches.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core risks both QCOM and NVDA face due to geopolitical tensions involving Taiwan, with correct references to their reliance on foundry partners in the region. It correctly identifies that QCOM could face severe supply limitations from a China-Taiwan conflict, citing the material adverse impact—matching the original answer's key point. For NVDA, it accurately notes reliance on a small number of foundries, especially TSMC in Taiwan, and that geopolitical tensions could disrupt wafer production and delay product launches, which aligns with the original answer’s emphasis on supply continuity risks. All entities (QCOM, NVDA, TSMC, Taiwan) are correct, and no numerical data is misstated (quantitative accuracy is perfect, scoring 10). The qualitative accuracy is 9 because while the LLM captures the main multi-hop reasoning—linking geopolitical risk to foundry dependency and supply disruption—it omits some breadth from the original answer, such as NVDA’s reliance on assembly partners and contract manufacturers beyond just foundries, and the broader impact on fulfilling customer orders and market position. However, the core logic and synthesis across both companies are sound. Contextual relevance is full, as every part of the response directly addresses the question. Minor omission prevents a perfect 10, but the answer is factually strong and semantically equivalent in key aspects.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 397,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How might Southern Company's environmental compliance costs, driven by regulatory requirements, affect electricity demand from industrial customers, and how does this potential demand shift compare to Duke Energy's exposure to industrial customer demand volatility as outlined in their risk factors?",
      "original_answer": "Southern Company estimates that compliance with environmental regulations could result in increased costs that are recovered through regulated rates, but this may contribute to reduced demand for electricity and natural gas from industrial customers. Many of these industrial customers may also face their own compliance costs under the same environmental requirements, further reducing their energy consumption. Duke Energy, on the other hand, explicitly notes that declines in industrial production due to economic conditions will reduce electricity and natural gas consumption, directly impacting their revenues and cash flows. Both companies are exposed to industrial demand shifts, but Southern Company's exposure is tied to regulatory cost pass-through effects, while Duke Energy highlights direct economic sensitivity of industrial customers.",
      "llm_answer": "Southern Company notes that the significant costs of complying with federal and state environmental laws—such as air‑quality, water‑quality and coal‑ash‑management rules—may be recovered through regulated rates, and that “increased costs that are recovered through regulated rates could contribute to reduced demand for electricity and natural gas” (see pages 24‑28).  This suggests that higher compliance costs could prompt industrial customers to cut back on their electricity and gas usage, shifting demand downward.  In contrast, Duke Energy’s risk factors emphasize the *volatility* of industrial demand that stems from economic cycles and market conditions, rather than a direct regulatory‑cost trigger (see pages 25‑29); thus, Duke’s exposure is to unpredictable swings in industrial consumption, whereas Southern’s potential shift is a cost‑induced contraction.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: Southern Company's environmental compliance costs may be recovered through regulated rates but could reduce industrial demand due to cost pass-through effects; industrial customers may also face their own compliance costs, indirectly reducing demand. Duke Energy’s exposure is framed around economic volatility affecting industrial production and thus energy consumption. The LLM correctly identifies this distinction—Southern’s demand shift is regulatory-cost-induced, while Duke’s is economically driven. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either answer, so quantitative accuracy is not compromised; the LLM does not introduce any incorrect figures. (3) Multi-hop reasoning is sound: the model synthesizes risk factor disclosures from both companies, correctly contrasting the nature of industrial demand risk—cost-induced reduction vs. economic volatility—across two different regulatory and business contexts. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'cost-induced contraction' vs. 'regulatory cost pass-through effects'), the meaning is preserved. The only minor shortcoming is that the LLM does not explicitly mention that industrial customers themselves face compliance costs (a point emphasized in the original answer), which slightly weakens completeness. However, the core contrast between the two companies’ risk exposures is accurately captured, warranting a high correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 442,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the $9.9 billion notional amount of foreign exchange cash flow hedges used by NKE compare to MCD's foreign currency net asset exposures in managing cross-border financial risk?",
      "original_answer": "NKE utilizes $9.9 billion in notional foreign exchange cash flow hedges to manage transactional exposures from product costs, external sales, and other foreign currency-denominated assets and liabilities. These hedges, primarily in euros, Canadian dollars, Japanese yen, British pounds, and Chinese yuan, are designed to offset earnings fluctuations from currency movements. Meanwhile, MCD manages its foreign currency risk by maintaining diversified net asset exposures across a broad basket of currencies. While NKE actively hedges forecasted transactions and exposures through derivatives, MCD's approach focuses on balancing foreign currency assets and liabilities directly on its balance sheet, reflecting differing strategies to mitigate cross-border financial risk.",
      "llm_answer": "Nike’s $9.9 billion notional amount of foreign‑exchange cash‑flow hedges is roughly twice the size of McDonald’s total net‑asset exposure, which totals about $4.9 billion (AUD 1,479 m + GBP 1,149 m + PLN 636 m + CNY 334 m + HKD 226 m). This indicates Nike maintains a larger hedging program relative to its net‑asset exposure than McDonald’s does.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains major factual and quantitative errors. First, the claim that MCD's total net-asset exposure is $4.9 billion—calculated from AUD 1,479m, GBP 1,149m, PLN 636m, CNY 334m, and HKD 226m—is not supported by the original answer or any verifiable data in the ground truth. The original answer does not provide any numerical value for MCD’s net asset exposures, nor does it mention these specific currencies or amounts. Therefore, the $4.9 billion figure and the comparison that NKE’s $9.9 billion hedge is 'roughly twice' MCD’s exposure are entirely fabricated. This invalidates the core quantitative assertion. Second, the original answer describes a qualitative contrast in risk management strategies: NKE uses active cash flow hedging with derivatives, while MCD manages risk through balance sheet net asset positioning across currencies—without specifying amounts. The LLM incorrectly shifts focus to a numerical comparison that is not present or inferable from the ground truth. While the LLM correctly identifies that NKE uses $9.9 billion in foreign exchange hedges, it misrepresents MCD’s approach by introducing false data. The reasoning is flawed due to unsourced calculations and incorrect multi-hop synthesis—there is no evidence in the original answer to support summing those foreign currency amounts or converting them to $4.9 billion. Contextually, the answer is relevant in discussing cross-border risk management, but the invented numbers severely undermine accuracy. Semantic equivalence fails on the quantitative claim, though the general idea of differing strategies is aligned with the original. Overall, the answer is mostly incorrect due to hallucinated data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 460,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the exposure of The Coca-Cola Company through Coca-Cola HBC's operations in Ukraine compare to Procter & Gamble's direct reliance on Ukraine for its manufacturing and supply chain stability?",
      "original_answer": "The Coca-Cola Company relies on Coca-Cola HBC for bottling and distribution operations in Ukraine, which is part of a broader network contributing to 41% of Coca-Cola's global unit case volume through its top five bottlers. Meanwhile, Procter & Gamble reports that its Ukraine-related assets account for less than 1% of net assets, with potential risks including physical damage to its two manufacturing facilities in Ukraine and disruptions in raw material sourcing or product distribution. While Coca-Cola's exposure is indirect through a key bottler, P&G's exposure is more direct but smaller in scale, with both companies facing similar regional supply chain risks tied to geopolitical instability.",
      "llm_answer": "Coca‑Cola’s exposure to Ukraine is indirect and very small – Coca‑Cola HBC’s two manufacturing sites in Ukraine account for less than 1 % of Coca‑Cola’s consolidated net sales and earnings (see page 8 of the 10‑K). In contrast, Procter & Gamble’s 10‑K (pages 22‑26) notes a direct reliance on Ukrainian facilities for manufacturing and supply‑chain operations, indicating a more substantial exposure to the country’s risks. Thus, Coca‑Cola’s Ukraine exposure is comparatively minimal, whereas P&G’s reliance is considerably larger.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims Coca-Cola HBC’s two manufacturing sites in Ukraine account for less than 1% of Coca-Cola’s consolidated net sales and earnings, citing page 8 of the 10-K. However, the ground truth does not state this figure—instead, it notes that Coca-Cola HBC is part of a network contributing to 41% of Coca-Cola’s global unit case volume through its top five bottlers. There is no mention in the ground truth that Ukraine-specific operations account for less than 1% of Coca-Cola’s sales or earnings. This number appears fabricated or misattributed. Conversely, the LLM correctly states that P&G has direct reliance on Ukrainian facilities but incorrectly frames this as 'considerably larger' exposure, while the ground truth clarifies that P&G’s Ukraine assets are less than 1% of net assets—meaning its exposure is direct but small. Thus, the LLM reverses the correct comparative conclusion. (2) Quantitative accuracy is low: the <1% figure for Coca-Cola is unsupported by the ground truth and misrepresents the actual exposure metric (which is indirect via a major bottler contributing to 41% of volume across top bottlers, not Ukraine-specific). The claim about P&G’s exposure being 'larger' contradicts the ground truth that P&G’s exposure is small in scale. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize that while Coca-Cola’s exposure is indirect but through a strategically significant bottler network, P&G’s is direct but minimal in financial scale. Instead, it incorrectly infers that direct = larger exposure, missing the nuance in the original answer. (4) Contextual relevance is high—the answer addresses the comparison between Coca-Cola and P&G regarding Ukraine operations and attempts to use 10-K references. However, due to key factual and logical errors in quantitative data and comparative reasoning, the correctness score is low at 4, with moderate qualitative accuracy due to correct identification of entities and general risk themes.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 552,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What is the combined exposure of MET and BAC to commercial mortgage-backed securities (CMBS), and how does MET's fair value of CMBS compare to BAC's amortized cost for the same category as of December 31, 2023?",
      "original_answer": "MET's fair value exposure to CMBS was $4,551 million as of December 31, 2023, while BAC's amortized cost for commercial mortgage-backed securities was $10,922 million. The combined exposure of both companies to CMBS totals $15,473 million. MET's CMBS, as part of its Structured Securities portfolio, are reported at fair value, whereas BAC reports its CMBS at amortized cost, reflecting different accounting treatments for similar asset classes.",
      "llm_answer": "MET’s CMBS exposure is $10.909 billion (amortized cost) with a fair‑value of $10.435 billion as of December 31 2023. BAC’s CMBS exposure is not disclosed in the provided pages, so the combined exposure is $10.909 billion. MET’s fair‑value of CMBS ($10.435 billion) exceeds BAC’s amortized cost (not disclosed).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. It assigns MET a CMBS amortized cost of $10.909 billion and fair value of $10.435 billion, which contradicts the ground truth where MET's fair value is $4,551 million. It claims BAC's CMBS exposure is not disclosed, which is false—BAC's amortized cost is $10,922 million. The combined exposure is incorrectly stated as $10.909 billion instead of the correct $15,473 million. (2) All key numbers are wrong: MET's fair value should be $4,551 million, not $10.435 billion; BAC's amortized cost is $10,922 million, not 'not disclosed'. The sum of $15,473 million is completely missed. (3) The multi-hop reasoning failed: the model did not correctly identify or synthesize data for both companies from the knowledge base. It incorrectly attributes BAC's data to MET and omits BAC entirely. (4) Due to pervasive factual errors, incorrect calculations, and failure to address the question's core components, the scores are very low. The only partial relevance is that it attempts to discuss fair value vs amortized cost, but even this comparison is based on false data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 319,
        "total_tokens": 1524
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How do cyber intrusion risks at nuclear power plants impact the financial obligations and operational strategies of both Duke Energy and Southern Company, given their respective exposures to decommissioning trusts and compliance costs?",
      "original_answer": "Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida have significant obligations tied to decommissioning nuclear plants, with funded trusts subject to market fluctuations that could increase funding requirements if asset values decline. Southern Company's nuclear units, operated by Southern Nuclear, are subject to compliance costs related to cyber intrusion risks, which could increase licensing or security expenditures. Both companies face potential financial strain: Duke Energy may need to inject additional capital if decommissioning trusts underperform, while Southern Company could face higher operational costs due to mandatory cybersecurity standards and potential threats, both of which could materially affect their financial positions and cash flows.",
      "llm_answer": "Cyber‑intrusion threats at nuclear sites can trigger NRC‑mandated security upgrades, fines or shutdowns, forcing both Duke Energy and Southern Company to spend extra capital and operating dollars on compliance. For Duke Energy, such events could raise the funding needed for its nuclear decommissioning trusts if market values decline, while Southern Company faces comparable compliance costs and the risk of contributory payments that could exceed trust coverage. Consequently, both utilities must invest in stronger cyber and physical security and adjust their funding strategies to preserve regulatory compliance and financial stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All factual elements are correct: both Duke Energy and Southern Company face financial and operational impacts from cyber intrusion risks at nuclear plants. Duke's decommissioning trusts are exposed to market fluctuations, and Southern faces compliance and potential contributory costs. The LLM correctly identifies that cyber threats can lead to NRC-mandated upgrades, fines, or shutdowns, increasing capital and operating expenses. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) Multi-hop reasoning is sound: the model synthesizes cyber risks with financial obligations (decommissioning trusts for Duke, compliance for Southern) and correctly infers downstream impacts on funding strategies and financial stability. (4) Minor phrasing differences exist (e.g., 'contributory payments that could exceed trust coverage' is slightly less precise than the original's focus on Southern's operational compliance costs), but the core meaning and financial implications are preserved. The LLM captures the necessity for both companies to adjust security and funding strategies, aligning fully with the original answer’s intent and factual basis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 363,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does the treatment of dividend equivalents on unvested restricted stock units at HD influence the issuance of additional shares, and how does this compare to LOW's delivery of additional shares under its ASR agreements in fiscal 2021?",
      "original_answer": "At HD, dividend equivalents accrue on unvested restricted stock units and are paid out in the form of additional shares upon vesting. This mechanism increases the total number of shares ultimately delivered to employees. For example, HD's 2022 10-K shows that dividend equivalents are reinvested and paid out as additional shares when RSUs vest. This practice results in a higher share count over time, as unvested units continue to accrue dividends. In contrast, LOW delivered additional shares in the context of accelerated share repurchase (ASR) agreements. In fiscal 2021, LOW executed ASR agreements in Q1, Q4, and Q2, under which it received additional shares at settlement—0.2 million, 1.6 million, and 4 million shares respectively—depending on the final calculation of the stock price during the settlement period. Therefore, while HD's additional shares arise from reinvested dividend equivalents tied to employee compensation, LOW's additional shares are a byproduct of its capital return strategy through ASR agreements.",
      "llm_answer": "At Home Depot, dividend equivalents on unvested restricted‑stock units accrue and are paid out as additional shares on the vesting date, so each vesting event increases the number of shares issued. In contrast, Lowe’s 2021 accelerated‑share‑repurchase (ASR) agreements required the company to deliver extra shares at settlement; the ASR contracts in fiscal 2021 resulted in roughly 7.5 million additional shares being delivered to the financial institutions.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the mechanism at HD—dividend equivalents on unvested RSUs are paid out as additional shares upon vesting, increasing total shares issued—which aligns with the ground truth. However, the LLM makes a critical error regarding LOW’s ASR agreements: it states that Lowe’s *delivered* additional shares *to financial institutions*, which is the opposite of the correct direction. In reality, under ASR agreements, the company *receives* shares from the financial institution at settlement, not delivers them. This reverses the economic meaning and is a major factual error. (2) Quantitatively, the LLM aggregates the ASR share amounts (0.2M + 1.6M + 4M = 5.8M), but reports 'roughly 7.5 million', which is incorrect. The correct total is 5.8 million, so both the calculation and the number are wrong. The individual quarterly figures are not mentioned, further reducing precision. (3) The reasoning correctly distinguishes between HD’s employee compensation-related share issuance and LOW’s capital return mechanism, showing sound multi-hop synthesis in intent and structure. However, the reversal of share delivery direction in ASRs undermines the validity of the comparison. (4) Contextual relevance is high because the answer addresses both companies and both mechanisms, and uses appropriate financial terminology. The qualitative accuracy is moderate because core concepts are understood but key details are flawed. The correctness score is 6 due to partially accurate information with significant factual and numerical errors that affect interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 438,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does AT&T's use of sensitivity analyses in auditing its $67,854 million goodwill balance compare to Netflix's application of similar analyses in evaluating content amortization assumptions, given both companies are audited by the same firm?",
      "original_answer": "AT&T utilized sensitivity analyses to evaluate the goodwill impairment testing for its $67,854 million goodwill balance, focusing on assumptions like terminal growth rates and weighted average cost of capital. Netflix, on the other hand, applied sensitivity analyses to assess the impact of changes in estimated viewing patterns on content amortization, a key accounting estimate given its content licensing and production model. Both companies are audited by the same firm, which performed these sensitivity analyses as part of their audit procedures to evaluate the reasonableness and robustness of management’s assumptions in each case.",
      "llm_answer": "AT&T’s auditor performed independent sensitivity analyses on its $67,854 million goodwill balance, testing how changes in terminal growth rates, long‑term EBITDA margins and the weighted‑average cost of capital would alter the discounted‑cash‑flow valuation (see AT&T audit notes, pages 42‑46). Netflix’s auditor likewise ran sensitivity tests, but focused on the impact of variations in historical and forecasted viewing‑hour consumption on the amortization schedule of its content library (see Netflix audit notes, pages 38‑42). Thus, while both Ernst & Young use sensitivity analysis to evaluate the robustness of management’s key assumptions, AT&T applies it to goodwill impairment valuation and Netflix to content amortization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $67,854 million goodwill balance for AT&T is correctly stated, and no other numerical discrepancies exist. The formatting ($67,854 million) is acceptable and matches the original. (2) The LLM correctly identifies that both companies are audited by the same firm—Ernst & Young is implied by context and consistent with public knowledge—and explains that sensitivity analyses were applied in both cases, though to different accounting estimates: goodwill impairment for AT&T and content amortization for Netflix. (3) The reasoning is sound and reflects proper multi-hop synthesis: it contrasts the use of sensitivity analysis across two companies, linking the common audit firm and differing applications based on business models. The mention of specific audit note pages (42–46 for AT&T, 38–42 for Netflix) adds detail not in the ground truth but does not contradict it and may reflect additional data; however, since the original answer does not include page references, this extra detail doesn’t affect scoring negatively. (4) Minor deduction in qualitative accuracy due to slightly stronger emphasis on the auditor’s independence in performing analyses—while plausible, the original emphasizes evaluation of management’s assumptions rather than independent modeling. Still, the core message about testing key assumptions via sensitivity analysis is preserved. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 423,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does Mastercard's concern about disintermediation from fintech-developed payment platforms compare to Visa's strategic partnership approach with fintechs in the context of regulatory-driven competition in the digital payments ecosystem?",
      "original_answer": "Mastercard expresses concern that fintechs could develop platforms or networks that disintermediate them from digital payments, especially when sharing data under partnerships, which could give fintechs a competitive advantage. This aligns with the broader risk that fintechs may develop competitive products that replace Mastercard’s offerings. In contrast, Visa actively partners with fintechs and emphasizes leveraging local financial institutions and tailored solutions to maintain a competitive edge. Visa sees fintechs as both partners and potential competitors, but strategically integrates them into its 'network of networks' approach. The regulatory environment, particularly in the EEA with PSD2, exacerbates these dynamics by enabling third-party providers to route transactions away from traditional networks like Mastercard, while Visa adapts by strengthening partnerships to remain central in the evolving digital payments ecosystem.",
      "llm_answer": "Mastercard’s 2022 10‑K (pp. 29‑33) frames its strategy defensively, warning that fintech‑built platforms and regulations such as PSD2 could disintermediate its four‑party network and erode demand for its integrated products. In contrast, Visa’s 2022 10‑K (pp. 14‑18) adopts a collaborative stance, using programs like Fintech Fast Track, the Visa Everywhere Initiative and Fintech Partner Connect to embed fintech solutions into its ecosystem and capture new flows created by regulatory‑driven competition. Thus, while Mastercard focuses on protecting its intermediary role amid regulatory‑enabled competition, Visa seeks to partner with fintechs to stay competitive and leverage those same regulatory opportunities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Mastercard's defensive stance regarding disintermediation risks from fintech platforms and regulations like PSD2, and contrasts it with Visa's collaborative strategy through programs such as Fintech Fast Track, Visa Everywhere Initiative, and Fintech Partner Connect. These specifics are consistent with the original answer’s emphasis on Visa’s 'network of networks' integration approach. (2) There are no numeric values, dates, or financial figures in either answer that require verification—both reference the 2022 10-Ks, which is factually correct per the knowledge graph context. Format and citation (e.g., page numbers) are appropriately used and do not affect accuracy. (3) The multi-hop reasoning is sound: the model synthesizes strategic differences between Mastercard and Visa, links them to regulatory dynamics (PSD2 in the EEA), and correctly infers contrasting responses to fintech-driven competition. The only minor shortcoming is that the LLM answer does not explicitly state that Visa views fintechs as both partners *and* competitors—a nuance present in the original—but this does not undermine the overall correctness. (4) The answer is contextually precise, directly addressing the comparative strategic posture of both companies in light of regulatory-driven competition. Thus, while slightly less comprehensive than the ground truth in nuance, it remains factually and semantically equivalent on core content.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 419,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the expected impact of the 15% global minimum tax under Pillar 2 differ between MCD and SBUX, considering the OECD's framework and the earliest effective dates for implementation?",
      "original_answer": "MCD stated that while the global minimum tax under Pillar 2 was enacted in several countries with the earliest effective date for taxable years beginning after December 31, 2023, it does not expect a material impact on its consolidated financial statements. SBUX, on the other hand, noted that Pillar 2 will not be effective for the company until fiscal 2025 and also does not expect a material impact to its consolidated financial statements. The OECD's framework proposes a 15% global minimum tax applied on a country-by-country basis, and although many countries are incorporating Pillar 2 model rule concepts into domestic laws, differences in implementation timelines and domestic tax adjustments may affect the tax's impact on multinational companies like MCD and SBUX differently.",
      "llm_answer": "McDonald’s 10‑K (p. 18‑22) notes that the OECD’s 15 % Pillar 2 rule is already in force in some jurisdictions for taxable years beginning after Dec 31 2023, but the company “does not expect a material impact on its consolidated statements” and will simply monitor the situation. Starbucks’ 10‑K (p. 26‑30) states that the same rule will not be effective for the company until fiscal 2025 and is likewise “not expected to materially affect its consolidated financial statements,” with the earliest effective dates for countries on or after Dec 31 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: McDonald’s (MCD) does not expect a material impact from Pillar 2, which is effective in some jurisdictions for taxable years beginning after December 31, 2023; Starbucks (SBUX) will not be subject until fiscal 2025 and also does not expect a material impact. The 15% global minimum tax under OECD’s Pillar 2 is correctly cited. (2) Quantitative elements—percentages (15%), dates (Dec 31, 2023), and fiscal years (2025)—are all accurate and match the original answer. Format variations (e.g., 'Dec 31 2023' vs 'December 31, 2023') are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies, their respective implementation timelines, and their financial impact assessments. It captures the core difference in effective dates (immediate for MCD in some countries vs. 2025 for SBUX) and the commonality in expected impact (no material effect). (4) The only minor shortcoming is that the LLM omits a brief contextual note from the original about differences in domestic implementation affecting multinationals differently, which slightly reduces completeness in qualitative synthesis. However, the core comparison is fully accurate and relevant. Thus, the answer is factually excellent with near-perfect semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 390,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the capital adequacy position of BlackRock Institutional Trust Company (BTC) as of December 31, 2024, compare to American Express's (AXP) regulatory capital ratios, given both entities are subject to U.S. banking regulatory requirements?",
      "original_answer": "As of December 31, 2024, BlackRock Institutional Trust Company (BTC) exceeded its applicable capital adequacy requirements, including minimum Common Equity Tier 1 (CET1), Tier 1 leverage, and risk-based capital ratios. Similarly, American Express (AXP) met all capital requirements and maintained regulatory capital ratios above the thresholds to qualify as 'well capitalized' under Federal Reserve and OCC guidelines. Both entities are subject to U.S. banking regulatory capital requirements, with BTC regulated by the Office of the Comptroller of the Currency (OCC) and AXP supervised by the Federal Reserve and its subsidiary AENB also regulated by the OCC.",
      "llm_answer": "BlackRock Institutional Trust Company’s capital adequacy as of December 31 2024 is exceptionally strong – its Common Equity Tier 1 and Tier 1 capital ratios are 151.9 % of risk‑weighted assets and its total capital ratio is 153.2 %, far above the OCC’s minimums of 4.5 %–8 %. By contrast, American Express’s regulatory ratios are around 10–13 % for CET1, Tier 1 and total capital (with a 9.8 % leverage ratio), which are comfortably above the required minimums but roughly one‑tenth of BTC’s levels. Thus, while both entities are well‑capitalized under U.S. banking rules, BTC maintains a markedly higher capital cushion than AXP.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that both BTC and AXP exceeded regulatory requirements and were 'well capitalized,' but does not provide specific numerical capital ratios. However, the LLM asserts precise figures—151.9% for CET1 and Tier 1, and 153.2% for total capital for BTC, and 10–13% for AXP—which are not present in the original answer and are implausibly high (e.g., 151.9% CET1 is over 15 times higher than typical well-capitalized banks, which usually range from 10–15%). These numbers are likely fabricated or misinterpreted. (2) There are no calculations in the original answer to verify, but the LLM's comparison that BTC’s ratios are 'one-tenth of AXP’s levels' is factually backward and mathematically incorrect given the numbers cited. (3) The multi-hop reasoning is partially sound—both entities are correctly identified as being under U.S. banking regulation, with BTC regulated by the OCC and AXP by the Federal Reserve and OCC (via AENB)—but the synthesis is undermined by the invention of specific ratios not present in the source. (4) While the LLM captures the general idea that both firms are well-capitalized, it goes far beyond the original answer by introducing unsupported quantitative claims, leading to a low correctness and quantitative accuracy score. Contextual relevance is high because the structure and intent of the comparison are appropriate, and entities/timeframes are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 419,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the $88.4 million in construction loans provided by SPG to joint ventures compare to AMT's utilization of the 2021 Multicurrency Credit Facility for acquisitions, and what does this reveal about their respective financing strategies for growth?",
      "original_answer": "SPG provided $88.4 million in construction loans to joint ventures as of December 31, 2021, indicating a strategy of internally financing development through joint ventures. In contrast, AMT borrowed $7.8 billion under the 2021 Multicurrency Credit Facility, including €2.4 billion ($2.9 billion), to fund major acquisitions like the Telxius and CoreSite deals. This reveals that AMT pursued a more aggressive, acquisition-driven growth strategy backed by large-scale credit facilities, while SPG focused on smaller-scale development financing through joint venture partnerships.",
      "llm_answer": "SPG’s $88.4 million in construction loans to joint‑venture partners is a modest, project‑level financing that is recorded as deferred costs and other assets (SPG 10‑K, p. 114‑118). In contrast, AMT’s 2021 Multicurrency Credit Facility had an outstanding balance of $4.388 billion, of which a large portion was drawn to fund the Telxius and CoreSite acquisitions and refinance existing debt (AMT 10‑K, p. 50‑54, 109‑113). This contrast shows SPG’s preference for incremental, low‑leveraged joint‑venture financing, whereas AMT relies on a sizable, flexible credit line to support aggressive acquisition‑driven growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies SPG's $88.4 million in construction loans to joint ventures as of December 31, 2021 (implied by context), which matches the ground truth. However, it inaccurately states AMT’s outstanding balance under the 2021 Multicurrency Credit Facility as $4.388 billion, while the ground truth specifies that AMT borrowed $7.8 billion, including €2.4 billion ($2.9 billion), for acquisitions. The $4.388 billion figure may reflect a partial draw or net balance after repayments but is not equivalent to the total utilization for acquisitions emphasized in the original answer. This is a significant quantitative discrepancy. (2) The LLM omits the specific breakdown of AMT’s borrowing (€2.4 billion / $2.9 billion) and does not explicitly state the total $7.8 billion drawn, weakening the precision of the comparison. (3) The reasoning and synthesis are otherwise sound: the contrast between SPG’s joint-venture development financing and AMT’s large-scale acquisition-driven strategy is correctly interpreted and logically presented. The use of terms like 'aggressive acquisition-driven growth' and 'low-leveraged joint-venture financing' reflects accurate qualitative understanding. (4) Contextual relevance is high—the answer directly addresses the comparative financing strategies and draws appropriate inferences. The main deduction is for quantitative inaccuracy in representing the scale of AMT’s credit facility utilization, though the core strategic interpretation remains valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 418,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the $0.5 billion interest rate swap held by CSCO to hedge its fixed-rate senior notes compare with AVGO's exposure to $56.3 billion in fixed-rate senior notes in terms of sensitivity to interest rate fluctuations?",
      "original_answer": "CSCO uses a $0.5 billion interest rate swap to hedge a portion of its fixed-rate senior notes, converting the fixed interest rate to a floating rate based on SOFR, thereby reducing interest rate risk for that specific liability. In contrast, AVGO holds $56.3 billion in fixed-rate senior notes as of November 3, 2024, and a 50 basis point interest rate increase would decrease the fair value of these notes by $1.7 billion. This indicates that AVGO has significant interest rate exposure on its fixed-rate debt, while CSCO has mitigated part of its exposure through active hedging.",
      "llm_answer": "CSCO’s $0.5 billion interest‑rate swap is a fair‑value hedge that converts the fixed‑rate portion of its senior notes to a floating rate, effectively offsetting changes in the debt’s fair value and neutralizing sensitivity to rate moves for that $0.5 billion. In contrast, Broadcom’s $56.3 billion of fixed‑rate senior notes would see its fair value shift by roughly $1.7 billion for a 50‑basis‑point change in market rates, indicating a large and still‑significant exposure to interest‑rate fluctuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: CSCO's $0.5 billion interest rate swap hedges part of its fixed-rate senior notes by converting fixed to floating rates (based on SOFR, though not explicitly named in LLM answer, 'floating rate' is sufficient), and AVGO's $56.3 billion in fixed-rate senior notes would lose $1.7 billion in fair value with a 50 bps rate increase. These numbers match the original answer exactly. (2) Quantitative accuracy is perfect: $0.5 billion, $56.3 billion, and $1.7 billion are all correctly reported; the 50-basis-point sensitivity is accurately described. (3) The multi-hop reasoning is sound—comparing CSCO’s hedging strategy to AVGO’s unhedged exposure is correctly synthesized across entities and financial instruments. The LLM correctly infers that CSCO has neutralized interest rate sensitivity for the hedged portion, while AVGO remains exposed. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly name SOFR as the floating rate benchmark (though this is a small omission), and slightly less contextual detail on the purpose of the hedge (e.g., 'reducing interest rate risk' is implied but not stated). However, the core logic and comparison are intact. Contextual relevance is full—every part of the question is addressed with precise, relevant information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 388,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the use of option contracts by NKE to hedge foreign currency exposures compare to TSLA's exposure to foreign currency assets, given the impact of such hedging instruments on deferred gains and losses in other comprehensive income?",
      "original_answer": "NKE actively uses option contracts as part of its foreign currency risk management program to hedge exposures from product costs, external sales, and other costs, with $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024. These contracts are designated as cash flow hedges, with mark-to-market gains and losses deferred in AOCI, including $99 million in net deferred gains expected to mature in the next twelve months. In contrast, TSLA does not typically hedge foreign currency risk and instead experiences significant fluctuations in foreign exchange gains and losses from period to period, particularly on intercompany balances, which flow through 'Other income (expense), net.' This highlights a more proactive hedging strategy by NKE versus TSLA’s reactive exposure to foreign currency assets.",
      "llm_answer": "Nike’s foreign‑exchange program uses option (and forward) contracts to hedge a portfolio of exposures, with a $9.9 billion notional amount in 2024.  The mark‑to‑market gains and losses on those hedges are deferred in AOCI (a $97 million OCI gain in 2024) and reclassified to earnings (about $472 million) when the hedged transaction occurs.  Tesla, by contrast, hedges the value of its foreign‑currency‑denominated assets and liabilities with forward contracts; the fair‑value changes of those hedges are also recorded in OCI and subsequently reclassified to earnings, but the disclosure does not provide the dollar magnitude of the exposure or the OCI impact in the excerpt.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and misrepresents key aspects of both NKE and TSLA's foreign currency hedging practices, despite capturing some correct elements. (1) Quantitatively, the $9.9 billion notional amount for NKE is correct, aligning with the ground truth. However, the LLM states a $97 million OCI gain in 2024, whereas the original answer specifies $99 million in net deferred gains expected to mature in the next twelve months — a close but incorrect figure. More critically, the LLM claims $472 million is 'reclassified to earnings,' which is unsupported by the ground truth and appears fabricated; the original answer does not mention any reclassification amount. (2) The qualitative error is significant: the LLM incorrectly asserts that Tesla hedges foreign currency assets/liabilities with forward contracts and records those in OCI, directly contradicting the ground truth that TSLA does *not* typically hedge foreign currency risk and instead recognizes FX gains/losses in 'Other income (expense), net.' This mischaracterization undermines the core comparison. (3) The multi-hop reasoning fails because the LLM does not correctly contrast NKE’s proactive cash flow hedging (with AOCI deferral) versus TSLA’s lack of hedging and direct income statement volatility. Instead, it falsely attributes a similar hedging program to TSLA, leading to an invalid comparison. (4) Contextual relevance is moderate — the structure addresses the question’s intent and discusses both companies and OCI impacts — but the factual foundation is flawed. Overall, the answer is partially correct on NKE but fundamentally wrong on TSLA, resulting in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 459,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does Boeing's use of Citibank, N.A. as administrative agent in its Five-Year Credit Agreement compare with Caterpillar's use of Citibank in its 5-Year Facility, particularly in terms of Citibank's role and the amendment timelines?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, and amended on August 25, 2022, lists Citibank, N.A. as the administrative agent. Similarly, Caterpillar's Third Amended and Restated Credit Agreement (5-Year Facility), dated September 1, 2022, also names Citibank, N.A. as the Agent. Both companies rely on Citibank in a leadership capacity—Boeing in a dual role as administrative agent and joint lead arranger, and Caterpillar as Agent. Boeing’s amendment occurred in August 2022, while Caterpillar’s Amendment No. 1 to the 5-Year Facility was dated August 31, 2023, showing staggered but comparable timelines for credit agreement adjustments.",
      "llm_answer": "Boeing’s Five‑Year Credit Agreement names Citibank, N.A. as the **administrative agent** and the agreement was amended on **25 Aug 2022**.  \nCaterpillar’s 5‑Year Facility lists Citibank, N.A. as the **agent** (not the administrative agent) and the facility was amended on **31 Aug 2023**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key factual aspects. (1) Quantitative accuracy: The dates of amendments—August 25, 2022, for Boeing and August 31, 2023, for Caterpillar—are correct. Citibank, N.A.'s roles are correctly identified: as administrative agent for Boeing and as agent for Caterpillar. (2) The answer correctly notes the distinction in titles (administrative agent vs. agent), which aligns with the original answer’s observation that Caterpillar refers to Citibank as 'Agent' while Boeing uses the more specific 'administrative agent'—and even adds value by clarifying that it's not the same title, which is a subtle but accurate point. (3) Multi-hop reasoning: The LLM successfully synthesizes information across two companies and their respective credit agreements, correctly comparing roles and amendment timelines. (4) Completeness: The answer addresses both parts of the question—Citibank’s role and amendment timelines—though it omits Boeing’s dual role as joint lead arranger, which is mentioned in the ground truth. This is a minor omission that slightly reduces completeness but does not affect the core correctness. Semantic equivalence is maintained. Overall, the response is concise, factually precise, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 359,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the difference in voting rights per share between Netflix's common stock and Meta's Class B common stock compare, given the structure of voting rights tied to different stock classes as disclosed by both companies?",
      "original_answer": "Netflix's common stock provides one vote per share, while Meta's Class B common stock provides 10 votes per share, reflecting a significant disparity in shareholder voting power between the two companies' stock structures.",
      "llm_answer": "Netflix’s common stock is entitled to **one vote per share** (see the “Voting Rights” section on pages 58‑62 of its 10‑K).  \nMeta’s Class B common stock carries **ten votes per share** (see the “Class A and Class B Common Stock” section on pages 1‑5 of its 10‑K).  \nConsequently, each Meta Class B share has **nine additional votes**—or ten‑times the voting power—compared with a Netflix share.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the voting rights per share are accurately reported: Netflix's common stock has 1 vote per share, and Meta's Class B common stock has 10 votes per share. The comparison stating that Meta Class B shares have 'nine additional votes' and 'ten-times the voting power' is mathematically and factually accurate. (2) The answer is complete, addressing both companies' voting structures and directly comparing them as required by the question. (3) Entities are correctly identified—Netflix and Meta (not confused with other firms), and the correct stock classes (common stock for Netflix, Class B for Meta) are referenced. (4) The reasoning is sound and demonstrates proper multi-hop synthesis: it pulls data from two different 10-K filings, correctly interprets the voting rights structures, and draws a valid comparative conclusion. Minor wording differences (e.g., 'ten-times the voting power' vs 'significant disparity') do not affect semantic equivalence—the core factual content and intent match the original answer exactly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 316,
        "total_tokens": 1490
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does BMY's reliance on Cardinal Health for 23% of its distribution in 2023 intersect with CVS’s financial consolidation of Red Oak Sourcing, given Cardinal Health’s 50% ownership stake in the same generic pharmaceutical sourcing entity?",
      "original_answer": "BMY relies on Cardinal Health, Inc. for 23% of its distribution network as of 2023, making Cardinal a critical third-party logistics partner. At the same time, CVS co-owns Red Oak Sourcing, LLC with Cardinal Health (each holding a 50% stake), and consolidates Red Oak’s operations into its financial statements due to its role as the primary beneficiary. This creates a complex interdependency where BMY’s supply chain is partially dependent on a company (Cardinal Health) that is structurally and financially tied to CVS through Red Oak Sourcing. The quarterly payments from Cardinal to CVS, totaling $183 million annually, influence CVS’s cost of goods sold, which could indirectly affect the pricing or efficiency of Cardinal’s distribution services to BMY.",
      "llm_answer": "BMY’s 2023 distribution mix shows that Cardinal Health handled roughly 23 % of its sales, a commercial distribution relationship disclosed in BMY Note 2 (pages 78‑82). CVS consolidates Red Oak Sourcing because it is the primary beneficiary of that VIE, in which Cardinal Health owns 50 % (see CVS Note 18, pages 18‑22 and 134‑138). Thus, Cardinal Health is a distributor for BMY and a 50 % partner in a sourcing entity that CVS consolidates, but the two arrangements are independent and do not directly affect each other’s financial reporting.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative facts: BMY’s 23% distribution reliance on Cardinal Health in 2023 and the 50% ownership stake of Cardinal Health in Red Oak Sourcing, as well as CVS’s consolidation of Red Oak due to being the primary beneficiary. These numbers and ownership percentages match the ground truth exactly, earning full marks for quantitative accuracy. The citations to specific notes and page ranges (e.g., BMY Note 2, CVS Note 18) add precision and suggest alignment with source documents. However, the qualitative reasoning is significantly flawed in its conclusion. The LLM asserts that the two arrangements are 'independent and do not directly affect each other’s financial reporting,' which contradicts the ground truth’s emphasis on the 'complex interdependency' between the entities. The ground truth highlights that CVS’s consolidation of Red Oak and the $183 million in annual payments from Cardinal to CVS impact CVS’s cost of goods sold, which could indirectly influence Cardinal’s distribution services to BMY. This indirect financial linkage is a critical part of the multi-hop synthesis that the LLM fails to acknowledge. While the LLM correctly identifies the entities and relationships, it misses the nuanced implication of these structural ties, resulting in a partially correct but incomplete analysis. The answer is contextually relevant and addresses the core entities and relationships, but the reasoning downplays the interconnectedness that the question specifically asks to explore. Thus, the correctness score is reduced due to this significant omission in synthesis, despite accurate data reporting.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 451,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does MetLife's exposure to interest rate scenarios in its Retirement and Income Solutions segment affect its Life Insurance product line, and how does this compare to AIG's experience with Life Insurance reserve updates under similar interest rate dynamics?",
      "original_answer": "MetLife's Retirement and Income Solutions segment includes life insurance products and is exposed to interest rate scenarios that could compress gross margins due to minimum crediting rate guarantees and reinvestment risks. In declining rate environments, this leads to margin compression, while rising rates allow for reinvestment in higher-yielding assets. Similarly, AIG experienced a $106 million favorable impact in 2021 from actuarial assumption updates in Life Insurance, driven by policy fee modeling, but also faced margin pressures from lower projected investment earnings. Both companies show sensitivity in their Life Insurance lines to interest rate dynamics, with MetLife managing through ALM strategies and AIG adjusting reserves and assumptions.",
      "llm_answer": "MetLife’s RIS segment’s exposure to interest‑rate scenarios mainly influences the discount rates used for its Life‑Insurance reserves, but because those reserves are set on a lock‑in basis and only updated during loss‑recognition events, the impact is limited to periodic adjustments rather than continuous changes (MetLife 10‑K, pp. 59‑63, 182‑186). In contrast, AIG’s Life‑Insurance reserves are more directly sensitive to interest‑rate dynamics: lower projected investment earnings in 2021 produced a $106 million favorable impact on reserves, while higher mortality assumptions in 2020 increased reserves by $101 million, illustrating a more immediate adjustment to interest‑rate shifts (AIG 10‑K, pp. 132‑136).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AIG's $106 million favorable impact in 2021 from actuarial updates, matching the ground truth. However, it incorrectly attributes this to 'lower projected investment earnings'—the ground truth states the favorable impact was due to 'policy fee modeling,' while lower investment earnings caused margin pressure, not reserve increases. This misrepresents the cause-effect relationship. Additionally, the LLM introduces a $101 million reserve increase for AIG in 2020 due to higher mortality, which is factually accurate per AIG’s 10-K but not mentioned in the original answer and not directly tied to interest rate dynamics, thus adding extraneous information that shifts focus. (2) Quantitatively, the $106 million figure is correct in amount and year. No calculations are required, so numerical accuracy is high. The $101 million figure is accurate in isolation but not relevant to the interest rate comparison asked. (3) The multi-hop reasoning is partially sound: the LLM correctly contrasts MetLife’s lock-in reserve methodology with AIG’s more dynamic assumptions. However, it fails to mention MetLife’s exposure through minimum crediting rate guarantees and reinvestment risks—key elements in the ground truth—and omits MetLife’s use of ALM strategies. Instead, it overemphasizes accounting mechanics (discount rate lock-in) without linking to product-level margin impacts. (4) Contextual relevance is strong as the answer addresses both companies and interest rate sensitivity, but qualitative accuracy suffers due to misattribution of AIG’s reserve drivers and omission of key MetLife risk factors. The answer captures structural differences in reserve sensitivity but misses the core financial implications on margins and product lines as described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 495,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What specific battery supply agreements exist between Tesla and Panasonic Corporation, and how do these agreements compare to known battery sourcing dependencies reported by General Motors?",
      "original_answer": "Tesla has multiple agreements with Panasonic Corporation for battery supply, including the 2011 Supply Agreement, its 2019 and 2021 Pricing Agreements for Japan-sourced cells, and the 2020 Pricing Agreement for Gigafactory 2170 cells. These agreements are supported by ongoing amendments, investment letters, and shared facility leases that indicate a deep strategic partnership. In contrast, General Motors’ filings only state a general dependency on batteries without specifying agreements or suppliers, making Tesla’s battery sourcing strategy with Panasonic more explicitly defined and contractually secured.",
      "llm_answer": "Tesla’s 10‑K discloses a long‑term supply agreement with Panasonic Corporation dated October 5 2011, followed by an amendment dated October 29 2013, a 2014 agreement, a 2014 general‑terms and conditions, a 2016 amendment to the Gigafactory general terms, an amended and restated general‑terms and conditions dated June 10 2020, a production‑pricing agreement, and pricing agreements for 2019, 2020 and 2021 that cover cell production at the Nevada Gigafactory and Japan cells. In contrast, GM’s battery sourcing is largely dependent on its joint venture Ultium Cells Holdings LLC—a partnership with LG Energy Solution—and the company has a battery‑supply agreement with LG Energy Solution to provide Ultium cells for its Ultium platform, indicating a more centralized sourcing strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies Tesla's long-standing agreements with Panasonic, including the 2011 Supply Agreement and subsequent amendments and pricing agreements (2019, 2020, 2021), as well as references to Gigafactory production and Japan-sourced cells, which aligns partially with the ground truth. However, it introduces specific dates (e.g., October 5, 2011; October 29, 2013) and documents (e.g., 2014 general terms, 2016 amendment) not present in the original answer, which lacks such granular detail—this over-specification introduces factual uncertainty not supported by the ground truth. The original answer emphasizes the strategic nature of Tesla-Panasonic agreements through investment letters and shared leases, which the LLM omits. Regarding General Motors, the LLM incorrectly states that GM has a battery supply agreement with LG Energy Solution for Ultium cells and highlights a joint venture with LG, whereas the ground truth explicitly states GM’s filings report only a general dependency on batteries without specifying agreements or suppliers. This is a significant factual error: the LLM fabricates a specific supplier relationship (LG) and joint venture (Ultium Cells Holdings LLC) not acknowledged in the ground truth, which undermines the comparison. While the LLM attempts multi-hop reasoning by contrasting Tesla’s explicit contracts with GM’s sourcing, the comparison is flawed due to incorrect GM information. Quantitative accuracy is moderate—dates mentioned may be real but are not in the source answer, so they cannot be verified as relevant. The core issue is qualitative: the LLM invents entities and agreements beyond the knowledge graph, reducing factual reliability. Contextual relevance is high as it addresses the question structure and intent, but factual correctness is compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 493,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How does MDLZ's use of commodity futures, which are classified as Level 1 financial assets, compare to COST's disclosure about holding no Level 1 financial assets, in the context of their respective risk management strategies involving financial instruments?",
      "original_answer": "MDLZ actively uses commodity futures, which are categorized as Level 1 financial assets based on quoted market prices, as part of its hedging strategy to manage exposure to input cost fluctuations such as cocoa, sugar, and energy. In contrast, COST disclosed that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a different approach to financial risk management that does not involve exchange-traded futures. This contrast highlights that while MDLZ relies on Level 1 commodity futures for price risk mitigation, COST does not utilize such instruments in its financial strategy.",
      "llm_answer": "MDLZ uses exchange‑traded commodity futures (e.g., for cocoa, sugar, wheat) as part of its hedging program; these instruments are classified as Level 1 financial assets because they are quoted on active commodity exchanges (MDLZ, p. 92‑96). In contrast, COST discloses that it holds no Level 1 financial assets (COST, p. 49‑53), indicating that it does not rely on exchange‑traded commodity futures or listed options in its risk‑management strategy and likely uses other, non‑Level 1 instruments or less exposure to commodity price risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: MDLZ uses commodity futures (e.g., cocoa, sugar, wheat) classified as Level 1 due to exchange quotes, and COST discloses holding no Level 1 financial assets. The LLM correctly identifies the source documents (MDLZ pp. 92–96, COST pp. 49–53), which supports verifiability. (2) There are no numeric values, dates, or calculations in the question or answer that conflict with the ground truth; the absence of specific dates (e.g., COST’s August 28, 2022, disclosure date) is a minor omission but does not affect factual correctness since the core fact—COST holds no Level 1 assets—is preserved. (3) Multi-hop reasoning is sound: the model correctly contrasts MDLZ’s use of Level 1 commodity futures for hedging input costs with COST’s non-use of such instruments, inferring a difference in risk management strategies. (4) Semantic equivalence is strong: the LLM captures the essence that MDLZ relies on exchange-traded futures while COST does not, possibly using alternative methods or having less exposure. The only minor shortcoming is the slightly broader mention of 'wheat' (not in the original answer, which lists cocoa, sugar, energy), but this is consistent with MDLZ’s known hedging activities and does not constitute an error. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 394,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does the adoption of Rule 10b5-1(c) trading plans by Apple executives compare with Broadcom's use of similar plans in terms of volume and timing of potential stock sales?",
      "original_answer": "Apple executives Deirdre O'Brien and Jeff Williams entered into Rule 10b5-1(c) trading plans in August 2024, covering the sale of shares vesting between April 1, 2025, and October 1, 2026 (O'Brien) and up to 100,000 shares plus additional vesting shares through October 1, 2025 (Williams), with expiration dates in 2025 and 2026. Broadcom director Diane M. Bryant adopted a similar plan in September 2024, allowing for the sale of up to 15,000 shares of Broadcom common stock contingent on market price thresholds, expiring September 12, 2025. Both companies utilize Rule 10b5-1(c) plans to structure insider trading in compliance with SEC regulations, but Apple’s plans involve significantly larger volumes and longer time horizons.",
      "llm_answer": "Apple’s Rule 10b5‑1(c) plans cover a much larger potential sale and a longer vesting window than Broadcom’s.  Apple’s COO Jeff Williams entered a plan that permits the sale of up to 100,000 shares, with shares vesting from April 1 2025 to October 1 2025 and the plan expiring December 15 2025; Deirdre O’Brien’s plan covers shares vesting from April 1 2025 to October 1 2026 (no specific cap is disclosed) and expires December 31 2026.  In contrast, Broadcom’s board member Diane Bryant’s plan allows the sale of up to 15,000 shares and expires September 12 2025.  Thus Apple’s plans involve a larger volume and a longer timing horizon than Broadcom’s smaller, shorter‑term plan.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the key executives and director involved (Jeff Williams, Deirdre O'Brien at Apple; Diane Bryant at Broadcom), the adoption timing (August and September 2024), and the general structure of the Rule 10b5-1(c) plans. It accurately captures that Apple's plans involve larger volumes and longer time horizons compared to Broadcom's. However, there are minor but notable inaccuracies in dates and details: (1) The original answer states Williams' plan covers sales through October 1, 2025, and does not specify an expiration date of December 15, 2025—this date is not in the ground truth and appears to be fabricated or inferred incorrectly. (2) Similarly, O'Brien’s plan expiration is stated as December 31, 2026 in the LLM answer, but the original only specifies the vesting period ending October 1, 2026, with no explicit expiration date. (3) The LLM omits that Williams’ plan includes 'additional vesting shares' beyond the 100,000, which slightly understates the potential volume. (4) The LLM correctly reports Bryant’s 15,000-share limit and September 12, 2025 expiration. Despite these quantitative discrepancies, the qualitative comparison—Apple’s plans being larger in volume and duration—is sound and well-reasoned. The multi-hop synthesis across companies and executives is accurate and relevant. The answer is semantically close to the original and addresses the volume and timing aspects of the question. The core conclusion is valid, but the incorrect expiration dates and missing detail on additional vesting shares prevent a top score on quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 437,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does the involvement of JPMorgan Chase Bank, N.A. as syndication agent in both 3M's May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement reflect a shared banking relationship in their respective credit facilities?",
      "original_answer": "JPMorgan Chase Bank, N.A. serves as syndication agent in both 3M’s May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement, indicating a shared banking relationship where JPMorgan plays a key coordinating role in managing the syndicate of lenders for both companies’ credit facilities. This suggests that both companies rely on JPMorgan Chase Bank, N.A. to help structure and administer large-scale financing arrangements, potentially reflecting a strategic alignment in how they access syndicated credit markets.",
      "llm_answer": "JPMorgan Chase Bank, N.A. is named the syndication agent in both companies’ five‑year credit facilities. In 3M’s May 11, 2023 Five‑Year Credit Agreement (3M 10‑K, pp. 112‑116) and in Honeywell’s March 20, 2023 Amended and Restated Five‑Year Credit Agreement (Honeywell 10‑K, pp. 123‑127), the bank is listed as the syndication agent, coordinating the distribution of the loans to other lenders. This common role shows a shared banking relationship, with JPMorgan acting as the key coordinator for the syndication of both credit facilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) All key facts are accurate: JPMorgan Chase Bank, N.A. is correctly identified as the syndication agent in both 3M’s May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement. The dates, roles, and companies are all correct. (2) There are no numerical values requiring calculation in this question, but the dates (May 11, 2023 and March 20, 2023) are accurately cited, and the references to the respective 10-K pages (pp. 112–116 for 3M, pp. 123–127 for Honeywell) are consistent with the source data, supporting authenticity. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different companies’ credit agreements to identify the common role of JPMorgan Chase Bank, N.A., and draws the logical conclusion of a shared banking relationship. (4) The answer captures the core insight of the ground truth—that JPMorgan plays a coordinating role in both syndicated facilities—though it omits the slightly broader strategic implication mentioned in the original answer (e.g., 'strategic alignment in how they access syndicated credit markets'). This minor omission in depth prevents a perfect 10 on qualitative accuracy, but the response remains semantically equivalent in factual content. Overall, the answer is highly relevant, accurate, and correctly reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 396,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How might the EU and U.S. sanctions targeting the tobacco sector in Belarus impact Coca-Cola HBC's operations in the country, and what implications could this have for The Coca-Cola Company's overall unit case volume given its reliance on Coca-Cola HBC as a key bottler?",
      "original_answer": "The EU and U.S. sanctions targeting the tobacco sector in Belarus, including restrictions on trade of goods used for tobacco production, could disrupt local supply chains and economic activity, potentially affecting Coca-Cola HBC's operations in the country. Since Coca-Cola HBC is a major independent bottler representing 41% of The Coca-Cola Company’s total worldwide unit case volume in 2021 and operates in Belarus, any operational constraints or economic instability in Belarus could reduce its production and distribution capacity. This, in turn, could negatively impact The Coca-Cola Company’s overall unit case volume, especially since non-U.S. markets accounted for 83% of the company’s total volume in 2021 and bottlers like Coca-Cola HBC are contractually required to purchase concentrates from KO, forming a critical link in the supply chain.",
      "llm_answer": "EU and U.S. sanctions that restrict the trade of goods used to produce tobacco in Belarus could disrupt Coca‑Cola HBC’s supply chain or logistics in that market, potentially curbing its bottling operations there【Trade Policy: EU and U.S. sanctions targeting the tobacco sector in Belarus】.  Because Coca‑Cola HBC is one of the company’s five largest bottlers—accounting for a sizable share of the 31.3 billion unit cases sold in 2021【Bottling partners list: Coca‑Cola HBC AG operations in Belarus】—a decline in Belarus activity would slightly lower Coca‑Cola Company’s overall unit case volume, though the impact would be modest given Belarus represents only a small fraction of global sales.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the potential impact of EU and U.S. sanctions on Coca-Cola HBC's operations in Belarus due to supply chain disruptions, and acknowledges the link between Coca-Cola HBC and The Coca-Cola Company’s unit case volume. However, it contains significant quantitative inaccuracies. The ground truth states that Coca-Cola HBC accounted for 41% of The Coca-Cola Company’s total worldwide unit case volume in 2021, but the LLM incorrectly states that Coca-Cola HBC accounted for a share of 31.3 billion unit cases — which is actually the total volume for The Coca-Cola Company, not Coca-Cola HBC’s contribution. This misrepresents both the magnitude and the metric. (2) The number '31.3 billion' appears to be the total unit cases sold by The Coca-Cola Company in 2021, but the LLM presents it as if it were Coca-Cola HBC’s volume, which is factually incorrect. The 41% figure from the ground truth is missing entirely, undermining the quantitative foundation of the analysis. (3) The reasoning chain is partially sound: the model connects sanctions → supply chain disruption → impact on bottler → impact on parent company, which reflects multi-hop understanding. It also correctly notes that the impact would be modest due to Belarus’s small market size, which is a reasonable inference. However, it fails to emphasize that Coca-Cola HBC is a critical bottler representing a large portion of global volume, thus underplaying the systemic risk. (4) Contextual relevance is high because the answer addresses both parts of the question: operational impact in Belarus and implications for global volume. Qualitative accuracy is moderate due to correct entity identification (Coca-Cola HBC, sanctions, Belarus) and logical flow, but weakened by the flawed data interpretation. Quantitative accuracy is low due to the incorrect use of 31.3 billion as Coca-Cola HBC’s volume instead of the total company volume and omission of the 41% figure. Correctness score reflects partial accuracy with a major factual flaw affecting the conclusion’s strength.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 559,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How might the proposed 28%-30% reduction in U.S. debit interchange rate caps impact Capital One’s interchange fee income, given its exposure to Mastercard’s four-party network and the ongoing legal challenges involving interchange fees that Visa and Mastercard face?",
      "original_answer": "The proposed 28%-30% reduction in U.S. debit interchange rate caps by the Federal Reserve could significantly lower Capital One’s interchange fee income, as COF relies on interchange fees from transactions processed through four-party networks like Mastercard. This impact could be exacerbated by the fact that merchants continue to pursue legal actions against Mastercard and Visa, as seen in the ongoing multidistrict litigation where interchange fee practices remain under scrutiny. Mastercard, being subject to regulatory oversight and interchange fee limitations, may be forced to further reduce fees or face additional settlements, which would directly affect Capital One’s revenue model tied to those networks.",
      "llm_answer": "Capital One’s interchange‑fee revenue could shrink because the Federal Reserve’s October 2023 proposal would cut the U.S. debit‑card interchange‑rate cap by roughly 28‑30 % (COF 10‑K, p. 40‑41).  Because a large share of its debit‑card income comes from Mastercard’s four‑party network, the lower cap would directly reduce the maximum fee Capital One can earn on those transactions.  The company’s exposure to Mastercard, coupled with the ongoing litigation and regulatory scrutiny of Visa and Mastercard interchange rates (MA 10‑K, p. 22‑26; V 10‑K, p. 97‑101), could further erode or add uncertainty to its interchange‑fee income.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 28%-30% reduction in U.S. debit interchange rate caps is correctly cited, and the reference to the Federal Reserve’s proposal (from Capital One’s 10-K, pp. 40–41) is factually sound. The percentage range matches the original answer, and no calculations are required beyond that. (2) The answer correctly identifies Capital One’s exposure to Mastercard’s four-party network as a key vulnerability, which is central to the multi-hop reasoning (COF → Mastercard network → interchange fee dependency). (3) It appropriately references ongoing litigation and regulatory scrutiny involving Visa and Mastercard (with citations to MA and V 10-Ks), accurately reflecting the legal challenges mentioned in the ground truth. (4) The only minor shortcoming is that it does not explicitly mention the multidistrict litigation by name or clarify that settlements or further regulatory actions could directly impact Mastercard’s fee structure, which in turn affects Capital One—this nuance is present in the original answer and slightly strengthens the causal chain. However, the core reasoning and synthesis across entities (COF, MA, V, Fed policy, litigation) are logically sound and semantically equivalent. Wording differs but meaning is preserved. No factual errors; minor omission prevents a perfect 10 on qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 390,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does Duke Energy's exposure to LIBOR-indexed financial contracts influence its adoption timeline for ASU 2020-04 compared to Southern Company's approach, given both companies' assessments of the regulation's financial impact?",
      "original_answer": "Duke Energy is assessing LIBOR-indexed financial arrangements and evaluating the optional expedients in ASU 2020-04 for contracts extending beyond the LIBOR phase-out in 2023, with the transition not expected to have a material impact on its financial statements. Southern Company, similarly, is evaluating the provisions of ASU 2020-04 and the impact of transitioning to alternative rates, though the ultimate outcome remains uncertain. Both companies are applying the guidance as it relates to contract modifications and hedge accounting under the reform, but Duke Energy had until December 31, 2022, to apply the optional expedients, suggesting a time-bound evaluation window compared to Southern Company's ongoing assessment.",
      "llm_answer": "Duke Energy, which has variable‑rate debt and LIBOR‑indexed swaps, has not yet adopted ASU 2020‑04 and is still evaluating optional expedients, delaying implementation until it can assess the impact of the LIBOR transition (DUK 10‑K, pp. 135‑139). Southern Company, also exposed to LIBOR‑based debt and hedges, has elected to apply the amendments prospectively and expects no material impact, effectively adopting the standard earlier than Duke Energy (SO 10‑K, pp. 193‑197). Both companies view the transition as unlikely to materially affect their financial statements.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor inaccuracies in the characterization of Southern Company's adoption timeline. (1) Quantitatively, no specific numbers (dates, dollar amounts, percentages) are incorrect—the mention of Duke Energy’s evaluation window implicitly aligns with the December 31, 2022 deadline for optional expedients, though not explicitly stated. Southern Company’s prospective application is consistent with early adoption. (2) The LLM correctly identifies both companies’ LIBOR exposure (variable-rate debt and swaps) and their conclusion of immaterial financial impact, which matches the original answer. (3) The multi-hop reasoning is sound: it synthesizes information about both companies’ approaches to ASU 2020-04, compares their timelines, and links LIBOR exposure to adoption decisions. (4) However, the LLM states Southern Company 'effectively adopted the standard earlier' and 'elected to apply the amendments prospectively,' which implies a firmer adoption stance than the ground truth suggests—Southern’s outcome is described as 'uncertain' and still under assessment, not definitively adopted. This overstates the certainty of Southern’s approach. Duke Energy’s delayed implementation is accurately portrayed. (5) Despite this nuance, the core facts—exposure, evaluation status, immaterial impact, and relative timing—are correct. Wording differences are acceptable under semantic equivalence, but the stronger claim about Southern’s adoption slightly reduces qualitative and overall correctness. Contextual relevance is perfect—directly addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 449,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does the application of the Black-Scholes-Merton model for stock option valuation at KO compare to the use of weighted-average assumptions in pension plan cost calculations at CL, particularly in terms of the specific inputs and their financial reporting implications?",
      "original_answer": "KO uses the Black-Scholes-Merton model to estimate the fair value of stock option awards, with the weighted-average fair value of options granted in 2023 being calculated using assumptions such as volatility, risk-free interest rate, and expected term. These weighted-average assumptions are a key input in the model. CL also utilizes weighted-average assumptions, but in the context of pension plan cost calculations, where factors like discount rate (5.66% in 2023), expected long-term rate of return on plan assets (6.25% in 2023), and compensation increase (3.50% in 2023) directly impact the reported net periodic benefit cost. While both companies rely on weighted-average assumptions, KO applies them in equity compensation valuation using a formal pricing model, whereas CL integrates them into actuarial estimates for pension liabilities, highlighting different financial reporting applications of similar statistical inputs.",
      "llm_answer": "At Coca‑Cola, the Black‑Scholes‑Merton model uses weighted‑average inputs—dividend yield (3.0%–3.3%), expected volatility (17.5%–18.0%), risk‑free rate (0.9%–4.1%) and option term (6 years)—to estimate the fair value of each stock option, which is expensed over the vesting period and recorded as a liability on the balance sheet.  In contrast, Colgate‑Palmolive’s pension calculations rely on weighted‑average actuarial assumptions—discount rate (5.40%–5.66%), expected return on assets (6.25%–6.50%), compensation‑increase rate (3.5%–3.22%), medical‑cost trend (6.0%–4.88%) and interest‑crediting rate (4.99%–5.21%)—to compute the projected benefit obligation and net periodic benefit cost, which are recognized as pension expense and affect the pension liability.  Thus, KO’s model uses market‑derived inputs to value equity awards, while CL’s approach uses actuarial estimates to determine pension obligations, each driving distinct expense and liability items in the financial statements.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the use of the Black-Scholes-Merton model at KO for stock option valuation and CL's use of weighted-average assumptions in pension accounting, aligning with the core comparison in the original answer. However, there are quantitative inaccuracies: the original answer specifies only the 2023 values (e.g., discount rate 5.66%, expected return 6.25%, compensation increase 3.50%) without ranges, while the LLM provides ranges (e.g., 5.40%–5.66%, 6.25%–6.50%, 3.5%–3.22%) not present in the ground truth. These ranges may reflect multi-year data but are not supported by the provided truth. Additionally, the LLM introduces new metrics like 'medical-cost trend' and 'interest-crediting rate' not mentioned in the original, adding detail but potentially extrapolating beyond the source. (2) The dividend yield (3.0%–3.3%) and volatility (17.5%–18.0%) for KO are plausible but not specified in the original answer, which only notes that such assumptions are used without giving values. The LLM thus adds numerical precision not present in the ground truth, reducing quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly distinguishes KO’s application of weighted-average inputs in equity valuation from CL’s use in pension actuarial estimates, capturing the conceptual contrast in financial reporting implications (expense recognition, liability measurement). (4) Despite numerical over-specification, the qualitative and contextual understanding is strong—correct entities (KO, CL), correct models (Black-Scholes-Merton, pension actuarial assumptions), and correct financial reporting outcomes. The answer conveys the same central idea: similar statistical methods (weighted averages) applied in different contexts with distinct reporting effects. Hence, correctness is reduced primarily due to unsupported numerical ranges, but reasoning and relevance remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 523,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does AMT's use of subsidiary equity interests as collateral for the $525.0 million Series 2015-2 Notes compare with SPG's strategy of monetizing equity interests through disposals, particularly in light of SPG's $18.8 million gain from such transactions?",
      "original_answer": "AMT utilized the equity interests in its subsidiary GTP Acquisition Partners as part of the collateral structure for the $525.0 million Series 2015-2 Notes, which were secured by a security interest in substantially all of the personal property of the GTP Entities, including GTP Acquisition Partners' equity interests in its subsidiaries. This approach allowed AMT to securitize cash flows from specific communications sites while retaining control over excess cash flows. In contrast, SPG pursued a strategy of actively monetizing its equity interests through disposals, as evidenced by a $18.8 million gain from the sale of equity interests in 2021, indicating a more direct capital realization approach. The comparison highlights different financial strategies: AMT leveraged equity interests for secured financing, while SPG liquidated equity interests for immediate financial gain.",
      "llm_answer": "AMT secures the $525 million Series 2015‑2 Notes by pledging the equity interests of its wholly‑owned subsidiary GTP Acquisition Partners as collateral—American Tower Holding Sub II, whose only material assets are those equity interests, guarantees the debt rather than selling them.  In contrast, Simon Property Group monetizes its equity interests through disposals, which in 2021 generated an $18.8 million gain from the sale of those interests.  Thus, AMT’s strategy focuses on using equity as security for debt, while SPG’s approach involves selling equity to raise cash and realize a profit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: AMT pledged equity interests in GTP Acquisition Partners as collateral for the $525.0 million Series 2015-2 Notes, and SPG realized an $18.8 million gain from disposals of equity interests in 2021. The dollar amounts and years match the original answer exactly. (2) Quantitative accuracy is perfect: $525 million and $18.8 million are correctly reported with proper context and formatting variations (e.g., $525 million vs $525.0 million) are acceptable. (3) The multi-hop reasoning is sound—correctly contrasting AMT’s secured financing strategy with SPG’s monetization via sales. The LLM correctly identifies that AMT retains control by using equity as collateral, while SPG realizes gains through disposal. (4) Minor deduction in qualitative accuracy due to a slight misstatement: the LLM mentions 'American Tower Holding Sub II' as the guarantor, which is not in the original answer and introduces an entity not confirmed in the ground truth, potentially over-specifying the structure. However, this does not contradict the main point and may be factually accurate but unverified in the provided truth. Otherwise, the comparison logic and synthesis across companies and strategies are strong. Contextual relevance is full—directly addresses the comparison asked in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 388,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does ConocoPhillips' operational exposure in Nigeria compare to ExxonMobil's reliance on production-sharing contracts in terms of reserve reporting and contractual term structures?",
      "original_answer": "ConocoPhillips operates in Nigeria, where exploration and production activities are governed by production-sharing contracts (PSCs) with a typical term of 30 years, including a 10-year exploration period and a 20-year production period that may be extended under the Petroleum Industry Act. ExxonMobil reports that 12% of its total proved reserves (on an oil-equivalent basis) in 2021 were associated with PSC arrangements, where reserve volumes fluctuate inversely with price changes due to the fiscal terms of these contracts. This indicates that while both companies are exposed to PSCs in Nigeria, ExxonMobil's reserve reporting methodology must account for the dynamic nature of PSC-based reserves, whereas ConocoPhillips must manage its operations under fixed-term contractual obligations that include partial relinquishment requirements.",
      "llm_answer": "ConocoPhillips reports its Nigerian reserves under PSCs using the economic‑interest method, with PSCs having a fixed 30‑year term that includes a 10‑year exploration phase and a 20‑year production phase that may be extended (COP 10‑K, pp. 151‑152, 155).  ExxonMobil, in contrast, relies on a portfolio of PSCs whose terms are property‑specific—exploration periods range from 1 to 10 years and production continues until it ceases, with the option to extend or relinquish early (XOM 10‑K, pp. 128‑129).  Thus, ConocoPhillips’ reserve reporting is tied to a standardized PSC structure, whereas ExxonMobil’s reserve reporting reflects a more variable contractual framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some correct elements about ConocoPhillips' and ExxonMobil's PSC structures in Nigeria but misses key quantitative and comparative aspects from the ground truth. (1) Quantitatively, the LLM fails to include ExxonMobil's specific 12% of total proved reserves tied to PSCs in 2021, a critical data point in the original answer. This omission significantly weakens the comparison on reserve reporting. Additionally, while the LLM correctly notes ConocoPhillips' 30-year PSC term (10-year exploration, 20-year production), it does not mention the Petroleum Industry Act's role in enabling extensions, which is present in the ground truth. (2) The LLM introduces the 'economic-interest method' for ConocoPhillips, which is not mentioned in the original answer and cannot be verified from the provided truth, potentially introducing unsupported information. (3) Regarding reasoning, the LLM correctly identifies that ConocoPhillips operates under more standardized PSC terms while ExxonMobil has variable, property-specific contracts—this aligns with the multi-hop logic of comparing contractual term structures. However, it fails to address how PSC fiscal terms cause ExxonMobil's reserves to fluctuate inversely with price changes, a core aspect of the original answer's insight on reserve reporting dynamics. (4) The answer is contextually relevant and well-structured, citing correct document sources (10-K pages), but lacks the depth of financial and regulatory nuance required for full accuracy. Overall, the answer is partially correct with sound qualitative framing but significant omissions in key quantitative and cause-effect relationships.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 453,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does IBM's focus on generative AI innovation compare with QCOM's investment in edge-based generative AI and cloud computing, particularly in terms of their respective strategies for commercializing AI technologies in high-performance, low-power computing environments?",
      "original_answer": "IBM is actively investing in generative AI as part of its broader innovation initiatives, emphasizing cutting-edge R&D to differentiate itself in hybrid cloud and AI markets, with the goal of attracting a developer ecosystem and maintaining market share. In contrast, QCOM is embedding generative AI capabilities directly into edge devices, such as smartphones and PCs, to optimize performance, privacy, and personalization while coordinating with cloud applications. QCOM's cloud computing processing initiative supports this strategy by enabling intelligent data sharing between edge devices and cloud systems. While IBM focuses on enterprise-level AI innovation and ecosystem development, QCOM is commercializing generative AI through high-performance, low-power mobile platforms, projecting that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024.",
      "llm_answer": "IBM’s 2024 10‑K risk‑factor pages (pp. 3‑7) describe generative‑AI as part of a broader “hybrid‑cloud and AI” strategy that relies on IBM’s research, R&D investments and a developer ecosystem to commercialise AI services for enterprise customers. In contrast, Qualcomm’s 10‑K (pp. 5‑9, 80‑84) shows a focus on edge‑based generative‑AI powered by high‑performance, low‑power SoCs (CPU, GPU, Hexagon NPU) and a unified AI stack that lets large‑language, vision and multimodal models run on‑device, while still linking to cloud back‑ends; the company monetises this through chip sales, licensing and integrated cloud‑edge solutions for mobile, automotive and IoT. Thus, IBM targets enterprise AI through hybrid‑cloud platforms, whereas Qualcomm drives commercialisation via hardware‑centric, low‑power edge AI that complements its cloud‑computing initiatives.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth in terms of strategy, focus areas, and commercialization approaches for both IBM and QCOM. It correctly identifies IBM's enterprise-level, hybrid-cloud and AI strategy centered on R&D and ecosystem development, and contrasts it with QCOM's edge-based, low-power, hardware-centric approach using SoCs and on-device AI. The answer accurately reflects QCOM's integration with cloud back-ends and monetization via chip sales and licensing. However, it omits the specific forward-looking projection from the original answer that '46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024'—a key quantitative element that directly addresses the commercialization trajectory in high-performance, low-power environments. This omission reduces completeness but does not affect the accuracy of the information provided. All entities (IBM, QCOM, generative AI, edge computing, cloud) and their strategic distinctions are correctly identified and logically synthesized. The reasoning is sound, with proper multi-hop comparison between the companies' technological focus and business models. Wording differs but maintains semantic equivalence on all points except the missing statistic. Quantitative accuracy is perfect as no incorrect numbers are introduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 373,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Duke Energy's exposure to nuclear decommissioning funding risks compare to NextEra Energy's financial risk management for nuclear generation, given both companies' reliance on market performance for trust-funded obligations?",
      "original_answer": "Duke Energy Carolinas, Progress, and Florida have significant obligations tied to decommissioning nuclear plants, with trust assets subject to market fluctuations that could increase funding requirements if returns fall below projections. Similarly, NextEra Energy and FPL maintain decommissioning funds and insurance coverage, but the cost of decommissioning could exceed available funds. Both companies are exposed to financial risks stemming from nuclear power plants, particularly as market performance directly affects their ability to meet long-term decommissioning obligations.",
      "llm_answer": "Duke Energy’s nuclear decommissioning risk is largely a passive exposure: the value of its NDTF assets can decline with market performance, potentially creating a funding gap that could hurt its cash flows and results (pages 33‑37). NextEra Energy, while also relying on the market value of its decommissioning funds, has an explicit hedging and trading framework and other risk‑management tools to mitigate commodity and financial market volatility, though it acknowledges that poor market performance could still increase funding needs (pages 28‑32). Thus, Duke Energy faces a more direct, asset‑value‑driven risk, whereas NextEra supplements its trust‑fund exposure with active risk‑management practices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: both Duke Energy and NextEra Energy face nuclear decommissioning funding risks tied to market performance; Duke's exposure is primarily passive through its Nuclear Decommissioning Trust Funds (NDTF), with potential funding gaps if market returns fall short. NextEra also relies on market-funded trusts but employs active risk management, including hedging and trading frameworks, to mitigate financial and commodity volatility—details consistent with the original answer’s emphasis on market-linked risks. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either answer, so quantitative accuracy is not compromised; the LLM correctly avoids inventing figures. (3) The multi-hop reasoning is sound: the LLM synthesizes information across both companies, compares their risk management approaches, and draws a valid contrast—Duke’s more direct, asset-value-driven risk versus NextEra’s active mitigation strategies—going slightly beyond the original answer with specific insight about hedging practices (supported by cited pages 28–32). (4) Semantic equivalence is strong: while the LLM adds nuance (e.g., 'hedging and trading framework'), it does not contradict the ground truth and enhances the comparison without introducing errors. The only reason for not scoring a 10 is that the original answer emphasizes insurance coverage (mentioned for NextEra) and broader cost-exceeding-funds risk, which the LLM omits briefly—though the core financial risk from market performance is fully addressed. Contextual relevance is perfect: the response directly answers the comparative risk management question with precise, document-supported reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 481,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does CAT's application of hedging relationship accounting under ASU 2020-04 compare to UPS's adoption of the same standard, particularly in terms of their respective derivative contract management strategies and transition timelines?",
      "original_answer": "CAT formally documents and designates derivatives as either fair value or cash flow hedges, using foreign currency forward and option contracts to manage up to five years of anticipated foreign currency cash flow exposure. Under ASU 2020-04, CAT applied optional expedients for contract modifications affected by reference rate reform through December 31, 2024, though the adoption did not have a material impact. In contrast, UPS transitioned its affected debt instruments and contracts to SOFR as the alternative reference rate by December 31, 2023, but did not elect to apply the practical expedients provided under ASU 2020-04, continuing to assess potential impacts through 2024. Both companies applied the standard to manage derivative and debt contract modifications, but CAT leveraged the extended relief period while UPS opted for direct transition without using the optional relief.",
      "llm_answer": "CAT’s transition to the new reference‑rate regime was completed on December 31, 2023, when it moved all affected debt and contracts to SOFR without electing the optional practical expedients under ASU 2020‑04 and will continue to monitor any residual impact into 2024. UPS likewise switched to SOFR on the same date, but its filing notes that it has elected to use the practical‑expedient relief, allowing it to apply the optional guidance for reference‑rate changes. Both firms use a similar mix of foreign‑currency forwards, options, cross‑currency swaps, interest‑rate swaps and commodity forwards to hedge forecasted cash‑flow and fair‑value exposures, though UPS’s derivative portfolio is broader, with a larger emphasis on commodity‑price hedges.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors in both quantitative and qualitative aspects. (1) Incorrect dates and company-specific actions: The LLM states that CAT completed its transition to SOFR on December 31, 2023, but the ground truth indicates that CAT applied optional expedients under ASU 2020-04 through December 31, 2024, and did not complete a SOFR transition like UPS. Conversely, the LLM incorrectly claims that UPS elected to use the practical expedients, while the original answer clearly states that UPS did *not* elect them. In fact, it was CAT that used the expedients, not UPS. (2) The LLM reverses the core comparative point: CAT used the relief (expedients), UPS did not — the answer flips this, which is a critical error in multi-hop reasoning. (3) The derivative instruments listed (e.g., cross-currency swaps, interest-rate swaps, commodity forwards) are not mentioned in the original answer for CAT, and the claim that UPS has a broader portfolio with more commodity hedges is unsupported by the ground truth. (4) The original answer does not state that both companies switched on the same date; only UPS transitioned by December 31, 2023, while CAT extended relief to 2024. (5) While the question asks for a comparison of hedging strategies and transition timelines under ASU 2020-04, the LLM invents details not present in the source, leading to a mostly incorrect synthesis. The contextual relevance is moderate because the answer addresses the right topic and structure, but the factual inaccuracies severely undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 427,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Comcast's lack of voting rights in Atairos compare to Alphabet's dual-class stock structure, particularly in terms of control implications given Alphabet's significant share repurchase activity in Classes A and C?",
      "original_answer": "Comcast has no voting rights in Atairos and only certain consent rights, which means it lacks control over Atairos’s activities despite a remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. In contrast, Alphabet maintains a dual-class stock structure where Class B shares have 10 votes per share, allowing key stakeholders to retain outsized voting power. Despite repurchasing $62.0 billion in Class A and Class C shares in 2024 alone, Alphabet has preserved the Class B structure, which ensures concentrated control while reducing public float in the lower-vote and no-vote classes.",
      "llm_answer": "Comcast’s investment in Atairos is a non‑voting equity method investment; the company has no voting rights or power to direct Atairos’s operations, so it has no control over the VIE. In contrast, Alphabet’s dual‑class structure gives Class B holders 10 votes per share while Class A shares carry one vote and Class C shares are non‑voting. Alphabet’s large repurchase program—$62 billion of Class A and Class C shares in 2024—shrinks the overall voting base (by buying back Class A shares) and the equity base (by buying back Class C shares), thereby concentrating control further in the hands of the voting Class B holders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Comcast has no voting rights in Atairos and only consent rights, which is accurately described as a non-voting equity method investment without control. Alphabet's dual-class structure is correctly detailed, with Class B having 10 votes, Class A one vote, and Class C non-voting. The $62 billion share repurchase in 2024 for Class A and C shares is exactly matched. (2) Quantitative accuracy is perfect: the $62 billion repurchase amount and the structural details (10 votes for Class B, etc.) are correct. Format variations (e.g., $62 billion vs $62.0 billion) are acceptable and semantically equivalent. (3) Multi-hop reasoning is sound: the LLM correctly contrasts Comcast’s lack of control in Atairos despite capital commitment with Alphabet’s maintained control via dual-class shares, and further enhances the analysis by explaining how repurchases of Class A and C shares concentrate voting power—this goes slightly beyond the original answer but remains logically valid. (4) The only minor shortcoming is that the LLM does not explicitly mention Comcast’s $1.4 billion unfunded capital commitment as of December 31, 2024, which is part of the original answer and adds context about the scale of Comcast’s financial exposure despite no control. This omission slightly reduces completeness but does not affect the core correctness. Overall, the answer is factually precise, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 425,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does the extension of reference rate reform accounting relief under ASU 2022-06 impact the transition timelines for both UPS and FedEx, given that UPS had already transitioned its affected debt to SOFR by December 31, 2023, while FedEx continued monitoring its contracts through May 31, 2024?",
      "original_answer": "The deferral of the sunset date of ASU 2020-04 from December 31, 2022, to December 31, 2024, via ASU 2022-06, allowed both UPS and FedEx to extend their evaluation and application of reference rate reform accounting relief. UPS had already transitioned its affected debt instruments and contracts to SOFR by December 31, 2023, and did not elect to apply the practical expedients under Topic 848, but continued to assess potential impacts through 2024. FedEx, on the other hand, had not experienced any material effect from reference rate reform as of May 31, 2024, and continued to monitor its contracts and transactions for potential application of ASUs 2020-04 and 2022-06. The extension provided FedEx additional time to evaluate whether to apply the optional expedients, while UPS used the period to ensure full alignment with the new rates and assess any residual effects.",
      "llm_answer": "The ASU 2022‑06 extension keeps the optional relief for reference‑rate reform in effect through December 31 2024. UPS had already moved all affected debt to SOFR by December 31 2023, so the extension does not alter its transition schedule. FedEx, still monitoring contracts as of May 31 2024, will need to complete any remaining transitions by the end of 2024 under the extended relief.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts, dates, and entities. (1) Quantitatively, all dates (December 31, 2023 for UPS transition; December 31, 2024 for ASU 2022-06 sunset; May 31, 2024 for FedEx monitoring) are accurately reported, and there are no calculation errors. (2) The answer correctly identifies that UPS completed its transition to SOFR by December 31, 2023, and thus the extension does not affect its timeline—this matches the original answer. It also correctly states that FedEx was still monitoring contracts as of May 31, 2024, and benefits from the extended deadline. (3) However, the LLM omits key qualitative details present in the ground truth: it does not mention that UPS did not elect to apply Topic 848 practical expedients but continued assessing residual impacts, nor does it clarify that FedEx had not experienced any material effect from the reform as of May 2024. Additionally, the LLM implies FedEx 'will need to complete any remaining transitions,' which overstates the requirement—ASU relief is optional, and the original answer emphasizes FedEx was evaluating whether to apply expedients, not that a transition was necessary. (4) Despite these nuances, the core multi-hop reasoning—comparing the impact of the ASU 2022-06 extension on two companies with different transition statuses—is sound and contextually relevant. The answer captures the essential contrast between UPS (post-transition) and FedEx (ongoing evaluation), justifying a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 424,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does PepsiCo's beverage revenue concentration in Africa, Middle East, and South Asia (29% in 2023) compare with Target's beverage sales geographic exposure, given that Target's merchandise segments only describe domestic operations in the U.S.?",
      "original_answer": "PepsiCo generated 29% of its beverage revenue from the Africa, Middle East, and South Asia (AMESA) region in 2023, indicating a significant international presence in this sector. In contrast, Target's 2023 10-K filing only describes its beverage offerings as part of grocery sales within its U.S. operations, with no mention of international retail presence or beverage sales outside the United States. This suggests that Target's beverage sales are entirely domestic, while PepsiCo maintains a substantial international footprint in beverages, particularly in the AMESA region.",
      "llm_answer": "PepsiCo’s 2023 beverage revenue includes 29 % from its Africa, Middle East and South Asia (AMESA) division, indicating a sizable international exposure (PEP_10k_2023, p.70‑74). Target, by contrast, notes that nearly all of its merchandise—including beverage sales—is generated in the United States (TGT_10k_2023, p.45‑49). Thus PepsiCo’s beverage revenue is more geographically diversified, whereas Target’s beverage sales are concentrated solely in the U.S.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 29% beverage revenue figure for PepsiCo in the AMESA region in 2023 is correctly stated, matching the original answer. The claim that Target’s merchandise—including beverage sales—is nearly all in the U.S. is consistent with the 10-K and the ground truth. (2) The citation of page ranges (e.g., PEP_10k_2023, p.70–74; TGT_10k_2023, p.45–49) adds precision and supports the claims, though exact page numbers are not part of the ground truth verification—they do not detract from accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes that PepsiCo has international beverage revenue exposure while Target’s operations are entirely domestic, leading to the valid conclusion that PepsiCo’s beverage revenue is more geographically diversified. (4) The only minor shortcoming is the use of 'nearly all' for Target’s U.S. sales, whereas the ground truth states 'entirely domestic'—a slight softening of certainty, but still factually acceptable given typical 10-K disclosures. Overall, the answer captures the core contrast accurately, with excellent contextual relevance and strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 342,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does the absence of the Countercyclical Capital Buffer impact the minimum capital requirements for SCHW compared to GS's TLAC to RWAs requirement, given both are subject to multi-layered regulatory buffers?",
      "original_answer": "For SCHW, the absence of the Countercyclical Capital Buffer (which was set to zero) still results in a minimum Common Equity Tier 1 Risk-Based Capital ratio of 7.0%, Tier 1 Risk-Based Capital ratio of 8.5%, and Total Risk-Based Capital ratio of 10.5%, inclusive of other buffers like the 2.5% stress capital buffer. For GS, the TLAC to RWAs requirement includes a 18% minimum, a 2.5% buffer, and also incorporates the Countercyclical Capital Buffer (also set to zero), along with a 1.5% G-SIB surcharge. Therefore, even without the Countercyclical Capital Buffer, both firms face layered capital requirements, but GS's baseline (18%) is significantly higher due to its global systemic importance and TLAC framework.",
      "llm_answer": "Because Schwab’s counter‑cyclical capital buffer is zero, its minimum capital requirement is only the regulatory minimum risk‑based capital ratio plus the stress (2.5 %) and conservation (2.5 %) buffers—yielding 7.0 % CET1, 8.5 % Tier 1 and 10.5 % total. In contrast, Goldman Sachs’ TLAC to RWAs requirement is 22 % (18 % minimum + 2.5 % buffer + 0 % counter‑cyclical buffer + 1.5 % G‑SIB surcharge), which is higher than Schwab’s minimum requirement. Thus, the absence of a counter‑cyclical buffer lowers Schwab’s minimum capital requirement relative to GS’s TLAC requirement.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the capital ratios for SCHW (7.0% CET1, 8.5% Tier 1, 10.5% Total) and attributes them to the absence of the Countercyclical Capital Buffer (CCyB), which is set to zero, along with inclusion of the stress capital buffer. However, it incorrectly adds a 'conservation buffer' (2.5%) not mentioned in the ground truth — the original answer only references a 2.5% stress capital buffer. This introduces a factual inaccuracy in the composition of buffers. For GS, the LLM correctly lists the components: 18% TLAC minimum, 2.5% buffer, 0% CCyB, and 1.5% G-SIB surcharge. But it sums these to 22%, which is incorrect: 18 + 2.5 + 1.5 = 22, but the 2.5% buffer is likely inclusive or overlapping with other buffers, and the ground truth does not state a 22% total. The original answer emphasizes that GS’s requirement 'includes' these elements but does not explicitly sum them, suggesting the 18% may already incorporate some buffers. Thus, the summation to 22% is a quantitative overreach. (2) Number verification: SCHW ratios are correct. GS component percentages (18%, 2.5%, 1.5%) are correct, but the implied total of 22% is not supported by the ground truth and introduces a calculation error. (3) Multi-hop reasoning is mostly sound — the model compares SCHW’s regulatory framework to GS’s TLAC requirements and correctly notes GS has a higher baseline due to systemic importance. It synthesizes across regulatory regimes, though with minor misinterpretation of buffer additivity. (4) Scores reflect mostly correct facts and reasoning, with deductions for introducing an unsupported buffer (conservation) and incorrect aggregation of GS’s TLAC requirement. Contextual relevance is perfect — the answer directly addresses the comparative impact of CCyB absence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 489,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does Dalton's $5.3 million reimbursement from Georgia Power for Plant Vogtle construction reflect its involvement in self-owned generation facilities, and how does this ownership model contrast with NEE's approach to revenue generation through long-term contracts covering 94% of its capacity?",
      "original_answer": "Dalton receives $5.3 million in reimbursements from Georgia Power for its share of Plant Vogtle Units 3 and 4 construction costs, indicating its partial ownership stake in this nuclear generation facility. This aligns with Dalton’s broader strategy of serving its energy requirements through self-owned generation assets, some of which are jointly owned with Georgia Power. In contrast, NEE generates revenue by contracting 94% of its net generating capacity under long-term bilateral agreements, focusing on full-output commitments rather than joint ownership of facilities. This highlights a structural difference: Dalton participates in shared infrastructure ownership to meet its load needs, while NEE monetizes its generation assets through extensive contractual commitments in competitive markets.",
      "llm_answer": "Dalton’s $5.3 million reimbursement from Georgia Power is a cost‑sharing payment under the joint‑ownership agreement for Plant Vogtle Units 3 and 4, reflecting Dalton’s role as a self‑owned generation partner that recovers construction costs rather than selling power under a contract (see pages 188‑189).  By contrast, NextEra Energy’s revenue model relies on long‑term PPAs and full‑requirements contracts that cover roughly 94 % of its net generating capacity, providing a predictable, contract‑based income stream from wholesale markets (see pages 18‑21).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $5.3 million reimbursement and the 94% of net generating capacity under long-term contracts are accurately reported. Format variations (e.g., '94 %' with space) do not affect correctness. (2) The answer correctly identifies the entities: Dalton and Georgia Power’s joint ownership of Plant Vogtle Units 3 and 4, and contrasts it with NextEra Energy (NEE)’s revenue model. (3) Multi-hop reasoning is sound: it synthesizes Dalton’s cost-recovery model through joint ownership with Georgia Power and contrasts it with NEE’s contract-based revenue strategy, correctly interpreting the structural difference in business models. (4) The LLM slightly omits the explicit mention that Dalton uses self-owned generation to meet its own load needs (i.e., load-serving utility model), which is implied but not stated as clearly as in the original. However, the core contrast—ownership for cost recovery vs. contracting for revenue—is preserved. Wording differences (e.g., 'PPAs and full-requirements contracts' vs. 'bilateral agreements') are semantically equivalent. Overall, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score with only minor room for elaboration on Dalton’s load-serving purpose.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 376,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do RTX and BA differ in their approaches to managing customer financing obligations, particularly regarding RTX's $7.0 billion in credit facilities versus BA's long-term lease structures?",
      "original_answer": "RTX manages its customer financing obligations by leveraging its strong liquidity position, including $7.0 billion in available credit facilities, which provides flexibility for funding such obligations without relying on short-term commercial paper borrowings. In contrast, BA structures its customer financing through long-term lease arrangements, with terms ranging from 1 to 12 years, often including options to extend, terminate, or purchase the underlying asset. These lease-based financing strategies reflect BA's capital-intensive model, particularly in its BCC segment, and are accounted for under operating or finance leases, impacting both asset and liability balances on its balance sheet. The differing approaches highlight RTX's reliance on liquidity buffers versus BA's use of extended lease terms to manage financing commitments.",
      "llm_answer": "RTX relies on a $7.0 billion line of credit to meet liquidity and customer‑financing needs (RTX_10k_2022.pdf: page 50). In contrast, Boeing structures customer financing through long‑term lease agreements that generate lease income and create lease assets and liabilities on its balance sheet (BA_10k_2022.pdf: pages 76‑80, 91‑95).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and matches the ground truth on key quantitative and entity-specific details. The $7.0 billion credit facility for RTX and Boeing's use of long-term lease structures are correctly reported, with proper sourcing from the respective 10-Ks. Quantitative accuracy is perfect: the dollar amount is correct and properly attributed. Contextual relevance is strong, as the response directly addresses the contrast in customer financing approaches between RTX and BA. However, the answer lacks some completeness in qualitative depth compared to the original. Specifically, it omits details about the terms of Boeing’s leases (1 to 12 years), options to extend, terminate, or purchase, and the distinction between operating and finance leases impacting balance sheet items. It also does not mention RTX’s strategic avoidance of short-term commercial paper borrowings, which is a key differentiator in their liquidity management. While the multi-hop reasoning is sound—correctly synthesizing data from two different filings—the synthesis is less detailed than the ground truth. Thus, while the answer is factually correct and relevant, it misses some nuanced but important elements, warranting a score of 8 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 359,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do Coca-Cola and Philip Morris differ in their application of weighted-average assumptions within their financial reporting frameworks?",
      "original_answer": "Coca-Cola uses the Black-Scholes-Merton option-pricing model to estimate the fair value of stock option awards, with the weighted-average assumptions applied specifically to these stock options granted during the years ended December 31, 2023, 2022, and 2021. In contrast, Philip Morris applies weighted-average assumptions to determine net pension and postretirement healthcare costs, which is a different financial reporting framework focused on employee benefits beyond stock compensation. The difference in application highlights how the same accounting methodology is used for distinct compensation components—equity-based incentives at Coca-Cola versus retirement and healthcare liabilities at Philip Morris.",
      "llm_answer": "Coca‑Cola’s weighted‑average assumptions are used almost exclusively in its equity‑based‑compensation reporting (Note 13, pages 93‑97).  They include market‑derived parameters—dividend yield, volatility, risk‑free rate and expected term of options—used in the Black‑Scholes‑Merton model and a weighted‑average vesting period to spread unrecognized compensation cost.  Philip Morris, on the other hand, applies weighted‑average actuarial assumptions in its pension and post‑retirement benefit note (Note 14, pages 120‑124), such as discount rates, compensation‑increase rates, interest‑crediting rates, health‑care cost trends and ultimate‑trend rates, to calculate the present value of benefit obligations and related costs.  Thus, Coca‑Cola’s weighted‑average assumptions are market‑based and focused on option pricing, whereas Philip Morris’s are actuarial and focused on pension liability valuation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies that Coca-Cola applies weighted-average assumptions to equity-based compensation using the Black-Scholes-Merton model, while Philip Morris uses them for pension and postretirement benefits—matching the core distinction in the original answer. (2) There are no numeric values (e.g., percentages, dollar amounts, years) in either answer that conflict; both correctly reference the relevant financial reporting periods (implied by 'years ended December 31, 2023, 2022, and 2021' in the original) and correctly associate assumptions with their respective models (market-based for Coca-Cola, actuarial for Philip Morris). (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies use weighted-average assumptions but in different financial contexts—stock option valuation vs. pension liability—demonstrating understanding across two distinct reporting frameworks. (4) The LLM adds valuable detail not in the original (e.g., specific assumptions like dividend yield, volatility, health-care cost trends, and note numbers/pages), enhancing precision without introducing error. Wording differs but meaning is identical: 'market-based and focused on option pricing' = 'used for stock option awards'; 'actuarial and focused on pension liability valuation' = 'determine net pension and postretirement healthcare costs'. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 410,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does the expiration timeline of regulatory exclusivity for Merck's Januvia family of products compare to Gilead's U.S. regulatory exclusivity expiration in 2032, and what impact might this have on their respective market positions given the role of exclusivity in delaying generic competition?",
      "original_answer": "Merck's Januvia family of products is expected to lose U.S. market exclusivity in May 2026 (Januvia and Janumet) and July 2026 (Janumet XR), while Gilead has a U.S. regulatory exclusivity that expires in 2032. According to the evidence, regulatory exclusivity provides a period during which generic competitors cannot rely on the innovator’s data for approval, thus delaying market entry of generics. Since Gilead benefits from a significantly longer exclusivity period, it may maintain a more protected market position through 2032, whereas Merck will face substantial sales declines starting in 2026 due to generic competition and pricing pressures, as seen in other markets post-expiry.",
      "llm_answer": "Merck’s Januvia family enjoys U.S. regulatory exclusivity until **May 2026 for Januvia and Janumet and July 2026 for Janumet XR** (MRK 10‑K, pp. 56‑60). In contrast, Gilead’s key product’s U.S. regulatory exclusivity is slated to expire in **2032** (GILD 10‑K, pp. 6‑10). Because exclusivity blocks generic entry, Merck will face generic competition roughly six years earlier than Gilead, likely accelerating sales erosion for its diabetes line while Gilead retains a longer protected market window to sustain revenue and market share.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the U.S. regulatory exclusivity expiration dates for Merck's Januvia family—May 2026 for Januvia and Janumet, and July 2026 for Janumet XR—and correctly states that Gilead’s exclusivity expires in 2032. These dates match the ground truth exactly. (2) All quantitative elements are accurate: the years 2026 and 2032 are correctly cited, and the comparison of a roughly six-year difference in exclusivity timelines is logically sound (2032 - 2026 = 6 years). No calculations are required beyond this temporal comparison, which is appropriately handled. (3) The multi-hop reasoning is strong: the model synthesizes information across two companies (Merck and Gilead), correctly attributes the data to their respective 10-K filings, and draws a valid conclusion about the impact on market positions. It correctly explains that regulatory exclusivity delays generic entry and that Merck will face earlier competition, leading to likely sales erosion, while Gilead retains a longer protected period. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the mechanism of data exclusivity (i.e., generics cannot rely on innovator’s data), which is part of the ground truth explanation. However, it captures the functional outcome—blocking generic entry—so the omission is minor. Overall, the answer is factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 400,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does Intel's amortization expense for developed technology used in cybersecurity compare with Cisco's revenue recognition timing for its cloud security offerings?",
      "original_answer": "Intel reported $1,283 million in amortization expenses for developed technology in 2021, which includes technology used for cybersecurity solutions like cloud security. Cisco recognizes revenue for its cloud security offerings ratably over the contract term, aligning with the ongoing delivery of updates and upgrades critical to the software’s performance. This contrasts with Intel’s cost recognition pattern, where developed technology is amortized over a 9-year weighted average useful life, reflecting a more fixed cost structure compared to Cisco’s recurring revenue model.",
      "llm_answer": "Intel’s 2021 10‑K reports an amortization expense of $1,283 million for “developed technology” (the intangible asset that includes its cybersecurity solutions) – a straight‑line cost spread over a 9‑year useful life【page 95】.  In contrast, Cisco’s 2022 10‑K discloses that revenue from its cloud‑security offerings is recognized over the term of the customer contract, ratably over time【pages 73‑77】.  Thus, Intel records a fixed amortization expense each period, whereas Cisco spreads revenue recognition across the duration of the contract.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and timeframes are correct: Intel's $1,283 million amortization expense in 2021 for developed technology is accurately reported, and the 9-year useful life is correctly cited. Cisco’s revenue recognition policy for cloud security offerings being ratably over the contract term is also correctly stated. The LLM references the correct fiscal years (Intel 2021, Cisco 2022), which is acceptable given the context of available filings. (2) The answer correctly identifies both companies, relevant financial metrics (amortization expense vs. revenue recognition), and the nature of the assets/offerings (developed technology including cybersecurity, cloud security offerings). (3) The multi-hop reasoning is sound: it contrasts Intel’s cost recognition (fixed, straight-line amortization) with Cisco’s revenue recognition (ratable over time), capturing the core comparison in the question. (4) While the LLM omits a minor detail from the original answer—specific mention that Cisco’s ratable recognition aligns with delivery of updates critical to performance—the omission does not detract from the essential correctness or the synthesis. The answer is semantically equivalent and contextually precise, hence a high score. Minor deduction in qualitative accuracy due to slightly less depth in explaining the rationale behind Cisco’s revenue model.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 399,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the adoption of ASU 2022-02 affected MET's loan modification disclosures compared to JPM's reporting under the legacy TDR guidance, particularly in terms of the types and financial impact of modifications made to borrowers experiencing financial difficulty?",
      "original_answer": "MET adopted ASU 2022-02 on January 1, 2023, which eliminated the TDR accounting framework and introduced the concept of Financial Difficulty Modifications (FDMs), requiring expanded disclosures. MET reported that the adoption did not have a material impact on its financial statements, but it now discloses FDMs instead of TDRs. JPM, under the legacy TDR guidance prior to 2023, reported $362 million in new TDRs for 2022, with modifications typically involving interest rate reductions, term extensions, and payment delays. In 2023, under FDM reporting, JPM noted $136 million in FDMs, predominantly term extensions and rate reductions, which extended the weighted-average life of loans by 20 years and reduced the weighted-average interest rate from 7.21% to 4.44%. This shift reflects a more principles-based approach under ASU 2022-02, focusing on financial difficulty rather than concession-based criteria, resulting in more consistent and transparent reporting of loan modifications across both institutions.",
      "llm_answer": "MetLife’s adoption of ASU 2022‑02 reclassifies all borrower‑concession modifications as financial‑difficulty modifications (FDMs) rather than troubled debt restructurings (TDRs), but the types of changes—principal forgiveness, interest‑rate cuts, payment delays, and term extensions—remain unchanged. In 2023, MetLife’s FDMs totaled $136 million, extending loan lives by 20 years and reducing the weighted‑average interest rate from 7.21 % to 4.44 %. By contrast, JPMorgan’s legacy TDR reporting for 2023 shows a much larger total of roughly $1.9 billion in TDRs, with significant charge‑offs, principal deferrals, and redefaults, indicating a greater financial impact.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly attributes $136 million in FDMs to MetLife (MET), when in fact this figure belongs to JPMorgan (JPM) in 2023. Additionally, it states that JPM reported $1.9 billion in TDRs for 2023, which contradicts the ground truth: JPM did not report TDRs in 2023 because ASU 2022-02 was effective in 2023, and the $362 million in TDRs was for 2022 under legacy guidance. The $1.9 billion figure is entirely fabricated. (2) The quantitative accuracy is very low: correct numbers in the ground truth are $362 million in TDRs for JPM in 2022 and $136 million in FDMs for JPM in 2023 (not MET). The interest rate drop from 7.21% to 4.44% and 20-year extension of loan life are correctly cited but wrongly assigned to MetLife instead of JPM. (3) The multi-hop reasoning is flawed: the model fails to correctly attribute data to the right institutions and time periods. It incorrectly implies MET had $136 million in FDMs, while the ground truth states MET adopted ASU 2022-02 but reported no material financial impact and did not disclose a specific FDM dollar amount. The comparison between MET and JPM is therefore invalid. (4) Contextual relevance is moderate—the answer addresses loan modifications, FDMs vs TDRs, and types of changes, so it stays on topic. However, due to severe factual and attribution errors, the qualitative and correctness scores are low. The reasoning misaligns entities and timelines, undermining the core of the multi-hop comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 422,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does CVX's upstream position in South American natural gas reserves compare with XOM's downstream footprint across the broader Americas region?",
      "original_answer": "CVX reported 329 billion cubic feet of natural gas reserves in South America as of December 31, 2022, reflecting its upstream exposure in the region. South America is geographically included within the broader 'Americas' reporting segment, which encompasses both North and South America. XOM maintains a large downstream presence across the Americas, with integrated refining, marketing, and logistics operations focused on delivering refined products like gasoline, diesel, and synthetic motor oils. While CVX's position centers on upstream resource extraction in South America, XOM's downstream operations span the entire Americas region, highlighting complementary but distinct strategic focuses within the energy value chain.",
      "llm_answer": "CVX’s upstream portfolio in South America is sizable, with about **105 BCF of natural‑gas reserves reported at year‑end 2021** (CVX 10‑K, pp. 106‑110). In contrast, **ExxonMobil’s downstream footprint spans the entire Americas, operating a large network of refineries, marketing and logistics assets that make it one of the region’s biggest integrated downstream businesses** (XOM 10‑K, pp. 61‑65).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in key quantitative data: it reports CVX's South American natural gas reserves as 105 BCF as of year-end 2021, whereas the ground truth states 329 BCF as of December 31, 2022. This is a major discrepancy in both magnitude and timing. The LLM uses an outdated year (2021 vs 2022) and less than one-third of the correct reserve volume. (2) Quantitative accuracy is low because the core number is wrong—105 BCF vs 329 BCF—and the date is off by a year. Even allowing for format variation, the values are not close enough to be considered accurate. (3) Qualitatively, the reasoning structure is sound: the model correctly identifies CVX’s upstream focus in South America and contrasts it with XOM’s integrated downstream footprint across the broader Americas. It appropriately cites the nature of XOM’s refining, marketing, and logistics operations. The multi-hop synthesis—comparing upstream vs downstream positioning across companies and regions—is logically framed and relevant. (4) Contextual relevance is high because the answer addresses the strategic contrast implied in the question and correctly frames the companies’ distinct roles in the energy value chain. However, due to the critical error in the reserve figure and reporting year, the overall correctness score is significantly reduced, as financial and operational comparisons in energy depend heavily on accurate reserve data and current timeframes.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 404,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the $25 million commercial paper exposure of Duke Energy Ohio compare with Tesla's $470 million commercial paper holdings in terms of their short-term liquidity strategies?",
      "original_answer": "Duke Energy Ohio reports a $25 million commercial paper exposure as part of its short-term liabilities, reflecting its reliance on modest short-term borrowing for operational needs. In contrast, Tesla holds $470 million in commercial paper as part of its short-term investments, indicating a cash deployment strategy rather than a funding need. This comparison highlights two distinct uses of commercial paper: Duke Energy utilizes it as a financing tool, while Tesla treats it as an investment to optimize liquidity returns.",
      "llm_answer": "Duke Energy Ohio’s $25 million commercial‑paper exposure is a modest part of its short‑term debt program, used mainly to refinance day‑to‑day working‑capital needs and repay short‑term maturities (weighted‑average maturity ≈ 23 days)【DUK_10k_2023, p. 166‑167】. In contrast, Tesla holds $470 million in commercial paper as part of its short‑term investment portfolio, using it to earn higher yields on excess cash while preserving liquidity【TSLA_10k_2023, p. 72‑73】. Thus, Duke Energy relies on commercial paper primarily as a borrowing tool for liquidity, whereas Tesla treats it as an investment vehicle within its broader liquidity strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Duke Energy Ohio's $25 million commercial paper exposure is accurately described as short-term debt used for working capital and refinancing, with a weighted-average maturity of ~23 days, consistent with its short-term borrowing strategy. Tesla's $470 million holding is correctly characterized as part of its short-term investment portfolio, used to earn yield on excess cash. (2) Quantitative accuracy is perfect: both dollar amounts ($25M and $470M) match the original answer exactly, with no calculation required. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two different companies and filings (DUK_10k_2023 and TSLA_10k_2023), distinguishing between commercial paper as a liability (financing tool) versus an asset (investment vehicle). (4) The qualitative interpretation is strong, clearly contrasting the two companies' liquidity strategies—borrowing for operations vs. investing excess cash—mirroring the original answer’s core insight. Minor enhancements like citation references and maturity detail add value without introducing error. The response fully addresses the comparative aspect of the question with precise, relevant, and correctly interpreted data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 368,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the voting power structure of META's Class A common stock compare to GOOGL's Class B common stock in terms of shareholder influence, given the dual-class stock structures described in their filings?",
      "original_answer": "META's Class A common stock has limited voting power compared to its Class B common stock, where a single shareholder (Mr. Zuckerberg) retains significant control, with Class B shares requiring majority approval for change-in-control transactions until they represent less than 35% of combined voting power. In contrast, GOOGL's Class B common stock provides 10 votes per share, significantly more than the 1 vote per share for Class A, though Class B shares automatically convert to Class A upon sale or transfer. CMCSA's example shows a similar dual-class structure where Class A holds 66 2/3% of voting power with 1 vote per share and Class B holds 33 1/3% with 15 votes per share, illustrating a pattern of concentrated voting control in dual-class structures like those of META and GOOGL.",
      "llm_answer": "Meta’s 2023 10‑K (pp. 48‑52) notes that each Class A share has **one vote per share**, while each Class B share has **ten votes per share** – a structure that concentrates control with Zuckerberg and other Class B holders. Alphabet’s 2023 10‑K (pp. 79‑83) confirms that its Class B shares likewise carry **ten votes per share** (Class A shares have one vote). Consequently, holders of Alphabet’s Class B shares wield a ten‑fold voting advantage over Meta’s Class A shareholders, giving them far greater influence in corporate decisions under each company’s dual‑class setup.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that both META and GOOGL have dual-class structures where Class B shares carry 10 votes per share and Class A shares carry 1 vote per share, which aligns with the ground truth. However, it makes a critical error in stating that 'holders of Alphabet’s Class B shares wield a ten-fold voting advantage over Meta’s Class A shareholders'—this comparison is invalid because it conflates two different companies and misrepresents the intent of the question, which asks for a comparison of voting power *structures*, not cross-company voting power metrics. The ground truth emphasizes structural control mechanisms (e.g., Zuckerberg’s sustained control until Class B falls below 35% voting power, automatic conversion upon sale for GOOGL), which the LLM omits. (2) Quantitatively, the vote ratios (1 vs 10) are accurate for both companies, and the references to 10-K pages are plausible. However, the 'ten-fold voting advantage' claim is a misinterpretation—it compares GOOGL Class B to META Class A, which is not logically or contextually valid. (3) The multi-hop reasoning is partially sound in identifying dual-class structures and vote ratios, but fails in synthesis: it does not address the key structural differences in shareholder influence (control thresholds, transfer restrictions, conversion rules) highlighted in the original answer. The CMCSA example in the ground truth illustrates a broader pattern, which the LLM ignores. (4) Contextual relevance is high because the response addresses dual-class structures and voting power, but correctness is limited by factual misrepresentation in the comparison logic and omission of key governance details that define shareholder influence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 471,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the dividend structure for non-voting share classes at Mastercard and Charles Schwab impact the alignment of shareholder returns between voting and non-voting equity holders, given Mastercard's explicit distinction in dividend rights for B Class Shares and Charles Schwab's statement that dividend rights are identical across voting and nonvoting stock classes?",
      "original_answer": "At Mastercard, both A Class (voting) and B Class (non-voting) shares have dividend rights, indicating equal treatment in shareholder returns through dividends despite differences in voting power. In contrast, Charles Schwab explicitly states that dividend and liquidation rights are identical between its voting and nonvoting stock classes, ensuring full alignment in shareholder returns across share types. This means that while both companies provide dividend rights to non-voting shares, Charles Schwab maintains a stronger structural alignment in returns between share classes, whereas Mastercard preserves dividend parity but separates voting control.",
      "llm_answer": "Mastercard’s B‑class shares are explicitly stated as “non‑voting but with dividend rights” (see the 2024 10‑K note on capital stock, pages 90‑94), meaning that holders receive the same dividend per share as Class A holders but have no voting power.  \nCharles Schwab confirms that “dividend and liquidation rights are identical for voting and non‑voting shares” (Note 20, pages 64‑68), so all shareholders receive the same dividend income regardless of voting status.  \n\nThus, in both firms the dividend structure aligns cash returns for voting and non‑voting holders, but only Mastercard’s structure separates voting rights from dividend rights, leaving non‑voting shareholders with equal economic but not governance influence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that Mastercard's B Class shares are non-voting but have dividend rights, matching the original answer's claim of equal dividend treatment despite voting differences. It also correctly cites Charles Schwab’s identical dividend and liquidation rights across share classes. (2) There are no numerical values, dates, or calculations in the question or answer that require verification—only qualitative financial disclosures—which are accurately represented. Page references (e.g., 10-K note pages) are included as supporting detail but do not affect correctness since the focus is on the disclosed policy, not the location. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies and compares their dividend structures with respect to voting vs. non-voting shares. It draws the correct conclusion that both companies align dividend returns, but only Mastercard explicitly separates voting and economic rights. (4) The only minor shortcoming is a slight reversal in emphasis: the original answer notes that Charles Schwab has 'stronger structural alignment' due to identical rights, while the LLM implies Mastercard’s structure is notable for separation—this is still accurate but less precise in comparative framing. However, the core facts, synthesis, and conclusions are correct. Wording differences do not affect semantic equivalence. All entities (Mastercard, Charles Schwab, Class A/B shares, dividend rights) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 438,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How might the implementation of the OECD's Pillar Two global minimum tax differently affect Microsoft's and Oracle's effective tax rates, given Microsoft's expectation of no material impact and Oracle's concern about materially increased international tax costs?",
      "original_answer": "Microsoft expects no material impact from the OECD's Pillar Two global minimum tax due to its current operations not being concentrated in jurisdictions with tax rates below the 15% threshold. In contrast, Oracle explicitly notes that the adoption of Pillar Two in many jurisdictions could materially increase its international tax costs. While both companies are subject to the same global regulatory framework, their differing geographic footprints and tax planning strategies appear to lead to divergent expectations about the financial impact of the new rules.",
      "llm_answer": "Microsoft’s 10‑K notes that the OECD’s Pillar Two rules will apply to it from FY 2025 but “we do not currently estimate a material impact to our consolidated financial statements,” implying its effective tax rate should remain essentially unchanged (see MSFT_10‑K, pp. 45‑49).  By contrast, Oracle’s filing warns that the same 15 % global minimum tax “may materially increase the level of income tax on our international profits,” suggesting its effective tax rate could rise as the new regime takes effect (see ORCL_10‑K, pp. 27‑31).  Thus, Microsoft expects stability in its tax rate, while Oracle anticipates a potential upward adjustment due to higher international tax costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Microsoft expects no material impact on its financial statements starting FY 2025, and Oracle warns of materially increased international tax costs under Pillar Two. The 15% global minimum tax rate is correctly cited. (2) Quantitative accuracy is perfect: no numerical errors, and the fiscal year (FY 2025) and percentage (15%) match the ground truth. Format variations (e.g., '15 %' vs '15%') are acceptable. (3) Multi-hop reasoning is sound: the model correctly synthesizes information from both Microsoft’s and Oracle’s 10-K filings, compares their differing expectations, and attributes the divergence to their respective international tax exposures. The only minor shortcoming is that the LLM does not explicitly mention the reason Microsoft sees no impact (i.e., its operations are not concentrated in low-tax jurisdictions), which is in the original answer and adds explanatory depth. (4) The response is fully contextually relevant, directly addressing how Pillar Two might differentially affect the two companies’ effective tax rates. Overall, the answer is factually correct, well-supported, and semantically equivalent to the ground truth with only slight room for enhanced explanatory detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 364,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How do GM's and LOW's applications of Level 3 valuation techniques differ in their financial reporting, particularly regarding the unobservable inputs and methodologies used for fair value measurements?",
      "original_answer": "GM utilizes Level 3 valuation techniques primarily for marketable debt securities and finance receivables, relying on pricing models, discounted cash flow models, and industry-standard pricing models with unobservable inputs such as economic forecasts, including unemployment rates, interest rate spreads, disposable personal income, and GDP growth rates. LOW, on the other hand, applies Level 3 valuation specifically to contingent consideration from the fiscal 2022 sale of its Canadian retail business, using an income approach with unobservable inputs like total equity value, volatility, and expected term. While both companies use Level 3 valuations, GM focuses on macroeconomic assumptions across a range of financial instruments, whereas LOW applies it to a specific long-term investment with performance-based metrics.",
      "llm_answer": "GM’s Level 3 fair‑value measurement is applied to a broad array of financial instruments (e.g., RMBS, CMBS, derivatives) and is based on model‑derived valuations that blend observable market data with unobservable assumptions such as benchmark yields, spreads, pre‑payment speeds and credit ratings (GM, pp. 61‑65). In contrast, Lowe’s Level 3 is applied only to the performance‑based contingent consideration from its Canadian retail sale and is measured with an option‑pricing model that relies on unobservable inputs like total equity value, volatility, expected term and a risk‑adjusted discount rate (LOW, pp. 51‑55). Thus, GM’s Level 3 approach is broader and more general, while Lowe’s is focused on a single contingent‑consideration investment with a specific income‑approach model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies GM's use of Level 3 valuations for a broad range of financial instruments (e.g., RMBS, CMBS, derivatives), which matches the original answer's focus on marketable debt securities and finance receivables. The unobservable inputs mentioned—benchmark yields, spreads, prepayment speeds, credit ratings—are consistent with the types of macroeconomic and model-driven assumptions noted in the ground truth (e.g., unemployment rates, interest rate spreads, GDP growth). While not identical in phrasing, these represent similar classes of unobservable inputs used in pricing and discounted cash flow models. (2) For LOW, the LLM correctly specifies that Level 3 is applied only to the contingent consideration from the Canadian retail business sale in fiscal 2022, using an option-pricing model—an income approach—as stated in the ground truth. The unobservable inputs listed (total equity value, volatility, expected term, risk-adjusted discount rate) match or closely correspond to those in the original answer. (3) The multi-hop reasoning is sound: the model correctly contrasts GM’s broad, macroeconomic-driven application across instruments with LOW’s narrow, event-specific use for contingent consideration. (4) Minor deduction in qualitative accuracy due to slightly different framing of GM’s inputs (more market-observable blended in) versus the ground truth’s emphasis on economic forecasts; however, this does not constitute a factual error but a difference in emphasis. No numeric inaccuracies present—both answers avoid specific dollar amounts or dates requiring verification, and all referenced financial instruments and methodologies are correctly attributed. Fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 486,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA influence the potential conversion dynamics of Class A shares, especially in light of Alphabet's aggressive share repurchase strategy involving Class A and Class C shares?",
      "original_answer": "At CMCSA, Class B common stock holds 33 1/3% of the voting power, with each share entitled to 15 votes, and this voting power is non-dilutable under the company's articles of incorporation. This structure creates a concentrated voting control that could influence decisions regarding potential conversions of Class A shares, as Class B shares can be converted share-for-share into Class A under certain restrictions. Meanwhile, Alphabet (GOOGL) has been actively repurchasing Class A and Class C shares, spending $62.2 billion in 2023 alone and maintaining $36.3 billion in remaining authorization as of year-end. This aggressive repurchase strategy could reduce the number of outstanding shares in similar classes, potentially increasing the proportional influence of remaining shareholders, including those holding voting shares like CMCSA's Class B. The combination suggests that while CMCSA's Class A shareholders may see increased influence through potential Class B conversion, GOOGL's repurchase activity could further concentrate ownership and influence within its own capital structure.",
      "llm_answer": "CMCSA’s Class B shares carry 15 votes each and represent 33 ⅓ % of the company’s total voting power, a percentage that is non‑dilutable under its charter. Because Class B shares are convertible share‑for‑share into Class A shares, a conversion would raise the number of Class A shares and dilute the voting power of existing Class A holders, but the aggregate 33 ⅓ % voting power of Class B holders would remain unchanged. Alphabet’s aggressive repurchase of Class A and Class C shares (≈$50‑$62 B in 2021‑23 plus an additional $70 B authorized) shrinks the outstanding share base and can lift share prices, potentially making a conversion of CMCSA’s Class B shares less attractive if the market value of Class A shares rises, though the conversion mechanics are governed solely by CMCSA’s own voting‑power structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the core structure of CMCSA's Class B shares: 15 votes per share, 33 1/3% of total voting power, non-dilutable, and convertible share-for-share into Class A. It also correctly notes that such conversion would dilute existing Class A voting power while preserving the Class B block's aggregate voting influence. The discussion of Alphabet's share repurchases and their potential market effect is relevant and logically connected. However, the quantitative details for Alphabet's repurchases are inaccurate: the LLM states '≈$50-$62 B in 2021-23' and '$70 B authorized', while the ground truth specifies $62.2 billion spent in 2023 alone and $36.3 billion remaining authorization as of year-end. The LLM conflates multiple years and overestimates the authorization, introducing significant numerical error. 2) The dollar amounts and timeframes are not aligned with the ground truth. The original answer cites a precise 2023 figure ($62.2B spent) and remaining authorization ($36.3B), whereas the LLM provides a broad, multi-year range and an incorrect authorization figure. This affects quantitative accuracy despite capturing the 'aggressive' nature of the repurchases. 3) The multi-hop reasoning is sound: the model connects CMCSA's internal share conversion dynamics with external market influences from Alphabet’s repurchases, recognizing that rising Class A share values due to buybacks might affect conversion incentives. This synthesis across companies and capital structures is logically valid, even if speculative. 4) The answer is contextually relevant and captures the key qualitative dynamics. The correctness score is 7 because the core facts about CMCSA are accurate, the reasoning is strong, but the misuse of Alphabet's financial figures reduces confidence in the quantitative foundation of the cross-company comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 504,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the difference in remaining securities available for future issuance under equity compensation plans between MDLZ and CL, based on their 2022 10-K disclosures?",
      "original_answer": "MDLZ reported 48,932,017 securities remaining available for future issuance under equity compensation plans, while CL reported 37,028,000 securities (in thousands). The difference between the two companies' remaining issuance capacity is 11,904,017 securities.",
      "llm_answer": "MDLZ reported 37,028 thousand securities remaining available for future issuance under its equity‑compensation plans (MDLZ 10‑K, p. 127‑131), and Colgate‑Palmolive reported the identical figure of 37,028 thousand (CL 10‑K, p. 59‑63). Consequently, the difference between the two companies is zero.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both entities' reported values. According to the ground truth, MDLZ reported 48,932,017 securities available, while CL reported 37,028,000. The LLM incorrectly states that MDLZ reported 37,028 thousand, which is actually CL's figure. It then falsely claims both companies have identical values, leading to a difference of zero. (2) The quantitative error is severe: the LLM swaps MDLZ's correct value with CL's and fails to compute the correct difference of 11,904,017. Instead, it reports a difference of zero due to the erroneous assumption of equality. (3) The multi-hop reasoning fails completely — the model should have extracted the remaining securities for each company from their respective 10-Ks and computed the difference. Instead, it misattributes CL's number to MDLZ and does not perform valid cross-company comparison. (4) Scores are low because the core numbers and the final calculation are wrong. Contextual relevance is slightly above zero because the answer attempts the right type of comparison and cites relevant filings, but all substantive content is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 323,
        "total_tokens": 1468
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the impact of Illinois' Clean Energy Law on ComEd's transmission rate structure compare to Tesla's exposure to state-level regulatory challenges in markets with direct sales restrictions?",
      "original_answer": "Illinois' Clean Energy Law directly affects ComEd's transmission rate structure by requiring a new four-year multi-year plan to establish rates after the expiration of its performance-based distribution formula rate, and accelerating the amortization of ComEd's unprotected excess deferred income taxes over approximately 39.5 years. These regulatory changes introduce uncertainty around ComEd’s rate of return on equity, which is currently set at 11.50% with a 50-basis-point incentive adder as a RTO member. In contrast, Tesla faces state-level regulatory challenges related to its direct-to-consumer sales model, where certain U.S. states have laws interpreted to restrict its ability to sell vehicles through company-owned stores or obtain dealer licenses. While ComEd’s exposure centers on rate-setting mechanisms and compliance with decarbonization mandates, Tesla’s risk is tied to legal interpretations of motor vehicle industry laws and potential legislative pushback from dealer associations. Both face significant regulatory uncertainty, but the financial implications differ: ComEd’s are embedded in its cost recovery and capital structure, while Tesla’s affect its go-to-market strategy and expansion potential.",
      "llm_answer": "ComEd’s Illinois Clean Energy Law forces the utility to file a new general rate case or four‑year multi‑year plan by Jan. 20 2023 to replace its performance‑based distribution formula, which will adjust its transmission rate base, revenue requirements and potentially raise rates.  In contrast, Tesla’s exposure is to state‑level restrictions on direct‑to‑consumer sales that could require dealer licenses or limit store openings, creating a regulatory risk that could curtail its sales model.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core regulatory impacts on both ComEd and Tesla, correctly identifying the multi-year plan requirement for ComEd and Tesla's direct sales restrictions. However, it omits key details from the ground truth: the accelerated amortization of excess deferred income taxes over 39.5 years and the specifics of ComEd’s 11.50% ROE with a 50-basis-point incentive adder. These omissions reduce completeness and quantitative accuracy. (2) The date 'Jan. 20 2023' is specific but not present in the ground truth, which does not specify a filing deadline—this introduces a potentially incorrect detail, lowering quantitative accuracy. No other numbers (e.g., ROE, amortization period) are mentioned in the LLM answer, so they cannot be verified as correct in this response. (3) The multi-hop reasoning is partially sound: the model correctly links Illinois’ Clean Energy Law to ComEd’s rate structure changes and contrasts it with Tesla’s regulatory challenges. However, it fails to fully synthesize the difference in financial implications—ComEd’s cost recovery and capital structure vs. Tesla’s go-to-market strategy—reducing qualitative depth. (4) The answer is contextually relevant and well-structured, addressing both entities and the nature of their regulatory exposures. While the core comparison is valid, missing financial metrics and incorrect or unsupported dates prevent a higher score. Thus, correctness is 7 due to partial but not full alignment with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 417,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How will the IRA-driven Medicare Part D redesign, which imposes manufacturer discounts and price caps starting in 2025, affect the gross-to-net rebate accruals for both AMGN's ENBREL and BMY's Medicare Part D-dependent products, given AMGN's regulatory exposure and BMY's accounting for GTN adjustments based on payer channel mix and contract prices?",
      "original_answer": "The IRA-driven Medicare Part D redesign, which introduces manufacturer discounts and caps beneficiary out-of-pocket costs starting in 2025, will increase the gross-to-net (GTN) rebate accruals for both AMGN and BMY. For AMGN, the redesign compounds the impact of the set price for ENBREL starting in 2026, which is significantly lower than current pricing, and the potential inclusion of Otezla in the next round of Medicare price setting in 2027. This will likely reduce profitability and necessitate larger GTN adjustments. For BMY, which depends on Medicare Part D and accounts for GTN rebates using assumptions like payer channel mix and contract prices, the new obligations under the IRA will increase rebate liabilities, particularly in the catastrophic phase where manufacturers absorb more costs. The combined effect will be a material adverse impact on both companies' revenues and financial reporting accuracy, as they must adjust accruals to reflect the new regulatory environment and pricing pressures.",
      "llm_answer": "The IRA’s Medicare Part D redesign will raise the amount of rebates that both companies must accrue under gross‑to‑net adjustments. For Amgen, the mandated manufacturer discounts and price caps on ENBREL will increase its GTN accruals because the company must record the higher rebates and lower net price it must provide to Medicare Part D plans. For Bristol‑Myers Squibb, the redesign will similarly boost GTN accruals for its Medicare Part D‑dependent products, with the impact quantified through BMY’s GTN model that incorporates payer‑channel mix and contract‑price assumptions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in its core assertions and aligns well with the ground truth. It correctly identifies that the IRA-driven Medicare Part D redesign will increase gross-to-net (GTN) rebate accruals for both AMGN and BMY due to manufacturer discounts and price caps starting in 2025. The answer accurately reflects that AMGN will face higher GTN adjustments for ENBREL due to lower net prices, and that BMY uses a GTN model incorporating payer channel mix and contract prices—both key points from the original. However, the LLM omits several important multi-hop details present in the ground truth: (1) the specific 2026 effective date of the set price for ENBREL and its material impact, (2) the potential inclusion of Otezla in 2027 price setting, and (3) the heightened impact on BMY during the catastrophic phase of Part D where manufacturers absorb more costs. These omissions reduce completeness and depth of reasoning, particularly in connecting future regulatory timelines and phase-specific financial exposure. There are no numerical inaccuracies—no specific dollar amounts, percentages, or dates are misstated (the LLM avoids citing dates beyond 'starting in 2025', which is correct but less precise than the original). The reasoning is sound but less comprehensive, missing the forward-looking implications on profitability and financial reporting accuracy emphasized in the ground truth. Despite these gaps, the answer captures the essential mechanism and direction of impact for both companies, maintaining semantic equivalence on the primary claim: increased GTN accruals due to IRA. Hence, high scores for quantitative accuracy and contextual relevance, with a slight deduction in qualitative accuracy and overall correctness for missing key temporal and structural details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 488,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How do AIG's and MET's differing accounting treatments for structured securities impact the valuation and reporting of ABS & CLO assets in their respective financial statements?",
      "original_answer": "AIG applies the effective yield method to structured securities, recalculating yields based on expected cash flows and adjusting amortized cost accordingly, with changes in expected cash flows either charged or credited to net investment income. MET, on the other hand, classifies ABS & CLO as available-for-sale (AFS) and measures them at estimated fair value, including those valued using Level 3 inputs, which are disclosed in recurring fair value measurements. These differing approaches—AIG's yield-based adjustments versus MET's fair value measurement—result in different financial statement presentations and sensitivity to market changes, affecting how investors assess the valuation and risk profile of each company's structured securities portfolio.",
      "llm_answer": "AIG measures all structured securities, including ABS & CLO, at fair value with a credit‑loss allowance for non‑high‑credit‑quality instruments; unrealized gains/losses on AFS securities are recorded in OCI (see AIG pages 167‑171).  MetLife, by contrast, values structured securities at fair value on a recurring basis without a separate credit‑loss allowance and reports unrealized gains/losses in earnings or OCI depending on classification (see MET pages 90‑94 and 307‑311).  Consequently, AIG’s allowance lowers the carrying value of ABS & CLO and can trigger higher impairment charges, whereas MetLife’s approach generally yields higher carrying amounts and fewer impairment adjustments, affecting how these assets are presented in each company’s statements.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the core accounting treatments of AIG and MET for structured securities, despite including some correct contextual elements like references to fair value and OCI. According to the ground truth, AIG uses the effective yield method with amortized cost adjustments based on expected cash flows, not fair value measurement with a credit-loss allowance. The LLM incorrectly states that AIG measures structured securities at fair value and applies a credit-loss allowance, which contradicts the ground truth. In contrast, MET does classify ABS & CLO as available-for-sale and measures them at fair value (including Level 3), which the LLM partially captures, but it fails to emphasize the key distinction—MET’s use of fair value vs. AIG’s yield-based amortized cost approach. (2) There are no explicit numbers (dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not penalized; the LLM correctly avoids inventing figures. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the fundamental difference in accounting models—AIG’s income-based yield adjustment method versus MET’s fair value approach. Instead, it fabricates a credit-loss allowance for AIG not mentioned in the ground truth and misrepresents both companies’ treatments. This undermines the qualitative accuracy. (4) Contextual relevance is moderate because the answer discusses valuation, reporting, and financial statement impacts of ABS & CLO for both companies, aligning with the question's intent, but the incorrect accounting premises lead to a misleading conclusion about carrying values and impairments. Thus, while the structure and intent of the response are relevant, the factual foundation is unsound, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 500,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the percentage of Chevron's (CVX) reserves tied to production-sharing contracts (PSCs) compare with ExxonMobil's (XOM) operational exposure in Nigeria, given Nigeria's reliance on PSCs for deepwater offshore exploration and production?",
      "original_answer": "Chevron's (CVX) reserves tied to production-sharing contracts (PSCs) accounted for 8% of its consolidated reserves in 2021. ExxonMobil (XOM) operates in Nigeria, where deepwater offshore exploration and production are governed by PSCs with terms typically lasting 30 years, including a 10-year exploration period and a 20-year production period. This indicates that both companies are exposed to PSC frameworks, but while CVX quantifies its PSC exposure directly in terms of reserves, XOM's exposure in Nigeria is structural and long-term, embedded in the regulatory framework of a key operational region.",
      "llm_answer": "Chevron’s 2021 reserves that are tied to production‑sharing contracts (PSCs) represent about **7 % of its total proved reserves** (the 10‑K notes state 7 % for 2021, 9 % for 2020 and 11 % for 2019).  In contrast, ExxonMobil’s 10‑K does not disclose a specific percentage of its assets in Nigeria, but it notes that Nigeria’s deep‑water offshore operations are almost entirely governed by PSCs with the national oil company, indicating that ExxonMobil’s operational exposure in Nigeria is likely substantial and largely PSC‑based.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states that Chevron's 2021 reserves tied to PSCs were 7%, while the ground truth reports 8%. This discrepancy in the percentage is a factual error, though the trend of declining percentages over years (9% in 2020, 11% in 2019) is correctly noted and aligns with the direction of change. The 1% difference is minor but material in a precise financial context. (2) Quantitatively, the key number (7% vs 8%) is inaccurate, which lowers confidence in exact reporting; however, no calculations were required beyond reporting, so the error is limited to one data point. Other years are consistent with a downward trend, suggesting correct interpretation of the data series. (3) Qualitatively, the reasoning is sound: the model correctly identifies that ExxonMobil does not disclose a specific percentage of Nigerian assets under PSCs but operates in a jurisdiction where deepwater activities are governed by PSCs. It appropriately contrasts Chevron’s quantified exposure with ExxonMobil’s structural exposure, capturing the multi-hop comparison between corporate reserve disclosures and operational frameworks. (4) Contextual relevance is high—the answer addresses both companies, the role of PSCs in Nigeria, and the nature of exposure (quantitative vs structural). Despite the numerical inaccuracy, the overall synthesis and logic are strong, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 390,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does Tesla's fixed share reservation under the 2019 Plan compare with HD's approach to stock appreciation rights in terms of long-term equity compensation flexibility, given Tesla's 49.0 million reserved shares and HD's forfeiture-adjusted vesting methodology?",
      "original_answer": "Tesla's 2019 Plan establishes a fixed reservation of 49.0 million shares for equity incentives including stock appreciation rights (SARs), indicating a structured long-term approach to compensation with defined capacity. In contrast, HD's SAR program incorporates estimated forfeitures into its compensation expense calculation and recognizes value on a straight-line basis as restrictions lapse, allowing for dynamic adjustment based on actual retention of talent. While both companies utilize SARs, Tesla's approach suggests greater predictability and constraint in equity issuance, whereas HD's method provides flexibility in response to workforce attrition and vesting outcomes.",
      "llm_answer": "Tesla’s 2019 Equity Incentive Plan reserves a fixed 49.0 million shares for future issuance, creating a predictable but static pool for long‑term equity awards (TSLA, 2022, pp. 81‑85). Home Depot, by contrast, uses a forfeiture‑adjusted vesting methodology for its stock‑appreciation rights, recalculating the number of shares that vest based on expected forfeitures and thereby providing a more dynamic, flexible compensation framework (HD, 2022, pp. 51‑55). Thus, Tesla’s approach offers certainty at the cost of flexibility, while HD’s method allows the award size to adapt to actual retention and performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Tesla's 49.0 million fixed share reservation under the 2019 Plan and HD's forfeiture-adjusted vesting methodology are accurately described. The numbers match exactly, and no calculations are required beyond correct interpretation. (2) Quantitative accuracy is perfect—49.0 million shares is correctly cited, and the concept of forfeiture adjustment is properly framed without introducing numerical errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across Tesla and HD, contrasting Tesla’s static, predictable equity pool with HD’s dynamic, retention-sensitive approach. The conclusion that Tesla sacrifices flexibility for certainty mirrors the original answer’s logic. (4) The only minor shortcoming is a slight reduction in depth compared to the original answer—specifically, the LLM omits explicit mention that HD recognizes compensation expense on a straight-line basis as restrictions lapse, which adds nuance to the flexibility argument. However, this does not undermine the core correctness. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing the comparison of long-term equity compensation flexibility as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 368,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does Chevron's financial exposure to Tengizchevroil in Kazakhstan, including its $4,500 million loan for the FGP/WPMP development, compare to ExxonMobil's reported long-lived asset value in Kazakhstan of $8,463 million as of 2021?",
      "original_answer": "Chevron holds a 50% equity stake in Tengizchevroil (TCO), which operates major oil fields in Kazakhstan, and has extended a $4,500 million loan to TCO specifically for the FGP/WPMP development. In 2021, Chevron's upstream earnings from TCO contributed positively to its income from equity affiliates. Meanwhile, ExxonMobil reported a total long-lived asset value in Kazakhstan of $8,463 million as of 2021. This suggests that while Chevron's exposure is primarily through equity investment and project-specific financing, ExxonMobil's presence is reflected in substantial asset holdings, indicating differing capital deployment strategies in the same geographic region.",
      "llm_answer": "Chevron’s investment in Tengizchevroil—including the $4.5 B loan for the FGP/WPMP development—is $23.7 B (Note 15, CVX 10‑K, pp. 40‑44). ExxonMobil’s long‑lived assets in Kazakhstan were $8.463 B in 2021 (Long‑Lived Assets table, XOM 10‑K, pp. 121‑125). Thus Chevron’s exposure is about $15.3 B greater—roughly 2.8 times larger—than ExxonMobil’s Kazakhstan asset value.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual and quantitative errors. The claim that Chevron's total investment in Tengizchevroil is $23.7 billion is not supported by the original answer or ground truth data; the only figure provided in the ground truth is the $4,500 million ($4.5 billion) loan for the FGP/WPMP project. There is no mention of a $23.7 billion total investment, making this a significant fabrication or misinterpretation. The comparison calculation is therefore invalid: stating Chevron's exposure is $15.3 billion greater or 2.8 times larger than ExxonMobil's $8.463 billion is incorrect because the $23.7 billion baseline is false. (2) While the $4.5 billion loan amount and ExxonMobil's $8.463 billion long-lived asset value are correctly cited (matching the ground truth), the synthesis and resulting comparison are fundamentally flawed due to the erroneous total exposure figure. (3) The multi-hop reasoning fails because the model incorrectly aggregates or infers Chevron's total exposure beyond the known loan and equity stake described in the original answer. The original answer emphasizes Chevron's exposure via a 50% equity stake and a $4.5 billion loan, but does not provide a total investment figure. The LLM invents a total exposure figure not present in the source, leading to a misleading conclusion. (4) Contextual relevance is moderate because the answer attempts to compare Chevron and ExxonMobil in Kazakhstan and cites correct document locations, but the core conclusion is factually wrong due to the unsupported $23.7 billion number. The qualitative reasoning is weak because it misrepresents the nature of Chevron's exposure as a single monetary total rather than a combination of equity and project financing. Correctness and quantitative accuracy are low due to the critical error in magnitude and calculation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 503,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How do Duke Energy's PPA negotiations for renewable facilities compare to Southern Power's PPA structures in wind facilities, particularly in terms of cash flow implications given Southern Power's utilization of production tax credits through 2024?",
      "original_answer": "Duke Energy negotiates PPAs as part of its commercial renewables strategy, where these agreements significantly influence the economic performance of its renewable energy VIEs. Southern Power, on the other hand, acts as a lessor in PPAs related to wind facilities, which are accounted for as operating leases with terms up to 25 years. These PPAs directly affect Southern Power's cash flows through lease income, which is further enhanced by production tax credits (PTCs) tied to the first 10 years of energy production from these wind facilities. Southern Power had approximately $0.8 billion in unutilized PTCs at the end of 2021, expected to be fully utilized by 2024. This creates a distinct cash flow dynamic: while Duke's PPAs are central to the performance of its consolidated VIEs, Southern Power's PPAs are structured to align with tax credit monetization strategies, directly shaping its lease income and tax equity partnership returns.",
      "llm_answer": "Duke Energy’s renewable‑facility PPAs are negotiated as part of its VIEs and involve the typical fixed‑price or capacity‑charge terms that give the company a more predictable cash‑flow profile (see the “Commercial Renewables” discussion that notes PPAs are a key driver of economic performance).  In contrast, Southern Power’s wind PPAs are structured as operating leases with no capacity charge, tying revenue to actual energy output, and are supplemented by production tax credits that are expected to be fully utilized through 2024, providing a temporary cash‑flow boost that offsets the variability of energy‑based revenue【Commercial Renewables】【Southern Power PPA structure】【PTC utilization】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core distinctions between Duke Energy's and Southern Power's PPA structures and their cash flow implications. (1) All factual elements are correct: Duke Energy's PPAs are tied to VIEs and influence economic performance (as stated in the original answer), and Southern Power structures its wind PPAs as operating leases with revenue linked to energy output. The LLM correctly notes the absence of capacity charges and the role of production tax credits (PTCs) in enhancing cash flow through 2024. (2) Quantitatively, while the original answer mentions $0.8 billion in unutilized PTCs at end-2021, this specific figure is not included in the LLM response. However, the statement that PTCs are 'expected to be fully utilized through 2024' aligns with the original's timeline, and no incorrect numbers are presented. Thus, quantitative accuracy remains high due to absence of errors, though minor incompleteness. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across Duke Energy’s commercial renewables strategy and Southern Power’s lease-based, tax-credit-optimized model. It draws a valid contrast in cash flow profiles—predictable for Duke via fixed terms, variable but PTC-boosted for Southern Power. (4) The answer is contextually relevant and directly addresses the comparison requested, particularly on cash flow implications and PTC utilization. The only minor gap is the omission of the $0.8 billion PTC figure, which slightly reduces completeness but does not affect the overall correctness. Hence, a score of 9 is warranted for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 461,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does LOW's receipt of additional shares through ASR agreements compare to HD's issuance of additional shares via dividend equivalents in deferred share awards for non-employee directors?",
      "original_answer": "LOW receives additional shares from third-party financial institutions as part of variable notional ASR agreements, where the final share delivery depends on the difference between the maximum notional amount paid and the final notional value of shares repurchased. In contrast, HD issues additional shares to non-employee directors through dividend equivalents that accrue on deferred shares and are paid out in stock upon termination of board service. While LOW's additional shares result from share repurchase efficiency, HD's additional shares are a structured compensation element tied to deferred share awards.",
      "llm_answer": "LOW’s ASR agreements let the company receive additional shares from a third‑party financial institution as part of a share‑repurchase program (15.4 million shares repurchased in 2023).  \nIn contrast, Home Depot’s deferred share awards grant non‑employee directors shares that accrue dividend equivalents and are issued as additional shares only upon termination of service (19,000 deferred shares granted in 2023).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core distinction between LOW's ASR agreements and HD's deferred share awards with dividend equivalents. It accurately describes that LOW receives additional shares from third-party financial institutions as part of a share repurchase program, while HD issues additional shares to non-employee directors upon termination of service due to accrued dividend equivalents. This aligns with the ground truth's qualitative explanation. (2) However, the quantitative accuracy is partially flawed. The LLM introduces specific numbers—15.4 million shares repurchased by LOW and 19,000 deferred shares granted by HD in 2023—that are not present in the original answer (ground truth). Since the ground truth does not include any numerical data, the introduction of these figures cannot be verified and appears to be fabricated or inferred beyond available information, reducing confidence in quantitative precision. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different companies (LOW and HD), two distinct financial mechanisms (ASR agreements vs. deferred share awards with dividend equivalents), and correctly identifies the conditions under which additional shares are received or issued. The contrast in purpose—share repurchase efficiency vs. compensation structure—is logically and accurately drawn. (4) Despite the unsupported numbers, the answer remains contextually relevant and semantically aligned with the ground truth in terms of conceptual accuracy. The inclusion of unverified figures prevents a top score, but the reasoning and entity identification are correct, warranting a high correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 466,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How does Boeing's equity income from ULA in 2024 correlate with Lockheed Martin's commercial satellite launch revenue, given ULA's role in serving both government and commercial customers?",
      "original_answer": "Boeing reported equity income of $125 million from ULA in 2024, reflecting its stake in the joint venture. ULA, co-owned by Boeing and Lockheed Martin, provides expendable launch services to both the U.S. Government and commercial customers. Lockheed Martin’s Space segment includes revenue from commercial satellite launches facilitated through ULA. Additionally, Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes payments related to ULA’s commercial launch services. Therefore, Boeing’s equity income from ULA is directly tied to the revenue Lockheed Martin recognizes from commercial satellite launches via ULA’s dual customer base.",
      "llm_answer": "Boeing’s equity‑method income from its 50 % stake in United Launch Alliance (ULA) was **$125 million in 2024**.  Lockheed Martin’s commercial satellite‑launch business generated **about $1.1 billion in revenue** that year.  Because ULA serves both U.S. government and commercial customers, its commercial launch activity underpins Boeing’s equity income, while Lockheed Martin’s larger commercial launch portfolio drives a substantially higher revenue stream.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM correctly identifies Boeing's $125 million equity income from ULA in 2024 and acknowledges ULA's dual role serving government and commercial customers. However, it incorrectly states that Lockheed Martin's commercial satellite launch revenue was 'about $1.1 billion,' which contradicts the ground truth. The original answer does not provide a total revenue figure for Lockheed Martin's commercial satellite launches; instead, it mentions $665 million in receivables (not revenue) from commercial customers as of December 31, 2024, which includes payments related to ULA’s commercial launch services. This is a significant factual error. (2) The quantitative inaccuracy is critical: $1.1 billion vs. $665 million is a large discrepancy, and 'receivables' are not equivalent to 'revenue'—they represent amounts owed, not recognized income. The LLM also fails to mention that ULA is a joint venture co-owned by Boeing and Lockheed Martin, which is central to the equity income mechanism. (3) The reasoning partially captures the multi-hop link—Boeing’s equity income ties to ULA’s performance, which includes commercial launches benefiting Lockheed Martin—but incorrectly frames Lockheed Martin as having a separate 'larger commercial launch portfolio,' implying independence from ULA, when in fact its commercial launch revenue via ULA is the linkage. The synthesis is flawed because it invents a revenue figure and mischaracterizes the financial relationship. (4) Correctness is scored low due to the major numerical and conceptual error. Quantitative accuracy is poor because of the invented $1.1B figure and mislabeling of receivables as revenue. Qualitative accuracy is moderate because the structural understanding of ULA’s role is partially correct. Contextual relevance is high as the answer addresses the core entities and relationships, albeit inaccurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 505,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How does the loss of market exclusivity for LLY's pharmaceutical products, influenced by patent rights and regulatory data protection, compare to MRK's exposure to patent-related risks, particularly in light of the varying durations of exclusivity in major markets such as the U.S., Europe, and Japan?",
      "original_answer": "LLY faces a severe and rapid revenue decline when pharmaceutical products lose effective market exclusivity, which is often tied to patent expiration. However, LLY may retain exclusivity through later-expiring patents on formulations or methods of use, or through regulatory data protection, such as 12 years for biologics in the U.S., 10 years in Europe, and 8 years in Japan. This market exclusivity is determined by both patent rights and regulatory protections, as noted in the BMY evidence, which explains that patent coverage and data exclusivity (e.g., orphan drug exclusivity for 7 years or pediatric exclusivity for 6 months) are the two key determinants of exclusivity. MRK similarly depends on patent rights for market exclusivity and faces material adverse impacts if those rights are invalidated or circumvented. MRK frequently engages in patent litigation to defend its exclusivity, especially against generic manufacturers seeking to enter the market before patent expiration. Thus, both companies are highly exposed to patent-related risks, but LLY may have more nuanced opportunities to extend exclusivity through regulatory mechanisms, while MRK emphasizes legal defense of its patents as a core strategy.",
      "llm_answer": "LLY’s loss of market exclusivity is tied to the expiration of compound patents and data‑protection periods—5 years in the U.S. for chemical products (12 years for biologics), 10 years in the EU, and 8 years in Japan—so that generics can enter quickly and erode sales.  MRK also faces patent‑related risks, with its 10‑K noting that loss of exclusivity can similarly erode revenue, though the specific exclusivity durations for its products are not detailed; MRK’s risk factors emphasize the importance of maintaining patent protection across the U.S., EU, and Japan to mitigate generic competition.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both LLY and MRK face revenue erosion due to loss of market exclusivity from patent expiration and data protection expiry, and it appropriately references key regulatory exclusivity durations in major markets. However, there is a critical error in stating that chemical products have 5 years of data protection in the U.S., which is incorrect—the standard data exclusivity for new chemical entities in the U.S. is 5 years only if not qualifying for longer protections, but more importantly, the ground truth emphasizes biologics (12 years in the U.S.), which the LLM mentions, but incorrectly implies a 5-year standard for chemical products without context. This misrepresents a key quantitative aspect. The EU and Japan durations (10 and 8 years) are correctly attributed, though it's unclear if these refer to biologics or small molecules. (2) The original answer notes additional mechanisms like orphan drug (7 years) and pediatric exclusivity (6 months), which the LLM omits, reducing completeness. Also, MRK’s active engagement in patent litigation as a core strategy is missing in the LLM response, weakening the comparative analysis. (3) The multi-hop reasoning is partially sound—LLY and MRK are correctly compared on patent and regulatory risks, and geographic differences in exclusivity are addressed. However, the LLM fails to fully synthesize the strategic distinction: LLY’s use of formulation/method-of-use patents and regulatory extensions vs. MRK’s reliance on litigation to defend patents. This nuance is central to the original answer and missing in the LLM version. (4) Despite these gaps, the LLM captures the core idea that both companies are exposed to patent risks and depend on exclusivity mechanisms across the U.S., EU, and Japan. Wording is clear and relevant, and the overall structure addresses the comparative nature of the question. The correctness score is 7 due to accurate high-level framing but significant omissions and one key factual inaccuracy in data exclusivity duration for chemical products in the U.S.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 564,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How do the potential financial impacts of cyber intrusion-related compliance costs at Southern Company's nuclear facilities compare to Duke Energy's decommissioning trust fund funding risks given both companies' exposure to nuclear power plant operations?",
      "original_answer": "Southern Company highlights that cyber intrusions could result in increased nuclear licensing or compliance costs that are difficult to predict, particularly at its nuclear facilities where Alabama Power and Georgia Power hold ownership interests representing 26% and 28% of their total KWH generation in 2021, respectively. These compliance costs could rise unpredictably due to threats of cyber intrusions or physical attacks. Meanwhile, Duke Energy notes that a decline in the market value of assets in its Nuclear Decommissioning Trust Funds (NDTF) could increase funding requirements for decommissioning its nuclear plants. Both companies face distinct financial risks tied to nuclear power plant operations—Southern Company through potential cyber-related compliance costs and Duke Energy through market-dependent decommissioning funding obligations.",
      "llm_answer": "Southern Company’s nuclear plants face potentially large, event‑driven compliance costs if a cyber intrusion occurs—such incidents could trigger NRC fines, shutdowns or additional security and remediation outlays that are difficult to predict. Duke Energy’s nuclear exposure is tied to the performance of its decommissioning trust funds; market volatility that erodes trust‑asset values could force extra contributions to meet decommissioning obligations and strain cash flows. Thus, Southern Company’s risk is regulatory‑and‑incident‑driven, while Duke Energy’s is a market‑based funding risk that could require additional capital to cover long‑term decommissioning liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with strong qualitative and contextual alignment. (1) All factual elements are correct: Southern Company faces unpredictable compliance costs due to cyber intrusions at its nuclear facilities, while Duke Energy faces funding risks tied to the market performance of its Nuclear Decommissioning Trust Funds. The LLM correctly identifies the nature of each risk—Southern's as incident- and regulation-driven, Duke's as market-driven—without introducing errors. (2) Quantitative accuracy is perfect: while the LLM does not repeat the specific 26% and 28% generation percentages from Alabama Power and Georgia Power, these figures are contextually relevant but not essential to answering the comparative risk question. Their omission does not impair the correctness of the comparison, as the question focuses on financial impact types, not generation mix specifics. (3) Multi-hop reasoning is sound: the model synthesizes distinct risk types across two companies, correctly linking cyber threats to regulatory/compliance costs for Southern and market volatility to decommissioning funding for Duke. (4) Semantic equivalence is maintained—wording differs but meaning matches. The LLM enhances clarity by specifying potential consequences like NRC fines or shutdowns, which are reasonable inferences. Only a minor deduction in qualitative accuracy due to omission of the ownership percentages, which add context but do not alter the fundamental correctness of the comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 426,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the treatment of dividend equivalents on deferred stock units granted to non-employee directors in 2023 by Lowe's compare with Home Depot's policy on dividend equivalents related to deferred shares, particularly in terms of vesting schedules and payout structure?",
      "original_answer": "Lowe's provides dividend equivalents on deferred stock units granted to non-employee directors, which vest either on the first anniversary of the grant date or the day before the next Annual Meeting of Shareholders, with immediate vesting for awards granted prior to 2022. In contrast, Home Depot pays dividend equivalents on deferred shares granted to non-employee directors that accrue and are paid out in additional shares upon termination of service, with the fair value expensed immediately upon grant. This shows differences in both vesting timing and payout mechanisms between the two companies’ deferred compensation structures.",
      "llm_answer": "Lowe’s deferred stock units for non‑employee directors vest on the earlier of the first anniversary of the grant or the day before the next Annual Meeting of Shareholders, with dividend equivalents earned and paid out in additional shares at vesting (expense recognized straight‑line over the service period)【page 64】. In contrast, Home Depot’s deferred shares vest only upon termination of board service, with dividend equivalents accruing and paid in additional shares when the underlying shares are finally paid out, and the awards are expensed immediately upon grant【page 68】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Lowe's vesting is on the earlier of the first anniversary or the day before the next Annual Meeting, with dividend equivalents paid in additional shares at vesting and expense recognized over the service period. Home Depot’s deferred shares vest upon termination of service, dividend equivalents accrue and are paid in additional shares at payout, and the award is expensed immediately upon grant. (2) There are no numeric inaccuracies—though no specific numbers (e.g., dollar amounts) are present, the timing and structural details (e.g., vesting events, payout triggers) are factually correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes policies from two companies, comparing vesting schedules and payout structures for deferred stock units and dividend equivalents. (4) The only minor omission is that the original answer notes Lowe's immediate vesting for awards granted prior to 2022, which the LLM answer does not mention. However, the question focuses on 2023 grants, so this detail is contextually less critical. Wording differs slightly but maintains semantic equivalence. Thus, the answer is excellent in quantitative accuracy, contextual relevance, and overall correctness, with a slight deduction in qualitative accuracy for the omitted pre-2022 policy nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 388,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the potential loss of 12-year biologic data exclusivity in the U.S. impact AMGN's competitive position compared to MRK's strategy of leveraging compound patents and pediatric exclusivity extensions?",
      "original_answer": "The potential removal of the 12-year biologic data exclusivity in the U.S., as highlighted in AMGN's 10-K, could expose AMGN to earlier biosimilar competition, particularly for products like EPOGEN, which is sold almost exclusively to a concentrated customer base. In contrast, MRK's strategy, as outlined in its 10-K, relies on a layered approach to market exclusivity, including compound patents, pediatric exclusivity extensions (which can add six months), and regulatory data protection. This layered approach allows MRK to maintain commercial control even after initial patent expiration, giving it a more diversified defense against generic erosion compared to AMGN's reliance on regulatory exclusivity.",
      "llm_answer": "The loss of the 12‑year biologic data exclusivity would expose AMGN to biosimilar competition earlier, eroding its pricing power and market share (AMGN_10k_2022, pp. 44‑48).  In contrast, MRK’s 10‑K (pp. 16‑20) explains that it relies on a portfolio of compound patents and seeks pediatric exclusivity extensions to extend exclusivity beyond the statutory period, giving it a stronger competitive moat.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and captures the core contrast between AMGN and MRK's exclusivity strategies as described in the ground truth. (1) All entities—AMGN, MRK, biologic data exclusivity, compound patents, pediatric exclusivity—are correctly identified and contextually accurate. (2) There are no numeric values requiring verification (e.g., 12-year exclusivity, six-month pediatric extension), but the LLM correctly references the 12-year biologic exclusivity without stating an incorrect number, and while it doesn't explicitly mention the 'six-month' extension for pediatric exclusivity, this detail is implied in the concept of extending exclusivity. The omission is minor and does not affect overall correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes that AMGN is vulnerable to earlier biosimilar competition due to reliance on regulatory exclusivity, while MRK uses a layered strategy including patents and exclusivity extensions. (4) The answer is semantically equivalent to the original, with slightly less detail (e.g., no mention of EPOGEN or concentrated customer base), but the core competitive dynamics are preserved. The answer is highly relevant and concise. A score of 9 is justified due to minor completeness gaps, but factual and quantitative accuracy is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 368,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the treatment of the countercyclical capital buffer under TLAC requirements for GS compare with SCHW's application of the same buffer, particularly in light of GS's 18% minimum TLAC to RWAs threshold and SCHW's 2.5% stress capital buffer?",
      "original_answer": "Goldman Sachs (GS) includes the countercyclical capital buffer as part of its TLAC to RWAs requirement, which the Federal Reserve has set to zero percent, within the broader 18% minimum TLAC threshold (as stated in GS's 10-K filing). In contrast, Schwab (SCHW) is also subject to a countercyclical capital buffer above the minimum risk-based capital ratios, which was zero percent as of December 31, 2024 (as disclosed in SCHW's 10-K). However, SCHW specifically maintains a 2.5% stress capital buffer, indicating a differentiated approach to regulatory capital planning despite both institutions operating under a zero percent countercyclical buffer.",
      "llm_answer": "Goldman Sachs’ TLAC calculation requires an 18 % minimum of risk‑weighted assets, a 2.5 % buffer, a 1.5 % G‑SIB surcharge, but the countercyclical capital buffer is set to **zero** under the FRB’s TLAC rules. In contrast, Schwab’s regulatory framework also has a countercyclical buffer of **zero**, but it applies a separate **2.5 % stress‑capital buffer** above the regulatory minimum risk‑based capital ratios. Thus, GS’s countercyclical buffer is effectively omitted from its TLAC requirement, whereas Schwab relies on a 2.5 % stress buffer to provide additional capital cushion.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core comparison between Goldman Sachs (GS) and Schwab (SCHW) regarding the countercyclical capital buffer and the presence of a 2.5% stress capital buffer at SCHW, which aligns with the ground truth. However, there are significant quantitative inaccuracies: the LLM incorrectly states that GS has a '2.5% buffer' and a '1.5% G-SIB surcharge' as part of its TLAC calculation—this information is not present in the original answer and introduces unsupported details. The ground truth only confirms that GS includes the countercyclical buffer (set to zero by the Federal Reserve) within its 18% minimum TLAC to RWAs threshold, with no mention of a 2.5% buffer or G-SIB surcharge in this context. Additionally, while both institutions have a zero percent countercyclical buffer, the LLM's claim that it is 'effectively omitted' from GS’s TLAC requirement misrepresents the situation—the buffer is included in the regulatory framework but currently set to zero, not omitted. The qualitative reasoning is mostly sound in contrasting GS’s TLAC-based regime with SCHW’s stress capital buffer, reflecting appropriate multi-hop synthesis across regulatory frameworks. Contextually, the response is relevant and addresses the comparative treatment of capital buffers. Semantic equivalence is partially achieved, but the introduction of unverified numerical components reduces factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 388,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does XOM's asset exposure in Kazakhstan compare with CVX's stake in TCO's operations in the region?",
      "original_answer": "XOM reported $7,728 million in long-lived assets in Kazakhstan in 2023, reflecting its operational exposure in the region. Meanwhile, CVX holds a significant stake in TCO, which operates major oil fields like Tengiz and Korolev under a concession agreement expiring in 2033. TCO achieved mechanical completion of the Future Growth Project (FGP) in 2023, with start-up expected in the first half of 2025, and is also advancing the Karachaganak Expansion Project, with Stage 1A expected to complete in 2024. CVX’s involvement through TCO demonstrates its strategic positioning in Kazakhstan’s upstream sector, despite not directly owning long-lived assets like XOM.",
      "llm_answer": "XOM’s long‑lived assets in Kazakhstan total roughly $7.7 billion (2023).  In contrast, Chevron’s exposure in the same country is a 50 % equity interest in the Tengizchevroil (TCO) affiliate, giving it a half‑share of TCO’s operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states XOM's long-lived assets in Kazakhstan as approximately $7.7 billion in 2023, which aligns with the ground truth value of $7,728 million (rounded appropriately). It also accurately identifies CVX's 50% equity interest in Tengizchevroil (TCO), which is factually correct. However, the LLM omits key qualitative details present in the original answer, such as the status of TCO’s Future Growth Project (FGP) achieving mechanical completion in 2023 and expected start-up in H1 2025, as well as the Karachaganak Expansion Project with Stage 1A completion expected in 2024. Additionally, the concession expiration in 2033 and the strategic implications of CVX’s indirect exposure versus XOM’s direct asset ownership are not mentioned. (2) Quantitatively, the $7.7 billion figure is a valid rounding of $7,728 million, and the 50% stake in TCO is accurate. No calculations were required, but the representation of financial figures and ownership percentage is precise. (3) The reasoning correctly contrasts direct asset exposure (XOM) with indirect equity participation (CVX via TCO), demonstrating sound multi-hop logic across corporate structures and operational models. However, the lack of project-level updates and forward-looking developments weakens the depth of synthesis. (4) The answer is contextually relevant and addresses the core comparison between XOM’s asset base and CVX’s stake in TCO. While factually sound on the main points, the omission of key operational details from the ground truth reduces completeness, warranting a score of 7 for correctness and qualitative accuracy despite strong quantitative and relevance scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 458,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does Southern Company's uncertainty around the financial impact of transitioning from LIBOR to alternative rates under ASU 2020-04 compare with NextEra Energy's disclosure that it is applying the same standard to its interest rate contracts, given that both companies rely on reference rate reform guidance to manage derivative exposures?",
      "original_answer": "Southern Company explicitly states that the 'ultimate outcome of the transition [from LIBOR] cannot be determined at this time,' indicating uncertainty in assessing the financial impact of ASU 2020-04. In contrast, NextEra Energy affirms that it is applying the guidance under ASU 2020-04 to manage its interest rate contracts affected by reference rate reform. Both companies are subject to the same regulatory framework and are actively navigating the transition from LIBOR to alternative rates, but NEE demonstrates a more definitive implementation stance compared to SO's ongoing evaluation.",
      "llm_answer": "Southern Company notes that, although it has elected to use ASU 2020‑04 for LIBOR‑referenced debt and hedges, “the ultimate outcome of the transition cannot be determined at this time” (see Southern Company notes, pp. 193‑197). In contrast, NextEra Energy confirms it is applying the same ASU to its LIBOR‑based debt and derivative contracts and has “continued to evaluate … and, to date, has not been a material impact” (NEE notes, pp. 76‑80). Thus, Southern Company remains uncertain about the financial effect of the transition, whereas NextEra Energy has already implemented the guidance and reports no material impact so far.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures Southern Company's uncertainty, quoting the exact phrase 'the ultimate outcome of the transition cannot be determined at this time,' and accurately reflects NextEra Energy's position of applying ASU 2020-04 with no material impact to date. (2) There are no numerical values, dates, or financial figures in the original or LLM answer, so quantitative accuracy is not applicable in a traditional sense, but all referenced disclosures (e.g., page numbers) are consistent and correctly attributed. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures from both companies regarding their use of ASU 2020-04 and contrasts their stances—SO's ongoing uncertainty versus NEE's implementation and assessment of immaterial impact. The only minor shortcoming is that the LLM slightly strengthens the contrast by stating NEE 'has already implemented the guidance and reports no material impact,' while the original answer emphasizes NEE's active application but stops short of confirming full implementation. This is a nuance, not a factual error. (4) The answer is contextually relevant, directly addressing the comparison of uncertainty and implementation under the same standard. Overall, the LLM conveys the same semantic meaning with high fidelity, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 405,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the dual-class stock structure and voting rights limitations in META's Class A Common Stock compare to GOOGL's governance framework under their respective Certificates of Incorporation, particularly in terms of protecting minority shareholder interests?",
      "original_answer": "GOOGL's Certificate of Incorporation ensures equal dividend and liquidation rights across all stock classes and mandates unanimous board approval before amendments affecting stockholder rights can be proposed, with affected classes requiring to approve such changes. This provides a structural safeguard for minority shareholders. In contrast, META's Class A Common Stock is subject to a controlled company structure where the board is not required to be majority independent, and key governance decisions require approval from Class B stockholders, who hold superior voting rights. META's Certificate of Incorporation also includes anti-takeover provisions that require a two-thirds majority vote for certain amendments once Class B voting power drops below 35%, further entrenching control and potentially limiting minority shareholder influence.",
      "llm_answer": "META’s dual‑class structure (pages 48‑52) gives Class B shares ten votes each and lets holders of those shares—primarily the CEO and founders—control the majority of voting power, thereby limiting minority shareholders’ influence.  In contrast, Alphabet’s certificate of incorporation (pages 79‑83) contains safeguards that require approval by the affected class for any amendment that alters rights and unanimous board consent before such amendments, and it sets a voting regime where Class A common stockholders vote on all matters while Class B and C common stockholders have only limited voting rights, providing stronger protections for minority shareholders.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts and structure. (1) It accurately identifies META's dual-class structure with Class B shares having superior voting rights (10 votes per share), which concentrates control among insiders and limits minority shareholder influence—this matches the original answer. It also correctly contrasts this with GOOGL’s governance framework, noting that GOOGL requires class-level approval for amendments affecting rights and mandates unanimous board consent before proposing such changes, which protects minority shareholders. (2) There are no explicit numbers (e.g., percentages, dollar amounts, vote counts) in either answer, so quantitative accuracy is not compromised; all referenced procedural requirements (e.g., unanimous board approval) are correctly stated. (3) The multi-hop reasoning is sound: the model synthesizes governance differences between META and GOOGL by comparing voting rights, board amendment procedures, and implications for minority shareholders. However, it omits a specific detail present in the ground truth: META’s anti-takeover provision requiring a two-thirds majority vote for certain amendments once Class B voting power falls below 35%, which further entrenches control. This omission slightly weakens completeness and qualitative accuracy. (4) Despite this, the answer remains contextually relevant and semantically equivalent in conveying that GOOGL has stronger structural protections for minority shareholders compared to META’s controlled company model. Wording differs but meaning is preserved. Hence, correctness is high but not perfect due to the missing anti-takeover clause detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 463,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How might the implementation of the OECD's global minimum tax framework impact the effective tax rates of both PepsiCo and Altria, given their differing U.S. tax burdens and exposure to international tax changes?",
      "original_answer": "The implementation of the OECD's global minimum tax framework could increase PepsiCo's effective tax rate due to its international operations and exposure to countries implementing the 15% minimum tax, as noted in PepsiCo's 10-K. Altria, which reported $2,346 million in federal tax payments in the U.S. and minimal foreign tax liabilities, may not face the same upward pressure on its effective tax rate, as its tax burden is more concentrated domestically. The U.S. tax legislation context suggests that multinational corporations with significant overseas earnings, like PepsiCo, are more likely to see tax increases under the new framework, while companies like Altria with limited international exposure may remain relatively unaffected.",
      "llm_answer": "PepsiCo’s effective tax rate could rise as the OECD’s 15 % global minimum tax forces higher taxes on its foreign profits, which currently benefit from lower effective rates (PEP_10k_2023, pp. 23‑27).  Altria, whose tax burden is already high in the U.S. (effective tax rate 25.6 % in 2023, 22.0 % in 2022, 35.3 % in 2021) and has limited overseas exposure, would see a smaller impact—its effective rate would likely remain largely unchanged or increase only modestly if any of its foreign subsidiaries are affected (MO_10k_2023, pp. 76‑80).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that PepsiCo is likely to face an increase in its effective tax rate due to the OECD's 15% global minimum tax impacting its international operations, citing its lower foreign tax rates (supported by PEP_10k_2023). This matches the original answer's reasoning about PepsiCo's exposure to international tax changes. (2) For Altria, the LLM correctly notes minimal foreign exposure and provides specific effective tax rates (25.6% in 2023, 22.0% in 2022, 35.3% in 2021), which are plausible and consistent with high domestic tax burden, though these exact figures are not in the ground truth. However, the ground truth emphasizes Altria's $2,346 million in federal taxes and minimal foreign liabilities—information not contradicted, but not included in the LLM response. (3) The multi-hop reasoning is sound: the model correctly synthesizes that multinational firms like PepsiCo with overseas earnings are more exposed to the minimum tax, while domestically focused firms like Altria are less affected. (4) Minor deduction in quantitative accuracy because the specific tax rate percentages for Altria, while reasonable, are not confirmed in the ground truth and could be seen as over-precision. Otherwise, all logic, entity identification, and contextual relevance are excellent. The answer fully addresses the comparative impact on both companies and explains the differential exposure clearly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 409,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the extension of market exclusivity through orphan drug designation in the U.S. impact AbbVie's risk of generic competition, given Eli Lilly's reliance on the same regulatory mechanism to protect its products beyond compound patent expiration?",
      "original_answer": "In the U.S., orphan drug designation grants seven years of market exclusivity, which runs in parallel with any applicable patents and can extend beyond the expiration of compound patents, as noted in Eli Lilly's 2023 10-K. This exclusivity period prevents the FDA from approving another application for the same drug product for the same orphan use, as described in the regulatory overview. For AbbVie, the loss or weakening of such exclusivity—whether through patent challenges, regulatory changes, or compulsory licensing—could accelerate generic competition and significantly reduce revenues, as stated in AbbVie's 2023 10-K. Therefore, the strength and duration of orphan drug exclusivity directly influence AbbVie’s exposure to market erosion, especially in the context of competitors like Eli Lilly leveraging the same protections to maintain market control beyond traditional patent life.",
      "llm_answer": "Orphan‑drug designation in the U.S. gives a product up to seven years of market exclusivity that runs concurrently with any active patents, thereby extending AbbVie’s protection beyond the expiration of compound patents and lowering the likelihood of generic entry 【ABBV_10k_2023.pdf, pages 16‑20】.  Lilly’s 10‑K notes that it likewise relies on orphan‑drug exclusivity to shield its products after patent life ends, showing that this regulatory tool is a common strategy for mitigating generic competition 【LLY_10k_2023.pdf, pages 8‑12】.  Consequently, AbbVie can use orphan exclusivity to reduce its generic‑competition risk, though the benefit is limited to the 7‑year period and may not fully offset competition if other exclusivities lapse sooner.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the 7-year U.S. orphan drug exclusivity period is accurately stated, and it is correctly noted that this runs concurrently with patents and can extend beyond compound patent expiration. The reference to Eli Lilly’s reliance on the same mechanism is supported and correctly contextualized. (2) The answer correctly cites AbbVie’s and Eli Lilly’s 2023 10-Ks (implied by the document names and page ranges), maintaining entity and year accuracy. (3) The multi-hop reasoning is sound: it connects orphan drug exclusivity as a regulatory tool used by both companies, explains how it delays generic competition, and infers that AbbVie benefits similarly—though with appropriate caveats about duration and limitations. (4) Semantically, the LLM captures the core insight from the original answer: that orphan exclusivity reduces generic risk and is a strategic tool used across the industry, directly impacting revenue protection. The only minor shortcoming is a slightly weaker emphasis on the risk to AbbVie if exclusivity is weakened (e.g., via regulatory changes or challenges), which is a key point in the original answer. However, the mention that the benefit is 'limited' and may not 'fully offset competition' shows awareness of this vulnerability. Overall, the answer is factually correct, well-sourced, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 400,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Coca-Cola FEMSA's operational footprint in Argentina in 2021 influence KO's equity investee sales exposure compared to PEP's direct exposure to Argentina's economic volatility during the same period?",
      "original_answer": "KO reported net sales to equity method investees, including Coca-Cola FEMSA, of $14,471 million in 2021, which were influenced by recovery from the pandemic. Coca-Cola FEMSA operated in Argentina's federal capital and surrounding areas in 2021, contributing to KO's indirect exposure in that market. Meanwhile, PEP directly operated in Argentina and faced economic volatility, including currency controls and inflationary pressures, which posed risks to their financial results. Therefore, while KO's exposure to Argentina was indirect through Coca-Cola FEMSA's operations and tied to equity investee sales, PEP faced direct exposure to Argentina's macroeconomic instability in 2021.",
      "llm_answer": "Coca‑Cola FEMSA operated in Argentina (federal capital of Buenos Aires and surrounding areas) in 2021, and because KO holds an equity stake in Coca‑Cola FEMSA, a portion of KO’s equity‑method sales exposure came from Argentina through that investee【Distribution System, page 8】. In contrast, PepsiCo’s own operations in Argentina exposed it directly to the country’s economic volatility, as noted in its risk‑factor discussion on pages 39‑43 of the 2022 10‑K【PEP risk factors, pages 39‑43】. Thus, KO’s exposure was indirect via its equity investee, while PEP’s was direct through its own operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All entities are correct: Coca-Cola FEMSA, KO, PEP, Argentina, 2021 time frame. The operational footprint in Buenos Aires and surrounding areas is accurately stated. (2) Quantitative accuracy is perfect—while the LLM does not repeat the $14,471 million figure from KO’s equity-method sales, this omission does not constitute a factual error, as the question does not explicitly require that specific number. The absence of a numeric value is a minor completeness gap but not a quantitative inaccuracy. (3) Multi-hop reasoning is sound: the model correctly links KO’s indirect exposure via equity investment in Coca-Cola FEMSA to Argentina’s market, and contrasts it with PEP’s direct operational presence and associated risks. It references appropriate sections of the 10-Ks (e.g., PEP risk factors, pages 39–43), indicating proper sourcing. (4) Semantic equivalence is strong—the conclusion that KO had indirect exposure while PEP faced direct exposure to Argentina’s economic volatility is fully aligned with the original answer. The only minor shortcoming is the lack of explicit mention of pandemic recovery influencing KO’s equity investee sales, which adds contextual depth in the ground truth. However, this does not undermine the correctness of the exposure comparison. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 401,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does AbbVie's reliance on patent rights for emraclidine through its acquisition of Cerevel Therapeutics influence its market exclusivity strategy compared to Merck's experience with Januvia's patent expiration and regulatory exclusivity timeline?",
      "original_answer": "AbbVie's acquisition of Cerevel Therapeutics included an exclusive global license under certain Pfizer patent rights, which were critical for developing and commercializing emraclidine. However, despite this licensing arrangement, AbbVie recorded a $4.5 billion intangible asset impairment charge related to emraclidine, suggesting that the expected market exclusivity or commercial viability did not materialize as anticipated. Patent rights are a key determinant of market exclusivity in the pharmaceutical industry, often supplemented by regulatory exclusivity periods that can extend beyond patent terms. In contrast, Merck was able to extend its market exclusivity for Januvia and Janumet in the U.S. until May 2026 and for Janumet XR until July 2026 due to favorable court rulings and settlement agreements around a later-expiring patent on the sitagliptin salt form, despite the core compound patent expiring in January 2023. This demonstrates that while AbbVie's strategy relied heavily on patent licensing to secure exclusivity, it faced significant financial consequences when that exclusivity or market uptake failed to deliver expected returns, unlike Merck, which successfully leveraged later-stage intellectual property strategies to delay generic competition.",
      "llm_answer": "AbbVie’s emraclidine strategy hinges on the exclusive global license it obtained from Pfizer through the Cerevel acquisition, which gives it patent protection but is now reflected in a $4.5 billion intangible impairment charge—indicating that the patents may be eroding and limiting long‑term exclusivity (AbbVie 10‑K, pp. 66‑70). In contrast, Merck has extended Januvia’s market exclusivity beyond the January 2023 patent expiration through settlement agreements and the FDA’s five‑year regulatory exclusivity, keeping the drug protected in the U.S. until May 2026 (and Janumet XR until July 2026) (Merck 10‑K, pp. 56‑60).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all key numbers and dates are accurate: the $4.5 billion impairment charge is correctly cited; Januvia's core patent expiration in January 2023 and extended exclusivity until May 2026 (Janumet XR until July 2026) match the original answer. The mention of FDA’s five-year regulatory exclusivity is contextually relevant, though the original answer emphasizes settlement agreements and court rulings around the sitagliptin salt patent as the mechanism for extension—this nuance is slightly underemphasized but not incorrect. (2) The entity identification is accurate: AbbVie, Cerevel Therapeutics, Pfizer (via licensing), and Merck are all correctly referenced. Emraclidine and Januvia/Janumet are properly associated. (3) Multi-hop reasoning is sound: the model correctly contrasts AbbVie’s reliance on licensed patent rights that led to a significant impairment charge with Merck’s successful extension of exclusivity beyond core patent expiry through legal and regulatory strategies. However, the LLM omits the specific detail that Merck’s extension was due to a later-expiring patent on the sitagliptin salt form, which is a key differentiator in the original answer and part of the multi-hop synthesis. This omission slightly weakens the qualitative accuracy. (4) The answer is contextually relevant and directly addresses the comparison between AbbVie’s patent-dependent strategy and Merck’s successful exclusivity extension. Wording differs but meaning is semantically equivalent in most parts. The reference to 'FDA’s five-year regulatory exclusivity' is a simplification—the original specifies that the extension came via litigation settlement on a formulation patent, not standard regulatory exclusivity. This minor mischaracterization prevents a top score. Overall, the answer is factually strong with only minor gaps in completeness and precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 523,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does Chevron's investment in the Caspian Pipeline Consortium (CPC) influence its crude oil export capacity, and how does this compare to ConocoPhillips' reliance on crude oil production for its upstream operations?",
      "original_answer": "Chevron's 15% interest in the Caspian Pipeline Consortium (CPC) enables it to export approximately 1.2 million barrels of crude oil per day from Kazakhstan, which is critical for transporting output from the Tengiz and Karachaganak fields. The CPC pipeline's debottlenecking project, completed in January 2023, increased throughput capacity, directly supporting Chevron's Future Growth Project (FGP) expected to ramp up in early 2025. In contrast, ConocoPhillips' upstream operations are fundamentally dependent on crude oil production, as evidenced by its 2023 filings, where crude oil remains a core component of its asset base and revenue generation. Therefore, Chevron's exposure to crude oil export capacity is mediated through its stake in CPC, while ConocoPhillips has a more direct operational dependency on crude oil production.",
      "llm_answer": "Chevron’s 15 % stake in the Caspian Pipeline Consortium gives it access to a pipeline that moved an average of 1.4 million barrels of crude per day in 2023—about 1.2 million from Kazakhstan—thereby expanding its export capacity (CPC transported an average of 1.4 million barrels of crude oil per day, composed of 1.2 million barrels per day from Kazakhstan and 0.2 million barrels per day from Russia). In contrast, ConocoPhillips’ upstream business is almost entirely driven by crude‑oil production, with its 2023 proved reserves totaling 4,550 million BOE and production figures dominated by oil, underscoring a heavy reliance on extracting crude for its upstream operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's 15% stake in the CPC and its relevance to crude oil export capacity, and accurately contrasts this with ConocoPhillips' reliance on crude oil production. However, there are key quantitative discrepancies: the ground truth states Chevron's interest enables it to export approximately 1.2 million barrels per day *from Kazakhstan*, while the LLM claims the CPC moved 1.4 million barrels per day (1.2M from Kazakhstan and 0.2M from Russia) and links Chevron’s access to this total volume. This overstates Chevron's direct benefit, as the 1.2 million barrels from Kazakhstan aligns with the ground truth, but the inclusion of Russian volumes and the higher total throughput is not attributed in the original answer and may misrepresent Chevron's actual export capacity. Additionally, the LLM introduces ConocoPhillips' 2023 proved reserves of 4,550 million BOE, which is not in the original answer and, while potentially true, is extraneous and unverified in the ground truth. (2) The date of the CPC debottlenecking project (January 2023) and the Future Growth Project (FGP) ramp-up in early 2025 mentioned in the original answer are missing in the LLM response, representing a notable omission in timeline context. (3) The multi-hop reasoning is generally sound—linking Chevron’s equity stake to export infrastructure and contrasting it with ConocoPhillips’ direct production dependency—but misses the synthesis of project timelines and their strategic implications. (4) The contextual relevance is high, as the answer addresses both companies and the core contrast in business model exposure. However, the quantitative accuracy is reduced due to unsupported volume figures and the introduction of unverified data, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 492,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Oracle's integration of generative AI in MySQL HeatWave compare with Qualcomm's strategic vision for on-device generative AI in edge computing, given both companies' investments in cloud computing infrastructure?",
      "original_answer": "Oracle integrates generative AI into its MySQL HeatWave cloud service, combining transactions, real-time analytics, machine learning, and generative AI in one managed service to enhance data processing and decision-making capabilities. Meanwhile, Qualcomm envisions generative AI becoming ubiquitous across industries, with a focus on running complex models on edge devices such as smartphones and PCs to improve immediacy, privacy, and personalization. Qualcomm expects that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024, and sees cloud computing as a complementary enabler of these edge AI capabilities. Both companies are investing in cloud computing—Oracle through its Oracle Cloud Infrastructure (OCI) and Autonomous Database offerings, while Qualcomm supports cloud-edge coordination through its cloud computing processing initiative within its QSI segment.",
      "llm_answer": "Oracle embeds generative‑AI models into its MySQL HeatWave, a managed cloud database that combines transactions, real‑time analytics, machine learning and generative‑AI inference on OCI (Oracle Cloud Infrastructure) to accelerate analytics workloads. Qualcomm’s strategy is to ship generative‑AI models onto its Snapdragon SoCs and AI Engine, enabling low‑power, on‑device inference for smartphones, PCs, automotive and IoT, with cloud support for training and data sharing through its cloud‑computing‑processing initiative. Both firms invest heavily in cloud infrastructure—Oracle via OCI AI and data services, Qualcomm via its cloud‑computing initiative—but Oracle focuses on cloud‑centric analytics, whereas Qualcomm prioritizes edge‑centric, on‑device generative‑AI capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core strategies of both Oracle and Qualcomm regarding generative AI. Oracle's integration of generative AI into MySQL HeatWave on OCI is accurately described, including its combination of transactions, analytics, ML, and generative AI. Qualcomm's focus on on-device generative AI via Snapdragon SoCs and AI Engine for edge devices (smartphones, PCs, automotive, IoT) is also correctly conveyed. The answer notes cloud support for training and data sharing through Qualcomm’s cloud-computing-processing initiative, aligning with the ground truth. (2) Quantitative accuracy is perfect: while the LLM answer does not include the specific forecast of 46% of smartphones being generative AI-capable by 2027 (up from 19% in 2024), this omission does not introduce inaccuracy—only incompleteness. No incorrect numbers are presented. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across Oracle’s cloud-centric AI (via OCI and MySQL HeatWave) and Qualcomm’s edge-centric vision with cloud as a complement. It distinguishes Oracle’s cloud-managed service model from Qualcomm’s device-first approach, and acknowledges both companies’ cloud investments—Oracle directly, Qualcomm via coordination. (4) The answer is contextually relevant and semantically equivalent to the ground truth in all key aspects, though slightly less detailed in projecting market adoption metrics. This minor omission prevents a perfect 10, but the core facts, entities, and strategic contrasts are correct and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 433,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Walmart's use of firm commitments for inventory and utility purchases compare to Colgate-Palmolive's use of option contracts in managing financial exposure, given the role of such instruments in mitigating cash flow risks?",
      "original_answer": "Walmart has $15.9 billion in firm commitments due within one year, primarily for inventory, utilities, and capital expenditures, which represent legally binding contracts that lock in future cash outflows. These obligations are managed through operational cash flows and are not typically hedged with financial derivatives. In contrast, Colgate-Palmolive actively uses option contracts as part of its foreign exchange risk management strategy to hedge forecasted transactions, protecting against currency fluctuations. Both companies aim to reduce cash flow volatility, but Walmart focuses on operational liquidity planning while Colgate employs financial instruments like options to manage exposure. This distinction reflects differing approaches to financial risk mitigation aligned with their respective business models.",
      "llm_answer": "Walmart’s firm commitments lock in inventory and utility purchases with suppliers, creating fixed or minimum‑quantity contracts that fix prices and delivery dates and thereby stabilize cash outflows and inventory levels. Colgate‑Palmolive, in contrast, uses option contracts—primarily as part of its foreign‑exchange and commodity‑hedging programs—to cap adverse currency or commodity price movements while preserving upside, which mitigates cash‑flow volatility from exchange‑rate and price swings. Both instruments serve to reduce cash‑flow risk, but Walmart’s focus is on supply‑chain cost certainty, whereas Colgate’s focus is on hedging financial exposure to currency and commodity price fluctuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor omissions. (1) Quantitative accuracy: The LLM does not include the specific $15.9 billion figure for Walmart's firm commitments, which is present in the original answer. However, the question does not explicitly ask for dollar amounts, so this omission does not severely impact correctness. All other non-numeric information is factually correct. (2) Completeness: The LLM addresses both Walmart's use of firm commitments (for inventory and utilities) and Colgate-Palmolive's use of option contracts in managing financial exposure, correctly contrasting their approaches. It captures the essence that Walmart locks in costs via supply-chain contracts while Colgate uses financial instruments (options) to hedge currency and commodity risks. (3) Entity accuracy: Both companies are correctly identified with accurate descriptions of their risk management instruments. Terms like 'firm commitments' and 'option contracts' are used appropriately. (4) Reasoning: The multi-hop synthesis is sound—correctly linking Walmart’s operational approach to cash flow stability and Colgate’s financial hedging strategy to volatility mitigation. The conclusion that both reduce cash flow risk but through different mechanisms aligns with the ground truth. (5) Semantic equivalence: Despite not citing the $15.9B figure, the LLM answer effectively communicates the functional and strategic differences between the two companies’ approaches. The absence of the number slightly reduces completeness but not enough to undermine the overall correctness. Hence, a score of 9 is warranted, with full marks in quantitative accuracy because no stated numbers are incorrect (only one omitted), and high scores in all other categories due to strong reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 500,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Morgan Stanley's use of credit default swaps (CDS) to hedge default risk relate to Capital One's reliance on default rate assumptions in valuing their net derivative assets, given the sensitivity of both institutions to credit event outcomes?",
      "original_answer": "Morgan Stanley actively uses credit default swaps (CDS) to hedge against the risk of default on debt obligations, entering into contracts where it receives or provides protection against credit events such as bankruptcy or failure to pay. The firm manages exposure through risk mitigation strategies and monitors aggregate market risk limits. Meanwhile, Capital One values its net derivative assets using discounted cash flow models that depend heavily on unobservable inputs, including a weighted average default rate assumption of 4% with a range of 53–163%. The connection between the two lies in the systemic sensitivity both institutions have to default outcomes: Morgan Stanley’s CDS contracts are triggered by defaults, directly affecting its derivative liabilities, while Capital One’s valuation models depend on projected default rates, meaning actual deviations from these assumptions would materially impact the fair value of its derivative assets. Thus, both firms are indirectly exposed to the same macroeconomic or sector-specific credit events that could simultaneously affect their derivative positions.",
      "llm_answer": "Morgan Stanley uses credit‑default swaps (CDS) to hedge default risk, providing direct protection that is triggered when a credit event—such as bankruptcy, failure to pay or restructuring—occurs (MS 10‑K, pp. 109‑113).  Capital One, by contrast, values its net derivative assets through Level‑3 fair‑value models that rely on default‑rate assumptions (53‑163 % range, weighted 4 %) as a key unobservable input (COF 10‑K, pp. 206‑210).  Both institutions are therefore highly sensitive to credit events: Morgan Stanley’s CDS positions generate payouts or losses upon default, while Capital One’s derivative valuations shift with changes in the assumed default rates that drive fair‑value estimates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: Morgan Stanley uses CDS to hedge default risk with payouts triggered by credit events (e.g., bankruptcy, failure to pay), and Capital One relies on Level-3 fair-value models with a 4% weighted average default rate assumption and a 53–163% range. These numbers match the original answer exactly, with only a formatting difference (53–163% vs 53–163 %) that does not affect meaning. (2) Quantitative accuracy is perfect: the 4% weighted average and 53–163% range are correctly cited, and no calculations are required beyond accurate reporting. (3) The multi-hop reasoning is sound: the answer correctly identifies that both firms are sensitive to credit events, though through different mechanisms—Morgan Stanley via direct CDS exposure and Capital One via model assumptions. The synthesis across institutions and derivative valuation methods is logically coherent. (4) The only minor shortcoming is that the LLM omits the explicit statement that deviations from Capital One’s default rate assumptions would 'materially impact' the fair value of its derivative assets, which slightly weakens the connection in the conclusion. However, the implication is still clear from context. Wording differences (e.g., 'Level-3 fair-value models' vs 'discounted cash flow models') are acceptable as they are semantically consistent in financial reporting contexts. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 419,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How do Duke Energy's natural gas distribution assets in Georgia compare to Southern Company Gas's investment in SNG in terms of capital scale and contribution to regional infrastructure reliability, given their respective exposures to Georgia's energy market?",
      "original_answer": "Duke Energy operates 28,000 miles of natural gas distribution and transmission pipelines in Georgia, directly contributing to local infrastructure reliability by delivering gas to end-users. Southern Company Gas holds a 50% interest in SNG, a 7,000-mile pipeline system that connects supply basins in the Gulf Coast to markets including Georgia, underpinning supply-side reliability. While Duke’s assets are focused on distribution with direct customer delivery, SNG serves as a backbone transmission system feeding regional utilities, including those in Georgia like Duke, creating an integrated infrastructure network. Southern Power’s 97% investment coverage ratio through 2028 indicates strong contracted revenue stability for SNG-related assets, while Duke’s localized pipeline miles reflect a high dependency on regional demand and regulatory frameworks governing distribution rates and returns.",
      "llm_answer": "Duke Energy’s 2023 10‑K reports a total natural‑gas network of 35,700 mi of pipelines and 28,800 mi of service lines, of which the Georgia segment is a subset of that extensive, largely underground system that underpins local reliability.  Southern Company Gas’s 50‑percent stake in the Southern Natural Gas (SNG) pipeline represents a single, 7,000‑mile cross‑state asset that directly feeds Georgia’s markets from major supply basins, giving it a large capital footprint and a key role in regional reliability.  While Duke Energy’s Georgia assets are part of a broader, multi‑state network, SNG’s dedicated pipeline provides a focused, high‑capacity conduit that bolsters Georgia’s reliability and market connectivity.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies. It states Duke Energy has '35,700 mi of pipelines and 28,800 mi of service lines' in its total network, but this figure is not limited to Georgia—whereas the ground truth specifies Duke operates 28,000 miles *in Georgia*. The LLM incorrectly implies these large totals are relevant to Georgia’s assets, overstating the scale of Duke’s presence in the state. The 7,000-mile length of SNG is correctly reported. 2) The LLM fails to mention Southern Power’s 97% investment coverage ratio through 2028, a key financial metric from the original answer that speaks to capital stability and revenue predictability for SNG-related assets—this omission weakens the capital scale assessment. 3) While the LLM correctly identifies the functional distinction between Duke’s distribution focus and SNG’s transmission role, it misses the critical interdependence noted in the ground truth: that SNG feeds utilities like Duke in Georgia, creating an integrated system. This multi-hop synthesis is partially present but underdeveloped. 4) The qualitative reasoning is sound in distinguishing asset types (distribution vs. transmission) and their roles in reliability, and entity names (Duke Energy, Southern Company Gas, SNG) are correct. Contextual relevance is high as the response directly addresses capital scale and infrastructure reliability in Georgia. However, due to the misrepresentation of Duke’s pipeline mileage in Georgia and omission of key financial data, the overall correctness is reduced to a 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 427,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the enactment of Louisiana's corporate tax rate reduction legislation in 2024 impact Union Pacific's deferred tax expense, and how does this compare to the impact from similar legislation in Arkansas during the same year?",
      "original_answer": "Louisiana's enactment of corporate tax rate reduction legislation in 2024 resulted in a $34 million reduction in Union Pacific's deferred tax expense. This mirrors a similar impact from Arkansas, which also enacted tax rate reductions, contributing to a comparable adjustment. Together, these state-level legislative changes reflect a broader regional shift in corporate tax policy affecting Union Pacific's financial position.",
      "llm_answer": "Union Pacific’s 2024 10‑K notes that the Louisiana corporate‑tax‑rate‑reduction law lowered its deferred‑tax expense by **$34 million**.  Arkansas’s similar legislation had the same effect, contributing to that $34 million reduction in deferred tax expense.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $34 million reduction in deferred tax expense due to Louisiana's tax legislation, which matches the ground truth. However, it inaccurately states that Arkansas’s legislation contributed to the same $34 million reduction, implying the total impact was $34 million combined rather than $34 million from Louisiana and a 'comparable' amount from Arkansas. The original answer suggests Arkansas had a similar, separate impact, not that it was included in or identical to the Louisiana adjustment. (2) Quantitatively, the $34 million figure is accurate and properly attributed to Louisiana; no calculation errors are present. (3) The multi-hop reasoning is partially flawed: while the model correctly links both states’ legislation to deferred tax expense reductions, it fails to distinguish the impacts as separate but comparable, instead conflating them into a single $34 million figure. This misrepresents the synthesis of the two legislative effects. (4) Despite this, the answer remains contextually relevant and captures the core financial impact and states involved, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 328,
        "total_tokens": 1519
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does the difference in voting rights between META's Class B Common Stock and GOOGL's Class A Common Stock influence their respective corporate governance structures, particularly in light of the specified voting limitations tied to Class B shares in merger scenarios?",
      "original_answer": "META's Class B Common Stock has no voting rights except in specified merger or consolidation scenarios, where they receive voting power proportional to their conversion rate. This limits shareholder influence outside of exceptional corporate actions. In contrast, GOOGL's Class A Common Stock provides one vote per share, offering more consistent voting influence to shareholders. This structural difference means that at META, decision-making control is more concentrated among holders of shares with superior voting rights (e.g., Class A), while at GOOGL, Class A shareholders have a steadier role in corporate governance. The specified voting limitations in META's charter for Class B shares in merger scenarios create a tailored influence mechanism that only activates under specific corporate events, unlike GOOGL's ongoing voting rights for Class A shares.",
      "llm_answer": "Meta’s Class B common stock carries 10 votes per share, giving its holders outsized influence over corporate decisions, whereas Alphabet’s (GOOGL) Class A common stock is limited to one vote per share, ensuring a more dispersed voting structure【META_10k_2024.pdf: 2】【GOOGL_10k_2024.pdf: 80】. In merger scenarios, Meta’s Class B shares are subject to voting limitations—such as being required to vote as a single class or tied to conversion rates—reducing their influence compared to Alphabet’s Class A shareholders, who retain full voting rights on mergers【V_10k_2024.pdf: 90】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that severely undermine its correctness. (1) It incorrectly states that Meta’s Class B common stock carries 10 votes per share, which is false: according to the ground truth and actual SEC filings, Meta’s Class B shares have *no voting rights* except in specified merger or consolidation scenarios, where they gain voting power proportional to their conversion rate. In contrast, Meta’s Class A shares (not Class B) are the ones with superior voting rights (typically 10 votes per share). The LLM reverses this critical structure. (2) It misrepresents GOOGL’s structure: while it correctly notes that GOOGL Class A shares have one vote per share, it fails to contrast this meaningfully with Meta’s limited activation of voting rights, instead implying a general difference in vote count without capturing the core governance distinction—Meta’s Class B shares are mostly non-voting, unlike GOOGL’s consistently voting Class A shares. (3) The citation of 'V_10k_2024.pdf' for merger voting rights is irrelevant (V refers to Visa, not Meta or Google), indicating potential source confusion or hallucination. (4) Multi-hop reasoning is flawed: the question asks how voting differences influence corporate governance, especially in merger contexts. The LLM attempts this but bases its analysis on incorrect voting rights assignments, leading to invalid conclusions. While the answer addresses the general topic and attempts to compare governance structures, the core factual inversion (Class B having 10 votes vs. having no votes) results in a mostly incorrect response. Quantitative accuracy is very low due to the erroneous vote count. Qualitative accuracy is slightly higher because the answer recognizes that merger scenarios involve special voting rules and attempts to contrast governance models, albeit incorrectly. Contextual relevance is moderate as it stays on topic and references relevant concepts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 525,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How might U.S. payer restrictions on high-cost therapies like Repatha impact Pfizer's revenue recognition strategy for similar cardiovascular products, given both companies face challenges with formulary placement and patient affordability?",
      "original_answer": "U.S. commercial payer actions have significantly restricted access to high-cost therapies like Repatha through formulary exclusions, prior authorization requirements, and increased patient cost-sharing, which has directly limited sales despite price reductions. Pfizer faces similar risks, as it notes challenges in obtaining or maintaining favorable formulary placement and pricing for its products amid managed care and healthcare cost containment trends. Gilead's revenue recognition strategy accounts for these payer dynamics through complex gross-to-net deductions that factor in expected payer mix, rebate levels, and patient affordability trends. Therefore, if Pfizer markets similar high-cost cardiovascular therapies, it would likely face comparable pressures requiring careful estimation of rebates and chargebacks to align with payer realities and maintain revenue integrity.",
      "llm_answer": "U.S. payer restrictions on high‑cost therapies such as Repatha force Pfizer to recognize revenue only after net‑to‑gross deductions (rebates, chargebacks, patient‑assistance) are resolved, which can delay or reduce the amount of revenue recorded for similar cardiovascular products (PFE 10‑K, pp. 11‑12).  The company’s revenue‑recognition policy requires that revenue be recorded net of estimated government and other rebates and chargebacks, so increased payer‑driven discounts and step‑therapy requirements can postpone revenue recognition (PFE 10‑K, pp. 11‑12).  Amgen and Gilead face comparable formulary placement and affordability pressures, leading them to adopt similar net‑to‑gross adjustments when recognizing revenue for high‑cost cardiovascular therapies (Amgen 10‑K, pp. 39‑43; Gilead 10‑K, pp. 46‑50).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that U.S. payer restrictions on high-cost therapies like Repatha impact revenue recognition by necessitating net-of-deductions accounting, specifically through rebates, chargebacks, and patient assistance programs. This matches the original answer's emphasis on gross-to-net deductions and revenue integrity. (2) There are no numeric values in the question or answers that require verification—both responses are qualitative and consistent in their descriptions of financial mechanisms. Format and terminology (e.g., 'net-to-gross deductions') are used appropriately and interchangeably with 'gross-to-net' as seen in the ground truth. (3) The multi-hop reasoning is sound: the LLM connects Amgen’s experience with Repatha to Pfizer’s potential challenges, then links to broader industry practices at Gilead and Amgen, correctly inferring that Pfizer would apply similar revenue recognition strategies under ASC 606, which requires estimating variable consideration (rebates, discounts). The citation of specific 10-K pages (though not to be validated here) adds contextual support. (4) The only minor shortcoming is that the LLM slightly overemphasizes *delay* in revenue recognition, whereas the original answer focuses more on *reduction* due to lower realized prices—though both are valid aspects of revenue impact. However, the core insight about the necessity of complex rebate estimation and its effect on net revenue is preserved. Semantic equivalence is strong, entities (Pfizer, Amgen, Gilead, Repatha) are correct, and the synthesis across companies and financial reporting practices is logically coherent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 466,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does Chevron's 15% ownership stake in TCO's Kazakhstan crude oil operations influence its exposure to TCO's planned production ramp-up from the FGP project starting in 2025, especially when compared to COP's broader dependence on crude oil as a raw material?",
      "original_answer": "Chevron's 15% ownership in TCO provides it with partial exposure to TCO's planned production ramp-up from the FGP project in Kazakhstan, which is expected to start-up in the first half of 2025 and ramp up to full production within three months. This production increase will flow through the Caspian Pipeline Consortium (CPC), in which Chevron also holds a 15% interest, enabling increased throughput capacity. In contrast, COP has a direct and full dependency on crude oil as a raw material, indicating a more concentrated exposure to crude oil supply dynamics. Chevron’s partial ownership in TCO creates a more indirect exposure to crude oil production volumes and timelines in Kazakhstan, as opposed to COP’s direct reliance on crude oil for its operations.",
      "llm_answer": "Chevron’s 15 % stake in TCO’s Kazakhstan crude‑oil assets means that only 15 % of the incremental output from the Future Growth Project (FGP) – which is slated to start up in 2025 and ramp to full production within three months – will be attributable to Chevron.  In contrast, ConocoPhillips’ (COP) entire petrochemical business relies on crude oil as a core raw material, so the company’s exposure to crude‑oil price and supply shocks is pervasive across all of its product lines.  Thus, Chevron’s exposure is limited to a specific, incremental source of oil, whereas COP’s exposure is broader and company‑wide.  (CVX_10k_2023.pdf: pages 112‑115; COP_10k_2023.pdf: pages 143‑147)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Chevron's 15% ownership in TCO, the FGP project start in 2025, ramp-up within three months, and the attribution of only 15% of incremental output to Chevron are all factually consistent with the original answer. The mention of ConocoPhillips' (COP) broad reliance on crude oil as a raw material is also accurate. (2) Quantitative elements—percentages (15%), timeframes (2025 start, three-month ramp-up)—are correctly reported with no calculation errors. Format variations (e.g., '15 %' with space) do not affect accuracy. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes Chevron’s partial ownership in TCO and contrasts it with COP’s company-wide crude oil dependency. However, the LLM omits mention of Chevron’s 15% stake in the Caspian Pipeline Consortium (CPC), which is part of the original answer and adds context about throughput capacity—this is a minor but relevant omission affecting qualitative depth. (4) Despite this omission, the core comparison between Chevron’s limited, project-specific exposure and COP’s broad operational dependence is clearly and correctly conveyed. The answer is contextually relevant, directly addressing the comparative exposure question with appropriate sourcing references. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 406,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How does Goldman Sachs' exposure to hotel-related commercial real estate loans compare to MetLife's investment in real estate funds focused on hotels, given the role of real estate funds in both companies' strategies?",
      "original_answer": "Goldman Sachs has significant credit exposure to commercial real estate loans secured by hotels, as detailed in their 2024 10-K filing, which highlights the importance of this asset class in their lending portfolio. These loans are often channeled through or connected to real estate funds, which are also a key vehicle for investment in hotel assets. MetLife, on the other hand, holds $13.3 billion in real estate investments as of December 31, 2024, including interests in real estate funds that invest in hotel properties. While both companies are exposed to hotel real estate, Goldman Sachs' involvement is primarily through lending, whereas MetLife participates through direct ownership stakes in funds. This distinction reflects different risk profiles and strategic approaches to the hotel sector within the broader commercial real estate market.",
      "llm_answer": "Goldman Sachs’ hotel exposure is modest – hospitality loans make up about 5 % of its commercial‑real‑estate loan portfolio (≈6.5 % of its net commercial‑mortgage loans)【GS_10k_2024.pdf:118‑120】.  MetLife’s real‑estate strategy, by contrast, is largely driven by its real‑estate‑fund investments, which account for 27.4 % of its real‑estate holdings【MET_10k_2024.pdf:94‑96】; the funds include hotel assets, but the specific allocation to hotels is not disclosed.  Thus, GS’s hotel exposure is a small slice of its loan book, whereas MetLife’s hotel‑focused funds form a larger, though not precisely quantified, portion of its overall real‑estate strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces specific quantitative details not present in the original answer, such as '5% of its commercial-real-estate loan portfolio' and '≈6.5% of its net commercial-mortgage loans' for Goldman Sachs, and '27.4% of its real-estate holdings' for MetLife’s fund investments. These percentages are not found in the ground truth, which does not quantify the proportion of hotel-related loans or fund allocations. The original answer only states that Goldman Sachs has 'significant credit exposure' and MetLife holds $13.3 billion in real estate investments including hotel-focused funds, without breaking down percentages. Thus, the LLM fabricates precise metrics unsupported by the ground truth, leading to major quantitative inaccuracies. (2) The dollar amount of $13.3 billion in MetLife’s real estate investments is missing from the LLM answer, which undermines completeness and quantitative accuracy. This is a key factual omission. (3) The qualitative reasoning is sound in distinguishing between Goldman Sachs’ lending exposure and MetLife’s ownership via funds, correctly identifying the strategic difference in how each company engages with hotel real estate. This reflects accurate multi-hop synthesis across business models. (4) Contextually, the answer is highly relevant, addressing the comparative exposure and strategic roles of real estate funds. However, the inclusion of unsourced percentages reduces factual reliability. While the direction of the comparison (Goldman more modest, MetLife more fund-focused) aligns with the original, the unsupported numbers significantly detract from correctness. Hence, the correctness score is 6—partially correct but with significant factual gaps and invented metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 487,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How do the liquidity risk profiles of BA's limited partnership investments compare with UPS's pension fund commitments in real estate, particularly regarding the 10–15 year partnership terms and UPS's $3.3 billion in unfunded obligations?",
      "original_answer": "Both BA and UPS hold investments through limited partnerships, which expose them to long-term liquidity risks due to the structural characteristics of these vehicles. BA invests in limited partnerships that focus on real estate and private assets, with investment durations typically spanning 10–15 years, limiting liquidity until the end of the partnership term. Similarly, UPS has $3.3 billion in unfunded commitments to limited partnerships as of December 31, 2023, with redemption provisions restricted until the end of the fund’s life, also generally 10–15 years from inception. This shared structure implies both companies face limited short-term liquidity and are exposed to market risks over extended periods without the ability to exit early without discounts.",
      "llm_answer": "BA’s limited‑partnership investments, described on pages 90‑94 of its 10‑K, are long‑term (10‑15 yr) and illiquid, with redemption rights only at the end of the partnership term. UPS’s pension‑fund real‑estate commitments have the same 10‑15‑year partnership terms, but the fund carries an unfunded obligation of roughly $3.3 bn (disclosed on pages 87‑91), indicating a higher liquidity exposure than BA’s commitments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $3.3 billion unfunded obligation for UPS is accurately cited, and the 10–15 year partnership terms for both BA and UPS are correctly reported. Format variations (e.g., $3.3 bn vs $3.3 billion) are acceptable. (2) The answer addresses all parts of the question: it compares BA’s limited partnership investments with UPS’s pension fund commitments in real estate, notes the shared 10–15 year illiquidity horizon, and correctly identifies UPS’s $3.3 billion in unfunded obligations. (3) Entity accuracy is strong: both companies (BA and UPS), the nature of the investments (limited partnerships), and the relevant financial metric (unfunded commitments) are correctly identified. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers that UPS’s unfunded commitment implies a higher liquidity exposure compared to BA’s fully funded (implied) investments, which is a reasonable qualitative interpretation supported by the data. The only minor shortcoming is that the original answer emphasizes the structural similarity in liquidity risk due to redemption restrictions, while the LLM slightly overemphasizes the difference in exposure without fully balancing the similarity in structural illiquidity. However, the conclusion about higher liquidity exposure for UPS is logically derived from the unfunded obligation and is not incorrect. Overall, the answer is factually precise, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 430,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the voting power distribution tied to Class A and Class B common stock at META compare to the voting structure at CMCSA, particularly in terms of control concentration and shareholder influence?",
      "original_answer": "At META, the dual-class structure gives Class B common stockholders, primarily Mark Zuckerberg, outsized control, requiring a majority of Class B shares to approve change-of-control transactions until they represent less than 35% of combined voting power. In contrast, CMCSA's structure grants Class A common stockholders 66 2/3% of the combined voting power, with each Class B share having 15 votes, but Class B stock is non-dilutable and owned entirely by Brian L. Roberts. This means both companies use dual-class structures to concentrate control, but META's governance rules and anti-takeover provisions make it harder for investors to influence corporate decisions compared to CMCSA, where Class A shareholders collectively hold significant voting influence.",
      "llm_answer": "Meta’s dual‑class structure gives Class B shares ten votes each, and holders of those shares (the founder, CEO and board chair) hold a majority of the combined voting power—even when Class B represents only about 9 % of the total shares—so control is highly concentrated in a small group.  \nComcast’s structure is less concentrated: Class B shares have 15 votes each but account for only 33.3 % of voting power, while Class A shares hold 66.7 %; the two classes normally vote as one class, giving ordinary shareholders a larger share of influence.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the core idea that both META and CMCSA use dual-class structures to concentrate control, with outsized voting power in certain share classes. It correctly identifies that Class B shares at CMCSA have 15 votes and that Class A holds a majority of voting power (66.7%), aligning with the ground truth's 66 2/3%. However, it incorrectly states that Meta's Class B shares have 'ten votes each', which is inaccurate—Meta’s Class B shares have 10 votes per share, but this detail, while commonly known, is not explicitly confirmed in the ground truth provided. More critically, the LLM claims that Class B represents 'about 9%' of total shares, which is not mentioned or verifiable from the original answer and introduces unsupported data. Additionally, the original answer highlights specific governance mechanisms at Meta—such as the requirement for a majority of Class B shares to approve change-of-control transactions until they fall below 35% of voting power—which the LLM omits entirely. This is a significant qualitative omission affecting completeness and correctness. 2) Quantitative accuracy is partially correct: 66.7% for Class A at CMCSA matches 66 2/3%, and 33.3% for Class B is acceptable. However, the 9% figure for Meta’s share count is unsupported and likely incorrect, and the 'ten votes' claim, while plausible, isn't in the ground truth and thus cannot be verified. 3) The reasoning correctly compares control concentration and shareholder influence across the two companies and infers that CMCSA gives more influence to ordinary shareholders. However, it fails to incorporate Meta’s anti-takeover provisions and voting thresholds that make investor influence harder, a key differentiator emphasized in the original answer. This weakens the multi-hop synthesis. 4) Despite missing key governance details and introducing unverified numbers, the LLM answer remains contextually relevant and conveys a broadly accurate comparison of control concentration. The core contrast—Meta’s extreme founder control vs. CMCSA’s relatively more balanced (though still concentrated) structure—is reasonably conveyed. Hence, a score of 7 is justified: factually mixed with correct main ideas but notable errors and omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 598,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the allocation of PEP's U.S. qualified defined benefit plan assets to government securities compare with the investment profile of COST's short-term holdings in government and agency securities, particularly in terms of risk management and expected return strategy?",
      "original_answer": "PEP's U.S. qualified defined benefit plans allocated $1.812 billion to government securities in 2023 as part of a diversified investment strategy aiming for a 7.4% long-term return, while COST holds short-term investments in government and agency securities primarily for capital preservation with a focus on low volatility and effective maturities of three months to five years. PEP's approach includes active management and use of derivatives to mitigate risk, whereas COST limits exposure to interest rate fluctuations by investing in fixed-rate, short-duration instruments.",
      "llm_answer": "PEP’s U.S. qualified defined‑benefit plan assets allocate roughly 56 % to fixed‑income, of which about $1.8 billion (2023) is in U.S. government securities (Table on page 98).  The plan targets a 7.4 % long‑term return and uses derivatives to hedge interest‑rate and currency risk, reflecting a moderate‑risk, higher‑return strategy.  In contrast, COST’s short‑term portfolio is limited to U.S. government and agency securities with maturities of 3 months to 5 years (policy on page 30), aimed at principal preservation and modest yield; risk is managed by restricting holdings to high‑quality, fixed‑rate instruments and money‑market funds, with no explicit pursuit of higher returns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies PEP's $1.8 billion allocation to U.S. government securities in 2023 (matches ground truth $1.812 billion, acceptable rounding), and accurately states the 7.4% long-term return target. It correctly characterizes COST's short-term holdings as being in government and agency securities with maturities from 3 months to 5 years, focused on principal preservation. (2) Quantitative accuracy is excellent: $1.8 billion is a valid approximation of $1.812 billion, and all percentages and timeframes align with the ground truth. No calculation errors. (3) Multi-hop reasoning is sound—correctly contrasts PEP’s long-term, return-oriented strategy using derivatives for risk mitigation with COST’s short-duration, low-volatility, capital-preserving approach. The LLM adds contextual detail (e.g., money-market funds, fixed-rate instruments) consistent with the investment policies. (4) Minor deduction in qualitative accuracy because the LLM introduces a '56% to fixed-income' figure not present in the ground truth, which could imply overprecision or unsupported inference, though it doesn’t contradict the original. Otherwise, the reasoning, entity identification (PEP, COST, 2023), and synthesis across strategies are accurate and relevant. Contextual relevance is perfect—directly addresses risk management and expected return strategy as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 387,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Southern Company's actual allocation to mortgage-backed securities within its fixed income portfolio compare to NextEra Energy's target allocation framework for fixed income investments, given that both classify mortgage-backed securities under fixed income assets?",
      "original_answer": "Southern Company had only $9 million allocated to mortgage-backed securities as part of its $6,154 million in fixed income investments measured using significant other observable inputs (Level 2), representing less than 0.15% of its fixed income portfolio. In contrast, NextEra Energy's pension plan targets 32% allocation to fixed income investments as part of its broader pension asset strategy, which explicitly includes mortgage-backed securities under its fixed income classification. Both companies classify mortgage-backed securities under fixed income investments, with Southern Company valuing them at yields on comparable securities and NextEra Energy utilizing a combination of directly held securities and commingled investment arrangements.",
      "llm_answer": "Southern Company’s fixed‑income holdings include **$3 million in mortgage‑ and asset‑backed securities**—about **3 % of its $22 million fixed‑income portfolio** (see the 2021 10‑K table on pages 296‑300).  \nIn contrast, NextEra Energy’s pension‑plan investment policy targets **32 % of its assets in fixed‑income securities** (the 2021 10‑K on pages 99‑103), a broader allocation that would encompass mortgage‑backed securities as part of that mix but does not set a separate target for them.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Southern Company had $9 million in mortgage-backed securities within a $6,154 million fixed income portfolio, making the allocation less than 0.15%. However, the LLM claims only $3 million in mortgage- and asset-backed securities within a $22 million fixed income portfolio, which is both quantitatively and contextually wrong—the portfolio size is off by two orders of magnitude. The 3% allocation cited is therefore incorrect and misleading. (2) The numbers are not accurate: $3M vs $9M for MBS and $22M vs $6,154M for total fixed income are massive discrepancies. The calculation of 3% is based on incorrect inputs and does not match the ground truth (<0.15%). NextEra Energy’s 32% target for fixed income is correctly cited, but the LLM fails to note that this is part of a pension plan strategy and omits that mortgage-backed securities are explicitly included under fixed income in their framework. (3) The multi-hop reasoning is partially sound in that it attempts to compare Southern Company’s actual allocation with NextEra’s target, and both are classified under fixed income. However, the synthesis fails due to reliance on incorrect data for Southern Company, undermining the comparison. The LLM also references specific page numbers in 10-K filings, which may lend false credibility if unsupported by actual documents. (4) The contextual relevance is fair because the structure and intent align with the question—comparing actual vs. target allocation of MBS within fixed income—but the severe quantitative errors and incomplete qualitative details (e.g., valuation methods, investment structures) reduce correctness. Due to major factual and numerical errors, the correctness score is low at 3.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 491,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What specific pricing agreements and supply arrangements did Tesla and Panasonic Corporation formalize in their Gigafactory partnership, and how does GM’s dependency on batteries compare in terms of supplier integration and contractual depth?",
      "original_answer": "Tesla and Panasonic Corporation formalized multiple pricing agreements and supply arrangements under their Gigafactory partnership, including the Amended and Restated General Terms and Conditions for Gigafactory (June 10, 2020), the 2020 Pricing Agreement (Gigafactory 2170 Cells), and the 2021 Pricing Agreement (Japan Cells). These agreements establish detailed pricing mechanisms, production responsibilities, and shared facility leasing arrangements. In contrast, GM’s dependency on batteries is noted without equivalent supplier integration details or specific contractual commitments in the evidence provided, indicating a less transparent or structured supplier partnership compared to Tesla’s explicit agreements with Panasonic.",
      "llm_answer": "Tesla and Panasonic formalized a series of long‑term agreements for the Gigafactory: a supply agreement dated Oct 5 2011, a production‑pricing agreement, a general terms and conditions agreement, and subsequent pricing agreements for 2019 (Japan cells), 2020 (2170 cells) and 2021 (Japan cells) that set pricing, volume commitments and supply of battery cells (TSLA p. 104‑109). In contrast, GM’s battery supply is provided through an equity‑based joint venture, Ultium Cells Holdings LLC, which supplies cells for its EVs but relies on a less formal, equity‑driven arrangement rather than a series of long‑term pricing contracts, indicating a shallower contractual depth and less direct supplier integration than Tesla’s agreements (GM p. 76‑80).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core idea of Tesla's detailed pricing and supply agreements with Panasonic and contrasts it with GM's less formal, equity-driven approach via Ultium Cells LLC, which aligns with the ground truth. However, there are factual inaccuracies in dates and documents: the LLM cites a 'supply agreement dated Oct 5 2011' and a '2019 Pricing Agreement (Japan cells)', which are not present in the ground truth. The correct agreements are the Amended and Restated General Terms and Conditions (June 10, 2020), the 2020 Pricing Agreement for 2170 cells, and the 2021 Pricing Agreement for Japan cells. The LLM incorrectly adds a 2019 agreement and misrepresents the 2020 agreement as part of a broader 'production-pricing agreement' without specifying the correct title. While the reference to 'TSLA p. 104-109' may indicate sourcing, the specific agreements listed do not match the ground truth, hurting quantitative accuracy. The characterization of GM’s arrangement is semantically equivalent—highlighting equity-based joint venture (Ultium Cells LLC) and lack of long-term pricing contracts—as the ground truth notes 'no equivalent supplier integration details or specific contractual commitments'. Thus, the reasoning and contextual relevance are strong, and the qualitative comparison is sound, but the incorrect dates and agreement names reduce factual precision. Minor point: 'equity-driven arrangement' is a reasonable interpretation, though the ground truth emphasizes lack of transparency rather than structure type. Overall, core facts are correct but with notable errors in specific document dates and titles.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 445,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Chevron's ongoing tax audit exposure in Nigeria compare to Exxon's production-sharing contract risk in the same country, given the specific terms of Nigeria's PSCs and Chevron's unresolved tax positions?",
      "original_answer": "Chevron faces unresolved tax audits in Nigeria with $5,288 million in unrecognized tax benefits at year-end 2021, where the latest audit finalized was for the year 2007, leaving over a decade of tax exposure open to scrutiny. Meanwhile, Exxon operates in Nigeria under production-sharing contracts (PSCs) that typically last 30 years, with a 10-year exploration period followed by a 20-year production period, which may be extended subject to relinquishment provisions. Exxon also reports that 12% of its total proved reserves in 2021 were under PSC arrangements, where production volumes fluctuate inversely with price changes. Therefore, while Chevron's risk in Nigeria is tied to legacy tax liabilities and regulatory uncertainty, Exxon's exposure is more operational and tied to the fiscal terms and duration of its PSCs, which are sensitive to commodity price volatility.",
      "llm_answer": "Chevron’s exposure in Nigeria is mainly tax‑related: the company still has unresolved tax positions from 2007 onward, and ongoing audits could materially alter its tax expense. Exxon’s risk is contractual, tied to the 30‑year PSC framework that includes a 10‑year exploration phase, a 20‑year production period, partial relinquishment at the end of the exploration phase and optional extensions—factors that could affect production and revenue but are defined by the contract rather than an audit outcome.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's unresolved tax positions in Nigeria and Exxon's exposure through 30-year PSCs with a 10-year exploration and 20-year production period. However, it omits key quantitative details from the ground truth: Chevron's $5,288 million in unrecognized tax benefits at year-end 2021 and the fact that the latest audit finalized was for 2007, leaving over a decade of exposure. These omissions reduce quantitative accuracy. (2) The LLM does not mention Exxon's 12% of total proved reserves in 2021 being under PSC arrangements, nor the inverse relationship between production volumes and price changes under these contracts—important qualitative context about fiscal sensitivity. (3) The multi-hop reasoning is sound in distinguishing Chevron's tax audit risk from Exxon's contractual/operational risk, and correctly frames the nature of PSCs including relinquishment and extension provisions. The synthesis across entities (Chevron vs. Exxon) and risk types (tax vs. contractual) is logical and relevant. (4) While the LLM captures the core contrast in risk types and correctly describes PSC structure, the absence of specific dollar amounts, percentages, and year-specific audit status means it falls short on full factual completeness. Wording is semantically aligned, but missing key metrics justifies a 7 for correctness. Quantitative accuracy is penalized more due to missing $5.288B figure and 12% reserves; qualitative and contextual scores remain high due to accurate framing and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 426,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does Tesla's use of commercial paper compare to companies with significant operations in Ohio, such as Duke Energy Ohio?",
      "original_answer": "Tesla reported $470 million in commercial paper holdings as of December 31, 2023, as part of its short-term investment strategy. In contrast, Duke Energy Ohio, a major company operating in the state, had $25 million in commercial paper outstanding as disclosed in its financial details. This comparison highlights different approaches to short-term financing and liquidity management between Tesla, a technology and automotive company, and Duke Energy Ohio, a utility provider.",
      "llm_answer": "Tesla reports $470 million of commercial paper (TSLA 10‑K, pp. 70‑74), whereas Duke Energy Ohio’s commercial paper is only $25 million (DUK 10‑K, pp. 163‑167).  Thus Tesla’s commercial‑paper exposure is far larger and represents a more substantial portion of its short‑term debt than the modest amount used by the Ohio subsidiary.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies Tesla's commercial paper holdings as $470 million and Duke Energy Ohio's as $25 million, matching the ground truth in both amount and context (short-term financing). These figures are accurately cited from the respective 10-K filings, with page references provided. 2) Quantitatively, all numbers are correct and properly formatted; no calculation errors are present. The comparison of scale ('far larger') is logically supported by the data. 3) The multi-hop reasoning is sound: the model correctly synthesizes information from two different companies (Tesla and Duke Energy Ohio) to compare their use of commercial paper, addressing the core of the question. It appropriately contrasts the scale of usage, which reflects different liquidity strategies. 4) The answer is semantically equivalent to the original, though slightly more concise. It omits explicit mention of the differing business models (technology/automotive vs. utility), which is a minor contextual omission but does not detract from factual correctness. Overall, the response is highly accurate, relevant, and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 319,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does JPMorgan's exposure to transition risk, as outlined in its climate risk management framework, influence its compliance risk profile compared to Morgan Stanley's experience with regulatory scrutiny tied to climate-related disclosures?",
      "original_answer": "JPMorgan acknowledges transition risk as a key component of climate risk, which may amplify compliance risk due to increased regulatory scrutiny tied to climate-related disclosures. JPMorgan has established a Climate Risk Management function that integrates climate risk into its broader risk management framework, including developing metrics and stress testing mechanisms to assess potential financial impacts. According to Morgan Stanley’s disclosures, compliance risk includes exposure to legal sanctions or reputational damage from failure to meet climate-related regulatory requirements, such as increased disclosure mandates or carbon taxes. Furthermore, Morgan Stanley notes that transition risk can lead to reputational, compliance, and litigation risks due to heightened legal and regulatory scrutiny. Therefore, both firms recognize that transition risk directly influences compliance risk, but JPMorgan emphasizes proactive integration into risk frameworks, whereas Morgan Stanley highlights the regulatory enforcement dimension.",
      "llm_answer": "JPMorgan’s climate‑risk framework defines transition risk as encompassing regulatory and legislative requirements—such as increased disclosure or carbon taxes—so the firm must continuously monitor and adapt to evolving rules, which elevates its compliance‑risk profile (JPM, 2023, pp. 146‑150).  In contrast, Morgan Stanley’s 10‑K notes that similar transition‑risk drivers trigger regulatory scrutiny and that the firm has faced regulatory attention over its climate‑related disclosures, underscoring a compliance risk that is driven by external regulatory demands (MS, 2023, pp. 59‑63; 76‑80).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: JPMorgan's recognition of transition risk including regulatory and legislative factors (e.g., disclosure requirements, carbon taxes) and its impact on compliance risk is accurately represented, citing its 2023 10-K (pp. 146–150). Similarly, Morgan Stanley’s experience with regulatory scrutiny over climate disclosures and its framing of compliance risk due to external regulatory demands are correctly drawn from its 2023 10-K (pp. 59–63, 76–80). (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—format and citations are consistent and plausible. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two firms, linking transition risk to compliance risk in both cases, while contrasting JPMorgan’s internal, framework-driven approach with Morgan Stanley’s emphasis on external regulatory enforcement and scrutiny. (4) The LLM omits a minor nuance present in the original answer—specific mention of JPMorgan’s Climate Risk Management function, metrics, and stress testing, and Morgan Stanley’s linkage of transition risk to reputational and litigation risks. However, the core comparison and causal logic (transition risk → compliance risk → differing emphasis in risk management) are preserved. Wording differs but semantic equivalence is maintained. Thus, the answer is factually correct and contextually appropriate, meriting a high score with only a slight deduction for minor completeness gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 446,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What implications does Nigeria's 30-year production-sharing contract framework have for both ConocoPhillips' deepwater operations and Chevron's reserve accounting practices in the region?",
      "original_answer": "Nigeria's regulatory framework for deepwater offshore exploration establishes 30-year production-sharing contracts (PSCs) that include a 10-year exploration period followed by a 20-year production period, which may be extended under certain conditions. Since ConocoPhillips operates in Nigeria, this structure directly influences its long-term planning and investment decisions in the region. Chevron, which reports that 8-10% of its reserves are tied to PSCs like those in Nigeria, must align its reserve accounting and production forecasts with the specific terms of these contracts, including the partial relinquishment provisions under Nigeria's Petroleum Industry Act. Both companies must therefore manage exploration timelines, commercial discovery requirements, and reserve disclosures in accordance with this regulatory framework.",
      "llm_answer": "Nigeria’s 30‑year production‑sharing contract (PSC) framework – a 10‑year exploration phase followed by a 20‑year production phase with partial relinquishment and possible extensions – dictates ConocoPhillips’ deepwater operations by requiring the company to plan for relinquishment, extensions and the timing of reserve recognition in line with PSC terms (COP_10k_2022, pp.151‑155). For Chevron, the same 30‑year PSC regime means that reserves in Nigeria must be reported under the economic‑interest method, which shapes reserve estimates, the classification of PSC‑related reserves, and the discounting of future cash flows in its financial statements (COP_10k_2022, pp.151‑155).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its description of Nigeria's 30-year production-sharing contract (PSC) framework, accurately stating the 10-year exploration and 20-year production phases, along with possible extensions and partial relinquishment. These details align with the ground truth and are quantitatively accurate. The mention of ConocoPhillips' operational planning in response to PSC terms is supported and contextually appropriate. However, the LLM incorrectly attributes information about Chevron's reserve accounting practices to a ConocoPhillips 10-K filing (COP_10k_2022, pp.151-155), which is a critical error in entity sourcing. The ground truth does not specify the source document, but the LLM's citation implies that Chevron's PSC-related accounting practices are disclosed in ConocoPhillips' filing, which is factually implausible and undermines the qualitative accuracy. While the economic-interest method and its impact on reserve classification and cash flow discounting may be technically correct, this information is not verifiable from the cited source in the context of Chevron. Additionally, the ground truth mentions that 8-10% of Chevron's reserves are tied to PSCs like Nigeria's, a key quantitative and contextual detail entirely missing in the LLM response, leading to a partial omission. The reasoning is sound in structure but flawed in sourcing and completeness. The answer remains contextually relevant and semantically close, but the missing percentage and incorrect citation prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 421,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does Boeing's exposure to U.S. government contract modifications influence its application of ASU 2022-06, and how does this compare to FedEx's use of the same standard in managing reference rate reform impacts on their contracts?",
      "original_answer": "Boeing faces significant risk from U.S. government contract modifications, which could impact 37% of its revenues earned under government contracts. While Boeing must apply accounting standards like ASU 2022-06, which extends relief for contract modifications related to reference rate reform (e.g., LIBOR), the evidence shows Boeing did not experience material impacts from such modifications. Similarly, FedEx, though not directly exposed to government contract risk like Boeing, also applies ASU 2022-06 to manage contract modifications related to reference rate reform, with no material effect on its financial condition or results of operations as of May 31, 2024. Both companies benefit from the extended sunset date of ASU 2022-06 through 2024, easing the burden of contract adjustments.",
      "llm_answer": "Boeing’s U.S.‑government contracts are highly susceptible to modifications—often at the government’s convenience or for default—and many of those contracts embed reference rates such as LIBOR. Because ASU 2022‑06 offers optional relief for contract modifications that replace a reference rate, Boeing must evaluate each change to determine whether the standard applies and apply the expedients, thereby reducing the need to remeasure or reclassify the contract. FedEx, by contrast, actively monitors its contracts for reference‑rate changes and applies ASU 2022‑06 to mitigate the operational and financial impacts of such modifications, reporting that the guidance has lowered those impacts and has not materially affected its financial statements.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core reasoning and context correctly: both Boeing and FedEx apply ASU 2022-06 to manage contract modifications related to reference rate reform (e.g., LIBOR), and neither reports material financial impact. The qualitative explanation of Boeing’s exposure to U.S. government contract modifications and the optional relief under ASU 2022-06 is sound, as is the description of FedEx’s application of the standard. However, the LLM answer omits the specific quantitative figure from the ground truth—Boeing’s exposure to government contracts representing 37% of its revenues under such contracts—which is a key data point. While the LLM correctly states that Boeing must evaluate modifications and apply expedients, it does not mention that Boeing did not experience material impacts, a fact explicitly stated in the original answer and critical to completeness. Similarly, the LLM notes FedEx’s lack of material effect but does not include the specific date (as of May 31, 2024), which is present in the ground truth. These omissions affect quantitative accuracy and completeness, though the overall reasoning and synthesis across companies and standards are logically sound and contextually appropriate. The LLM also correctly identifies the extended sunset date implication (through 2024) by implication, though not explicitly. Thus, while the answer is semantically close and contextually strong, the missing specifics reduce quantitative accuracy and prevent a higher correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 414,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does ExxonMobil's offshore acreage in Angola compare to Chevron's stake in Angola LNG, given Chevron's reported upstream earnings contributions from that asset in 2021?",
      "original_answer": "ExxonMobil held 2.9 million net offshore acres in Angola at year-end 2021, while Chevron reported a stake in Angola LNG, which contributed to upstream-related earnings improvements in 2021 due to higher performance from equity affiliates like Angola LNG. Chevron's volumes in Angola reflect its share of production through affiliates, including Angola LNG.",
      "llm_answer": "ExxonMobil held 2.9 million net offshore acres in Angola at year‑end 2021 (XOM 10‑K, p. 24).  By contrast, Chevron owns a 10 % stake in the Angola LNG joint venture, and that stake generated roughly $0.3 billion of upstream earnings for Chevron in 2021 (CVX 10‑K, p. 40‑44).  Thus, while ExxonMobil’s acreage footprint in Angola is large, Chevron’s smaller equity stake in Angola LNG delivered a notable earnings contribution.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states ExxonMobil's 2.9 million net offshore acres in Angola at year-end 2021, which matches the ground truth. However, it introduces specific details not present in the original answer: Chevron's 10% stake in Angola LNG and $0.3 billion in upstream earnings from that asset in 2021. These quantitative claims are not supported by the original answer, which only states that Chevron's stake in Angola LNG contributed to upstream-related earnings improvements due to higher performance from equity affiliates, without specifying the size of the stake or dollar amount of earnings. (2) The numbers $0.3 billion and 10% are not found in the ground truth and cannot be verified from the provided information, making them factually unsupported additions. This significantly impacts quantitative accuracy. (3) The reasoning structure is sound—comparing ExxonMobil's physical acreage footprint to Chevron's financial return from a different type of asset (an LNG stake)—and reflects an attempt at multi-hop synthesis across companies and asset types. The qualitative logic of contrasting scale (acreage) vs. earnings impact is reasonable and contextually appropriate. (4) While the core contrast (ExxonMobil's acreage vs. Chevron's earnings from Angola LNG) is aligned with the question and original answer, the inclusion of unsupported specifics reduces factual correctness. The answer is semantically related and addresses the multi-part comparison, but overstates precision. Correctness score is reduced due to unverified numbers, though the direction of reasoning is valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 441,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Accenture's $6.6 billion investment in 46 strategic acquisitions in fiscal 2024, focused on scaling industry solutions, compare to Microsoft's revenue from enterprise and partner services—which includes industry solutions—in the same period?",
      "original_answer": "Accenture invested $6.6 billion across 46 strategic acquisitions in fiscal 2024 to scale its industry solutions, while Microsoft reported $7.594 billion in revenue from 'Enterprise and partner services'—a category that includes 'Industry Solutions'—during the same fiscal year. This indicates that while Accenture is heavily investing in expanding its industry-specific offerings through acquisitions, Microsoft is generating substantial revenue from its own industry solutions and enterprise services, suggesting differing strategic approaches to growth in the enterprise technology space.",
      "llm_answer": "Accenture’s FY 2024 investment of **$6.6 billion** in 46 strategic acquisitions is slightly below Microsoft’s FY 2024 revenue from its Enterprise and Partner Services segment (which includes industry solutions), which was **$7.594 billion**. In other words, Microsoft generated roughly **$1 billion more** in that revenue line than Accenture’s acquisition spend.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the $6.6 billion investment by Accenture and $7.594 billion revenue from Microsoft are accurately reported, with the correct comparison that Microsoft's revenue exceeds Accenture's spend by approximately $1 billion (difference is $994 million, which rounds to ~$1 billion—reasonable approximation). (2) The answer addresses all parts of the question: Accenture’s acquisition investment (amount and purpose) and Microsoft’s revenue from the relevant segment, both in FY2024. (3) Entities are correctly identified: Accenture, Microsoft, 'Enterprise and Partner Services' including industry solutions, and the fiscal year 2024. (4) The reasoning is sound—comparing investment spend to revenue generation highlights differing strategic approaches (investment vs. monetization), which aligns with the qualitative insight in the original answer. The LLM conveys the same core information with equivalent semantics, even if slightly more concise. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 310,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How might Duke Energy's experience with maintaining a 30% equity threshold under FERC-approved dividend policies inform Southern Company's financial planning for its 50% cost share in the $3 billion SNG pipeline project requiring similar FERC approval?",
      "original_answer": "Duke Energy Ohio was required to maintain equity, adjusted to remove push-down accounting impacts, at no less than 30% of total capital as part of FERC and PUCO approval for dividend policies. Southern Company Gas has a 50% cost share in a $3 billion pipeline project through its stake in SNG, which also requires FERC approval. Given this regulatory overlap, Southern Company may reference Duke Energy's equity management strategies to structure its capital allocation and ensure compliance with potential FERC equity requirements for the SNG pipeline project.",
      "llm_answer": "Duke Energy Ohio’s 30 % equity‑threshold requirement—set out on pages 145‑149 of its 10‑K—illustrates how FERC can impose a minimum equity level to qualify for dividend approvals.  Southern Company can use this precedent to ensure its own equity base remains above any similar FERC‑mandated threshold for the SNG pipeline (see pages 215‑219), thereby guiding its debt‑equity mix, dividend policy and capital allocation for the $3 billion, 50 % cost‑share investment.  By proactively maintaining sufficient equity, Southern Company can secure FERC approval, avoid dividend restrictions, and support the financial viability of the pipeline project.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all figures are correct: Duke Energy's 30% equity threshold, Southern Company's 50% cost share in the $3 billion SNG pipeline project—these match the original answer exactly. No calculations were required, but the financial parameters are correctly stated. Format variations (e.g., $3 billion) are acceptable. (2) The answer addresses all parts of the multi-hop question: it identifies Duke Energy’s regulatory requirement, links it to FERC’s role in dividend approvals, and applies this precedent to Southern Company’s planning for the SNG pipeline. The reference to capital structure, dividend policy, and FERC approval shows strong synthesis. (3) Entity accuracy is excellent: Duke Energy Ohio, Southern Company Gas, SNG pipeline, FERC, and PUCO (implied via context) are correctly referenced. The mention of 10-K page numbers (145–149, 215–219) adds specificity, though these are not in the ground truth; however, they do not contradict it and may reflect actual filing details, so they don’t reduce accuracy. (4) The reasoning is sound: the LLM correctly infers that Southern Company can use Duke’s precedent to guide its own equity management under similar regulatory scrutiny. The conclusion about maintaining equity to avoid dividend restrictions and ensure project viability is a logical extension of the original answer. The only minor gap is that the original emphasizes 'adjusting equity to remove push-down accounting impacts,' a technical nuance not mentioned in the LLM response—hence a slight deduction in qualitative accuracy. Overall, the answer is factually correct, contextually relevant, and demonstrates strong multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 473,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the use of matrix pricing for corporate debt instruments differ between UPS's fair value hierarchy disclosures and MMM's valuation methodologies, given that both companies rely on this pricing technique when broker quotes are unavailable?",
      "original_answer": "UPS categorizes its corporate debt instruments under Level 2 inputs in the fair value hierarchy and utilizes matrix pricing when broker quotes are not available, as seen in its 2022 disclosures. Similarly, MMM also applies matrix pricing for corporate debt instruments when broker quotes are unavailable, valuing them based on yields from comparable securities or discounted cash flow models. Both companies depend on matrix pricing as a fallback method for valuing these instruments, though MMM specifically notes adjustments for non-observable risks like credit and liquidity, unlike UPS, which does not mention such adjustments. This reveals a nuanced difference in how each company applies matrix pricing depending on the complexity of risk factors considered.",
      "llm_answer": "UPS’s fair‑value hierarchy table lists corporate debt securities as Level 2 items and notes that matrix pricing is applied when broker quotes are not available.  In contrast, MMM’s (MO’s) valuation‑methodology narrative also cites matrix pricing for corporate debt instruments when broker quotes are missing, but it does not attach the method to a specific hierarchy level in a table.  Thus, UPS explicitly ties matrix pricing to Level 2 fair‑value inputs, whereas MMM references it more generally within its broader valuation framework.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key qualitative distinctions present in the ground truth. (1) It correctly identifies that UPS categorizes corporate debt instruments as Level 2 and uses matrix pricing when broker quotes are unavailable, which aligns with the 2022 disclosures. This factual point is accurate. (2) It also correctly notes that MMM references matrix pricing in its valuation methodology when broker quotes are missing. However, the LLM introduces an error by referring to 'MMM’s (MO’s)', incorrectly associating MMM with MO (which is Molson Coors), a clear entity confusion. (3) The multi-hop reasoning is flawed: while both companies use matrix pricing as a fallback, the ground truth highlights that MMM adjusts for non-observable risks like credit and liquidity—information entirely omitted in the LLM response. Instead, the LLM incorrectly claims MMM does not tie matrix pricing to a specific hierarchy level, which is not supported by the original answer and misrepresents MMM's disclosures. (4) The LLM focuses on structural differences in reporting (table vs. narrative) not mentioned in the ground truth, introducing a misleading contrast. While the core use of matrix pricing is acknowledged for both firms, the nuanced difference in risk adjustments—central to the question—is missing. Thus, despite correct basic facts and no numerical errors (quantitative accuracy is high), the qualitative accuracy suffers due to omissions and an incorrect entity reference, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 421,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the $2.8 billion upfront payment from Vertical Bridge REIT, LLC to VZ in 2024 compare to T's prior tower transaction with Crown Castle in 2013, particularly in terms of the financing structure and the retained operational control over the towers?",
      "original_answer": "The $2.8 billion upfront payment from Vertical Bridge to VZ in 2024 was primarily recorded as prepaid rent ($2.0 billion) and a financing obligation ($830 million), reflecting the retained operational control and right-of-use for a portion of the towers. In contrast, T's 2013 transaction with Crown Castle resulted in a $4.827 billion cash payment, which was fully accounted for as a financing obligation, with T retaining control and continuing to depreciate the tower assets ($608 million at the end of 2024). Both companies maintained ownership on their balance sheets and depreciated the assets, but VZ's arrangement included a dual treatment of prepaid rent and financing, while T's was entirely structured as a financing obligation with interest at approximately 3.9%.",
      "llm_answer": "Verizon’s $2.8 billion upfront payment to Vertical Bridge was split into $2.0 billion of prepaid rent and an $830 million financing obligation for the portion of towers it still occupies, and Verizon keeps operational control of those towers by leasing back capacity from Vertical Bridge. By contrast, AT &T’s 2013 Crown Castle transaction was a $4.827 billion cash sale that was recorded entirely as a financing obligation; AT &T subleases space on towers it no longer controls. In both cases the tower assets remain on the balance sheet and the deals do not qualify as sale‑leasebacks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, all numbers are correct: $2.8 billion total upfront payment (split into $2.0 billion prepaid rent and $830 million financing obligation), and the $4.827 billion from AT&T's 2013 Crown Castle transaction are all accurately reported. The years (2024 and 2013) are correct. (2) The qualitative reasoning is sound: the LLM correctly identifies that both VZ and T retained operational control via leasebacks, kept the tower assets on their balance sheets, and did not treat the deals as sale-leasebacks. It accurately contrasts VZ's dual accounting treatment (prepaid rent + financing obligation) with T's single financing obligation structure. (3) The multi-hop reasoning is strong—synthesizing across two companies (VZ and T), two transactions (2024 and 2013), and comparing financing structures and control implications. (4) Minor point: the ground truth mentions T continued to depreciate the tower assets ($608 million at end of 2024) and specifies the 3.9% interest rate on the financing obligation, which the LLM omits. While not critical to the core comparison, these details add depth. Also, the LLM says 'Verizon’s $2.8 billion upfront payment to Vertical Bridge'—this is factually inverted (it's a payment *from* Vertical Bridge *to* Verizon), which is a significant directional error in phrasing, though the rest of the context implies the correct flow. This prevents a perfect 10. Overall, the answer is semantically equivalent in intent and mostly complete, with only minor omissions and one wording inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 445,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the potential tax liability from MRK's TCJA-related IRS examination compare with MDT's BEAT-related tax impact in 2024, given the TCJA's introduction of BEAT as a minimum tax?",
      "original_answer": "MRK faces a potential significant tax liability if the IRS disagrees with its transition tax position under the TCJA, which includes BEAT as a component of its minimum tax framework. The TCJA introduced BEAT as a minimum tax based on cross-border service payments, directly linking it to the broader tax reform that both MRK and MDT are subject to. In 2024, MDT reported a 0.3% increase in effective tax rate due to BEAT, indicating a measurable but relatively small impact. Comparatively, MRK's exposure could be more substantial if the IRS challenges its TCJA transition tax calculations, potentially reversing unrecognized tax benefits that stood at $2.3 billion as of December 31, 2024. Thus, while MDT's BEAT impact is quantifiably modest, MRK's TCJA-related risk remains high and contingent on IRS resolution.",
      "llm_answer": "MRK’s IRS examination of its 2017‑18 TCJA transition tax is described as “may result in a significant tax liability” but is not quantified (MRK, 2024, pp. 125‑129).  By contrast, MDT’s 2024 BEAT impact is disclosed as a 0.5 % lift to its effective tax rate—roughly $24 million on $4.8 billion of pre‑tax income (MDT, 2024, pp. 85‑89).  Thus, MRK faces an uncertain, potentially large liability, whereas MDT’s BEAT cost is a defined, modest dollar amount.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that MRK faces a potential significant but unquantified tax liability from the IRS examination of its TCJA transition tax, which aligns with the ground truth. It also correctly notes that MDT’s BEAT impact is quantified, but here lies the key error: the LLM states MDT’s BEAT impact is a 0.5% increase in effective tax rate, whereas the ground truth reports 0.3%. This discrepancy affects factual accuracy. Additionally, the LLM calculates the dollar impact as ~$24 million based on $4.8 billion pre-tax income, but this data (both the income figure and the resulting $24M) is not present in the original answer and appears to be an unsupported inference. The ground truth does not provide a dollar amount for MDT’s BEAT impact, only the 0.3% ETR increase. (2) The quantitative inaccuracy is significant: 0.5% vs 0.3% is a 67% overstatement of the tax rate impact. The $24 million figure is entirely fabricated from assumed data not in the ground truth. While the MRK unrecognized tax benefits of $2.3 billion are omitted in the LLM answer, the general characterization of 'significant/unquantified liability' is directionally correct. (3) The multi-hop reasoning is partially sound: the model correctly distinguishes between MRK’s uncertain, high-risk exposure and MDT’s measurable BEAT impact. It also correctly links BEAT to the TCJA framework. However, it fails to mention that BEAT is part of the broader TCJA minimum tax system, and misses the key comparative point in the ground truth that MRK’s exposure could reverse $2.3 billion in unrecognized tax benefits—critical context for assessing relative magnitude. (4) The correctness score is 6 due to a mix of correct qualitative framing and serious quantitative inaccuracies. Quantitative accuracy is penalized heavily (5/10) for incorrect percentages and invented dollar figures. Qualitative accuracy is moderate (7/10) as the reasoning structure is logical and entities are correct (MRK, MDT, TCJA, BEAT, 2024). Contextual relevance is high (9/10) as the answer stays focused on the comparison and regulatory context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 570,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Nigeria's 30-year production sharing contract framework influence both ConocoPhillips' operational footprint and Chevron's reserve disclosures in Africa?",
      "original_answer": "Nigeria's regulatory framework establishes 30-year production sharing contracts (PSCs) with a 10-year exploration period followed by a 20-year production period, requiring partial relinquishment at the end of exploration (from hop2_evidence). ConocoPhillips operates in Nigeria under this framework (from hop1_evidence), which shapes its exploration timelines and asset management strategy. Chevron's 2021 reserves in Africa totaled 106 million barrels (from hop3_evidence), indicating continued exposure to jurisdictions like Nigeria where regulatory terms directly affect reserve life and development planning. The 30-year PSC duration influences both companies' capital allocation decisions, reserve booking practices, and long-term operational strategies in the region.",
      "llm_answer": "Nigeria’s 30‑year production‑sharing contract (PSC) framework—10 years of exploration followed by a 20‑year production period with mandatory partial relinquishment—sets the maximum duration and renewal conditions for any operator in the country.  ConocoPhillips’ footprint in Nigeria is therefore limited to the PSC terms, constraining the number and timing of wells it can develop and requiring it to relinquish acreage after the 10‑year exploration phase (ConocoPhillips 10‑K, pp. 151‑155).  Chevron’s Africa reserve disclosures reflect the same PSC structure, as reserves under PSCs are reported separately and are subject to the 30‑year term, which influences how reserves are classified and the timing of reserve revisions (Chevron 10‑K, pp. 105‑109).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Nigeria's 30-year PSC framework with a 10-year exploration and 20-year production period, including partial relinquishment, is accurately described. ConocoPhillips' operational constraints under this framework are correctly tied to exploration timelines and acreage relinquishment. Chevron's reserve disclosures are properly contextualized within the PSC structure, noting how the 30-year term affects reserve classification and revisions. (2) There are no numeric inaccuracies—while the LLM does not explicitly state Chevron's 2021 African reserves as 106 million barrels (from the ground truth), this omission does not introduce inaccuracy but represents a minor completeness gap. The reference to Chevron’s 10-K pages supports the claim and implies the data source. (3) Multi-hop reasoning is sound: the model correctly links Nigeria’s regulatory framework to ConocoPhillips’ operations and Chevron’s reserve reporting practices, demonstrating synthesis across entities and regulatory impact. (4) The answer is contextually precise, directly addressing how the PSC framework influences both companies. The only reason for not scoring a 10 is the omission of the specific 106 million barrel figure, which is part of the ground truth and enhances completeness, though the qualitative reasoning remains strong. Thus, correctness is rated 9 due to this minor omission, not due to any error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 411,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the limited voting rights structure attached to AT&T's Series C Preferred Stock influence potential restructuring decisions compared to Netflix's one-share-one-vote governance model?",
      "original_answer": "AT&T's Series C Preferred Stockholders have no voting rights except in specific restructuring scenarios such as mergers or consolidations where their equity treatment might change, requiring their separate approval. This constraint limits their influence on broader corporate decisions but protects their interests in defined high-impact events. In contrast, Netflix grants one vote per share to common stockholders on all matters, enabling broader shareholder participation in governance and strategic direction. This difference means Netflix’s shareholders have more consistent influence over corporate decisions, whereas AT&T’s Series C Preferred Stockholders only exert influence in narrowly defined restructuring contexts.",
      "llm_answer": "AT&T’s Series C Preferred Stock is **limited‑voting**: holders can vote only on a narrow set of matters (e.g., mergers or conversions) and vote as a single class equal to shares held, which constrains their influence on restructuring decisions【AT&T 10‑K, pages 100‑104】.  \nBy contrast, Netflix’s governance model is **one‑share‑one‑vote** (NFLX 10‑K, pages 59‑63), giving every common‑shareholder a full vote on all matters, including restructuring, and thus providing broader shareholder influence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It accurately describes AT&T’s Series C Preferred Stock as having limited voting rights, exercisable only in specific scenarios like mergers or conversions, which aligns with the original answer’s emphasis on restructuring events requiring separate approval. The contrast with Netflix’s one-share-one-vote model is correctly articulated, emphasizing broader shareholder influence. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance structures from two different companies (AT&T and Netflix) using their respective 10-K filings, compares their voting rights frameworks, and draws a valid conclusion about influence on restructuring decisions. (4) Minor wording differences exist (e.g., 'limited-voting' vs. 'no voting rights except in...'), but these do not affect factual accuracy. The LLM slightly simplifies the protective intent behind AT&T’s structure but does not misrepresent it. Overall, the answer is contextually precise, factually correct, and fully addresses the comparative governance question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 355,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the expiration timeline of key patent protections for Enbrel impact Pfizer's long-term revenue strategy for the product, particularly given AbbVie's broader approach to patent term restoration and regulatory exclusivity for biologics?",
      "original_answer": "Enbrel (etanercept) has multiple U.S. patents expiring at different points: fusion protein composition in 2028, DNA encoding the fusion protein in 2029, and formulations in 2037. This staggered expiration allows Pfizer to maintain some level of market protection until 2037, though biosimilar competition could begin as early as 2028. AbbVie, in contrast, actively pursues patent protection and patent term restoration under the Hatch-Waxman Act, which can extend exclusivity by up to five years, with total post-approval exclusivity potentially reaching 14 years. Given that AbbVie emphasizes both patent and regulatory exclusivity strategies for its biologics, Pfizer may need to adopt a similarly aggressive lifecycle management approach—such as filing secondary patents or seeking regulatory extensions—to preserve Enbrel's revenue stream beyond its core patent expirations.",
      "llm_answer": "Enbrel’s key patents expire between 2028 and 2037, giving AbbVie a long window of protection (AbbVie 10‑K, p. 11).  AbbVie can further extend this period through Hatch‑Waxman patent‑term restoration and the 12‑year regulatory exclusivity granted under the Biologics Price Competition and Innovation Act, which delays biosimilar entry (AbbVie 10‑K, p. 7‑11).  Consequently, Pfizer’s long‑term revenue strategy for an Enbrel biosimilar must take this extended exclusivity into account, likely postponing launch until the final patent and exclusivity dates lapse.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual and entity errors. It incorrectly attributes Enbrel's patent strategy and 10-K disclosures to AbbVie, when Enbrel is a product originally developed by Immunex (acquired by Amgen) and licensed to Pfizer in certain territories; AbbVie does not own Enbrel. The original answer correctly identifies Pfizer as the entity managing Enbrel’s patent timeline, while the LLM confuses AbbVie’s broader biologics strategy with Enbrel’s actual ownership. Furthermore, the LLM incorrectly frames Pfizer as planning a biosimilar launch for Enbrel, when Pfizer is already a marketer of Enbrel (via agreement with Amgen) and the question concerns Pfizer’s revenue strategy for Enbrel itself, not a biosimilar version. (2) Quantitatively, the LLM correctly identifies the 2028–2037 patent expiration range, aligning with the ground truth (2028 composition, 2029 DNA, 2037 formulations). However, it misstates the regulatory exclusivity period: the Biologics Price Competition and Innovation Act (BPCIA) provides 12 years of regulatory exclusivity from first approval, but Enbrel was approved in 1998, so this expired long ago. Thus, the claim that this delays biosimilar entry now is factually incorrect. (3) The multi-hop reasoning is flawed: the model fails to correctly link Enbrel to Pfizer (not AbbVie), misidentifies the nature of Pfizer’s role (originator vs. biosimilar developer), and incorrectly applies AbbVie’s patent-term restoration strategy to Enbrel’s context. The synthesis across entities is invalid due to this confusion. (4) The contextual relevance is partially maintained because the answer discusses patent expirations and exclusivity strategies for biologics, but the misattribution of product ownership and strategy severely undermines factual correctness. The conclusion about Pfizer delaying a biosimilar launch is based on a fundamental misunderstanding of the product’s commercial structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 529,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the ethylene production capacity of ExxonMobil's Singapore facility compare to the ethylene manufacturing capacity that Chevron indirectly supports through its ownership stake in the Map Ta Phut Olefins joint venture in Thailand?",
      "original_answer": "ExxonMobil's Singapore facility has an ethylene production capacity of 1.9 million metric tons per year. Chevron indirectly owns a 32.77% stake in the Map Ta Phut Olefins Company Limited in Thailand, which manufactures ethylene, although the exact ethylene capacity attributable to Chevron is not specified in the evidence provided.",
      "llm_answer": "ExxonMobil’s Singapore plant produces roughly 1.9 million metric tons of ethylene per year. The Map Ta Phut Olefins joint venture’s ethylene manufacturing capacity is not disclosed in the supplied excerpts, so a direct numerical comparison cannot be made.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly states that ExxonMobil's Singapore facility has an ethylene production capacity of 1.9 million metric tons per year, matching the ground truth exactly. It also accurately acknowledges that the ethylene manufacturing capacity of the Map Ta Phut Olefins joint venture is not disclosed in the provided evidence, making a direct numerical comparison impossible. This reflects sound reasoning and aligns with the original answer's conclusion that Chevron's attributable capacity cannot be determined due to lack of disclosed capacity data. The only minor shortcoming is that the LLM does not explicitly mention Chevron's 32.77% ownership stake in the joint venture, which is included in the ground truth and adds context about the nature of Chevron's indirect involvement. However, since the question focuses on capacity comparison and the missing capacity data prevents such a comparison, this omission does not undermine the core correctness. All entities (ExxonMobil, Singapore facility, Map Ta Phut Olefins, Chevron) and metrics are correctly identified. The reasoning is logically sound, and the answer is semantically equivalent to the original in intent and factual content.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 336,
        "total_tokens": 1506
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How does the financial impact of Southern Company's disallowance of capital investments at Nicor Gas in Illinois compare to the scale of infrastructure assets that NextEra Energy operates in the same state?",
      "original_answer": "Southern Company recorded a pre-tax charge of $96 million related to the disallowance of capital investments at Nicor Gas, which operates in Illinois and serves approximately 2.3 million customers across 34.7 thousand miles of gas pipelines. Meanwhile, NextEra Energy operates 90 thousand miles of transmission lines in Illinois, Indiana, Kentucky, New Hampshire, and New York combined, with Illinois being a part of this footprint. This comparison highlights the relative scale of infrastructure assets under regulatory scrutiny versus those actively operated by NextEra in the same state.",
      "llm_answer": "Southern Company’s disallowance of capital investments at Nicor Gas in Illinois produced a pre‑tax charge of roughly **$96 million** (about $72 million after tax).  In contrast, NextEra Energy’s infrastructure footprint in Illinois consists of **≈90 miles of transmission lines and 5 substations** (as reported in the “Rate‑Regulated Transmission” table).  Thus, the financial hit is a monetary figure of $96 million, while NextEra’s assets in the state are measured in a physical network of 90 miles and five substations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. While it correctly states Southern Company's pre-tax charge of $96 million related to Nicor Gas, it grossly misrepresents NextEra Energy's infrastructure in Illinois. The LLM claims NextEra operates '≈90 miles of transmission lines and 5 substations' in Illinois alone, which is incorrect. The ground truth states that NextEra operates 90 thousand miles of transmission lines across five states—Illinois, Indiana, Kentucky, New Hampshire, and New York—combined, not 90 miles in Illinois. This is a critical error in both magnitude (90 vs 90,000) and geographic scope. (2) The quantitative accuracy is very low: the $96 million charge is correct, but the '90 miles' figure is off by three orders of magnitude and misattributes a multi-state total to Illinois alone. The after-tax figure of $72 million is not in the original answer and is an unsupported addition. (3) The multi-hop reasoning fails: the model does not correctly synthesize the geographic and asset-scale comparison. It incorrectly narrows a regional asset total to a single state without justification, undermining the comparative analysis. (4) Contextual relevance is moderate because the answer attempts the right comparison (financial impact vs. infrastructure scale), but the flawed data renders the conclusion misleading. The original answer emphasizes the contrast between a disallowed investment and the vast operational footprint of a competitor, but the LLM's version minimizes NextEra's presence due to the error, reversing the intended insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 435,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "What percentage of KO's equity method investments as of December 31, 2021, was represented by its stake in CCEP, and how does this relate to CCEP's operational presence in Iceland, where COST also operates?",
      "original_answer": "KO owned approximately 19% of CCEP as of December 31, 2021. CCEP operates in Iceland, which is also a market where COST operates through its wholly owned subsidiaries. This shared presence in Iceland indicates both companies have exposure to the same geographic market, with KO indirectly participating in the Icelandic beverage market through its equity stake in CCEP, while COST directly operates retail warehouses there.",
      "llm_answer": "KO’s stake in Coca‑Cola Europacific Partners (CCEP) accounted for roughly 20 % of its equity‑method investments as of December 31, 2021 (about $3.6 billion of a $17.6 billion total). CCEP operates bottling and distribution facilities in Iceland, a market where Costco also runs warehouses, linking KO’s investment to a region in which it sells its products.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer states that KO's stake in CCEP accounted for roughly 20% of its equity-method investments, while the ground truth specifies KO owned approximately 19% of CCEP. These are close but not identical; the 1% difference is minor but meaningful in precise financial contexts. Additionally, the LLM introduces specific dollar figures ($3.6 billion of $17.6 billion) not present in the original answer, which may be accurate but are unverifiable from the ground truth provided and could be misleading if incorrect. 2) The quantitative accuracy is partially compromised: while the percentage is approximately correct (20% vs 19%), the dollar amounts are not confirmed by the ground truth and appear to be inferred or hallucinated. The original answer does not mention total equity-method investment values, so including them reduces quantitative reliability. 3) The qualitative reasoning is sound: the LLM correctly identifies that CCEP operates in Iceland and that COST (Costco) also operates there, establishing the multi-hop connection between KO’s indirect presence via CCEP and COST’s direct retail operations. The synthesis across KO, CCEP, and COST with respect to Iceland is logically coherent and captures the intended insight. 4) Contextual relevance is high—the answer addresses both parts of the question: the percentage stake and the relationship to operations in Iceland. Despite the numerical discrepancy and unverified dollar figures, the core informational intent is preserved, and the explanation links the entities and geography appropriately. Overall, the answer is mostly correct with minor factual inaccuracies and some unsupported numerical additions, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 466,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does Duke Energy's direct exposure to electricity price volatility compare with Southern Company's indirect exposure through its subsidiaries' ownership stake in PowerSouth, which receives 100 MW of capacity from Alabama Power under a 2021 agreement?",
      "original_answer": "Duke Energy directly manages exposure to electricity price volatility through fuel adjustment clauses, formula-based contracts, and hedging programs that defer cost differences as regulatory assets or liabilities. In contrast, Southern Company's exposure is indirect through its subsidiaries' ownership stake in PowerSouth, which receives 100 MW of year-round capacity service from Alabama Power starting in 2024 under a 2021 agreement. This arrangement, combined with a 10-year coordinated planning and operations agreement, allows Southern Company to mitigate some volatility through shared dispatch and cost-offsetting mechanisms, rather than direct hedging. While Duke Energy actively hedges its exposure using financial instruments, Southern Company's risk is mediated through contractual agreements and operational coordination with PowerSouth.",
      "llm_answer": "Duke Energy’s exposure to electricity‑price volatility is **direct** – it stems from its own generation portfolio and bulk‑power market transactions, which the company manages with commodity‑derivative hedges (see the “Commodity Price Risk” discussion on pages 177‑181 of the 10‑K). In contrast, Southern Company’s exposure is **indirect** and limited to the 100 MW of year‑round capacity that Alabama Power supplies to its subsidiary PowerSouth under the 2021 agreement (see the PowerSouth capacity note on pages 15‑19). Thus, Duke Energy faces a broader, core‑operations‑driven volatility risk, while Southern Company’s risk is confined to a small, subsidiary‑level capacity arrangement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the 100 MW capacity, the 2021 agreement, and the year-round service starting in 2024 (implied in both answers, though the LLM omits 'starting in 2024'—a minor omission). The reference to specific 10-K pages adds precision. (2) The LLM correctly identifies Duke Energy’s direct exposure via hedging and commodity derivatives, consistent with the ground truth’s mention of fuel adjustment clauses, formula-based contracts, and hedging programs. (3) Southern Company’s indirect exposure through its subsidiary PowerSouth is accurately described, including the contractual nature of the 100 MW arrangement. (4) The LLM emphasizes operational and subsidiary-level limitation of risk, which aligns with the ground truth’s point about risk mediation through contractual and operational coordination. The only minor shortcoming is that the LLM does not mention the 10-year coordinated planning and operations agreement or shared dispatch and cost-offsetting mechanisms, which are part of the indirect mitigation strategy in the original answer. This results in a slightly less complete qualitative picture, but the core reasoning and multi-hop synthesis—comparing direct vs. indirect exposure mechanisms across two companies using correct entities and timeframes—remains sound. Wording differs but semantic equivalence is strong. No calculation errors. Contextual relevance is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 411,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does the growth in Starbucks' store count in Taiwan compare to Nike's revenue contribution from the Greater China region, considering that Taiwan is included within the Greater China geographic segment?",
      "original_answer": "Starbucks reported a net increase of 21 stores in Taiwan from fiscal year 2021 to 2022, bringing its total store count in Taiwan to 544. Nike, which includes Taiwan within its Greater China segment, reported total revenues of $7.547 billion from that region in fiscal year 2022. Given that Greater China includes mainland China, Hong Kong, and Taiwan, Starbucks’ store presence in Taiwan is a component of the broader regional market that contributes to Nike’s revenue, though the specific revenue contribution from Taiwan alone is not disclosed by Nike.",
      "llm_answer": "Starbucks added 21 licensed stores in Taiwan during FY 2022 (523 to 544 stores, net +21【SBUX_10k_2022.pdf page 12】). In the same year, Nike’s Greater China segment – which includes Taiwan – generated $74.2 billion in revenue (net sales of $74,200 million【NKE_10k_2022.pdf page 86】). Thus, the modest store‑count growth of 21 outlets is dwarfed by the multi‑billion‑dollar revenue contribution from the Greater China region.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numeric values. While it correctly states that Starbucks added 21 stores in Taiwan (from 523 to 544), it incorrectly reports Nike's Greater China revenue as $74.2 billion ($74,200 million), which is more than 9 times the actual figure of $7.547 billion per the ground truth. This is a major quantitative error that undermines the core comparison. (2) The citation references appear fabricated or incorrect—Nike’s 10-K does not report $74.2 billion in Greater China revenue; the actual reported value is $7.547 billion. The format variation ($74,200 million) does not excuse this discrepancy. (3) The reasoning structure is sound in that it attempts to compare Starbucks’ store growth in Taiwan to Nike’s revenue from Greater China and acknowledges that Taiwan is part of that region. However, the conclusion that 'store-count growth is dwarfed by multi-billion-dollar revenue' is based on an inflated revenue number, leading to flawed synthesis. (4) Despite the incorrect revenue figure, the answer addresses the multi-hop nature of the question by linking Starbucks’ Taiwan store count to Nike’s Greater China segment and correctly identifying the geographic inclusion. The contextual relevance is high because it frames the comparison appropriately, but the factual foundation is compromised by the erroneous Nike revenue data. Correctness score is low due to the critical error in financial data, which is central to the question’s intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 417,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How do the supplier finance disclosures required by ASU 2022-04 affect the visibility of 3M's $0.3 billion in confirmed invoice obligations, and how does FedEx's adoption of the same standard compare in terms of transparency?",
      "original_answer": "ASU 2022-04 significantly enhances the visibility of 3M's supplier finance obligations, which stood at $0.3 billion as of December 31, 2024, by mandating detailed disclosures such as key terms, balance sheet presentation, and roll-forward information. This requirement was adopted by 3M starting in 2023, with full roll-forward reporting effective in 2024. Similarly, FedEx adopted ASU 2022-04 effective June 1, 2023, and also included disclosures related to its supplier finance program obligations. Both companies now provide stakeholders with clearer insights into their supplier finance activities, aligning their reporting practices under the new standard to enhance transparency.",
      "llm_answer": "ASU 2022‑04 requires a buyer to disclose the confirmed amount outstanding and a roll‑forward of supplier‑finance obligations. 3M’s Note 16 (pp. 75‑79) reports a $0.3 billion balance of confirmed invoices and presents a roll‑forward table showing beginning, confirmed, paid, translation adjustments and ending balances, thereby making the obligation fully visible. FedEx’s adoption of the same standard (Note 90‑94) likewise discloses its supplier‑finance program with a roll‑forward table and the amounts approved to sell to banks, providing comparable transparency—FedEx’s disclosure includes the same key details and even lists translation adjustments, offering a similarly clear view of its obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: 3M's $0.3 billion in confirmed invoice obligations is accurately reported, and the mention of roll-forward disclosures matches the ground truth. While the exact adoption dates (e.g., 3M starting in 2023, FedEx effective June 1, 2023) are not explicitly repeated, the context implies correct timing through reference to implementation of ASU 2022-04. (2) The LLM correctly identifies both companies (3M and FedEx), the relevant accounting standard (ASU 2022-04), and the nature of required disclosures (roll-forward tables, balance sheet visibility, translation adjustments). (3) Multi-hop reasoning is sound: the model synthesizes how the standard affects transparency for both companies, drawing correct parallels in disclosure practices. It references specific footnotes (Note 16 for 3M, Note 90-94 for FedEx), which demonstrates granular alignment with actual filings. (4) The only minor shortcoming is the lack of explicit mention of the 'December 31, 2024' date for 3M’s obligation and slightly less emphasis on the 'enhanced visibility' framing compared to the original, but the core meaning and factual content are preserved. Wording differs but is semantically equivalent. Overall, the answer is factually robust, contextually appropriate, and demonstrates strong qualitative and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 394,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How might the dual-class stock structures at CMCSA and META, particularly the 15-vote-per-share advantage for Class B stockholders at CMCSA and the 35% Class B voting power threshold for blocking change-of-control transactions at META, similarly expose minority shareholders to governance risks?",
      "original_answer": "At CMCSA, Class B common stockholders, led by Brian L. Roberts, hold 33⅓% of the combined voting power due to a 15-vote-per-share advantage, which can influence corporate decisions disproportionately relative to their economic stake. Similarly, at META, Class B stockholders control key governance decisions, including blocking change-of-control transactions, as long as they hold at least 35% of the combined voting power. Both structures concentrate decision-making authority in a small group, potentially undermining minority shareholder influence and making the companies less attractive to investors, which could depress stock valuations.",
      "llm_answer": "Both companies’ dual‑class structures concentrate voting power in a small group of shareholders, giving those holders the ability to override minority interests.  At Comcast, each Class B share carries 15 votes, giving the sole Class B holder a 15‑fold voting advantage over Class A shares (CMCSA 10‑K, p. 31).  At Meta, the 35 % Class B voting‑power threshold means that if Class B holders control at least 35 % of the vote, they can block any change‑of‑control transaction, effectively controlling corporate direction (META 10‑K, p. 48).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual information is correct: the 15-vote-per-share advantage for CMCSA Class B stock is accurately cited (CMCSA 10-K, p. 31), and the 35% Class B voting power threshold at META that enables blocking change-of-control transactions is correctly stated (META 10-K, p. 48). These numbers match the original answer exactly. (2) Quantitative accuracy is perfect—percentages, voting ratios, and thresholds are all correct, with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance risks across two companies, identifying how concentrated voting power in a small group (e.g., Brian L. Roberts at CMCSA and Mark Zuckerberg at META) can override minority shareholder interests. While the LLM does not explicitly name Brian L. Roberts or state the exact 33⅓% voting power figure for CMCSA (mentioned in the ground truth), this is a minor omission that does not undermine the core correctness. (4) The answer conveys the same essential conclusion: dual-class structures at both firms expose minority shareholders to governance risks by entrenching control, potentially depressing valuations. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent—the response directly addresses the comparative governance risks posed by both companies’ structures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 390,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What percentage of V's U.S. pension plan assets classified as Level 2 in 2022 consists of investments in collective investment funds, and how does this allocation strategy compare to COF's use of 'other securities' in terms of investment focus and yield profile?",
      "original_answer": "In 2022, V reported $319 million in collective investment funds under Level 2 assets, out of a total of $960 million in U.S. pension plan assets, representing approximately 33.2%. These funds are described as unregistered investment vehicles that commingle assets from multiple fiduciary clients to invest in portfolios of stocks, bonds, or other securities, including equity and debt instruments. In contrast, COF held $2,834 million in 'other securities' as part of its available-for-sale securities, with a weighted-average yield of 1.57%. While V's collective investment funds focus on diversified portfolios for institutional investors, COF's 'other securities' likely reflect a different risk-return profile given the lower yield and potentially different asset composition.",
      "llm_answer": "Visa’s U.S. pension plan had $733 million of Level 2 assets in 2022, of which $319 million—about **43.5 %**—were collective investment funds (Visa, 10‑K, pp. 85‑89). This allocation emphasizes diversified equity‑and‑bond exposure through mutual‑fund vehicles, delivering a moderate‑to‑higher yield profile. In contrast, Capital One’s “other securities” are largely asset‑backed and foreign‑bond holdings, a more fixed‑income‑centric mix with a lower weighted‑average yield of roughly **1.6 %** (COF, 10‑K, pp. 160‑164), reflecting a more conservative yield outlook.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains a critical quantitative error: it states that Visa's total Level 2 assets were $733 million, but the ground truth reports total U.S. pension plan assets as $960 million. This leads to an incorrect percentage calculation: $319M / $733M ≈ 43.5%, whereas the correct percentage is $319M / $960M ≈ 33.2%. The $319 million figure for collective investment funds is correct, as is COF's 'other securities' yield of 1.57% (rounded to 1.6% is acceptable). (2) The calculation of the percentage is based on incorrect total assets, making the 43.5% figure inaccurate. The correct percentage is 33.2%, a significant deviation. COF's yield is correctly reported within rounding tolerance. (3) The multi-hop reasoning is otherwise sound: the model correctly identifies V (Visa) and COF (Capital One), extracts relevant asset classes (collective investment funds vs. other securities), and attempts a comparison of investment focus and yield. The characterization of Visa's funds as diversified equity-and-bond exposure and COF's as fixed-income-centric is consistent with the ground truth. (4) Despite the incorrect denominator and resulting percentage, the answer includes correct raw data for collective funds and COF yield, shows appropriate reasoning about investment focus, and addresses both parts of the question. However, the major calculation error undermines factual accuracy, warranting a moderate score. Contextual relevance is high as all parts of the question are addressed with mostly accurate framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 419,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How do Adobe's compliance costs related to Saudi Arabia's data localization laws compare to Microsoft's financial exposure from similar regulations, and what does this reveal about their respective cloud service strategies?",
      "original_answer": "Adobe faces significant compliance costs due to its global operations, including exposure to Saudi Arabia's data localization requirements, which could 'adversely impact our business and our enterprise customers' business, our financial condition and our results of operations in those jurisdictions' (ADBE_10k_2024.pdf). Saudi Arabia is explicitly mentioned as one of the jurisdictions implementing data localization requirements that mandate data to remain stored within national borders (MA_10k_2024.pdf). Microsoft discloses that such localization laws globally 'may require changes in services, business practices, or internal systems that result in increased costs, lower revenue, reduced efficiency' and specifically references compliance engineering costs that 'involve substantial expense and the diversion of engineering resources from other projects' (MSFT_10k_2024.pdf). The comparison reveals Adobe's vulnerability through its enterprise customer contracts in Saudi Arabia, while Microsoft faces broader systemic challenges due to its cloud infrastructure and AI services that rely heavily on cross-border data flows.",
      "llm_answer": "The 10‑K excerpts you supplied do not contain any specific dollar amounts for Adobe’s compliance costs under Saudi Arabia’s data‑localization rules, nor do they provide a quantified financial exposure for Microsoft under similar regulations. Consequently, a direct comparison of the two companies’ costs and what that implies for their cloud‑service strategies cannot be drawn from the pages you provided.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually accurate in stating that no specific dollar amounts are provided in the 10-Ks for Adobe's compliance costs or Microsoft's financial exposure related to Saudi Arabia's data localization laws, which aligns with the ground truth. Thus, the quantitative accuracy is high because it correctly refrains from asserting any numerical figures that aren't present. However, the LLM fails on qualitative accuracy and overall correctness because it misses the core intent of the question: a comparative analysis based on disclosed risks and strategic implications, not quantified dollar amounts. The original answer synthesizes qualitative disclosures from both companies—Adobe’s vulnerability through enterprise customer contracts and Microsoft’s systemic engineering and operational challenges due to cross-border data dependencies. The LLM incorrectly concludes that 'no comparison can be drawn,' when in fact the 10-Ks do allow for a meaningful qualitative comparison of their cloud service strategies based on how each company describes the impact of data localization. This reflects a failure in multi-hop reasoning: the model did not connect Adobe’s customer-facing risk exposure with Microsoft’s infrastructure-level compliance burden, both of which are disclosed in the documents. While the response is contextually relevant in noting the absence of numbers, it is insufficient in addressing the strategic comparison the question demands, resulting in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 411,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Duke Energy's divestiture of KO Transmission's pipeline facilities impact its FERC regulatory exposure, and how does this contrast with Southern Company's ongoing capital expenditure risks tied to FERC rule changes?",
      "original_answer": "Duke Energy Ohio divested all of KO Transmission's pipeline facilities on February 1, 2023, for approximately book value, which reduces its direct exposure to FERC-regulated interstate pipeline operations. This contrasts with Southern Company’s ongoing capital expenditure programs, which are subject to FERC rule changes that could materially affect construction costs and recovery of investments. Southern Company specifically notes uncertainty in recovering costs related to capital expenditures due to potential changes in FERC regulations. While Duke Energy has mitigated its FERC-related risk in the pipeline business through divestiture, Southern Company remains exposed to regulatory shifts that could impact its construction programs and cost recovery.",
      "llm_answer": "By selling KO Transmission’s 90‑mile pipeline and related real property to Columbia Gas Transmission in February 2023, Duke Energy removed a FERC‑regulated asset from its balance sheet, thereby reducing its regulatory oversight and compliance burden under FERC (see DUK 10‑K, pp. 16‑20, 22‑26). In contrast, Southern Company’s construction programs remain exposed to FERC rule changes, which can alter project costs, design requirements or cost‑recovery mechanisms and thus pose ongoing risk to its capital‑expenditure budgets (see SO 10‑K, pp. 102‑106).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies Duke Energy's divestiture of KO Transmission's pipeline facilities in February 2023, aligning with the ground truth date (February 1, 2023); the month-level precision is acceptable. The buyer (Columbia Gas Transmission) is an accurate detail not in the original but not contradictory. (2) No explicit dollar amount is given in the LLM answer (e.g., 'approximately book value'), but this omission is minor as the focus is on regulatory impact, not transaction value. All other key facts—removal of FERC-regulated asset, reduced regulatory burden—are correct. (3) The contrast with Southern Company is well-reasoned: both companies are correctly identified, and the LLM accurately states that Southern Company faces ongoing risks from FERC rule changes affecting capital expenditures, cost recovery, and construction programs. (4) The multi-hop reasoning—linking Duke’s divestiture to reduced FERC exposure and contrasting it with Southern’s continued exposure due to regulatory uncertainty—is logically sound and synthesizes information across entities and filings. The LLM cites relevant 10-K page ranges, enhancing credibility. The only minor shortcoming is the lack of explicit mention that the sale was 'for approximately book value,' which slightly affects completeness but not the core regulatory impact conclusion. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 425,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does the $2.7 billion in unfunded commitments to private debt and private equity funds reported by UPS compare to Caterpillar's allocation of $55 million in NAV-measured assets for its other postretirement benefit plans, in terms of liquidity and investment strategy?",
      "original_answer": "UPS reports $2.7 billion in unfunded commitments to private debt and private equity funds, which are illiquid and typically have redemption restrictions for 10–15 year terms, indicating a long-term investment horizon. In contrast, Caterpillar allocates $55 million in NAV-measured assets for its other postretirement benefits, which include less complex instruments like U.S. corporate bonds and short-term instruments, suggesting a more liquid and conservative investment approach. The difference highlights UPS's focus on alternative investments for long-term growth versus Caterpillar's preference for liquidity and stability in managing postretirement obligations.",
      "llm_answer": "UPS’s $2.7 billion in unfunded commitments to private‑debt and private‑equity funds is a large, long‑term, less‑liquid portion of its plan assets—limited redemption rights until the end of the partnership term (10–15 years) and expected to be contributed over 3–6 years (UPS, notes 91‑95). By contrast, Caterpillar’s $55 million in NAV‑measured assets for its other post‑retirement benefit plans is a much smaller, more liquid allocation that can be accessed more readily and is part of a more conservative, diversified investment strategy for those plans (CAT, notes 100‑104).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: UPS's $2.7 billion in unfunded commitments and Caterpillar's $55 million in NAV-measured assets are accurately reported. The timeframes (10–15 years for redemption restrictions, 3–6 years for expected contributions) match the original context. (2) The answer correctly identifies the entities—UPS and Caterpillar—and their respective investment disclosures, with appropriate reference to note ranges in their filings (notes 91–95 for UPS, 100–104 for CAT), which supports entity and source accuracy. (3) The reasoning is sound: it contrasts the illiquidity and long-term nature of UPS’s private fund commitments with Caterpillar’s more liquid and conservative NAV-measured assets. While the LLM does not explicitly name the types of instruments in Caterpillar’s portfolio (e.g., U.S. corporate bonds, short-term instruments) as in the original, it correctly infers a more liquid and conservative strategy, maintaining semantic equivalence. (4) The answer fully addresses the question’s focus on liquidity and investment strategy comparison. The only minor shortcoming is the lack of explicit mention of the specific asset classes in Caterpillar’s portfolio, which slightly reduces qualitative completeness but does not impair the core correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 412,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Alphabet's selective repurchase of Class A and Class C shares, while retaining Class B shares with enhanced voting rights, contrast with Netflix's uniform voting rights structure, and what might this imply about Alphabet's governance strategy?",
      "original_answer": "Alphabet selectively repurchased $62.2 billion of Class A and Class C shares in 2023 while retaining Class B shares, which carry 10 votes per share, suggesting a strategy to maintain concentrated voting control. In contrast, Netflix provides one vote per share across all common stock, indicating a more egalitarian governance approach. This contrast implies that Alphabet's repurchase strategy may be designed to preserve the influence of stakeholders holding Class B shares, which could include insiders or long-term investors, rather than diluting their control through broader ownership.",
      "llm_answer": "Alphabet’s share‑repurchase program targets only Class A and Class C shares, leaving the Class B shares—each with 10 votes per share—intact (GOOGL 10‑K, pp. 79‑83).  In contrast, Netflix has a single class of common stock, with every share entitled to one vote (NFLX 10‑K, pp. 59‑63).  This suggests Alphabet’s governance strategy is to preserve concentrated insider control while still returning value to shareholders, whereas Netflix follows a more egalitarian, uniform voting‑rights model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Alphabet repurchased Class A and C shares while preserving Class B shares with 10 votes per share, and Netflix has a single class of common stock with one vote per share. The LLM correctly identifies the governance contrast between concentrated control (Alphabet) and egalitarian structure (Netflix). (2) Quantitative accuracy is perfect: although the exact $62.2 billion figure is omitted, the ground truth does not require the LLM to reproduce it verbatim for correctness—this omission is minor and does not affect the core reasoning. The focus is on the selective repurchase behavior, which is accurately described. (3) Multi-hop reasoning is sound: the model synthesizes information across Alphabet and Netflix 10-Ks, correctly contrasting their share structures and inferring governance implications. (4) Semantic equivalence is maintained: while the LLM does not explicitly state that Class B holders 'could include insiders or long-term investors,' it captures the essential implication—preservation of insider control—which is the central point. The answer is contextually complete and directly addresses all parts of the question. Minor deduction in qualitative accuracy due to slightly less elaboration on stakeholder implications, but not enough to reduce correctness score below 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 387,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the Tax Reform Act's GILTI provisions impact Coca-Cola's 2022 effective tax rate, and how does this compare to Philip Morris International's 2021 effective tax rate benefit from the corporate income tax reduction enacted in the Philippines where it operates and completed business combinations?",
      "original_answer": "The Tax Reform Act's GILTI provisions impacted Coca-Cola's 2022 effective tax rate by requiring the company to account for these taxes in the period subject to such tax, contributing to a $431 million net tax expense (4.4% impact on effective tax rate). For Philip Morris International, the corporate income tax rate reduction enacted in the Philippines in Q1 2021 contributed to a 0.1 percentage point decrease in its 2021 effective tax rate, which stood at 21.8%. This tax benefit occurred in a jurisdiction where PMI completed business combinations, including in the Philippines, as part of its global expansion strategy.",
      "llm_answer": "Coca‑Cola’s 2022 effective tax rate was higher because the Tax Reform Act’s GILTI provisions added a tax‑expense component that increased the effective rate (KO_10k_2022, pp. 105‑108).  In contrast, Philip Morris International’s 2021 effective tax rate was lowered by the corporate‑income‑tax‑rate reduction enacted in the Philippines, which partially offset the negative impact of GILTI and other tax factors (PM_10k_2022, pp. 78‑82).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general direction of the impact on both companies' effective tax rates—Coca-Cola's rate increased due to GILTI, and Philip Morris International (PMI) benefited from a tax rate reduction in the Philippines. However, it omits all specific quantitative figures from the ground truth. The ground truth states Coca-Cola had a $431 million net tax expense, which contributed a 4.4% increase to its effective tax rate. The LLM answer fails to mention either the dollar amount or the precise percentage impact. Similarly, for PMI, the ground truth specifies that the Philippine tax reduction led to a 0.1 percentage point decrease in its 2021 effective tax rate (which was 21.8%). The LLM answer does not include any of these numbers, including the 0.1 ppt benefit or the 21.8% baseline rate. (2) Quantitative accuracy is low because no actual numbers are provided despite their availability in the source documents cited. Even approximate values or directional magnitudes (e.g., 'minor benefit') are missing. The answer also fails to note that PMI’s benefit occurred in a jurisdiction where it completed business combinations—a key part of the multi-hop reasoning. (3) The qualitative reasoning is partially sound: it correctly identifies the causal relationship (GILTI increasing Coca-Cola’s rate, tax cut lowering PMI’s), and cites appropriate documents. However, it does not synthesize the full chain of logic—especially the connection between PMI’s business combinations and the tax benefit in the Philippines. This weakens the multi-hop aspect. (4) Contextual relevance is high because the answer addresses both companies and the correct tax events in the right years. But due to missing critical numbers and incomplete synthesis, the correctness score is moderate—partially correct but significantly lacking in detail and precision required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 513,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does the $3.1 billion in mortgage loans sold by BAC to GSEs in 2023 influence the risk exposure of MET's $12.392 billion portfolio of pass-through mortgage-backed securities, given that these securities are directly secured by mortgage loans serviced by institutions like BAC?",
      "original_answer": "BAC sold $3.1 billion in mortgage loans to GSEs in 2023, which are part of the broader pool of loans that can be securitized into pass-through mortgage-backed securities (MBS). MET holds $12.392 billion in such pass-through MBS as of 2023, which are directly secured by mortgage loans—often serviced by institutions like BAC. If BAC, as a servicer, experiences issues in fulfilling its obligations (e.g., due to cybersecurity incidents or servicing breaches), this could lead to disruptions in cash flows or increased credit risk for the underlying loans, which in turn affects the value and performance of MET’s pass-through MBS portfolio.",
      "llm_answer": "BAC’s 2023 filing notes that it sold roughly **$3.1 billion of mortgage loans to GSEs (primarily Freddie Mac)** while continuing to **service those loans** (BAC 10‑K, p. 19‑20).  MET’s 2023 RMBS holdings include **$12.392 billion of pass‑through securities that are secured by mortgage loans serviced by institutions such as BAC** (MET 10‑K, p. 95‑97).  Thus, although BAC’s direct credit exposure to those loans has decreased, MET’s portfolio risk remains tied to the credit quality of the GSE‑backed loans and the ongoing servicing performance of BAC, which governs the payment streams to the pass‑through holders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: BAC sold $3.1 billion in mortgage loans to GSEs in 2023 and continues to service them; MET holds $12.392 billion in pass-through MBS secured by loans serviced by institutions like BAC. These numbers match the ground truth exactly, with acceptable formatting (e.g., $3.1 billion = $3.1 billion). (2) Quantitative accuracy is perfect—both dollar amounts ($3.1 billion and $12.392 billion) are correctly reported, and no calculations are required beyond accurate representation. (3) The multi-hop reasoning is sound: the model correctly links BAC’s role as a loan servicer to the performance of MET’s MBS portfolio, noting that while BAC has reduced its credit exposure by selling loans to GSEs, MET remains exposed to servicing risk and underlying loan performance. This aligns with the ground truth’s emphasis on servicing risk affecting cash flows and credit risk. (4) The only minor shortcoming is that the LLM does not explicitly mention potential triggers like 'cybersecurity incidents or servicing breaches' as in the original, which slightly weakens the completeness of risk explanation—hence a 9 instead of 10 on qualitative accuracy. However, the core logic and synthesis across BAC and MET filings are accurate and relevant. Contextual relevance is full, as the answer directly addresses the influence of BAC’s actions on MET’s risk exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 393,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How does the valuation complexity of NKE's embedded derivatives, which result in Level 3 classification, compare to LOW's use of unobservable inputs for fair value measurements, particularly in terms of reliance on non-market-based assumptions?",
      "original_answer": "NKE disclosed $5 million in embedded derivatives as of May 31, 2022, which resulted in Level 3 classification due to the use of significant unobservable inputs such as extrapolation beyond observable limits and policyholder behavior assumptions. Similarly, Level 3 classifications—as described in MET_10k_2022—rely on non-market-based assumptions like actuarial inputs for policyholder behavior and mortality, which cannot be corroborated by observable market data. LOW, however, reported no material fair value measurements on a nonrecurring basis and emphasized that its financial assets and liabilities not measured at fair value on a recurring basis (such as long-term debt) primarily use observable inputs like quoted market prices or discounted cash flow analyses with incremental borrowing rates, indicating a lesser reliance on unobservable assumptions compared to NKE's Level 3 embedded derivatives.",
      "llm_answer": "NKE’s embedded derivatives are classified as Level 3 because their fair‑value estimates depend on unobservable inputs—such as management‑determined foreign‑currency exposure indices—requiring significant judgment (NKE_10k_2022, pp. 81‑85). LOW also uses unobservable inputs for fair‑value measurements, as noted in its Fair Value Measurements note, but the valuation spans a broader mix of Level 2 and Level 3 assets (LOW_10k_2022, pp. 54‑58). Thus, while both firms rely on non‑market‑based assumptions, NKE’s embedded‑derivative valuation is more concentrated and complex due to its exclusive Level 3 classification.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but introduces inaccuracies and omits key distinctions from the ground truth. It correctly identifies that NKE's embedded derivatives are Level 3 due to unobservable inputs, but incorrectly specifies the nature of those inputs as 'management-determined foreign-currency exposure indices,' which does not match the ground truth (extrapolation beyond observable limits and policyholder behavior assumptions). Furthermore, the LLM claims LOW uses unobservable inputs and has Level 3 assets, which directly contradicts the ground truth stating LOW reported no material fair value measurements on a nonrecurring basis and primarily relies on observable inputs for its non–fair value-measured liabilities like long-term debt. (2) Quantitatively, the LLM fails to mention NKE’s $5 million embedded derivatives as of May 31, 2022—a specific figure in the original answer—thus missing a key data point. No incorrect numbers are presented, but the absence of this amount reduces quantitative accuracy. (3) The multi-hop reasoning is flawed: the comparison between NKE and LOW should center on NKE’s use of Level 3 inputs for embedded derivatives versus LOW’s minimal reliance on unobservable inputs. Instead, the LLM incorrectly equates both companies’ use of unobservable inputs and suggests LOW has Level 3 classifications, which the ground truth denies. This undermines the core comparative logic. (4) Despite these issues, the answer is contextually relevant—it addresses the question about valuation complexity and reliance on non-market assumptions—and correctly infers that NKE’s valuation is more complex due to exclusive Level 3 classification, which aligns with the conclusion in the original answer. However, this correct conclusion is supported by incorrect premises, limiting its accuracy. Overall, the answer is partially correct but contains significant factual and reasoning errors, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 535,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "As defense industry peers managing significant pension assets, how do GD's and LMT's approaches to Level 3 asset valuations differ, given GD's use of valuation models with observable inputs for fixed-rate notes versus LMT's reliance on unobservable inputs for its $4,951 million private equity fund holdings?",
      "original_answer": "GD values its Level 3 assets, including fixed-rate notes, using valuation models that incorporate observable inputs such as interest rates and quoted prices for similar assets. In contrast, LMT's $4,951 million in private equity funds, which are also Level 3 assets, are valued using NAV based on valuation models that rely on unobservable inputs not corroborated by verifiable market data. This highlights a key difference in their fair value accounting methodologies for similar asset classifications, with GD relying on more market-validated inputs while LMT uses internally-derived assumptions for its private equity investments.",
      "llm_answer": "GD’s pension assets are valued using observable market data – its fixed‑rate notes are priced with valuation models that incorporate observable inputs such as interest rates, bond yields and quoted prices for similar securities, placing those instruments in the Level‑2 hierarchy (and any direct private‑equity holdings in Level‑3). In contrast, Lockheed Martin’s Level‑3 holdings are private‑equity funds, whose net asset values are derived from valuation models that rely on unobservable inputs that cannot be corroborated with observable market data, totaling $4,951 million as of December 31 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: LMT's $4,951 million in private equity fund holdings is accurately reported, and the reference to December 31, 2023, is consistent with the data source. No calculations were required, but the dollar amount is correctly stated. (2) The LLM correctly identifies that GD uses observable inputs (interest rates, bond yields, quoted prices) in valuation models for fixed-rate notes, though it adds a detail not in the original—that these are placed in Level 2—while the original states they are Level 3 assets. This is a minor discrepancy: if GD’s fixed-rate notes use observable inputs, they may indeed be Level 2, but the original answer explicitly classifies them as Level 3, suggesting limited market activity. This creates a slight conflict in classification, but the core point about use of observable inputs stands. (3) The multi-hop reasoning is sound: the model contrasts GD’s approach (observable inputs) with LMT’s (unobservable inputs for private equity via NAV), correctly identifying the key difference in fair value methodologies. (4) The answer is contextually relevant and directly addresses the question about differing Level 3 valuation approaches. The only shortcoming is the potential misclassification of GD’s fixed-rate notes as Level 2 when the ground truth treats them as Level 3, which slightly affects qualitative accuracy. However, the main comparative insight—GD relies on more market-validated inputs, LMT on unobservable ones—is preserved. Thus, the answer is factually strong with minor nuance issues.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 451,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How does the legal exposure from Slack's shareholder litigation, including the timeline and procedural history of the motion to dismiss, compare to Disney's recent antitrust litigation strategy involving motions to dismiss in the Biddle and Fendelander actions?",
      "original_answer": "Slack faced a multi-year shareholder litigation process beginning in 2019, with the motion to dismiss filed in January 2020, partial denial in April 2020, and eventual reversal by the Ninth Circuit on February 10, 2025, leading to dismissal with prejudice. In contrast, Disney filed motions to dismiss in both the Biddle and Fendelander actions on January 31, 2023, which were granted in part and denied in part by September 30, 2023. Disney then filed another motion to dismiss the consolidated amended complaint on December 1, 2023, which was also granted in part and denied in part on June 25, 2024. While Slack’s litigation reached the U.S. Supreme Court and resulted in a definitive dismissal, Disney’s antitrust cases remain ongoing with class certification deadlines set for March 27, 2026.",
      "llm_answer": "Slack’s shareholder litigation began in September 2019, and a motion to dismiss filed in January 2020 was partially granted in April 2020, followed by an interlocutory appeal (May 2020), a petition to the Ninth Circuit (July 2020), oral argument (May 2021), a Ninth Circuit affirmation (Sept 2021), a rehearing denial (May 2022), a Supreme Court certiorari (Aug 2022), a remand (Jun 2023), and ultimately a dismissal with prejudice by the Ninth Circuit in February 2025 (Google 10‑K, Slack Litigation section). In contrast, Disney’s antitrust actions (the Biddle and Fendelander cases) were filed in November 2022, with motions to dismiss filed on Jan 31 2023 that were partially granted and denied by the district court in September 2023, a consolidation in October 2023, and a motion to dismiss the consolidated complaint filed Dec 1 2023 that was partially granted by the court in June 2024 (Disney 10‑K, pages 114‑118), leaving the litigation still pending. Thus, Slack’s exposure has been largely resolved with a final dismissal, whereas Disney’s strategy of motions to dismiss has only achieved partial relief and the cases remain active.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core comparison between Slack's and Disney's litigation strategies and correctly identifies that Slack's case concluded with a dismissal with prejudice in February 2025, while Disney's cases remain ongoing. However, there are significant inaccuracies in the procedural timeline for Slack's litigation. The original answer states the motion to dismiss was 'partially denied' in April 2020, but the LLM claims it was 'partially granted'—this is a factual error that affects the interpretation of the case's progression. Additionally, the LLM fabricates or misrepresents several procedural events not present in the ground truth, including an interlocutory appeal (May 2020), petition to the Ninth Circuit (July 2020), oral argument (May 2021), Ninth Circuit affirmation (Sept 2021), rehearing denial (May 2022), Supreme Court certiorari (Aug 2022), and remand (Jun 2023). The ground truth only mentions the Ninth Circuit reversal on February 10, 2025, leading to dismissal with prejudice, without detailing this extensive appellate history. While the final outcome (dismissal with prejudice) is correct, the intermediate steps are largely invented or incorrect, undermining quantitative and factual accuracy. For Disney, the LLM correctly reports the filing of motions to dismiss on January 31, 2023, partial grant/denial by September 30, 2023, consolidation, and a second motion to dismiss on December 1, 2023, with a partial ruling on June 25, 2024—this aligns with the original answer. The conclusion that Disney’s litigation remains pending with class certification due in 2026 is accurate. Thus, while the qualitative reasoning and contextual relevance are strong—correctly contrasting resolved vs. ongoing exposure—the quantitative accuracy is compromised by incorrect dates and procedural events in the Slack timeline. The answer synthesizes across entities appropriately but introduces false precision in the appellate history.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 526,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Intel's tax benefit from operations in Hong Kong compare to Apple's revenue contribution from the Greater China region, considering the inclusion of Hong Kong within Apple's Greater China reporting?",
      "original_answer": "Intel reported deriving effective tax rate benefits from operations in Hong Kong, where statutory tax rates range from 12.5% to 24.0%, as part of its broader non-US tax strategy. Meanwhile, Apple reported $74.2 billion in net sales from the Greater China region in 2022, which includes Hong Kong. This indicates that while Intel leverages Hong Kong for tax optimization, Apple generates significant revenue from the broader Greater China region, which encompasses Hong Kong.",
      "llm_answer": "Intel’s operations in Hong Kong produced a deferred tax benefit of **$146 million** in 2021 (the non‑US deferred tax benefit shown in the 10‑K).  By contrast, Apple’s Greater China segment – which includes Hong Kong – generated **$74.2 billion** in net sales in 2022, a figure vastly larger than Intel’s tax benefit.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Apple's $74.2 billion in net sales from the Greater China region in 2022, which matches the ground truth and includes Hong Kong as stated. However, the Intel tax benefit figure of $146 million in 2021 is not present in the original answer or implied by it; the ground truth only mentions that Intel derives tax benefits from Hong Kong due to favorable statutory rates (12.5%–24.0%) as part of its non-US tax strategy, without citing a specific dollar amount or year. This introduces a specific quantitative claim not supported by the source. (2) The Apple revenue number ($74.2 billion, 2022) is accurate and correctly attributed. The Intel figure ($146 million, 2021) is precise but unsupported by the original answer, which provides no such figure—making the quantitative accuracy partially incorrect. (3) The multi-hop reasoning is sound in concept: comparing Intel’s tax benefit from Hong Kong operations to Apple’s revenue from Greater China (including Hong Kong). The model correctly synthesizes that these are different types of financial impacts (tax benefit vs. revenue) and makes a valid qualitative comparison in scale. However, the unsupported specific figure for Intel undermines the factual basis of the comparison. (4) The contextual relevance is high—the answer directly addresses the comparison asked, includes correct entities (Intel, Apple, Hong Kong, Greater China), correct metric types, and appropriate years. The qualitative reasoning and structure align well with the question, but the inclusion of an unverified dollar amount for Intel reduces quantitative accuracy. Correctness score is 7 because core facts about Apple are correct and the conceptual framework is sound, but a key cited figure for Intel is not in the ground truth and thus factually unsupported.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 498,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does the 70% CO₂ emissions reduction target set by North Carolina's HB 951 impact Duke Energy's Carolinas Resource Plan, and how does this regulatory requirement compare with NextEra Energy's operational exposure in North Carolina?",
      "original_answer": "North Carolina passed HB 951 in 2021, directing the NCUC to develop and approve a carbon reduction plan targeting a 70% reduction in CO₂ emissions from Duke Energy Progress' and Duke Energy Carolinas' electric generation by 2030. In response, Duke Energy filed its 2023 Carolinas Resource Plan, recommending Portfolio 3 as the most prudent path forward, which includes retiring coal by 2035 and leveraging nuclear and energy storage to meet the emissions targets. Meanwhile, NextEra Energy operates in North Carolina, exposing it to the same regulatory environment, though it is not directly subject to HB 951. This creates a differentiated regulatory burden and transition pathway between the two companies in the same state.",
      "llm_answer": "The HB 951 70 % CO₂‑reduction mandate forces Duke Energy to adopt the most cost‑effective path in its 2023 Carolinas Resource Plan – Portfolio 3 – which includes early coal retirements, expanded renewables, and extended nuclear and storage assets to meet the 2030 target (DUK_10k_2023, pp. 67‑73). In contrast, NextEra Energy’s North Carolina exposure is limited to its regulated utility operations, which are subject to state and federal rules but are not directly bound by HB 951’s specific emissions target (NEE_10k_2023, pp. 43‑47).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 70% CO₂ reduction target from HB 951, the 2030 deadline, Duke Energy's adoption of Portfolio 3 in its 2023 Carolinas Resource Plan, and the focus on coal retirements, nuclear, and storage. The mention of Duke Energy Progress and Duke Energy Carolinas is implied through context, though not explicitly named—this is a minor omission. (2) The years (2021 for HB 951 passage, 2023 for the Resource Plan) are correct, and no calculations are required. Format variations (e.g., '70 %' vs '70%') are acceptable. (3) The multi-hop reasoning is sound: the LLM correctly links HB 951 to Duke Energy’s regulatory obligation, connects it to the specific portfolio choice in the 2023 plan, and contrasts Duke’s direct compliance burden with NextEra’s indirect exposure due to operating in the same state but not being subject to the law. (4) The answer is contextually relevant and addresses both parts of the question: the impact on Duke Energy and the comparison with NextEra. The only minor shortcoming is the lack of explicit mention that HB 951 applies specifically to Duke Energy Progress and Duke Energy Carolinas (as regulated subsidiaries), which slightly weakens entity precision. However, the overall meaning and factual content are preserved, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 385,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How do MDLZ's use of weighted-average assumptions for measuring postretirement healthcare costs differ from KO's application of these assumptions in the Black-Scholes-Merton model for stock option valuation?",
      "original_answer": "MDLZ uses weighted-average assumptions to determine its net periodic postretirement healthcare costs, which resulted in costs of $14 million in 2021, $12 million in 2022, and a benefit of $5 million in 2023. These assumptions are applied to liability cash flows using spot rates along a yield curve to measure service and interest costs. In contrast, KO uses weighted-average assumptions as inputs in the Black-Scholes-Merton option-pricing model to estimate the fair value of stock options granted, which are then expensed on a straight-line basis over a four-year vesting period. The key difference lies in the financial valuation context: MDLZ applies the assumptions for postretirement benefit accounting, while KO uses them for equity compensation valuation.",
      "llm_answer": "MDLZ uses weighted‑average actuarial assumptions—discount rates, expected return on plan assets, health‑care cost trend rates, ultimate trend rates, and the year to reach the ultimate trend—to calculate the present value of post‑retirement health‑care benefit obligations and net periodic costs (see pages 105‑108). KO, by contrast, applies weighted‑average market assumptions—risk‑free interest rate, expected life, expected volatility, expected dividend yield, and expected term—to estimate the fair value of stock options under the Black‑Scholes‑Merton model (see pages 93‑97). Thus, MDLZ’s assumptions are plan‑specific actuarial inputs for benefit valuation, whereas KO’s are option‑specific financial inputs for option pricing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential distinction between MDLZ's and KO's use of weighted-average assumptions, aligning well with the ground truth. (1) Quantitatively, while the LLM answer does not include the specific dollar amounts ($14M, $12M, -$5M) from MDLZ's postretirement costs over 2021–2023, this omission does not introduce inaccuracy—only a slight reduction in completeness. No incorrect numbers are presented, so quantitative accuracy remains high. (2) The qualitative explanation is strong: it correctly identifies that MDLZ uses actuarial assumptions (discount rates, healthcare cost trends, etc.) for postretirement benefit valuation, while KO uses financial assumptions (risk-free rate, volatility, dividend yield, etc.) in the Black-Scholes-Merton model for stock option valuation. This matches the core reasoning in the ground truth. (3) The multi-hop reasoning is sound—correctly synthesizing differences in purpose, context, and type of assumptions across two companies and distinct financial models. (4) Contextual relevance is perfect: the response directly addresses the comparative question and distinguishes the two applications clearly. The only minor shortcoming is the lack of specific financial figures from MDLZ’s disclosures, which were present in the original answer and would have strengthened completeness. However, since the question does not explicitly ask for those numbers, and the conceptual contrast is accurately rendered, the answer earns a 9/10 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 420,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does JPMorgan Chase's exposure to derivatives under the Dodd-Frank Act compare to Bank of America's resolution planning obligations under the Orderly Liquidation Authority, particularly in terms of liquidity risk management during financial distress?",
      "original_answer": "JPMorgan Chase is subject to Dodd-Frank regulations that govern its use of derivatives through enforceable set-off and close-out netting provisions under ISDA Master Agreements, which are constrained by the Orderly Liquidation Authority (OLA) under Title II of Dodd-Frank. Similarly, Bank of America must submit resolution plans under the OLA that outline a 'single point of entry' strategy, restricting liquidity flows from subsidiaries to the parent company during financial distress. Both firms face regulatory constraints on liquidity: JPMorgan through enforceable netting limitations and Bank of America through intercompany liquidity contribution arrangements that prioritize subsidiary solvency over parent company funding needs.",
      "llm_answer": "JPMorgan’s 10‑K notes that its OTC‑bilateral derivatives are governed by ISDA Master Agreements and subject to Dodd‑Frank margin, netting and collateral rules—including the Orderly Liquidation Authority—so that in a counterparty’s bankruptcy the firm can set off receivables, apply collateral and limit liquidity loss (see pages 12‑13 of the JPM 10‑K).  By contrast, Bank of America’s 10‑K describes a resolution plan that requires it to keep sufficient capital and liquidity for key subsidiaries, to contribute remaining assets to a holding company if its own liquidity deteriorates, and to allow the FDIC to invoke the Orderly Liquidation Authority for an orderly liquidation if the plan is deemed uncredible (see pages 11‑15 of the BAC 10‑K).  Thus, JPMorgan focuses on counterparty‑risk mitigation within its derivatives portfolio, while Bank of America focuses on ensuring systemic liquidity and solvency during a potential resolution or liquidation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of regulatory frameworks and firm-specific obligations. It accurately identifies that JPMorgan Chase's derivatives exposure is governed by ISDA Master Agreements under Dodd-Frank, including netting and collateral rules subject to the Orderly Liquidation Authority (OLA), which supports liquidity risk mitigation through set-off and close-out netting. This matches the original answer’s emphasis on enforceable netting limitations under OLA. Similarly, the LLM correctly notes Bank of America’s resolution plan requirements under OLA, including maintaining subsidiary liquidity and allowing FDIC intervention if the plan is uncredible—consistent with the 'single point of entry' strategy and restrictions on intercompany liquidity flows described in the ground truth. The answer captures the core contrast: JPMorgan’s focus on counterparty risk in derivatives vs. Bank of America’s systemic resolution planning. However, it omits explicit mention of the 'single point of entry' strategy and does not clearly articulate that both firms face parallel but structurally different liquidity constraints—JPMorgan via netting limitations, Bank of America via restricted subsidiary-to-parent liquidity. These are key nuances in the original answer that enhance completeness. There are no numerical inaccuracies (quantitative accuracy is perfect by default, as no specific numbers are involved), and all entities (JPMorgan, Bank of America, Dodd-Frank, OLA, ISDA) are correctly identified. The reasoning is sound and reflects multi-hop synthesis across regulatory structure and firm-specific disclosures. Wording differs but meaning is semantically close. Minor omission prevents a top score, but overall highly accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 487,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Ohio's continued reliance on coal influence the contrasting energy transition strategies of XOM and CVX, particularly considering XOM's European coal tax burden and CVX's 2024 renewable natural gas investments in the state?",
      "original_answer": "XOM faced a significant $1.8 billion after-tax charge in 2022 due to the EU's new tax on coal and other energy sectors, which targeted companies with surplus profits, signaling regulatory pressure to reduce fossil fuel dependency. Meanwhile, Duke Energy Ohio, a subsidiary operating in the state, held only $23 million in coal inventory as of December 31, 2024, suggesting a cautious but ongoing reliance on coal. In contrast, CVX made targeted investments in Ohio through Brightmark RNG Holdings LLC, achieving commercial operations at renewable natural gas projects in 2024, aligning with a cleaner energy transition. This divergence highlights how regulatory penalties in Europe are pushing XOM toward compliance, while CVX is proactively investing in low-carbon alternatives like RNG in coal-reliant states such as Ohio.",
      "llm_answer": "Ohio’s persistent coal‑heavy power mix—evidenced by its $23 m coal inventory and reliance on coal‑based generation—amplifies the cost of coal exposure for companies operating there. XOM’s European coal tax burden, amounting to roughly $1.8 bn in 2022 and $0.2 bn in 2023 (XOM 10‑K, pp. 113‑117), underscores the financial penalty of coal and drives its strategy to reduce coal reliance. In contrast, CVX’s 2024 renewable natural gas investments, including Brightmark RNG projects in Ohio (CVX 10‑K, pp. 17‑21), represent a proactive shift toward cleaner energy to replace coal and support Ohio’s transition.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Ohio's $23 million coal inventory and XOM's $1.8 billion European coal tax burden in 2022, which aligns with the ground truth. However, it introduces a new figure—$0.2 billion in 2023 tax burden for XOM—that is not present in the original answer or supported by the provided context. This addition undermines quantitative accuracy, as there is no evidence in the ground truth to support a 2023 tax amount. (2) The mention of CVX’s 2024 renewable natural gas investments via Brightmark RNG Holdings LLC in Ohio is accurate and contextually appropriate, showing proactive low-carbon investment. The use of document citations (e.g., 'CVX 10-K, pp. 17-21') adds specificity but cannot be verified without source access; however, they do not contradict the ground truth. (3) The multi-hop reasoning is largely sound: the model connects Ohio’s coal reliance to regulatory pressures on XOM in Europe and contrasts it with CVX’s clean energy investments in the same state. This synthesis reflects an understanding of how regional energy profiles interact with corporate strategies under regulatory and investment dynamics. (4) While the core contrast between XOM’s reactive compliance due to penalties and CVX’s proactive investment is preserved and well-reasoned, the inclusion of an unsupported 2023 tax figure reduces confidence in the quantitative claims. Despite this, the overall narrative remains semantically aligned with the original answer, earning high marks for qualitative accuracy and contextual relevance. The correctness score is 7 due to the factual error in the added tax amount, which could mislead if taken as verified truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 460,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How does the structure of MS's CLNs, which embed credit protection sold by the issuer, compare with JPM's credit-related notes in terms of payout mechanics upon a credit event, given that both instruments involve the transfer of credit risk on reference entities?",
      "original_answer": "Morgan Stanley structures CLNs as hybrid instruments where it purchases credit protection from the issuer, and if a credit event occurs with the reference entity, the principal balance of the note may not be repaid in full. JPMorgan, on the other hand, sells credit protection through credit-related notes, where the issuer pays the investor the difference between the par value and the fair value of the defaulted reference obligation upon a credit event. Both instruments transfer credit risk on reference entities, but MS acts as the buyer of protection while JPM often acts as the seller, affecting payout obligations differently based on their respective positions in the transaction.",
      "llm_answer": "MS’s credit‑linked notes are structured so that the firm (the issuer) buys credit protection from an SPE and then issues the notes to investors.  Upon a credit event the issuer pays investors the difference between the note’s par value and the fair value of the defaulted reference obligation, while the SPE delivers collateral to the issuer that can offset that payout.  \n\nJPM’s credit‑related notes are a funded derivative in which the issuer sells credit protection to the investor.  The investor pays par value at inception and the issuer makes periodic payments and, on a credit event, pays the investor the difference between the note’s par value and the fair value of the defaulted reference obligation—there is no collateral from a third party to offset the payment.  \n\nThus, both instruments trigger a payment of the par‑value minus fair‑value gap to the note holder, but MS’s CLNs include collateral from the SPE that can reduce the issuer’s liability, whereas JPM’s credit‑related notes involve a direct payment with no collateral offset.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical factual error in the characterization of Morgan Stanley's role in its CLNs, which undermines the core comparison. The ground truth states that MS *purchases* credit protection from the issuer (i.e., MS is the buyer of protection), meaning MS is synthetically short the credit risk and would suffer a loss upon a credit event. However, the LLM incorrectly states that MS (as issuer) *buys protection from an SPE*, implying MS is hedging its risk — but then describes the payout as going *from the issuer (MS) to investors*, which contradicts standard CLN mechanics where investors bear the credit loss. In a typical CLN, the investor receives less than par upon a credit event due to reduced collateral value, not a cash payout from the issuer. The LLM frames MS’s structure as an issuer making a funded payment to investors, which aligns more with selling protection (like JPM), not buying it. This misrepresents MS’s position and the payout mechanics. In contrast, the description of JPM’s notes is accurate: JPM sells protection, receives par, and pays out the par-fair value difference upon default. The LLM correctly identifies that both involve a par-minus-fair-value payout and contrasts the presence of collateral offset in MS’s case versus direct payment in JPM’s, but this is misleading because in a true CLN where MS buys protection, the collateral (often treasuries) is what gets marked down, reducing investor repayment — not a payment funded by the issuer and offset by third-party collateral. There are no numeric values in the question or answer, so quantitative accuracy is not applicable — but all conceptual financial mechanics are treated as correct where present. The reasoning is logically consistent within its flawed premise, and the answer is highly relevant to the question. However, due to the fundamental mischaracterization of MS’s role and payout mechanism, the qualitative accuracy and overall correctness are significantly reduced despite strong structure and partial correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 554,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the application of the reduced disclosure format differ between Georgia Power Company (a subsidiary of Southern Company) and Florida Power & Light Company (a subsidiary of NextEra Energy) in their respective 2022 Form 10-K filings, particularly in terms of their compliance with General Instruction I.(1)(a) and (b) of Form 10-K?",
      "original_answer": "Georgia Power Company, as part of Southern Company's consolidated 10-K filing, explicitly states that it meets the conditions in General Instructions I(1)(a) and (b) of Form 10-K and therefore uses the reduced disclosure format specified in General Instructions I(2)(b), (c), and (d). Similarly, Florida Power & Light Company also asserts compliance with General Instruction I.(1)(a) and (b), qualifying for the reduced disclosure format in its 2022 Form 10-K filing. However, while Georgia Power is one of multiple registrants in a combined filing with Southern Company, Florida Power & Light Company is one of only two registrants in its combined filing, the other being NextEra Energy, Inc., which holds all 1,000 shares of its common stock. Both companies file information only on their own behalf and disclaim responsibility for the other registrants’ data.",
      "llm_answer": "Georgia Power Company, as part of a combined filing with Southern Company and its other regulated subsidiaries, states that “each of Georgia Power Company, Mississippi Power Company, Southern Power Company, and Southern Company Gas meets the conditions set forth in General Instruction I(1)(a) and (b) of Form 10‑K and is therefore filing this Form 10‑K with the reduced disclosure format specified in General Instruction I(2)(b), (c), and (d).” In contrast, Florida Power & Light Company, in a combined filing with NextEra Energy, simply notes that “Florida Power & Light Company meets the conditions set forth in General Instruction I.(1)(a) and (b) of Form 10‑K and is therefore filing this Form with the reduced disclosure format.” Thus, both companies comply with the same General Instruction I.(1)(a) and (b) requirements, but Georgia Power’s statement applies to a group of subsidiaries while Florida Power & Light’s applies only to itself.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that both Georgia Power Company and Florida Power & Light Company comply with General Instruction I.(1)(a) and (b) of Form 10-K and therefore qualify for the reduced disclosure format. The answer accurately quotes the language used in the filings and correctly notes that Georgia Power is part of a combined filing with multiple subsidiaries, while Florida Power & Light's filing is with NextEra Energy only. The key difference in the scope of the registrants (group vs. individual) is correctly highlighted. The only minor omission is that the original answer includes the detail that NextEra Energy holds all 1,000 shares of Florida Power & Light’s common stock, which the LLM answer leaves out. Additionally, the ground truth clarifies that both companies file only on their own behalf and disclaim responsibility for other registrants’ data—a nuance not fully captured in the LLM response. However, these are secondary details that do not undermine the core correctness. All entities, instructions, and filing structures are accurately represented. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning correctly synthesizes multi-hop information from the two filings. The answer is contextually relevant and directly addresses the comparative application of the reduced disclosure format.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 393,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does RTX's revenue recognition timing on U.S. government fixed-price contracts, influenced by FAR guidelines, compare to GD's cost allocation practices under the same regulatory framework, particularly in relation to performance-based payments and contract modifications?",
      "original_answer": "RTX recognizes revenue in excess of billings on U.S. government fixed-price contracts due to performance-based payments (PBPs) or progress payments, where the customer retains a portion of the contract price until completion. This practice is guided by the Federal Acquisition Regulation (FAR), which outlines allowable cost structures and payment mechanisms. Similarly, GD operates under the FAR and Cost Accounting Standards (CAS), which regulate cost allowability and allocation across contracts. GD's cost allocation practices are subject to audits and reviews by the government, ensuring that costs charged to contracts comply with FAR stipulations. Both companies must manage contract modifications and revenue or cost adjustments in response to FAR-mandated acquisition phases, including planning, competition, and contractor qualifications, though RTX specifically highlights the impact of these regulations on contract assets and liabilities, while GD emphasizes compliance and auditability under FAR and CAS.",
      "llm_answer": "RTX recognizes revenue on U.S. government fixed‑price contracts over time using a percentage‑of‑completion method, recording revenue in excess of billings (contract assets) and treating performance‑based payments as earned when the related performance obligations are satisfied. Contract modifications are accounted for on a cumulative catch‑up or prospective basis, depending on whether they create new or change existing rights.  \n\nGD, under the same FAR and CAS framework, allocates costs to contracts—direct, indirect, and overhead—using cost‑allocation bases that reflect the cost of fulfilling each performance obligation. Cost allocation is applied to performance‑based payments and to contract modifications so that the cost of the modified or new obligations is properly reflected in the cost of sales. Thus, RTX focuses on timing revenue recognition, while GD focuses on allocating the associated costs to the appropriate contract components.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies RTX's revenue recognition practice—recognizing revenue in excess of billings under fixed-price contracts using percentage-of-completion, driven by performance-based payments (PBPs), which matches the original answer's emphasis on FAR-influenced timing and contract assets. It also accurately notes that PBPs are recognized as performance obligations are satisfied. For GD, the LLM correctly states that cost allocation follows FAR and CAS, with proper assignment of direct, indirect, and overhead costs—consistent with the original answer’s focus on auditability and compliance. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable in a literal sense, but all conceptual financial treatments (e.g., contract assets, cost allocation bases) are correctly represented—thus scoring 10. (3) The reasoning is sound: the LLM synthesizes multi-hop concepts—FAR’s impact on both companies, differences in focus (RTX on revenue timing, GD on cost allocation), and treatment of contract modifications—and draws a valid comparative insight. The only minor gap is that the original answer explicitly mentions government audits and acquisition phases (planning, competition), which the LLM omits, slightly reducing completeness. (4) Contextual relevance is perfect: every part of the question—revenue timing, cost allocation, PBPs, contract modifications, FAR framework—is addressed directly and accurately. Overall, the answer is semantically equivalent to the ground truth with only slight omission of contextual detail on audits and acquisition phases, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 468,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the difference in voting rights structure between Class A and Class B shares at GOOGL compare to CMCSA's disclosure regarding its lack of voting rights in Atairos, and what implications does this have for corporate governance control in both entities?",
      "original_answer": "At GOOGL, Class A shares carry one vote per share while Class B shares carry ten votes per share, creating a dual-class structure that concentrates voting power among holders of Class B shares. This structure allows certain shareholders to maintain control over corporate decisions despite owning a minority of shares. In contrast, CMCSA explicitly discloses that it has no voting rights in Atairos, which is accounted for as an equity method investment, limiting its influence over Atairos’s operations. While GOOGL uses differentiated voting rights to preserve control through a structured share class system, CMCSA lacks such control mechanisms entirely in its investment in Atairos, affecting its corporate governance influence in that entity.",
      "llm_answer": "GOOGL’s dual‑class structure gives Class B shareholders a ten‑fold voting advantage—each Class B share votes ten times as many times as a Class A share—concentrating control in the hands of the founders and insiders. In contrast, CMCSA’s investment in Atairos carries no voting rights; the company has only economic exposure and limited consent rights, so it cannot direct the VIE’s governance. Thus, GOOGL’s structure centralizes corporate control among a minority of shareholders, whereas CMCSA’s lack of voting rights in Atairos limits its influence to financial participation only.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all facts are correct: GOOGL's Class B shares have 10 votes per share versus 1 vote for Class A, and CMCSA has no voting rights in Atairos—both match the original answer. There are no calculations, but the comparative voting ratios are correctly stated. (2) The answer addresses all parts of the multi-hop question: it compares GOOGL’s dual-class voting structure with CMCSA’s lack of voting rights in Atairos and discusses implications for corporate governance control in both entities. (3) Entities are correctly identified: GOOGL, CMCSA, Atairos, Class A and Class B shares, and the nature of the equity method investment are accurately referenced. (4) The reasoning is sound: the LLM correctly infers that GOOGL’s structure centralizes control with insiders, while CMCSA lacks governance influence over Atairos despite economic exposure. The only minor shortcoming is that the LLM does not explicitly mention that Atairos is a VIE (variable interest entity) or that CMCSA accounts for it under the equity method—details present in the original answer that add technical precision. However, the phrase 'limited consent rights' and 'cannot direct the VIE’s governance' imply this understanding. Overall, the answer is semantically equivalent with only slight omission of technical terminology, warranting a high score but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 398,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does Amgen's reliance on McKesson Corporation for 33% of its gross product sales in 2021 compare to Merck's risk disclosures about pharmaceutical product distribution concentration, given Amgen's specific exposure to wholesaler distribution risks outlined in its 2022 filing?",
      "original_answer": "Amgen's 2022 filing reveals that McKesson Corporation accounted for 33% of its gross product sales in 2021, highlighting a significant dependency on a single wholesaler. This concentration risk is explicitly acknowledged in Amgen's disclosure that the substantial majority of its U.S. product sales are made to just three distributors, including McKesson, and that financial or operational difficulties at any of these could significantly disrupt its business. Merck's 2022 filing similarly warns that 'pharmaceutical products can develop unexpected safety or efficacy concerns' and that 'reliance on third-party relationships and outsourcing arrangements could materially adversely affect the business,' reinforcing the industry-wide sensitivity to distribution chain vulnerabilities. Together, these disclosures underscore the material financial and operational risk both companies face from overreliance on a concentrated pharmaceutical distribution network.",
      "llm_answer": "Amgen’s 2022 filing shows that McKesson accounted for 33 % of its gross product sales in 2021, and the company explicitly warns that concentration at a single wholesaler and the potential financial distress of that distributor could materially disrupt its business (Amgen 2022, p. 44‑47).  Merck’s 2022 filing also acknowledges distribution‑concentration risk, but it does not quantify the exposure and discusses the risk in more general terms of a limited number of distributors or customers affecting sales (Merck 2022, p. 29‑33).  Thus, Amgen’s reliance on McKesson represents a more pronounced and quantified concentration risk than Merck’s broader, less specific disclosure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Amgen's 33% reliance on McKesson in 2021 is accurately cited, and the years (2021 sales, 2022 filings) match the original. No calculations were required, but the percentage is correctly reported. (2) The answer addresses all parts of the multi-hop question: it identifies Amgen’s specific concentration risk (33% to McKesson), references Amgen’s explicit risk disclosure about distributor dependency, compares it to Merck’s risk disclosures, and draws a valid conclusion about the relative specificity of the two companies’ risk reporting. (3) Entity accuracy is strong: both Amgen and Merck are correctly identified with their respective 2022 filings, and McKesson is accurately named as the wholesaler. The reference to page numbers (e.g., p. 44–47, p. 29–33) adds precision, though these were not in the ground truth; however, they do not detract as long as they are plausible. (4) The reasoning is sound: the LLM correctly infers that while both companies acknowledge distribution concentration risks, Amgen provides a quantified exposure whereas Merck’s is more general—this is a valid synthesis across filings. The only minor shortcoming is that the LLM does not explicitly mention Merck’s related point about 'unexpected safety or efficacy concerns' or 'third-party relationships' as in the original, which slightly reduces qualitative completeness. However, the core comparison on distribution concentration is accurately captured. Thus, the answer is factually correct, contextually relevant, and well-reasoned, warranting a 9/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 455,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "What is ConocoPhillips' financial exposure from its ownership in Alba Plant LLC, given Chevron's production of condensate and the plant's role in processing natural gas from the Alba Unit in Equatorial Guinea?",
      "original_answer": "ConocoPhillips has a 56.0% ownership interest in EG LNG and a 52.2% interest in Alba Plant LLC, which processes natural gas from the Alba Unit and extracts condensate and LPG for sale at market prices. According to COP's 2024 10-K, ConocoPhillips has $116 million in maximum potential future payments related to guarantees for Alba Plant LLC’s agreements to process third-party gas. This exposure is tied to Chevron’s upstream production of condensate, which feeds into the Alba Unit’s gas stream, and the downstream monetization through the LPG plant and EG LNG’s liquefaction facility.",
      "llm_answer": "ConocoPhillips’ exposure from Alba Plant LLC is the share of the plant’s earnings that is reported in the “Equity in earnings of affiliates” line of its consolidated income statement.  The company owns 52.2 % of the joint‑venture that processes natural gas from the Alba Unit and extracts condensate (produced by Chevron) and LPG, selling the products at market prices.  ConocoPhillips’ financial exposure is therefore its 52.2 % share of the revenue generated by that processing operation.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies ConocoPhillips' 52.2% ownership interest in Alba Plant LLC and acknowledges the plant's role in processing natural gas from the Alba Unit, including condensate produced by Chevron. It also correctly notes that the financial impact is reflected in 'Equity in earnings of affiliates,' which aligns with standard accounting treatment for joint ventures. However, the answer fails to address the key element of financial exposure as defined in the ground truth: the $116 million in maximum potential future payments related to guarantees for third-party gas processing agreements. Instead, the LLM redefines 'financial exposure' narrowly as revenue share, which is not equivalent to risk exposure in this context. While the ownership percentage (52.2%) is accurate, the answer omits the $116 million figure entirely, which is central to quantifying the actual risk. The reasoning is partially sound in describing the operational structure but fails in the multi-hop synthesis between ConocoPhillips' guarantee obligations, Chevron's upstream production, and the downstream monetization via EG LNG and the LPG plant. The contextual relevance is moderate because it discusses the right entities and relationships but misinterprets the nature of 'exposure' as equity earnings rather than contingent liabilities. Quantitative accuracy is high for the numbers it includes, but the omission of a critical dollar amount reduces overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 404,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does the use of valuation models incorporating observable market inputs by General Dynamics' Level 2 assets compare with Union Pacific's disclosure of real estate funds at NAV, given that real estate funds are typically valued using unobservable inputs over 8-10 year terms?",
      "original_answer": "General Dynamics values its Level 2 fixed-income assets using valuation models with observable inputs like interest rates and bond yields, contrasting with Union Pacific's $30 million allocation to real estate funds that are valued at NAV based on unobservable inputs according to LMT's explanation of real estate fund valuation practices which involve long-term valuations over 8-10 year periods.",
      "llm_answer": "General Dynamics’ Level‑2 assets are valued using a market approach that incorporates observable inputs—interest rates, bond yields and quoted prices for comparable securities—making the valuation more transparent and less reliant on management estimates. In contrast, Union Pacific’s real‑estate funds are valued at NAV using valuation models and periodic appraisals that depend on unobservable inputs, a common practice for real‑estate vehicles with 8‑10‑year terms and therefore subject to greater estimation uncertainty.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers and financial terms are correct: while the LLM does not explicitly state Union Pacific's $30 million allocation, this omission is minor and does not distort the factual comparison. The absence of a specific dollar amount is not a critical error since the focus of the question is on valuation methodology. (2) The qualitative analysis is strong: the LLM correctly identifies that General Dynamics uses observable inputs (interest rates, bond yields, comparable securities) for its Level 2 assets, aligning with the ground truth. It also accurately contrasts this with Union Pacific’s use of NAV for real estate funds, which rely on unobservable inputs and periodic appraisals. (3) The multi-hop reasoning is sound—linking General Dynamics’ observable-input valuation approach to Union Pacific’s less transparent, NAV-based method for long-term real estate funds (8–10 year terms) demonstrates proper synthesis across entities and valuation practices. (4) The LLM references 'common practice' for real estate funds rather than attributing the explanation to LMT (Lockheed Martin), which is a minor shortcoming in entity linkage but does not affect the technical accuracy of the valuation description. Overall, the answer is semantically equivalent, contextually precise, and factually correct with only a slight omission in entity attribution, warranting a high score but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 413,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "Given Citibank's co-branding role in Costco's credit card program and its administrative role in Colgate's five-year credit agreement, how does the nature of Citibank's involvement differ in these two financial arrangements?",
      "original_answer": "Citibank's involvement with Costco is characterized by a co-branded credit card program that has undergone twelve amendments since 2015, most recently on October 11, 2023, indicating an ongoing consumer financial product partnership. In contrast, Citibank's role with Colgate is as administrative agent and arranger for a five-year credit agreement most recently amended on November 4, 2022, which represents a corporate lending facility rather than a consumer credit product. The Costco relationship centers on a retail financial service partnership while the Colgate arrangement involves managing a syndicated corporate credit facility.",
      "llm_answer": "Citibank’s role in Costco’s program is that of a co‑branded card issuer—providing the credit‑card product, underwriting and managing the program (see Exhibit 10.8, “Citibank, N.A. Co‑Branded Credit Card Agreement,” Costco 10‑K pp. 66‑70).  In contrast, in Colgate’s five‑year credit agreement Citibank serves only as an administrative agent, handling administrative duties for the loan but not underwriting or issuing the credit (see Exhibit 10‑I, “Amended and Restated Five‑Year Credit Agreement…Citibank, N.A., as Administrative Agent and Arranger,” Colgate 10‑K pp. 65‑69).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential distinction between Citibank's roles in the two financial arrangements. (1) It correctly identifies Citibank as a co-branded card issuer for Costco, responsible for underwriting and managing the program, and as administrative agent and arranger (not underwriter) for Colgate's credit agreement—this aligns with the ground truth's emphasis on consumer partnership vs. corporate lending facility. (2) There are no numeric values, dates, or financial figures in the LLM answer, so quantitative accuracy is not compromised; it omits the specific dates (October 11, 2023, and November 4, 2022) and the count of amendments (twelve since 2015) mentioned in the original answer, but these omissions do not affect the core factual correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different 10-K filings and distinguishes the nature of Citibank’s involvement—consumer credit product vs. corporate administrative role—based on document roles and responsibilities. (4) The answer achieves semantic equivalence by focusing on the functional differences in Citibank’s roles, even if it doesn't use the exact phrasing like 'syndicated corporate credit facility' or 'ongoing retail financial service partnership.' The reference to specific exhibits and page numbers adds credibility and context. The only minor shortcoming is the lack of detail about the frequency and recency of amendments, which slightly reduces completeness but does not detract from the central accuracy. Hence, a score of 9 is justified, with full marks in contextual relevance and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 455,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What is Chevron's net daily crude oil production contribution from its stake in QatarEnergy LNG, considering the average daily net production and Chevron's ownership percentage in 2023?",
      "original_answer": "Chevron's net daily crude oil production from its stake in QatarEnergy LNG in 2023 was 3.9 MBD (thousand barrels per day), calculated as 30% ownership of the 13 MBD average daily net crude oil production from QatarEnergy LNG.",
      "llm_answer": "QatarEnergy LNG N(3) averaged **13 barrels per day (MBD)** of crude oil in 2023【source: table for QatarEnergy LNG N(3) – average daily net production 13 MBD】.  Chevron owned **30 %** of the joint venture【source: note on ownership – ConocoPhillips 30 % (Chevron’s stake)】, so its net daily crude‑oil contribution was **13 × 0.30 ≈ 3.9 MBD**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and matches the ground truth in all key aspects. (1) Quantitative accuracy: The numbers are correct — 13 MBD average daily net production and 30% ownership by Chevron. The calculation (13 × 0.30 = 3.9 MBD) is accurate. The unit 'MBD' is correctly used, and the value matches the ground truth. (2) Completeness: The answer addresses all parts of the question — it identifies the average daily net production, Chevron's ownership percentage, and computes the net daily crude oil contribution. (3) Entity accuracy: The entity 'QatarEnergy LNG' is correctly identified, and the ownership attribution to Chevron (via the note stating ConocoPhillips 30% but clarifying it as Chevron’s stake) is accurate in context, though this phrasing is slightly confusing but ultimately correct per the source note. (4) Reasoning: The multi-hop reasoning — combining production data with ownership percentage — is sound and clearly explained. (5) Semantic equivalence: The answer conveys the same information as the original, with clear calculation and sourcing. The only minor issue is the potentially confusing note about 'ConocoPhillips 30% (Chevron’s stake)', which could mislead but in context appears to be a labeling error in the source rather than a reasoning flaw in the model. Overall, the answer is correct in substance and synthesis, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 383,
        "total_tokens": 1534
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does Caterpillar's use of pricing models for valuing Level 3 non-U.S. pension assets compare to Lockheed Martin's valuation methodology for fixed income investments categorized as Level 3, particularly in terms of the inputs and approaches used?",
      "original_answer": "Caterpillar values its Level 3 non-U.S. pension assets, which include insurance contracts, using pricing models that reflect management's judgment of assumptions a market participant would use. In contrast, Lockheed Martin categorizes fixed income investments as Level 3 when observable inputs are unavailable and uses discounted cash flow approaches or indicative quotes from vendors and brokers, with significant inputs including projected annuity payments and discount rates. Both companies rely on unobservable inputs for Level 3 assets, but Caterpillar focuses on pricing models based on management assumptions, while Lockheed Martin employs a broader set of valuation techniques including discounted cash flows and third-party indicative quotes.",
      "llm_answer": "Caterpillar’s Level 3 non‑U.S. pension assets are valued with pricing models that “reflect the assumptions a market participant would use” (see CAT 10‑K, pp. 100‑104).  In contrast, Lockheed Martin’s Level 3 fixed‑income holdings are priced either from indicative quotes or bid evaluations obtained from vendors, brokers or the investment manager, and for some instruments a discounted‑cash‑flow model is applied using projected annuity payments and a discount rate (see LMT 10‑K, pp. 87‑91).  Thus, Caterpillar’s approach is a general market‑participant model, whereas Lockheed Martin’s method explicitly relies on observable market data for Level 2 and on indicative quotes or DCF inputs for Level 3.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of entities, inputs, and valuation approaches for both Caterpillar and Lockheed Martin. It accurately states that Caterpillar uses pricing models based on assumptions a market participant would use for its Level 3 non-U.S. pension assets, citing insurance contracts implicitly. For Lockheed Martin, it correctly identifies the use of indicative quotes, bid evaluations, and discounted cash flow (DCF) models with inputs like projected annuity payments and discount rates. The citation of specific 10-K page ranges adds credibility. However, the LLM slightly mischaracterizes Lockheed Martin’s approach by implying that indicative quotes are considered observable market data — but for Level 3 assets, such quotes are based on unobservable inputs and are not considered truly observable. The ground truth emphasizes that both companies rely on unobservable inputs, whereas the LLM suggests Lockheed Martin uses observable data for Level 2 and indicative quotes for Level 3, which, while technically accurate in structure, creates a misleading contrast by not clarifying that Level 3 reliance on indicative quotes still involves significant unobservable inputs. This nuance is important for fair comparison and is present in the original answer but underemphasized in the LLM response. No numerical inaccuracies exist — there are no explicit numbers in the query or answer, so quantitative accuracy is scored as 10. The reasoning is sound and multi-hop synthesis across two companies and their distinct valuation methodologies is appropriately handled. Contextual relevance is perfect — the answer directly addresses the comparison of inputs and approaches. Thus, the correctness score is 8 due to a minor but meaningful omission in conceptual precision around 'observable' vs 'unobservable' inputs in Lockheed Martin's Level 3 methodology.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 516,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How might the expiration of Enbrel's formulation patents in 2037 impact Pfizer's Specialty Care segment revenue concentration risk, especially considering Bristol Myers Squibb's external innovation strategy focused on future pipeline assets?",
      "original_answer": "Enbrel remains a key product in Pfizer's Specialty Care segment, where it is listed among major inflammation & immunology offerings. The expiration of its formulation patents in 2037 could expose Pfizer to increased generic competition, potentially exacerbating revenue concentration risk if other pipeline or partnered products have not sufficiently diversified the segment's portfolio by then. Meanwhile, Bristol Myers Squibb's external innovation strategy, which emphasizes acquiring and developing disruptive therapies beyond internal R&D, may position it to enter the post-patent market with new assets, assuming favorable clinical and regulatory outcomes. This dynamic could shift competitive positioning in the inflammation & immunology space if BMY successfully brings alternative therapies to market ahead of the 2037 timeline.",
      "llm_answer": "Enbrel’s formulation patents expire in 2037 (Pfizer 10‑K, p. 10), meaning generic competition could erode a key specialty‑care revenue stream and heighten concentration risk in that segment (Pfizer 10‑K, pp. 8‑12).  BMY’s 10‑K (pp. 9‑13) notes that the company is pursuing an external‑innovation strategy that focuses on future pipeline assets, which could provide new products to offset the loss and help diversify Pfizer’s specialty‑care portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2037 patent expiration for Enbrel and cites Pfizer's 10-K, aligning with the ground truth on timing and risk of generic competition. However, it incorrectly implies that Bristol Myers Squibb's external innovation strategy would help diversify *Pfizer's* portfolio, which is a critical factual and logical error. BMY's strategy cannot directly benefit Pfizer; instead, it may position BMY as a competitor in the same therapeutic space. This misattribution undermines the qualitative accuracy. (2) Quantitatively, the date '2037' is correct and matches the ground truth; no other numbers are present, so quantitative accuracy is fully satisfied. (3) The multi-hop reasoning fails: while the model connects Enbrel’s patent cliff to Pfizer’s revenue concentration risk (valid), it erroneously synthesizes BMY’s external innovation as a mitigating factor for *Pfizer*, rather than a competitive threat or alternative market positioning for BMY. This breaks the logical chain and reflects a misunderstanding of corporate boundaries and competitive dynamics. (4) Contextually, the answer addresses the core issue of patent expiration and revenue risk, and references relevant sections of both companies’ 10-Ks, supporting relevance. However, the incorrect attribution of BMY’s strategy to Pfizer’s benefit significantly reduces qualitative and overall correctness, warranting a mid-range score of 5 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 404,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How do AIG's market risk stress testing practices compare with COF's credit loss forecasting methods in terms of their reliance on scenario-based modeling and sensitivity analysis?",
      "original_answer": "AIG employs stress testing as part of its market risk management to evaluate the impact of adverse market developments, including through sensitivity analysis and scenario analysis, which are aligned with its corporate risk appetite. This includes analyzing the effects of hypothetical shocks to interest rates, credit spreads, and equity prices. On the other hand, COF uses scenario-based forecasting models to estimate its allowance for credit losses (ACL), which totaled $13.0 billion as of December 31, 2024, incorporating both quantitative forecasts and qualitative adjustments for current and forward-looking economic conditions. Both firms rely on scenario and sensitivity analysis, but AIG applies these techniques to market risk exposures while COF integrates them into credit risk modeling for consumer loan portfolios.",
      "llm_answer": "AIG’s market‑risk stress‑testing framework explicitly uses scenario‑based modeling and sensitivity analysis to quantify the impact of adverse market moves across all risk factors. In contrast, COF’s credit‑loss forecasting is driven by quantitative loss‑forecasting models built on statistical analyses and supplemented by qualitative judgments, with no explicit reliance on scenario‑based modeling or sensitivity analysis.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in describing AIG's use of scenario-based modeling and sensitivity analysis for market risk stress testing, which aligns with the ground truth. However, it incorrectly states that COF does not use scenario-based modeling or sensitivity analysis, which directly contradicts the original answer. The ground truth explicitly states that COF uses scenario-based forecasting models for credit loss estimation, incorporating both quantitative forecasts and qualitative adjustments under varying economic conditions—this is a form of scenario-based modeling. Therefore, the core comparison is flawed: while AIG applies these techniques to market risk and COF to credit risk, both firms do rely on scenario and sensitivity analysis. The LLM's claim that COF has 'no explicit reliance' on these methods is factually incorrect. There are no numeric inaccuracies (e.g., COF's ACL of $13.0 billion is not mentioned but also not contradicted), so quantitative accuracy is high. However, the qualitative error in misrepresenting COF's methodology significantly undermines the reasoning and correctness. The answer is contextually relevant and addresses the comparative structure of the question, but with a critical factual flaw in the multi-hop synthesis between the two companies' risk practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 366,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does Qualcomm's exposure to EAR regulations on advanced semiconductor technologies compare with AMD's specific constraints on exporting Versal VC2602 and VE2602 FPGAs to China, given both companies' involvement in high-performance computing markets?",
      "original_answer": "Qualcomm's business and products, including those of its customers and licensees, are subject to a broad range of regulations, including the U.S. Export Administration Regulations (EAR), which govern the export and re-export of advanced technologies, potentially affecting its business operations and results. In contrast, AMD faces specific export constraints under EAR, including requirements to file a Notified Advanced Computing (NAC) notification 25 days before shipping certain Versal VC2602 and VE2602 FPGAs to China or to customers outside the U.S. whose ultimate parent is headquartered in a D5 country, including China. These FPGAs are part of AMD's Data Center segment, which includes Field Programmable Gate Arrays (FPGAs) and other adaptive computing products. While both companies are impacted by EAR regulations, AMD's exposure is more directly constrained in terms of specific product lines and geographic markets, particularly affecting its ability to serve Chinese customers without prior regulatory approval, whereas Qualcomm's exposure is more diffuse across its broader regulatory risk profile.",
      "llm_answer": "Qualcomm’s 10‑K notes that U.S. export controls—including the Export Administration Regulations—could restrict the sale of its advanced semiconductor technologies to China and other restricted countries, potentially limiting its high‑performance‑computing product exports (Legal and regulatory risks).  In contrast, AMD’s filing specifies that its Versal VC2602 and VE2602 FPGAs are subject to BIS’s new advanced‑computing controls, requiring a license and a 25‑day Notified Advanced Computing (NAC) notification before shipping to China (October 2023 BIS controls).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core distinction between Qualcomm's broad exposure to EAR regulations and AMD's specific constraints on exporting Versal VC2602 and VE2602 FPGAs to China. (1) All factual elements are correct: both companies are subject to U.S. Export Administration Regulations (EAR); AMD requires a 25-day Notified Advanced Computing (NAC) notification before shipping specified FPGAs to China, which aligns with the October 2023 BIS controls mentioned—this timing is contextually accurate and consistent with the ground truth. (2) Quantitative accuracy is perfect: the 25-day NAC requirement is correctly stated, and no other numbers (e.g., dollar amounts, percentages) are involved. Format and references are precise. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies, their respective regulatory exposures, and specific product lines (FPGAs for AMD, broader semiconductor tech for Qualcomm), drawing a valid comparative conclusion. (4) The only minor shortcoming is that the LLM answer does not explicitly mention that AMD’s requirement applies not only to China directly but also to non-U.S. customers whose ultimate parent is headquartered in a D5 country, which adds nuance to the export constraint. Additionally, the original answer notes that these FPGAs are part of AMD’s Data Center segment, providing contextual business unit alignment, which the LLM omits. These omissions are minor and do not undermine the central accuracy or relevance. The answer remains semantically equivalent in substance and fully addresses the comparative regulatory exposure as required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 455,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does CMCSA's relinquishment of voting rights in Hulu contrast with META's dual-class stock structure in terms of control retention strategies?",
      "original_answer": "CMCSA relinquished substantially all voting rights associated with its investment in Hulu in 2019, including board seats, in exchange for a put/call arrangement with Disney that guaranteed a minimum equity value of $27.5 billion for its interest and resulted in an $8.6 billion payment from Disney in 2023. This contrasts with META's dual-class stock structure where Class B shares carry 10 votes per share compared to 1 vote for Class A shares, allowing certain stockholders to maintain significant voting power while owning a minority of economic interests. CMCSA's approach involved transferring control to Disney in exchange for financial guarantees, whereas META retains internal control differentiation through its stock classification framework.",
      "llm_answer": "CMCSA gave up its board seats and almost all voting rights in Hulu, handing Disney full operational control while keeping an economic interest (CMCSA 10‑K, pp. 83‑85).  Meta, by contrast, keeps control through a dual‑class structure: Class B shares carry ten votes each while Class A shares have one vote and Class C shares are non‑voting (META 10‑K, pp. 1‑5).  In short, CMCSA chose to relinquish control for financial and risk reasons, whereas Meta retains control by concentrating voting power in a minority of shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core contrast between CMCSA's relinquishment of voting rights in Hulu and META's dual-class stock structure. (1) All factual elements are correct: CMCSA gave up board seats and voting rights in Hulu, transferring control to Disney while retaining economic interest. META maintains control via a dual-class structure with Class B shares having 10 votes vs. 1 for Class A, and Class C non-voting—this aligns with the ground truth. (2) Quantitative accuracy is perfect: although the LLM does not explicitly mention the $27.5 billion guaranteed equity value or the $8.6 billion payment in 2023, these specific figures are not required to answer the *comparative control retention strategy* question. Their omission does not impair the correctness of the strategic contrast being made. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across CMCSA and META 10-Ks, identifying that CMCSA externalized control for financial certainty, while META internally preserves control via share structure. (4) Semantic equivalence is strong—the LLM conveys the same essential meaning as the ground truth, using slightly different phrasing (e.g., 'handing Disney full operational control' vs. 'transferring control to Disney'). The only minor shortcoming is the lack of explicit mention of the put/call arrangement and financial guarantees, which are part of CMCSA’s strategic rationale. However, the phrase 'relinquish control for financial and risk reasons' reasonably encapsulates this. Thus, the answer is excellent but not fully exhaustive, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 453,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does Goldman Sachs' $113.9 billion in broker-dealer assets influence its approach to managing conflicts of interest under Regulation Best Interest, compared to Morgan Stanley's compliance framework for the same regulatory obligations?",
      "original_answer": "Goldman Sachs manages $113.9 billion in broker-dealer assets as of December 2024, which necessitates a robust compliance framework under Regulation Best Interest to ensure recommendations align with retail customers' best interests, especially given the SEC's requirement that broker-dealers avoid placing their own interests ahead of clients. This asset size increases the complexity of conflict management, particularly in areas like variable insurance product sales and investment strategy recommendations. Similarly, Morgan Stanley explicitly states it is subject to Regulation Best Interest, which governs its broker-dealer sales practices and customer relationships, including conflict mitigation. Both firms must maintain stringent internal controls, but Goldman's larger broker-dealer asset base may require more extensive monitoring and disclosure protocols to satisfy the same impartial conduct standards outlined in the regulation, particularly as both firms face potential litigation and regulatory scrutiny tied to compliance.",
      "llm_answer": "Goldman Sachs’ $113.9 billion in broker‑dealer assets (shown in the GCLA table on page 107) underscores the scale of its broker‑dealer business and drives a comprehensive, enterprise‑wide compliance program that actively monitors and mitigates conflicts of interest under Regulation Best Interest.  In contrast, Morgan Stanley’s compliance framework for Reg BI, described in its 10‑K (pages 7‑11), relies on a set of policies, procedures and oversight mechanisms to ensure that broker‑dealer and investment‑adviser activities are conducted in the best interest of retail customers.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Goldman Sachs' $113.9 billion in broker-dealer assets, matching the ground truth in amount and context. No other numerical values are present, and this figure is accurately cited. The mention of 'GCLA table on page 107' and 'Morgan Stanley’s 10-K (pages 7-11)' adds document-level specificity, though these references are not part of the ground truth and cannot be verified as correct or incorrect without access to the filings; however, they do not contradict the truth. (2) Quantitative accuracy is perfect: the $113.9 billion figure is correct and properly attributed to Goldman Sachs as of December 2024 in the ground truth. No calculations are required, and no errors exist in number reporting. (3) The multi-hop reasoning is partially sound: the LLM correctly links asset size to the need for robust conflict management under Regulation Best Interest for Goldman Sachs and acknowledges Morgan Stanley’s Reg BI obligations. However, it omits key comparative elements from the ground truth—specifically, that both firms face similar regulatory standards but Goldman’s larger asset base may necessitate more extensive monitoring and disclosure. The answer does not fully synthesize the comparative scale-driven compliance implications, which is central to the question. It also fails to mention specific conflict areas like variable insurance products or the risk of litigation and regulatory scrutiny, weakening the qualitative depth. (4) The correctness score is 7 because core facts (asset amount, regulatory framework) are accurate and the response is contextually relevant, but it lacks the full comparative analysis and nuanced reasoning about scale-driven compliance complexity present in the ground truth. Qualitative accuracy is 7 due to incomplete synthesis; quantitative accuracy is 10; contextual relevance is 9 due to strong alignment with the question’s focus on compliance frameworks under Reg BI.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 528,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How might Intel's IDM 2.0 strategy, which includes expanding manufacturing capacity with the aim of attracting foundry customers, be affected by Samsung's development of in-house integrated circuits, and what implications could this have for Qualcomm's semiconductor business given its reliance on external integrated circuit customers?",
      "original_answer": "Intel's IDM 2.0 strategy involves significant capital expenditures to expand manufacturing capacity with the goal of attracting foundry customers (chunk 1). However, Samsung, a key potential customer for Intel's foundry services, is developing its own integrated circuit products, which it may increasingly use in its own devices and potentially sell to third parties in competition with others in the market (chunk 2). This vertical integration by Samsung could limit Intel's ability to secure foundry business from Samsung, making Intel's IDM 2.0 capacity investments riskier and potentially leading to underutilized facilities or increased pricing pressure to attract other customers. Qualcomm, which derives a significant portion of its revenues from sales of its own integrated circuit products to OEMs (chunk 3), could face intensified competition if Samsung's in-house chips gain market traction, particularly in segments like mobile and automotive. Additionally, if Intel responds by lowering prices to attract other foundry clients, it could indirectly affect the broader semiconductor pricing environment, potentially impacting Qualcomm's cost structure or competitive positioning.",
      "llm_answer": "Intel’s IDM 2.0 plan to grow foundry capacity (IFS) hinges on attracting external customers, but Samsung’s move to produce its own integrated circuits could shrink that customer base, limiting the revenue Intel can capture from its expanded fabs (Intel 10‑K, pp. 53‑55).  Because Qualcomm’s semiconductor business derives most of its revenue from selling ICs to external customers (Qualcomm 10‑K, pp. 18‑22), a similar shift toward vertical integration by those customers would expose Qualcomm to revenue erosion and heightened competition (Qualcomm 10‑K, pp. 37‑41).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically aligned with the ground truth, with no numeric inaccuracies (quantitative accuracy = 10). It correctly identifies Intel's IDM 2.0 strategy involving foundry expansion (Intel 10-K references), Samsung's in-house IC development limiting Intel's customer acquisition, and Qualcomm's reliance on external IC sales (Qualcomm 10-K references). While the LLM does not explicitly state that Samsung could compete with Qualcomm in mobile and automotive segments, it captures the core risk to Qualcomm from customer vertical integration, which is a key multi-hop link. The answer omits the indirect pricing pressure effect—where Intel lowering foundry prices could impact the broader semiconductor pricing environment and thus Qualcomm’s cost structure—but correctly infers competitive and revenue risks. This missing nuance prevents a top score in qualitative accuracy (8/10), though reasoning is still sound. Contextual relevance is full (10/10) as all entities and strategic dynamics are appropriately addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 301,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How does VZ's monetization of wireless tower infrastructure through exclusive arrangements with American Tower Corporation compare to NFLX's reliance on exclusive content rights in terms of upfront capital impact and long-term strategic control?",
      "original_answer": "VZ received an upfront payment of $5.0 billion from American Tower Corporation in 2015 for exclusive rights to 11,300 wireless towers, while retaining operational control through subleased capacity and continuing depreciation of the towers. This allowed VZ to monetize infrastructure assets while maintaining network usage flexibility. In contrast, NFLX pursues exclusive content rights to differentiate its service, which requires ongoing licensing costs and exposes the company to risks of content withdrawal and increased programming expenses. Unlike VZ's capital-generating tower arrangement, NFLX's exclusive content strategy represents a cost center rather than a revenue source, with no upfront payments received and instead involves financial commitments to secure programming advantages.",
      "llm_answer": "VZ’s $5.0 billion upfront payment to American Tower for exclusive lease‑and‑operate rights on 11,300 towers provides an immediate cash inflow that cuts VZ’s capital outlays on infrastructure, while VZ still owns the towers, leases back capacity for 10 years (with renewal options) and retains an option to reacquire them—so the company keeps long‑term control of the assets even though operational control is ceded to AT&T. In contrast, Netflix’s strategy of securing exclusive content rights involves upfront licensing fees that are typically smaller and spread over the term of each license; the company retains exclusive distribution control of the content, but must continually negotiate and pay for new rights, making its long‑term strategic control contingent on ongoing renewal agreements rather than a single large capital transaction.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $5.0 billion upfront payment from American Tower Corporation and the 11,300 wireless towers, which matches the ground truth. However, it incorrectly states that operational control was ceded to 'AT&T'—this is a critical error, as the correct entity is American Tower Corporation (a real estate investment trust), not AT&T (a telecom operator). This misidentification undermines the accuracy of the strategic control analysis. (2) Quantitatively, the $5.0 billion and 11,300 towers are accurate, and no calculations are required beyond these figures. The mention of a 10-year lease with renewal options is plausible but not confirmed in the ground truth, introducing unverified detail. (3) The multi-hop reasoning is partially sound: the model correctly contrasts VZ’s capital-generating infrastructure monetization with NFLX’s content cost center strategy. However, it mischaracterizes NFLX’s payments as 'upfront licensing fees that are typically smaller and spread over the term,' whereas the ground truth emphasizes ongoing costs with no upfront receipts—Netflix pays to secure exclusivity but does not receive payments. The LLM incorrectly implies Netflix receives smaller upfront payments, reversing the cash flow direction. (4) Contextual relevance is high, as the response addresses both capital impact and strategic control for both companies. However, due to the entity error (AT&T vs American Tower) and the misrepresentation of Netflix’s cash flows (portraying licensing fees as received rather than paid), the qualitative accuracy is significantly reduced. The core contrast—capital inflow vs. outflow—is partially grasped but distorted in execution.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 466,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the Tax Reform Act's GILTI provisions impact KO's effective tax rate in 2022, and how does this contrast with the effect of the corporate income tax rate reduction in the Philippines on PEP's operations in that market?",
      "original_answer": "KO's effective tax rate in 2022 was impacted by the Tax Reform Act's GILTI provisions, which required the inclusion of foreign subsidiaries' excess earnings in U.S. income tax returns, contributing to a 1.2% impact on KO's effective tax rate through pretax charges of $710 million related to equity method investee impairments. In contrast, PEP's operations in the Philippines experienced low-single-digit growth, and the corporate income tax rate reduction enacted in the Philippines in Q1 2021 contributed to a favorable impact on PEP's effective tax rate, lowering it by an unspecified but notable amount. This illustrates how the same U.S. tax reform had divergent effects—raising KO's tax burden through GILTI while enabling PEP to benefit from lower local corporate taxes.",
      "llm_answer": "KO’s effective tax rate in 2022 rose by roughly 0.8 percentage points because the Tax Reform Act’s GILTI provisions added U.S. tax on foreign earnings (see discussion of “Global intangible low‑taxed income” and its 0.8 pp impact on the effective rate). In contrast, PEP’s operations in the Philippines were helped by a corporate income‑tax‑rate cut that lowered its effective tax burden and improved profitability in that market (see the note on the Philippines tax‑rate reduction).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the GILTI provisions' impact on KO's effective tax rate and the Philippines tax rate reduction benefiting PEP, showing good contextual understanding. However, it inaccurately states the GILTI impact as 0.8 percentage points, while the ground truth specifies a 1.2 percentage point impact due to $710 million in pretax charges related to equity method investee impairments—this is a significant quantitative error. The LLM omits the specific $710 million figure and the link to impairments, weakening completeness. For PEP, the LLM correctly notes the favorable tax environment and improved profitability but lacks the detail that the tax cut occurred in Q1 2021 and contributed to low-single-digit growth, and it does not acknowledge that the exact magnitude of the tax rate impact is unspecified but notable. (2) The 0.8 pp vs. 1.2 pp discrepancy is a clear quantitative inaccuracy. The ground truth’s 1.2% stems from $710 million in charges, which the LLM fails to mention, suggesting either a misremembered figure or incorrect sourcing. No calculations are performed in the answer, so no computational errors beyond the incorrect percentage. (3) The multi-hop reasoning is partially sound: the model connects U.S. tax policy (GILTI) to KO’s tax rate and local tax changes in the Philippines to PEP’s operations, correctly contrasting divergent effects. However, it misses the deeper synthesis that GILTI increased KO’s burden while local reforms reduced PEP’s, with one being a U.S. outbound tax rule and the other a local rate cut—this contrast is implied but not clearly articulated. (4) Correctness is scored 6 due to the core facts being directionally right but quantitatively flawed and partially incomplete. Quantitative accuracy is 5 due to the incorrect percentage and missing dollar amount. Qualitative accuracy is 7 because entity identification (KO, PEP, GILTI, Philippines tax cut) and general reasoning are correct. Contextual relevance is 9 as the answer directly addresses both parts of the question and remains focused on the tax impacts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 565,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does the $1.3 billion in restricted retained earnings at Nicor Gas impact Southern Company's ability to receive dividends from its subsidiaries, given that Nicor Gas is a key subsidiary under Southern Company Gas?",
      "original_answer": "Nicor Gas, as a regulated subsidiary under Southern Company Gas, has $1.3 billion in retained earnings that are restricted from being distributed as dividends or loans to affiliates. This restriction directly limits Southern Company's ability to receive dividend payments from Nicor Gas, which in turn affects the consolidated cash flows and financial flexibility of Southern Company, especially since Southern Company relies on equity earnings and dividends from its subsidiaries for a significant portion of its income.",
      "llm_answer": "The $1.3 billion of retained earnings at Nicor Gas is “restricted” by regulation, meaning Nicor Gas may only pay dividends to its parent up to the amount of those retained earnings. Because Nicor Gas is a key subsidiary of Southern Company Gas, this restriction limits how much dividend income Southern Company can receive from Nicor Gas (and, by extension, from its other subsidiaries), thereby reducing the pool of distributable earnings available to Southern Company and its shareholders.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the $1.3 billion in restricted retained earnings at Nicor Gas and acknowledges that this restriction impacts dividend payments to its parent, Southern Company Gas, and by extension Southern Company. The quantitative accuracy is perfect—$1.3 billion is correctly cited with no calculation errors. However, the reasoning contains a subtle but important inaccuracy: it states that Nicor Gas 'may only pay dividends to its parent up to the amount of those retained earnings,' which misrepresents the nature of the restriction. The restriction means that the $1.3 billion is *not available at all* for distribution as dividends or loans, not that it caps dividends *up to* that amount. This mischaracterization affects the qualitative accuracy, as it misleads on the regulatory mechanism. Additionally, the original answer emphasizes that these restrictions directly affect Southern Company’s consolidated cash flows and financial flexibility due to its reliance on subsidiary dividends—this broader financial impact is underdeveloped in the LLM response. While the core entity relationships (Nicor Gas → Southern Company Gas → Southern Company) are correctly identified and the multi-hop logic is partially sound, the explanation of the restriction’s effect lacks precision. Contextual relevance is high, as the answer stays focused and addresses the key issue of dividend limitations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 390,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How do Tesla's and GM's compliance costs related to evolving vehicle safety standards compare, given the increasing regulatory complexity under the National Traffic and Motor Vehicle Safety Act?",
      "original_answer": "Tesla faces rising compliance costs due to evolving international vehicle safety standards, particularly for its Autopilot and FSD (Supervised) features, which must meet varying requirements across jurisdictions and may delay or restrict functionality. GM similarly notes that compliance with the National Traffic and Motor Vehicle Safety Act is costly, with global regulatory divergence—especially between North American and UN-ECE based standards—adding complexity and expense to vehicle development. Both companies emphasize the financial burden of maintaining compliance as safety standards evolve and expand globally, with GM specifically highlighting the lack of harmonization as a key driver of increased costs.",
      "llm_answer": "Tesla’s 10‑K notes that the National Traffic and Motor Vehicle Safety Act “requires manufacturers to remedy defects through safety recall campaigns and that the cost of such recall campaigns could be substantial,” but it does not disclose a specific dollar amount for compliance costs (see Tesla 10‑K, pages 26‑30).  By contrast, GM reports compliance‑related costs of roughly $1.0 billion in 2024, $0.7 billion in 2023 and $0.5 billion in 2022, reflecting the financial impact of meeting evolving safety standards (see GM 10‑K, pages 11‑15).  Thus, GM’s compliance costs are quantified and have been in the billions, whereas Tesla’s are acknowledged as potentially significant but remain undisclosed.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The GM compliance costs cited—$1.0 billion in 2024, $0.7 billion in 2023, and $0.5 billion in 2022—are not present in the original ground truth answer and cannot be verified from the provided context. The original answer makes no mention of specific dollar amounts for either company, so introducing precise figures for GM is a fabrication. This is a critical error. (2) Completeness: While the question asks for a comparison of Tesla’s and GM’s compliance costs in the context of evolving safety standards under the National Traffic and Motor Vehicle Safety Act, the LLM incorrectly implies that GM quantifies its compliance costs in dollar terms, which is not supported by the ground truth. The original answer states both companies acknowledge rising costs due to regulatory complexity, especially from global divergence, but neither provides specific cost figures. (3) Entity Accuracy: The companies (Tesla and GM) and the regulatory framework (National Traffic and Motor Vehicle Safety Act) are correctly identified. However, the LLM misattributes specific compliance cost disclosures to GM’s 10-K without evidence, and incorrectly suggests Tesla only references recall costs under the Act, narrowing the scope inaccurately. (4) Reasoning: The multi-hop reasoning is partially sound in that it attempts to compare the two companies’ disclosures, but it fails because it builds on false numerical data. The conclusion that GM’s costs are 'in the billions' while Tesla’s are 'undisclosed' is misleading—the original answer emphasizes both face rising costs due to global regulatory divergence, with GM highlighting lack of harmonization as a key cost driver, not specific dollar figures. (5) Semantic Equivalence: The LLM answer diverges significantly in meaning by introducing unverified financial data, thus failing to match the ground truth’s emphasis on shared challenges due to regulatory complexity rather than a quantitative comparison. The contextual relevance is moderate because it addresses compliance costs and regulation, but the incorrect data severely limits accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 586,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does General Dynamics' deferral of $305 million in other contract costs under FAR regulations compare to Raytheon Technologies' exposure to cost overruns under its fixed-price U.S. government contracts, given the differing financial risk profiles associated with these contract cost management approaches?",
      "original_answer": "General Dynamics defers $305 million in other contract costs under FAR regulations that govern cost allowability and allocation to U.S. government contracts, with recovery expected through existing backlog and follow-on contracts. These costs are not currently allocable but are maintained as assets pending future allocation. In contrast, Raytheon Technologies faces financial risk on its fixed-price contracts, particularly firm fixed-price (FFP) contracts, where it bears the full burden of cost overruns without reimbursement. This creates a more direct financial exposure compared to General Dynamics’ deferred cost model. The difference in risk stems from the fact that FAR-regulated cost recovery allows General Dynamics to defer recognition of certain costs until allocable, while Raytheon must absorb overruns on fixed-price contracts, which constitute a significant portion of its U.S. government contract portfolio.",
      "llm_answer": "General Dynamics defers $305 million in other contract costs that are not yet allocable to U.S. government contracts, effectively postponing the expense until those costs can be recovered from future backlog (Other Contract Costs, 2021). In contrast, Raytheon Technologies’ fixed‑price U.S. government contracts expose the company to cost‑overrun risk—any cost that exceeds the contract price must be absorbed by Raytheon, directly impacting profitability. Thus, GD’s approach shifts risk to future recovery, while RTX’s approach places immediate financial risk on the company’s earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the $305 million deferral by General Dynamics is correctly stated, and no other numbers or dates are misrepresented. The reference to '2021' in parentheses is not in the original answer but may be inferred contextually; however, since the ground truth does not specify a year, this is a minor addition but not an error. (2) The comparison between General Dynamics’ deferral of non-allocable costs under FAR and Raytheon’s exposure to cost overruns on fixed-price contracts is correctly framed. The key distinction—that GD defers costs with expectation of future recovery while Raytheon absorbs overruns—is accurately captured. (3) Multi-hop reasoning is sound: the model correctly synthesizes contrasting risk profiles based on contract type (cost-reimbursement vs. firm fixed-price) and regulatory framework (FAR). (4) The LLM omits a minor detail about Raytheon’s fixed-price contracts constituting a 'significant portion' of its government portfolio, which slightly reduces completeness. However, the essential contrast in financial risk is clearly and correctly explained. Wording differs but semantic equivalence is maintained. No factual inaccuracies; only slight reduction in qualitative score due to minor omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 370,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does the compound annual growth rate (CAGR) of Intel's Taiwan revenue from 2019 to 2021 compare to Apple's Greater China segment revenue growth over the same period, given that Taiwan is included within Apple's Greater China reporting?",
      "original_answer": "Intel's Taiwan revenue grew from $10,058 million in 2019 to $13,461 million in 2021, representing a CAGR of approximately 15.6%. Apple's Greater China revenue increased from $40,308 million in 2019 to $68,366 million in 2021, yielding a CAGR of approximately 30.8%. Therefore, Apple's Greater China segment revenue grew at more than double the rate of Intel's Taiwan-specific revenue during this period.",
      "llm_answer": "Intel’s Taiwan revenue grew from $10,058 million in 2019 to $13,461 million in 2021, a compound annual growth rate of about 15.7 % (13,461/10,058)^(½) – 1 【Intel 10‑K, pages 88‑89】. Apple’s Greater China segment rose from $40,308 million in 2020 to $68,366 million in 2021, a 69.5 % increase over the one‑year period (68,366/40,308 – 1) 【Apple 10‑K, pages 23‑27】. Thus, Apple’s Greater China revenue expanded at a markedly higher rate than Intel’s Taiwan revenue over the comparable timeframe.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports Intel's Taiwan revenue figures ($10,058M in 2019 and $13,461M in 2021) and calculates a CAGR of approximately 15.7%, which is close to the ground truth 15.6% (minor rounding difference is acceptable). However, it incorrectly uses Apple's Greater China revenue for 2020 ($40,308M) instead of 2019, despite stating the period as '2020 to 2021'. The ground truth specifies Apple's revenue increased from $40,308M in 2019 to $68,366M in 2021 — a two-year period. By using only one year of growth (2020–2021), the LLM fails to compute the correct CAGR and instead reports a one-year increase of 69.5%, which is not comparable to Intel's two-year CAGR. (2) The calculation for Intel’s CAGR is accurate: (13,461 / 10,058)^(1/2) – 1 ≈ 15.7%, acceptable vs. 15.6%. But Apple’s CAGR over 2019–2021 should be (68,366 / 40,308)^(1/2) – 1 ≈ 30.8%, not a one-year change. The LLM uses the wrong base year, leading to a fundamentally incorrect comparison. (3) The multi-hop reasoning is partially sound — it identifies both companies, relevant geographies (Taiwan, Greater China), and attempts CAGR logic — but fails on cross-temporal alignment. The question explicitly asks for 2019–2021; using 2020 as a starting point breaks the comparison. Also, the conclusion that Apple grew at a 'markedly higher rate' is directionally correct but based on flawed data. (4) Correctness score is 5 due to significant error in time period used for Apple, undermining the core comparison. Quantitative accuracy is 5 because half the numbers are right but the key comparative metric (Apple’s CAGR) is missing. Qualitative accuracy is 5 due to correct entities and partial reasoning, but flawed synthesis. Contextual relevance is high (8) as the answer addresses the right companies, metrics, and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 492,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "Given Alphabet's $70 billion share repurchase authorization targeting Class A and Class C shares in 2024, how might the repurchase activity influence Class B shareholders' decisions to convert shares to Class A, especially in light of Meta's disclosure of a significantly larger Class A share base compared to Class B outstanding shares?",
      "original_answer": "Alphabet's $70 billion share repurchase program, which includes Class A shares, could reduce the supply of Class A shares in the market, potentially increasing their relative value. This may incentivize Class B shareholders—who hold shares with 10x voting rights but often face restrictions on holding Class A shares after conversion—to convert and sell Class A shares before further scarcity and price appreciation occur. However, Meta's 2024 disclosure shows that it has 2,189,898,148 Class A shares and only 343,761,117 Class B shares outstanding, indicating a much larger float of Class A shares in the market. This abundance of Class A shares at Meta may temper conversion urgency compared to Alphabet, as Class A shares at Meta are likely more liquid and less affected by repurchase-induced scarcity.",
      "llm_answer": "Alphabet’s board authorized a $70 billion share‑repurchase program for Class A and C shares (GOOGL 10‑K, pp. 80‑84), which will shrink the outstanding pool and likely lift the price of the remaining Class A shares, making conversion of Class B shares more attractive to holders who want the higher‑voting, higher‑price shares.  Meta’s 10‑K (pp. 1‑5) shows that its Class A share base is far larger than its Class B outstanding shares, indicating that a modest conversion of Class B shares would have a relatively small dilutive effect and may dampen the incentive for Class B holders to convert, especially if the price premium on Class A shares is modest.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its quantitative details: Alphabet's $70 billion share repurchase authorization for Class A and C shares is accurately cited, and the reference to Meta's Class A and Class B share counts (though not explicitly stated in the LLM answer) is contextually implied by the comparison. The dollar amount, share classes, and document references (10-K pages) are factually consistent with typical disclosures. However, the LLM does not provide the actual numbers from Meta's filing (2.19B Class A vs 343.8M Class B), which were included in the ground truth and are critical for full completeness and precision in multi-hop reasoning. This omission reduces completeness and weakens the synthesis. The reasoning about Alphabet's repurchase reducing supply and increasing Class A share value is sound and correctly links to potential conversion incentives for Class B holders. However, the LLM incorrectly frames Meta's large Class A base as reducing dilutive effects, whereas the ground truth emphasizes that abundant Class A shares reduce scarcity and thus conversion urgency due to lower price impact from repurchases. This mischaracterization of the causal mechanism (dilution vs. scarcity/liquidity) affects qualitative accuracy. The answer remains contextually relevant and captures the core dynamic, but the flawed logic in interpreting Meta's structure slightly undermines the multi-hop synthesis. Semantic equivalence is mostly preserved, but the reasoning gap prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 415,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does the treatment of dividend equivalents in RSU awards differ between PepsiCo and Philip Morris International in terms of vesting conditions and financial obligations as of 2023?",
      "original_answer": "PepsiCo accrues dividend equivalents during the vesting period for both RSUs and PSUs, which are paid out in cash when the award vests. Philip Morris International also accrues dividend equivalents on RSU awards, but its RSUs generally vest on the third anniversary of the grant date and do not carry voting rights. As of December 31, 2023, PMI had $160 million of total unrecognized compensation costs related to non-vested RSU awards, which are being amortized over the restriction period or upon specific life events.",
      "llm_answer": "PepsiCo’s RSUs vest at the end of the service period (typically three years) and accrue dividend equivalents that are paid in cash immediately upon vesting, creating a cash liability for the company. In contrast, PMI’s RSUs vest on the third anniversary of the grant date, earn dividend equivalents that are treated as participating securities and are included in EPS, but the dividend equivalents are not paid out in cash until the award vests and the RSUs are subject to forfeiture if employment conditions are not met. Thus, PepsiCo records a cash obligation at vesting, whereas PMI’s dividend equivalents remain a non‑cash, EPS‑included obligation until vesting.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both PepsiCo and PMI accrue dividend equivalents on RSUs with payout upon vesting, and that PMI RSUs typically vest on the third anniversary. It accurately contrasts PepsiCo's cash liability at vesting with PMI's treatment of dividend equivalents as participating securities included in EPS. However, the original answer notes that PMI had $160 million in unrecognized compensation costs as of December 31, 2023, which the LLM answer omits entirely—this is a significant quantitative and qualitative omission. (2) No explicit numbers are incorrect (no false dollar amounts or dates), but the failure to mention the $160 million unrecognized cost from the ground truth reduces quantitative completeness. All other referenced facts (vesting periods, cash vs. non-cash treatment) are consistent in meaning, though wording differs. (3) The multi-hop reasoning is generally sound: the model correctly synthesizes vesting conditions and financial obligations across two companies. However, it introduces the concept that PMI’s dividend equivalents are 'included in EPS' and 'treated as participating securities,' which, while plausible, is not present in the original answer and cannot be verified from the provided ground truth—this adds unverified qualitative detail. (4) The answer is contextually relevant and addresses the core comparison on vesting and financial obligations, but misses a key financial obligation metric ($160M) and adds unsupported detail about EPS treatment, reducing its factual accuracy. Hence, correctness is reduced to 7 for partial completeness and minor factual overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 452,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does DHR's use of NAV and discounted cash flow in valuing private investments compare to LLY's reliance on fair value estimation for acquired intangible assets, considering the inherent subjectivity in both approaches as highlighted in their respective disclosures?",
      "original_answer": "DHR utilizes NAV based on fund manager inputs and applies discounted cash flows, earnings multiples, and third-party appraisals to estimate the fair value of private investments, acknowledging that these methods may not reflect net realizable value or future fair values. LLY, on the other hand, applies fair value estimation to acquired intangible assets such as IPR&D, which required $3.80 billion in charges in 2023 alone, and admits that final valuations may change significantly as fair values are finalized within one year post-acquisition. Both companies recognize the subjectivity involved in fair value estimation, with DHR noting that different methodologies can yield materially different results and LLY emphasizing the need for considerable judgment in determining the fair value of acquired assets, especially under limited access to pre-acquisition data.",
      "llm_answer": "DHR values its private‑investment holdings by applying a practical expedient of net‑asset‑value and, where necessary, discounted‑cash‑flow models, and it cautions that using different assumptions or valuation methods can materially change the fair‑value estimate (see DHR 10‑K, pp. 97‑101).  LLY records acquired intangible assets at fair value under the acquisition method, noting that management must make significant estimates and assumptions to determine those values (see LLY 10‑K, pp. 66‑70).  Both companies therefore acknowledge that their valuation approaches are inherently subjective and can lead to materially different fair‑value measurements.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically aligned with the ground truth, but lacks one key quantitative detail present in the original answer: LLY's $3.80 billion in charges related to acquired intangible assets in 2023. All other elements are correctly represented. (1) Quantitative Accuracy: No incorrect numbers are provided; the LLM avoids making up figures and only states what is supported. Since it omits the $3.80 billion charge but does not misstate any numbers, this is a minor omission rather than an inaccuracy—hence a score of 10 for quantitative accuracy as no actual number is wrong. (2) Completeness: The LLM addresses both DHR’s and LLY’s valuation methods and their recognition of subjectivity, but misses the specific financial impact ($3.80 billion charge in 2023), which is a significant detail in the original answer and relevant to the comparison of material consequences of subjectivity. (3) Entity Accuracy: Correct companies (DHR, LLY), correct valuation methods (NAV, discounted cash flow, fair value estimation), and correct context (10-K disclosures) are all accurately identified. (4) Reasoning: The multi-hop reasoning is sound—correctly comparing DHR’s private investment valuation with LLY’s intangible asset valuation and highlighting the shared theme of subjectivity. The synthesis across both companies’ disclosures is logical and relevant. (5) Semantic Equivalence: The core message—that both companies use subjective fair value estimation methods and acknowledge potential material differences in outcomes—is preserved. The omission of the $3.80 billion charge reduces completeness but does not distort the meaning. Contextual relevance is perfect as the response directly addresses the comparison of valuation approaches and their inherent subjectivity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 487,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does the concentrated voting power in CMCSA's Class B common stock compare to the shareholder structure disclosed for GOOGL's Class A common stock in terms of control and ownership distribution?",
      "original_answer": "CMCSA's Class B common stock, held entirely by Brian L. Roberts, represents 33⅓% of the combined voting power with each share carrying 15 votes, creating significant control concentration. In contrast, GOOGL's Class A common stock, with 300,754,904 shares outstanding as of January 25, 2022, is broadly distributed among non-affiliates, with voting rights presumably more dispersed given the large number of shares and absence of similar super-voting structures described for CMCSA. This indicates a stark difference in governance dynamics, with CMCSA maintaining centralized control through Class B shares, while GOOGL's structure suggests more distributed shareholder influence.",
      "llm_answer": "Comcast’s Class B shares are highly concentrated: each share carries 15 votes and represents about one‑third (33 ⅓ %) of the company’s voting power, all of which is held by Mr. Brian L. Roberts (CMCSA, pp. 36‑40). In contrast, Alphabet’s Class A shares are broadly held – 300 million shares outstanding – so ownership is dispersed and no single shareholder controls a significant portion of the company (GOOGL, pp. 1‑5).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all key figures are correct: CMCSA's Class B shares carry 15 votes and represent 33⅓% of voting power, held entirely by Brian L. Roberts; GOOGL's Class A shares have approximately 300 million outstanding (ground truth specifies 300,754,904 as of January 25, 2022), which the LLM rounds appropriately. (2) The answer correctly contrasts concentrated control in CMCSA with broad, dispersed ownership in GOOGL, accurately noting the absence of super-voting concentration in GOOGL’s structure. (3) Multi-hop reasoning is sound—information from both CMCSA and GOOGL filings is synthesized to compare governance structures. (4) Minor omission: the LLM does not explicitly state that GOOGL’s voting rights are 'presumably more dispersed due to lack of super-voting shares' as in the original, but this is implied. Wording differences (e.g., '300 million' vs exact figure) are acceptable under semantic equivalence. No factual errors; only slight reduction in qualitative accuracy due to less detailed articulation of governance implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 323,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does the ratio of securities remaining available for future issuance to those issuable upon exercise of outstanding options differ between UnitedHealth Group and Johnson & Johnson under their respective equity compensation plans approved by security holders?",
      "original_answer": "For UnitedHealth Group, the ratio is approximately 9.64 (241 million remaining available / 25 million issuable upon exercise), while for Johnson & Johnson, the ratio is approximately 1.79 (240,344,013 remaining available / 133,794,708 issuable upon exercise). This indicates that UnitedHealth Group has a significantly higher proportion of remaining available securities compared to those already issuable, relative to Johnson & Johnson.",
      "llm_answer": "UnitedHealth Group’s equity‑compensation plans show a ratio of about **241 million remaining securities to 25 million exercisable options** – roughly **9.6:1**.  \nJohnson & Johnson’s plans show a ratio of **37,028 thousand remaining securities to 28,011 thousand exercisable options** – roughly **1.3:1**.  \nThus, UnitedHealth Group’s available‑for‑future‑issuance pool is far larger relative to its current options than Johnson & Johnson’s.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant quantitative errors. For UnitedHealth Group, the ratio is correctly approximated as 9.6:1 (241M / 25M), which matches the ground truth of ~9.64, so this part is accurate. However, for Johnson & Johnson, the LLM reports 37,028 thousand (i.e., ~37 million) remaining available securities and 28,011 thousand (~28 million) issuable upon exercise, yielding a ratio of ~1.3:1. This is incorrect: the ground truth states 240,344,013 remaining available and 133,794,708 issuable, which gives a correct ratio of ~1.79:1. The LLM’s numbers for J&J are therefore factually wrong—both the numerator and denominator are off by more than an order of magnitude. (2) The calculation for UnitedHealth is correct; however, the calculation for Johnson & Johnson is based on incorrect input values, making the resulting ratio inaccurate. The model fails to reflect the actual scale of securities involved. (3) The multi-hop reasoning structure is sound—the model attempts to compute and compare ratios across two companies, which aligns with the question’s requirement. However, due to incorrect data retrieval for Johnson & Johnson, the synthesis is flawed. It appears the model may have pulled data from a different year, plan, or company entirely for J&J. (4) Contextual relevance is high because the answer follows the correct format, identifies the right companies and concepts, and performs the intended comparison. Qualitative accuracy is moderate because the reasoning framework is valid, but entity-level data for J&J is severely inaccurate. Quantitative accuracy is low due to major numerical errors. Correctness score is reduced to 4 due to one correct half and one significantly incorrect half.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 467,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does AMD's reliance on third-party motherboard suppliers compare to Intel's dependency on Dell Inc. as a major customer, particularly in terms of revenue concentration risk?",
      "original_answer": "AMD depends on third-party companies for the design, manufacture, and supply of motherboards that support its microprocessor, GPU, and APU offerings, making it vulnerable to supply chain disruptions. In contrast, Intel reports that Dell Inc. accounted for 21% of its net revenue in 2021, highlighting a significant revenue concentration risk tied to a single customer. While AMD's risk centers on supply chain limitations that could prevent product delivery, Intel's exposure is tied directly to customer dependency, with Dell representing a substantial portion of both revenue and accounts receivable.",
      "llm_answer": "AMD’s business model relies on third‑party motherboard suppliers, a supply‑chain risk that could affect product availability but does not create a concentrated revenue base (AMD 10‑K, p. 28).  In 2021 its top three customers represented 43 % of revenue, with Dell accounting for 21 % (AMD 10‑K, p. 30).  By contrast, Intel’s dependence on Dell is a direct revenue‑concentration risk, as Dell represents a substantial share of Intel’s sales and exposes the company to greater revenue volatility from that single customer (Intel 10‑K, pp. 85‑89).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that in 2021, AMD's top three customers represented 43% of revenue, with Dell accounting for 21% — this is false. The ground truth specifies that it was Intel, not AMD, whose revenue from Dell accounted for 21% in 2021. The LLM conflates AMD’s customer concentration with Intel’s, misattributing Intel’s 21% Dell dependency to AMD. This is a critical error in entity attribution. (2) Quantitative accuracy is low: the 43% figure for AMD’s top three customers and the claim that Dell is one of them at 21% are not supported by the ground truth and contradict it. The ground truth makes no mention of AMD’s top customer breakdown, so introducing specific percentages undermines factual correctness. (3) Reasoning is partially sound in structure — it attempts to contrast supply-chain risk (AMD) vs. customer concentration risk (Intel) — but fails in multi-hop synthesis by assigning Intel’s customer data to AMD. The model should have used Intel’s 10-K to report Dell’s 21% share of Intel’s revenue, not AMD’s. (4) Contextual relevance is high because the answer addresses the core comparison of risk types (supply chain vs. revenue concentration) and cites appropriate risk categories. However, due to the major misattribution of financial data, the correctness score is low despite relevant framing. Semantic equivalence fails on key facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 396,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How do Louisiana's corporate tax rate reductions impact the financial exposure of both Boeing and Union Pacific, given Boeing's dependence on federal appropriations influenced by broader legislative dynamics and Union Pacific's direct operations in the state?",
      "original_answer": "Louisiana enacted legislation to reduce its corporate income tax rate for future years, resulting in a $34 million reduction of Union Pacific’s deferred tax expense in 2024. Union Pacific directly benefits from this tax reduction due to its operational presence in Louisiana, as evidenced by its major classification yard in Livonia. Boeing, on the other hand, does not directly benefit from Louisiana’s tax changes but faces exposure to broader legislative uncertainty, particularly in terms of federal appropriations for the U.S. Department of Defense and other government agencies. A lapse or delay in federal funding could disrupt Boeing’s operations, delay aircraft certifications, or impact future orders. Therefore, while Union Pacific experiences a quantifiable financial benefit ($34 million reduction in deferred tax expense) from Louisiana’s tax legislation, Boeing’s exposure is indirect and tied to the uncertainty of federal budget dynamics influenced by the same legislative environment.",
      "llm_answer": "Boeing’s 2024 income‑tax notes that Louisiana’s corporate‑tax cut (along with Arkansas’s) lowered its deferred‑tax expense by **$34 million** (page 12), improving after‑tax earnings but leaving its exposure to federal appropriations—subject to congressional appropriations cycles and policy shifts—unchanged. Union Pacific’s 2024 financial statements likewise show a reduction in state‑level tax expense for its Louisiana operations, easing its operating‑cost base for the rail lines that run through the state; the amount is not disclosed in the excerpt but the cut modestly improves its profitability without materially altering its broader revenue mix or capital‑investment decisions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly attributes the $34 million deferred tax benefit to Boeing, when the ground truth clearly states that Union Pacific—not Boeing—received the $34 million reduction in deferred tax expense due to Louisiana’s tax changes. This is a critical factual error. Boeing is exposed to federal appropriations and legislative uncertainty, not state tax benefits from Louisiana. (2) The quantitative inaccuracy is severe: the $34 million figure is misassigned to Boeing instead of Union Pacific. While the number itself matches the ground truth, its attribution is wrong, which undermines the entire financial interpretation. No other numbers are provided for Union Pacific in the LLM answer, and it admits the amount is 'not disclosed in the excerpt,' contradicting the ground truth where it is clearly stated. (3) The multi-hop reasoning is partially sound in recognizing that Boeing is affected by federal appropriations and that state tax changes could affect companies operating in Louisiana. However, it fails the core synthesis: it incorrectly links Boeing to Louisiana’s tax cut and does not clearly establish that only Union Pacific benefits directly. The reasoning for Union Pacific is vague and lacks the specific evidence (e.g., classification yard in Livonia) that grounds the original answer. (4) Contextual relevance is high because the answer addresses both companies, the tax changes, and broader legislative dynamics. However, due to the misattribution of the $34 million, the qualitative and quantitative accuracy scores are significantly reduced. The answer conveys the opposite of the truth on a key financial point, warranting a correctness score of 4—partially correct on structure and context, but fundamentally flawed in factual assignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 486,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does Netflix's one-vote-per-share governance model contrast with Meta's dual-class stock structure, particularly in relation to Charter Communications' disclosure about the link between Class A common stock and voting rights?",
      "original_answer": "Netflix operates under a one-vote-per-share governance model for its common stock, as explicitly stated in its 2024 10-K filing. In contrast, Charter Communications' 2024 financial statements clarify that its Class A common stock carries one vote per share, while its Class B common stock has variable voting rights tied to A/N's economic interests. Meta's 2024 10-K filing discloses the existence of both Class A and Class B common stock, a dual-class structure that suggests differentiated voting rights similar to Charter's framework, though Meta does not specify the exact voting power of each class in the provided chunk. This creates a contrast between Netflix's egalitarian voting model and the more complex, tiered voting structures used by both Charter and Meta.",
      "llm_answer": "Netflix’s 10‑K (pp. 58‑62) states that “each share of common stock shall be entitled to one vote per share,” giving all shareholders equal voting power. In contrast, Meta’s 10‑K (pp. 1‑5) discloses a dual‑class structure in which Class A shares carry one vote per share while Class B shares carry many more votes, concentrating control. Charter’s 10‑K (pp. 93‑97) echoes this arrangement by noting that its Class A shares have one vote per share, whereas Class B shares have a number of votes tied to Charter Holdings units—illustrating how a dual‑class scheme can link voting rights to a specific shareholder’s economic interest.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies Netflix's one-vote-per-share model and accurately contrasts it with dual-class structures at Meta and Charter. It correctly states that Netflix’s common stock has one vote per share, aligning with the 2024 10-K. It also correctly notes Charter’s Class A common stock carries one vote per share and that Class B voting rights are tied to Charter Holdings units, matching the ground truth. However, the LLM makes a significant overstatement about Meta: while Meta does have a dual-class structure (Class A and Class B shares), the provided 10-K chunk does not specify that Class B shares carry 'many more votes'—this detail is not present in the source material. The ground truth correctly notes that Meta does not disclose the exact voting power of each class in the provided filing chunk, so asserting a quantitative difference ('many more votes') goes beyond the available information. This is a reasoning error in the multi-hop synthesis, as the model assumes a detail not confirmed in the data. Quantitatively, all stated facts (e.g., one vote per share) are accurate, and formatting is consistent. Contextually, the answer is highly relevant and addresses the core contrast. The qualitative accuracy is reduced due to the unsupported inference about Meta’s voting power, though the overall structure and intent of the comparison remain sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 381,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does the daily cash-settlement mechanism for exchange-traded commodity futures described in PEP's 2022 filing impact the valuation methodology used by MDLZ for its Level 1 financial liabilities, given that both companies rely on quoted market prices from commodity exchanges?",
      "original_answer": "The daily cash-settlement mechanism for exchange-traded commodity futures described in PEP's 2022 filing aligns with the valuation methodology used by MDLZ for its Level 1 financial liabilities, which are also based on quoted market prices from commodity exchanges. PEP notes that exchange-traded commodity futures are 'cashsettled on a daily basis' and therefore not included in the balance sheet table as of year-end, indicating a standard market practice. MDLZ explicitly states that the fair value of its Level 1 financial assets and liabilities 'is determined based on quoted market prices on commodity exchanges.' This shows that the market standard of daily cash settlement directly informs MDLZ's valuation approach for Level 1 liabilities, as both companies are subject to the same pricing and settlement mechanisms in commodity futures markets.",
      "llm_answer": "PEP’s 2022 filing notes that exchange‑traded commodity futures are cash‑settled daily, so their fair value is always the daily settlement price – a Level 1 input (PEP, pp. 105‑109). MDLZ’s Level 1 liabilities are also valued at quoted market prices from commodity exchanges (MDLZ, pp. 110‑114). Thus, the daily cash‑settlement mechanism in PEP’s filing simply reinforces that MDLZ’s valuation methodology uses the most recent Level 1 market price, ensuring consistent and transparent fair‑value measurement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core relationship between PEP's description of daily cash settlement and MDLZ's Level 1 valuation methodology. It correctly identifies that PEP’s 2022 filing states exchange-traded commodity futures are cash-settled daily (a Level 1 input), and that MDLZ values its Level 1 financial liabilities using quoted market prices from commodity exchanges. The answer aligns with the ground truth in substance: both companies rely on the same market mechanism, and the daily settlement reinforces the use of current market prices for fair value. Quantitatively, no specific numbers are misstated; references to Level 1 inputs and quoted prices are consistent with the filings. The reasoning is sound and reflects proper multi-hop synthesis across PEP and MDLZ. The only minor shortcoming is that the LLM does not explicitly mention that daily cash settlement leads to exclusion from year-end balance sheets (as noted in PEP’s filing and highlighted in the ground truth), which slightly weakens the completeness of the explanation. However, this omission does not undermine the central correctness of the response. Wording differs but semantic equivalence is maintained. Contextual relevance is strong—directly addresses the impact of settlement mechanics on valuation methodology.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 367,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does Apple's 2022 net sales performance in the Greater China region, which includes Taiwan, compare with AMD's 2022 sales in Taiwan alone, given both companies' exposure to the technology market in that geographic area?",
      "original_answer": "Apple reported $74,200 million in net sales in the Greater China region in 2022, which includes China mainland, Hong Kong, and Taiwan. AMD, on the other hand, reported $2,091 million in sales specifically in Taiwan for the same year. This indicates that while Apple has a significantly larger overall presence in the broader Greater China region, AMD's direct sales in Taiwan are much smaller in scale.",
      "llm_answer": "Apple’s 2022 net sales in the Greater China region (which includes Taiwan) were **$74.2 billion**【source: Apple 10‑K, Net sales by reportable segment table】.  AMD’s 2022 sales in Taiwan are not separately disclosed in the provided AMD 10‑K pages, so a direct numeric comparison cannot be made; however, Apple’s figure is far larger than AMD’s Taiwan‑only sales, reflecting Apple’s broader presence in that market.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Apple's 2022 net sales in the Greater China region as $74.2 billion ($74,200 million), matching the ground truth in both value and source (Apple 10-K), which demonstrates quantitative accuracy. However, it incorrectly states that AMD’s 2022 sales in Taiwan are not disclosed, when in fact the ground truth confirms AMD reported $2,091 million in sales specifically in Taiwan in 2022. This is a critical factual omission that undermines the answer’s completeness and correctness. (2) The numeric value for Apple is accurate and correctly formatted ($74.2 billion = $74,200 million). The AMD figure, however, is entirely missing despite being available in the knowledge base, leading to a failed comparison. (3) The reasoning is partially sound in noting Apple’s broader presence, but the multi-hop synthesis fails because the model does not access or acknowledge AMD’s disclosed Taiwan sales, which is a required component of the comparison. The conclusion that Apple’s figure is larger may be correct, but it is unsupported by referenced data in the answer. (4) The correctness score is 4 due to significant factual incompleteness despite accurate Apple data. Quantitative accuracy is 8 because Apple’s number is correct and properly formatted, but AMD’s missing number prevents a perfect score. Qualitative accuracy is 4 due to failure in entity synthesis and incorrect claim of non-disclosure. Contextual relevance is 7 because the answer addresses the geographic and market context appropriately but fails in delivering the core comparative insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 437,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does Duke Energy's exposure to environmental remediation liabilities compare to Southern Company's ability to recover similar costs through regulatory mechanisms, given that Duke Energy's remediation costs are typically expensed as incurred unless recovery is probable, while Southern Company Gas' natural gas utilities specifically include environmental remediation in their approved cost recovery mechanisms?",
      "original_answer": "Duke Energy faces environmental remediation liabilities at multiple sites, with costs typically expensed as incurred unless regulatory recovery is deemed probable. In contrast, Southern Company Gas explicitly includes environmental remediation among the costs eligible for recovery through regulatory riders in its natural gas distribution utilities. This means that while Duke may bear these costs directly unless recovery is approved, Southern Company has a more structured pathway to recover such expenses through approved rate mechanisms, reducing its direct financial exposure to environmental remediation liabilities.",
      "llm_answer": "Duke Energy records environmental‑remediation liabilities in reserves and expends the costs in operating expenses unless a regulatory recovery is judged probable (the 2024 reserve is $73 million). In contrast, Southern Company Gas’s natural‑gas utilities have regulatory riders that explicitly allow recovery of environmental‑remediation costs as part of approved cost‑recovery mechanisms, giving the company a systematic path to offset those expenses.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states Duke Energy's practice of expensing remediation costs unless recovery is probable and notes that Southern Company Gas has explicit regulatory riders allowing recovery of such costs—this captures the key contrast in financial exposure and recovery mechanisms. (2) The LLM introduces a specific dollar amount ($73 million reserve in 2024) not present in the original answer; while this may be factually correct based on filings, it is not part of the ground truth provided, so it cannot be verified from the knowledge graph. This addition does not contradict but adds detail beyond the original, which is acceptable but slightly affects quantitative accuracy since the original answer contained no numbers. (3) The multi-hop reasoning is sound: the model correctly synthesizes Duke's cost-expensing policy with Southern's regulatory recovery framework to highlight a structural difference in risk exposure. (4) All entities (Duke Energy, Southern Company Gas, regulatory riders, environmental remediation) are correctly identified and contextually used. The answer is fully relevant and semantically equivalent to the original, with slightly more detail. Minor deduction in quantitative accuracy due to unverifiable specificity, but no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 377,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does LOW's use of broker/dealer quotes for Level 2 fair value measurements compare to GM's reliance on valuation models for product warranty reserves, given the role of industry-standard models in both companies' financial reporting?",
      "original_answer": "LOW uses broker/dealer quotes as inputs to Level 2 fair value measurements for financial assets when quoted prices in active markets are not available, relying on third-party pricing models with observable market inputs like issuer spreads and benchmark securities. GM, on the other hand, applies valuation models to estimate product warranty reserves, incorporating significant assumptions such as warranty claims frequency, average cost per claim, and historical claims data. Both companies utilize industry-standard valuation models, but LOW's approach is market-driven with observable inputs (Level 2), while GM's involves more management judgment and forward-looking assumptions. This highlights different applications of valuation models: LOW's fair value measurements are more directly tied to current market data, whereas GM's depend on internal forecasts and historical performance.",
      "llm_answer": "LOW’s Level‑2 fair‑value estimates for its financial assets are calculated with pricing models that use observable market inputs, notably broker‑dealer quotes, benchmark yields and reported trades—an industry‑standard approach to valuing securities. GM, on the other hand, relies on valuation models for its product‑warranty reserves that draw on historical claims experience and assumptions about future frequency and cost, again applying industry‑standard actuarial and statistical techniques. Thus, while both companies use industry‑standard models, LOW’s model inputs are market‑observable quotes for securities, whereas GM’s inputs are historical claim data and predictive assumptions for warranty costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: LOW uses broker/dealer quotes and observable market inputs (e.g., benchmark yields, reported trades) for Level 2 fair value measurements, which aligns with industry-standard pricing models. GM uses valuation models for warranty reserves based on historical claims and assumptions about future frequency and cost, using actuarial/statistical methods. These points match the original answer. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense—however, the absence of any incorrect figures supports a score of 10. (3) The multi-hop reasoning is sound: the model correctly contrasts two different uses of valuation models across companies and industries—LOW’s market-observable, Level 2 approach versus GM’s assumption-driven, forward-looking warranty modeling. It captures the distinction in input types (market data vs. internal forecasts) and the role of industry standards in both. (4) The only minor shortcoming is that the LLM answer does not explicitly mention that LOW’s approach falls under Level 2 of the fair value hierarchy due to observable inputs, nor does it emphasize the degree of management judgment in GM’s model as clearly as the original. However, these ideas are implied. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 423,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How would the implementation of the Basel III Finalization Proposal's Expanded Risk-Based Approach impact both Capital One and Citigroup's regulatory capital requirements, considering the phased-in effective date of July 1, 2025, and the requirement to use the lower of the two calculated risk-based capital ratios?",
      "original_answer": "The Basel III Finalization Proposal introduces a new Expanded Risk-Based Approach that would require both Capital One and Citigroup to calculate their risk-based capital ratios under both this new framework and the existing Basel III standardized approach, using the lower of the two ratios for compliance. For Capital One, this includes a three-year transition period starting July 1, 2025, during which risk-weighted assets under the Expanded Risk-Based Approach would be phased in. Citigroup has indicated that, if the proposal is finalized as written, it would materially increase its required regulatory capital. Both banks must also comply with all capital buffer requirements regardless of which approach yields the lower ratio, further constraining capital flexibility.",
      "llm_answer": "Under the Basel III Finalization Proposal, both Capital One and Citigroup will be required to compute risk‑weighted assets under the new Expanded Risk‑Based Approach (ERA) and under the existing Basel III standardized approach, and for each capital ratio (CET1, Tier 1, total) they must use the lower of the two ratios. The proposal’s effective date of July 1 2025 and a three‑year transition period (ending July 1 2028) means the full impact will be phased in, potentially raising their required CET1, Tier 1 and total capital ratios and, for both, requiring recognition of certain AOCI elements in CET1 capital.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its description of the Basel III Finalization Proposal's Expanded Risk-Based Approach, including the requirement to calculate risk-based capital ratios under both the new ERA and existing standardized approach and use the lower of the two. It correctly identifies the July 1, 2025 effective date and the three-year transition period (ending July 1, 2028), which aligns with the phased-in implementation for Capital One mentioned in the ground truth. The inclusion of AOCI elements in CET1 capital is a relevant technical detail consistent with Basel III reforms.\n\nQuantitatively, all dates and timeframes are accurate (July 1, 2025 start; three-year transition), and no incorrect numbers are presented. The answer correctly references CET1, Tier 1, and total capital ratios, though it does not quantify the actual increase in capital requirements—this omission is acceptable given the original answer also lacks specific numerical impacts.\n\nHowever, the LLM answer falls short on completeness and entity-specific synthesis. It fails to explicitly state that Citigroup has indicated the proposal would *materially increase* its required regulatory capital—a key qualitative point in the ground truth. While it mentions both banks generally, it does not differentiate their exposures or responses as the original answer does. Additionally, the ground truth emphasizes that both banks must comply with *all capital buffer requirements regardless of which approach yields the lower ratio*, a critical constraint on capital flexibility that the LLM omits entirely.\n\nThus, while the core mechanics of the ERA are accurately described (supporting a high contextual relevance and solid quantitative accuracy), the lack of differentiation between the banks’ expected impacts and missing emphasis on capital buffers results in a moderate deduction in qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 518,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does ConocoPhillips' exposure to condensate production through its ownership in Alba Plant LLC compare to Chevron's direct condensate production volumes in 2024, given Chevron reports zero condensate reserves in its 2024 10-K filing?",
      "original_answer": "ConocoPhillips holds a 52.2% interest in Alba Plant LLC, which extracts condensate from the Alba Unit natural gas stream and sells it at market prices, with COP's share reflected in 'Equity in earnings of affiliates.' In contrast, Chevron's 2024 10-K shows no condensate production or reserves across all categories, including both consolidated and affiliated companies. This indicates that while COP has exposure to condensate through its Alba Plant investment, Chevron had no direct condensate production in 2024.",
      "llm_answer": "ConocoPhillips’ exposure to condensate comes only indirectly through its 52.2 % stake in Alba Plant LLC, which extracts condensate from the Alba Unit gas stream and sells it as part of the joint‑venture’s LPG processing.  The 10‑K does not disclose a specific condensate‑production volume for this asset; the revenue is reflected only in the “Equity in earnings of affiliates” line.  By contrast, Chevron’s 2024 10‑K reports zero condensate reserves, implying that it has no direct condensate‑production volumes in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: ConocoPhillips has a 52.2% stake in Alba Plant LLC, which processes condensate from the Alba Unit gas stream, and its share is reported in 'Equity in earnings of affiliates'—this matches the original answer. Chevron’s 2024 10-K reports zero condensate reserves, implying no direct production, which is correctly interpreted. (2) Quantitative accuracy is perfect: the 52.2% ownership figure is correct, and no specific production volume is disclosed, consistent with the source. (3) The multi-hop reasoning is sound—correctly linking COP’s indirect exposure via equity investment versus Chevron’s lack of reserves and thus production. The only minor gap is that the LLM answer does not explicitly state that Chevron also has no condensate production in affiliated companies (as mentioned in the original answer), which slightly reduces completeness in entity-level synthesis. (4) The answer is fully relevant, directly addressing the comparison of condensate exposure between the two firms in 2024. Wording differs but meaning is semantically equivalent. No calculation errors. Minor omission prevents a perfect 10, but overall excellent accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 351,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the application of ASU 2020-04 to contract modifications impact both AVGO's revenue recognition practices and ORCL's financial reporting, particularly in relation to reference rate reform?",
      "original_answer": "AVGO evaluates contract modifications to determine whether additional products or services should be accounted for as a separate contract or part of the existing contract, using standalone selling prices adjusted for specific contract circumstances. ORCL adopted ASU 2020-04 related to reference rate reform, which allowed optional expedients for contract modifications affected by changes in reference rates such as LIBOR. According to the evidence, AVGO uses standalone selling prices to allocate consideration in bundled arrangements, and modifications are accounted for prospectively, cumulatively, or a combination depending on the nature of the change. ASU 2020-04 applied to contract modifications made between March 12, 2020, and December 31, 2024, and both AVGO and ORCL reported no material impact on their consolidated financial statements from applying this guidance. ORCL finalized its adoption of ASU 2020-04 in Q1 of fiscal 2024, with no material effect on its financial statements or notes.",
      "llm_answer": "AVGO’s contract‑modification policy (p. 61‑65) requires that any additional product or service added to a contract be evaluated against its standalone selling price and accounted for either as a separate contract or as part of the existing contract, with variable‑consideration reserves adjusted accordingly—this shapes its revenue recognition under ASC 606. ORCL’s adoption of ASU 2020‑04 (p. 70‑74) had no material impact on its consolidated financial statements but, by addressing reference‑rate reform, it reduced the operational and financial effects of contract modifications that replace reference rates such as LIBOR and extended the optional relief period to December 31 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) All key facts are correct: AVGO evaluates contract modifications using standalone selling prices to determine whether to account for additional goods/services as a separate or modified contract, which aligns with ASC 606 and impacts revenue recognition. ORCL adopted ASU 2020-04 related to reference rate reform (e.g., LIBOR transition), applied optional expedients, and reported no material impact on financial statements, with relief extended to December 31, 2024—this matches the ground truth. (2) Quantitatively, the date December 31, 2024, is correctly cited as the end of the relief period; no other numbers (e.g., financial impacts) are misstated, and the claim of 'no material impact' is consistent across both answers. (3) Multi-hop reasoning is sound: the model correctly links ASU 2020-04 to both AVGO’s revenue recognition practices and ORCL’s financial reporting in the context of reference rate reform, synthesizing across entities and standards. (4) Minor omission: the ground truth notes ORCL finalized adoption in Q1 of fiscal 2024 and that modifications may be accounted for prospectively, cumulatively, or a combination—details absent in the LLM answer. However, these are secondary to the core conclusion of no material impact and correct application of the standard. Wording differs but meaning is semantically equivalent. Thus, correctness is high but not perfect due to slight incompleteness in procedural details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 420,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does the dual-class stock structure at META, which negatively impacts the attractiveness of its Class A Common Stock, compare to CMCSA's Class B Common Stock convertibility policy in terms of governance control and shareholder influence?",
      "original_answer": "META's dual-class structure gives disproportionate voting control to Class B shareholders like Mark Zuckerberg, requiring a majority of Class B shares to approve change-of-control transactions until they fall below 35% of combined voting power. In contrast, CMCSA allows Class B Common Stock (with 15 votes per share) to convert share-for-share into Class A Common Stock, maintaining a non-dilutable 33⅓% aggregate voting power for Class B shares. While both structures concentrate governance influence, META's system entrenches control more rigidly through class-vote requirements, whereas CMCSA enables gradual dilution through conversion.",
      "llm_answer": "META’s dual‑class structure gives the CEO and other Class B holders ten votes per share, concentrating majority voting power and limiting Class A shareholders’ influence (META 10‑K, pp. 48‑52). In contrast, Comcast’s Class B shares are convertible on a share‑for‑share basis into Class A shares, a policy that can dilute the voting power of Class B holders and does not create a concentrated control structure but simply offers shareholders the option to convert (CMCSA 10‑K, pp. 67‑71).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core governance structures at META and CMCSA and addresses the key contrast in shareholder control. It accurately notes META's dual-class structure with superior voting rights for Class B shares (though it states 'ten votes per share' without citing the exact number from the ground truth, which is implied but not explicitly confirmed in the original answer). The statement about CMCSA’s convertibility of Class B to Class A on a share-for-share basis is correct and aligns with the ground truth. However, the LLM omits two critical quantitative and structural details: (1) CMCSA’s Class B shares have 15 votes per share (missing this number reduces quantitative accuracy), and (2) the non-dilutable 33⅓% aggregate voting power cap for CMCSA Class B shares, which is central to understanding how control is structured and gradually diluted. Additionally, the LLM incorrectly implies that CMCSA’s structure does not create a concentrated control structure, whereas the ground truth clarifies that both structures concentrate influence—just through different mechanisms. The LLM also fails to mention META’s class-vote requirement for change-of-control transactions or the 35% threshold that triggers a potential shift in control, a key element of entrenchment. These omissions affect completeness and qualitative reasoning, particularly in multi-hop synthesis. Despite these gaps, the answer captures the essential comparison and cites appropriate document locations, maintaining strong contextual relevance and mostly accurate qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 433,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does PEP's use of exchange-traded commodity futures, which are cash-settled daily, compare with COST's disclosure regarding the absence of Level 1 financial assets measured at fair value on a recurring basis, given that Level 1 financial assets typically include exchange-traded commodity futures?",
      "original_answer": "PEP utilizes exchange-traded commodity futures that are cash-settled daily to manage market risk, and these are excluded from the fair value table as of December 25, 2021. These commodity futures fall under Level 1 financial assets, as defined by MDLZ's disclosure, which includes exchange-traded commodity futures valued at quoted market prices. However, COST explicitly states that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a distinct difference in financial instrument usage between PEP and COST.",
      "llm_answer": "PEP reports that its commodity‑derivative portfolio includes exchange‑traded futures that are cash‑settled daily, and it explicitly notes that these are not included in the fair‑value table because of the daily settlement (PEP, 10‑K, pp. 105‑109).  By contrast, COST states that it holds no Level 1 financial assets measured at fair value on a recurring basis, which means it does not carry any exchange‑traded commodity futures or other Level 1 instruments (COST, 10‑K, pp. 49‑53).  Thus, PEP actively uses such futures but excludes them from the Level 1 classification, whereas COST has no Level 1 assets at all.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately states that PEP uses exchange-traded commodity futures that are cash-settled daily and excludes them from the fair value table, consistent with the original answer. It also correctly notes that COST reports no Level 1 financial assets measured at fair value on a recurring basis. These key facts are correct and properly attributed. (2) There are no numeric values, dates, or calculations in the question or answer that are incorrect; the LLM does not introduce any false quantitative data. The absence of specific dates (e.g., December 25, 2021 for PEP and August 28, 2022 for COST) is a minor omission but does not affect factual accuracy, as the core disclosures are still correctly represented. (3) The multi-hop reasoning is sound: the model correctly contrasts PEP’s use of Level 1-type instruments (which are excluded from fair value tables due to daily settlement) with COST’s absence of any Level 1 assets. However, the LLM incorrectly implies that PEP excludes these futures from Level 1 classification, whereas the ground truth clarifies that such instruments *are* Level 1 assets (as per MDLZ's disclosure), but are excluded from the fair value table due to daily settlement. This is a subtle but important distinction—the instruments are Level 1 in nature but not reported in the fair value hierarchy table because of accounting rules for daily settled derivatives. The LLM misattributes the exclusion as a classification choice by PEP rather than an accounting exclusion. (4) Despite this nuance, the answer remains contextually relevant and factually strong, earning high marks for quantitative accuracy and relevance, with a slight deduction in qualitative accuracy due to the mischaracterization of the Level 1 classification issue.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 496,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does the value of securities loaned with maturities of 31-90 days at Goldman Sachs compare to the total securities loaned value reported by Morgan Stanley, and what does this suggest about their relative exposure to short-term securities lending risk?",
      "original_answer": "Goldman Sachs reports $1,634 million in securities loaned with maturities of 31-90 days, while Morgan Stanley reports a total of $281 million in securities loaned (U.S. and Non-U.S. combined). This suggests that Goldman Sachs has a significantly higher exposure to short-term securities lending risk compared to Morgan Stanley.",
      "llm_answer": "Goldman Sachs reported $1.634 billion in securities loaned with maturities of 31‑90 days (see the “Gross Carrying Value of Repurchase Agreements and Securities Loaned” table on page 188).  By contrast, Morgan Stanley’s 10‑K shows a total securities‑loaned balance of roughly $30.9 billion (page 149).  The much smaller 31‑90‑day exposure at Goldman Sachs indicates a relatively lower short‑term securities‑lending risk compared with Morgan Stanley.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains major factual and quantitative errors. (1) Quantitative Accuracy: The LLM incorrectly states that Morgan Stanley's total securities loaned is $30.9 billion, while the ground truth is $281 million—a massive discrepancy (over 10x too high). It also misrepresents Goldman Sachs' 31-90 day securities loaned as $1.634 billion (which is numerically equivalent to $1,634 million, so this part is acceptable in value but misrepresented in context). (2) Completeness: The answer fails to correctly compare the two firms' exposures because of the incorrect Morgan Stanley figure. (3) Entity Accuracy: While company names are correct, the financial metrics are wrong—Morgan Stanley's total securities loaned is grossly overstated. (4) Reasoning: The logic is flawed—the LLM concludes that Goldman Sachs has 'relatively lower' risk due to smaller 31-90 day exposure, but in reality, Goldman Sachs has a much larger short-term exposure ($1,634M) compared to Morgan Stanley’s total securities loaned ($281M), meaning Goldman has significantly higher short-term risk. The conclusion is therefore the opposite of the correct inference. (5) Semantic Equivalence: The answer conveys the opposite meaning of the ground truth due to incorrect data and reasoning. The citation of page numbers does not compensate for factual inaccuracy. The model appears to have misread or misinterpreted Morgan Stanley’s filing, leading to a completely incorrect comparison and conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 405,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What percentage of PowerSouth's owned generating capacity comes from its undivided interest in Alabama Power's Plant Miller Units 1 and 2, and how does this compare to Duke Energy's total electricity generation in GWh for 2021?",
      "original_answer": "PowerSouth owns an undivided 8.16% interest in Alabama Power's Plant Miller Units 1 and 2, which contributes to its total generating capacity of over 1,600 MWs. In comparison, Duke Energy generated a combined total of 22,344 GWh of electricity in 2021 across all its operating segments. This comparison highlights the relative scale of PowerSouth’s partial ownership in a specific plant versus Duke Energy’s full system-wide electricity generation.",
      "llm_answer": "PowerSouth’s undivided interest in Alabama Power’s Plant Miller Units 1 and 2 represents **8.16 %** of its owned generating capacity (the 1,600 MW of PowerSouth’s own capacity includes an 8.16 % stake in those units – Southern Company 10‑K, p. 19). In contrast, Duke Energy generated **22,344 GWh** of electricity in 2021 (Duke Energy 10‑K, p. 187).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies PowerSouth's 8.16% undivided interest in Plant Miller Units 1 and 2 and accurately states Duke Energy's total electricity generation of 22,344 GWh in 2021. All numeric values match the ground truth exactly, including percentage and GWh figures. (2) Quantitative accuracy is perfect: 8.16% and 22,344 GWh are correct, and no calculations were required beyond accurate reporting. (3) The multi-hop reasoning is sound—correctly linking PowerSouth’s partial ownership in a specific plant to Duke Energy’s system-wide generation. However, the LLM slightly misrepresents the 8.16% figure: it states that this percentage represents '8.16% of its owned generating capacity', whereas the original answer clarifies that PowerSouth owns an 8.16% stake in Plant Miller Units 1 and 2, which contributes to its over 1,600 MW of capacity. The percentage refers to the stake in the asset, not the proportion of total capacity, so this is a minor qualitative inaccuracy. (4) Despite this nuance, the answer is factually strong, complete, and contextually appropriate, citing correct sources and addressing both parts of the question with high precision. Hence, correctness is docked slightly to 9 for the minor mischaracterization, but all other scores remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 364,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does NIKE's exposure to interest rate risk in its $11.6 billion portfolio of fixed-income investments compare to McDonald's sensitivity to market inputs like interest rate yield curves, given both companies rely on pricing models that use observable market data for valuation?",
      "original_answer": "NIKE holds $11.6 billion in short-term investments, including investment-grade fixed-income securities, which are exposed to interest rate risk. These investments are valued using pricing models that incorporate observable market data such as interest rates and yield curves. Similarly, McDonald’s discloses that its derivatives are valued using pricing models that rely on observable market parameters, including interest rate yield curves. While NIKE’s risk stems from changes in interest rates affecting investment returns, McDonald’s exposure is tied to derivative valuations that reflect market fluctuations. Both companies depend on observable inputs for fair value measurements, though the nature and magnitude of risk differ based on the type of financial instrument involved.",
      "llm_answer": "NIKE’s $11.6 billion of short‑term fixed‑income securities have a weighted‑average duration of only 65 days, so its exposure to interest‑rate movements is minimal.  \nMcDonald’s valuation of many assets and liabilities relies on Level 2 pricing models that use observable market inputs—including interest‑rate yield curves—making its reported fair values more directly sensitive to changes in those inputs.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core comparison between NIKE and McDonald's regarding their use of observable market inputs in valuation models and correctly identifies that both companies rely on pricing models using interest rate yield curves and other market data. It accurately reflects that NIKE has $11.6 billion in fixed-income investments and that these are sensitive to interest rates, while McDonald’s fair value measurements (particularly derivatives) are sensitive to changes in yield curves via Level 2 inputs. However, the LLM introduces a specific quantitative detail not present in the original answer — a 'weighted-average duration of 65 days' — which is not mentioned or supported in the ground truth. This adds precision that cannot be verified from the provided knowledge and may misrepresent the extent of NIKE’s risk as 'minimal' based on that duration, which is an unsupported inference. While the general idea that short-term investments have lower interest rate risk is reasonable, this specific metric undermines quantitative accuracy. The qualitative reasoning is otherwise sound, with correct entity identification (NIKE, McDonald’s), appropriate financial concepts (Level 2 inputs, observable market parameters), and good synthesis across both companies’ disclosures. The answer is contextually relevant and addresses the multi-hop aspect by comparing two firms’ sensitivity to interest rates through different financial instruments. Thus, while the core facts are mostly aligned, the addition of unverified quantitative detail reduces confidence in the numerical accuracy, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 443,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does the difference in voting rights structure between Netflix's common stock and Alphabet's Class A common stock potentially influence their respective shareholder governance dynamics, given Netflix's uniform one-vote-per-share policy and Alphabet's multi-class structure with differential voting rights?",
      "original_answer": "Netflix's common stock provides each share with one vote, promoting a more egalitarian shareholder governance model. In contrast, Alphabet's multi-class structure, where Class A common stock grants one vote per share while Class B common stock grants 10 votes per share, concentrates voting power among holders of Class B shares. This structural difference means Alphabet's governance is more susceptible to control by a smaller group of insiders or major shareholders, while Netflix maintains a more evenly distributed voting environment.",
      "llm_answer": "Netflix’s common stock, as disclosed on pages 58‑62 of its 10‑K, gives each share one vote, so every shareholder’s influence is directly proportional to ownership and the board is accountable to the entire shareholder base. Alphabet’s 10‑K (pages 80‑84) describes a multi‑class structure: Class A shares vote one‑to‑one, Class B shares vote ten‑to‑one, and Class C shares are non‑voting, concentrating voting power in the hands of Class B holders and allowing them to maintain control even with a smaller economic stake. Consequently, Netflix’s governance is more egalitarian and responsive to all shareholders, whereas Alphabet’s structure can centralize decision‑making among a minority of controlling shareholders.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Netflix's one-vote-per-share policy and Alphabet's multi-class structure with Class A (1 vote), Class B (10 votes), and Class C (non-voting) shares are accurately described. (2) No numerical inaccuracies: the voting ratios (1:1 and 10:1) are correctly stated, and there are no calculations required beyond these ratios, which are properly interpreted. (3) Multi-hop reasoning is sound—the model correctly synthesizes governance implications across both companies, contrasting Netflix’s egalitarian, proportional influence model with Alphabet’s concentrated control structure that enables minority control via Class B shares. (4) The answer addresses all parts of the question: it explains how voting rights differ and how those differences influence shareholder governance dynamics. The inclusion of specific 10-K page references adds contextual support without detracting from accuracy. Wording differs slightly from the original answer but conveys the same meaning with equal or greater detail. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 327,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How might the IRA's price-setting provisions for Medicare Part D drugs like Imbruvica and XARELTO differently impact AbbVie and Johnson & Johnson's revenue strategies, given their respective exposure to the Medicare program?",
      "original_answer": "The IRA's price-setting provisions for Medicare Part D drugs will likely impact AbbVie and Johnson & Johnson differently due to their distinct product portfolios and revenue strategies. AbbVie has Imbruvica selected for price-setting starting in 2026, which could significantly affect its revenue stream, especially if more high-revenue products are selected in the future. Johnson & Johnson has XARELTO selected under the same program, a major anticoagulant with substantial Medicare utilization. Both companies face uncertainty around the final government-set prices, but J&J has already filed litigation challenging the constitutionality of the IRA’s pricing mechanism, suggesting a more aggressive stance to protect revenue. AbbVie, on the other hand, is more focused on evaluating the broader strategic impact of the IRA, including potential acceleration of revenue erosion prior to patent expirations. The differing responses reflect their respective risk exposure and strategic priorities within the Medicare program.",
      "llm_answer": "AbbVie’s Medicare‑Part D exposure is concentrated in Imbruvica, which the CMS has already selected for government‑set pricing under the IRA (AbbVie, pp. 20‑21).  Johnson & Johnson’s Xarelto is likewise a single‑source drug subject to the same Part D price‑setting risk (J&J, pp. 9‑13), but J&J’s broader portfolio of devices, consumer products and other biologics means the relative revenue hit is smaller, allowing the company to offset losses through other product lines.  Consequently, AbbVie may need to adjust pricing or negotiate new reimbursement terms more urgently than J&J, which can rely on diversified revenue streams to cushion the impact.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in identifying that both AbbVie's Imbruvica and Johnson & Johnson's XARELTO are subject to the IRA's Medicare Part D price-setting provisions, and correctly notes CMS selection (with reference to internal document pages, though these are not part of the ground truth and should not affect scoring). There are no numeric values in either answer, so quantitative accuracy is not applicable in a traditional sense—but since no numbers are misstated, it scores highly. The LLM correctly identifies the multi-hop element: both companies have exposure via specific drugs. However, it omits key strategic differences highlighted in the ground truth: J&J’s active litigation against the IRA and AbbVie’s concern about accelerated revenue erosion pre-patent expiry. Instead, the LLM emphasizes J&J’s diversified portfolio as a buffer, which is contextually reasonable but not explicitly stated in the original answer. While diversification is a plausible interpretation, the ground truth focuses on legal action and strategic evaluation as differentiating factors, not just revenue mix. Thus, the reasoning is partially aligned but misses the core contrast in corporate responses. The answer remains contextually relevant and captures the differential impact, but lacks completeness in synthesizing the full strategic dimension of both companies’ approaches.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 382,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does Citi's governance structure for managing compliance risk specifically address the potential amplification of credit and liquidity risks stemming from transition climate risks as outlined in Morgan Stanley's risk disclosures?",
      "original_answer": "Citi's governance structure includes the Board and Executive Management Team, which oversee enterprise risk management (ERM) and hold management accountable for the effectiveness of internal controls and compliance with legal and regulatory requirements. This includes ensuring that compliance risk is effectively managed across the organization. Transition climate risks, as outlined in Morgan Stanley's disclosures, may amplify credit and liquidity risks by reducing customers' operating income or the value of their assets. These risks also expose firms to reputational, compliance, and litigation risks due to increased legal and regulatory scrutiny. Citi’s Internal Audit, which reports functionally to the Chair of the Citi Audit Committee, provides independent assurance over the effectiveness of governance, risk management, and controls, including those addressing climate-related risks. This structure ensures that compliance risk management processes are aligned with evolving regulatory expectations, such as those related to climate risk, which Morgan Stanley notes are increasingly focused on disclosure and regulation of carbon emissions.",
      "llm_answer": "Citi embeds climate‑risk considerations into its compliance‑risk governance through the Independent Compliance Risk Management (ICRM) unit, which reports to the CRO and the Board’s Risk Management Committee and sits on the Risk Management Executive Council.  The Climate Risk Committee—co‑chaired by the CRO and Chief Sustainability Officer—oversees the integration of climate‑risk scenarios into credit and liquidity risk limits and stress tests, while the Business Risk and Control Committee and the Board’s Risk Management Committee receive regular updates on climate‑risk impacts.  This governance structure ensures that compliance controls are applied to credit and liquidity exposures that may be amplified by transition climate risks, keeping the Board and senior management informed and able to adjust risk appetite accordingly.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually plausible and contextually relevant, addressing the core of how Citi's governance structure integrates climate-risk considerations into compliance and risk management, particularly as they may amplify credit and liquidity risks. There are no numeric values in either the ground truth or the LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. The LLM correctly identifies key governance bodies (Board’s Risk Management Committee, CRO, Internal Audit equivalent via ICRM), and describes a structured approach to managing climate risk, including stress testing and oversight committees. However, the LLM introduces specific entities not present in the ground truth—such as the 'Independent Compliance Risk Management (ICRM) unit', 'Climate Risk Committee', and 'Business Risk and Control Committee'—which are not mentioned in the original answer derived from the knowledge graph. While these may be accurate in reality, they are not supported by the provided ground truth, which focuses on the Board, Executive Management, and Internal Audit without naming these specific sub-committees. Additionally, the ground truth emphasizes the link between Morgan Stanley’s disclosures and regulatory scrutiny (reputational, compliance, litigation risks) and how Citi’s governance responds to evolving regulatory expectations around climate disclosures and carbon emissions—this linkage is underdeveloped in the LLM answer. The multi-hop reasoning is partially sound: it connects Citi’s governance to climate risk and its impact on credit and liquidity, but does not fully synthesize how Morgan Stanley’s specific risk disclosures inform Citi’s compliance governance. Thus, while the qualitative description is coherent and relevant, it adds unverified structural details and omits the regulatory-expectation linkage emphasized in the ground truth, warranting a 7 for qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 525,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does QCOM's reliance on Chinese OEMs for 30% of its licensing revenue create different supply chain risks compared to TXN's strategy of expanding internal 300mm wafer fabrication capacity?",
      "original_answer": "QCOM derives a significant portion of its licensing revenues from Chinese OEMs, with 30% of total licensing revenue coming from this group of manufacturers. Delays or disputes in license agreements with these OEMs can directly impact QCOM's revenue and cash flows. In contrast, TXN is expanding internal 300mm wafer fabrication capacity through investments in RFAB2, LFAB1, and SM1 facilities, aiming to achieve greater supply chain control and reduce dependency on external foundries. While QCOM's business model depends heavily on maintaining licensing agreements with external manufacturers, particularly in China, TXN's strategy reduces exposure to external supply chain disruptions by vertically integrating manufacturing. This creates different risk profiles: QCOM faces higher exposure to geopolitical and contractual risks in China, while TXN mitigates manufacturing risks through capital investments in internal capacity.",
      "llm_answer": "QCOM’s licensing revenue is heavily concentrated in Chinese OEMs—about 30 % of royalties come from a handful of firms in China—so the company is exposed to U.S.–China trade tensions, export‑control restrictions, tariffs and the risk that Chinese policy or payment defaults could abruptly cut its licensing income. Texas Instruments, by contrast, is expanding its own 300‑mm wafer fabs, which increases internal capacity, gives it greater control over the supply chain, reduces reliance on external foundries and mitigates the likelihood of supply disruptions or geopolitical constraints.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 30% figure for QCOM's licensing revenue from Chinese OEMs is correctly stated, and no other numerical data is introduced that contradicts the original. (2) The qualitative analysis correctly identifies the key contrast: QCOM faces geopolitical and contractual risks due to reliance on Chinese OEMs for licensing revenue, while TXN reduces supply chain risk through vertical integration via 300mm wafer fab expansions. The LLM correctly references TXN’s strategy of building internal capacity to reduce dependence on external foundries, which matches the ground truth. (3) Multi-hop reasoning is sound—linking QCOM’s revenue model to external geopolitical risks and contrasting it with TXN’s capital-intensive, control-oriented manufacturing strategy demonstrates proper synthesis across two different business models and risk profiles. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly name TXN’s specific facilities (RFAB2, LFAB1, SM1) mentioned in the original, though this detail is contextual and not central to the core comparison. Wording differs slightly (e.g., 'payment defaults' and 'policy' are not in original) but captures the essence of geopolitical and contractual risks. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 393,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does Southern Company's evaluation of ASU 2020-04 in relation to interest rate derivatives compare with Duke Energy's assessment of the same accounting standard's impact on its LIBOR-indexed financial contracts?",
      "original_answer": "Southern Company continues to evaluate the provisions of ASU 2020-04 and its impact on transitioning to alternative interest rates, particularly in relation to its interest rate derivatives as noted in Note 14, while Duke Energy is assessing the optional expedients provided by the same standard to manage contractual amendments or terminations for LIBOR-indexed financial arrangements, including variable-rate debt and interest rate swaps, which may extend beyond the 2023 LIBOR phase-out. Both companies recognize the uncertainty around the ultimate financial impact, with Duke Energy specifically noting it is not expected to be material.",
      "llm_answer": "Southern Company notes that ASU 2020‑04 is unlikely to have a material effect on its interest‑rate‑derivative contracts and that it will continue to monitor the transition to an alternative rate. Duke Energy likewise is evaluating the impact of the standard on its LIBOR‑indexed swaps, considering the optional expedients, but also expects no material impact on its financial statements. Both companies therefore view the reform as non‑material while remaining vigilant about the transition.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts and overall message. (1) Both Southern Company and Duke Energy are evaluating ASU 2020-04 and its impact on LIBOR transition, particularly regarding interest rate derivatives and LIBOR-indexed contracts, and both conclude the impact is not expected to be material—this is accurately reflected. (2) There are no specific numbers, dates, or calculations in the question or ground truth beyond the mention of the 2023 LIBOR phase-out, which the LLM does not contradict; thus, quantitative accuracy is high. (3) The multi-hop reasoning is sound: the model correctly identifies both companies, the relevant accounting standard, and their respective assessments. However, the LLM omits some contextual details present in the original: Southern Company's reference to Note 14 and its focus on monitoring transition impacts, and Duke Energy's specific use of optional expedients for contractual amendments or terminations, including variable-rate debt and swaps extending beyond 2023. These omissions reduce completeness slightly. (4) Despite these nuances, the core meaning—that both companies are assessing the standard, using its guidance, and expect no material impact—is preserved, and the answer remains contextually relevant and factually accurate overall. Hence, a score of 8 is appropriate for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 410,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the exposure of AMZN's foreign currency assets to British Pounds and Euros compare to NKE's reliance on option contracts for managing similar currency risks, given their differing approaches to foreign exchange risk management?",
      "original_answer": "AMZN holds foreign currency assets in British Pounds, Euros, and other currencies, and is exposed to foreign exchange risk due to fluctuations that may materially impact translated values of these assets. NKE actively manages its foreign exchange risk using option contracts, specifically hedging exposures related to product costs, external sales, and other costs denominated in currencies like the British Pound and Euro. While AMZN discloses its exposure to these currencies, it does not specify the use of derivative instruments like options to hedge this risk. In contrast, NKE explicitly states its use of option contracts as part of its foreign currency risk management program to hedge forecasted transactions and balance sheet exposures. This suggests that NKE takes a more proactive and structured approach to mitigating foreign exchange impacts through financial instruments, while AMZN's strategy remains less transparent in terms of derivative usage.",
      "llm_answer": "Amazon’s foreign‑currency assets include cash equivalents and marketable securities denominated in British Pounds and Euros (see the “Foreign Exchange Risk” discussion on pages 7‑11), and it hedges those exposures with a mix of forward and option contracts as part of its broader FX program. Nike, by contrast, relies mainly on option contracts (often paired with forwards) to hedge its foreign‑currency exposures, as described in the “Foreign Currency Exposures and Hedging Practices” section on pages 46‑50. Thus, Amazon’s approach involves direct exposure to the currencies and a blended hedging strategy, whereas Nike’s strategy centers on option contracts to manage similar risks.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in context and addresses the comparison between AMZN and NKE regarding foreign exchange risk management, but contains a critical factual error in qualitative accuracy. (1) The LLM incorrectly states that Amazon uses 'a mix of forward and option contracts' to hedge its foreign currency exposures. The ground truth explicitly states that while AMZN is exposed to British Pounds and Euros and discloses foreign exchange risk, it does *not* specify the use of derivative instruments like options to hedge this risk. This misrepresentation undermines the core comparison. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no numbers to verify, hence scored as 10 by default. (3) The multi-hop reasoning is structurally sound—comparing AMZN's asset exposure to NKE's hedging practices—but the synthesis is flawed because it attributes derivative usage (options/forwards) to AMZN that are not confirmed in the ground truth. (4) NKE's reliance on option contracts is accurately represented, aligning with the original answer. However, the contrast fails because AMZN’s strategy is misrepresented as using derivatives, when the truth emphasizes its lack of transparency and explicit disclosure about such instruments. Thus, while the framing and relevance are strong, the factual inaccuracy in entity-specific practices (AMZN’s hedging) significantly reduces correctness. Semantic equivalence is not achieved due to this key discrepancy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 415,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the voting power distribution between Class A and Class B common stock at META compare to GOOGL's structure, given the dynamic relationship between share class voting rights?",
      "original_answer": "At META, Class A common stockholders hold 66 2/3% of the combined voting power, while Class B common stockholders hold 33 1/3%, with each share of Class B having 15 votes. In contrast, at GOOGL, each share of Class A has one vote and each share of Class B has 10 votes, with no specific percentage provided for their distribution. This indicates that META grants significantly more voting influence to Class B shares relative to Class A compared to GOOGL's structure.",
      "llm_answer": "META’s 10‑K does not disclose the voting rights of its Class A versus Class B shares – the filing only lists the number of shares outstanding.  By contrast, Alphabet (GOOGL) explicitly states that each Class A share carries one vote while each Class B share carries ten votes, giving Class B shares ten‑times the voting power of Class A shares.  Thus, GOOGL’s structure creates a 10:1 voting‑power ratio that is not detailed for META in the provided pages.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It falsely claims that META's 10-K does not disclose voting rights for Class A and Class B shares, when in fact the original answer (ground truth) states specific voting power distribution: Class A holds 66 2/3% and Class B holds 33 1/3% of combined voting power, with each Class B share having 15 votes. This is a major factual error. (2) The quantitative accuracy is very low: the LLM omits META's actual voting percentages and the 15:1 vote ratio per share (Class B vs Class A), instead asserting no data is available. While it correctly states GOOGL’s 10:1 voting ratio (Class B to Class A), it fails to note that no overall percentage distribution is provided for GOOGL, which the ground truth acknowledges. (3) The reasoning is flawed because it fails to perform the required multi-hop comparison: the core of the question is to contrast META’s structure—where Class B has 15 votes per share and a concentrated voting share (33.3% of votes from presumably fewer shares)—versus GOOGL’s 10:1 ratio but without specified vote distribution. The LLM incorrectly concludes that only GOOGL discloses its structure, undermining the comparison. (4) Contextual relevance is moderate because it attempts to address the question’s structure and mentions both companies and their share classes, but due to factual inaccuracy and missing key data, the response fails to meet the core requirements. The answer would mislead a user about META’s governance structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 418,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Southern Company's (SO) investment in SNG and SNG's need for FERC approval on its pipeline project compare to Duke Energy Ohio's (DUK) experience with FERC approval in terms of regulatory constraints and capital implications?",
      "original_answer": "Southern Company's (SO) investment in SNG was $1,245 million as of December 31, 2024. SNG is developing a $3 billion pipeline project requiring FERC approval, with Southern Company Gas owning 50% of the project. This regulatory dependency could delay the project until 2029 if approvals are not met. Similarly, Duke Energy Ohio (DUK) requires FERC and PUCO approval to pay dividends from specific equity accounts, with a condition to maintain equity at no less than 30% of total capital. Both entities face regulatory constraints from FERC, but while SNG's challenge centers on project execution and timing, DUK's is tied to capital structure and dividend policy.",
      "llm_answer": "Southern Company’s investment in the SNG joint‑venture is a $3 billion pipeline project that will not begin until all regulatory approvals—including a FERC permit—are obtained, creating a project‑level constraint that could delay the 2029 completion and obligates Southern Company Gas to a 50 % share of the capital cost. In contrast, Duke Energy Ohio’s FERC approval concerns dividend distribution: the regulator has granted permission only if the company keeps equity at 30 % of total capital, a capital‑structure constraint that limits dividend payouts but does not involve a new capital outlay for a construction project. Thus, SO faces a regulatory hurdle tied to a large capital investment, whereas DUK faces a regulatory hurdle that restricts dividend payments and preserves equity but does not require additional project capital.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core regulatory constraints for both Southern Company (SO) via its SNG investment and Duke Energy Ohio (DUK), and accurately contrasts project-level vs. capital-structure regulatory hurdles. However, it omits the specific $1,245 million investment figure by Southern Company in SNG as of December 31, 2024, which is a key quantitative fact from the ground truth. Instead, it refers only to the $3 billion pipeline project and Southern Company Gas’s 50% share, which is correct but less precise. (2) The $3 billion pipeline cost and 50% ownership are accurate and consistent with the original answer. The 2029 timeline is mentioned correctly as a potential completion or delay point. The 30% equity requirement for DUK is correctly stated. However, the absence of the $1,245 million investment amount—a specific, documented figure—represents a material omission in quantitative accuracy. (3) The multi-hop reasoning is strong: the model correctly synthesizes that SO’s FERC dependency relates to project execution (pipeline approval) while DUK’s relates to capital structure and dividend policy, drawing a valid qualitative distinction between the two types of regulatory constraints. The logic and comparison are sound and reflect the intended contrast in the question. (4) Contextual relevance is perfect—the answer directly addresses the comparison of regulatory constraints and capital implications for both companies. The qualitative analysis is excellent, but the missing $1,245 million figure prevents a top score in correctness and quantitative accuracy. Overall, the answer is semantically close and well-reasoned but lacks one key data point.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 465,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Lowe's share repurchase activity through financial institutions in 2021-2022 compare with Home Depot's use of dividend equivalents in terms of shareholder value distribution mechanisms?",
      "original_answer": "Lowe's authorized $13.0 billion in additional share repurchases in December 2021, bringing total authorization to $28.0 billion since 2020, and executed a $3.0 billion accelerated share repurchase (ASR) with a financial institution, receiving 11.9 million shares. Meanwhile, Home Depot pays dividend equivalents on unvested restricted stock units and performance shares, which accrue and are paid out in the form of additional shares upon vesting or payout. This shows Lowe's prioritized direct share reduction through financial intermediaries, while Home Depot focused on equity-based dividend equivalent compensation aligned with vesting timelines.",
      "llm_answer": "Lowe’s repurchased roughly $13.1 billion of common stock in 2021‑22, including an accelerated share‑repurchase (ASR) with a third‑party financial institution that delivered about 11.9 million shares (10.3 million initially and 1.6 million later).  The ASR and the additional $13 billion of share‑repurchase authorization represent a direct, cash‑based return that immediately reduces shares outstanding and boosts earnings per share.  In contrast, Home Depot’s shareholder‑value mechanism is the use of dividend equivalents that accrue on performance shares and restricted‑stock units; these equivalents are paid in additional shares (or cash) only at vesting or award payout, tying the distribution to performance rather than providing an immediate cash outflow.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in substance and conveys the key differences between Lowe's and Home Depot's shareholder value distribution mechanisms. It correctly identifies Lowe's $13 billion share repurchase authorization and the $3 billion ASR with a financial institution resulting in 11.9 million shares, though it slightly misstates the total repurchase amount as $13.1 billion over 2021–22, which is not directly supported by the ground truth (which emphasizes authorization, not execution, of $13 billion). The ground truth does not specify total repurchases as $13.1B, so this figure lacks direct support—minor overprecision. (2) The quantitative details are mostly accurate: the $13 billion authorization (matches ground truth), 11.9 million shares from ASR (exact match), and breakdown into 10.3M + 1.6M is plausible but not in the original and may be inferred. However, the original does not mention the split of shares delivered, so this is an addition not present in the source. (3) The reasoning is sound: the LLM correctly contrasts Lowe’s direct cash-based share reduction via financial intermediaries with Home Depot’s equity-aligned dividend equivalents on unvested awards, accurately describing the timing and performance linkage. (4) The answer is contextually excellent—directly addresses the comparison of mechanisms, synthesizes across both companies and timeframes, and explains strategic differences. The minor issues are: overstating executed repurchases as $13.1B (vs. authorization of $13B), and adding unverified detail about share delivery timing. These prevent a perfect 10 but do not undermine the core correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 456,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does the adoption of ASU 2022-04 impact the disclosure of supplier finance program obligations for both Caterpillar and Honeywell, particularly in terms of the rollforward requirement effective in 2024?",
      "original_answer": "Caterpillar and Honeywell both adopted ASU 2022-04, which mandates enhanced disclosures for supplier finance programs. The guidance requires annual disclosure of key terms, balance sheet presentation, and a rollforward of obligations, with the rollforward specifically becoming effective on January 1, 2024. Caterpillar included the rollforward in its 2024 disclosures, showing $830 million in obligations at year-end. Honeywell also adopted the rollforward requirement for 2024, aligning with the new standard. Both companies now provide more transparent reporting of their supplier finance obligations, which were $830 million for Caterpillar and would be similarly detailed for Honeywell under the new rules.",
      "llm_answer": "Both companies adopted ASU 2022‑04, which requires annual disclosure of key terms, presentation, and a roll‑forward of supplier‑finance program obligations.  Beginning in 2024 the roll‑forward requirement became effective, and each firm has complied by including a roll‑forward table in its 2024 10‑K (Caterpillar’s table appears in Note 15 on pages 109‑113; Honeywell’s in Note 15 on pages 58‑62), showing the beginning balance, invoices confirmed, invoices paid, and ending balance.  The guidance does not alter recognition or measurement of the obligations, only the transparency of their presentation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both Caterpillar and Honeywell adopted ASU 2022-04, and that the rollforward requirement became effective in 2024, aligning with the ground truth. It accurately notes that the standard enhances disclosure transparency without changing recognition or measurement. The mention of the rollforward tables in Note 15 of both companies’ 10-Ks, including specific page ranges, adds precise contextual detail that matches real filing structures. (2) Quantitatively, while the LLM does not explicitly state Caterpillar’s $830 million ending obligation (mentioned in the ground truth), this omission is minor given that the structure, timing, and compliance with the rollforward requirement are correctly conveyed. The absence of Honeywell’s specific dollar amount is also consistent with the LLM answer’s focus on disclosure practices rather than numerical results, which does not contradict the ground truth. All dates (2024 effective date) and requirements are factually accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes the impact of ASU 2022-04 across two companies and links the new disclosure requirements to specific reporting elements (rollforward tables) in their 2024 filings. It demonstrates understanding of the distinction between disclosure and accounting recognition. (4) The answer is contextually relevant and highly accurate, missing only the explicit mention of Caterpillar’s $830 million figure, which slightly reduces completeness but does not impair the core correctness. Hence, a score of 9 is justified—excellent accuracy with a minor omission in quantitative detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 456,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does the $49,549 million in credit card loans due within 1 year reported by Company C compare to Visa's strategy of driving growth through credit card issuance, given the $20 trillion global opportunity they identify in converting non-card payments to digital credentials?",
      "original_answer": "Company C reports holding $49,549 million in credit card loans due within 1 year, indicating a significant portion of short-term consumer credit exposure. This aligns with Visa's strategic focus on expanding credit card usage to capture a share of the $20 trillion global opportunity in converting non-card payments to digital credentials on their network. Visa's emphasis on growing credit card programs through financial institution partnerships suggests a continued push to increase the volume and velocity of credit card transactions, which would likely feed into larger short-term loan balances across institutions like Company C.",
      "llm_answer": "Company C’s $49.5 billion of credit‑card loans due within one year is a snapshot of its short‑term balance‑sheet exposure.  Visa, by contrast, sees a $20 trillion global opportunity to convert non‑card payments into digital credentials and is pursuing aggressive credit‑card issuance to capture that growth.  Thus, Company C’s exposure is a tiny fraction of the market that Visa is targeting through new card issuance.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies Company C's $49,549 million (rounded to $49.5 billion) in credit card loans due within one year and accurately references Visa's $20 trillion opportunity in converting non-card payments to digital credentials. The quantitative values are correct with acceptable rounding ($49,549 million ≈ $49.5 billion). 2) The numbers are accurate: $49,549 million is properly converted to $49.5 billion (within standard rounding conventions), and the $20 trillion figure is preserved exactly. No calculations are required beyond this representation, and the comparison in scale (tiny fraction) is qualitatively reasonable. 3) The multi-hop reasoning is mostly sound: it connects Company C’s short-term credit exposure to Visa’s broader growth strategy via credit card issuance. However, the LLM answer stops at stating that Company C’s exposure is a 'tiny fraction' of the $20T market, while the original answer adds deeper synthesis—explaining that Visa’s strategy of expanding card issuance through partnerships would increase transaction volume and velocity, thereby contributing to growing short-term loan balances like those at Company C. This causal link is partially missing in the LLM response. 4) Despite the slightly shallower reasoning, the LLM answer remains factually correct, contextually relevant, and conveys a semantically similar conclusion. It correctly interprets the relationship between Visa’s strategy and balance sheet items at financial institutions like Company C. The omission of the mechanism (how Visa’s strategy directly influences loan balances) prevents a top score, but core facts and logic are intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 451,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the impact of weather conditions on Southern Company's gas distribution revenues compare to the exposure of NextEra Energy's electricity demand, considering their respective risk mitigation strategies?",
      "original_answer": "Southern Company Gas' earnings are affected by customer consumption patterns that are largely a function of weather conditions and natural gas price levels. For example, in 2023, Southern Company Gas experienced a 6.2% decrease in net income compared to 2022, partly due to lower gas volumes sold driven by weather patterns. However, the company utilizes mechanisms like weather normalization and weather derivative instruments to limit exposure to typical weather variations. In contrast, NextEra Energy (NEE) faces more direct and severe operational risks from weather conditions, such as hurricanes, extreme temperatures, and disruptions to power generation from wind and solar facilities. NEE's Florida-based operations are particularly vulnerable to hurricanes, which can cause power outages, infrastructure damage, and increased costs for service restoration. While NEE also seeks cost recovery through regulatory mechanisms, its exposure to unpredictable weather events poses a more immediate threat to both operations and financial performance compared to Southern Company Gas' structured risk management approach.",
      "llm_answer": "Southern Company Gas’s gas‑distribution revenues are weather‑sensitive, but the company limits exposure through regulatory weather‑and‑revenue‑normalization mechanisms and weather‑derivative instruments that cap the impact of typical seasonal swings (see pages 84‑88, 198‑202). In contrast, NextEra Energy’s electricity demand is also weather‑driven—especially for heating‑cooling loads and renewable output—but the company relies on a broader set of hedging, trading and risk‑management tools (swaps, options, futures, internal controls and forecasting systems) to mitigate commodity and weather risk, though these measures do not fully eliminate the risk of severe weather events (see pages 24‑28). Thus, Southern’s exposure is largely neutralized by regulatory and derivative safeguards, whereas NextEra’s exposure is managed through financial hedges and operational controls but remains more directly tied to weather‑induced demand and generation variability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of both companies' exposure to weather conditions and their respective risk mitigation strategies, with no incorrect numbers or entities. It correctly identifies that Southern Company Gas uses weather normalization and derivative instruments to manage weather-related revenue volatility, and that NextEra Energy employs financial hedges and operational controls. There are no numeric inaccuracies—though the LLM does not include the specific 6.2% net income decline for Southern Company Gas in 2023 mentioned in the ground truth, this omission does not undermine the overall correctness. The qualitative reasoning is sound: it correctly contrasts Southern’s more structurally insulated model (via regulatory mechanisms) with NextEra’s broader but less protective financial and operational risk management, especially given hurricane exposure in Florida. However, the LLM underemphasizes the severity and operational nature of NextEra’s physical risks (e.g., infrastructure damage, outages) compared to Southern’s primarily revenue-based exposure, which is a key differentiator in the original answer. While the LLM mentions 'severe weather events,' it does not explicitly highlight hurricanes or the geographic concentration of risk in Florida, which weakens the multi-hop synthesis slightly. The answer remains contextually relevant and semantically aligned, with strong reasoning and complete coverage of the core comparison, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 417,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does McDonald's revenue model relying on affiliates compare to General Motors' production strategy for crossovers through nonconsolidated affiliates, particularly in terms of revenue contribution and operational structure?",
      "original_answer": "McDonald's generates revenue from affiliates through royalty payments based on a percentage of sales, along with initial fees, as part of its franchise model. This structure allows McDonald's to maintain a steady income stream tied directly to the performance of affiliate-operated restaurants. In contrast, General Motors produces crossovers through nonconsolidated affiliates involved in development, manufacturing, and marketing, where GM engages in purchasing and selling transactions with these entities. While McDonald's affiliate model centers on brand licensing and royalty income, GM's affiliate relationships focus on vehicle production and distribution. This results in distinct revenue contributions: McDonald's sees recurring revenue from affiliate royalties, whereas GM's revenue from affiliates is transactional and tied to the volume of crossover production and sales.",
      "llm_answer": "McDonald’s revenue is largely generated through its franchise network – the company records rent, royalties and initial fees from conventional franchisees, developmental licensees and other affiliates, which together constitute a major share of its consolidated sales (see MCD pages 44‑48). In contrast, General Motors produces cross‑overs through non‑consolidated affiliates (joint ventures and equity‑owned partners) and sells the finished vehicles to those affiliates, generating only about $90 million of automotive sales revenue in 2024 – a very small fraction of GM’s total sales (GM pages 75‑79, 101‑105). Thus, McDonald’s model relies on affiliates for core revenue and is fully integrated into its consolidated financials, whereas GM’s cross‑over strategy uses separate affiliates for manufacturing and sales, with revenue captured via the equity method and representing a minor portion of its overall revenue.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core contrast between McDonald's franchise-based revenue model and GM's use of nonconsolidated affiliates for crossover production, showing good understanding of operational structure and revenue contribution differences. However, it introduces a specific quantitative claim not present in the ground truth: that GM generated 'about $90 million of automotive sales revenue in 2024' from these affiliates. This figure is not supported by the original answer, which makes no mention of any dollar amount or specific year (e.g., 2024), nor does it state that this revenue is reported under automotive sales. The introduction of this unverified number significantly undermines quantitative accuracy. Additionally, the claim that this amount is 'a very small fraction of GM’s total sales' and that McDonald’s affiliate revenue is 'a major share of its consolidated sales' extends beyond the original answer’s scope, which does not make comparative magnitude statements about overall revenue contribution. While the qualitative distinction—McDonald’s earning recurring royalty-based income versus GM’s transactional, production-focused affiliate model—is correctly identified and well-articulated, the unsupported numerical claim and lack of verification against the ground truth reduce overall correctness. The contextual relevance is high, as the response directly addresses the comparison in revenue model and operational structure. Multi-hop reasoning is partially sound but weakened by the inclusion of fabricated data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 422,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the voting power dilution protection for Class B Common Stock at CMCSA compare with the automatic conversion provisions for Class B Common Stock at GOOGL, particularly in light of CMCSA's share-for-share conversion restriction and GOOGL's voluntary and transfer-triggered conversion policy?",
      "original_answer": "At CMCSA, the Class B Common Stock has a non-dilutable 33 1/3% aggregate voting power, which cannot be diluted by additional issuances of any other class of common stock, and is convertible share-for-share into Class A Common Stock, subject to certain restrictions. In contrast, at GOOGL, Class B Common Stock is entitled to 10 votes per share and can be voluntarily converted to Class A Common Stock at any time, with automatic conversion upon sale or transfer. This means CMCSA’s Class B shares maintain structural voting protection unaffected by issuance volumes, while GOOGL’s Class B shares lose enhanced voting rights upon transfer, making CMCSA's Class B shares more resilient to voting dilution.",
      "llm_answer": "CMCSA’s Class B shares are protected by a 33 ⅓ % voting‑power clause that cannot be diluted by new issuances of other classes, and the shares are convertible on a share‑for‑share basis into Class A only under restricted circumstances—conversion is not automatic on sale or transfer. Alphabet’s Class B shares, by contrast, are automatically converted into Class A shares whenever they are sold or transferred, and holders may also voluntarily convert at any time; this automatic conversion eliminates the need for a separate dilution‑protection provision.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: CMCSA's Class B has non-dilutable 33 1/3% voting power, share-for-share conversion to Class A with restrictions, and no automatic conversion on transfer. GOOGL's Class B has 10 votes per share (implied by context), voluntary conversion, and automatic conversion upon sale/transfer. The answer correctly contrasts CMCSA’s structural voting protection with GOOGL’s transfer-triggered loss of voting rights. (2) Quantitatively, the 33 1/3% figure is accurate and properly formatted (33 ⅓ % = 33 1/3%). No calculations are required, but the comparison of conversion mechanisms is factually sound. (3) The multi-hop reasoning is strong: the model correctly synthesizes voting rights, conversion rules, and their implications across two companies (CMCSA and GOOGL), linking structural protections to dilution resilience. (4) The only minor omission is that the LLM does not explicitly state that GOOGL’s Class B shares lose enhanced voting rights upon conversion (though it is implied by the automatic conversion to Class A). This slightly reduces qualitative completeness but does not undermine the correctness. The answer is fully contextually relevant, directly addressing the comparison of dilution protection and conversion policies as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 377,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does AXP's valuation methodology for Level 3 investment securities expose it to the risks of illiquid market conditions, and how might this impact MS's ability to manage market risk during periods of asset devaluation?",
      "original_answer": "AXP relies on internal credit models and third-party valuations for its Level 3 investment securities, which include debt securities from Community Development Financial Institutions and an embedded derivative in GBT JerseyCo Limited valued using Monte Carlo simulations. These valuation techniques are sensitive to changes in market inputs and assumptions, particularly in illiquid market conditions where observable data is scarce. JPM_10k_2024.pdf confirms that illiquid markets make it extremely difficult to value financial instruments, and valuations may materially change when market conditions shift, leading to potential losses upon disposition. MS_10k_2024.pdf further states that during periods of market volatility and illiquidity, the firm faces challenges in valuing and monetizing financial instruments, which can negatively affect its results of operations and risk management strategies, including hedging inefficiencies and increased counterparty risk.",
      "llm_answer": "AXP’s Level 3 securities are valued with internal credit models and unobservable inputs (e.g., its internal model for community‑development‑institution debt), which can be highly uncertain when markets are illiquid, leading to large valuation swings and potential mispricing.  In a period of asset devaluation, those sharp fair‑value shifts can erode the effectiveness of Morgan Stanley’s hedging and risk‑management framework—particularly for concentrated positions—making it harder for the firm to contain market‑risk losses when liquidity dries up.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and captures the essential multi-hop reasoning required. It correctly identifies AXP's use of internal credit models and unobservable inputs for Level 3 securities, noting the valuation uncertainty in illiquid markets—consistent with the ground truth referencing internal models for Community Development Financial Institutions and Monte Carlo simulations for the GBT JerseyCo Limited derivative. The answer correctly links AXP's valuation methodology to increased valuation volatility during illiquidity, which impacts MS's risk management. It accurately reflects MS_10k_2024.pdf's point about challenges in valuing and hedging during market stress, particularly the erosion of hedging effectiveness and difficulty managing concentrated risks. However, the LLM omits specific details present in the original answer: (1) the mention of third-party valuations as part of AXP's methodology, (2) the specific example of the embedded derivative valued via Monte Carlo, and (3) explicit reference to potential losses upon disposition and counterparty risk escalation. These omissions reduce completeness but do not undermine the central factual or logical accuracy. There are no numerical values to verify, so quantitative accuracy is scored as 10 by default. The reasoning is sound and synthesizes across AXP and MS disclosures appropriately. The answer is highly contextually relevant and semantically aligned with the ground truth, just slightly less detailed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 415,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the valuation approach for Chevron's Level 2 derivatives compare to Exxon's use of discounted cash flow models in valuing upstream assets acquired from Pioneer, particularly in terms of observable market inputs and management judgment?",
      "original_answer": "Chevron classifies its derivatives as Level 2 when valued using third-party broker quotes, industry pricing services, and exchanges, relying on observable market data like interest rates and foreign exchange rates, with minimal adjustments. In contrast, Exxon used discounted cash flow models incorporating management judgment and unobservable inputs—such as projected production volumes, commodity prices based on third-party industry experts, and risk-adjusted discount rates—to determine the fair value of upstream assets acquired from Pioneer. While Chevron's Level 2 derivatives rely on largely consistent and observable inputs, Exxon's valuation required significant assumptions about future market conditions and asset performance, reflecting a higher degree of subjectivity and forward-looking judgment.",
      "llm_answer": "Chevron’s Level 2 derivatives are valued primarily with observable market data—broker quotes, industry pricing services and exchange prices—so the fair‑value calculation is largely driven by market‑observable inputs and the company makes only minimal adjustments. In contrast, Exxon Mobil’s valuation of the upstream assets it acquired from Pioneer relies on discounted‑cash‑flow models that use management‑estimated inputs (future production volumes, commodity prices, drilling and development costs, discount rates), which are not directly observable and require significant judgment. Thus, Chevron’s approach is more market‑based and less judgment‑intensive, whereas Exxon’s approach is judgment‑heavy and less reliant on observable market data.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Chevron's Level 2 derivatives are valued using observable inputs such as broker quotes, industry pricing services, and exchange data, with minimal adjustments—this matches the original answer. Exxon's use of discounted cash flow (DCF) models for valuing upstream assets from Pioneer is correctly described, including reliance on unobservable, management-judgment-driven inputs like projected production, commodity prices, costs, and discount rates. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—both responses are qualitative and consistent. (3) The multi-hop reasoning is sound: the model correctly contrasts Chevron’s market-based, observable-input approach (Level 2 under fair value hierarchy) with Exxon’s forward-looking, judgment-intensive DCF model involving unobservable inputs, demonstrating proper synthesis across two companies, valuation methods, and input types. (4) The only reason for not scoring a perfect 10 is minor: the LLM mentions 'drilling and development costs' as an input, which, while plausible and consistent with industry practice, is not explicitly mentioned in the original answer. However, this addition does not introduce inaccuracy and falls within reasonable inference. Overall, the answer is semantically equivalent, contextually precise, and factually correct, with only slight expansion beyond the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 418,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does Duke Energy's negotiation of PPAs for renewable facilities compare with Southern Power's investment in solar facilities in terms of financial structure and tax credit utilization, given the role of PPAs in financing solar assets?",
      "original_answer": "Duke Energy negotiates PPAs as part of its commercial renewables strategy, which significantly influences the economic performance of its renewable energy VIEs, particularly through siting, PPA negotiation, and ongoing operations. These PPAs are also central to Southern Power's financial structure, where they are accounted for as operating leases with terms up to 25 years for solar facilities. Southern Power utilizes federal tax credits (ITCs and PTCs), with $1.2 billion of unutilized credits at the Southern Company level as of December 31, 2021, largely tied to solar and wind investments. This indicates that while both companies rely on PPAs in the development and operation of solar facilities, Southern Power integrates tax equity partnerships and federal incentives more directly into its investment model, affecting cash flows and net income differently than Duke’s VIE and guarantee-based financing.",
      "llm_answer": "Duke Energy’s renewable projects are structured as VIEs that combine debt financing, tax‑equity arrangements, and PPAs negotiated by the company; the PPAs provide the revenue stream that backs the debt and the VIEs are consolidated, so Duke retains control of the tax‑credit benefits.  Southern Power, by contrast, builds solar assets through tax‑equity partnerships that capture the federal ITCs, while the PPAs are used only to secure the energy‑sale revenue; the tax credits are largely transferred to the equity partner, leaving Southern Power with the operating cash flow but not the full tax‑credit upside.  In both cases PPAs are the key financing lever for solar assets, but Duke’s structure keeps the tax‑credit benefit in‑house, whereas Southern Power outsources it to the tax‑equity partner.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of financial structure and tax credit utilization. (1) It accurately captures that Duke Energy uses PPAs within VIEs, consolidates them, and retains tax credit benefits, while Southern Power relies on tax-equity partnerships where tax credits are transferred to equity partners. This reflects the core distinction in how each company structures its solar investments and utilizes federal incentives. (2) There are no explicit numbers in the LLM answer, but the ground truth mentions $1.2 billion in unutilized tax credits at Southern Company as of December 31, 2021. The LLM omits this specific figure, which is a minor gap in quantitative completeness; however, since the LLM does not introduce any incorrect numbers, its quantitative accuracy remains high. (3) The multi-hop reasoning is sound: the model correctly synthesizes the role of PPAs in financing, differentiates between Duke’s consolidation and retention of tax benefits versus Southern Power’s outsourcing of tax credits via partnerships, and links this to cash flow and income impacts. (4) The answer is contextually relevant and directly addresses the comparison asked. The only shortcoming is the lack of the specific $1.2 billion unutilized credit figure and the reference to Southern Company’s level reporting as of 2021, which slightly reduces completeness and qualitative accuracy. However, the conceptual contrast is well articulated, supporting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 417,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does the concentration of voting power in NKE's Class A Common Stock, which elects three-quarters of the Board of Directors, compare with HD's treatment of voting rights for restricted stock awards in terms of governance influence?",
      "original_answer": "NKE's Class A Common Stockholders elect three-quarters of the Board of Directors, consolidating governance control within a single class of shares. In contrast, HD grants voting rights to recipients of restricted stock awards at the grant date, allowing them to vote on matters even before the restrictions lapse. This indicates that HD distributes voting influence more broadly across equity compensation recipients, while NKE centralizes it among Class A shareholders. Neither company allows Class B or C common stockholders to vote on most matters, but HD’s approach introduces earlier voting participation through restricted shares.",
      "llm_answer": "Nike’s Class A common stock is highly concentrated – holders elect three‑quarters of the board, giving them a dominant governance role (see NKE 10‑K, anti‑takeover provisions, pp. 25‑29).  By contrast, Home Depot’s restricted‑stock awards only grant voting rights to the award recipients (and for restricted‑stock units only after vesting), so voting power is dispersed among many employees and is limited by vesting schedules, resulting in a much less concentrated governance influence (see HD 10‑K, Restricted Stock and Performance Share Awards, pp. 65‑69).",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that NKE's Class A Common Stock elects three-quarters of the board, which matches the ground truth (quantitatively accurate). It also correctly contrasts NKE’s concentrated voting power with HD’s broader distribution of voting rights through restricted stock awards. However, the LLM incorrectly states that HD only grants voting rights after vesting for restricted stock awards, when the ground truth explicitly states that HD grants voting rights at the grant date, even before restrictions lapse. This is a critical factual error in the multi-hop comparison, undermining the qualitative accuracy. The answer misrepresents HD’s governance model by conflating restricted stock awards with restricted stock units (RSUs), which may have different voting rights. While the general direction of the comparison (centralized vs. dispersed influence) is valid, the reasoning is flawed due to incorrect synthesis of HD’s policy. The contextual relevance is high as it addresses governance influence and compares both companies, but the error in HD’s voting rights timing significantly reduces correctness. Semantic equivalence fails on this key point. The citation references appear plausible but do not compensate for the factual inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 353,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does the foreign exchange risk exposure of Netflix's forecasted revenue transactions compare to Disney's VAR model estimates, given both companies' use of financial instruments to hedge against currency fluctuations?",
      "original_answer": "Netflix uses forward contracts to hedge foreign exchange risk on forecasted revenue transactions denominated in non-U.S. dollar currencies, while Disney employs a VAR model that excludes forecasted transactions from its risk estimation. Netflix's foreign currency transactions resulted in a $293 million loss in 2023, indicating volatility in unhedged positions, whereas Disney's VAR estimate for maximum one-day loss decreased to $255 million in 2024 from $284 million in 2023 due to lower interest rate volatility. This suggests that while both companies manage FX risk, Disney's modeled approach excludes certain forecasted exposures that Netflix explicitly hedges.",
      "llm_answer": "Netflix’s 10‑K (Note 7, Derivative Financial Instruments, pp. 46‑48) states that it uses forward contracts to hedge the foreign‑currency risk on forecasted revenue transactions, but the filing does not disclose the dollar amount of that exposure. Disney’s 10‑K (Value at Risk, pp. 58‑61) estimates the currency‑sensitive portion of its portfolio at roughly $40 million at year‑end 2024 (≈ $45 million at year‑end 2023). Thus, while both firms hedge foreign‑currency risk, Disney’s exposure is quantified and relatively modest, whereas Netflix’s forecasted revenue exposure remains undisclosed in the filing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims Disney’s currency-sensitive portion is $40 million in 2024 and $45 million in 2023, which contradicts the ground truth stating Disney’s VAR estimate for maximum one-day loss was $255 million in 2024 (down from $284 million in 2023). These numbers are not equivalent under any interpretation, and the LLM incorrectly characterizes Disney’s VAR as a 'currency-sensitive portion of its portfolio' rather than a one-day loss estimate. Additionally, the LLM states Netflix does not disclose the dollar amount of its exposure, but the ground truth reports a $293 million loss in 2023 from foreign currency transactions—this key quantitative fact is missing. (2) The quantitative inaccuracies are severe: Disney’s VAR values are off by over $200 million, and Netflix’s $293 million loss is entirely omitted. The LLM invents numbers not present in the ground truth (e.g., $40M, $45M), which cannot be justified as formatting variations. (3) The reasoning is partially sound in identifying that Netflix hedges forecasted transactions with forwards and Disney uses a VAR model, but it fails the multi-hop synthesis: it does not compare Netflix’s actual hedging of forecasted revenues to Disney’s exclusion of such transactions in VAR, nor does it incorporate the performance outcomes (losses and VAR trend). Instead, it incorrectly infers Disney has lower exposure based on fabricated numbers. (4) Correctness is low due to major factual and numerical errors. Quantitative accuracy is very poor. Qualitative accuracy is limited—while entities (Netflix, Disney, hedging, VAR) are correctly identified, the reasoning and synthesis are flawed. Contextual relevance is moderate as the answer addresses FX risk and hedging but misrepresents the core data needed for comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 500,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How do the Value at Risk (VAR) calculations for MDLZ and PM differ in terms of the time periods used to estimate expected return distributions under normal market conditions, and what does this imply about their respective risk assessment horizons?",
      "original_answer": "MDLZ uses the prior quarter's interest rate, currency exchange, and commodity price movements to estimate return distributions for VAR calculations at year-end (December 31, 2024 and 2023), and the four prior quarters for average VAR amounts. In contrast, PM primarily uses the preceding quarter for year-end VAR calculations and the four preceding quarters for average, high, and low VAR amounts. This indicates that while both companies rely on recent market data, MDLZ explicitly applies a multi-quarter approach for average VAR, suggesting a slightly more extended risk assessment horizon compared to PM.",
      "llm_answer": "MDLZ’s VAR model uses market‑movement data from the **prior quarter** to estimate the expected return distribution for the one‑day VAR at December 31 2024 and 2023, and a rolling **four‑quarter window** for the average VAR over the year. PMI applies the same one‑quarter window for its December 31 VAR and a rolling four‑quarter window for its average, high, and low VAR figures. Thus, both firms rely on a short‑term, one‑day risk horizon based on recent data, with PMI’s additional high/low metrics giving a slightly broader view of extreme risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both MDLZ and PM use the prior quarter for year-end VAR calculations and a four-quarter window for average VAR, which aligns with the ground truth. The mention of PM using the four-quarter window for average, high, and low VAR amounts is accurate and adds detail consistent with the original answer. However, the LLM implies that PM's use of high/low metrics gives it a 'slightly broader view of extreme risk,' which is not present in the ground truth and introduces an interpretive claim not supported by the source. The ground truth emphasizes that MDLZ has a 'slightly more extended risk assessment horizon' due to its explicit multi-quarter approach for average VAR, a nuance that is downplayed in the LLM answer. (2) All numbers, time periods (prior quarter, four-quarter window), and dates (December 31, 2024 and 2023) are factually correct and match the original. (3) The multi-hop reasoning is mostly sound—correctly comparing the time periods used by both companies—but the conclusion about PM having a broader risk view misaligns with the original implication that MDLZ has a longer horizon. (4) Scores reflect high factual accuracy and relevance, with a minor deduction in qualitative accuracy due to the misleading interpretation about PM’s risk assessment breadth, and a slight impact on overall correctness despite strong quantitative fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 392,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How does the $0.6 billion goodwill impairment charge recorded by DIS in fiscal 2024 relate to the auditor's evaluation of significant assumptions, and how does this compare to the auditor's approach in testing significant assumptions at NFLX related to content amortization estimates?",
      "original_answer": "The $0.6 billion goodwill impairment charge recorded by DIS in fiscal 2024 was directly tied to the fair value assessment of the entertainment linear networks reporting unit, which relied on significant assumptions such as future revenues, operating margins, terminal growth rates, and discount rates. The auditor, PricewaterhouseCoopers LLP, evaluated the reasonableness of these assumptions by comparing them to historical performance, external market data, and evidence obtained elsewhere in the audit. Similarly, at NFLX, the auditor (also PricewaterhouseCoopers LLP) tested significant assumptions used in content amortization estimates, including forecasted viewing hour consumption and historical viewing patterns, by comparing them to current trends and prior actual results. Both audits involved sensitivity analyses and the use of professionals with specialized skills to assess the impact of changes in these assumptions on financial outcomes.",
      "llm_answer": "Disney’s $0.6 billion goodwill impairment was the result of management’s quantitative fair‑value assessment of the entertainment‑linear‑networks unit; the auditor evaluated the significant assumptions in the discounted‑cash‑flow model—future revenues, operating expenses, margins, terminal growth and discount rates—testing their reasonableness, controls, and employing specialists. In contrast, Netflix’s auditor focused on the assumptions underlying its content‑amortization model—historical and forecasted viewing‑hour consumption—by comparing them to actual viewing data, performing sensitivity analyses, and testing controls over the amortization method and data accuracy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the $0.6 billion goodwill impairment charge for DIS in fiscal 2024 is correctly stated. No other numerical values are present, and all are accurate. (2) The entities—DIS, NFLX, goodwill impairment, content amortization, and the relevant assumptions—are correctly identified. The fiscal year is implied as 2024 through context, which aligns with the original answer. (3) The multi-hop reasoning is sound: the answer correctly links DIS’s impairment to the fair value assessment of the entertainment linear networks unit and identifies the key assumptions (revenues, margins, terminal growth, discount rates). It accurately states that the auditor tested these using reasonableness checks, controls, and specialists. For NFLX, it correctly identifies that the auditor tested assumptions around viewing-hour consumption by comparing to actual data, performing sensitivity analyses, and testing controls. (4) Minor omission: the original answer notes that both audits used comparisons to historical performance, external market data, and evidence from elsewhere in the audit—this broader evidentiary basis is slightly underemphasized in the LLM version, which focuses more on controls and data accuracy. Also, the LLM says 'in contrast' which slightly overemphasizes difference, whereas the original highlights similarity in approach (both used sensitivity analysis, specialists). However, this does not distort the facts. Overall, the answer is semantically equivalent with high completeness and precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 440,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How does the cost-sharing structure between Gilead and Merck for long-acting HIV injectable products compare to Gilead's other collaboration agreements, such as the one with Arcellx, in terms of financial commitment and milestone-based payments?",
      "original_answer": "Gilead and Merck share global development and commercialization costs for long-acting HIV injectable products at 60% and 40%, respectively, with no material expenses recognized under the agreement through 2024. This contrasts with Gilead's collaboration with Arcellx, where Gilead made a $313 million upfront payment and a $299 million equity investment in 2023, and paid $68 million in development milestones in 2024. Unlike the Merck agreement, which involves shared costs and revenue splits upon approval, the Arcellx collaboration includes significant upfront and milestone-based payments, profit sharing in the U.S., and royalties outside the U.S., indicating a more financially committed and risk-shared structure with Arcellx compared to the cost-sharing model with Merck.",
      "llm_answer": "The Merck collaboration is structured as a 60/40 cost‑share of global development and commercialization expenses, with Gilead and Merck sharing revenues equally until sales hit $2 B (oral) or $3.5 B (injectable), after which Gilead’s share rises to 65 % (Merck 10‑K, p. 72‑73).  It contains no milestone‑payment provisions—only cost‑sharing and revenue‑sharing terms (p. 73).  In contrast, the Arcellx deal requires upfront payments of $313 M, an equity investment of $299 M, and up to $1.5 B in performance‑based development and regulatory milestones (plus profit‑split and royalty provisions), with $68 M already paid for milestones met in 2024 (p. 75‑76).  Thus, Arcellx represents a larger financial commitment and a milestone‑payment structure that Merck’s partnership lacks.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 60/40 cost-sharing structure between Gilead and Merck and the $313M upfront and $299M equity investment with Arcellx, as well as the $68M milestone payment in 2024. However, it introduces revenue-sharing terms (equal split until $2B/$3.5B thresholds, then 65% to Gilead) that are not present in the original answer or ground truth, which only states that Merck and Gilead share costs at 60/40 with no material expenses recognized through 2024 and implies revenue split upon approval without specifying thresholds or changing percentages. This is a significant factual overstatement. Additionally, the LLM claims up to $1.5B in potential milestones for Arcellx, which is not in the original answer and lacks corroboration in the provided truth. (2) Quantitative accuracy is partially compromised: while $313M, $299M, and $68M are correct, the $1.5B potential milestones and revenue thresholds ($2B, $3.5B) are unsupported by the ground truth. The original answer does not mention these figures, making them hallucinated. (3) Multi-hop reasoning is generally sound—comparing cost-sharing vs. milestone-heavy structures—but the inclusion of unverified financial terms undermines the logic. The core contrast (cost-sharing with Merck vs. upfront/milestone payments with Arcellx) is valid and well-synthesized. (4) Scores reflect mostly correct entity identification and structure comparison, but the addition of unsupported financial terms reduces quantitative and overall correctness. Contextual relevance is perfect—the answer directly addresses the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 444,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How do Tesla's multi-year pricing agreements with Panasonic for Gigafactory 2170 and Japan-sourced battery cells compare to GM's battery procurement cost exposure in terms of contractual stability and long-term cost predictability?",
      "original_answer": "Tesla has structured long-term pricing agreements with Panasonic Corporation for both Gigafactory 2170 cells (executed June 9, 2020) and Japan-sourced cells (executed December 29, 2020), providing multi-year cost predictability. In contrast, GM's 2023 10-K filing on page 78 indicates a dependency on battery procurement costs without equivalent visibility into long-term pricing agreements, suggesting greater exposure to market volatility. This creates a differentiated risk profile where Tesla has locked in pricing through 2020+ agreements while GM's battery cost structure appears more variable.",
      "llm_answer": "Tesla’s 2023 10‑K (pp. 104‑109) notes that the company entered into multi‑year pricing agreements with Panasonic for both Gigafactory 2170 cells and Japan‑sourced cells, locking in pricing formulas and supply for several years and thus providing strong contractual stability and long‑term cost predictability. In contrast, GM’s 10‑K (pp. 76‑80) indicates that its battery procurement cost exposure is more variable, lacking comparable long‑term contracts and leaving costs subject to market price fluctuations, which reduces contractual stability and predictability.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies Tesla's multi-year pricing agreements with Panasonic for both Gigafactory 2170 and Japan-sourced cells, noting strong contractual stability and cost predictability. It accurately contrasts this with GM's lack of equivalent long-term contracts, citing variable procurement costs and exposure to market fluctuations. (2) Quantitatively, the LLM does not include the specific execution dates (June 9, 2020, and December 29, 2020) mentioned in the ground truth, which is a minor omission but does not affect the overall correctness of the conclusion. The page numbers cited (pp. 104–109 for Tesla, pp. 76–80 for GM) are close to the ground truth (p. 78 for GM) and plausible within the document structure, though not exact. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across Tesla’s and GM’s 10-K filings to compare contractual stability and cost predictability, drawing a valid contrast in risk profiles. (4) The answer is semantically equivalent to the original, with slightly different phrasing but no factual errors. The minor lack of specific agreement dates prevents a perfect score, but all key entities, logic, and conclusions are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 361,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does Coca-Cola's use of non-derivative instruments to hedge foreign exchange risk compare to Procter & Gamble's exposure to foreign exchange fluctuations, given that both operate in similar international markets such as the United Kingdom and Germany?",
      "original_answer": "Coca-Cola actively uses non-derivative instruments, such as foreign currency-denominated third-party debt, to hedge foreign exchange risk related to its net investments in foreign subsidiaries, with these instruments designated in hedging relationships to offset currency exposure. In contrast, Procter & Gamble discloses that it is significantly exposed to foreign exchange fluctuations due to its international operations — particularly in the United Kingdom and Germany, which are among its largest markets — and while it employs strategies to manage these risks, it explicitly acknowledges that exchange rate movements have historically negatively impacted its net sales, earnings, and cash flows. Therefore, while Coca-Cola appears to have a more structured hedging approach, Procter & Gamble reports a more direct and material financial sensitivity to FX volatility.",
      "llm_answer": "Coca‑Cola mitigates FX risk by using non‑derivative instruments—specifically foreign‑currency‑denominated senior notes that act as net‑investment hedges, with gains or losses recorded in AOCI until the investment is sold (pages 79‑83). Procter & Gamble, on the other hand, reports significant translation and transaction exposure to foreign‑exchange fluctuations that have materially affected its net sales, earnings and cash flows, but the filing does not describe a comparable use of non‑derivative hedges (pages 19‑23). Consequently, Coca‑Cola’s strategy actively offsets FX volatility, whereas P&G’s exposure remains largely unhedged, leaving it more vulnerable to currency swings in markets such as the United Kingdom and Germany.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Coca-Cola uses non-derivative instruments—specifically foreign-currency-denominated senior notes—as net investment hedges, with gains/losses recorded in AOCI, which matches the original answer's description of hedging foreign exchange risk via third-party debt. (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; all references to financial mechanisms are factually consistent. (3) The multi-hop reasoning is sound: it synthesizes information about both companies’ FX risk management strategies from their respective filings, correctly contrasting Coca-Cola’s structured hedging approach with Procter & Gamble’s lack of comparable non-derivative hedging despite significant exposure in the UK and Germany. (4) The LLM accurately captures the core conclusion: Coca-Cola actively offsets FX volatility through designated hedges, while P&G remains more exposed and vulnerable, which is semantically equivalent to the original answer’s claim that P&G reports material financial sensitivity to FX movements. The only minor limitation is that the LLM slightly strengthens the contrast by stating P&G’s exposure is 'largely unhedged,' whereas the original acknowledges P&G uses risk management strategies (though not necessarily non-derivative instruments), leaving room for some hedging activity. This nuance is downplayed but not entirely misrepresented, warranting a high but not perfect qualitative score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 436,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does Amgen's exposure to state-level drug affordability regulations in Maryland, through PDAB laws, compare to Gilead's operational risks in the same state, particularly in relation to their respective biopharma manufacturing and pricing strategies?",
      "original_answer": "Amgen is subject to Maryland’s PDAB laws that grant authority to set upper payment limits on certain drugs for in-state patients, payers, and providers, which affects its pricing strategy and rebate obligations under Medicaid and the 340B Drug Pricing Program. These laws are part of a broader regulatory framework that includes the Inflation Reduction Act’s Medicare price-setting provisions, which began with ENBREL being selected among the first ten drugs for Medicare price negotiation. Meanwhile, Gilead operates a CAR T-cell therapy manufacturing facility in Maryland, exposing it to operational risks such as quality control, production delays, and regulatory compliance. Unlike Amgen, whose primary risk in Maryland is regulatory and pricing-related, Gilead faces logistical and manufacturing risks tied to the complexity of cell therapy production and delivery. Both companies are impacted by Maryland’s healthcare ecosystem, but through different risk vectors—Amgen through pricing regulation and Gilead through manufacturing execution.",
      "llm_answer": "Amgen’s 2023 10‑K states that Maryland’s Prescription Drug Affordability Board (PDAB) can set upper payment limits on certain drugs, meaning Amgen’s pricing for those biologics could be capped by state‑level regulation.  By contrast, Gilead’s 2023 10‑K notes that its in‑house CAR‑T manufacturing sites in Maryland carry operational risks—such as supply disruptions or quality issues—that could indirectly affect product availability and pricing, but are not subject to the same PDAB‑style price caps.  Thus, Amgen faces a direct regulatory pricing constraint in Maryland, while Gilead’s risk is primarily manufacturing‑related, with pricing implications arising from potential supply disruptions rather than state‑mandated price limits.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Amgen is subject to Maryland’s PDAB laws, which can set upper payment limits on certain drugs, affecting its pricing strategy—this matches the original answer’s emphasis on regulatory and pricing-related risks. It also accurately notes that Gilead operates CAR T-cell manufacturing in Maryland, facing operational risks like supply disruptions and quality issues, which is consistent with the ground truth’s focus on manufacturing execution risks. (2) There are no numeric values, dates, or financial figures in dispute; both the LLM and original answers reference 2023 10-Ks, which is factually plausible and contextually appropriate. No calculations are required, so quantitative accuracy is fully preserved. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Amgen and Gilead), two types of risk (pricing regulation vs. manufacturing), and two strategic exposures within the same state. The only minor gap is that the LLM answer does not mention ENBREL being selected for Medicare price negotiation under the Inflation Reduction Act—a detail included in the original answer that adds context to Amgen’s broader pricing risk. While this omission slightly weakens completeness, it does not undermine the core correctness. (4) The answer is semantically equivalent in meaning, uses appropriate terminology (e.g., 'direct regulatory pricing constraint' vs. 'pricing regulation'), and maintains high contextual relevance by directly comparing the two companies’ risk profiles in Maryland. Overall, the response is factually correct, well-reasoned, and focused.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 466,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does AIG's use of separate accounts for policyholder-directed investments compare to MET's utilization of investment management firms in managing ERISA plan assets, particularly in terms of asset diversification strategies and risk mitigation through sub-advisory discretion?",
      "original_answer": "AIG discloses that its separate accounts are legally segregated funds where investment gains and losses accrue directly to policyholders who bear the investment risk, with assets primarily including fixed maturity securities, equity securities, and derivatives. MET utilizes separate accounts backed by similar asset classes (cash, fixed maturities, equities, derivatives, real estate, and private equity) for its ERISA pension and postretirement plans, engaging investment management firms with discretionary authority to manage these assets. Both companies emphasize diversification across asset categories and multiple managers to minimize risk concentration, with MET explicitly stating that its investment policies aim to maximize funded status and minimize volatility, aligning with the long-term nature of benefit obligations. The use of derivatives is restricted to risk mitigation and duration management in both contexts.",
      "llm_answer": "AIG’s separate accounts (p. 193‑197) are segregated, policy‑holder‑directed vehicles that carry investment risk directly to the policyholder and are valued at fair value; the filing does not describe a multi‑manager or sub‑advisor structure for diversification.  In contrast, MetLife’s ERISA plan assets (p. 302‑306) are managed through a network of investment‑management firms that act as sub‑advisors with portfolio‑management discretion, and the plan’s assets are deliberately diversified across multiple asset classes and managers to reduce concentration risk.  Thus, AIG relies on segregation and direct policy‑holder exposure, whereas MetLife mitigates risk by diversifying across managers and leveraging sub‑advisor discretion.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and reasoning. (1) It accurately captures the key distinction between AIG's policyholder-directed separate accounts, where risk is borne by policyholders and assets are segregated, and MET's use of discretionary investment management firms (sub-advisors) for ERISA plan assets. The characterization of MET’s strategy—using multiple managers with discretion to diversify and reduce concentration risk—is factually consistent with the original answer. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable in a traditional sense, but all descriptive financial terms (e.g., fair value, asset classes) are used appropriately—hence a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies and contexts (AIG’s separate accounts vs. MET’s ERISA asset management), identifying differences in risk allocation and diversification mechanisms. However, the LLM answer omits some key details present in the ground truth: specifically, it does not mention that both companies use similar underlying asset classes (fixed maturities, equities, derivatives, etc.), nor does it note that both restrict derivatives to risk mitigation and duration management. Additionally, the ground truth highlights that MET’s investment policy explicitly aims to maximize funded status and minimize volatility—context that strengthens the risk mitigation rationale and is missing in the LLM response. (4) Despite these omissions, the core comparison is accurate and relevant, with appropriate focus on sub-advisory discretion and diversification. The answer is concise and directly addresses the comparative aspect of the question, warranting high scores for contextual relevance and qualitative accuracy. The correctness score is 8 due to these minor but meaningful omissions that affect completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 531,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How might the structural differences in voting rights between NKE's Class B Common Stock, which grants no voting rights except on certain defined matters, and HD's restricted stock awards, which grant voting rights from the grant date, impact investor influence on corporate governance decisions such as board composition or takeover defenses?",
      "original_answer": "NKE's Class B Common Stockholders have limited voting rights, only participating on certain defined matters such as exiting the core payments business or major corporate transactions, and do not influence the election of the Board of Directors, which is controlled by Class A Common Stockholders. In contrast, HD's restricted stock recipients are granted voting rights immediately upon grant, allowing them to influence governance matters throughout the vesting period. This structural difference means that NKE's Class B investors have significantly less influence over corporate governance, including board composition and takeover defenses, compared to HD shareholders who hold restricted stock and can exercise voting rights from the outset.",
      "llm_answer": "Nike’s Class B common stock carries no voting rights except on a narrow set of defined matters, so holders of those shares have limited influence over board elections or takeover‑defense decisions (NKE_10k_2023, pp. 25‑29). In contrast, Home Depot’s restricted‑stock awards grant voting rights from the grant date, giving award recipients immediate voting power on all corporate‑governance matters—including board composition and takeover defenses (HD_10k_2023, pp. 65‑69). Consequently, investors holding Nike’s Class B shares are largely passive in governance, whereas Home Depot restricted‑stock holders can actively shape board decisions and defend against hostile takeovers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: NKE Class B shareholders have no voting rights except on defined matters and cannot influence board elections; HD restricted stock recipients have immediate voting rights from grant date. These points align with the original answer. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance implications across two companies (NKE and HD), contrasting their share structures and their effects on investor influence over board composition and takeover defenses. (4) The LLM slightly simplifies the explanation by not explicitly mentioning that HD's voting rights apply 'throughout the vesting period,' but it correctly states that voting rights are granted from the grant date, which implies ongoing participation. This minor omission does not detract from the overall correctness. Wording differs but meaning is preserved. Contextual relevance is perfect—the response directly addresses the impact of structural differences on investor influence as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 346,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the voting structure for Class B common stock at META compare to NFLX's general voting rights framework, considering the specific limitations outlined in the voting rights policies of both companies?",
      "original_answer": "NFLX provides one vote per share to all common stockholders on all matters, while META restricts voting rights for Class B common stockholders to specific defined matters such as amendments to the certificate of incorporation affecting Class B or C stock, decisions to exit the core payments business, or certain consolidation or merger transactions. In these limited cases, Class B stockholders vote together either as a single class or alongside Class A stockholders, but they do not have voting rights on all matters like NFLX's common stockholders.",
      "llm_answer": "Netflix’s common stock is fully voting, giving each share one vote on all matters with no restrictions (NFLX 10‑K, pp. 59‑63). In contrast, Meta’s Class B common stock is largely non‑voting; it may vote only on a few defined matters—such as exit of the core payments business, mergers or amendments affecting B or C common stock—and votes are cast as a single class with a number of votes equal to the shares held times the conversion rate (META 10‑K, pp. 55‑59). Thus, Netflix offers unrestricted voting rights, whereas Meta’s Class B shares have heavily restricted voting authority.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that NFLX provides one vote per share on all matters with no restrictions, while META's Class B common stock has limited voting rights only on specific matters such as exit from the core payments business, mergers, or amendments affecting Class B or C stock. This matches the original answer's key point about the restricted nature of META’s Class B voting rights versus the unrestricted rights at NFLX. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in the traditional sense—but all descriptive metrics (e.g., 'one vote per share') are correctly stated. (3) The multi-hop reasoning is sound: the model correctly synthesizes voting structures from two different companies (META and NFLX) using their respective 10-K disclosures and draws a valid comparison. (4) The only minor shortcoming is that the LLM answer does not explicitly mention that in certain cases, Class B stockholders at META vote together with Class A stockholders, which adds a nuance to the voting mechanics. However, stating that votes are cast 'as a single class with a number of votes equal to the shares held times the conversion rate' captures part of this mechanism, though slightly less clearly than the original. Overall, the answer is factually correct, contextually relevant, and semantically equivalent with only minor omissions in detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 416,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the use of the parametric delta-gamma approximation technique under normal market conditions by PM compare to MDLZ's application of the same method in their VAR model for estimating potential one-day losses in pre-tax earnings?",
      "original_answer": "PM uses the parametric delta-gamma approximation technique under normal market conditions to estimate the risk of underlying positions in its portfolio, observing interest rate and forward currency rate movements primarily over the preceding quarter for determining value at risk (VAR) at year-end. Similarly, MDLZ applies the same technique to estimate the expected return distribution in interest rates, currencies, and commodity prices for calculating VAR, also observing movements over the prior quarter for year-end calculations. Both companies estimate potential one-day losses using a 95% confidence interval and a one-day holding period, with MDLZ specifically reporting the estimated potential one-day loss in pre-tax earnings from currency and commodity instruments as part of its VAR computation.",
      "llm_answer": "PM uses the parametric delta‑gamma approximation under normal market conditions to compute a one‑day value‑at‑risk of its interest‑rate‑ and foreign‑currency‑sensitive derivatives, focusing on fair‑value loss (PM, pp. 79‑83).  Mondelēz applies the same technique in its VAR model to estimate both the one‑day fair‑value loss of interest‑rate‑sensitive instruments and the one‑day pre‑tax earnings loss of its currency‑ and commodity‑price‑sensitive derivatives, with separate risk portfolios and parameters derived from prior‑quarter movements (MDLZ, pp. 62‑66).  Both use a 95 % confidence interval and a one‑day holding period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: both PM and MDLZ use the parametric delta-gamma approximation under normal market conditions, rely on prior-quarter movements for VAR estimation, and apply a 95% confidence interval with a one-day holding period. The focus on pre-tax earnings loss for MDLZ’s currency and commodity instruments is correctly noted, as is PM’s focus on fair-value loss. (2) Quantitatively, all metrics—95% confidence level, one-day holding period—are accurately reported with no calculation issues. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both firms use the same technique, same time window (prior quarter), and same confidence/horizon, while distinguishing the scope of exposure (PM: interest rates and FX; MDLZ: interest rates, currencies, commodities, with pre-tax earnings impact explicitly mentioned). (4) The only minor omission is that the original answer notes MDLZ specifically reports the 'estimated potential one-day loss in pre-tax earnings' as part of VAR, which the LLM implies but could state more explicitly. However, the LLM does state MDLZ estimates 'one-day pre-tax earnings loss,' which captures the essential point. Wording differs slightly but semantic equivalence is maintained. No entity errors—PM and MDLZ correctly identified with accurate metric mappings.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 392,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the application of the 2.5% Capital Conservation Buffer for Bank of America under the Advanced Approach compare with American Express's reliance on the Stress Capital Buffer under the Standardized Approach for meeting Basel III regulatory requirements?",
      "original_answer": "Bank of America applies a 2.5% Capital Conservation Buffer under the Advanced Approach as part of its CET1 capital regulatory minimum to meet Basel III requirements, while American Express uses the Stress Capital Buffer under the Standardized Approach, which is also a component of its Basel III compliance framework. The two institutions thus rely on different buffer mechanisms depending on their regulatory frameworks, with BAC using the Capital Conservation Buffer and AXP referencing the Stress Capital Buffer as part of their respective capital adequacy strategies.",
      "llm_answer": "Bank of America’s Advanced Approach requires a 2.5 % capital‑conservation buffer that is added to the 4.5 % CET1 minimum and the 2.5 % G‑SIB surcharge, creating a CET1 regulatory minimum of 9.5 % (BAC_10k_2023, pp. 146‑147). American Express, using the Standardized Approach, relies on a 2.5 % stress‑capital buffer (3.4 % in 2022) that is added to the same 4.5 % CET1 minimum and 2.5 % G‑SIB surcharge, also yielding a CET1 minimum of 9.5 % in 2023 (AXP_10k_2023, pp. 133‑137). Thus, both banks use a 2.5 % buffer to meet Basel III, but Bank of America applies it as a capital‑conservation buffer under the Advanced Approach, while American Express applies it as a stress‑capital buffer under the Standardized Approach, with the latter potentially higher during stressed periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and provides a detailed, correct comparison between Bank of America and American Express regarding their respective buffer mechanisms under Basel III. (1) Quantitatively, all percentages are correct: the 2.5% Capital Conservation Buffer for BAC and the 2.5% Stress Capital Buffer for AXP in 2023 (with the note that it was 3.4% in 2022) match the expected data. The calculation of the 9.5% CET1 minimum (4.5% base + 2.5% G-SIB surcharge + 2.5% buffer) is accurate for both banks and aligns with regulatory frameworks. (2) The answer correctly identifies the entities (Bank of America/BAC and American Express/AXP), their respective regulatory approaches (Advanced vs. Standardized), and the correct buffers applied. (3) The multi-hop reasoning is sound: it synthesizes information across two companies, their distinct regulatory methodologies, and correctly explains how different buffers serve similar purposes in capital adequacy. (4) The LLM adds contextual value by noting that the Stress Capital Buffer can be higher during stressed periods, which is consistent with regulatory design, even if not in the original answer. This is a reasonable inference and does not contradict the ground truth. The only reason for not scoring a 10 is that the original answer emphasizes the structural difference in buffer types as part of compliance frameworks, while the LLM focuses more on numerical equivalence; however, the core factual and conceptual content is preserved with high fidelity. Semantic equivalence is maintained with enhanced detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 430,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does LMT's use of a discounted cash flow approach in valuing certain fixed income investments compare with HON's application of the same methodology in testing goodwill and intangible asset impairments, particularly in terms of the significance and sensitivity of the discount rate assumptions used?",
      "original_answer": "LMT applies the discounted cash flow approach to value certain Level 3 fixed income investments, where significant inputs include projected annuity payments and the discount rate applied to those payments. This valuation method introduces sensitivity due to the reliance on unobservable inputs. Similarly, HON uses a discounted cash flow approach to estimate the fair value of goodwill and indefinite-lived intangible assets during impairment testing, incorporating strategic and annual operating plans with terminal value assumptions. HON also acknowledges the sensitivity of these valuations to changes in assumptions, particularly the discount rate, and performs sensitivity analyses to address uncertainty. Both companies rely on the discounted cash flow method with key assumptions around discount rates, making the valuation outcomes at both firms sensitive to changes in these inputs, though applied in different asset contexts—fixed income investments at LMT and intangible assets at HON.",
      "llm_answer": "Lockheed Martin applies a discounted‑cash‑flow (DCF) model to value Level‑3 fixed‑income holdings, noting that the discount rate is a significant input but the company does not disclose a sensitivity analysis for those valuations (LMT, p. 87‑88). Honeywell uses the same DCF approach for goodwill and indefinite‑life intangible impairment testing, explicitly stating that the discount rate is a key assumption and that management performs sensitivity analyses to gauge how changes in the rate affect fair‑value estimates and potential impairments (HON, p. 44‑45). Thus, while both firms rely on discount rates in DCF valuations, Honeywell’s disclosures include a formal sensitivity assessment, whereas Lockheed Martin’s do not.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth, with only a minor omission affecting completeness. (1) All entities—LMT and HON—are correctly identified, and the contexts of DCF application (Level 3 fixed income investments for LMT, goodwill and intangible asset impairments for HON) are accurately described. The key point about the discount rate being a significant and sensitive assumption in both cases is correctly conveyed. (2) There are no numeric values (e.g., percentages, dollar amounts, years) in either the original or LLM answer, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies use DCF with sensitivity to discount rates, but differ in disclosure practices around sensitivity analysis. The LLM adds a specific detail—absence of sensitivity analysis in LMT disclosures (p. 87–88) versus explicit inclusion in HON (p. 44–45)—that enhances precision beyond the ground truth, suggesting strong document grounding. (4) The only reason for not scoring a 10 is that the original answer emphasizes the shared sensitivity of valuations to discount rate assumptions at both firms, while the LLM focuses more on disclosure differences. This shifts emphasis slightly but does not misrepresent facts. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 394,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA influence the potential impact of share repurchases on voting control, given Alphabet's dual-class share structure where Class B shares convert to Class A with voting dilution?",
      "original_answer": "At CMCSA, holders of Class B common stock maintain a non-dilutable 33 1/3% of the voting power, with each Class B share entitled to 15 votes, whereas voting rights for Class A shares fluctuate based on the number of shares outstanding. This contrasts with Alphabet (GOOGL), where Class B shares convert to Class A shares with a 10:1 voting dilution, and repurchases of Class A and Class C shares totaled $62.0 billion in 2024. Since CMCSA’s Class B shares are convertible share-for-share into Class A stock, but retain a fixed voting percentage, repurchases of Class A shares could increase the relative voting power of Class B holders, unlike Alphabet’s structure where repurchases of Class A and C shares do not create a similar fixed voting skew due to the dilutive conversion mechanism.",
      "llm_answer": "CM CSA’s Class B shares carry 15 votes each and together represent about one‑third of the company’s voting power, a proportion that is protected from dilution (see CM CSA Note on voting power, pp. 65‑69).  Because the Class B voting share is fixed, buying back Class B shares simply removes high‑vote shares and reduces the total voting power available, but the relative control of the remaining Class B holders stays roughly unchanged.  In contrast, Alphabet’s Class B shares have 10 votes each and automatically convert to one‑vote Class A shares on sale or transfer (Alphabet Note, pp. 80‑84), so repurchasing Class B shares both eliminates high‑vote shares and increases the proportion of low‑vote shares, diluting the voting influence of the remaining shareholders.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but also significant inaccuracies in reasoning and entity comparison, leading to a partially correct response. (1) Quantitatively, the statement that CMCSA Class B shares carry 15 votes and represent one-third of voting power is correct (matches ground truth: '33 1/3%' and '15 votes'). However, the LLM incorrectly implies that Class B share repurchases are relevant to the analysis — the original answer and context indicate that repurchases of Class A shares (not Class B) are what increase Class B's relative voting power. The LLM instead focuses on repurchasing Class B shares, which misrepresents the mechanism. (2) Regarding Alphabet, the LLM correctly notes that Class B shares convert to Class A upon sale/transfer with 10:1 dilution (i.e., loss of super-voting rights), but it fails to mention the $62.0 billion in 2024 repurchases of Class A and C shares — a key quantitative fact in the ground truth. This omission affects completeness and quantitative accuracy. (3) The reasoning is flawed in the comparison: the LLM suggests that repurchasing Class B shares at Alphabet dilutes remaining shareholders, but the ground truth emphasizes that repurchases of Class A and C shares do not create a fixed voting skew due to the conversion mechanism — the real contrast is how CMCSA’s fixed 33 1/3% voting floor for Class B creates structural insulation, while Alphabet lacks such a cap. The LLM misidentifies the causal mechanism. (4) Entity accuracy is mostly correct (CMCSA and Alphabet correctly identified, share classes and voting rights generally accurate), but the reasoning fails to capture the multi-hop insight: CMCSA’s fixed voting percentage means Class A repurchases amplify Class B’s relative control, whereas Alphabet’s repurchase of low-vote shares doesn’t similarly entrench Class B due to convertibility and lack of fixed share. (5) Contextual relevance is high — the answer addresses voting structures and repurchase effects — but the incorrect focus on repurchasing high-vote shares undermines the qualitative accuracy. Overall, core facts are partially right, but synthesis and logic are significantly flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 582,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does TGT's beverage sales mix compare to PEP's beverage revenue contribution in the APAC region, given both companies' exposure to this market?",
      "original_answer": "TGT includes beverages as part of its grocery segment, which is a key category within its retail operations. PEP, on the other hand, reports that beverages contribute 23% of its revenue in the APAC region. Additionally, PEP's APAC segment generated $10 million in reported revenue for 2024. This indicates that while both companies operate in the beverages category in APAC, PEP provides a specific quantification of its beverage exposure in the region, whereas TGT does not break down beverage sales separately from its broader grocery offering.",
      "llm_answer": "Target’s beverage sales make up 23 % of its net revenue in the APAC region, while PepsiCo’s beverage revenue represents 23 % of its APAC net revenue.  Thus, the two companies have an almost identical beverage mix in that market.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect. It claims that Target's beverage sales make up 23% of its net revenue in the APAC region, which is false according to the ground truth. The original answer states that TGT does not break down beverage sales separately from its broader grocery segment, so no such percentage exists in the data. The only correct quantitative point is that PEP's beverage revenue contributes 23% in the APAC region. (2) The LLM incorrectly attributes the 23% beverage mix to TGT in APAC, which is not supported by any data in the original answer. Additionally, it fails to mention that PEP's APAC segment generated $10 million in revenue in 2024, omitting a key factual anchor. The comparison of 'identical beverage mix' is therefore based on a fabricated data point. (3) The multi-hop reasoning is flawed: the model should have recognized that while PEP provides a specific beverage revenue contribution (23%), TGT does not disclose such granularity, making a direct comparison impossible. Instead, it falsely equates the two, failing to synthesize the absence of data for TGT. (4) Scores are low because of major factual inaccuracies, especially in quantitative claims. Contextual relevance is moderate since the answer addresses the right companies and region, but with incorrect data and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 372,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How might the Medicare price negotiation under the IRA, which will apply to Otezla starting in 2027, impact Amgen's $5.2 billion intangible asset valuation for Otezla, considering that Bristol-Myers Squibb (BMY) also markets Otezla under a licensing agreement?",
      "original_answer": "The Medicare price negotiation under the IRA, which will apply to Otezla starting January 1, 2027, introduces regulatory and financial risk that could impair Amgen's $5.2 billion intangible asset valuation for Otezla. Since BMY also markets Otezla under a licensing agreement, the negotiated price could affect overall revenue from the drug, further influencing Amgen's ability to recover the carrying value of the asset. Amgen has explicitly stated that future changes in estimates related to IRA price negotiations could unfavorably impact the intangible asset's recoverability.",
      "llm_answer": "Amgen’s 2024 10‑K states that the Otezla “Developed‑product‑technology rights” intangible asset carries $5.2 billion and that CMS’s Medicare price‑setting under the IRA will take effect in 2027, which could lower Otezla’s price and revenue and trigger an impairment review (Amgen 10‑K, pp. 138‑139). Because Bristol‑Myers Squibb also sells Otezla under a licensing agreement (BMS 10‑K, pp. 136‑140), Amgen’s revenue share and the overall market dynamics could be further diluted, making it harder to recover the carrying value of the intangible asset.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $5.2 billion intangible asset valuation for Otezla and the 2027 effective date of Medicare price negotiation under the IRA, both of which match the ground truth. It accurately references Amgen's 10-K and BMS's 10-K as sources, aligning with the knowledge graph. (2) All quantitative elements—dollar amount ($5.2 billion), year (2027)—are correct and properly contextualized. No calculations were required, but the temporal and financial data are precise. (3) The multi-hop reasoning is sound: it connects Amgen’s asset valuation, the IRA’s impact on pricing starting in 2027, the potential for impairment, and the added complexity from BMS’s licensing agreement affecting revenue share and market dynamics. This synthesis across two companies and regulatory impact matches the ground truth’s logic. (4) The only minor shortcoming is that the LLM does not explicitly quote Amgen’s statement about 'future changes in estimates' potentially impacting recoverability, which is a key qualitative nuance in the original answer. However, the implication of impairment risk due to lower revenue is clearly conveyed, making the answer largely equivalent. Thus, the answer is factually correct, well-supported, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy for missing the direct strategic caveat from Amgen.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 392,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does AMD's production of FPGAs for hyperscale data centers compare to Altera's FPGA offerings, given Intel's strategic decision to operate Altera as a standalone business?",
      "original_answer": "Altera, now operated as a standalone business by Intel, offers programmable semiconductors primarily FPGAs, targeting embedded, communications, and cloud and enterprise markets. Intel is pursuing monetization opportunities with Altera, including a potential IPO. Meanwhile, AMD produces FPGAs and Adaptive SOCs that are directly incorporated into servers and data center appliances used by hyperscale customers, including for AI workloads such as generative AI models. This positions both companies in competitive yet distinct roles within the FPGA market, with AMD directly serving hyperscale data centers and Intel seeking to unlock value through Altera's standalone structure.",
      "llm_answer": "AMD produces its FPGAs for hyperscale data‑center customers by outsourcing wafer fabrication to third‑party foundries such as TSMC, GF, UMC and Samsung (see AMD 10‑K, pp. 11‑13) and sells them as part of its data‑center portfolio to large cloud providers. In contrast, Intel’s Altera business—now a standalone entity (Intel 10‑K, pp. 21‑25, 68‑72)—offers programmable semiconductors (primarily FPGAs) for embedded, communications, cloud and enterprise markets and is being positioned for monetization or an IPO. Thus, while AMD’s FPGA production is integrated into its broader data‑center strategy and targets hyperscale customers, Altera’s FPGA line is a separate, strategically focused business aimed at a wider set of markets with Intel’s intent to capture more value from the FPGA segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: AMD produces FPGAs and Adaptive SOCs for hyperscale data centers, integrating them into its data-center portfolio for cloud providers, while Intel operates Altera as a standalone business with plans for potential monetization or IPO. The LLM correctly identifies Altera's target markets (embedded, communications, cloud, enterprise) and AMD's focus on hyperscale customers, including for AI workloads. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes information about AMD’s FPGA production strategy (outsourced fabrication, integration into data center offerings) and contrasts it with Intel’s strategic positioning of Altera as a separate entity for value extraction. The reasoning correctly infers distinct but competitive market roles. (4) The LLM adds useful context not in the original answer—specifically naming third-party foundries (TSMC, GF, UMC, Samsung) and citing page numbers from 10-K filings—which enhances detail without introducing inaccuracies. The only minor gap is that the original answer mentions AMD’s use in AI workloads like generative AI, which the LLM omits, but this is a small omission in an otherwise complete and accurate response. Hence, correctness is rated 9/10, with full marks for contextual relevance and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 420,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to the ownership structure of Class A common stock at GOOGL, given the relative number of shares outstanding and holder concentration?",
      "original_answer": "At CMCSA, the Class B common stock represents 33⅓% of the combined voting power, with all shares beneficially owned by Brian L. Roberts, and only 3 record holders as of December 31, 2021. In contrast, GOOGL’s Class A common stock had 300,754,904 shares outstanding as of January 25, 2022, with a much broader base of non-affiliate ownership contributing to a market value of approximately $1,451.1 billion as of June 30, 2021. Both structures tie voting rights to distinct stock classes, but CMCSA’s Class B shares grant concentrated control to a single individual, while GOOGL’s Class A shares are more widely distributed.",
      "llm_answer": "Comcast’s Class B shares are highly concentrated—Mr. Roberts owns all of the 15‑vote‑per‑share stock, which represents about one‑third (33.33 %) of the company’s voting power despite being far fewer in number than the Class A shares. Alphabet’s Class A shares, of which 300,754,904 are outstanding, are widely held by many investors, so each share carries only one vote and the voting power is distributed across a large, dispersed shareholder base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong semantic equivalence. (1) Quantitatively, all key numbers are correct: the 33.33% voting power for CMCSA Class B stock (equivalent to 33⅓% in the original), the 300,754,904 shares outstanding for GOOGL Class A stock as of January 25, 2022, and the correct attribution to Brian L. Roberts as the sole owner of CMCSA’s Class B shares. The LLM correctly notes the concentrated control despite fewer shares, and the broad distribution of GOOGL’s Class A shares. (2) The LLM adds a detail not in the original—'15-vote-per-share' for CMCSA Class B stock—which is plausible and consistent with known Comcast ownership structures but not present in the provided ground truth. While this doesn’t contradict the original, it introduces unverified specificity, slightly affecting qualitative accuracy. (3) The multi-hop reasoning is sound: the model correctly compares voting power concentration at CMCSA with ownership distribution at GOOGL, synthesizing across two companies and their distinct share classes. (4) The answer is contextually relevant, directly addressing the comparison of voting power distribution and ownership concentration. The only minor gap is the omission of the '3 record holders' detail for CMCSA and the $1,451.1 billion market value figure for GOOGL, which were in the original but not critical to the central comparison. Overall, the answer is factually correct, well-reasoned, and focused.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 413,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the change in Keytruda royalty structure post-2023 impact Bristol-Myers Squibb's revenue dependency on Merck, considering Merck's co-development and financial obligations tied to Keytruda in combination therapies?",
      "original_answer": "The royalty rate Merck pays to Bristol-Myers Squibb (BMS) and Ono for Keytruda drops from 6.5% to 2.5% starting January 1, 2024, which will reduce BMS’s royalty income from Merck. This is significant because Merck co-develops Keytruda-based combination therapies like V940 (mRNA-4157) with Moderna, where Merck bears 50% of development costs and receives 50% of any future profits. Since BMS's revenue from Merck is partly tied to Keytruda's global sales through this licensing agreement and has been a growing component of BMS's income (noted by the 2023 increase in royalties), the reduced royalty rate may diminish the financial upside BMS experiences from Keytruda's continued use in these new combination regimens.",
      "llm_answer": "The Keytruda royalty rate will fall from 6.5 % to 2.5 % effective Jan 1 2024, cutting BMS’s royalty income from Keytruda sales (which was $1.186 B in 2023) by roughly 60 % (BMS receives 75 % of the royalty). This shift reduces BMS’s revenue dependence on Merck, although Merck’s co‑development of Keytruda combination therapies still generates milestone and profit‑sharing payments that partially offset the decline【BMY_10k_2023 pages 53‑57, 88‑92】【MRK_10k_2023 pages 88‑92】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the royalty rate change from 6.5% to 2.5% effective January 1, 2024, which matches the ground truth. However, it introduces specific financial figures not present in the original answer: $1.186B in 2023 royalty income and a claim that BMS receives 75% of the royalty. These numbers, while possibly accurate, are not in the ground truth and cannot be verified from the provided context. The 60% reduction calculation is derived from these unverified inputs and thus introduces unsupported precision. (2) The quantitative accuracy is compromised because the original answer does not specify dollar amounts or BMS's share of the royalty; including them constitutes an overreach without explicit support. The calculation of a 60% decline hinges on the assumption that BMS receives 75% of a royalty that drops by ~61.5% (from 6.5% to 2.5%), but this ownership split was not confirmed in the ground truth. (3) Qualitatively, the LLM captures the core multi-hop reasoning: the royalty reduction impacts BMS’s revenue from Merck, and Merck’s co-development of combination therapies (e.g., with Moderna) still generates some offsetting payments. It correctly frames the reduced royalty as decreasing BMS’s revenue dependence on Merck, which aligns with the original answer’s implication. However, it omits mention of Ono (the other royalty recipient) and fails to explicitly tie the impact to Keytruda’s use in new combination regimens, a key point in the original. (4) Contextual relevance is high because the response directly addresses the question’s focus on revenue dependency and co-development implications. Despite incorrect or unsupported numbers, the overall direction and logic are reasonable. The score is reduced primarily due to unsupported quantitative claims that affect factual reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 499,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does the adoption of ASU 2022-06, which CAT has listed as applicable to its financial reporting, impact the treatment of contract modifications under U.S. government agreements that BA identified as a material risk in its 2023 disclosures?",
      "original_answer": "ASU 2022-06 extends the sunset date for optional expedients and exceptions related to reference rate reform through December 31, 2024. This allows companies like BA to apply simplified accounting treatments for contract modifications made in response to reference rate changes, such as replacing LIBOR, during that period. BA, which reported that 37% of its 2023 revenues came from U.S. government contracts—where modifications can occur without prior notice—benefits from reduced operational complexity and financial impact when adjusting contracts affected by reference rate reform. CAT, in its 2023 10-K, listed ASU 2022-06 under recently adopted accounting standards, confirming its applicability and alignment with broader corporate practices around reference rate reform.",
      "llm_answer": "CAT’s adoption of ASU 2022‑06 (Reference‑Rate Reform) extends optional relief for contract modifications that replace a reference rate (e.g., LIBOR) until December 31 2024, thereby reducing the operational and financial impact of such modifications.  BA’s 2023 risk disclosure notes that U.S. government contracts may be modified, curtailed or terminated, which could materially affect performance and funding.  The ASU’s optional relief therefore mitigates the financial impact of these contract‑modification risks identified by BA, lessening the materiality of the risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core impact of ASU 2022-06 on contract modifications in the context of BA's U.S. government agreements. (1) All factual elements are correct: ASU 2022-06 extends relief until December 31, 2024 (correct date), applies to reference rate reform (e.g., LIBOR), and reduces operational and financial impacts of contract modifications. (2) Quantitative accuracy is perfect: no incorrect numbers or miscalculations; the only numeric element (December 31, 2024) matches the ground truth exactly. (3) Multi-hop reasoning is sound: the model correctly links CAT’s adoption of ASU 2022-06 to the broader accounting relief, then connects it to BA’s risk disclosure about U.S. government contract modifications, even though the two companies are different. It infers correctly that the ASU mitigates risks BA identified, despite not explicitly stating BA adopted the ASU. (4) The only minor omission is that the original answer includes BA’s 37% revenue from U.S. government contracts in 2023, which adds contextual weight to the materiality of the risk. The LLM answer mentions the risk but not the quantitative significance (37%), slightly reducing completeness. However, the semantic meaning and logical conclusion are preserved. Wording differences are acceptable and do not affect accuracy. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 391,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does the $4.8 billion transaction with Crown Castle in 2013 compare to Verizon's 2024 $2.8 billion deal with Vertical Bridge REIT in terms of asset treatment and financing obligations, particularly given both companies retained depreciation responsibilities and structured payments as financing obligations?",
      "original_answer": "Both AT&T’s 2013 transaction with Crown Castle and Verizon’s 2024 deal with Vertical Bridge REIT involved transferring exclusive rights to operate wireless towers while retaining depreciation responsibilities on their balance sheets. AT&T received $4.827 billion from Crown Castle, accounted for as a financing obligation with an effective interest rate of ~3.9%, and continues to sublease space on the towers. Similarly, Verizon received $2.8 billion from Vertical Bridge, of which $830 million was recorded as a financing obligation related to the towers Verizon continues to use, with the remainder treated as prepaid rent. Both arrangements reflect a structured financing model where the original owner maintains accounting control and depreciation charges, rather than achieving sale-leaseback treatment.",
      "llm_answer": "AT&T’s 2013 Crown Castle transaction was a sale‑leaseback that did **not** transfer control of the towers, so AT&T kept the towers on its books, continued to depreciate them, and treated the $4.8 billion cash proceeds as a financing obligation that accrues interest at about 3.9 %. Verizon’s 2024 Vertical Bridge deal sold the lease‑rights to 6,000 towers but retained a lease‑back for part of the capacity; Verizon recorded the $2.8 billion upfront payment as prepaid rent ($2.0 billion) and a $830 million financing obligation for the towers it still occupies, and it also continues to depreciate the towers. Thus, both companies retained depreciation responsibilities and structured the payments as financing obligations, but AT&T’s deal kept all tower assets on‑balance‑sheet with a larger financing obligation, while Verizon’s split the payment into prepaid rent and a smaller financing obligation for the portion of towers it still uses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AT&T received $4.827B (rounded to $4.8B in both answers), Verizon received $2.8B, with $830M treated as a financing obligation and the remainder as prepaid rent. The 3.9% effective interest rate for AT&T is correctly noted. (2) Quantitative accuracy is excellent—dollar amounts, breakdowns, and percentages match the original answer. The $2.8B total split into $2.0B prepaid rent and $830M financing obligation is consistent with the ground truth. (3) The reasoning correctly identifies that both transactions retained depreciation responsibilities and were not sale-leaseback treatments due to lack of control transfer. The distinction in accounting treatment—AT&T’s full financing obligation vs. Verizon’s split treatment—is accurately highlighted. (4) Minor point: the LLM refers to 'AT&T’s 2013 Crown Castle transaction' while the question mentions 'Verizon’s 2013 transaction', which is factually incorrect—the 2013 deal was AT&T’s, not Verizon’s. However, the LLM correctly attributes it to AT&T, so this appears to be a typo in the question, not the answer. The LLM correctly synthesizes multi-hop information across companies and years, accurately comparing asset treatment and financing obligations. Semantic equivalence is strong, with slightly more detail than the original. No factual errors—only a minor stylistic difference in emphasis. Hence, correctness is 9 (not 10) due to the slight risk of confusion in framing, though the substance is fully accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 431,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does PEP's direct operational presence in New Zealand's beverage market compare to KO's financial influence through its 19% stake in CCEP, which bottles and distributes Coca-Cola products in the same region?",
      "original_answer": "PEP operates in New Zealand through its APAC regional structure, selling branded beverages and convenient foods directly and through partners. CCEP, in which KO holds a 19% stake, is responsible for bottling and distributing Coca-Cola products in New Zealand under a bottler's agreement. KO's financial stake allows it to influence CCEP's operations indirectly, while PEP maintains full operational control over its New Zealand beverage activities. This creates two distinct models—direct operation for PEP and equity influence for KO through CCEP—both active in the New Zealand beverage market.",
      "llm_answer": "PepsiCo’s Asia Pacific, Australia and New Zealand segment operates its own bottling and distribution facilities in New Zealand, giving it a direct operational presence in the country’s beverage market (PEP 10‑K, pp. 3‑7). In contrast, Coca‑Cola’s influence in New Zealand is indirect; the company holds a 19 % equity stake in Coca‑Cola Europacific Partners plc (CCEP), the bottler and distributor of Coca‑Cola products in the region, which provides financial influence but not direct operational control (KO 10‑K, pp. 5‑9, 86‑90).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PEP has a direct operational presence in New Zealand through its APAC segment, including bottling and distribution; KO holds a 19% stake in CCEP, which bottles and distributes Coca-Cola products in the region. The percentage (19%) is correctly stated, and the distinction between direct operations (PEP) and indirect financial influence (KO via equity stake) is accurately conveyed. (2) Quantitative accuracy is perfect—no calculations required, but the 19% stake is correctly cited and matches the original answer. (3) Multi-hop reasoning is sound: the model synthesizes information about PEP’s operational structure and KO’s financial investment in CCEP, correctly contrasting operational control vs. equity-based influence. (4) The only minor shortcoming is that the LLM does not explicitly name CCEP’s role in New Zealand as per the ground truth (though it implies it by stating CCEP is the regional bottler), and slightly less detail on PEP’s use of partners. However, the core contrast—direct operation vs. indirect financial influence—is clearly and correctly articulated. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent as it directly addresses the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 366,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does AIG's use of internal valuation models for mortgage-backed securities compare to SCHW's reliance on broker/dealer quotes for similar asset classes like commercial mortgage-backed securities in determining fair value?",
      "original_answer": "AIG utilizes internal valuation models and third-party asset managers to determine fair values for mortgage-backed securities, subject to management review to ensure model reasonableness. These models incorporate inputs like interest rates, borrower creditworthiness, collateral, and market pricing for comparable loans. In contrast, SCHW primarily relies on broker/dealer quotes and third-party pricing services for similar asset classes such as commercial mortgage-backed securities, using observable market data like trades, spreads, and maturity information to validate pricing. GILD’s evidence further supports that broker/dealer quotes are commonly used alongside valuation models with observable inputs for fair value estimation, indicating a shared industry practice that bridges AIG's internal modeling and SCHW's external pricing reliance.",
      "llm_answer": "AIG’s fair‑value policy for mortgage‑backed securities (RMBS and CMBS) is to use internal valuation models when observable market inputs are scarce – the models incorporate discount rates that reflect credit spreads and other observable information (AIG, 2024, pp. 111‑115).  In contrast, Schwab’s CMBS fair‑value approach relies primarily on broker‑dealer quotes and independent third‑party pricing services that provide observable trades and discounted‑cash‑flow estimates; internal models are used only if such quotes are unavailable (Schwab, 2024, pp. 79‑83).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies AIG's use of internal valuation models for mortgage-backed securities (including RMBS and CMBS), incorporating inputs such as credit spreads and observable market data, which matches the original answer's description of models using interest rates, borrower creditworthiness, collateral, and comparable loan pricing. It also accurately states that AIG subjects these models to management review (implied through 'model reasonableness' in the original). (2) For SCHW (Schwab), the LLM correctly notes reliance on broker/dealer quotes and third-party pricing services for CMBS, using observable trades and discounted cash flow estimates—this aligns with the original answer’s emphasis on observable market data like trades, spreads, and maturity. The conditional use of internal models only when quotes are unavailable is an added nuance supported by Schwab’s policy and consistent with the broader practice mentioned in the original answer. (3) The multi-hop reasoning is sound: the LLM correctly contrasts AIG’s model-first approach with SCHW’s quote-first approach, synthesizing information across two companies and asset classes (RMBS/CMBS). (4) The mention of GILD in the original answer adds contextual industry validation, which the LLM omits; however, this is a minor omission that does not detract from the core comparison. All entities (AIG, SCHW), asset classes (mortgage-backed, commercial mortgage-backed securities), and valuation methods are correctly identified. No numeric inaccuracies exist—there are no explicit numbers in either answer, so the qualitative descriptions are appropriately matched. Wording differs slightly but maintains semantic equivalence. The LLM answer is concise, relevant, and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 495,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does AVGO's valuation methodology for Level 2 securities compare to ADBE's reliance on matrix pricing, given the use of observable market inputs like yield curves and benchmark rates in their fair value determinations?",
      "original_answer": "AVGO categorizes its investments, including equity and short-term money market instruments, as Level 2 securities when they are valued using inputs such as interest rates, yield curves, and broker quotes. These inputs are observable but not quoted prices in active markets, distinguishing them from Level 1 securities. Matrix pricing, which is used for Level 2 securities like corporate bonds and asset-backed securities, relies on observable market data such as yield curves to estimate fair value. ADBE also categorizes its fixed income available-for-sale debt securities as Level 2 and explicitly uses matrix pricing techniques that incorporate benchmark yields, issuer spreads, interest rates, and U.S. Treasury or swap curves to determine fair value. Both companies rely on similar observable inputs, indicating a shared dependence on market-derived data rather than direct quotations for active trading in valuing their Level 2 portfolios.",
      "llm_answer": "AVGO’s Level‑2 securities are valued with a mix of market‑corroborated pricing, matrix pricing or other models that draw on observable inputs such as yield curves, pre‑payment speeds, collateral performance and broker/dealer quotes.  ADBE, by contrast, explicitly relies on matrix pricing from independent vendors for all of its Level‑2 fixed‑income available‑for‑sale securities, using benchmark yields, issuer spreads, interest rates and Treasury or swap curves as the key observable inputs.  Both firms use observable market data—including yield curves and benchmark rates—but ADBE’s approach is more narrowly defined as matrix‑pricing‑based, whereas AVGO allows a broader set of valuation models.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: both AVGO and ADBE use observable market inputs like yield curves and benchmark rates for Level 2 securities; ADBE explicitly relies on matrix pricing, while AVGO uses a broader set of models including matrix pricing and broker quotes. These points are consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes valuation methodologies across two companies (AVGO and ADBE), identifies their use of Level 2 inputs, and contrasts ADBE’s narrow reliance on matrix pricing with AVGO’s broader approach—this nuance is supported by the ground truth. (4) Semantic equivalence is strong: while the LLM adds slight detail (e.g., 'pre-payment speeds, collateral performance'), these are plausible extensions of 'observable inputs' and do not contradict the original. The core conclusion—that both rely on similar observable data but differ in methodological specificity—is preserved. One minor point: the original emphasizes the shared dependence more than the contrast, whereas the LLM highlights the difference in approach ('broader set of models'), which slightly shifts emphasis but does not reduce factual accuracy. Hence, a score of 9 is justified—excellent, with negligible interpretive variance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 417,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "What percentage of Coca-Cola's non-U.S. unit case volume is managed by Coca-Cola HBC, and in how many of its operational countries—including the Czech Republic—does it coordinate distribution for Coca-Cola's trademark beverages?",
      "original_answer": "Coca-Cola HBC manages 17% of Coca-Cola's non-U.S. unit case volume and coordinates distribution for Coca-Cola's trademark beverages in 30 countries, including the Czech Republic.",
      "llm_answer": "Coca‑Cola HBC accounts for roughly **13 % of Coca‑Cola’s non‑U.S. unit‑case volume**.  \nIt coordinates distribution in **28 operational countries**—including the Czech Republic.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative figures. The percentage of Coca-Cola's non-U.S. unit case volume managed by Coca-Cola HBC is stated as 13%, but the ground truth is 17%. Similarly, the number of countries where distribution is coordinated is reported as 28, whereas the correct number is 30. These errors affect core components of the answer. (2) Both numeric values are incorrect—13% vs. 17% and 28 vs. 30 countries—and no calculation is involved, so accuracy hinges solely on correct recall. Format variations are not relevant here as percentages and counts are unambiguous. (3) The multi-hop reasoning appears structurally sound—the model identifies the correct entity (Coca-Cola HBC), the correct metric (non-U.S. unit case volume), and the correct scope of distribution coordination including the Czech Republic. However, it fails in synthesizing the correct values from the knowledge base, indicating a data retrieval or training gap. (4) Despite correct framing and contextual understanding, the two major numerical errors severely impact factual correctness, warranting a low-to-mid correctness score. Contextual relevance is high as all parts of the question are addressed with proper entity alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1109,
        "completion_tokens": 356,
        "total_tokens": 1465
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How do Duke Energy's 50% equity stake in Hardy Storage in West Virginia and NextEra Energy's 31.9% ownership in a 303-mile pipeline under construction in the same region reflect divergent strategic approaches to natural gas infrastructure investment, particularly in light of regulatory and market challenges?",
      "original_answer": "Duke Energy's 50% equity stake in Hardy Storage, an interstate underground natural gas storage facility in West Virginia, indicates a strategic focus on stable, long-term infrastructure assets that support regulated gas operations. This aligns with Duke's broader approach of investing in FERC-regulated infrastructure such as Pine Needle and Hardy Storage to ensure reliable supply and service. In contrast, NextEra Energy's 31.9% ownership in a 303-mile pipeline project in West Virginia and Virginia reflects a more ambitious and risk-exposed strategy aimed at expanding transportation capacity into new markets, despite facing regulatory delays and legal challenges. While both companies are investing in West Virginia's natural gas ecosystem, Duke's approach emphasizes secure, operational assets, whereas NextEra's involvement in a pipeline under construction—subject to permitting and legal hurdles—suggests a higher tolerance for uncertainty in pursuit of future capacity and market access.",
      "llm_answer": "Duke Energy’s 50 % equity stake in Hardy Storage (an underground, FERC‑regulated storage facility in West Virginia) represents a conservative, mature investment that delivers predictable, rate‑based revenue and limits exposure to construction or regulatory risk (DUK 10‑K 2022, pp. 17‑21). In contrast, NextEra’s 31.9 % ownership of a 303‑mile pipeline still under construction in West Virginia and Virginia reflects a more aggressive, growth‑oriented strategy that carries higher regulatory uncertainty—requiring approvals and facing legal challenges—and market volatility, but offers the potential for new transmission capacity and future gas flows (NEE 10‑K 2022, pp. 15‑19). These positions illustrate Duke Energy’s emphasis on stability and regulatory certainty versus NextEra’s pursuit of higher returns amid greater construction and regulatory exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Duke Energy's 50% stake in Hardy Storage and NextEra Energy's 31.9% ownership in a 303-mile pipeline under construction in West Virginia and Virginia are accurately reported. The percentages, project descriptions, and geographic scope match the original answer. (2) Quantitative accuracy is perfect—no calculations were required, but all numbers (50%, 31.9%, 303-mile) are correct and properly attributed. Format variations (e.g., spacing in percentages) do not affect meaning. (3) Multi-hop reasoning is sound: the model correctly synthesizes strategic implications from ownership stakes, contrasting Duke’s focus on FERC-regulated, operational storage assets (low risk, stable returns) with NextEra’s higher-risk pipeline investment exposed to regulatory delays and legal challenges. The inference about Duke seeking regulatory certainty versus NextEra pursuing growth with higher exposure is logically supported and consistent with the original. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'rate-based revenue', 'market volatility'), the core message about divergent strategies based on risk tolerance and regulatory exposure is preserved. One minor point preventing a perfect 10 is the absence of explicit mention of Pine Needle (referenced in ground truth as part of Duke’s broader strategy), but this detail is contextual and not central to the main comparison. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 435,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How does the difference in voting rights between Class A and Class B shares at META compare to GOOGL's dual-class structure, and what implications might this have on ownership concentration given META's 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding as of January 24, 2025, versus GOOGL's 10:1 voting ratio for Class B shares and $62.0 billion in 2024 share repurchases?",
      "original_answer": "META discloses two classes of stock—Class A and Class B—with the latter carrying greater voting rights, though the exact ratio is not quantified in the filing. As of January 24, 2025, META had 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding, indicating a significant concentration of voting power within Class B. In contrast, GOOGL explicitly states that each Class B share carries 10 votes, creating a defined 1:10 voting disparity. GOOGL also repurchased $62.0 billion in shares during 2024, predominantly from Class A and Class C, which may further consolidate voting control in Class B shares held by insiders. This suggests that while both companies utilize dual-class structures to concentrate voting power, GOOGL's is more explicitly weighted and reinforced through aggressive capital allocation, whereas META’s structure lacks detailed disclosure on voting disparity but similarly reflects a concentrated ownership base through disproportionate Class B shareholding.",
      "llm_answer": "Meta’s Class B shares carry ten votes each versus one for Class A, giving a 10:1 voting ratio that is identical to Google’s dual‑class structure (Meta, p. 1‑2; Google, p. 80‑84).  With 2,189,898,148 Class A and 343,761,117 Class B shares outstanding (Jan 24 2025, Meta, p. 1), the Class B holders command roughly 61 % of the 5.63 B total votes, concentrating control in a small group.  Google’s $62 B of 2024 share repurchases—primarily of Class A shares (Google, p. 82)—shrink the overall share base and further amplify the voting‑power concentration of its Class B shareholders.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in asserting that Meta's Class B shares carry ten votes each (10:1 ratio), which contradicts the ground truth stating that Meta does not disclose the exact voting ratio. This is a major error in both quantitative and qualitative terms. The number of shares outstanding (2,189,898,148 Class A and 343,761,117 Class B) is correctly cited, and the total votes calculation (5.63B) appears to be an approximation based on the incorrect 10:1 assumption. The $62.0 billion share repurchase by GOOGL is correctly reported. (2) The calculation of Class B voting power at 'roughly 61%' assumes a 10:1 ratio, which is not supported by the original filing—this leads to an incorrect conclusion. If Class B had 10 votes each, total votes would be (2.19B × 1) + (0.344B × 10) = 5.63B, with Class B holding 3.44B votes, or ~61.1%, so the math is correct under that assumption—but the assumption itself is false per the ground truth. (3) The multi-hop reasoning is structurally sound—comparing voting structures, incorporating share counts and repurchases—but it fails because it relies on an unsupported claim about Meta’s voting ratio. The synthesis with GOOGL’s explicit 10:1 ratio and repurchase activity is relevant and logical. (4) Scores reflect that core data (share counts, repurchase amount) are accurate and contextually well-used, but the critical error in Meta’s voting rights undermines the conclusion. While the answer is well-structured and attempts proper comparison, the lack of acknowledgment that Meta’s ratio is undisclosed (vs. GOOGL’s explicit 10:1) results in a misleading equivalence. Thus, correctness is partially compromised, warranting a mid-low score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 471,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the enactment of TRAF in Switzerland impact JNJ's effective tax rate in 2020, and how does this compare to MRK's tax benefit from its Swiss tax holiday that began in 2021?",
      "original_answer": "The enactment of TRAF in Switzerland allowed JNJ to adjust the tax basis of certain assets to fair value under transitional provisions, resulting in an incremental Swiss tax deduction and contributing to a 1.9% decrease in JNJ's 2020 effective tax rate compared to 2019. Meanwhile, MRK benefited from a Swiss tax holiday for a newly active legal entity, effective through 2030, which began yielding favorable tax impacts starting in 2021. These provisions in Switzerland contributed to both companies experiencing lower effective tax rates due to localized tax incentives, albeit through different mechanisms and in different fiscal years.",
      "llm_answer": "The TRAF enactment in Switzerland lowered JNJ’s 2020 effective tax rate by about **2.6 % (≈$0.4 billion)**, a benefit recorded as a “Swiss Tax Reform” item in the tax‑rate reconciliation.  \nIn contrast, MRK’s Swiss tax holiday that began in 2021 delivered a **tax benefit of roughly $0.5 billion**, a larger dollar amount but translating to a smaller percentage impact on its effective tax rate.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states that JNJ's effective tax rate decreased by 1.9% due to TRAF, but the LLM claims a 2.6% decrease, which is incorrect. Additionally, the LLM introduces a $0.4 billion benefit for JNJ and a $0.5 billion tax benefit for MRK—these dollar amounts are not present in the original answer and cannot be verified from the provided ground truth, making them unsupported additions. (2) The dates are partially correct: TRAF's impact in 2020 for JNJ and MRK's tax holiday starting in 2021 align with the original answer. However, the original does not quantify MRK’s benefit in dollar terms or specify its percentage impact on the effective tax rate, so the LLM’s claim of a 'smaller percentage impact' is speculative and unsupported. (3) The multi-hop reasoning is partially sound—the model correctly identifies that both companies benefited from Swiss tax incentives in different years and through different mechanisms (TRAF vs. tax holiday). However, it fails to accurately describe the mechanisms: the original specifies JNJ benefited via an adjustment to tax basis under transitional provisions leading to a deduction, while the LLM only vaguely references a 'Swiss Tax Reform' item without explaining the mechanism. For MRK, the original notes the holiday is effective through 2030 for a newly active entity, which the LLM omits, weakening completeness. (4) Despite incorrect numbers and unsupported dollar figures, the answer remains contextually relevant by addressing both companies, the correct years, and the general idea of Swiss tax incentives reducing effective tax rates. However, the incorrect magnitude of JNJ’s rate decrease and the introduction of unverified financial figures significantly reduce factual accuracy, warranting a low correctness and quantitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 510,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How do MCD's foreign currency asset hedging practices compare with NKE's transactional FX risk management strategies using options, particularly regarding notional amounts and objectives?",
      "original_answer": "MCD manages FX exposure by holding diversified foreign currency net asset positions, with its largest exposures denominated in major global currencies (chunk_1). To mitigate associated risks, MCD uses option and forward contracts to hedge forecasted foreign currency transactions, with $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024 (chunk_2). NKE also uses option contracts as part of its FX risk management, focusing on transactional exposures such as product costs and external sales in non-functional currencies, with hedging strategies aimed at stabilizing U.S. Dollar inventory costs amid FX fluctuations (chunk_3). While both companies use options, MCD's strategy centers on protecting existing foreign currency assets, whereas NKE's approach is more transaction-focused, targeting forecasted cash flows and cost stability.",
      "llm_answer": "McDonald’s uses options and forwards to hedge its foreign‑currency assets and forecasted transactions, with a $9.9 billion notional amount of cash‑flow hedges in 2024, aiming to smooth earnings and cash‑flow volatility. Nike, in contrast, applies options (and forwards) to its transactional exposures—product costs, external sales and other costs—without a disclosed notional figure in the filing, and its goal is to mitigate the impact of currency moves on forecasted cash flows and earnings. Thus, McDonald’s hedges are larger in notional size and focused on asset‑side exposures, while Nike’s hedges target transactional risks and lack a reported notional amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $9.9 billion notional amount for MCD as of 2024 is correctly reported, matching the original answer. The absence of a disclosed notional amount for NKE is also accurately reflected. (2) The entities—MCD and NKE—are correctly identified, and the time frame (2024) is consistent with the source. (3) The reasoning correctly synthesizes multi-hop information: MCD's strategy involves hedging foreign currency net assets and forecasted transactions using options and forwards, while NKE focuses on transactional exposures like product costs and sales in non-functional currencies. The distinction in objectives—MCD protecting asset positions vs. NKE stabilizing costs and cash flows—is accurately captured. (4) The only minor shortcoming is that the LLM slightly generalizes NKE’s goal as mitigating impact on 'earnings' and 'forecasted cash flows,' whereas the original emphasizes stabilizing U.S. Dollar inventory costs specifically. This nuance is downplayed but not incorrect. Overall, the answer is factually sound, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 331,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the exclusive use of RTX's PW800 engine on Gulfstream's G500 support General Dynamics' strategy to position the G500 as a next-generation replacement for the G450 and G550 models?",
      "original_answer": "The G500, developed by General Dynamics, is positioned as a next-generation replacement for the G450 and G550 models with a clean-sheet design that includes a new wing and advanced avionics. RTX's Pratt & Whitney Canada produces the PW800 engine, which exclusively powers the G500 (along with the G400 and G600). This exclusive engine-airframe pairing enhances the G500's performance with improved fuel efficiency, range, and speed, aligning with General Dynamics' investment in new technologies to differentiate the G500 as a modern, high-performance aircraft in the business jet market.",
      "llm_answer": "The G500 is a clean‑sheet replacement for the G450 and G550 that Gulfstream says is “faster, more fuel‑efficient, and has greater cabin volume, reduced emissions, more range and improved flight controls” (GD 10‑K, p. 5‑7).  Its exclusive use of Pratt & Whitney’s new PW800 engine—selected to power only the G400, G500 and G600—provides the advanced, fuel‑saving performance and lower emissions that underpin those gains (RTX 10‑K, p. 5‑7).  Together, the PW800’s modern technology and the G500’s design give General Dynamics a next‑generation business jet that clearly outperforms the older G450/G550 line, aligning with its strategy to deliver superior, efficient aircraft.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: the G500 is a clean-sheet design replacing the G450 and G550, RTX's Pratt & Whitney Canada produces the PW800 engine, and it exclusively powers the G500, G400, and G600. The performance benefits—fuel efficiency, range, speed, reduced emissions, cabin volume, and improved flight controls—are accurately described and tied to both the engine and airframe. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not compromised; the answer avoids making up figures and instead references qualitative improvements from the 10-Ks. (3) Multi-hop reasoning is sound: the answer correctly synthesizes information across General Dynamics and RTX filings, linking the exclusive engine-airframe pairing (PW800 on G500) to strategic differentiation in performance and technology. (4) The only minor shortcoming is that the LLM does not explicitly name 'Pratt & Whitney Canada' as the subsidiary of RTX producing the engine, though it refers to 'Pratt & Whitney’s new PW800 engine' and correctly attributes it to RTX via context. This is a slight omission but does not impair understanding. Otherwise, the answer captures the strategic intent—positioning the G500 as a next-gen, high-performance jet through technological advancement—fully and coherently.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 393,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the voting power distribution in META's dual-class structure compare to CMCSA's, particularly regarding the non-dilutable provisions under their respective articles of incorporation and the specific voting percentages allocated to Class A and Class B shareholders?",
      "original_answer": "META's Class B common stock is not publicly traded and as of December 31, 2023, there were only 23 stockholders of record of Class B common stock, suggesting concentrated voting control. In contrast, CMCSA explicitly states that holders of Class A common stock hold 66 2/3% of the combined voting power, while Class B common stockholders (beneficially owned entirely by Brian L. Roberts) hold 33 1/3% of the voting power. CMCSA's Class B common stock has 15 votes per share and its non-dilutable nature is specifically tied to the terms of its articles of incorporation, which preserves the voting power percentage regardless of additional Class A share issuances.",
      "llm_answer": "Meta’s 2023 10‑K (pp. 55‑59) states that each Class A share has one vote, each Class B share has ten votes, and the Class B shares are non‑dilutable under its articles of incorporation. Comcast’s 2023 10‑K (pp. 1‑5, 31‑35) shows that Class A shares collectively hold 66 ⅓ % of voting power, Class B shares hold 33 ⅓ % (each Class B share has 15 votes), and the 33 ⅓ % is generally non‑dilutable under its articles of incorporation. Thus, Meta’s Class B shares carry a 10:1 vote ratio to Class A, whereas Comcast’s Class B shares carry 15 votes per share and represent one‑third of voting power.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and addresses the core aspects of the question, with accurate quantitative data and proper contextual framing. (1) Quantitatively, the LLM correctly states that CMCSA's Class A holds 66 1/3% and Class B 33 1/3% of voting power, with 15 votes per Class B share, and that CMCSA’s structure is non-dilutable under its articles of incorporation—this aligns with the ground truth. It also correctly notes Meta’s 10:1 voting ratio and non-dilutable Class B shares. However, the ground truth specifies that Meta’s Class B non-dilutability is implied by concentrated ownership (only 23 stockholders of record as of Dec 31, 2023), but the LLM incorrectly implies that Meta explicitly codifies non-dilutability in its articles of incorporation like CMCSA does—this is a subtle but important distinction not supported by the original answer. (2) The percentages and vote ratios are accurate, though the LLM rounds 66 2/3% and 33 1/3% as 66 1/3% and 33 1/3%, which is a minor error in precision (66 2/3 ≠ 66 1/3). This affects quantitative accuracy slightly. (3) The reasoning correctly compares vote ratios and voting power distribution across the two companies, fulfilling the multi-hop requirement. However, it omits the key detail from the ground truth that CMCSA’s Class B shares are entirely beneficially owned by Brian L. Roberts, which adds context to the control structure. (4) Despite minor inaccuracies in wording and omission of ownership concentration details for Meta, the answer captures the essential comparison and remains contextually relevant and factually sound overall, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 449,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the risk of losing market exclusivity due to patent challenges for BMY's Revlimid in Europe compare to LLY's reliance on data protection for orphan drug designations, given that both companies depend on intellectual property frameworks to extend commercial exclusivity?",
      "original_answer": "BMY faces earlier-than-expected market exclusivity loss for Revlimid in Europe due to patent settlements allowing generic entry in the UK starting January 18, 2022, and in other European countries beginning February 18, 2022. This highlights the vulnerability of market exclusivity when patent rights are challenged or settled. In contrast, LLY leverages regulatory data protection, including orphan drug designations that provide seven years of market exclusivity independent of patent expiration. While BMY's exclusivity is determined largely by patent rights and settlements, LLY benefits from parallel regulatory protections that do not rely solely on patent enforcement, especially in markets where orphan designations apply.",
      "llm_answer": "Bristol‑Myers Squibb warns that generic entry for Revlimid in Europe is already scheduled to begin in the UK on Jan 18 2022 and in other EU markets on Feb 18 2022 because of patent settlements and the possibility of earlier‑than‑expected patent challenges (BMY 10‑K, pp. 34‑36).  Eli Lilly, by contrast, relies on the seven‑year data‑exclusivity that accompanies orphan‑drug designations; this regulatory protection is not tied to patents and will only lapse after the exclusivity period, after which competitors can enter (LLY 10‑K, pp. 8‑12).  Thus, BMY faces an immediate, litigation‑driven risk of losing exclusivity, whereas Lilly’s risk is the eventual expiration of data protection rather than patent disputes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BMY's Revlimid faces generic entry in the UK on January 18, 2022, and in other European countries on February 18, 2022, due to patent settlements—this matches the original answer exactly. The dates are correctly cited and formatted. (2) The contrast with LLY is also accurate: Eli Lilly relies on seven-year data exclusivity from orphan drug designation, which is regulatory and independent of patents. This is correctly portrayed as a non-patent-based protection mechanism. (3) The multi-hop reasoning—comparing BMY’s patent-litigation-driven risk to LLY’s regulatory exclusivity expiration risk—is sound and synthesizes information across both companies’ 10-Ks appropriately. (4) Minor deduction in qualitative accuracy due to slightly less detailed explanation of how orphan exclusivity operates in parallel to patents (e.g., no mention that it blocks competitor applications during the period), but the core distinction is preserved. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is perfect—directly addresses the comparison of IP strategies and associated risks.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 342,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the sensitivity of MS's asset management revenues to fixed income market fluctuations compare with PYPL's exposure to market risk through its use of pricing models for derivatives and debt securities?",
      "original_answer": "MS's asset management revenues are sensitive to changes in fixed income markets due to their reliance on fee-based client assets, which include fixed income investments valued using pricing models with observable market data like interest rates and credit spreads. MS specifically notes that revenues may not fully correlate with market changes due to factors like client behavior and asset mix. Meanwhile, PYPL also depends on pricing models for valuing its derivatives and available-for-sale debt securities, using observable inputs such as currency rates, interest rate yield curves, and equity prices. However, unlike MS, PYPL has elected the fair value option for foreign currency-denominated debt securities, directly tying gains and losses to market fluctuations. Both firms face market risk through their use of pricing models, but MS's exposure is more indirect through asset management fees, while PYPL's is direct through its investment and derivative valuations.",
      "llm_answer": "MS’s asset‑management revenue sensitivity is tied directly to the performance of client holdings that include fixed‑income securities; the firm notes that “these revenues depend on … the level and duration of a market increase or decline, price volatility … and client behavior” (MS 10‑K, pp. 60‑64).  In contrast, PayPal’s market‑risk exposure is indirect, arising from the valuation of its derivatives and debt securities, which are priced with models that use observable inputs such as interest‑rate curves, credit spreads, and equity volatility (PYPL 10‑K, pp. 91‑95).  Thus, MS’s revenue swings are driven by fixed‑income market movements, while PYPL’s risk stems from valuation changes in instruments whose fair value is model‑dependent.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical mischaracterization in the comparison between MS and PYPL, undermining the multi-hop reasoning. (1) Quantitatively, there are no numeric values in the question or answers, so no calculation errors—this aspect is accurate by default. (2) The LLM correctly identifies that MS's asset management revenues are sensitive to fixed income market movements due to fee-based assets and references client behavior and market volatility, which aligns with the original answer. It also correctly notes that PYPL uses pricing models with observable inputs (interest-rate curves, credit spreads) for derivatives and debt securities. (3) However, the LLM incorrectly frames PYPL’s exposure as 'indirect' when the ground truth states that PYPL has elected the fair value option for foreign currency-denominated debt securities, leading to *direct* recognition of market fluctuations in earnings. This is a key distinction: PYPL’s exposure is *more direct* than MS’s, which the LLM reverses. The original answer emphasizes that MS’s revenue link is indirect (via fees), while PYPL’s is direct (via fair value accounting). The LLM flips this logic, stating MS has 'direct' revenue sensitivity and PYPL has 'indirect' risk, which is factually inverted. (4) Despite good contextual relevance and proper sourcing references (10-K page ranges), the qualitative inaccuracy in reasoning and entity-level risk characterization significantly reduces correctness. The answer captures surface-level similarities but fails the core comparative analysis, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 439,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How do Oracle's integration of generative AI in MySQL HeatWave and Qualcomm's investment in IoT applications reflect their respective strategies for on-device AI processing in enterprise and consumer markets?",
      "original_answer": "Oracle integrates generative AI into Oracle MySQL HeatWave, offering it as a managed cloud service that combines transactions, real-time analytics, machine learning, and generative AI capabilities. This enables enterprise customers to deploy AI-driven analytics and applications more efficiently. In contrast, Qualcomm is investing heavily in expanding generative AI into IoT and edge devices, projecting that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024. Qualcomm’s QCT segment develops integrated circuits for IoT applications, including consumer electronics, industrial devices, and edge networking products, emphasizing on-device processing for immediacy, privacy, and personalization. While Oracle focuses on cloud-native AI integration for enterprise database workloads, Qualcomm is driving AI capabilities into edge devices across multiple industries, particularly IoT, to capitalize on the growing demand for on-device intelligence.",
      "llm_answer": "Oracle’s MySQL HeatWave now bundles generative‑AI inference with transactions and real‑time analytics in a single managed cloud service (Oracle 10‑K, p. 13‑14), underscoring Oracle’s strategy to embed AI directly into enterprise database workloads so that customers can run AI‑driven analytics in the cloud or on‑premise without separate infrastructure.  \nQualcomm, by contrast, is investing heavily in IoT and edge‑device markets and has built a dedicated AI engine—including the Hexagon NPU—into its Snapdragon platforms (Qualcomm 10‑K, p. 5‑9; 18‑22), reflecting its focus on delivering low‑power, high‑performance on‑device AI for consumer and industrial IoT devices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Oracle integrates generative AI into MySQL HeatWave as a managed cloud service to support enterprise database workloads with AI-driven analytics, which matches the original answer. Qualcomm is correctly described as investing in IoT and edge devices with on-device AI via its Snapdragon platforms and Hexagon NPU. (2) Quantitative accuracy is perfect—although the LLM answer does not include the specific projection of 46% of smartphones being generative AI capable by 2027 (up from 19% in 2024), this omission does not distort the meaning or strategy; the core quantitative claims (if any) are absent rather than incorrect, so no inaccuracy is introduced. (3) Multi-hop reasoning is sound: the model correctly contrasts Oracle’s cloud-native, enterprise-focused AI integration with Qualcomm’s edge-focused, consumer and industrial IoT strategy. (4) The answer is contextually relevant and directly addresses both companies’ strategies regarding on-device AI in enterprise and consumer markets. The only minor shortcoming is the absence of the specific smartphone AI adoption projection from Qualcomm, which is a detail present in the ground truth that would strengthen the quantitative backing of Qualcomm’s strategy. However, this does not undermine the overall correctness, as the strategic direction is accurately conveyed. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 432,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How might the compliance costs associated with the EU AI Act, which Adobe anticipates will require costly changes to its AI development practices, affect its competitive positioning against Salesforce, which relies heavily on its AI-powered Agentforce platform for sales and service offerings?",
      "original_answer": "Adobe anticipates that the EU AI Act, which will be implemented in phases through 2030, may require costly changes to its AI development practices, including delays or halts in development, changes to monetization strategies, and increased compliance costs. Meanwhile, Salesforce relies heavily on its AI-powered Agentforce platform across sales, service, and marketing offerings to drive productivity and growth. If Adobe is forced to divert resources to comply with the new regulations, it could slow the pace of its AI innovation, potentially giving Salesforce a competitive edge through its more established and integrated AI capabilities like Agentforce for Sales and Service. The GS_10k_2024 chunk reinforces that evolving AI regulations increase compliance costs and operational risks for companies relying on AI, suggesting both firms face similar pressures, but Salesforce’s deeper integration of AI across its platform may make it better positioned to absorb such regulatory changes.",
      "llm_answer": "Adobe’s risk‑factor discussion (pages 21‑22) warns that the EU AI Act will raise compliance, governance and R&D costs and may force costly changes to its AI development practices, potentially squeezing margins and slowing AI innovation. In contrast, Salesforce’s 10‑K (pages 44‑45) highlights its Agentforce platform as a core AI offering that lets it scale autonomous agents across sales and service with fewer regulatory constraints. These dynamics could erode Adobe’s competitive edge in AI‑driven solutions relative to Salesforce.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong semantic equivalence. (1) All factual elements are correct: Adobe anticipates increased compliance, governance, and R&D costs due to the EU AI Act, which may slow innovation; Salesforce’s Agentforce platform is highlighted as a key AI-driven differentiator in sales and service. The LLM correctly identifies the competitive risk to Adobe without misrepresenting either company’s position. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not compromised—no errors in this dimension. (3) The multi-hop reasoning is sound: the model synthesizes Adobe’s regulatory risks (from its 10-K) with Salesforce’s strategic reliance on AI (from its 10-K) to infer a potential shift in competitive positioning. The only minor omission is that the ground truth mentions the EU AI Act will be implemented in phases through 2030 and specifies possible impacts like delays/halts in development and changes to monetization—details absent in the LLM answer but not critical to the central argument. (4) Contextual relevance is excellent: the response directly addresses how compliance costs might affect Adobe’s competitive stance versus Salesforce, using accurate source references (page numbers in 10-Ks) and appropriate comparison logic. The conclusion that Adobe’s edge may erode relative to Salesforce is well-supported and aligns with the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 413,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does the payout structure of HD's deferred shares, which includes dividend equivalents paid in additional shares, compare with LOW's receipt of additional shares through ASR agreements, in terms of stock-based value distribution to stakeholders?",
      "original_answer": "HD issues additional shares as dividend equivalents to non-employee directors upon the payout of deferred shares following termination of service, based on accrued dividends. This represents a stock-based compensation mechanism tied to director retention and long-term alignment. In contrast, LOW receives additional shares from third-party financial institutions as part of variable notional ASR agreements, which are tied to repurchase efficiency and final notional value calculations. These additional shares in LOW's case are not compensation-related but are part of capital return strategy execution. Both companies issue additional shares, but the context, stakeholders, and triggers differ significantly, reflecting distinct financial strategies.",
      "llm_answer": "HD’s deferred‑share awards give non‑employee directors a direct equity benefit: each award entitles the director to one share upon termination of service and, in addition, dividend equivalents that accrue and are paid out as extra shares, so the directors receive a clear, share‑based value that is expensed immediately and carries no voting rights.  In contrast, Lowe’s ASR agreements are a repurchase mechanism: the company buys back shares with cash, then receives additional shares (or delivers cash) from the financial institution at settlement, which reduces the number of shares outstanding and can lift earnings per share but does not award new shares to individual stakeholders.  Thus, HD’s structure distributes stock value directly to directors, whereas LOW’s structure indirectly benefits shareholders by managing share count rather than granting shares to specific parties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that HD issues additional shares as dividend equivalents to non-employee directors upon payout of deferred shares, which are tied to accrued dividends and serve as stock-based compensation. It also accurately describes LOW's ASR agreements as a share repurchase mechanism where additional shares are received from financial institutions, not awarded to individuals. The distinction between direct distribution to directors (HD) vs. capital return benefiting all shareholders (LOW) is correctly captured. (2) There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is not applicable beyond correct use of financial terms—none are misstated. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies (HD and LOW), two distinct financial instruments (deferred shares with dividend equivalents vs. ASR agreements), and two stakeholder contexts (directors vs. shareholders). The only minor shortcoming is that the LLM does not explicitly mention that LOW’s additional shares are tied to 'variable notional' ASRs or 'repurchase efficiency and final notional value calculations'—details present in the original answer—but this does not undermine the core accuracy. (4) The answer is contextually excellent, directly addressing the comparison of stock-based value distribution mechanisms. Wording differs but semantic meaning matches the ground truth. One point deducted from qualitative accuracy for slight incompleteness in describing ASR mechanics; otherwise, fully correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 449,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does AT&T's adoption of ASU 2020-04, which facilitates contract modifications triggered by reference rate reform, compare to Verizon's disclosure of contract modifications in terms of impact on their respective revenue recognition timing and contract performance obligations?",
      "original_answer": "AT&T adopted ASU 2020-04, which provides optional expedients for contract modifications triggered by reference rate reform (e.g., LIBOR transition), and stated that the adoption did not materially impact its financial statements. Meanwhile, Verizon disclosed that contract modifications affect the timing and scope of performance obligations, with $25.7 billion, $18.7 billion, and $7.5 billion expected to be recognized in 2024, 2025, and beyond, respectively. The connection through ASU 2020-04 to contract modifications shows that while AT&T experienced minimal financial impact from reference rate-related modifications, Verizon's broader contract modification landscape significantly influences its future revenue recognition patterns.",
      "llm_answer": "AT&T’s adoption of ASU 2020‑04 simply provides optional expedients for contract changes driven by the LIBOR‑to‑alternative‑rate transition, and the company states that it “does not materially impact our financial statements” (T_10k_2023, p. 54).  Verizon, by contrast, explains that a contract modification that changes the transaction price or its allocation requires a re‑adjustment of contract liabilities and revenue, which can shift the timing of revenue recognition and alter the allocation of performance obligations (VZ_10k_2023, p. 68).  Thus, AT&T’s update has a neutral effect on revenue timing and performance‑obligation accounting, whereas Verizon’s modifications can directly affect those elements.",
      "correctness_score": 7,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AT&T's adoption of ASU 2020-04 and its statement that the impact was not material, which aligns with the ground truth. It also accurately describes Verizon's disclosure that contract modifications affect revenue timing and performance obligations. However, the LLM answer omits all quantitative figures provided in the ground truth—specifically, Verizon's $25.7 billion, $18.7 billion, and $7.5 billion expected to be recognized in 2024, 2025, and beyond—making it significantly less complete in terms of numerical accuracy. (2) These missing dollar amounts are critical to the original answer’s comparative analysis, as they quantify the scale of Verizon’s future revenue recognition impact, which the LLM fails to convey. No calculations are incorrect per se, but the absence of key numbers reduces quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly contrasts AT&T’s neutral financial impact with Verizon’s active influence on revenue timing and performance obligations, showing synthesis across both companies’ disclosures. The logic and entity identification (AT&T, Verizon, ASU 2020-04, LIBOR transition) are accurate. (4) The correctness score is 7 because the core qualitative comparison is accurate and contextually relevant, but the lack of specific financial figures from Verizon’s disclosures constitutes a significant omission that affects completeness and quantitative precision. Hence, quantitative accuracy is scored low (4), while qualitative accuracy (8) and contextual relevance (9) are high due to correct reasoning and focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 445,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How do Union Pacific's and Lockheed Martin's pension plan disclosures reflect differences in their reliance on Level 2 valuation methodologies for municipal bonds, and what does this imply about their adherence to ASC 820 fair value measurement standards?",
      "original_answer": "Union Pacific discloses that its pension plan classifies municipal bonds as Level 2 investments, which are valued using a bid evaluation process with bid data from independent pricing sources. Lockheed Martin's pension plan also discloses the use of Level 2 valuation methodologies for fixed income securities, where indicative quotes from pricing vendors are used if corroborated. UPS's filing explicitly confirms that municipal bonds fall under Level 2, valued via market-corroborated pricing or matrix pricing models using observable inputs like yield curves. The alignment in Level 2 classification for these instruments suggests both companies are applying ASC 820 consistently for fair value measurements, though UNP provides more specificity regarding municipal bonds, while LMT focuses on general fixed income treatment.",
      "llm_answer": "Union Pacific’s pension plan discloses $1.696 billion in Level 2 bonds and debentures—including municipal bonds (Bonds and Debentures section, pages 55‑59)—showing a substantial reliance on observable inputs for municipal securities. Lockheed Martin’s pension plan shows no municipal bond holdings and lists only Level 2 corporate and U.S. government debt securities ($4.495 billion and $2.376 billion, respectively; Plan Assets table, pages 85‑89), indicating a lower reliance on Level 2 valuations for municipal bonds. Both firms comply with ASC 820 by disclosing the valuation hierarchy, but Union Pacific’s higher Level 2 exposure suggests greater measurement risk compared to Lockheed Martin’s pension plan.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that both Union Pacific (UNP) and Lockheed Martin (LMT) use Level 2 valuation methodologies for fixed income securities, including municipal bonds. However, the LLM incorrectly claims that Lockheed Martin has no municipal bond holdings and only holds corporate and U.S. government debt. This contradicts the original answer, which confirms LMT uses Level 2 for fixed income securities with indicative quotes from pricing vendors—implying inclusion of instruments like municipal bonds, even if not explicitly named. The LLM fabricates specific dollar amounts ($1.696 billion for UNP, $4.495B and $2.376B for LMT) that are not present in the ground truth, which does not provide any numerical values. (2) Quantitative accuracy is very low because all cited numbers are invented. There is no mention of $1.696B, $4.495B, or $2.376B in the original answer. The LLM also misrepresents the structure of disclosures by referencing page numbers (e.g., pages 55–59, 85–89) and section names not present in the provided truth. (3) Multi-hop reasoning is flawed. The question asks how disclosures reflect differences in reliance on Level 2 for municipal bonds and implications for ASC 820 compliance. The ground truth emphasizes that both companies align under ASC 820, with UNP being more specific about municipal bonds and LMT discussing fixed income generally. The LLM incorrectly infers that LMT does not hold municipal bonds at all and thus has lower reliance on Level 2 for them, which is unsupported. It also draws an unsupported conclusion about 'greater measurement risk' for UNP, which is not implied in the original answer. (4) Contextual relevance is moderate because the response addresses pension plans, Level 2 valuations, and ASC 820, but the incorrect facts and fabricated data undermine the analysis. While the general direction (comparing Level 2 usage and ASC 820 compliance) is relevant, the conclusions are based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 548,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How does KO's reliance on Coca-Cola FEMSA for distribution in Argentina compare to MDLZ's exposure to economic volatility in the same market, given Coca-Cola FEMSA's specific operational footprint and MDLZ's inflation-related financial impacts?",
      "original_answer": "KO relies on Coca-Cola FEMSA for distribution in parts of Argentina, specifically the federal capital of Buenos Aires and surrounding areas, as part of its broader network of equity method investees to whom it sold $14.471 billion in net sales in 2021. Coca-Cola FEMSA operates in Argentina, a market that has been classified as highly inflationary since mid-2018, which directly affects MDLZ’s operations there. MDLZ reported a $13 million remeasurement loss in 2021 due to the volatility of the Argentine peso, with Argentina contributing $401 million (1.4%) to MDLZ’s consolidated net revenues. This highlights how both companies are exposed to Argentina, but through different mechanisms: KO through a distribution dependency and MDLZ through direct financial exposure to currency and inflation risks.",
      "llm_answer": "KO’s distribution in Argentina is confined to the federal capital of Buenos Aires and surrounding areas through Coca‑Cola FEMSA, whose bottling footprint in the country is limited to that region【KO_10k_2022, Distribution System section】.  By contrast, MDLZ’s Argentine operations represent a larger share of its business – contributing $401 million (1.4 % of consolidated net revenues) in 2021 – and the company has recorded significant inflation‑related remeasurement losses ($13 million in 2021, $9 million in 2020) as a result of Argentina’s highly inflationary environment【MDLZ_10k_2022, Currency Translation and Highly Inflationary Accounting section】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: KO's distribution via Coca-Cola FEMSA is limited to Buenos Aires and surrounding areas; MDLZ’s Argentina revenue was $401 million (1.4%) in 2021; MDLZ reported a $13 million remeasurement loss in 2021 (and additional $9 million in 2020, which is extra but accurate context). These numbers match the original answer exactly. (2) Quantitative accuracy is perfect: all dollar amounts, percentages, and years are correct and properly attributed. (3) The multi-hop reasoning is sound—correctly contrasting KO’s operational dependency (distribution footprint) with MDLZ’s financial exposure (inflation-related losses) in the same market. The LLM correctly synthesizes information from both companies’ 10-Ks. (4) The only minor omission is that the original answer notes KO’s $14.471 billion in net sales to equity method investees (including Coca-Cola FEMSA), which provides broader context about the significance of these partnerships. While not essential to the core comparison, it adds depth that the LLM answer leaves out. However, this does not detract significantly from the correctness. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is excellent—directly addresses the comparative exposure as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 374,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the voting rights structure of META's Class B common stock influence its shareholder equity strategy compared to Alphabet's dual-class stock framework, particularly in light of Alphabet's $62.0 billion share repurchase in 2024 targeting Class A and Class C shares?",
      "original_answer": "META's Class B common stock grants 10 votes per share, compared to 1 vote per share for Class A, giving certain shareholders disproportionate voting power. Similarly, Alphabet follows a dual-class structure where Class B shares also carry 10 votes each, while Class A shares have one vote, and Class C shares have no voting rights. In 2024, Alphabet repurchased $62.0 billion of its Class A and Class C shares, prioritizing repurchases based on economic cost and market conditions. This suggests that both companies maintain strategic flexibility in managing shareholder equity by leveraging their dual-class structures to preserve voting control while repurchasing shares to enhance shareholder value.",
      "llm_answer": "Meta’s Class B shares carry 10 votes per share, giving holders significant control and enabling the company to use share‑repurchase or equity‑mix adjustments to consolidate voting power or manage its capital structure. Alphabet’s dual‑class framework (Class A shares with one vote and Class C shares with none) means its $62 billion 2024 repurchase of Class A and Class C shares is a capital‑return strategy that reduces dilution but does not alter voting power. Thus, Meta’s voting‑rights structure focuses on preserving control, whereas Alphabet’s repurchase is aimed at shareholder value within its dual‑class setup.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Meta's Class B shares have 10 votes (vs. 1 for Class A), Alphabet's Class A has 1 vote, Class C has none, and the $62 billion 2024 repurchase targeted Class A and C shares—numbers and entity details match exactly. (2) Quantitative accuracy is perfect: $62 billion is correctly cited, years and share classes are accurate. (3) Multi-hop reasoning is sound: the model correctly synthesizes that both companies use dual-class structures to maintain control while executing repurchases, and it appropriately contrasts Meta’s focus on preserving voting control via share structure with Alphabet’s use of repurchases to return capital without affecting voting power. (4) The only minor shortcoming is that the LLM omits explicit mention of Alphabet’s Class B shares (which carry 10 votes but were not repurchased), though this does not distort the overall logic. The answer still captures the strategic distinction and similarity between the two firms’ equity strategies. Wording differs slightly from the original but maintains semantic equivalence. Thus, the answer is factually complete and well-reasoned, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 344,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the decline in GILD's Veklury sales in 2024, influenced by the availability of alternative treatments, compare to the negative impact AMGN reports from alternative treatments in competitive therapeutic markets?",
      "original_answer": "GILD reported that Veklury sales in 2024 were $1,799 million globally, a decline from $2,184 million in 2023, attributed to reduced demand linked to the availability and uptake of alternative treatments for COVID-19. This reflects a direct impact on revenue due to competitive therapeutic options. Similarly, AMGN notes that in competitive treatment markets such as those for ENBREL, Otezla, Repatha, and Aimovig, payers and PBMs are increasingly using formulary restrictions and cost-containment measures to shift patients toward alternative treatments, which has limited Amgen's product usage and sales. Both companies experience revenue pressure from alternative treatments, though GILD’s impact is more directly tied to pandemic-related dynamics, while AMGN faces systemic payer-driven shifts in competitive markets.",
      "llm_answer": "Gilead’s Veklury revenue dropped from $2.184 billion in 2023 to $1.799 billion in 2024—a decline of roughly $385 million (≈17.6 %) that the company attributes to the availability of vaccines and other COVID‑19 therapies (GILD, 10‑K, p. 17‑21).  Amgen likewise notes that the emergence of alternative treatments in competitive therapeutic markets erodes demand and pricing for its products, though the filing does not disclose a specific dollar loss (AMGN, 10‑K, p. 14‑18).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports GILD's Veklury sales decline from $2.184 billion in 2023 to $1.799 billion in 2024, matching the ground truth exactly. The calculated decline of $385 million and ~17.6% is accurate. The attribution to alternative treatments (and vaccines) aligns with GILD's 10-K. For AMGN, the answer correctly identifies that alternative treatments in competitive markets negatively impact demand and pricing, consistent with the original answer. While no specific dollar loss is provided by AMGN in either answer, the LLM appropriately notes this absence. 2) All numeric values are correct: $2.184 billion, $1.799 billion, and the implied $385 million drop (2.184 - 1.799 = 0.385) are precise. The percentage decline (~17.6%) is correctly calculated: (0.385 / 2.184) ≈ 0.176. 3) The multi-hop reasoning is sound: the model compares GILD’s pandemic-driven revenue decline due to therapeutic alternatives with AMGN’s broader competitive market challenges involving payer-driven formulary restrictions. While the LLM omits specific drug names (ENBREL, Otezla, etc.) and mechanisms like PBM influence mentioned in the ground truth, it still captures the core qualitative parallel—revenue pressure from alternative treatments. 4) The answer is contextually relevant, directly addressing the comparison between GILD and AMGN regarding the impact of alternative treatments. The omission of specific AMGN drug names and formulary dynamics is a minor shortcoming but does not undermine the central factual and comparative accuracy. Hence, a high score of 9 is warranted—excellent factual and quantitative accuracy with only slight incompleteness in qualitative detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 456,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does AMD's interest payment schedule on its $312 million 7.50% Senior Notes compare with QCOM's interest payment structure on its $14.0 billion aggregate fair value of notes, particularly in terms of payment frequency and fiscal year obligations?",
      "original_answer": "AMD's $312 million 7.50% Senior Notes require semi-annual interest payments on February 15 and August 15 of each year, as stated in the indenture governing the notes. In contrast, QCOM's interest payment structure on its $14.0 billion aggregate fair value of notes includes semi-annual payments for fixed-rate notes and quarterly payments for floating-rate notes. While AMD's interest obligations are tied to a specific fixed schedule with a final maturity in fiscal 2022, QCOM has significant upcoming principal payments starting in fiscal 2023 ($1.4 billion) and continuing through future fiscal years, with no principal due in fiscal 2026.",
      "llm_answer": "AMD’s $312 million 7.50% Senior Notes pay interest semi‑annually on February 15 and August 15 each year through the maturity of August 15, 2022, so all interest obligations fall within fiscal 2022. Qualcomm’s $14.0 billion aggregate notes pay interest in arrears quarterly for floating‑rate notes and semi‑annually for fixed‑rate notes, with principal repayments scheduled over fiscal 2023, 2024, 2025, 2027 and beyond, meaning interest obligations are spread across multiple fiscal years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AMD's semi-annual interest payment dates (February 15 and August 15) and the maturity date (August 15, 2022), aligning with the ground truth. It accurately states that AMD's interest obligations fall within fiscal 2022. For QCOM, it correctly distinguishes between quarterly interest payments for floating-rate notes and semi-annual for fixed-rate notes, matching the original answer. The principal repayment schedule is accurately described as occurring in fiscal 2023, 2024, 2025, 2027 and beyond, with the key detail that no principal is due in fiscal 2026 implied by the omission of that year. (2) All numeric values—$312 million, 7.50%, $14.0 billion—are correct and properly attributed. Dates and frequencies are factually accurate. (3) The multi-hop reasoning is sound: the model synthesizes payment frequency, fiscal timing, and maturity schedules across two companies and different note types. The only minor shortcoming is that the original answer explicitly notes the $1.4 billion principal due in fiscal 2023, which the LLM omits, slightly reducing completeness. (4) Despite this minor omission, the LLM answer conveys the core comparative structure accurately and remains semantically equivalent in intent and substance. Hence, high scores across all dimensions with a 9 on correctness due to the missing $1.4B specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 386,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How might the impending loss of U.S. patent protection for Prolia/XGEVA in February 2025 impact Merck's competitive position, given its reliance on strong patent rights to defend against generic competition and Amgen's own exposure to biosimilar threats in international markets?",
      "original_answer": "The loss of U.S. patent protection for Prolia/XGEVA in February 2025 will likely expose Amgen's product to biosimilar competition, reducing its market exclusivity and potentially decreasing revenue. This dynamic is particularly relevant for Merck, which emphasizes its reliance on strong patent rights to protect its portfolio from generic challenges. Given Merck's acknowledgment of increased global pricing pressure and weakened patent protection in international markets, the erosion of exclusivity for key competitors like Prolia/XGEVA could intensify biosimilar threats across markets, thereby indirectly affecting Merck’s own competitive strategy and market positioning in the therapeutic category.",
      "llm_answer": "Merck’s U.S. patent protection for Prolia/XGEVA expires in February 2025, after which generic or biosimilar competitors are likely to enter the market and erode sales, weakening Merck’s competitive position that relies on strong patent rights to fend off generic competition (Merck 10‑K, pp. 31‑32; 35).  This risk is amplified by Amgen’s own exposure to biosimilar threats in international markets, which could intensify competition for bone‑health products (Amgen 10‑K, pp. 9‑13).",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it incorrectly attributes Prolia/XGEVA to Merck, when these products are developed and marketed by Amgen, not Merck. This misidentification fundamentally undermines the answer's correctness. The expiration date of February 2025 for U.S. patent protection is accurate and matches the ground truth. However, the claim that 'Merck’s U.S. patent protection for Prolia/XGEVA expires' is false—Merck does not own these drugs. (2) Quantitatively, the date (February 2025) is correct and no other numerical values are present, so quantitative accuracy is preserved. (3) The multi-hop reasoning fails due to incorrect entity mapping: the model should have recognized that Amgen markets Prolia/XGEVA and that their patent cliff affects Amgen’s exposure to biosimilars, which in turn may influence competitive dynamics relevant to Merck. Instead, it inverts the relationship by placing Merck as the patent holder, leading to flawed logic. The mention of Merck’s reliance on patent rights and exposure to generic competition is contextually accurate (per Merck 10-K), but incorrectly tied to a product it does not own. (4) While the answer references correct document locations and touches on relevant themes (patent reliance, biosimilar threats), the core error in drug ownership invalidates the reasoning chain. Correctness score is low due to this fundamental misconception, despite accurate dates and partial contextual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 410,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What portion of Broadcom's VMware Cloud Foundation revenue in fiscal year 2024 was directly tied to enabling AI workloads, and how does this align with Cisco's strategic focus on providing infrastructure for AI training and inference?",
      "original_answer": "In fiscal year 2024, $1,380 million of Broadcom's $2,900 million VMware Cloud Foundation revenue was recognized, and this platform specifically enables advanced AI and machine learning workloads at enterprise scale. This aligns with Cisco's strategic focus on providing network infrastructure to power AI training and inference workloads through high-density routers and switches, improved network management, and high-performance optics, as stated in their 2024 10-K filing.",
      "llm_answer": "Broadcom’s VMware Cloud Foundation (VCF) revenue in FY 2024 was essentially 100 % tied to AI‑enabled workloads, as the platform’s “Advanced services for Private AI” are built to deliver AI without compromising data control 【Broadcom: page 9】. This mirrors Cisco’s own strategy, which emphasizes delivering the high‑density routers, switches and optics needed to power AI training and inference for web‑scale and enterprise customers 【Cisco: page 4】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that '100%' of VMware Cloud Foundation revenue was tied to AI workloads, which is not supported by the ground truth. The original answer specifies that $1,380 million of the $2,900 million in revenue was recognized and that the platform enables AI/ML workloads, but does not quantify the portion directly tied to AI as 100%. This is a major factual inaccuracy. The total revenue figure ($2.9 billion) is correct and aligns with ground truth, but the implied $2.9 billion × 100% = $2.9 billion AI-tied revenue contradicts the more nuanced $1.38 billion figure mentioned in the original, which may represent recognized revenue rather than AI-specific revenue. (2) Quantitative accuracy is low because the key percentage (100%) is fabricated and not present in the ground truth; no calculation or citation supports this exact figure. The ground truth does not specify a percentage, only that the platform enables AI at scale. (3) Qualitatively, the reasoning is partially sound: the LLM correctly identifies that VCF supports AI workloads and links Broadcom’s strategy to Cisco’s focus on AI infrastructure (routers, switches, optics), which is consistent with the Cisco 10-K reference. The multi-hop synthesis between Broadcom’s VCF and Cisco’s networking strategy is appropriate and relevant. (4) Contextual relevance is high because the answer addresses both parts of the question—AI linkage in VCF revenue and alignment with Cisco’s AI infrastructure focus—using appropriate entities and strategic context. However, the unsupported 100% claim significantly undermines factual correctness, warranting a moderate overall score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 457,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the $1,851 million in assets from NEE's consolidated solar VIEs compare to Southern Power's exposure through PPAs accounted for as operating leases, given both entities operate solar facilities under long-term power sales agreements?",
      "original_answer": "NEE consolidates solar VIEs with approximately $1,851 million in assets at year-end 2021, which sell electricity under long-term PPAs expiring between 2035 and 2052. Southern Power, a subsidiary of SO, operates PPAs related to solar facilities accounted for as operating leases with remaining terms of up to 25 years. While NEE's VIEs directly own the solar assets and bear construction and operational risk, Southern Power's exposure is structured as lessor under operating leases, receiving lease payments tied to energy production. Both entities demonstrate significant long-term commitments to solar generation through contractual arrangements, though NEE holds direct ownership and asset risk while SO participates through lease financing structures.",
      "llm_answer": "NEE’s consolidated solar VIEs carry about **$1,851 million** in assets (NEE 10‑K, 2022, p. 95‑99).  \nSouthern Power’s PPAs that are accounted for as operating leases generate roughly **$652 million** in undiscounted cash flows (SO 10‑K, 2022, p. 268‑270).  Thus, NEE’s solar‑VIE asset base is nearly **2.8 times larger**—or about **$1.2 billion greater**—than Southern Power’s operating‑lease exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states NEE's consolidated solar VIE assets as $1,851 million (from 2021, not 2022 as cited), it incorrectly quantifies Southern Power's exposure as $652 million in 'undiscounted cash flows' from operating leases. The original answer (ground truth) does not provide any dollar amount for Southern Power's exposure—only a description of the lease structure and duration. Thus, the $652 million figure is unsupported by the ground truth and appears to be an incorrect extraction or inference from the SO 10-K. This invalidates the comparison and the calculation that NEE's asset base is '2.8 times larger' or '$1.2 billion greater.' These calculations, while mathematically consistent with the cited numbers, are based on a false premise. (2) The quantitative accuracy is low because the core comparison relies on a number ($652 million) not present in the ground truth. The year 2022 is also cited, but the ground truth references year-end 2021, introducing a temporal mismatch. (3) The multi-hop reasoning is partially sound—LLM attempts to compare two entities' solar exposures via different accounting structures (consolidated VIEs vs. operating leases)—but fails because it fabricates a quantitative metric for Southern Power that isn't in the original answer. The qualitative insight about different risk structures (ownership vs. lease) is missing in the LLM answer, weakening the synthesis. (4) Contextual relevance is high because the LLM addresses the core entities (NEE, Southern Power), correct financial structures (VIEs, PPAs as operating leases), and attempts a direct comparison. However, the introduction of an unsupported figure undermines correctness. A correct answer should have acknowledged the lack of comparable asset-level data for Southern Power and focused on structural differences, as the original answer does.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 520,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the structure of Starbucks' stock-based compensation grants under Stock Appreciation Rights compare to Tesla's use of the 2019 Plan in terms of equity instruments available and vesting timelines?",
      "original_answer": "Starbucks grants Stock Appreciation Rights as part of its equity incentive plans, though it notes that stock options have not been broadly used recently. In contrast, Tesla's 2019 Plan, adopted in June 2019, explicitly includes Stock Appreciation Rights among the equity instruments available for grant, along with stock options, RSUs, and performance shares. Tesla's stock options and RSUs generally vest over four years and are exercisable over a maximum period of 10 years from grant dates. Starbucks records compensation expense based on the fair value of awards at grant date and recognizes it over the service period, with performance-based RSUs tied to metrics like earnings per share and return on invested capital. Tesla also uses vesting schedules and forfeitures estimates but does not specify performance-based conditions in this excerpt.",
      "llm_answer": "Starbucks’ Stock Appreciation Rights are a single equity instrument that grants employees a right to cash or shares tied to the appreciation of Starbucks’ common stock, vesting over a four‑year period (SBUX p. 61‑65). In contrast, Tesla’s 2019 Equity Incentive Plan offers a broader mix of awards—including stock options, restricted stock, RSUs, SARs, performance units and performance shares—with most awards vesting over four years and options exercisable for up to ten years (TSLA p. 81‑85). Thus, Tesla provides more equity‑instrument options while maintaining a vesting schedule similar to Starbucks’ SARs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key numbers and timelines are correct: both Starbucks and Tesla use four-year vesting periods for their equity awards, and Tesla's options are exercisable up to 10 years post-grant—both explicitly stated in the original and correctly reflected. The mention of page references (SBUX p. 61–65, TSLA p. 81–85) suggests document grounding, though not required for correctness. (2) The LLM correctly identifies that Starbucks primarily uses SARs (with limited use of stock options recently), while Tesla’s 2019 Plan includes a broader range of instruments: stock options, RSUs, SARs, performance shares, etc.—matching the original. (3) Reasoning is sound: the comparison highlights Tesla’s broader equity instrument availability versus Starbucks’ narrower SAR focus, while noting similar vesting timelines. (4) Minor omission: the original mentions Starbucks ties performance-based RSUs to metrics like EPS and ROIC, and that both firms recognize expense over service periods using fair value at grant. The LLM omits this detail about performance conditions and expense recognition, which is part of the compensation structure but not central to the question about instruments and vesting. However, since the question focuses on 'equity instruments available' and 'vesting timelines', the core elements are addressed accurately. Wording differences (e.g., 'restricted stock' vs 'RSUs') are semantically acceptable. Overall, the answer is factually correct, contextually relevant, and synthesizes multi-hop information properly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 441,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the difference in voting rights structure between META's Class B common stock and GOOGL's Class A common stock affect the potential influence of large shareholders on corporate governance decisions at each company?",
      "original_answer": "META's Class B common stock has no voting rights except for certain defined matters, such as exiting the core payments business or specific amendments to the certificate of incorporation, limiting the influence of large shareholders on most corporate governance decisions. In contrast, GOOGL's Class A common stock provides one vote per share, allowing shareholders of this class to have a more direct say in company decisions. This structural difference means that at META, significant shareholders holding Class B shares have limited ability to impact governance outside of specific scenarios, while at GOOGL, shareholders with Class A shares can exert more consistent influence on corporate decisions through their voting power.",
      "llm_answer": "Meta’s Class B common shares carry **10 votes each** (Meta 10‑K, note 11), so a large holder can exert a disproportionate influence on governance per share. Alphabet’s Class A common shares have **one vote per share** (Alphabet 10‑K, note 11), meaning large shareholders must rely on sheer volume of shares to achieve comparable influence, and each share’s voting power is much lower. Thus, Meta’s Class B holders can sway decisions more efficiently per share than Alphabet’s Class A holders.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) QUANTITATIVE INACCURACY: The LLM claims that Meta's Class B shares have 10 votes each, which is false. According to the ground truth, Meta's Class B common stock has *no voting rights* except in limited circumstances. Conversely, GOOGL's Class A shares do have one vote per share, which the LLM correctly states. However, the core numeric claim about Meta Class B voting rights is completely wrong. (2) COMPLETENESS: The answer fails to address the actual structure—Meta’s Class B shares are non-voting, not super-voting. It inverts the reality and thus misses the entire point of the question. (3) ENTITY ACCURACY: While the companies (Meta and Alphabet/GOOGL) are correctly identified, the stock class characteristics are misattributed. (4) REASONING: The multi-hop reasoning is flawed because it assumes Meta Class B shares are high-vote shares, leading to the incorrect conclusion that large shareholders have greater influence per share. In reality, Meta’s Class B shares are non-voting, so they confer *less* influence, not more. The comparison to GOOGL is therefore invalid. (5) SEMANTIC EQUIVALENCE: The answer conveys the opposite meaning of the ground truth. Instead of showing that Meta’s structure limits shareholder influence, it claims the opposite. This is a critical factual error. The contextual relevance is low but not zero, as it discusses voting rights and corporate governance. However, due to the inversion of facts, the correctness score is near the minimum.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 429,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the use of foreign currency derivatives in risk management activities differ between BAC and JPM, based on their respective derivative asset and liability disclosures?",
      "original_answer": "BAC includes foreign currency derivatives under 'Risk Management Activities' as part of its derivative assets and liabilities, which are presented on a gross basis before netting adjustments as of December 31, 2024, and 2023. JPM specifically states that foreign currency derivatives are used to manage foreign exchange risk associated with non-U.S. dollar-denominated assets, liabilities, and forecasted transactions, and that gains or losses on these instruments are expected to substantially offset this variability. The fair value of these derivatives is reflected in the balance sheets, either in 'Other' or shown separately under 'Risk Management Activities.'",
      "llm_answer": "BAC’s 2024 10‑K shows that the bulk of its foreign‑currency derivatives are classified as “trading and other risk‑management derivatives” – 46.8 bn of FX swaps and 55.4 bn of spot/futures/forwards are used for risk management, with only 0.1 bn and 2.1 bn, respectively, in the qualifying‑hedge column (pages 103‑107). In contrast, JPMorgan’s disclosures (pages 209‑213) list foreign‑currency derivatives almost exclusively as hedging instruments: fair‑value hedges for foreign‑currency assets and liabilities, cash‑flow hedges for forecasted revenue/expense, and net‑investment hedges for non‑U.S. subsidiaries, indicating a more formal hedge‑accounting approach. Thus, BAC relies on foreign‑currency derivatives mainly for general risk management, while JPM uses them primarily as designated hedges.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides a detailed and contextually relevant comparison between BAC and JPM regarding foreign currency derivatives, correctly identifying that BAC uses them primarily for general risk management while JPM employs a more formal hedge accounting approach. This aligns semantically with the original answer's emphasis on BAC’s presentation under 'Risk Management Activities' on a gross basis and JPM’s use of derivatives to manage specific foreign exchange risks with offsetting gains/losses. However, the quantitative accuracy is low: the LLM introduces specific dollar figures (e.g., $46.8B in FX swaps, $55.4B in forwards) and categorizes them into 'qualifying-hedge' vs. 'trading and other risk-management' buckets, which are not present in the original answer or supported by the provided ground truth. There is no mention in the ground truth of these exact amounts, breakdowns, or hedge classifications, nor of pages 103–107 or 209–213, suggesting potential hallucination of data. The qualitative reasoning is sound—drawing a contrast in usage philosophy between the two banks based on disclosure emphasis—and the multi-hop synthesis across entities (BAC vs. JPM) is appropriate and insightful. While the core idea (BAC: general risk management; JPM: designated hedges) is plausible and consistent with the original, the unsupported numerical precision undermines factual correctness. Thus, the answer is partially correct but contains significant fabricated quantitative details not found in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 418,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How does Duke Energy's exposure to economic downturns through industrial customers compare to Southern Company's risk from environmental compliance costs affecting similar customer segments, given both companies' regulated rate recovery mechanisms?",
      "original_answer": "Duke Energy notes that industrial customers reducing production during economic downturns can lead to reduced electricity consumption, lowering revenues and cash flows. Southern Company, on the other hand, faces risks that increased environmental compliance costs—estimated to impact capital expenditures through 2028—could be passed through regulated rates, potentially reducing demand from commercial and industrial customers. Both companies rely on rate mechanisms for cost recovery: Duke through periodic adjustment clauses and Southern through ECO Plan, CNP Compliance, and ECCR tariff mechanisms. However, while Duke's risk centers on demand volatility from macroeconomic conditions, Southern's exposure stems from regulatory-driven cost increases that may dampen industrial customer demand despite efforts to recover those costs through rates.",
      "llm_answer": "Duke Energy’s primary exposure to economic downturns comes from a decline in industrial‑customer demand, which can cut sales and cash flow; the company can still recover many of its costs through periodic rate‑adjustment clauses, but regulators may limit the rates that can be charged. In contrast, Southern Company faces a cost‑side risk: rising environmental‑compliance expenses (e.g., CCR, GHG, water‑quality rules) that may not be fully recoverable through its regulated retail and wholesale rate structures, potentially eroding earnings. Both utilities rely on regulated rate recovery, but Duke’s risk is demand‑driven while Southern’s is cost‑driven.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core distinction between Duke Energy's demand-driven risk during economic downturns and Southern Company's cost-driven risk from environmental compliance. (1) All factual elements are correct: Duke's exposure is tied to industrial demand reduction affecting sales and cash flow, mitigated partially by periodic rate-adjustment clauses; Southern faces rising compliance costs (CCR, GHG, water quality) that may not be fully recoverable, threatening earnings. These align with the ground truth, which notes Southern’s use of ECO Plan, CNP Compliance, and ECCR tariffs—specific mechanisms the LLM does not name but refers to generally as 'regulated retail and wholesale rate structures,' which is acceptable for semantic equivalence. (2) There are no numeric values, dates, or percentages in either answer, so quantitative accuracy is not compromised; the mention of environmental costs extending 'through 2028' in the original is omitted in the LLM response, but this is a minor contextual detail rather than a critical omission. (3) Multi-hop reasoning is sound: the model correctly synthesizes that both firms are regulated and use rate recovery mechanisms, but the nature of their risks differs—one demand-side, one cost-side—demonstrating proper cross-company, cross-risk analysis. (4) The LLM slightly generalizes Southern’s specific tariff mechanisms without naming them, which prevents a perfect qualitative score, but the conceptual accuracy remains high. Overall, the answer is contextually precise, factually correct, and logically structured, warranting a 9/10 correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 446,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How does the voting power distribution tied to CMCSA's Class B common stock, which is fully owned by Brian Roberts, influence the governance structure compared to GOOGL's dual-class stock system where Class A and Class B shares have different voting rights?",
      "original_answer": "CMCSA's Class B common stock, which is fully owned by Brian Roberts, holds 33 1/3% of the combined voting power with each share carrying 15 votes, creating a concentrated control mechanism that is non-dilutable under the company's articles of incorporation. This contrasts with GOOGL's structure, where Class A shares have 1 vote each and Class B shares have 10 votes each, and Class B shares automatically convert to Class A upon sale or transfer. While both companies utilize dual-class structures to preserve founder control, CMCSA's system entrenches Brian Roberts' influence more securely due to the non-dilutable nature and high per-share voting weight of the Class B stock, whereas GOOGL's structure allows for more fluidity in ownership and voting power distribution.",
      "llm_answer": "Comcast’s Class B common stock—entirely held by Brian Roberts—carries 15 votes per share and represents about one‑third of the company’s combined voting power (p. 29‑33, 65‑69), giving Roberts de‑facto control over board elections and major corporate decisions. Alphabet’s dual‑class structure (p. 80‑84) assigns one vote per share to publicly traded Class A shares and ten votes per share to privately held Class B shares, so the founders retain majority control while the public still holds a minority voting stake. Thus, Comcast’s governance is highly concentrated in a single individual, whereas Alphabet balances founder dominance with limited public voting rights.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information in the ground truth. (1) Quantitatively, it correctly states that CMCSA's Class B stock carries 15 votes per share and represents about one-third of voting power, which aligns with the ground truth (33 1/3%). The comparison to GOOGL's 10 votes per Class B share and 1 vote per Class A share is also accurate. (2) The answer correctly identifies that Brian Roberts holds all Class B shares and thus has de-facto control, and notes the contrast with GOOGL's structure where founders retain majority control but the public holds a minority stake. (3) The multi-hop reasoning is sound: it synthesizes information about ownership, voting rights, and governance implications across CMCSA and GOOGL. (4) The only minor omission is that the LLM does not explicitly mention that CMCSA's Class B shares are non-dilutable per the articles of incorporation—a key point in the ground truth that strengthens the entrenchment of control. Additionally, it does not note that GOOGL's Class B shares automatically convert to Class A upon sale, which limits long-term control fluidity. These omissions slightly reduce qualitative accuracy but do not undermine the overall correctness. Wording differences are semantically equivalent and acceptable. The answer is fully contextually relevant and directly addresses the comparative governance question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 386,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did KO's indirect exposure to Taiwan through Swire Beverages' operations compare to PEP's direct growth performance in the Taiwanese beverage market in 2022?",
      "original_answer": "KO had indirect exposure to Taiwan through Swire Beverages, one of its top five bottling partners, which operated in Taiwan and accounted for 17% of KO’s worldwide unit case volume in 2021. Meanwhile, PEP directly reported low-single-digit beverage unit volume growth in Taiwan as part of its APAC division's 34% net revenue increase in 2022. This highlights KO’s reliance on a third-party bottler versus PEP’s direct market performance in the same geography.",
      "llm_answer": "KO’s only exposure to Taiwan was indirect, coming through its bottling partner Swire Beverages, which operates in Taiwan but does not report standalone revenue for the Coca‑Cola Company【source: KO_10‑k_2022, pages 5‑9】. In contrast, PepsiCo reported a direct growth performance in Taiwan in 2022, indicating a measurable increase in sales in that market【source: PEP_10‑k_2022, pages 46‑50】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies KO's indirect exposure through Swire Beverages and PEP's direct growth in Taiwan, which addresses the core comparison in the question. However, it omits key quantitative details present in the ground truth: Swire Beverages accounted for 17% of KO’s worldwide unit case volume in 2021, and PEP reported low-single-digit beverage unit volume growth in Taiwan as part of its APAC division's 34% net revenue increase in 2022. These specific figures are critical for a complete, accurate comparison. (2) The LLM fails to include any numeric data—percentages, volumes, or revenue impacts—making the quantitative accuracy low. While no incorrect numbers are stated, the absence of all figures from the ground truth significantly reduces factual completeness. (3) The reasoning is logically sound in framing the contrast between indirect vs. direct exposure, and the entities (KO, PEP, Swire Beverages, Taiwan, 2022) are correctly identified. The multi-hop synthesis is partially achieved—linking KO’s partner operations to market exposure and contrasting with PEP’s direct reporting—but lacks depth due to missing data. (4) Contextual relevance is high because the answer stays focused on the question and draws the right conceptual contrast. However, the lack of specific metrics from the original answer limits correctness, warranting a moderate score of 6. The answer is not wrong, but incomplete in a way that affects financial comparability.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 411,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How might the expiration of Trulicity's patent protection impact LLY's revenue trajectory in light of MRK's strategic reliance on strong patent protection to maintain market exclusivity and competitive positioning?",
      "original_answer": "The expiration of Trulicity's patent protection, as noted in LLY's 2024 10-K, is expected to lead to a rapid and severe decline in revenue, as seen in 2024 where Trulicity's U.S. revenue decreased by 32% due to competitive dynamics and supply constraints. This aligns with the broader risk LLY faces as products lose exclusivity, typically resulting in generic competition and steep revenue drops. Similarly, MRK acknowledges that loss of patent protection leads to generic substitutes entering the market, adversely affecting sales and cash flows. Given MRK's emphasis on actively defending patent rights to maintain market exclusivity and profitability, the erosion of Trulicity's patent protection signals a critical vulnerability for LLY, especially if it lacks a robust pipeline or alternative strategies to offset the anticipated revenue losses.",
      "llm_answer": "Trulicity’s patents are expected to expire in the next few years, and LLY’s risk‑factor analysis warns that generic entry could quickly erode the drug’s sales, reversing the 32 % revenue decline seen in 2024.  Because Merck’s strategy relies on strong patent protection to secure market exclusivity and competitive positioning, the loss of Trulicity’s exclusivity would likely shift LLY’s revenue trajectory downward in a manner analogous to the competitive vulnerability Merck faces when its own patents lapse.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the core idea that Trulicity's patent expiration will negatively impact LLY's revenue trajectory and draws a valid comparison to MRK's reliance on patent protection. However, it misrepresents the 32% revenue decline: the original answer states this 32% drop *already occurred in 2024* due to competitive dynamics and supply constraints, while the LLM incorrectly frames it as a future event that could be 'reversed' by generic entry. This is a significant factual error in temporal and causal reasoning. 2) Quantitatively, the 32% figure is correct, and the years align (2024), but the interpretation is flawed—'reversing the 32% decline' implies the decline happened due to something other than competition and that patent expiration might somehow undo it, which is illogical and factually incorrect. The decline is a result of early competitive erosion, not a pre-generic baseline. 3) The multi-hop reasoning is mostly sound: the model correctly links LLY's Trulicity risk to MRK's strategic emphasis on patent protection and infers that LLY will face similar revenue pressures. It synthesizes across both companies' 10-K disclosures appropriately. 4) Despite the critical error in interpreting the 32% decline, the overall message about patent expiration leading to revenue decline and competitive vulnerability is correct and contextually relevant. Wording differences are acceptable, but the misrepresentation of a key data point reduces quantitative and overall correctness. Hence, correctness_score is 7: core facts and directionality are right, but a major detail is misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 440,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How might FedEx's operational reliance on leased retail locations at hotels, such as the 200 stores located at hotels and convention centers, compare with UPS's financial exposure to real estate funds—like the $10.1 billion in pension assets invested in real estate, private debt, and hedge funds—in terms of strategic risk during periods of real estate market volatility?",
      "original_answer": "FedEx maintains a direct operational exposure to hotels through its 200 leased retail locations at hotels and convention centers, positioning it in high-traffic hospitality venues but exposing it to lease renegotiations or relocations if hotel operators change tenants. These leases are typically for five to ten years, and FedEx's ability to maintain these locations depends on the ongoing operation of the hotels themselves. In contrast, UPS holds an indirect financial exposure to real estate through its pension and postretirement plan assets, which include $10.1 billion in investments in real estate funds, private debt, and hedge funds as of December 31, 2024. These funds may include investments in hotels and other commercial properties, meaning UPS’s exposure is tied to the performance of these funds rather than direct occupancy or lease agreements. During real estate market volatility, FedEx could face operational disruptions or increased leasing costs if hotel properties experience financial strain, while UPS could see fluctuations in the value of its pension assets, affecting long-term liability projections and funding obligations. Thus, while both companies are exposed to the real estate sector, the nature of their risk—operational for FedEx and financial for UPS—differs significantly in both timing and impact.",
      "llm_answer": "FedEx’s 200 leased retail locations at hotels and convention centers (FedEx 10‑K, Item 1, pp. 42‑46) are a modest operational exposure; the leases are generally 5‑10 years long, so a commercial‑real‑estate downturn would mainly raise operating costs and could be mitigated by renegotiation or relocation. In contrast, UPS’s pension plan holds roughly $10.1 billion in real‑estate, private‑debt and hedge‑fund investments (UPS 10‑K, pp. 59‑63), so a real‑estate market decline could erode plan asset values and increase pension liabilities, posing a larger long‑term financial risk. Thus, FedEx’s risk is operational and limited, whereas UPS’s risk is financial and potentially more significant during real‑estate volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: FedEx has 200 leased retail locations at hotels and convention centers with 5–10 year leases, and UPS has $10.1 billion in pension assets invested in real estate, private debt, and hedge funds as of December 31, 2024 (implied by context, though the LLM does not explicitly cite the date—minor omission). The dollar amount, lease duration, and entity-specific exposures are correctly reported. (2) Quantitative accuracy is perfect: $10.1 billion and 200 locations match the original; no calculations were required. (3) The multi-hop reasoning is sound—LLM correctly distinguishes FedEx’s direct operational exposure (physical presence, lease renegotiation risk) from UPS’s indirect financial exposure (pension asset volatility), which is the core of the comparison. It accurately characterizes FedEx’s risk as operational and manageable via relocation, while UPS’s risk is financial and potentially more significant due to impact on pension liabilities. (4) The answer is semantically equivalent to the original, though slightly less detailed—e.g., it omits that UPS’s funds may include hotel investments and doesn’t mention 'liability projections' explicitly, but still captures the essence of financial vs. operational risk. Wording differences are acceptable and do not affect meaning. Contextual relevance is excellent—directly addresses strategic risk during real estate volatility. One point deducted from correctness and qualitative accuracy for minor incompleteness in explaining the indirect nature of UPS’s exposure to real estate through fund holdings.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1571,
        "completion_tokens": 453,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does the voting rights structure of GOOGL's Class B Common Stock compare to CMCSA's disclosure around voting rights in its investment in Atairos, particularly in terms of control and influence over strategic decisions?",
      "original_answer": "GOOGL's Class B Common Stock provides its holders with 10 votes per share, significantly enhancing their influence over corporate decisions compared to Class A shares, which carry one vote per share. This structure allows holders of Class B Common Stock to maintain greater control over strategic decisions despite owning fewer shares. In contrast, CMCSA disclosed that it has no voting rights in Atairos, a VIE in which it holds a significant investment, and only retains certain consent rights. As a result, CMCSA lacks the power to direct Atairos’s activities that most significantly impact its economic performance, which limits its control and influence over strategic decisions at Atairos.",
      "llm_answer": "Google’s Class B common stock carries 10 votes per share (versus one vote for Class A), giving holders substantial voting power that can shape board and strategic decisions. In contrast, Comcast’s equity in Atairos carries no voting rights—control rests with management companies led by its former CFO—so Comcast’s influence over Atairos’ strategic choices is limited to economic participation and limited consent rights. Thus, Google’s Class B provides direct control, while Comcast’s Atairos stake offers only financial exposure without voting authority.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all key facts are correct: GOOGL's Class B shares carry 10 votes per share (vs. 1 for Class A), and CMCSA has no voting rights in Atairos—both match the original answer. There are no calculations, but the comparative voting structures are correctly represented. (2) The answer is complete: it addresses both parts of the multi-hop question—GOOGL’s voting structure and CMCSA’s lack of voting rights in Atairos—and contrasts their influence over strategic decisions. (3) Entity accuracy is strong: GOOGL (referred to as Google) and CMCSA (as Comcast) are correctly identified, and Atairos is accurately described as a VIE where CMCSA holds an investment without voting control. (4) Reasoning is sound: the LLM correctly infers that 10:1 voting power gives Class B holders outsized control, while CMCSA’s lack of voting rights and reliance on consent rights limits its strategic influence. The only minor shortcoming is that the LLM does not explicitly mention that CMCSA’s consent rights relate to activities that most significantly impact economic performance—a nuance in the original answer that strengthens the conclusion about control. However, the overall semantic meaning and factual content are equivalent. Wording differences (e.g., 'former CFO' not in original) add context but don’t contradict facts. Thus, the answer is excellent but not perfect, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 418,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does the use of commercial paper financing by Duke Energy Ohio compare to PepsiCo's short-term debt strategy, given Duke Energy Ohio's specific disclosures and PepsiCo's broader commercial paper obligations?",
      "original_answer": "Duke Energy Ohio reported $25 million in commercial paper obligations as of December 31, 2023, as part of its overall short-term financing strategy. In comparison, PepsiCo disclosed $2,286 million in commercial paper obligations in 2023, representing a significant portion of its broader short-term debt obligations totaling $6,510 million. This highlights a stark contrast in the scale of commercial paper usage between the two companies, with PepsiCo relying more heavily on this form of short-term financing.",
      "llm_answer": "Duke Energy Ohio’s balance sheet does not list a separate commercial‑paper line – the subsidiary’s “Notes payable and commercial paper” entry is shown as zero, indicating that commercial paper is either not used or is a negligible component of its short‑term debt.  By contrast, PepsiCo reports a dedicated commercial‑paper program of $2.286 million (at 5.5 %) as part of its $300 million in other short‑term borrowings, showing that commercial paper is a more prominent element of PepsiCo’s overall short‑term debt strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims Duke Energy Ohio has zero commercial paper, directly contradicting the ground truth that it reported $25 million as of December 31, 2023. This is a major error in both entity-specific disclosure and quantitative accuracy. For PepsiCo, the LLM incorrectly states commercial paper obligations as $2.286 million (off by a factor of 1,000), when the correct amount is $2,286 million. It also misrepresents PepsiCo’s broader short-term debt, stating $300 million in other short-term borrowings, whereas the ground truth reports total short-term debt of $6,510 million, of which commercial paper is a part. (2) Quantitative accuracy is severely compromised: both companies’ figures are wrong by orders of magnitude. The PepsiCo commercial paper amount is off by three decimal places ($2.286 million vs $2,286 million), and the broader debt context is incorrect. (3) Multi-hop reasoning fails because the LLM draws an incorrect contrast based on false data. It concludes PepsiCo uses commercial paper more prominently, which aligns with the ground truth directionally, but this conclusion is based on fabricated numbers and misinterpretations, not valid synthesis. (4) Contextual relevance is moderate because the answer attempts the right comparison and references appropriate financial concepts, but factual errors undermine all substantive value. The reasoning structure is present but built on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 411,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "Given Duke Energy's expectation of increasing commercial gas customers in the Carolinas, Ohio, and Kentucky, how might Southern Company's reliance on regulated rate recovery for environmental compliance costs be affected if commercial demand declines due to environmental regulations impacting industrial operations in these same regions?",
      "original_answer": "Duke Energy's gas utility operations expect an increase in the number of commercial and industrial customers over time, particularly in North Carolina, South Carolina, Ohio, and Kentucky. Southern Company, on the other hand, relies heavily on regulated rate recovery mechanisms to offset rising environmental compliance costs, which include upgrades to gas distribution infrastructure and compliance with GHG regulations. However, Southern Company also acknowledges that increased costs recovered through regulated rates could lead to reduced demand for natural gas from commercial and industrial customers—many of whom may be directly impacted by environmental requirements such as emission limits or carbon constraints. If these regulations lead to operational changes or reduced production among industrial users, the anticipated growth in commercial gas demand may not materialize, thereby undermining the effectiveness of rate recovery mechanisms and creating financial pressure on Southern Company's gas operations.",
      "llm_answer": "Duke Energy projects that its residential, commercial and industrial customer base will grow in the Carolinas, Ohio and Kentucky, which would expand its gas‑sales revenue base (see Duke Energy 10‑K, “GAS UTILITIES AND INFRASTRUCTURE,” p. 15‑19).  Southern Company recovers its environmental‑compliance outlays largely through regulated rate‑setting, so a shrinkage of the commercial‑industrial customer base would reduce the rate base and the revenue available to cover those costs, potentially forcing higher rates for remaining customers or requiring Southern to absorb a larger share of the compliance expense (see Southern Company 10‑K, “Environmental Matters,” p. 87‑91).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) There are no numeric values in the question or ground truth that require verification—both focus on qualitative trends and mechanisms—so quantitative accuracy is not compromised. (2) The LLM correctly identifies Duke Energy's expected customer growth in the specified regions (Carolinas, Ohio, Kentucky), though it adds 'residential' not emphasized in the original; this is a minor addition but not factually incorrect. (3) The core multi-hop reasoning is sound: it connects Duke Energy’s expanding customer base to Southern Company’s reliance on regulated rate recovery, then explains how declining commercial-industrial demand (due to environmental regulations) would reduce the rate base, undermining cost recovery. This mirrors the original logic. (4) The LLM cites relevant sections of the 10-Ks (e.g., 'Environmental Matters' for Southern Company), enhancing credibility. The only slight gap is that it does not explicitly mention that Southern Company’s own operations may face financial pressure due to failed demand growth expectations, which the original answer emphasizes. However, the implication is present through the discussion of reduced revenue and potential rate hikes. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong cross-company synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 386,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "Given that Comcast's Class B shares carry 15 votes each and represent 33 1/3% of the combined voting power, how does the absence of repurchase activity for these shares (only Class A shares were repurchased in 2023) impact Mr. Roberts' ownership control relative to the broader shareholder base?",
      "original_answer": "Comcast's Class B shares, which carry 15 votes per share and represent 33 1/3% of the combined voting power, are not being repurchased, while Class A shares (with fewer votes) are being actively repurchased. This selective repurchase activity reduces the number of outstanding Class A shares, thereby increasing the relative voting influence of the non-repurchased Class B shares. Since Mr. Brian L. Roberts owns all outstanding Class B shares, this dynamic strengthens his control over corporate decisions, even as the broader shareholder base sees its equity diluted through the retirement of Class A shares.",
      "llm_answer": "Mr. Roberts owns all of Comcast’s Class B shares, which account for 33 ⅓ % of the company’s voting power (Holders table, p. 31). Because no Class B shares were repurchased in 2023, his voting stake remains unchanged, while the repurchase of only Class A shares (Share Repurchases table, p. 31) reduces the number of Class A shares outstanding and therefore the voting power available to other shareholders—strengthening Mr. Roberts’ relative control.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Mr. Roberts owns all Class B shares, which carry 15 votes per share and represent 33 1/3% of voting power; only Class A shares were repurchased in 2023; Class B shares were not repurchased. These facts align with the original answer. (2) Quantitative accuracy is perfect: the percentage (33 1/3%) is correctly stated, and there are no calculations required beyond correct interpretation of voting power distribution. Format (33 1/3 vs 33 ⅓) is semantically equivalent. (3) The reasoning is sound: the LLM correctly infers that not repurchasing Class B shares preserves Mr. Roberts’ voting stake, while repurchasing Class A shares reduces their outstanding count, thereby increasing the relative voting weight of Class B shares. This strengthens Mr. Roberts’ control—a correct multi-hop synthesis of ownership structure and repurchase activity. (4) The only minor omission is that the LLM does not explicitly mention that Class B shares carry 15 votes each, though this is implied in the context of disproportionate voting power. The ground truth includes this detail, but the LLM still reaches the correct conclusion about enhanced control. Overall, the answer is factually complete, logically sound, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 375,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does the contractual structure of Amgen's performance units, which are subject to specific payout simulations based on stockholder returns, compare to Bristol-Myers Squibb's exposure to financial agreements that include counterparty credit risk mitigation strategies, particularly in terms of payout or risk management predictability?",
      "original_answer": "Amgen's performance units in 2023 were valued at $121 million and are subject to payout simulations that model stockholder returns based on correlations and volatilities of comparator company stocks over the performance period, as dictated by contractual terms. This creates a structured but variable payout mechanism tied to relative performance metrics. In contrast, Bristol-Myers Squibb enters into financial agreements that include counterparty credit risk mitigation strategies such as limiting exposure to individual counterparties, using conventional instruments, and requiring high credit quality standards. These strategies are designed to ensure predictability and minimize financial risk in derivative and other financial instrument transactions. The contractual frameworks differ in that Amgen’s focus is on performance-linked payout predictability, while BMY emphasizes counterparty risk control and financial stability in its agreements.",
      "llm_answer": "Amgen’s performance‑unit awards are contingent on a three‑year “payout simulation” that models stock‑holder returns versus a comparator group; the actual number of units (and thus shares) earned depends on market performance and the achievement of performance goals, making the payout highly variable and difficult to predict (Amgen 10‑K, pp. 122‑128).  \nIn contrast, Bristol‑Myers Squibb’s financial agreements are structured with counterparty‑credit‑risk mitigation—limits on exposure to any single counterparty, use of high‑quality counterparties, and no collateral requirement—so that the risk of default is actively managed and the resulting cash‑flow payouts are more predictable and stable (BMS 10‑K, pp. 95‑99).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, while the original answer specifies Amgen's performance units were valued at $121 million in 2023, the LLM answer does not include this dollar figure. However, no explicit request for numerical values was made in the question, and the absence does not undermine the core comparison about payout structure and risk predictability. All other factual elements are correct. (2) The LLM correctly identifies the three-year payout simulation for Amgen tied to stockholder returns versus a comparator group, accurately reflecting the variable and market-dependent nature of the payout. (3) For Bristol-Myers Squibb, the LLM correctly describes counterparty credit risk mitigation strategies—limits on exposure, use of high-quality counterparties, and no collateral requirement—as found in the BMS 10-K, which supports predictable cash flows. The original answer mentions 'conventional instruments' and 'high credit quality standards,' which are semantically consistent with the LLM’s phrasing. (4) The reasoning is sound: the LLM synthesizes information across two companies and contrasting financial mechanisms—performance-based payouts vs. risk-mitigated financial agreements—and draws a valid comparison regarding predictability. The only minor omission is the lack of the $121M valuation from Amgen, which adds quantitative context but is not central to the structural comparison. Wording differs slightly (e.g., 'more predictable and stable' vs. 'focus on performance-linked payout predictability'), but semantic equivalence is maintained. Overall, the answer is factually correct, contextually relevant, and demonstrates strong multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 471,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does MetLife's exposure to derivatives governed by ISDA Master Agreements under the Orderly Liquidation Authority compare to Bank of America's resolution planning risks, given both companies' regulatory obligations under Dodd-Frank?",
      "original_answer": "MetLife manages credit risk in its derivatives transactions through ISDA Master Agreements that allow for close-out netting, which is subject to financial regulations such as the Orderly Liquidation Authority (OLA) under Dodd-Frank. This means that in the event of a counterparty's bankruptcy, MetLife can offset receivables and apply collateral without being subject to the automatic stay. Similarly, Bank of America Corporation is required to submit resolution plans to the FDIC and Federal Reserve that outline a 'single point of entry' strategy under the U.S. Bankruptcy Code or potentially the OLA. If Bank of America were resolved under the OLA, the FDIC could replace the corporation with a bridge holding company, and security holders could face significant losses. Both firms are therefore subject to Dodd-Frank provisions that alter the treatment of their financial obligations and risk profiles during insolvency, with MetLife exposed through its derivative contracts and BAC through its parent company resolution strategy.",
      "llm_answer": "MetLife’s derivative exposure is limited to counter‑party risk that is mitigated by its ISDA Master Agreements, which provide set‑off and close‑out netting and, under the Orderly Liquidation Authority (Title II of Dodd‑Frank), allow the company to offset receivables against payables and apply collateral without an automatic stay.  By contrast, Bank of America, as a G‑SIB, must file a resolution plan with the FDIC and Federal Reserve and could be subject to FDIC‑led orderly liquidation under Dodd‑Frank, which would impose severe capital and liquidity constraints and potentially wipe out shareholder value.  Thus, MetLife’s risk is largely derivative‑specific and mitigated by netting, whereas Bank of America’s risk is systemic and tied to potential FDIC intervention and capital loss.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in emphasis. (1) All factual elements are correct: MetLife's use of ISDA Master Agreements with close-out netting under the Orderly Liquidation Authority (OLA) is accurately described, including the ability to offset receivables and apply collateral without being subject to automatic stay. Similarly, Bank of America's status as a G-SIB requiring resolution plans and potential FDIC-led liquidation under Dodd-Frank is correctly outlined, including the risk of shareholder losses and capital constraints. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes regulatory obligations under Dodd-Frank for both companies, distinguishing between MetLife’s derivative-specific exposure and BAC’s systemic resolution risks. The mention of 'single point of entry' is implied in the LLM’s reference to FDIC-led liquidation, though not explicitly named—this minor omission prevents a perfect 10 on qualitative accuracy. (4) The answer is contextually fully relevant, directly addressing the comparison of derivative exposure and resolution planning risks under Dodd-Frank. Wording differs slightly (e.g., 'wipe out shareholder value' vs 'security holders could face significant losses'), but semantic equivalence is maintained. Overall, the response is factually correct, well-reasoned, and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 424,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does Nike's revenue from the Greater China region, which includes Taiwan, compare to Starbucks' store count in Taiwan specifically, and what might this suggest about their relative market presence in that geographic area?",
      "original_answer": "Nike generated $7,547 million in revenue from the Greater China region in 2022, which includes Taiwan along with mainland China and Hong Kong. In contrast, Starbucks operated 544 stores in Taiwan as of October 2, 2022. Given that Nike's revenue figure represents a broader regional performance across multiple countries while Starbucks' store count is specific to Taiwan, the comparison highlights different dimensions of market presence—Nike's being revenue-based across a larger geographic cluster, and Starbucks' being operationally focused with a localized footprint in Taiwan.",
      "llm_answer": "Nike’s FY 2022 revenue from the Greater China region (which includes Taiwan) was **$7.547 billion** (Nike 10‑K, p. 86‑90).  Starbucks, by contrast, operated **544 licensed stores in Taiwan** as of October 2 2022 (Starbucks 10‑K, p. 10‑14).  This comparison shows that while Nike generates substantial sales volume across Greater China, Starbucks has a far larger physical footprint in Taiwan, indicating a stronger local retail presence relative to Nike’s sales‑driven market penetration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Nike's FY 2022 revenue from the Greater China region as $7.547 billion (equivalent to $7,547 million in the ground truth), and Starbucks' store count in Taiwan as 544 as of October 2, 2022—both figures are factually accurate and properly attributed to the respective 10-K filings. Number formats are acceptable variations (billion vs. million). (2) All quantitative data points match the original answer exactly; no calculations were required, but the comparison is presented accurately. (3) The reasoning is largely sound: it identifies that Nike’s metric is revenue across a broad region (Greater China), while Starbucks’ is a localized operational footprint (stores in Taiwan only). However, the LLM slightly mischaracterizes the implication by stating Starbucks has a 'far larger physical footprint in Taiwan, indicating a stronger local retail presence relative to Nike’s sales-driven market penetration.' This implies a direct comparison of scale between revenue and store count, which the ground truth avoids; the original answer emphasizes that the metrics reflect different dimensions of market presence rather than asserting relative strength. Thus, the qualitative reasoning is slightly overreaching in interpretation. (4) Despite this nuance, the LLM captures the core multi-hop synthesis—comparing two companies' geographic metrics from different filings, correctly identifying scope differences, and contextualizing market presence. Hence, correctness is high but not perfect due to interpretive overstatement.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 432,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does the $5.0 billion upfront payment from American Tower Corporation in March 2015 compare to the $2.8 billion received from Vertical Bridge in December 2024 in terms of Verizon's retained obligations and asset treatment related to the exclusive rights transactions?",
      "original_answer": "The $5.0 billion transaction with American Tower in 2015 and the $2.8 billion transaction with Vertical Bridge in 2024 both involved Verizon transferring exclusive rights to operate wireless towers while retaining ownership and depreciation responsibilities. In both cases, Verizon subleases capacity back from the acquiring entity and continues to include the towers in 'Property, Plant and Equipment - Net' on its balance sheet. However, the Vertical Bridge deal resulted in a $2.0 billion prepaid rent and $830 million financing obligation split based on usage, whereas the American Tower deal did not specify such a breakdown, indicating a potentially different structure in how the financing and lease obligations were allocated between the two transactions.",
      "llm_answer": "Verizon’s 2015 deal with American Tower left the towers on its books as property, plant and equipment and it continues to depreciate them, while it remains the primary obligor for the underlying ground leases. The 2024 transaction with Vertical Bridge likewise keeps the towers on Verizon’s balance sheet and the company remains the primary ground‑lease obligor, but it also records a $2.0 billion prepaid‑rent liability and an $830 million financing obligation for the portion of towers Verizon still occupies—entries that were not required under the 2015 American Tower transaction.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $5.0 billion 2015 American Tower deal and $2.8 billion 2024 Vertical Bridge deal are correctly dated and sized; both transactions involve Verizon retaining ownership and depreciation responsibilities while keeping towers on its balance sheet under 'Property, Plant and Equipment - Net'; and the $2.0 billion prepaid rent and $830 million financing obligation from the Vertical Bridge deal are accurately reported. (2) Quantitative accuracy is perfect: all dollar amounts and years match the original answer exactly, with no calculation errors. (3) The multi-hop reasoning is sound—LLM correctly synthesizes that both deals share similar asset treatment and retained obligations but differ in accounting entries, specifically noting the absence of prepaid rent and financing obligations in the 2015 deal. (4) The only minor shortcoming is that the LLM does not explicitly state that the American Tower deal 'did not specify' such a breakdown (as the ground truth notes), instead saying such entries 'were not required,' which slightly overinterprets the reason. However, this does not undermine the factual correctness. The answer is contextually complete and directly addresses the comparison in retained obligations and asset treatment. Thus, a score of 9 is warranted—excellent but not perfect in qualitative nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 393,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does JPMorgan's operational risk capital estimation under Basel III, which includes fraud risk as a key component, compare to Citigroup's exposure to fraud-related losses in emerging markets, particularly in scenarios involving asset confiscation or loss of control in Russia?",
      "original_answer": "JPMorgan uses the Advanced Measurement Approach (AMA) under Basel III to estimate operational risk capital, incorporating internal and external losses, scenario analysis, and business environment metrics, with fraud being a key risk category. Meanwhile, Citigroup reports exposure to fraud and political instability in emerging markets, with a specific scenario in Russia involving potential losses of $1.6 billion in CTA (Cumulative Translation Adjustment) and $0.9 billion on intercompany liabilities if control of AO Citibank is lost. These figures highlight how both firms face fraud-related risks but experience them through different financial mechanisms and geographic exposures.",
      "llm_answer": "JPMorgan’s Basel III operational‑risk capital is calculated under the Advanced Measurement Approach, which explicitly treats fraud risk as a key component of its loss‑distribution model and scenario analysis (JPM pages 153‑157). In contrast, Citi’s 10‑K discloses a concrete exposure to fraud‑related losses in emerging markets, noting that a loss of control of AO Citibank in Russia could trigger a CTA loss of roughly $1.6 billion and an additional $0.9 billion inter‑company liability loss (Citi pages 62‑66). Thus, while JPMorgan’s capital buffer is a quantified risk‑weighted amount that incorporates fraud risk, Citi’s exposure is presented as a potential loss scenario with specific dollar figures.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the $1.6 billion CTA loss and $0.9 billion intercompany liability loss for Citigroup in the Russia scenario are accurately reported, with acceptable formatting. (2) The explanation of JPMorgan’s use of the Advanced Measurement Approach (AMA) under Basel III, including fraud risk in loss-distribution modeling and scenario analysis, aligns with the original answer. (3) The multi-hop reasoning is sound: the model correctly contrasts JPMorgan’s forward-looking capital estimation framework with Citigroup’s specific, disclosed loss scenario in Russia, highlighting different financial mechanisms (capital modeling vs. potential realized losses). (4) Entities are accurate—JPMorgan, Citigroup, AO Citibank, fraud risk, emerging markets, Russia, CTA, intercompany liabilities—and the synthesis across firms and risk types is appropriate. (5) The semantic meaning is equivalent to the original answer, with slightly more detailed referencing (e.g., page numbers), but no factual deviations. All components of the question are addressed with precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 324,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact Qualcomm's chipset supply chain differently than Intel's operational footprint in the region, given Qualcomm's reliance on Taiwan-based foundry partners and Intel's $6.867 billion in 2023 revenue tied to the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan would impact Qualcomm and Intel through different mechanisms. For Qualcomm, the risk is operational, as the company explicitly states its 'business depends on our ability to receive consistent and reliable chipset supply from our foundry partners, particularly in Taiwan.' A disruption would 'severely limit or prevent us from receiving chipset supply,' directly threatening its product availability. In contrast, Intel's exposure is primarily financial, with $6.867 billion in 2023 revenue tied to Taiwan, but no explicit mention of reliance on Taiwan-based manufacturing in its disclosures. While both face risks from instability in Taiwan, Qualcomm's dependency is on supply continuity, whereas Intel's is on market demand and revenue generation in the region.",
      "llm_answer": "Qualcomm’s supply chain is heavily dependent on Taiwan‑based foundry partners; a prolonged conflict could severely limit or halt its ability to receive chipsets, creating a material adverse impact on its business【35】. In contrast, Intel’s $6.867 billion of 2023 revenue from Taiwan is part of a broader, more diversified regional mix (China, Singapore, U.S., and other regions), so while the conflict would affect that revenue stream, Intel’s overall operational footprint is less concentrated and could absorb the shock more readily【34】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $6.867 billion figure for Intel's 2023 revenue tied to Taiwan is correctly stated, matching the original answer. No other numerical values are present, and all are accurate. (2) The answer correctly identifies Qualcomm’s reliance on Taiwan-based foundries as a supply chain risk and Intel’s exposure as primarily financial, which reflects the core distinction in the ground truth. (3) The multi-hop reasoning is sound: it synthesizes Qualcomm’s operational dependency with Intel’s regional revenue concentration and contrasts their risk profiles—supply continuity vs. market demand. (4) While the LLM adds that Intel’s footprint is 'more diversified' across regions (China, Singapore, U.S.), this is a reasonable inference and does not contradict the original; however, the original emphasizes Intel’s lack of reliance on Taiwan *manufacturing*, whereas the LLM focuses on revenue diversification. This is a subtle but acceptable rephrasing. The answer omits the exact quote from Qualcomm about 'severely limit or prevent us from receiving chipset supply,' but captures the meaning. Overall, the semantic content and factual accuracy are excellent, warranting a 9/10 correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 357,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How does RTX's valuation methodology for private equity limited partnerships differ from BA's approach to valuing Level 3 assets measured on a nonrecurring basis, given that both companies report these investments through fair value processes?",
      "original_answer": "RTX values its private equity limited partnerships on a quarterly basis using discounted cash flows, earnings multiples, and market multiples, with valuation adjustments reflecting changes in operating results, financial condition, or prospects of the applicable portfolio company. In contrast, BA applies an income approach based on discounted cash flows for Level 3 assets measured on a nonrecurring basis, such as impaired customer financing assets, which include operating lease equipment and investments in finance leases valued using median collateral values from third-party aircraft publications. While RTX actively adjusts valuations quarterly based on portfolio company performance, BA relies on third-party publications and adjusts values only under specific circumstances, such as unique aircraft attributes or expected net sales prices.",
      "llm_answer": "RTX values its private‑equity limited‑partnership interests by applying the net‑asset‑value per unit reported by the fund administrator as a practical expedient to fair value—an approach that is used on a recurring basis.  By contrast, BA values Level 3 assets on a non‑recurring basis using an income approach that discounts the expected cash flows of each asset, incorporating significant unobservable inputs and detailed modeling for each type of asset.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but diverges significantly from the ground truth in key aspects. While both RTX and BA use fair value processes, the LLM incorrectly states that RTX uses the net asset value (NAV) per unit reported by fund administrators as a practical expedient. The ground truth specifies that RTX uses discounted cash flows, earnings multiples, and market multiples with active quarterly adjustments based on portfolio company performance—not NAV as a practical expedient. This is a major factual inaccuracy. For BA, the LLM correctly identifies the use of an income approach with discounted cash flows and significant unobservable inputs, which aligns with the ground truth description of Level 3 assets valued on a nonrecurring basis. However, it omits critical details such as the use of median collateral values from third-party aircraft publications and the specific context of impaired customer financing assets like operating lease equipment and finance leases. (2) There are no explicit numbers, dates, or dollar amounts in either the question or answers, so quantitative accuracy is not compromised by numerical errors; thus, this dimension scores higher. (3) The multi-hop reasoning is flawed because the LLM fails to accurately contrast RTX’s active, performance-based quarterly valuation methodology with BA’s reliance on third-party data and infrequent adjustments. The synthesis across companies is incomplete and based on incorrect premises for RTX. (4) The contextual relevance is moderate because the answer addresses the general topic of fair value methodologies for private equity and Level 3 assets, but the misrepresentation of RTX’s approach undermines the validity of the comparison. The omission of key differentiators—such as third-party publications for BA and the absence of NAV usage by RTX—reduces qualitative accuracy significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 518,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How does Netflix's use of forward contracts to manage foreign exchange risk on firm commitments compare to Disney's VAR model estimates in terms of potential one-day loss exposure, given the specific metrics disclosed in their respective financial reports?",
      "original_answer": "Netflix uses forward contracts to hedge foreign exchange risk on firm commitments related to foreign currency-denominated content assets, aiming to reduce cash flow volatility. However, Disney's Value at Risk (VAR) model estimates a maximum potential one-day loss of $255 million (as of September 28, 2024) across its interest rate, foreign exchange, commodities, and equity-sensitive instruments. While Netflix does not disclose a specific VAR metric, Disney's $255 million VAR figure provides a quantified estimate of its exposure, allowing for a comparative view of how each company assesses and manages financial risk in their operations.",
      "llm_answer": "Netflix’s 10‑K discloses that it uses forward contracts as cash‑flow hedges to reduce, but not eliminate, FX volatility on firm commitments, yet it does not provide a quantified one‑day loss figure for those hedges. In contrast, Disney’s 10‑K reports a VAR‑based estimate of a maximum one‑day loss of **$255 million** (combined portfolio) at year‑end fiscal 2024, with a range of $235‑$444 million across its risk categories. Thus, Netflix’s approach is qualitative and non‑quantified, whereas Disney’s model gives a specific potential loss exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the $255 million VAR figure is correctly cited, and the additional detail of a range ($235–$444 million) is consistent with Disney's disclosures, even if not in the original answer; this adds precision without contradicting the ground truth. The fiscal year-end (2024) and metric (one-day loss) are correct. (2) The LLM correctly identifies that Netflix uses forward contracts for cash-flow hedges on firm commitments but does not disclose a VAR or quantified one-day loss, which matches the original answer. (3) Multi-hop reasoning is sound: it synthesizes Netflix’s qualitative hedging approach from its 10-K with Disney’s quantitative VAR model from its filing, enabling a valid comparison of risk measurement methodologies. (4) The only minor deviation is the inclusion of a range not explicitly in the ground truth, but this likely reflects a more detailed reading of Disney’s report and does not reduce accuracy. Wording differs but semantic meaning and factual content are equivalent. All entities (Netflix, Disney, forward contracts, VAR, fiscal 2024) are correct. The answer fully addresses the comparative aspect of the question regarding potential one-day loss exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 355,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the corporate income tax rate reduction in the Philippines enacted in Q1 2021 impact AMD's tax provision compared to Texas Instruments' operational investments in the country, given both companies' exposure to international tax regulations?",
      "original_answer": "The corporate income tax rate reduction in the Philippines enacted in Q1 2021 had a favorable impact on AMD’s effective tax rate by partially offsetting increases from other tax factors, such as GILTI-related foreign tax credit limitations. Meanwhile, Texas Instruments had $370 million in property, plant, and equipment at its two sites in the Philippines as of December 31, 2021, indicating significant operational exposure that would be directly affected by the lower tax rate. AMD’s 2021 effective tax rate increased by 0.1 percentage point to 21.8%, with the Philippines tax reduction noted as a mitigating factor, while TXN’s capital investment in the country suggests a strategic commitment that would benefit from the lower corporate tax rate.",
      "llm_answer": "The pages supplied (the PMI 10‑K excerpts) contain no reference to AMD’s tax provision or Texas Instruments’ Philippine operations. Consequently, the requested comparison of the Philippine tax‑rate reduction’s effect on AMD versus TI cannot be drawn from the provided material.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is completely incorrect in the context of the evaluation. The question and ground truth reference specific information about AMD and Texas Instruments related to the Philippines' corporate tax rate reduction in Q1 2021 and its impact on tax provisions and operational investments. However, the LLM claims that the provided material (PMI 10-K excerpts) contains no relevant information, which suggests it either misidentified the source documents or failed to access the correct data. The ground truth contains precise quantitative and qualitative details: AMD’s effective tax rate increased by 0.1 percentage point to 21.8% in 2021, with the Philippines tax reduction acting as a mitigating factor against other tax headwinds like GILTI; Texas Instruments had $370 million in property, plant, and equipment in the Philippines as of December 31, 2021. These specific figures and multi-hop synthesis between tax policy impact and company-specific financial responses are entirely missing from the LLM response. The LLM did not attempt any factual retrieval or reasoning, instead defaulting to a refusal based on perceived lack of source material. Therefore, it fails on all dimensions: no numbers are correct (quantitative accuracy), no entities or reasoning are properly engaged (qualitative accuracy), and the response does not address the actual question despite the information being available in the expected knowledge base (contextual relevance).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 402,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How do GM's and McDonald's different approaches to affiliate relationships reflect their respective business models, particularly in terms of vehicle production and franchise operations?",
      "original_answer": "GM engages in transactions with nonconsolidated affiliates for the development, production, and marketing of trucks, crossovers, cars, and automobile parts, which are integral to its automotive manufacturing business model. These affiliates are primarily located in China and produce vehicles under the Baojun, Buick, Cadillac, Chevrolet, and Wuling brands. In contrast, McDonald's relies on affiliates for franchise operations, where revenues are generated through royalties based on a percentage of sales and initial fees. This reflects McDonald's asset-light business model centered on franchising and brand licensing. While GM's affiliate relationships are production-focused and tied to physical goods, McDonald's approach emphasizes service-based revenue through franchisee support and brand management, highlighting the distinct operational structures of the two companies.",
      "llm_answer": "GM’s affiliate strategy is built around joint‑venture and equity‑method investments in vehicle‑production and supply‑chain partners—such as its Chinese JV’s and battery‑cell manufacturing VIEs—so that it can influence manufacturing decisions and secure parts for its global automotive operations (GM Note 8, pages 101‑105). In contrast, McDonald’s affiliates are primarily franchisees and developmental licensees that operate restaurants independently; the company consolidates only its own operations and accounts for affiliates via the equity method, reflecting a franchise‑based model where revenue comes from royalties and lease payments rather than direct production (MCD Nature of Business, pages 44‑45; Revenue Recognition, page 47).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies GM's affiliate relationships as production-focused joint ventures and variable interest entities (VIEs), particularly in China, which supports its automotive manufacturing model. It also accurately characterizes McDonald's affiliate model as franchise-based, generating revenue through royalties and lease payments, reflecting its asset-light structure. While the original answer emphasizes brand names (Baojun, Buick, etc.) and specifies that GM's affiliates are involved in development, production, and marketing, the LLM answer captures the core operational distinction—GM's production orientation vs. McDonald's service/franchise orientation—without misrepresenting any facts. (2) There are no numerical values in the question or answers, so quantitative accuracy is not applicable; however, the LLM correctly references specific note numbers and page ranges from the SEC filings (e.g., GM Note 8, pages 101–105; MCD pages 44–45, 47), which supports its factual grounding. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies and their distinct use of affiliates, correctly contrasting GM’s manufacturing-driven equity-method investments with McDonald’s franchise-centric revenue model. (4) The only minor omission is the lack of specific brand names (e.g., Baojun, Wuling) under GM’s affiliates, which were present in the original answer and add contextual richness, but this does not detract from the core accuracy. Wording differs but semantic meaning is equivalent. Thus, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 467,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "Given Alphabet's significant share repurchase activity of $62.0 billion in Class A and Class C shares in 2024, and the automatic conversion of Class B shares to Class A upon sale or transfer, how might the reduction in outstanding Class A shares impact the relative voting power of remaining Class B shareholders, especially in light of the fact that Class B shares carry 10 votes per share compared to 1 vote for Class A?",
      "original_answer": "Alphabet repurchased $62.0 billion of Class A and Class C shares in 2024, reducing the number of outstanding Class A shares. Since Class B shares convert automatically to Class A shares upon sale or transfer, this limits the ability of Class B holders to retain higher-vote shares if they transact. With fewer Class A shares in circulation due to buybacks, the relative voting concentration among remaining Class B shareholders—who hold 10 votes per share—would increase, potentially consolidating control among long-term holders.",
      "llm_answer": "Alphabet’s $62.0 billion repurchase of Class A (and Class C) shares in 2024 sharply reduces the number of 1‑vote shares outstanding. Because Class B shares retain 10 votes each and only convert to Class A upon sale or transfer, the remaining Class B holders now command a larger proportion of the total voting power, giving them greater relative influence over corporate decisions. This shift amplifies the leverage of long‑term Class B shareholders in the company’s governance structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $62.0 billion share repurchase amount and the year 2024 are correctly stated, matching the original answer. There are no calculations required beyond correct interpretation of the amount and year, which are accurate. (2) The LLM correctly identifies that the repurchase targeted Class A and Class C shares, reducing the number of 1-vote shares outstanding—this is factually consistent with the original. (3) The reasoning is sound: by reducing the pool of low-vote shares (Class A and C), the relative voting power of the remaining high-vote Class B shares (10 votes per share) increases, especially since Class B shares only convert to Class A upon sale or transfer, which preserves their superior voting rights if not transacted. The LLM captures this dynamic clearly, noting the increased proportion of voting power held by Class B shareholders. (4) The only minor omission is that the original answer explicitly mentions the 'automatic conversion upon sale or transfer' as a constraint on Class B holders’ ability to retain high-vote shares, which the LLM implies but does not emphasize as strongly. However, the core multi-hop logic—buybacks reduce Class A shares → total voting denominator shifts → Class B holders gain relative control—is correctly synthesized. Wording differs slightly but the semantic meaning and factual content are equivalent. All entities (Alphabet, Class A/B/C shares, 2024, $62.0 billion) are correct. Thus, the answer is excellent, meriting a 9/10 for correctness due to slightly less emphasis on the conversion constraint, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 467,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does the adoption of ASU No. 2020-01 impact the accounting treatment for equity securities by both Colgate-Palmolive and The Coca-Cola Company, particularly in light of the clarification provided by the standard on the interaction between equity securities, equity method investments, and derivative contracts?",
      "original_answer": "ASU No. 2020-01 clarifies the interaction between the accounting for equity securities under Topic 321, equity method investments under Topic 323, and derivative contracts under Topic 815. Colgate-Palmolive adopted this guidance effective January 1, 2021, and concluded that it did not have a material impact on its Consolidated Financial Statements. Similarly, The Coca-Cola Company, which is also subject to the same accounting standard, applies the clarified guidance to its equity securities, including the calculation of net unrealized gains and losses recognized during the year related to equity securities still held at the end of the year (as disclosed in its financial statements). Both companies benefit from the standard’s clarification on when observable transactions should be considered before applying or upon discontinuing the equity method, and how derivatives linked to equity securities should be accounted for without considering whether the underlying securities would be accounted for under the equity method or fair value option.",
      "llm_answer": "ASU 2020‑01 clarifies that equity securities that are also the subject of forward contracts or purchase options should not be considered when deciding whether to apply the equity‑method or the fair‑value option, and it explains how equity‑method investments, equity securities and derivatives interact (Colgate‑Palmolive, pp. 79‑83; Coca‑Cola, pp. 78‑82). Both companies adopted the standard effective January 1, 2021 and each stated that the guidance had no material impact on their consolidated financial statements. Accordingly, they continue to measure non‑equity‑method securities at fair value, equity‑method investments at cost plus observable price changes, and derivatives are accounted for separately.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: ASU No. 2020-01's clarification on the interaction between equity securities (Topic 321), equity method investments (Topic 323), and derivatives (Topic 815) is correctly summarized. The adoption date of January 1, 2021, is accurate for both Colgate-Palmolive and The Coca-Cola Company, and the statement that the standard had no material impact on their financial statements matches the original answer. (2) There are no numeric inaccuracies—dates and qualitative assessments (e.g., 'no material impact') are consistent with the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across both companies and connects the standard’s technical guidance to its practical application in accounting treatment. (4) The LLM omits a minor detail present in the original answer—specifically, Coca-Cola’s disclosure of net unrealized gains and losses on equity securities still held at year-end—but this does not undermine the core correctness. The answer captures the key clarification about not considering derivative-linked securities when determining equity method applicability and correctly describes separate accounting for derivatives. Wording differs slightly but maintains semantic equivalence. Thus, the answer earns a 9/10 for correctness due to high accuracy with only a minor omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 397,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does the difference in the Stress Capital Buffer (SCB) components of the CET1 capital ratio requirements between Goldman Sachs and Citibank reflect their respective approaches to regulatory capital adequacy under the Standardized Capital Rules as of December 2024?",
      "original_answer": "As of December 2024, Goldman Sachs is subject to a Stress Capital Buffer (SCB) of 6.2% under the Standardized Capital Rules, while Citibank’s required CET1 capital ratio under the same rules is 7.0%, which includes the 4.5% minimum CET1 requirement and a fixed 2.5% Capital Conservation Buffer. This indicates that Goldman Sachs faces a higher SCB-driven capital requirement, suggesting a potentially more stringent stress-based capital adequacy assessment compared to Citibank, which does not explicitly include an SCB in its stated CET1 requirement under the Standardized Approach.",
      "llm_answer": "Goldman Sachs’ CET1 ratio under the Standardized Rules includes a 6.2 % stress‑capital buffer (SCB) as of December 2024, whereas Citibank’s CET1 ratio under the same rules incorporates only the fixed 2.5 % capital‑conservation buffer (the SCB component for Citibank)【GS_10k_2024.pdf:206-210】. This 3.7‑percentage‑point gap shows that Goldman Sachs adopts a more conservative capital‑adequacy stance—requiring a larger buffer to absorb losses under severe stress—while Citibank relies on the lower, fixed buffer mandated for all G‑SIBs under the Standardized framework【C_10k_2024.pdf:32-36】.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Goldman Sachs' SCB as 6.2% and references the 2.5% Capital Conservation Buffer (CCB) for Citibank, which aligns with the ground truth. However, it incorrectly states that Citibank's 2.5% buffer is 'the SCB component for Citibank,' conflating the CCB with the SCB. The ground truth clarifies that Citibank’s 7.0% CET1 requirement includes the 4.5% minimum plus the 2.5% CCB, but does not include an SCB under the Standardized Approach—this is a critical distinction the LLM misses. (2) The calculation of a '3.7-percentage-point gap' assumes that Citibank has a 2.5% SCB, which is factually incorrect; the SCB is not part of Citibank’s requirement under the Standardized Rules, so this comparison is invalid. The actual difference in regulatory treatment is not a simple arithmetic gap because SCB applies to Goldman Sachs but not to Citibank in this context. (3) The multi-hop reasoning fails because the model incorrectly equates the CCB with the SCB for Citibank, leading to flawed synthesis. It also draws an unsupported conclusion that Goldman Sachs 'adopts a more conservative capital-adequacy stance,' implying a voluntary or strategic choice, whereas the SCB is a regulatory requirement based on stress test outcomes, not a firm’s internal policy. (4) The contextual relevance is high because the answer addresses the regulatory capital framework and compares the two banks. However, due to the fundamental mischaracterization of Citibank’s SCB (which it does not have), the qualitative and quantitative accuracy scores are reduced significantly. The correctness score is 5 due to partial factual accuracy but major errors in financial concept application and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 470,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How do NextEra Energy's operational infrastructure investments in Indiana compare with Duke Energy Indiana's financing strategy through tax-exempt bonds as of December 31, 2023?",
      "original_answer": "NextEra Energy operates transmission infrastructure in Indiana, including 90 miles of lines and 5 substations operating at 161-345 kilovolts, as part of its broader multi-state network. Meanwhile, Duke Energy Indiana disclosed holding $285 million in tax-exempt bonds as of December 31, 2023, which represents a significant portion of its $435 million total debt portfolio. This contrast highlights different strategic focuses: NextEra's emphasis on physical infrastructure development in Indiana versus Duke Energy Indiana's reliance on tax-advantaged financing instruments to fund its operations.",
      "llm_answer": "NextEra Energy’s Indiana operations are a fully owned, rate‑regulated transmission corridor – 90 mi of line, 5 substations, 161‑345 kV, in service since 1953‑2022 (NEER p. 14‑18). By contrast, Duke Energy Indiana relies on a $352 million tax‑exempt bond program maturing 2027‑2046 to finance its infrastructure (DUK p. 161‑167). Thus, NextEra’s investment is a direct, owned asset, whereas Duke Energy funds its Indiana infrastructure through long‑term, tax‑advantaged debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies NextEra Energy's physical infrastructure in Indiana (90 miles of transmission lines, 5 substations, 161-345 kV), which matches the ground truth. However, it incorrectly states Duke Energy Indiana's tax-exempt bond amount as $352 million, whereas the ground truth specifies $285 million as of December 31, 2023. This is a significant quantitative error. Additionally, the LLM mentions a maturity range of 2027–2046, which is not present in the original answer and cannot be verified against the provided ground truth. (2) The dollar amount discrepancy ($352M vs $285M) is material and affects the accuracy of the financial comparison. The ground truth also notes that the $285M in tax-exempt bonds constitutes a portion of a $435M total debt portfolio, a contextual detail missing in the LLM response. (3) The multi-hop reasoning is partially sound: the model correctly contrasts physical asset investment (NextEra) with financing strategy (Duke), which aligns with the question’s intent. However, due to the incorrect bond value and missing context about the total debt portfolio, the synthesis is incomplete and factually flawed in key aspects. (4) The contextual relevance is high because the answer addresses the core contrast between infrastructure investment and financing strategy. Qualitative accuracy is moderate because the reasoning framework is valid, but quantitative accuracy is low due to the incorrect bond figure. Correctness score is reduced to 6 due to the major factual error in a key financial metric, despite correct identification of infrastructure details and logical structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 451,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does Apple's reliance on third-party content providers for its App Store revenue model create different business risks compared to Microsoft's strategy of producing its own content, particularly in light of Apple's changes to alternative payment processing and Microsoft's emphasis on brand reputation tied to content decisions?",
      "original_answer": "Apple's App Store revenue model depends heavily on third-party content providers, with developers retaining most of the revenue while Apple keeps a commission. This model is vulnerable to changes in developer incentives and regulatory compliance, such as Apple's recent adjustments to alternative payment processing in the EU under the DMA, which could reduce commission revenue. In contrast, Microsoft produces its own content and highlights the importance of brand reputation tied to its content decisions, noting that backlash could arise from public scrutiny or dissatisfaction with product offerings. While Apple risks losing developer support due to shifting business terms, Microsoft faces brand-related risks from its own content choices, creating fundamentally different exposure points in their respective content strategies.",
      "llm_answer": "Apple’s App Store model depends on third‑party developers, so the company faces regulatory and market risks from changes to payment processing and developer behavior; recent DMA‑related changes to alternative payment mechanisms could cut Apple’s commission and revenue (Apple, 10‑K, pp. 11‑15). In contrast, Microsoft’s strategy of producing its own content shifts the risk to brand reputation—any missteps in its own content decisions can directly affect customer perception, a risk highlighted in its 10‑K (Microsoft, 10‑K, pp. 30‑34).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Apple's reliance on third-party developers, the risk from regulatory changes like the DMA, and the potential reduction in commission revenue are accurately described. Microsoft's in-house content strategy and associated brand reputation risks are also correctly identified. (2) There are no numeric values (e.g., percentages, dollar amounts) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the model correctly contrasts Apple’s external dependency (developer and regulatory risk) with Microsoft’s internal risk (brand reputation from content decisions), synthesizing across both companies' 10-K disclosures. The citation of specific page ranges (pp. 11–15 for Apple, pp. 30–34 for Microsoft) adds precision and aligns with the knowledge graph’s grounding. (4) The only minor shortcoming is slight brevity compared to the original answer—e.g., it doesn’t explicitly mention that developers retain most of the revenue, or that backlash could come from public scrutiny, though the essence is preserved. This does not affect correctness but slightly limits completeness. Overall, the answer is semantically equivalent, contextually relevant, and factually sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 382,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the potential liability from tritium leakage at Southern Company's nuclear plants compare to the decommissioning fund shortfalls highlighted in NEE's disclosures, given both companies' exposure to nuclear health risks?",
      "original_answer": "Southern Company's nuclear facilities, which contributed approximately 26% and 28% of total KWHs generated for Alabama Power and Georgia Power respectively in 2021, face health risks including potential leakage of radioactive materials like tritium. These risks expose the company to potential liabilities that could exceed decommissioning trusts or insurance coverage. Similarly, NEE discloses that the cost of decommissioning its nuclear facilities could exceed the amounts available in decommissioning funds, leaving it exposed to additional financial risks. Both companies face comparable challenges in managing nuclear health risks, with Southern Company highlighting potential tritium exposure and NEE emphasizing the risk of decommissioning shortfalls, creating parallel financial exposures despite no direct business relationship.",
      "llm_answer": "Southern Company’s risk‑factor discussion notes that nuclear operations “could release radioactive materials, including tritium,” creating a potential environmental liability and remediation cost.  In contrast, NEE’s 10‑K warns that its nuclear decommissioning funds may be short because poor investment performance can erode the fund’s asset value, potentially requiring additional capital to meet decommissioning obligations.  Thus, Southern Company faces a possible tritium‑release liability, while NEE faces a potential shortfall in its decommissioning reserves—both reflecting nuclear‑health risks but in different financial forms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core comparison between Southern Company and NEE regarding nuclear-related financial risks. (1) There are no numeric values in the LLM answer that contradict the ground truth; while the original answer includes specific percentages (26%, 28%) of KWHs generated by nuclear facilities for Alabama and Georgia Power in 2021, the LLM answer omits these but does not introduce any incorrect numbers—this omission affects completeness but not correctness. (2) Quantitative accuracy is perfect: no incorrect figures or calculations are presented. (3) The multi-hop reasoning is sound: the model correctly identifies that Southern Company faces potential liability from tritium leakage (an operational/environmental risk), while NEE faces decommissioning fund shortfalls (a financial reserve risk), and both relate to nuclear health risks. The synthesis across the two companies is accurate and logically framed. (4) The answer is contextually relevant and directly addresses the question’s focus on comparing financial exposures from nuclear health risks. The only minor shortcoming is the lack of specific quantitative context from Southern Company’s nuclear generation share, which adds granularity but does not alter the fundamental correctness. Thus, the answer is semantically equivalent in intent and meaning, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 383,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the corporate income tax rate reduction in the Philippines, enacted in Q1 2021, impact both Altria's (MO) effective tax rate and Coca-Cola's (KO) capital investment strategy, given their respective exposures to the Philippine market?",
      "original_answer": "The corporate income tax rate reduction in the Philippines, enacted in Q1 2021, favorably impacted Altria's (MO) effective tax rate in 2021, contributing to a 0.1 percentage point increase to 21.8%. This suggests that Altria benefited from lower tax liabilities on its Philippine-related earnings. Meanwhile, Coca-Cola (KO) maintained a significant capital investment in the Philippines, with property, plant, and equipment in the country representing 10% of its consolidated PPE net as of December 31, 2021 and 2020. The tax cut likely improved the after-tax return on KO's Philippine operations, reinforcing its sustained capital commitment. Therefore, the tax reform positively influenced both companies’ financial positioning in the region, with MO seeing a direct tax benefit and KO maintaining a stable long-term asset base.",
      "llm_answer": "Altria’s 10‑K (pages 94‑98) notes that the reduction in the Philippine corporate income tax rate enacted in Q1 2021 helped lower its effective tax rate to 21.8 % for 2021 (down from 21.7 % in 2020). Coca‑Cola’s 10‑K (pages 122‑126) explains that the lower tax rate in the Philippines reduces the after‑tax cost of capital for projects there, encouraging the company to allocate more capital to Philippine operations as part of its investment strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a factual error in the direction of the change in Altria's effective tax rate. The ground truth states that the Philippine tax rate reduction contributed to a 0.1 percentage point *increase* in Altria’s effective tax rate to 21.8%, not a decrease from 21.7% to 21.8%. This misrepresents the impact: a higher effective tax rate is not a benefit and contradicts the claim that the reform lowered it. The LLM incorrectly frames the 21.8% as a reduction when it is actually a slight increase, which undermines the quantitative and qualitative accuracy. (2) The number 21.8% is correct, and the reference to Q1 2021 enactment aligns with the ground truth, but the comparison to 2020 (21.7%) implies a decrease, which is factually wrong per the original answer. There is no mention of the 0.1 percentage point *increase* due to the tax change, which is a key nuance. For Coca-Cola, no specific numbers are provided in the LLM answer (e.g., 10% of PPE), which omits a critical quantitative anchor from the ground truth. (3) The reasoning for Coca-Cola is plausible—lower tax rates reducing after-tax cost of capital and encouraging investment—but the LLM claims this leads to allocating *more* capital, while the ground truth states that KO *maintained* a stable capital investment (10% of PPE in both 2020 and 2021). Thus, the LLM infers an expansionary strategy not supported by the data, which showed stability, not increased allocation. This reflects a failure in multi-hop synthesis: the model infers a strategic shift when the evidence shows continuity. (4) Despite these errors, the answer is contextually relevant, addresses both companies, and correctly identifies the Philippine tax change as a factor. It draws reasonable causal links, even if the direction of impact and magnitude are incorrect. The qualitative reasoning is sound in structure but flawed in factual alignment, warranting moderate scores in accuracy but high relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 533,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How might Samsung's dual role as a supplier to NVIDIA for semiconductor wafer production and as a competitor to Qualcomm in the integrated circuit market impact Qualcomm's $12.8 billion in multi-year capacity purchase commitments, particularly if Samsung prioritizes its own product lines over external manufacturing demand?",
      "original_answer": "Samsung plays a critical role in NVIDIA's supply chain, producing semiconductor wafers for the company (Hop 1). At the same time, Samsung develops and produces its own integrated circuit products, directly competing with Qualcomm in this space (Hop 2). Qualcomm has $12.8 billion in multi-year capacity purchase commitments tied to its integrated circuit product manufacturing (Hop 3). If Samsung prioritizes its own competitive product lines over external manufacturing obligations, including those to Qualcomm, it could lead to capacity constraints or increased costs for Qualcomm. This would put pressure on Qualcomm’s ability to meet its manufacturing needs under existing commitments, potentially requiring renegotiation of terms or impacting margins if alternative suppliers must be sourced at higher costs.",
      "llm_answer": "Samsung’s dual role could squeeze the supply capacity that Qualcomm relies on.  Samsung supplies NVIDIA’s wafers (NVDA 10‑K, p. 10) while also competing with Qualcomm by producing its own ICs (QCOM 10‑K, p. 17‑21).  If Samsung prioritizes its own product lines, it may allocate more foundry capacity to its devices, reducing the capacity available to external customers and potentially limiting Qualcomm’s ability to meet its $12.8 billion in multi‑year purchase commitments or forcing renegotiation of those obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Samsung supplies wafers to NVIDIA (Hop 1), competes with Qualcomm in ICs (Hop 2), and Qualcomm has $12.8 billion in multi-year capacity commitments (Hop 3). The dollar amount is correctly stated and matches the original. (2) Quantitative accuracy is perfect: $12.8 billion is accurately reported with no calculation errors. (3) The reasoning correctly synthesizes the multi-hop logic: Samsung’s dual role as supplier and competitor creates potential capacity conflicts; if Samsung prioritizes its own products, Qualcomm’s access to foundry capacity could be constrained, impacting its ability to meet commitments. The conclusion about renegotiation or supply limitations is logically sound and matches the original. (4) The only minor shortcoming is that the LLM answer does not explicitly mention increased costs or margin pressure from sourcing alternatives, which is part of the original answer’s impact analysis. However, the core implications—capacity limits and obligation renegotiation—are covered. Wording differs slightly but maintains semantic equivalence. Citations to 10-K pages add precision but are not required for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 348,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the impact of Lockheed Martin's commercial customer receivables on United Launch Alliance's financial position, given Boeing's equity stake in ULA and its reported income from the joint venture?",
      "original_answer": "Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes entities like ULA. ULA is a key commercial customer for Lockheed Martin through its Space segment, where Lockheed holds a 50% ownership interest. Boeing also holds the other 50% and reported $125 million in equity income from ULA in 2024. This suggests that ULA’s financial performance is significant to both companies, and Lockheed’s exposure to ULA through receivables and ownership could influence its contract asset management and overall liquidity. Therefore, any financial strain on ULA could affect both Lockheed’s $665 million commercial receivables and Boeing’s equity income.",
      "llm_answer": "Lockheed Martin’s commercial‑customer receivables total about $665 million (expected to be collected in 2025) and form part of the revenue that United Launch Alliance (ULA) earns from its launch services.  Because Boeing owns 50 % of ULA, Boeing records a proportional share of ULA’s earnings – reported as part of its income from the joint venture – so the receivables indirectly lift ULA’s earnings and, by extension, Boeing’s reported income from the joint venture.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer correctly identifies Lockheed Martin's $665 million in commercial customer receivables and Boeing's 50% ownership in ULA, which aligns with the ground truth. It also correctly notes that Boeing reports income from its equity stake in ULA, though it does not specify the $125 million figure reported by Boeing in 2024, which is a significant omission. 2) Quantitatively, the $665 million receivables figure is accurate and correctly attributed to Lockheed Martin. However, the LLM fails to mention Boeing’s $125 million equity income from ULA in 2024, a key data point in the original answer. The timing (2025 collection) is plausible but not explicitly confirmed in the ground truth. 3) The reasoning is partially sound but flawed in synthesis: the LLM incorrectly implies that Lockheed’s receivables are revenue earned by ULA, when in fact the receivables are from commercial customers (including ULA) — meaning ULA is a customer of Lockheed, not that ULA earns the revenue. This misrepresents the financial relationship. The original answer clarifies that ULA is a commercial customer of Lockheed Martin’s Space segment, so the receivables reflect amounts owed by ULA (and others) to Lockheed, not revenue flowing to ULA. This misunderstanding undermines the multi-hop logic. 4) Contextual relevance is strong — the answer addresses the core entities and financial linkages — but due to the mischaracterization of the receivables as revenue earned by ULA, the qualitative accuracy is reduced. The conclusion that receivables indirectly affect ULA’s earnings and thus Boeing’s income is logically inverted: it is ULA’s own performance that generates income for Boeing and affects its ability to pay Lockheed, not the other way around. Therefore, while some facts are correct, the causal reasoning is flawed, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 502,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the invalidation of the '190 Patent in the CAR T litigation affect Gilead's amortization expense following its acquisition of Kite?",
      "original_answer": "The invalidation of the '190 Patent in August 2021 removed the risk of ongoing 27.6% running royalties on Kite’s Yescarta sales, which had been previously awarded to Juno and SKI. This resolution likely reduced Gilead’s contingent liabilities and improved the valuation of the acquired intangible assets. As a result, Gilead’s amortization expense for finite-lived intangible assets, which included Yescarta-related rights from Kite, was $1.7 billion in 2021, up from $1.2 billion in 2020, reflecting the clearer path to monetization of these assets post-litigation.",
      "llm_answer": "The court’s ruling that the “190 Patent” was invalidated removed the intangible‑asset component of Gilead’s Kite acquisition that had been amortized over the life of the CAR‑T product axicabtagene ciloleucel.  As a result, Gilead eliminated the amortization expense that had been tied to that asset—about $1.5 billion of accumulated amortization that had been recognized as part of the Kite purchase.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors that undermine its correctness. (1) Quantitatively, it incorrectly states that Gilead 'eliminated' amortization expense tied to the '190 Patent' and references '$1.5 billion of accumulated amortization' being removed. This contradicts the ground truth, which shows amortization expense *increased* from $1.2 billion in 2020 to $1.7 billion in 2021. The $1.5 billion figure does not appear in the original data and is factually incorrect. (2) The reasoning is flawed: the invalidation of the patent *reduced risk* and improved the valuation of intangible assets, leading to *higher* amortization due to a clearer path to monetization, not elimination of expense. The LLM incorrectly infers that removing a contested patent removes amortization, when in fact the opposite occurred. (3) Entity accuracy is partially correct—Gilead, Kite, and the CAR-T context are accurate—but the patent ('190) and product (Yescarta/axicabtagene ciloleucel) linkage is misrepresented in financial impact. (4) The multi-hop reasoning fails: the model does not correctly synthesize that patent invalidation reduced royalty risk, which positively affected asset valuation and amortization trajectory. Instead, it assumes patent invalidation removes an amortizable asset, reflecting a misunderstanding of accounting for acquired intangibles. (5) While the answer addresses the general topic and attempts to link patent status to amortization, the core conclusion is factually inverted. Contextual relevance is moderate, but correctness is severely compromised by incorrect numbers and logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 445,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does Apple's revenue from Greater China in 2022 compare to Intel's revenue from Taiwan in 2021, given that Greater China includes Taiwan as one of its key markets?",
      "original_answer": "Apple reported $74,200 million in net sales from Greater China in 2022, which includes Taiwan. Intel reported $13,461 million in net revenue from Taiwan in 2021. This indicates that Apple's revenue from the broader Greater China region was significantly higher than Intel's revenue specifically from Taiwan during those periods.",
      "llm_answer": "Apple’s Greater China revenue in 2022 was **$74.2 billion** (which includes Taiwan), whereas Intel’s revenue from Taiwan in 2021 was **$13.5 billion**【Apple 10‑K, Note 11 – Segment Information and Geographic Data, 2022】【Intel 10‑K, Net revenue by region, 2021】.  Thus Apple’s Greater China revenue was roughly **$60.7 billion higher**—about **5½ times** Intel’s Taiwan revenue.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: Apple's $74.2 billion (i.e., $74,200 million) in Greater China revenue for 2022 and Intel's $13.5 billion (rounded from $13,461 million) in Taiwan revenue for 2021 are correctly reported, with acceptable rounding. The difference of $60.7 billion is accurately calculated ($74.2B - $13.5B = $60.7B), and the ratio (~5.5x) is a reasonable approximation (74.2 / 13.5 ≈ 5.5). (2) The answer is complete, addressing both companies, correct years, and the geographic scope (noting that Greater China includes Taiwan). (3) Entities are correctly identified: Apple and Intel, their respective revenues, correct regions (Greater China and Taiwan), and correct fiscal years (2022 and 2021). (4) The multi-hop reasoning is sound—synthesizing data from two different companies, regions, and years, while acknowledging the geographic overlap and making a valid comparison. (5) The semantic meaning fully aligns with the original answer, conveying that Apple’s revenue from Greater China was significantly higher than Intel’s from Taiwan. Minor formatting differences (e.g., 'billion' vs 'million', rounding) do not affect factual accuracy. All citations are appropriately referenced.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 360,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How do UPS's derivative valuation practices involving yield curves and Boeing's approach to fixed income investments compare in terms of reliance on observable market data like credit spreads and interest rates?",
      "original_answer": "UPS relies on pricing models that use observable market data such as yield curves and foreign currency exchange rates for valuing derivatives, which are classified as Level 2. Similarly, Boeing's fixed income investments, including interest rate swaps, are valued using pricing models that incorporate verifiable observable market data like interest rates, yield curves at commonly quoted intervals, and credit spreads, also categorizing them as Level 2 when observable inputs are available. Both companies emphasize the use of market-observable inputs for Level 2 classifications, though UPS focuses on derivatives tied to foreign exchange and Boeing on fixed income instruments.",
      "llm_answer": "UPS values its interest‑rate and foreign‑currency derivatives with pricing models that use observable market inputs such as yield curves, foreign‑currency rates and forward prices (UPS 10‑K, p. 138). Boeing’s fixed‑income holdings are also priced with Level‑2 models that rely on observable data—specifically interest‑rate curves, credit spreads and dealer bids (Boeing 10‑K, p. 102). Thus, both firms depend on market‑observable inputs, but Boeing explicitly incorporates credit‑spreads in addition to yield curves and interest rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: UPS uses observable market data like yield curves and foreign currency exchange rates for derivative valuation (Level 2), and Boeing values fixed income investments using observable inputs such as interest rate curves, credit spreads, and dealer bids—also Level 2. The mention of specific 10-K page numbers (p. 138 for UPS, p. 102 for Boeing) adds precision and matches typical disclosure locations, though exact pages were not in the ground truth; this is acceptable as long as the content is accurate. (2) There are no numerical values requiring calculation, so quantitative accuracy is fully satisfied. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (UPS and Boeing), two types of financial instruments (derivatives vs. fixed income), and compares their reliance on observable inputs. It correctly identifies that both use yield curves and interest rates, but notes Boeing explicitly includes credit spreads—a key differentiator highlighted in the original answer. (4) Semantic equivalence is strong: the LLM captures the core comparison, correctly stating that both rely on observable market data with Level 2 classification, while distinguishing Boeing’s additional use of credit spreads. The only minor limitation is that the original answer notes UPS focuses on foreign exchange derivatives while Boeing on fixed income instruments—this contextual nuance is partially reflected but could be more explicit. However, the LLM does imply this through context. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 463,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the use of discounted cash flow models for impairment testing by META compare to DIS's application of these models in valuing Level 2 derivatives, particularly in terms of the inputs and assumptions each company relies on?",
      "original_answer": "META uses discounted cash flow (DCF) models with Level 3 inputs to estimate the fair value of impaired operating lease ROU assets and leasehold improvements, incorporating assumptions such as expected downtime, projected sublease income, and discount rates reflecting risk levels. In contrast, DIS applies internal DCF models to value Level 2 derivatives using observable inputs like interest rates, yield curves, and foreign currency exchange rates. While both companies utilize DCF models, META relies on less observable (Level 3) assumptions, whereas DIS uses more market-based (Level 2) data, reflecting different applications and risk profiles in their respective financial reporting.",
      "llm_answer": "META uses discounted‑cash‑flow (DCF) models to test the recoverability of operating‑lease right‑of‑use assets, relying on Level‑3 inputs such as expected downtime before subleases, projected sublease income over the remaining lease terms, and discount rates that reflect the risk of those cash flows (META 10‑K, pp. 96‑100). Disney, by contrast, applies internal DCF models to value Level‑2 derivatives, using observable market inputs—interest‑rate curves, foreign‑exchange rates, and, to a lesser extent, counterparty credit risk—so its assumptions are grounded in current market data rather than operational cash‑flow projections (DIS 10‑K, pp. 117‑121).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: META uses DCF models with Level 3 inputs for impairment testing of operating lease ROU assets, including assumptions like expected downtime, projected sublease income, and risk-adjusted discount rates. DIS uses internal DCF models for Level 2 derivatives with observable market inputs such as interest rate curves and foreign exchange rates. These points match the original answer exactly in substance. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in the question or answers, so quantitative accuracy is not compromised—no calculations or figures to verify. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (META and DIS), two distinct applications of DCF models (impairment testing vs. derivative valuation), and two different fair value hierarchy levels (Level 3 vs. Level 2), drawing a valid contrast in input observability and risk profiles. (4) The only minor shortcoming is a slight omission of the phrase 'leasehold improvements' in the LLM answer when describing META’s impaired assets—mentioned in the original answer but not in the LLM version—making it slightly less complete but not factually incorrect. Otherwise, semantic equivalence is strong, and the contextual relevance is excellent. Hence, a score of 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 419,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the IQOS device supply constraint mentioned in PM's 2022 filing impact PM USA's ability to commercialize heated tobacco products in the U.S., considering the FDA authorization dependency and PM USA's role as a guarantor under Altria's financial structure?",
      "original_answer": "The IQOS device supply constraint due to the global semiconductor shortage, as reported in PM's 2022 filing, limited IQOS user growth in the second half of 2021 and contributed to the delay in resuming U.S. supply following the ITC import ban. PM USA, as the exclusive commercialization partner for PMI's heated tobacco products in the U.S., depends on FDA authorization for IQOS devices, including IQOS 3, which is under review. The cessation of IQOS device sales in the U.S. after November 29, 2021, due to the ITC cease-and-desist order, further disrupted PM USA’s product portfolio. Given PM USA's role as a guarantor of Altria's debt obligations, any prolonged inability to market IQOS devices could strain PM USA's financial position, particularly if it affects cash flows or dividend distributions to Altria, thereby increasing the risk of insolvency considerations under fraudulent conveyance laws.",
      "llm_answer": "The semiconductor shortage and the ITC import ban have left IQOS devices scarce, so even though the FDA has authorized the IQOS PMTA and MRTP, PM USA cannot commercialize the heated‑tobacco product in the U.S. until device supply normalizes. Because PM USA’s sales of IQOS are contingent on FDA approval, the supply constraint effectively stalls its U.S. commercialization plans. As the 100 % owned guarantor of Altria’s debt, PM USA remains liable for those obligations regardless of the product’s commercial performance, but the supply shortfall could strain its cash flows and overall financial position.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the semiconductor shortage and ITC import ban as key constraints on IQOS device supply, and notes the impact on U.S. commercialization. It accurately states that PM USA is a 100% owned guarantor of Altria’s debt, aligning with the ground truth. However, it incorrectly implies that the FDA has already authorized the IQOS PMTA and MRTP applications for the devices currently under review—specifically, the ground truth clarifies that IQOS 3 is still under FDA review, and no authorization has been granted post-ban. This is a significant factual error affecting the reasoning chain. (2) There are no explicit numbers, dates, or calculations in the LLM answer beyond general references (e.g., no specific dates like 'November 29, 2021' or 'second half of 2021'), so quantitative accuracy is high by omission—no incorrect figures were stated, but key temporal details from the ground truth are missing. (3) The multi-hop reasoning is partially sound: it connects supply constraints → commercialization delay → financial risk to PM USA → implications due to guarantee role. However, it fails to fully synthesize the sequence of events: the ITC cease-and-desist order caused the sales halt, and supply constraints delayed resumption, but FDA authorization remains pending. The answer conflates authorization with availability, undermining the logic. (4) Contextual relevance is strong—the response stays focused on the question’s core elements: supply constraint, FDA dependency, and financial implications via PM USA’s guarantor role. Despite missing some nuances (e.g., dividend impacts, fraudulent conveyance risk), it captures the primary financial risk. Correctness score is 7 due to accurate core facts but a critical error in FDA authorization status; qualitative accuracy is reduced for flawed reasoning on regulatory status.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 508,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the impact of biosimilar competition on BMY's revenue outlook compare to ABBV's exposure given that Humira alone accounted for 27% of ABBV's 2023 net revenues and faces direct biosimilar pressure globally?",
      "original_answer": "BMY faces significant risk from biosimilar competition, which threatens to rapidly erode revenues for products losing market exclusivity, especially as seen with Eliquis and Revlimid. Meanwhile, ABBV's Humira, which accounted for 27% of its 2023 net revenues, is under direct global biosimilar pressure. While both companies are exposed to biosimilar threats, ABBV has a concentrated risk tied to a single product, whereas BMY faces broader portfolio risk across multiple products.",
      "llm_answer": "BMY’s revenue outlook is cautioned against erosion from biosimilar competition across its biologic portfolio, with the company noting that such competition could “negatively affect future revenues and profit margins” (BMY 10‑K, risk factors, pp. 25‑29).  In contrast, AbbVie’s exposure is far more concentrated: Humira alone accounted for roughly 27 % of AbbVie’s 2023 net revenues and is “facing direct biosimilar competition globally” (AbbVie 10‑K, concentration of risk, pp. 79‑83).  Thus, while biosimilar competition threatens BMY’s overall revenue outlook, AbbVie faces a sharper, product‑specific risk that could precipitate more pronounced revenue erosion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Humira accounted for 27% of AbbVie’s 2023 net revenues, and both BMY and ABBV face biosimilar pressure. The percentage (27%) matches exactly, and no incorrect numbers or dates are present. (2) Quantitative accuracy is perfect—27% is correctly cited, and no calculations were required beyond accurate reporting. (3) The multi-hop reasoning is sound: the model correctly contrasts BMY’s broad portfolio risk (e.g., Eliquis, Revlimid) with ABBV’s concentrated risk on Humira, synthesizing risk exposure across two companies and their respective 10-K disclosures. The LLM adds value by citing specific sections of the 10-Ks (risk factors, pp. 25–29 for BMY; concentration of risk, pp. 79–83 for ABBV), which strengthens credibility. (4) Semantic equivalence is strong—the core insight that ABBV has a more concentrated, product-specific risk while BMY faces broader portfolio erosion is clearly conveyed, matching the original answer’s intent. The only minor limitation is that the LLM does not explicitly name Eliquis and Revlimid (as in the ground truth), though it refers to 'biologic portfolio' and 'revenue outlook' erosion, which implicitly covers them. This slight omission in specificity prevents a perfect 10, but the answer remains factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 385,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the treatment of dividend equivalents on RSU awards differ between PM and PEP in terms of payout structure and vesting triggers, given PM's inclusion of dividend equivalents during vesting and PEP's cash payout upon vesting?",
      "original_answer": "PM includes dividend equivalents on RSU awards that accrue during the vesting period and are paid out as part of the RSU settlement, typically after three years or upon specific events like death, disability, or reaching age 58. PEP also accrues dividend equivalents on RSUs, but these are paid out in cash (without interest) only when the RSU vests and becomes payable. Unlike PM, which may vest RSUs upon age or disability, PEP ties payout strictly to the end of the service period or performance-based vesting for PSUs, with no mention of age-based triggers. This reflects a structural difference in how each company manages equity compensation benefits.",
      "llm_answer": "PM’s RSU awards earn dividend equivalents that are paid out as part of the award at vesting, with the awards vesting on the third anniversary of the grant date. PepsiCo’s RSU awards accrue dividend equivalents that are paid in cash when the award vests, with vesting triggered at the end of the service period (typically three years).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and matches the ground truth in key aspects. (1) It accurately states that PM includes dividend equivalents paid out at vesting, with vesting typically on the third anniversary—consistent with the three-year vesting in the original answer. PEP’s dividend equivalents are correctly described as being paid in cash upon vesting, tied to the end of the service period. (2) There are no numeric values requiring calculation, but the 'three years' or 'third anniversary' timeline is correctly cited, aligning with the ground truth. (3) The multi-hop reasoning is sound: the model correctly contrasts PM and PEP on payout structure (dividend equivalents included in settlement vs. cash payout) and vesting triggers (PM includes age 58, death, disability; PEP focuses on service period without age-based triggers). However, the LLM omits PM’s non-service-based vesting triggers (death, disability, age 58), which are key differentiators in vesting triggers and part of the original answer. This is a meaningful but not critical omission. (4) Despite this, the core comparison on payout structure and vesting timing is accurate and relevant. The answer is semantically close to the original, with slightly less detail on PM’s alternative vesting conditions. Hence, correctness and qualitative accuracy are high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 374,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does GE's $1,410 million investment in illiquid real estate funds through its run-off insurance operations compare to BA's broader real estate investment strategy, particularly in terms of liquidity risk and fund structure?",
      "original_answer": "BA invests in a diversified portfolio of global real estate, including office, retail, apartment, and industrial properties, primarily through limited partnerships or fund structures that allow for varied market exposure. These investments are part of a broader asset allocation strategy that includes private equity, hedge funds, and real assets. In contrast, GE holds $1,410 million in illiquid real estate funds through its run-off insurance operations, which are measured at net asset value and generally not eligible for redemption without the general partner's approval. Both use fund structures that limit liquidity, but GE's exposure is more concentrated and less flexible, as distributions depend on the liquidation of underlying assets at the discretion of the fund's general partner, whereas BA's approach is more diversified and integrated within a broader investment framework.",
      "llm_answer": "GE’s $1,410 million is held in limited‑partnership real‑estate funds through its run‑off insurance operations.  Those investments are not redeemable, are generally illiquid, and are valued at net asset value per share (or equivalent) as a practical expedient, meaning the company can only receive a distribution when the underlying assets are liquidated at the discretion of the general partner.  In contrast, Boeing’s broader real‑estate strategy (see BA 10‑K, pp. 97‑101) is diversified across publicly traded REITs and other real‑estate vehicles that offer greater liquidity and a more conventional fund structure, reducing the liquidity risk relative to GE’s limited‑partnership holdings.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies GE's $1,410 million investment in illiquid real estate funds through its run-off insurance operations, accurately describing the limited liquidity, valuation at net asset value, and dependence on general partner discretion for distributions. This matches the ground truth. However, the LLM incorrectly characterizes BA’s real estate strategy as including 'publicly traded REITs' and 'greater liquidity' based on its 10-K (pp. 97–101), which contradicts the ground truth stating BA invests primarily through limited partnerships or fund structures—similar to GE—and does not emphasize public REITs. The ground truth highlights BA’s diversification and integration into a broader asset allocation, not superior liquidity. (2) Quantitatively, the $1,410 million figure is accurate and correctly attributed; no other numbers are present. (3) The multi-hop reasoning is partially flawed: while the model correctly contrasts GE’s illiquidity and fund structure, it misrepresents BA’s strategy by implying a more liquid, publicly traded approach, which is not supported by the ground truth. The comparison should emphasize structural similarity in illiquidity but differences in diversification and strategic integration, not a fundamental difference in liquidity. (4) The correctness score is 7 because core facts about GE are accurate and the question’s main contrast is attempted, but the characterization of BA’s strategy introduces a significant qualitative error. Quantitative accuracy is perfect. Qualitative accuracy is reduced due to the misrepresentation of BA’s fund types and liquidity profile. Contextual relevance remains high as the response directly addresses the comparison on liquidity risk and fund structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 480,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does BAC's exposure to equity market risk, as managed through derivative instruments, compare to MET's use of equity market derivatives in terms of notional value and sensitivity to a 10% decrease in equity prices?",
      "original_answer": "BAC discloses exposure to equity market risk through trading positions involving equity-linked instruments such as options, futures, and swaps. MET reports a notional value of $23,595 million for its equity market derivatives, with a sensitivity of $522 million to a 10% decrease in equity prices. While BAC does not specify exact notional amounts for its equity derivatives, it emphasizes the use of similar hedging tools. MET's quantified exposure highlights a direct sensitivity to equity market movements, which contrasts with BAC's broader market risk management approach that includes equity risk as one of several components.",
      "llm_answer": "BAC’s equity‑market derivative portfolio carries a notional exposure of **$23.6 billion** and a 10 % drop in equity prices would reduce its fair value by **$522 million** (see BAC 10‑K, pages 73‑77).  \nMetLife’s equity‑market derivatives total roughly **$894 million** in fair value (assets $408 million, liabilities $486 million) and the filing does not disclose a sensitivity figure for a 10 % equity‑price decline, implying a far smaller exposure and likely lower sensitivity than BAC’s.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and misattributes data between the two companies. (1) Quantitatively, it states that BAC has a notional exposure of $23.6 billion and a sensitivity of $522 million to a 10% drop in equity prices. However, according to the ground truth, these figures belong to MET, not BAC. BAC does not disclose exact notional values for its equity derivatives. The LLM incorrectly assigns MET's notional value ($23,595 million ≈ $23.6 billion) and sensitivity ($522 million) to BAC. Conversely, it claims MetLife has only $894 million in fair value for equity derivatives and lacks sensitivity data—this contradicts the ground truth, which reports MET’s notional value as $23,595 million and explicitly provides the $522 million sensitivity figure. (2) The calculations are not applicable because the numbers are assigned to the wrong entities. (3) Qualitatively, the reasoning is flawed: the LLM reverses the roles of the two companies, failing to recognize that MET is the one with quantified disclosures, while BAC discusses equity risk qualitatively without specific notional or sensitivity numbers. The multi-hop comparison is therefore invalid. (4) Contextually, the answer attempts to address the question but does so with completely swapped data, leading to a false conclusion about relative exposure. The only minor redeeming factor is that it recognizes the type of derivative instruments used, but even that is overshadowed by factual inversion. Hence, the correctness score is very low due to fundamental factual and entity-level errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 430,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does Microsoft's operational footprint in Greater China compare to AMD's revenue concentration in Taiwan, and what does this suggest about their respective regional market strategies in 2022?",
      "original_answer": "Microsoft operates a regional center in Singapore that supports operations in Greater China, indicating a centralized approach to managing its activities across the region, which includes China mainland, Hong Kong, and Taiwan. AMD, on the other hand, reported $2,091 million in sales to Taiwan in 2022, highlighting a significant direct revenue contribution from the region. While Microsoft's presence in Greater China is part of a broader Asia-Pacific operational structure, AMD's financial data shows a more concentrated revenue exposure to Taiwan specifically, suggesting differing regional market strategies: Microsoft leans on regional hubs to support broad market access, while AMD has a pronounced financial dependency on Taiwan as a key market.",
      "llm_answer": "analysisWe need to answer: \"How does Microsoft's operational footprint in Greater China compare to AMD's revenue concentration in Taiwan, and what does this suggest about their respective regional market strategies in 2022?\"\n\nWe have sources: MSFT_10k_2022.pdf: pages [14, 15, 16, 17, 18] | AAPL_10k_2022.pdf: pages [23, 24, 25, 26, 27] | AMD_10k_2022.pdf: pages [76, 77, 78, 79, 80]\n\nBut the provided document pages above appear to be from MSFT_10k_2022? Actually the content above is from Microsoft 10-K. It includes \"OPERATIONS\" section that mentions \"regional center in Singapore supports the Japan, India, Greater China, and Asia-Pacific region\". Also earlier there is mention of \"Greater China\" as a segment. We need to find the operational footprint in Greater China. The question: \"How does Microsoft's operational footprint in Greater China compare to AMD's revenue concentration in Taiwan, and what does this suggest about their respective regional market strategies in 2022?\"\n\nWe need to find AMD's revenue concentration in Taiwan. The AMD 10-K pages 76-80 likely contain a note about revenue by geography, maybe a note about Taiwan. We need to locate that. The provided content above does not include AMD pages. We need to search the AMD_10k_2022.pdf pages 76-80. But the content above is only the Microsoft 10-K. We need to find AMD content. The user provided sources: MSFT_10k_2022.pdf: pages [14, 15, 16, 17, 18] | AAPL_10k_2022.pdf: pages [23, 24, 25, 26, 27] | AMD_10k_2022.pdf: pages [76, 77, 78, 79, 80]\n\nBut the content above is only Microsoft 10-K. We need to locate AMD content. The content above is huge, but not AMD. We need to search for AMD content. The user didn't provide AMD content in the message. However, the system might have loaded AMD pages? The content above is only Microsoft. But we might need to find AMD content from the provided pages. The user says \"Sources: MSFT_10k_2022.pdf: pages [14, 15, 16, 17, 18] | AAPL_10k_2022.pdf: pages [23, 24, 25, 26, 27] | AMD_10k_2022.pdf: pages [76, 77, 78, 79, 80]\". So we need to use those pages. The content above includes Microsoft pages 14-18? Let's check: The content above includes \"OPERATIONS\" section which might be page 14? The \"OPERATIONS\" section appears near the top of the content. The page numbers are not visible. But the content above includes \"OPERATIONS\" and \"OPERATIONS\" section. That might be page 14? The content above includes \"OPERATIONS\" and \"OPERATIONS\" section. So we have Microsoft pages 14-18. The content above includes \"OPERATIONS\" and \"OPERATIONS\" section. It also includes \"Segment Operating Performance\" and \"Net sales by reportable segment\" etc. So we have Microsoft content.\n\nWe need AMD content. The content above does not include AMD. We need to locate AMD content. The user didn't provide AMD content in the message. But the system might have loaded AMD content separately? The system might have loaded AMD content but not displayed. We need to search for AMD content in the conversation. The conversation only has the Microsoft content. So we need to find AMD content from the provided pages. But we don't have them. We might need to approximate from knowledge? But we should only use provided document pages. The user specifically says \"Sources: MSFT_10k_2022.pdf: pages [14, 15, 16, 17, 18] | AAPL_10k_2022.pdf: pages [23, 24, 25, 26, 27] | AMD_10k_2022.pdf: pages [76, 77, 78, 79, 80]\". So we need to use AMD pages 76-80. But we don't have them. We need to locate them. The system might have loaded them but not displayed. We need to search the conversation for AMD. There's no AMD content. So we need to request the AMD content? But the instruction says \"You will be given a question and relevant pages from financial documents.\" The relevant pages are provided. But the content above only includes Microsoft. So maybe the AMD content is not displayed but is available to the system. The system might have loaded AMD pages but not shown them because the user didn't request them. But we can still search for AMD content in the system's memory. We need to search for \"AMD\" in the conversation. There's no AMD content. But maybe the system has loaded AMD pages but not displayed. We need to ask the system to provide AMD content. But the instruction says we should not ask for more content. We need to answer based on the provided pages. But we don't have AMD pages. However, the user might have provided them but we didn't see them. Let's check the conversation again. The user message only includes the question and the sources list. The system message includes the content of Microsoft 10-K. The AMD content is not included. So we cannot answer about AMD's revenue concentration in Taiwan. But we might approximate from knowledge: AMD's revenue concentration in Taiwan? AMD is a semiconductor company. Taiwan is a major manufacturing hub. AMD's revenue concentration in Taiwan might be high due to manufacturing and sales. But we need to answer based on the provided document pages. We don't have AMD pages. This might be a problem. But maybe the AMD content is included in the conversation but not displayed due to length. The system might have truncated the content. The content above is huge, but maybe the AMD content is further down but not displayed. Let's scroll further down. The content above is extremely long. It might include AMD content further down. Let's search for \"AMD\" in the content above. I will scan the content. The content above includes a lot of Microsoft content, but maybe later includes AMD content. Let's search for \"AMD\" in the content above. I see \"AMD\" in the \"Segment Operating Performance\" section? No. I see \"AMD\" maybe in the \"NOTE 14 - Segment Reporting\" but that's about Microsoft. No. Let's search for \"AMD\" manually: I see \"AMD\" in \"AMD\" but not. The content above is huge, but I didn't see \"AMD\". Let's search for \"AMD\" in the content above. I see \"AMD\" in \"AMD\" but not. Actually I see \"AMD\" in \"AMD\" but not. Let's scan. The content above includes \"AMD\" in the \"Note 14 - Segment Reporting\" but no. Wait, the content above includes \"AMD\" in \"AMD\" but not. Let's search for \"AMD\" again. I see \"AMD\" in \"AMD\" but not. Let's search for \"AMD\" in the conversation. There's no \"AMD\" in the conversation. So the AMD content is not present. So we cannot answer about AMD's revenue concentration in Taiwan. But maybe the AMD content is in the \"AMD_10k_2022.pdf: pages [76, 77, 78, 79, 80]\" but not displayed. We need to request the content. But the instruction says we should not ask for more content. But we might need to approximate from knowledge. But the instruction says \"Answer based on the provided document pages.\" So we cannot use external knowledge. But we don't have AMD pages. This is a problem. However, maybe the AMD content is actually included in the conversation but not displayed due to length. Let's scroll further down. The content above is extremely long, but maybe the AMD content is at the end. Let's scroll further. The content above ends with \"The following table summarizes the components of Other income (expense), net:\" and then \"NOTE 16 - Commitments and Guarantees\". It continues with \"Operating Leases\" etc. It goes on for many pages. It might include AMD content later. But the content above is extremely long, but we need to find the AMD content. Let's search for \"AMD\" again. I see \"AMD\" in \"AMD\" but not. Let's search for \"Taiwan\" maybe. The content above includes \"Taiwan\" in the segment \"Greater China includes China mainland, Hong Kong and Taiwan.\" That is Microsoft. But we need AMD's revenue concentration in Taiwan. That might be in AMD's 10-K. But we don't have it. So we might need to approximate. But maybe the AMD content is included but we need to scroll further. The content above is huge, but we can search for \"Taiwan\" in the content above. I see \"Taiwan\" in the Microsoft segment. But we need AMD. So we need AMD content. Let's search for \"AMD\" again. I see \"AMD\" in \"AMD\" but not. Let's search for \"AMD\" again. I see \"AMD\" in \"AMD\" but not. Let's search for \"AMD\" again. I see \"AMD\" in \"AMD\" but not. Hmm.\n\nIt might be that the AMD content is not included in the conversation. The user might have omitted it inadvertently. But the instruction says we have to answer based on the provided document pages. So we might need to answer using only Microsoft content and approximate AMD content? But we can't approximate. We need to answer. We might need to request AMD content. But the instruction says we should not ask for more content. But we can ask for the AMD content? The instruction says \"You will be given a question and relevant pages from financial documents.\" So the relevant pages are given. But we only see Microsoft pages. So maybe the AMD pages are not displayed but are considered part of the provided pages. The system may have loaded them but not displayed. But we can still search for them. Let's search for \"AMD_10k_2022.pdf\" or \"AMD\" in the conversation. There's no mention. But the system might have loaded them but not displayed. We can try to request the content from the system. But the instruction says we should not ask for more content. But we might need to ask for the AMD content. But we can try to request the AMD content by referencing the page numbers. But the instruction says we should not ask for more content. But we can ask the system to provide the AMD content? The instruction says \"You will be given a question and relevant pages from financial documents.\" So the relevant pages are provided. The user provided the page numbers. The system might have loaded them but not displayed. But we can request them. But the instruction says \"Answer based on the provided document pages.\" So we can ask the system to provide the AMD content. But we might need to ask the system to provide the AMD content. But the instruction says \"You are a skilled financial analyst with expertise in SEC 10-K filings and corporate disclosures.\" We can ask for the AMD content. But the instruction says \"Answer format: Provide a focused, concise response (2-3 sentences) that directly answers the question based on the provided document pages.\" So we need to answer. But we don't have AMD content. So we might need to approximate. But we can also note that AMD's revenue concentration in Taiwan is high, maybe around 20% or something. But we need to provide a specific figure from the AMD 10-K. We need to find that figure. We need to locate AMD's revenue concentration in Taiwan. Let's search for \"Taiwan\" in the AMD 10-K. But we don't have the content. But we can approximate from knowledge: AMD's revenue by geography: In 2022, AMD had revenue by region: Americas, EMEA, APAC, etc. Taiwan might be part of Asia Pacific. But the question specifically: \"AMD's revenue concentration in Taiwan\". That might refer to a note that says \"Taiwan accounted for X% of revenue\" or \"Taiwan accounted for Y% of revenue in 2022.\" We need to find that. Let's search for \"Taiwan\" in the AMD 10-K. We don't have the content. But we can approximate. But we need to answer based on the provided pages. We might need to request the AMD content. But the instruction says we should not ask for more content. But we can ask for the AMD content. But the system might not allow that. But we can try to ask the system to provide the AMD content. But the instruction says \"You will be given a question and relevant pages from financial documents.\" So the relevant pages are provided. So we can assume the AMD content is available. But we need to find it. Let's see if the AMD content is included in the conversation but not displayed due to length. The conversation includes a huge block of text. It might include the AMD content but we didn't scroll far enough. Let's scroll further. The content above ends with \"NOTE 16 - Commitments and Guarantees\" and \"Operating Leases\" etc. It might continue with \"NOTE 17 - Contingencies\" etc. But the AMD content might be after that. The content above is huge but maybe truncated. But we can search for \"AMD\" again. I see \"AMD\" in \"AMD\" but not. Let's search for \"AMD\" again. I see \"AMD\" in \"AMD\" but not. This is confusing.\n\nLet's try to search for \"AMD\" in the conversation. The conversation only has the Microsoft content. The AMD content is not present. So we cannot answer about AMD's revenue concentration in Taiwan. But maybe the question expects us to answer based on the Microsoft content (operational footprint in Greater China) and AMD content (revenue concentration in Taiwan). But we don't have AMD content. So we might need to approximate. But we can still answer: \"Microsoft has a regional operations center in Singapore that supports Greater China, indicating a distributed operational footprint across the region. AMD's revenue concentration in Taiwan is X% of total revenue, indicating a heavy reliance on the Taiwanese market.\" But we need to provide a figure. We can approximate from knowledge: AMD's revenue by geography: In 2022, AMD's revenue by region: Americas: 53%, EMEA: 23%, APAC: 24%. Taiwan might be part of APAC. But the revenue concentration might be 20% or something. But we need to provide a figure. But we cannot guess. We need to find the actual figure. Let's search for \"AMD revenue Taiwan 2022\" from memory. I recall that AMD's 2022 10-K includes a note about \"Taiwan accounted for 10% of revenue\" maybe. But I'm not sure. Let's search memory: AMD's 2022 10-K: \"Revenue by geographic region: Americas 53%, EMEA 23%, APAC 24%.\" Within APAC, Taiwan might be a small part. But the question specifically: \"AMD's revenue concentration in Taiwan.\" That might refer to a note that says \"Taiwan accounted for 20% of revenue\" or \"Taiwan accounted for 9% of revenue.\" But we need to confirm.\n\nLet's search for \"AMD revenue Taiwan\" quickly. I can approximate: AMD's 2022 10-K: \"Revenue by geographic region: Americas 53%, EMEA 23%, APAC 24%.\" Then \"Taiwan accounted for 9% of revenue.\" But I'm not sure. Let's check memory: AMD's 2021 10-K: \"Revenue by geographic region: Americas 53%, EMEA 23%, APAC 24%.\" \"Taiwan accounted for 9% of revenue.\" That might be correct. But we need to confirm. Let's search memory: AMD 2022 10-K: \"Revenue by geographic region: Americas 53%, EMEA 23%, APAC 24%.\" \"Taiwan accounted for 9% of revenue.\" That might be the figure. But we need to be sure. Let's search the internet quickly (but we cannot use external sources). But we can approximate. But the instruction says we should answer based on the provided document pages. So we cannot rely on external knowledge. But we can still approximate if we can't find the figure. But we might need to ask the system for the AMD content. But we can't ask for more content. But maybe we can request the AMD content by referencing the page numbers. But the instruction says \"You will be given a question and relevant pages from financial documents.\" So the relevant pages are provided. So we should use them. But we don't have them. So maybe the AMD content is not needed? But the question explicitly asks about AMD's revenue concentration in Taiwan. So we need that. So we need to find AMD content. Let's search for \"AMD_10k_2022.pdf\" in the conversation. There's no mention. But maybe the system has loaded the AMD content but not displayed. We can request the system to provide the AMD content. But the instruction says we should not ask for more content. But we can ask the system to provide the AMD content. But the system might not allow that. But we can try. But the instruction says \"Answer format: Provide a focused, concise response (2-3 sentences) that directly answers the question based on the provided document pages.\" So we need to answer. But we can't answer without AMD content. So we need to request the AMD content. But we might be allowed to ask for more content. The instruction says \"You will be given a question and relevant pages from financial documents.\" So the relevant pages are provided. But the conversation only includes Microsoft content. So maybe the AMD content is not provided. But we can ask the system to provide the AMD content. But the instruction says \"You are a skilled financial analyst with expertise in SEC 10-K filings and corporate disclosures.\" We can ask for the AMD content. But the instruction says \"Answer based on the provided document pages.\" So we need to use the AMD pages. So we need to request them. But we might not be allowed to ask for more content. But we can ask the system to provide the AMD content. But the instruction says \"You will be given a question and relevant pages from financial documents.\" So the relevant pages are provided. But they are not in the conversation. So we need to ask for them. But maybe the system will provide them. Let's try to ask: \"Could you provide the AMD_10k_2022.pdf pages 76-80?\" But the instruction says we should not ask for more content. But maybe we can. But the system might allow it. But the instruction says \"You are a skilled financial analyst with expertise in SEC 10-K filings and corporate disclosures.\" So we can ask for the AMD content. But the instruction says \"Answer format: Provide a focused, concise response (2-3 sentences) that directly answers the question based on the provided document pages.\" So we need to answer. But we can't answer without AMD content. So we need to request it. But we might be allowed to ask for more content. But the instruction says \"You will be given a question and relevant pages from financial documents.\" So maybe the system will provide the AMD pages. But we need to ask. But the instruction says \"You are a skilled financial analyst with expertise in SEC 10-K filings and corporate disclosures.\" So we can ask. But the instruction says \"Answer format: Provide a focused, concise response (2-3 sentences) that directly answers the question based on the provided document pages.\" So we need to answer. But we cannot answer without AMD content. So we need to request it. But we might be allowed to ask for more content. But the instruction says \"You will be given a question and relevant pages from financial documents.\" So the relevant pages are provided. But they are not displayed. But maybe the system will provide them. Let's try to ask the system: \"Please provide AMD_10k_2022.pdf pages 76-80.\" But the instruction says we should not ask for more content. But maybe we can. But the instruction says \"You will be given a question and relevant pages from financial documents.\" So the relevant pages are provided. But they are not displayed. But we can ask for them. But the instruction says \"Answer based on the provided document pages.\" So we need to use them. So we need to request them. Let's try to request them.assistantcommentaryI will ask the system to provide the AMD pages.assistantcommentary to=browser.run code{\"query\": \"AMD_10k_2022.pdf pages 76-80\", \"topn\": 5, \"source\": \"news\"}",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer fails to provide any substantive response to the question. Instead of answering, it presents an internal monologue analyzing the sources, attempting to locate AMD 10-K data, and even includes a simulated request for external content (browser.run code). No actual comparison between Microsoft's operational footprint in Greater China and AMD's revenue concentration in Taiwan is made. No financial figures (e.g., AMD's $2,091 million in sales to Taiwan) are reported, and no analysis of regional market strategies is provided. The response is entirely meta-cognitive and does not fulfill the task, making it completely incorrect and irrelevant to the user's query.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 5919,
        "completion_tokens": 205,
        "total_tokens": 6125
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does the dual-class stock structure at META, which affects the voting rights of Class A common stockholders, compare to NFLX's approach to shareholder voting rights in terms of investor influence over corporate governance decisions?",
      "original_answer": "META's dual-class common stock structure gives disproportionate voting power to Class B stockholders, such as Mark Zuckerberg, limiting the influence of Class A common stockholders on key corporate decisions, including board composition and change-of-control transactions. This contrasts with NFLX's one-share-one-vote policy, where each share of common stock entitles the holder to one vote on all matters, ensuring equal voting influence for all shareholders. The difference in voting rights structures reflects divergent approaches to corporate governance, with META prioritizing founder control and NFLX emphasizing broad shareholder participation.",
      "llm_answer": "META’s dual‑class structure concentrates voting power in the hands of its Class B holders (ten votes per share versus one vote for Class A), giving the CEO, board chair and other insiders a majority of the combined voting power and limiting Class A shareholders’ influence over governance decisions【META_10k_2023.pdf: pages 48‑52】.  By contrast, Netflix has a single class of common stock with one vote per share, so all shareholders enjoy equal voting rights and can directly influence corporate governance without a privileged voting class【NFLX_10k_2023.pdf: pages 59‑63】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) It correctly identifies META's dual-class structure with Class B shares having 10 votes per share versus 1 vote for Class A, which matches the knowledge graph and is supported by the cited 10-K pages. This quantitative detail is precise and correctly attributed. (2) The answer accurately contrasts this with NFLX's single class of common stock with one vote per share, correctly stating that all shareholders have equal voting rights—this matches the ground truth's 'one-share-one-vote' description. (3) The multi-hop reasoning is sound: the model synthesizes governance structures from both META and NFLX filings and draws a valid comparison regarding investor influence over corporate governance. (4) Minor deduction in qualitative accuracy due to slightly less explicit mention of 'founder control' (e.g., Mark Zuckerberg) and 'broad shareholder participation' as framing themes, though the implication is clear. Wording differs slightly but maintains semantic equivalence. No calculation errors. All entities (META, NFLX, Class A/B shares, voting rights) are correct and contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 331,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does the expiration of patent rights for JNJ's pharmaceutical products impact their market exclusivity, and how does this compare to LLY's reliance on regulatory exclusivity extensions for maintaining competitive advantage in the U.S. market?",
      "original_answer": "JNJ notes that patent expirations are typically followed by the introduction of competing generic products, which can result in significant revenue and market share losses. Additionally, JNJ highlights that increasingly aggressive challenges to its patents may lead to a loss of market exclusivity sooner than expected. In contrast, LLY relies on regulatory exclusivity extensions—such as those granted for orphan drug designations or pediatric exclusivity—to maintain market exclusivity beyond patent terms. According to BMY’s 10-K, regulatory exclusivity can provide a market exclusivity period that expires beyond the patent term, offering a strategic buffer against generic competition. Thus, while JNJ faces declining sales due to patent erosion and legal challenges, LLY strategically leverages regulatory exclusivity to prolong its market protection.",
      "llm_answer": "When JNJ’s patents expire, the company loses its legal monopoly, allowing generics or biosimilars to enter the market and causing a rapid decline in sales, as the company no longer enjoys market exclusivity. In contrast, LLY relies on regulatory exclusivity extensions—such as data exclusivity, orphan‑drug exclusivity, and pediatric exclusivity—to extend the period during which competitors cannot launch generic or biosimilar versions, thereby preserving its competitive advantage in the U.S. market even after patent expiration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies that JNJ faces loss of market exclusivity and revenue decline upon patent expiration due to generic/biosimilar entry, and notes the risk of accelerated loss from patent challenges (implied in 'loses its legal monopoly'). The answer accurately contrasts this with LLY's strategy of using regulatory exclusivity extensions—specifically naming data exclusivity, orphan-drug, and pediatric exclusivity—as mechanisms to maintain market protection beyond patent terms. While the LLM does not explicitly mention BMY’s 10-K as the source for regulatory exclusivity extending beyond patent terms (a minor omission in provenance), the factual claim itself is correct and aligns with the knowledge graph. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound, multi-hop synthesis across JNJ and LLY is accurate, and the response fully addresses both parts of the question. Wording differs slightly but meaning is preserved. No factual errors or calculation issues present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 324,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does AMD's reduction in interest expense from convertible debt conversions compare with Nuance's outstanding convertible senior notes liability post-acquisition by Microsoft, and what does this imply about their respective capital structure strategies?",
      "original_answer": "AMD reduced its interest expense from $47 million in 2020 to $34 million in 2021 due to conversions of its 2.125% Convertible Senior Notes due 2026, indicating a proactive approach to reducing debt. Meanwhile, Nuance, which had issued $986 million in convertible senior notes in 2015 and 2017, had redeemed $985 million of those notes by June 30, 2022, leaving only $1 million outstanding. Microsoft, having acquired Nuance, now holds this remaining liability as part of its Intelligent Cloud segment. This suggests that AMD focused on reducing debt through voluntary conversions, while Nuance’s strategy under Microsoft involved largely redeeming its convertible notes, reflecting differing capital structure management approaches between the two companies.",
      "llm_answer": "AMD’s 2021 interest expense fell by $13 million – the drop was driven by holders converting its 2.125 % convertible senior notes, which lowered debt balances.  In contrast, Microsoft’s balance sheet shows only $1 million of Nuance’s convertible senior notes outstanding after the acquisition (the $986 million issued in 2015‑17 was largely redeemed).  Thus, AMD is actively converting debt to cut interest costs and improve leverage, while Microsoft has largely eliminated Nuance’s convertible debt, reflecting a strategy that prioritizes debt reduction and a leaner capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AMD's interest expense reduction from $47M to $34M as a $13M drop, accurately attributing it to conversions of its 2.125% Convertible Senior Notes due 2026. It also correctly states that Nuance issued $986M in convertible notes and that only $1M remained outstanding post-acquisition by Microsoft, with the rest redeemed. These numbers match the ground truth exactly, with acceptable formatting variations (e.g., $986 million = $986M). (2) All calculations are accurate: the $13M decrease is correct ($47M - $34M), and the redemption of $985M out of $986M is implied by stating only $1M remains, which aligns with the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across AMD’s debt conversion strategy and Nuance’s redemption under Microsoft, comparing their capital structure strategies. It infers that AMD is proactively reducing leverage via conversions, while Microsoft has largely eliminated Nuance’s convertible debt, reflecting a leaner capital structure—consistent with the original conclusion. (4) Minor deduction in qualitative accuracy because the LLM omits the specific redemption date (by June 30, 2022) and does not explicitly mention that the remaining liability is held within Microsoft’s Intelligent Cloud segment, though this detail is secondary. Otherwise, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 410,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does the $5.0 billion upfront payment from American Tower in 2015 for exclusive rights to 11,300 Verizon towers compare to the $4.827 billion transaction Crown Castle executed in 2013 for similar exclusive rights to AT&T's towers, considering both companies retained ownership and depreciation responsibilities?",
      "original_answer": "The $5.0 billion upfront payment from American Tower in 2015 for exclusive rights to 11,300 Verizon towers is slightly higher than the $4.827 billion Crown Castle paid in 2013 for 9,048 AT&T towers and the purchase of 627 towers. Both Verizon and AT&T retained ownership of the towers and continued to include them in Property, Plant and Equipment - Net on their balance sheets, depreciating them accordingly. In both cases, the companies subleased capacity back from the acquiring entity (American Tower or Crown Castle) for extended terms, with Verizon leasing back for a minimum of 10 years and AT&T subleasing for an estimated original term of 20 years.",
      "llm_answer": "The American Tower transaction in 2015 was a $5.0 billion upfront payment for exclusive lease‑and‑operate rights to 11,300 Verizon towers, slightly larger than Crown Castle’s $4.827 billion deal in 2013 for 9,048 AT&T towers. In both cases Verizon and AT&T retained ownership of the towers, continued to depreciate them, and the payments were treated as financing obligations rather than sale‑leasebacks. Thus, the two deals were structurally similar, with the only difference being the modest $173 million higher payment in the American Tower transaction.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $5.0 billion American Tower payment in 2015 for 11,300 Verizon towers and compares it to the $4.827 billion Crown Castle transaction in 2013, accurately noting the $173 million difference. These numbers, dates, and entities are all factually correct. (2) Quantitative accuracy is perfect: $5.0B - $4.827B = $173M is correct, and all dollar amounts, years, and tower counts (11,300 vs. 9,048) match the ground truth. (3) The reasoning is mostly sound—both deals involved retained ownership, depreciation, and exclusive rights. However, the LLM adds that the payments were 'treated as financing obligations rather than sale-leasebacks' and omits key details present in the original answer: specifically, that both companies subleased capacity back, with Verizon for a minimum of 10 years and AT&T for an estimated 20-year term. This omission reduces completeness and slightly affects qualitative accuracy. Also, the characterization of the accounting treatment ('financing obligations') is plausible but not confirmed in the ground truth, introducing a minor unsupported claim. (4) Despite these nuances, the core comparison is accurate and relevant, with strong quantitative precision and good synthesis. The answer is semantically close but misses some contextual depth on leaseback terms, justifying a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 383,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does Southern Power's use of tax equity partnerships for wind facilities, which are connected to long-term PPAs with up to 25-year terms, compare with Duke Energy's approach to structuring PPAs for its renewable VIEs, particularly in terms of monetizing federal tax credits like PTCs?",
      "original_answer": "Southern Power utilizes tax equity partnerships for its wind facilities, allowing a tax partner to capture most of the federal tax benefits, including PTCs tied to the first 10 years of energy production. These partnerships are consolidated using the HLBV method, and the associated PPAs have remaining terms of up to 25 years. The PPAs are critical in monetizing these tax credits through long-term revenue streams. Similarly, Duke Energy structures PPAs as part of its renewable VIEs, where it is the primary beneficiary and makes key decisions including PPA negotiations. These PPAs are also essential in monetizing tax credits, but Duke does so under a model involving third-party tax equity investors to finance eligible assets. Both companies rely on PPAs for revenue predictability, but Southern Power explicitly ties its PPA terms and tax equity structures to the PTC window, while Duke’s focus is on broader VIE financing and guarantees.",
      "llm_answer": "Southern Power monetizes federal tax credits by entering tax‑equity partnerships for its wind projects, with the partner assuming the PTCs and the PPAs being long‑term contracts of up to 25 years (Tax Credits section, pp. 95‑99). Duke Energy structures its renewable VIEs with tax‑equity arrangements that also allow the partner to capture the PTCs, but the PPAs are negotiated within the VIE and the VIE itself is not consolidated (Commercial Renewables, pp. 200‑204). Thus, Southern Power consolidates the tax‑equity partnership and relies on long‑term PPAs, whereas Duke Energy’s VIEs remain separate entities that monetize tax credits through the partner while the PPAs are part of the VIE’s operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core facts: both Southern Power and Duke Energy use tax equity partnerships to monetize PTCs, and long-term PPAs are involved in both models. The numeric details (e.g., up to 25-year PPAs) are accurate and consistent with the ground truth, earning a perfect quantitative accuracy score. However, there is a key qualitative inaccuracy: the LLM claims Duke Energy's VIEs 'are not consolidated,' which contradicts the ground truth stating Duke is the 'primary beneficiary' of the VIEs—implying consolidation under accounting rules. This is a significant error in financial reporting logic. Additionally, the LLM omits the detail that Southern Power uses the HLBV method for consolidation, a key differentiator. While the comparison touches on structural differences, it fails to capture the ground truth nuance that Southern Power explicitly aligns PPA terms with the 10-year PTC window, whereas Duke’s approach is more focused on broader VIE financing. The reasoning is partially sound and contextually relevant, but the consolidation misstatement and missing synthesis reduce qualitative accuracy. The answer remains contextually relevant and correctly identifies the role of tax equity and PPAs in monetizing credits.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 350,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How do the differences in voting rights structures between CMCSA's Class B common stock and GOOGL's dual-class stock system affect their respective corporate governance models, particularly in terms of shareholder influence on major corporate decisions?",
      "original_answer": "CMCSA's Class B common stock has no voting rights, limiting shareholder influence on major decisions unless specific conditions are met, such as exiting the core payments business or undergoing a merger. In contrast, GOOGL's dual-class structure allows Class B stockholders to have 10 votes per share, significantly concentrating voting power in the hands of a few, while Class A stockholders have 1 vote per share and Class C stockholders have no voting rights. This creates a governance model at GOOGL where a small group of insiders can dominate decision-making, whereas CMCSA maintains a more uniform governance structure among its voting shareholders. The differential voting rights at GOOGL can lead to more decisive strategic direction but less democratic shareholder oversight compared to CMCSA.",
      "llm_answer": "CMCSA’s Class B shares carry ten votes each (vs. one vote for each Class A share), so a relatively small group of shareholders can control board and corporate decisions (CMCSA 10‑K, pp. 65‑69). Alphabet’s dual‑class structure gives voting rights only to Class A shares (one vote per share) while Class C shares are non‑voting, concentrating decision‑making power in the hands of a limited group of insiders and limiting the influence of the majority of public shareholders (Alphabet 10‑K, pp. 80‑84).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) It incorrectly states that CMCSA's Class B shares have ten votes per share, when in fact CMCSA's Class B common stock has *no voting rights*—this is a critical reversal of the truth. The original answer specifies that CMCSA Class B shares are non-voting except under specific conditions, which the LLM completely misrepresents. (2) For GOOGL (Alphabet), the LLM incorrectly claims that only Class A shares have voting rights (1 vote per share) and that Class C are non-voting—while this part is mostly correct—it omits the existence and super-voting rights of Class B shares (10 votes per share held by insiders), which is central to understanding GOOGL's dual-class structure. The LLM implies Class A has voting power among public shareholders but fails to note that Class B's 10-vote structure dominates governance. (3) The multi-hop reasoning is flawed: the question asks for a comparative analysis of how voting structures affect corporate governance models, but the LLM misrepresents both companies' structures, leading to an invalid comparison. (4) Contextual relevance is moderate because the response addresses shareholder influence and governance, but due to fundamental errors in entity-level facts, the analysis is misleading. Wording differences are acceptable, but here the meaning is factually inverted on key points, especially regarding CMCSA. No calculations were required, but entity and structural accuracy is poor.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 416,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How might the difference in voting rights structures between GOOGL (with 1 vote per Class A share and 10 votes per Class B share) and NFLX (1 vote per common share) affect control dynamics, especially considering GOOGL's $62.2 billion in share repurchases during 2023?",
      "original_answer": "GOOGL's dual-class share structure, where Class B shares carry 10 votes per share compared to Class A's 1 vote, allows certain major shareholders to maintain outsized voting control despite owning a smaller economic stake. In 2023, GOOGL repurchased $62.2 billion of its Class A and Class C shares, which likely further consolidated voting power among remaining Class B shareholders. In contrast, NFLX maintains a one-share-one-vote structure, distributing control more evenly across all shareholders. This structural difference means GOOGL’s leadership has greater insulation from shareholder influence compared to NFLX, even as both companies manage capital through stock repurchases and equity grants.",
      "llm_answer": "GOOGL’s dual‑class structure gives Class B holders 10 votes per share versus one vote for each Class A share (Note 11, p. 80), so the 2023 repurchase of $62.2 billion of Class A and C shares (Share Repurchases, p. 81) cuts the number of one‑vote shares outstanding and proportionally boosts the voting influence of the ten‑vote Class B holders, concentrating control in the hands of the founders and early investors. In contrast, NFLX’s common shares carry only one vote each (NFLX 10‑K, p. 59‑63), so voting power is directly tied to share ownership and cannot be amplified by a dual‑class scheme, preventing the same concentration of control.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GOOGL's dual-class structure (10 votes for Class B, 1 for Class A), the $62.2 billion share repurchase in 2023, and NFLX's one-share-one-vote structure are all accurately stated. The dollar amount and structural details match the original answer exactly. (2) Quantitative accuracy is perfect: the $62.2 billion figure is correctly cited, and no calculations are required beyond accurate reporting. (3) The reasoning is sound: the LLM correctly infers that repurchasing Class A and C shares (which have lower voting rights) reduces the pool of low-vote shares, thereby increasing the relative voting power of Class B shareholders. This demonstrates correct multi-hop synthesis between capital allocation (repurchases) and governance impact. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the contrast in leadership insulation from shareholder influence—a qualitative point emphasized in the original answer. However, this is implied by the concentration of control narrative. The inclusion of citation markers (e.g., 'Note 11, p. 80') suggests grounding in source material, though not required. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth with only slight omission in framing the broader governance implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 392,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What is the financial significance of BMY's retained royalty rights related to Byetta*, given its divestiture of the diabetes business and the trademark's current ownership by LLY?",
      "original_answer": "BMY retains royalty rights related to Byetta*, a product originally associated with Amylin, even after divesting its diabetes business. According to BMY's 2022 10-K, pretax income from such royalties was approximately $1.9 billion in 2021, and a decline in these royalty streams could adversely affect BMY's future financial performance. Although Eli Lilly (LLY) now holds the trademark for Byetta*, BMY still has financial exposure through its retained royalty rights, indicating a continued revenue relationship between BMY and LLY despite the divestiture.",
      "llm_answer": "BMY’s retained royalty rights to Byetta are a small, ongoing source of royalty income that is bundled with its other royalty streams.  In 2021 the company’s total royalty income was about $1.9 billion, and the Byetta‑related portion is not disclosed separately, implying it is immaterial to BMY’s overall results.  Because Eli Lilly now owns the Byetta trademark, BMY receives royalty payments only on Lilly’s sales of the drug, so the financial impact is limited to a modest, recurring royalty fee.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that BMY had $1.9 billion in total royalty income in 2021, which matches the ground truth from BMY's 2022 10-K. However, it incorrectly implies that the Byetta-related royalty portion is immaterial and not separately disclosed, which contradicts the ground truth that explicitly highlights the $1.9 billion as pretax income from 'such royalties'—referring to Byetta-related royalties—indicating this figure is directly tied to Byetta and significant. (2) The quantitative accuracy is high because the $1.9 billion figure and 2021 timeframe are correct, and formatting is consistent. (3) The multi-hop reasoning is flawed: while the model correctly identifies that LLY owns the trademark and BMY receives royalties, it fails to recognize the financial significance emphasized in the original answer—that this royalty stream is a major contributor to BMY’s income and its decline could materially affect future performance. The LLM downplays the importance by calling it 'small' and 'modest,' which is inconsistent with the ground truth. (4) Contextual relevance is strong as the answer addresses royalty rights, ownership by LLY, and financial impact, but the qualitative misrepresentation of materiality reduces correctness. Thus, the answer is partially correct but contains a significant factual misinterpretation regarding the significance of the royalty income.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 391,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How does the difference in capital buffer structures between Schwab and JPMorgan Chase affect their respective minimum total risk-based capital ratio requirements, considering Schwab's requirement includes both a 2.5% stress capital buffer and 2.5% capital conservation buffer while JPMorgan Chase applies only a 2.5% capital conservation buffer?",
      "original_answer": "Schwab's minimum total risk-based capital ratio requirement is 10.5%, which incorporates both a 2.5% stress capital buffer and a 2.5% capital conservation buffer above the base regulatory minimum. In contrast, JPMorgan Chase's minimum total risk-based capital ratio is also 10.5%, but this only includes a 2.5% capital conservation buffer without an additional stress capital buffer component. This reflects different regulatory treatments where Schwab is subject to both buffers while JPMorgan Chase only applies the capital conservation buffer.",
      "llm_answer": "Schwab’s minimum total risk‑based capital ratio is 10.5 % (the figure reported for CSC and CSB inclusive of both a 2.5 % stress‑capital buffer and a 2.5 % capital‑conservation buffer). JPMorgan Chase Bank, N.A. also has a minimum total risk‑based capital ratio of 10.5 %, but that figure is calculated with only the 2.5 % capital‑conservation buffer (the bank is not subject to a stress buffer). Consequently, while the baseline ratio is identical, Schwab’s structure provides an additional 2.5 % buffer that can be invoked in stressed conditions, giving it a higher potential cushion than JPMorgan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: both Schwab and JPMorgan Chase have a 10.5% minimum total risk-based capital ratio, with Schwab including both a 2.5% stress capital buffer and a 2.5% capital conservation buffer, while JPMorgan only includes the 2.5% capital conservation buffer. These values match the original answer exactly. (2) The calculation implied—adding the buffers to the base minimum—is sound and consistent with regulatory frameworks, even if the base minimum (8%) is not explicitly stated. (3) The reasoning correctly synthesizes the multi-hop aspect by contrasting the two institutions’ regulatory treatments and correctly infers that Schwab’s structure provides an additional 2.5% buffer in stress conditions. (4) The only minor shortcoming is a slight overinterpretation in stating that Schwab has a 'higher potential cushion'—while technically true, the original answer emphasizes that both end up with the same 10.5% requirement, reflecting different paths rather than a current difference in required levels. The LLM implies a structural advantage without clarifying that the final required ratio is identical under normal conditions. This nuance prevents a perfect 10, but the core facts, entities, and logic are correct. Semantic equivalence is strong, and all entities (Schwab, JPMorgan Chase, buffer types) are accurately identified and compared.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 400,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How does the transition from LIBOR to alternative reference rates impact both LMT's credit facility and GE's floating-rate debt and preferred stock, considering the accounting relief provided under ASU 2020-04?",
      "original_answer": "The transition from LIBOR to alternative rates impacts LMT’s credit facility and derivatives through fallback provisions like SOFR, with LMT expecting minimal financial impact due to ASU 2020-04's accounting relief that limits the effect of contract modifications. Similarly, GE’s floating-rate debt and preferred stock will transition to SOFR plus a spread adjustment under New York law, with any financial impact also being accounted for under ASU 2020-04. Both companies rely on the same accounting standard to ease the financial reporting burden during the LIBOR transition, despite differing in the types of financial instruments affected.",
      "llm_answer": "LMT’s credit facility contains fallback provisions that automatically switch the reference rate to an alternative benchmark (e.g., SOFR) when LIBOR ceases, and ASU 2020‑04 allows the company to account for this change without a contract modification, so no material impact on its financial statements is expected (LMT, 10‑K, pp. 83‑87). GE’s floating‑rate debt and preferred stock, which are governed by New York law, will likewise be replaced by SOFR plus a spread once LIBOR is discontinued, and the ASU 2020‑04 relief permits GE to treat the transition as a change in the reference rate rather than a remeasurement, limiting any accounting impact (GE, 10‑K, pp. 35‑39).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) All factual elements are correct: LMT’s credit facility uses fallback provisions (e.g., SOFR) with minimal financial impact due to ASU 2020-04, which allows accounting for the transition without treating it as a contract modification. GE’s floating-rate debt and preferred stock will transition to SOFR plus a spread adjustment under New York law, and ASU 2020-04 similarly limits accounting impact by allowing treatment as a reference rate change rather than remeasurement. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (LMT and GE), their respective financial instruments (credit facility vs. floating-rate debt and preferred stock), and applies the same accounting standard (ASU 2020-04) to both, showing understanding of its role in easing reporting burdens. (4) The only minor shortcoming is that the LLM answer does not explicitly state that both companies rely on the same accounting standard to ease the financial reporting burden during LIBOR transition—a point emphasized in the original answer for synthesis. However, this is implied through parallel structure and accurate application of ASU 2020-04 to both firms. Wording differs slightly but maintains semantic equivalence. Contextual relevance is perfect—directly addresses all parts of the question with precise, on-topic information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 438,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "What is the significance of CMCSA's issuance of 9,444,375 shares of Class B common stock in 2023, and how does this structure compare to GOOGL's dual-class system where Class B shares automatically convert to Class A shares upon sale or transfer?",
      "original_answer": "CMCSA issued 9,444,375 shares of Class B common stock in 2023, indicating a strategic move to maintain control while potentially raising capital without diluting voting power significantly. This mirrors GOOGL's dual-class structure, where Class B shares carry 10 votes per share and convert to single-vote Class A shares upon sale or transfer, preserving founder control. However, unlike GOOGL, which actively repurchased $62.2 billion of Class A and Class C shares in 2023, CMCSA's equity strategy appears more focused on maintaining a stable capital structure with no mention of a similar buyback program for Class B shares.",
      "llm_answer": "Comcast’s 2023 10‑K shows that it issued 9,444,375 shares of Class B common stock— a small fraction of the 75 million authorized— giving holders 10 votes per share and enabling the company to use this class for equity‑compensation or control purposes (balance sheet, pages 70‑71). Alphabet’s dual‑class structure is different: its Class B shares automatically convert to Class A shares upon sale or transfer, ensuring that controlling shareholders retain voting power and preventing the separate holding of Class B shares after a transaction (dual‑class note, page 83).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the issuance of 9,444,375 Class B shares by CMCSA in 2023 and accurately notes the 10 votes per share for Class B, matching the ground truth. The quantitative details (number of shares, voting rights) are factually correct, earning a perfect score on quantitative accuracy. The comparison to GOOGL's dual-class structure correctly highlights the key distinction: GOOGL's Class B shares convert to Class A upon sale or transfer, which is accurately stated. However, the LLM omits a key element from the original answer — the contrast in capital return strategies, specifically that GOOGL repurchased $62.2 billion of shares in 2023, while CMCSA had no similar buyback program for Class B shares. This missing comparative insight slightly weakens the multi-hop synthesis, affecting completeness and qualitative accuracy. Despite this omission, the reasoning is sound, entities (CMCSA, GOOGL, Class B shares, voting rights) are correctly identified, and the response is highly relevant to the question. Semantic equivalence is largely preserved, but the lack of reference to buybacks prevents a top score in correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 331,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How do the vesting-related financial commitments in MDLZ's multiemployer pension plans compare with WMT's equity compensation vesting schedules in terms of duration and cost recognition patterns?",
      "original_answer": "MDLZ has long-term financial obligations tied to multiemployer pension plans, with vesting periods governed by union agreements that result in multi-year liabilities such as a $526 million withdrawal liability paid over 19 years. These costs are recognized through ongoing contributions and interest accruals (e.g., $11 million in 2021). In contrast, WMT structures its employee incentives through equity compensation with defined vesting periods—such as restricted stock units that vest 25% annually over four years—with fair value discounted for expected dividends (e.g., 3.8% in fiscal 2022) and expensed ratably over the vesting term. While MDLZ's obligations are shaped by collective bargaining and multiemployer fund rules, WMT's vesting schedules are internally designed to align with shareholder interests and are accounted for as equity or expense over shorter, fixed timeframes.",
      "llm_answer": "MDLZ’s multi‑employer pension commitments are long‑term: the company pays a $526 million withdrawal liability over 19 years (in addition to annual contributions of $4‑$5 million for continuing participation).  These costs are recorded as expense when incurred and the interest on the liability is amortized over the 19‑year payment period.  By contrast, Walmart’s equity‑based awards vest over 1–5 years (RSUs 4‑year, pre‑2020 3/5‑year, performance‑based 1–3 years) and the related expense is recognized ratably each year based on the fair value at grant.  Thus, MDLZ’s vesting‑related commitments are longer in duration and cost‑recognition is tied to withdrawal payments and interest, whereas Walmart’s vesting schedules are shorter and expense is spread evenly over the vesting period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the $526 million withdrawal liability over 19 years is correct, as is the mention of ongoing annual contributions—though the ground truth specifies $11 million in 2021 interest and contributions while the LLM cites $4–$5 million for continuing participation. This slight discrepancy in contribution amount is minor and may reflect different reporting years or scopes; it does not constitute a major error. The vesting periods for WMT (e.g., 4-year RSUs) are accurately described, though the ground truth emphasizes the 25% annual vesting and fair value discounting (3.8% dividend assumption), which the LLM omits. (2) The cost recognition patterns are correctly characterized: MDLZ’s expense recognition tied to withdrawal payments and interest amortization over 19 years, and WMT’s ratable expensing based on grant-date fair value. The LLM correctly notes the ratable (straight-line) expense pattern, a key accounting point. (3) Multi-hop reasoning is sound: the model successfully synthesizes information across two companies (MDLZ and WMT), two types of compensation (multiemployer pension vs. equity awards), and compares both duration and cost recognition. It correctly identifies that MDLZ’s obligations stem from collective arrangements with long durations, while WMT’s are internally structured with shorter, fixed vesting. (4) The answer is contextually excellent—directly addressing the comparison in duration and cost recognition. The only minor gaps are the omission of the dividend discounting in WMT’s equity valuation and slight variance in contribution figures, which prevent a perfect 10. Overall, the semantic meaning and factual core match the ground truth very closely.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 482,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How does the combined capital buffer requirement above the minimum risk-based capital ratios for BAC under the Advanced Approach compare to MS's requirement, considering both institutions' application of the 2.5% Capital Conservation Buffer and the zero Countercyclical Capital Buffer?",
      "original_answer": "Both BAC and MS apply the 2.5% Capital Conservation Buffer and face a zero Countercyclical Capital Buffer under the Advanced Approach. For BAC, this buffer combines with a 2.5% G-SIB surcharge, resulting in a total buffer requirement of 5.0% above the minimum risk-based capital ratio. Similarly, MS also computes its capital buffer as the sum of the 2.5% Capital Conservation Buffer and the 2.5% G-SIB surcharge, leading to an identical total buffer requirement of 5.0% above the minimum risk-based capital ratio. Thus, both institutions have the same total capital buffer requirement above minimums under the Advanced Approach.",
      "llm_answer": "Bank of America’s combined capital buffer requirement under the Advanced Approach is 5.5 % above the minimum risk‑based capital ratios (the sum of a 2.5 % Capital Conservation Buffer, a 3.0 % G‑SIB surcharge and a 0 % Countercyclical Buffer). Morgan Stanley’s requirement is the same 5.5 % above the minimum, because it also applies a 2.5 % Capital Conservation Buffer and a zero Countercyclical Buffer.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative values. It states that both BAC and MS have a 5.5% total capital buffer, calculated as 2.5% Capital Conservation Buffer + 3.0% G-SIB surcharge. However, the ground truth specifies that both institutions have a 2.5% G-SIB surcharge, not 3.0%, resulting in a correct total buffer of 5.0% (2.5% + 2.5%), not 5.5%. This miscalculation applies to both institutions and invalidates the numerical accuracy. (2) The quantitative inaccuracies are critical: the G-SIB surcharge is misstated for both banks, and the resulting total buffer is incorrectly calculated. While the Capital Conservation Buffer (2.5%) and Countercyclical Buffer (0%) are correctly identified, the erroneous G-SIB surcharge leads to an incorrect sum. (3) The reasoning structure is sound—multi-hop synthesis is attempted by combining buffers across institutions and comparing them—but it is based on incorrect underlying data. The conclusion that both banks have the same requirement is correct per the ground truth, but this is coincidental due to parallel errors. (4) Contextual relevance is high as the answer addresses the required components (buffers, institutions, comparison), but correctness is severely impacted by the wrong G-SIB surcharge value and resulting miscalculation. Thus, the correctness and quantitative accuracy scores are low; qualitative accuracy is moderate due to correct framework use; relevance remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 410,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does the sensitivity of AVGO's $56.3 billion fixed rate senior notes to interest rate changes compare to ORCL's effective interest rate management through swaps, considering the role of interest rate swaps in converting fixed-rate debt to floating-rate as demonstrated by CSCO's $0.5 billion swap?",
      "original_answer": "AVGO's $56.3 billion in fixed rate senior notes is highly sensitive to interest rate changes, with a 50 basis point shift affecting fair value by $1.7 billion. In contrast, ORCL uses interest rate swaps to stabilize its borrowing costs, achieving an effective interest rate of 4.74% for fiscal 2024 and 2023 on its floating-rate debt after converting it to fixed-rate debt with a 3.07% base rate. CSCO's use of a $0.5 billion interest rate swap illustrates how such instruments convert fixed-rate debt into floating-rate debt to offset fair value fluctuations, aligning with AVGO's and ORCL's broader strategies to manage interest rate exposure through financial hedging instruments.",
      "llm_answer": "AVGO’s $56.3 billion of fixed‑rate senior notes are highly sensitive to rate moves – a 50‑basis‑point change in market rates would shift their fair value by about $1.7 billion (≈$34 million per basis point)【AVGO_10k_2024.pdf:47-51】.  \nOracle, by contrast, employs interest‑rate swaps to convert portions of its fixed‑rate debt into floating‑rate exposure, thereby dampening the impact of rate swings on its effective interest rate【ORCL_10k_2024.pdf:86-90】.  \nCisco’s $0.5 billion swap illustrates this mechanism: the swap hedges fixed‑rate notes by switching the interest to a SOFR‑linked rate, offsetting fair‑value changes【CSCO_10k_2024.pdf:87-91】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AVGO's $56.3 billion fixed-rate senior notes and the $1.7 billion fair value impact from a 50 basis point shift, which matches the ground truth. It also accurately references CSCO's $0.5 billion swap. However, it misrepresents ORCL's strategy: the ground truth states ORCL uses swaps to convert floating-rate debt to fixed-rate (achieving a 4.74% effective rate), but the LLM incorrectly claims ORCL converts fixed-rate to floating-rate, which is the opposite of what is reported. This is a significant qualitative error in reasoning and entity-metric alignment. (2) Quantitatively, all numbers are correct—$56.3B, $1.7B, 50 bps, $0.5B—and the implied sensitivity (~$34M per basis point) is a valid derivation. The effective interest rate of 4.74% and base rate of 3.07% for ORCL are missing, which are key quantitative details from the original answer. (3) Multi-hop reasoning is partially sound: the model connects AVGO’s sensitivity, ORCL’s use of swaps, and CSCO’s example, but the incorrect characterization of ORCL’s swap direction undermines the synthesis. The comparison between companies is weakened because ORCL’s actual strategy (floating to fixed) is flipped. (4) Contextual relevance is strong—the response directly addresses the question’s focus on interest rate sensitivity and swap mechanisms. However, due to the misstatement about ORCL’s hedging strategy and omission of key rates, the correctness score is reduced to 7, with quantitative accuracy at 8 (missing specific percentages) and qualitative accuracy at 7 due to flawed reasoning on ORCL’s approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 445,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does the voting power distribution tied to Class B common stock at META compare to GOOGL's repurchase strategy across its multiple stock classes, given the interplay between voting rights and share structure?",
      "original_answer": "META's Class B common stock, which represents 33 1/3% of the combined voting power and has 15 votes per share, is non-dilutable and held entirely by a single individual, creating concentrated voting control. In contrast, GOOGL has a structure where Class B common stock has 10 votes per share and can be converted to Class A (1 vote per share), with no mention of non-dilutable voting power. Additionally, GOOGL actively repurchased $62.0 billion worth of shares in 2024 across both Class A and Class C shares, which have differing voting rights, suggesting a strategy that considers both capital allocation and governance dynamics.",
      "llm_answer": "Meta’s Class B shares carry 10 votes each, giving the founders a concentrated voting bloc (343 million shares as of Jan 24 2025)【META_10k_2024.pdf: pages 1‑5】. Alphabet has been buying back both its voting Class A shares and its non‑voting Class C shares, reducing the overall share count but not concentrating voting power, since Class C shares carry no votes【GOOGL_10k_2024.pdf: pages 80‑84】. Thus, Meta’s structure concentrates voting power in a small group, whereas Alphabet’s repurchase program dilutes share count without altering the dispersed voting structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it states that Meta’s Class B shares carry 10 votes per share, but the ground truth specifies 15 votes per share. Second, it mentions 343 million shares as of January 24, 2025, which is not present in the original answer and introduces unverified data. The original answer emphasizes that Meta’s Class B stock represents exactly 33 1/3% of combined voting power and is non-dilutable—key governance details omitted in the LLM response. Regarding GOOGL, the LLM incorrectly refers to repurchasing 'voting Class A' shares; in reality, GOOGL’s Class A shares are non-voting (1 vote per share), while Class B are the super-voting shares. The LLM correctly notes that GOOGL repurchased shares across classes but fails to specify the $62.0 billion amount in 2024, a major quantitative omission. (2) Quantitative accuracy is low: vote count per share (10 vs 15), missing repurchase dollar value ($62.0B), and introduction of unsupported share count (343M) reduce precision. The only correct number implied is that Class C has no votes, aligning with ground truth. (3) The reasoning partially captures the contrast between concentrated voting (Meta) and capital allocation without voting concentration (GOOGL), showing some multi-hop synthesis. However, mischaracterizing which share class has voting rights at GOOGL undermines the analysis. The conclusion about diluting share count without altering voting structure is directionally correct but based on flawed premises. (4) Contextual relevance is high—the answer addresses the core comparison between voting power and share repurchases across dual-class structures. Despite factual errors, it attempts the right conceptual contrast. Correctness score is 5 due to significant factual and numerical errors, especially in vote counts and missing key figures like the $62B repurchase, though some structural insights remain valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 525,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How does Qualcomm's projected growth in generative AI-capable smartphone shipments by 2027 influence its strategic focus on AI and connectivity technologies, as compared to Salesforce's investment in generative and agentic AI across its CRM products?",
      "original_answer": "Qualcomm projects that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024, which directly informs its strategic focus on developing on-device AI and advanced connectivity technologies like 5G and 5G Advanced to support edge computing and AI workloads. Meanwhile, Salesforce is investing in generative and agentic AI across its CRM products, including the introduction of Agentforce, a new platform layer enabling autonomous AI agents for sales, service, marketing, and commerce. While Qualcomm's strategy centers on enabling AI at the device level through hardware innovation, Salesforce is embedding AI into its cloud-based CRM platform to enhance customer engagement and productivity. The convergence lies in their shared emphasis on AI capabilities—Qualcomm enabling them at the edge, Salesforce deploying them in enterprise workflows—though neither company has stated a direct business relationship or dependency.",
      "llm_answer": "Qualcomm’s forecast that 46 % of smartphones sold in 2027 will be generative‑AI‑capable (up from 19 % in 2024) (see pages 7‑8) reinforces its strategy to embed AI engines and 5G connectivity into its Snapdragon platforms, enabling on‑device generative AI and expanding its reach into automotive, IoT and other edge markets. In contrast, Salesforce is channeling investment into generative and agentic AI across its cloud‑based CRM stack—introducing Agentforce to automate customer interactions—highlighting a software‑centric, cloud‑first approach rather than hardware‑centric connectivity (see pages 39‑40).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states Qualcomm's projected growth in generative AI-capable smartphone shipments from 19% in 2024 to 46% in 2027, matching the ground truth exactly. All quantitative figures are accurate. (2) The numbers are correctly cited and no calculations are required beyond the stated percentages, which are consistent with the original answer. Format variations (e.g., spacing in '46 %') do not affect factual accuracy. (3) The multi-hop reasoning is sound: the LLM correctly links Qualcomm’s market projection to its strategic focus on on-device AI and 5G/5G Advanced through Snapdragon platforms, and contrasts this with Salesforce’s cloud-based, software-centric AI investments via Agentforce in CRM products. It captures the core distinction—hardware vs. software AI integration—though it omits the explicit mention of '5G Advanced' and 'edge computing' terminology used in the ground truth, and does not note the absence of a direct business relationship between the two companies. (4) Despite minor omissions in technical phrasing and the lack of a concluding synthesis about convergence in AI emphasis, the answer conveys semantically equivalent information with high factual fidelity. Quantitative accuracy is perfect, contextual relevance is strong, and qualitative reasoning is robust but slightly less complete than the original, justifying a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 390,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does Adobe's focus on enhancing user experience through AI-driven digital media tools align with Qualcomm's projections for generative AI-capable edge devices in 2027, particularly in relation to on-device AI processing and user interface improvements?",
      "original_answer": "Adobe emphasizes that the intuitiveness and visual appeal of user interfaces are key competitive factors in its Digital Media segment, particularly as it integrates AI capabilities for digital media generation and editing. Qualcomm projects that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024, and highlights that on-device AI processing enhances user experiences with immediacy, privacy, and personalization. Qualcomm’s advancements in edge AI processing and user interface technologies are positioned to support Adobe’s strategic direction by enabling more powerful, responsive, and secure AI-driven tools directly on devices, aligning with Adobe’s need to deliver best-in-class user experiences across platforms.",
      "llm_answer": "Adobe’s 2023 10‑K shows that the company is embedding AI—through Adobe Sensei, Firefly and generative‑AI features in Creative and Experience Cloud—to deliver personalized, AI‑driven content creation and user‑interface experiences across devices (ADBE 10‑K, pp. 6‑10). Qualcomm projects that by 2027 roughly 46 % of smartphones will be generative‑AI‑capable, powered by on‑device AI engines such as its Hexagon NPU, enabling low‑latency, privacy‑preserving AI processing that can support Adobe’s AI‑enhanced UI and personalization (QCOM 10‑K, pp. 5‑10). Thus, Adobe’s focus on AI‑driven digital media tools aligns with Qualcomm’s edge‑device roadmap, as both aim to deliver richer, real‑time user experiences through on‑device AI and improved interface responsiveness.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Adobe's use of AI via Sensei, Firefly, and generative AI in Creative and Experience Cloud is accurately cited from its 10-K (pp. 6–10), and Qualcomm’s projection of 46% of smartphones being generative AI-capable by 2027 (up from 19% in 2024, though the 19% figure is omitted in the LLM answer) is correctly stated. The reference to Qualcomm’s Hexagon NPU and on-device AI processing for low-latency, privacy-preserving experiences matches the intent of the original. (2) Quantitative accuracy is perfect: the 46% figure for 2027 is correct and properly attributed. While the LLM omits the 19% baseline from 2024 mentioned in the ground truth, this does not detract significantly from correctness. (3) Reasoning is sound: the answer correctly synthesizes Adobe’s AI-driven UX focus with Qualcomm’s edge AI roadmap, identifying on-device processing as an enabler for responsive, secure, and personalized user interfaces. The multi-hop logic—linking Adobe’s software strategy with Qualcomm’s hardware capabilities—is well-executed. (4) Semantic equivalence is strong: though the LLM uses slightly different phrasing (e.g., 'low-latency' instead of 'immediacy'), the meaning is consistent with the original. The only minor gap is the lack of explicit mention of 'personalization, privacy, and immediacy' as user experience benefits directly tied to on-device processing, which slightly affects qualitative depth. Overall, the answer is factually correct, contextually relevant, and demonstrates strong cross-company, multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 446,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does the treatment of dividend equivalents on RSU awards differ between Lockheed Martin's and Honeywell's compensation plans, based on the specific vesting terms and payment structures disclosed?",
      "original_answer": "Lockheed Martin discloses that dividend equivalents on vested stock units for non-employee directors may be paid on the first business day of April following the one-year anniversary of the grant, indicating a delayed payment structure tied to director tenure and stock ownership guidelines. In contrast, Honeywell does not specify a delayed payment schedule for dividend equivalents on RSUs, focusing instead on vesting periods ranging from three to six years with payment in common stock upon vesting. Additionally, Lockheed Martin’s Deferred Management Incentive Compensation Plan (DMICP) credits dividend equivalents as stock units at dividend payment times, while Honeywell’s RSU awards are more focused on performance-based vesting tied to company goals.",
      "llm_answer": "Lockheed Martin’s RSU awards earn dividend equivalents that are credited as phantom‑stock units at the time dividends are paid, and the awards vest on the third anniversary of the grant date with shares paid upon vesting. Honeywell’s RSU awards vest over a 3‑to‑6‑year period and are paid in shares upon vesting, but the plan does not provide for dividend equivalents on the awards. Thus, Lockheed Martin includes dividend‑equivalent treatment in its RSU awards, whereas Honeywell’s RSU awards do not.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant inaccuracies in both factual content and reasoning. (1) On quantitative accuracy: The vesting period of 'third anniversary' for Lockheed Martin is partially correct but oversimplified; the ground truth emphasizes a one-year anniversary for non-employee directors with payment in April, not a uniform three-year vesting. Honeywell’s 3-to-6-year vesting range is correctly stated. However, the claim that Honeywell’s RSUs 'do not provide for dividend equivalents' is incorrect—while the payment structure isn't delayed like Lockheed’s, Honeywell does accrue dividend equivalents, just without specifying a delayed payout schedule. (2) The LLM incorrectly states that Honeywell’s RSU awards do not include dividend equivalents at all, which contradicts the original answer implying they are addressed differently, not absent. (3) Qualitatively, the multi-hop reasoning fails: the model does not recognize that both companies handle dividend equivalents, but with differing timing and structure—Lockheed has a delayed, director-specific payout and DMICP crediting, while Honeywell integrates them without explicit delay. The LLM instead creates a false dichotomy: 'Lockheed has them, Honeywell doesn’t.' This misrepresents the synthesis required. (4) Contextual relevance is high because the response addresses vesting terms, payment forms, and dividend treatment as asked, but the incorrect conclusion undermines usefulness. Minor phrasing differences would be acceptable, but denying dividend equivalents on Honeywell RSUs is a material error. Thus, partial credit is given for correct vesting ranges and Lockheed’s phantom unit crediting, but major deductions for factual inaccuracy and flawed comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 479,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the reliance of Texas Instruments (TXN) on subcontractors for 40% of its assembly and test services compare with NVIDIA's (NVDA) exposure to third-party manufacturers, given the shared dependency on external production capacity and the risks highlighted by AMD's experience with third-party suppliers?",
      "original_answer": "Texas Instruments relies on subcontractors for 40% of its assembly and test services, supplementing internal capacity to meet customer demand. This external dependency aligns with NVIDIA’s reliance on third-party manufacturers for semiconductor fabrication, assembly, and testing, which exposes them to risks such as limited control over delivery schedules, quality assurance, and potential prioritization of other customers. AMD's experience highlights the vulnerability in this model, as their dependence on third-party manufacturers—including GF and ATMP joint ventures—can lead to supply disruptions, capacity constraints, and financial penalties if purchase targets are not met. Therefore, both TXN and NVDA face similar exposure to third-party production risks, though NVDA's exposure is amplified by the complexity of its products and global supply chain dependencies.",
      "llm_answer": "Texas Instruments relies on subcontractors for roughly 40 % of its assembly‑and‑test services, a sizable external dependency. NVIDIA likewise outsources the bulk of its chip production to third‑party foundries (e.g., TSMC) and its risk factors note that supply constraints from those manufacturers could materially affect its business. AMD’s 10‑K highlights that third‑party supplier disruptions can cause capacity limits, delays and cost spikes, underscoring the shared vulnerability of both TXN and NVDA to external production‑capacity risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 40% subcontractor reliance for Texas Instruments is correctly stated, and there are no numerical inaccuracies. (2) The answer addresses all key parts of the question: TXN's 40% external dependency, NVDA's reliance on third-party manufacturers (specifically naming TSMC), and the risk context from AMD's experience with supply disruptions, delays, and cost spikes. (3) Entities are correct—Texas Instruments (TXN), NVIDIA (NVDA), AMD, and third-party suppliers like TSMC are accurately referenced. (4) The multi-hop reasoning is sound: it connects TXN’s subcontracting model to NVDA’s foundry dependence and uses AMD’s experience to highlight shared risks in external production. The only minor shortcoming is that the LLM does not explicitly note that NVDA's exposure is 'amplified by the complexity of its products and global supply chain dependencies,' a nuance present in the original answer. However, the core factual content and risk comparison are well-conveyed with semantic equivalence. Thus, the answer is factually correct, complete in key aspects, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 339,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total estimated cost of Duke Energy Florida's 10 new solar facilities, and how does this investment relate to Southern Power's use of PPAs as operating leases with terms up to 25 years for similar renewable energy projects?",
      "original_answer": "Duke Energy Florida's 10 new solar facilities have an estimated total cost of $1 billion over the next three years. These facilities are part of a voluntary solar program approved by the FPSC in January 2021. Southern Power, a subsidiary of Southern Company, utilizes Power Purchase Agreements (PPAs) related to solar and wind facilities, which are accounted for as operating leases with remaining terms of up to 25 years. This indicates that both Duke Energy Florida and Southern Power are investing in long-term renewable energy infrastructure, with Duke making direct investments included in base rates and Southern Power leveraging PPAs as a financial mechanism to support similar projects.",
      "llm_answer": "The Clean Energy Connection program notes that the 10 new solar facilities will cost **about $1 billion over the next three years** (DUK_10k_2022, pp. 151‑155).  Southern Power finances similar renewable projects through **PPAs accounted for as operating leases with terms of up to 25 years** (SO_10k_2022, pp. 266‑271), providing a long‑term lease structure and revenue stream that parallels Duke Energy Florida’s subscription‑fee and base‑rate financing approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $1 billion cost over three years for Duke Energy Florida's 10 solar facilities is correctly reported, matching the original answer. The mention of PPAs with terms up to 25 years for Southern Power is also factually correct. Number formats and values are consistent with the ground truth, allowing for phrasing like 'about $1 billion'. (2) The answer addresses both parts of the multi-hop question: the cost of Duke's solar facilities and Southern Power's use of PPAs as operating leases. (3) Entity accuracy is strong—Duke Energy Florida, Southern Power, and Southern Company (implied via Southern Power) are correctly identified, and the financial mechanisms (PPAs as operating leases, base-rate financing) are accurately described. (4) The reasoning is sound: the LLM correctly synthesizes information across two companies and financial models, drawing a valid parallel between Duke’s direct investment model and Southern Power’s PPA-based lease structure. The only minor shortcoming is that the original answer includes the detail about FPSC approval in January 2021, which the LLM omits. While not critical to the core question, this contextual detail enhances completeness. Otherwise, the semantic meaning, factual accuracy, and multi-hop synthesis are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 377,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the difference in voting rights structure between Netflix's common stock and Alphabet's Class C capital stock influence the strategic allocation of Alphabet's $62.0 billion share repurchase in 2024 between Class A and Class C shares?",
      "original_answer": "Netflix's common stock provides one vote per share, establishing a straightforward voting rights framework. In contrast, Alphabet's Class C capital stock carries no voting rights except as required by law, while Class A shares have one vote per share and Class B shares have 10 votes per share. Given this differentiated voting structure and Alphabet's 2024 repurchase of $62.0 billion in Class A and Class C shares, the lack of voting rights in Class C likely influences the company's repurchase strategy by prioritizing liquidity and cost efficiency over governance influence, allowing Alphabet to retire shares without diluting control held by voting-class shareholders.",
      "llm_answer": "Netflix’s common stock is fully voting – each share carries one vote (NFLX 10‑K, p. 58‑62).  Alphabet’s Class C capital stock, however, is non‑voting (GOOGL 10‑K, p. 80‑81).  Because repurchasing non‑voting shares does not dilute voting power, Alphabet allocated the bulk of its $62.0 B 2024 buy‑back to Class C shares (≈81 % of the dollar amount) while still buying a smaller portion of Class A shares (≈19 %) to preserve its voting structure (GOOGL 10‑K, p. 82‑84).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the voting structures of Netflix and Alphabet, noting that Netflix common stock has one vote per share and Alphabet Class C shares are non-voting, which aligns with the ground truth. It also correctly references the $62.0 billion 2024 share repurchase. However, the ground truth does not specify the exact allocation percentages (81% to Class C and 19% to Class A), nor does it state that Alphabet allocated the 'bulk' to Class C shares. These specific figures and the claim of allocation breakdown are not present in the original answer and appear to be fabricated or over-specified, introducing a significant quantitative inaccuracy. (2) The dollar amount ($62.0 billion) and years (2024) are correct and match the ground truth. However, the 81%/19% split is unsupported by the provided ground truth, which only states that repurchases included both Class A and Class C shares without quantifying the distribution. This introduces a major error in numerical precision. (3) The multi-hop reasoning is sound in logic—connecting the lack of voting rights in Class C shares to the strategic advantage of repurchasing them without diluting control. The model correctly infers that buying back non-voting shares preserves voting power among existing holders, which is consistent with the ground truth’s reasoning about governance influence. However, the addition of unsupported percentages undermines the factual reliability of the synthesis. (4) The contextual relevance is high—the answer directly addresses the influence of voting structure on repurchase strategy and ties it to governance and liquidity. The qualitative reasoning is strong and adds value, but the inclusion of unverified quantitative claims reduces overall correctness. Hence, correctness is scored 7 (core facts right, minor but significant omissions/overstatements), quantitative accuracy 6 (key number correct but added false precision), qualitative accuracy 8 (strong reasoning), and contextual relevance 10 (fully on-topic and insightful).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 554,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the activation of voting rights for preferred stockholders in BAC due to dividend arrears compare to the limited voting rights of Class C common stockholders at V, particularly in the context of corporate governance during financial stress?",
      "original_answer": "At BAC, if dividends on certain preferred stock series are in arrears for three or more semi-annual or six or more quarterly periods, holders gain voting rights to elect two additional directors, which terminate once dividends are paid for at least two semi-annual or four quarterly periods following the arrearage. This mechanism serves as a governance safeguard for preferred stockholders during financial distress. In contrast, V’s Class C common stockholders have no general voting rights except in specific defined matters, such as exiting the core payments business or certain corporate restructurings, and they do not participate in amendments solely affecting preferred stock. Unlike BAC’s contingent voting rights tied to dividend performance, V’s Class C stockholders’ voting power is structurally limited and not directly linked to financial performance metrics like dividend arrears.",
      "llm_answer": "At BAC, preferred shareholders only gain voting rights when dividends are in arrears for at least three semi‑annual or six quarterly periods, at which point they can vote for two additional directors (BAC_10k_2023.pdf, pages 140‑144). In contrast, Visa’s Class C common shareholders have virtually no voting power except on a handful of defined events (e.g., exit of core payments, mergers, or amendments to the certificate of incorporation), voting as a single class with votes equal to shares times the conversion rate (V_10k_2023.pdf, pages 88‑92). Thus, during financial stress BAC’s preferred holders can directly influence board composition, whereas Visa’s Class C holders have limited governance influence, constrained to specific corporate actions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and thresholds are correct: BAC's preferred stockholders gain voting rights after three semi-annual or six quarterly periods of dividend arrears, and lose them after two semi-annual or four quarterly periods of payment — these match the original answer exactly. The structural details about Visa’s Class C voting rights being limited to specific events are also correctly stated. (2) The LLM correctly identifies the entities: BAC (Bank of America) and V (Visa), and accurately references the relevant sections of their 2023 10-K filings. (3) The multi-hop reasoning is sound: it contrasts BAC’s performance-contingent voting rights (triggered by financial stress) with V’s structural, event-based limitations on Class C voting power, which is the core of the question. (4) The only minor shortcoming is that the LLM does not explicitly mention that BAC’s voting rights terminate upon sustained dividend payments — though this is implied in the mechanism. Also, it omits the detail that Class C votes do not apply to amendments affecting only preferred stock, a nuance present in the original. However, these omissions do not undermine the core correctness. Wording differences are semantically equivalent. The answer is contextually relevant, directly addressing corporate governance differences during financial stress.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 393,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How does Disney's licensing revenue from Star Wars-branded merchandise influence its ability to fund content development for Disney+ in European markets where it competes with CMCSA's Sky Glass and XClass TV platforms?",
      "original_answer": "Disney earns licensing royalties from third-party products featuring Star Wars characters, which contributes to funding content development for its DTC services, including Disney+ in European markets. Disney+ includes Star Wars programming as a core content tile, which is critical to attracting subscribers in competitive regions like Europe. CMCSA competes in this market with its own video services and DTC-aligned platforms like Sky Glass and XClass TV, which integrate with its European broadband offerings. Therefore, licensing revenue from Star Wars enhances Disney's content investment capacity, directly supporting its competitive positioning against CMCSA’s integrated hardware and content strategy in Europe.",
      "llm_answer": "Disney’s licensing revenue from Star Wars‑branded merchandise—one of its most valuable licensed properties (DIS_10k_2022, p.20)—provides a steady cash flow that underpins investment in new Disney+ content for European markets (DIS_10k_2022, p.13). This funding enables Disney to produce and acquire series and films that compete directly with CMCSA’s Sky Glass and XClass TV platforms in Europe (CMCSA_10k_2022, p.16‑20).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth, with only minor differences in depth of detail. (1) There are no numeric values in the question or original answer, so quantitative accuracy is not applicable—no errors present. (2) The LLM correctly identifies Disney's Star Wars licensing revenue as a funding source for Disney+ content development in Europe, citing its 2022 10-K (p.20 and p.13), which aligns with the knowledge graph's understanding of revenue use. (3) The multi-hop reasoning is sound: it connects Disney’s merchandise licensing → content investment → competitive positioning in Europe against CMCSA’s Sky Glass and XClass TV, referencing CMCSA’s 10-K (pp.16–20) for competitive context. This demonstrates proper cross-company, cross-document synthesis. (4) The original answer adds that Star Wars programming is a 'core content tile' and emphasizes CMCSA’s integrated hardware-content strategy, which the LLM omits—but this is a minor contextual gap, not a factual error. All key entities (Disney, CMCSA, Star Wars, Disney+, Sky Glass, XClass TV, European markets) are accurately identified and logically linked. The answer is highly relevant and captures the causal chain central to the question. Thus, correctness is rated 9/10 for near-perfect alignment, missing only slight nuance in describing the strategic importance of Star Wars content itself.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 388,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How does the sensitivity of AXP's net interest income to a 200 basis point increase in interest rates relate to MS's use of interest rate caps in securitization transactions, considering the role of repricing risk in both firms' financial strategies?",
      "original_answer": "AXP estimates that a 200 basis point increase in interest rates would negatively impact its net interest income, based on its repricing risk assumptions which include the effect of interest rate caps or floors. This sensitivity is linked to the repricing dynamics of interest-rate sensitive assets and liabilities, where certain deposits reprice at lower magnitudes than benchmark rate movements. On the other hand, MS enters into interest rate caps as part of its securitization transactions, which are designed to manage interest rate exposure. These caps are subject to similar repricing risk dynamics, suggesting that both firms are managing interest rate volatility through derivative instruments, though in different business contexts—AXP through its core interest income and MS through structured finance activities involving SPEs.",
      "llm_answer": "AXP’s sensitivity analysis shows that a 200‑basis‑point rise in rates would cut its net interest income by roughly $560 million, a figure that reflects the repricing risk of its interest‑rate‑sensitive assets and liabilities (Table 23, pages 79‑83). In contrast, Morgan Stanley uses interest‑rate caps in many securitization transactions to cap the upside of rising rates on the SPE’s cash flows, thereby managing the same repricing risk through a hedging mechanism (pages 126‑130). Thus, while AXP quantifies the potential impact of repricing, MS actively limits that impact in its securitization strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces a specific dollar amount—$560 million—that is not present in the original (ground truth) answer. There is no mention in the ground truth of a numerical estimate for the impact on AXP's net interest income, so this figure appears to be fabricated or misattributed. This is a significant quantitative inaccuracy. (2) While the ground truth confirms AXP’s sensitivity to a 200 bp increase and references repricing risk and the role of interest rate caps or floors, it does not provide any monetary impact figure. Thus, the $560 million claim fails verification and undermines quantitative accuracy. (3) Qualitatively, the LLM correctly identifies the conceptual link between AXP’s repricing risk and MS’s use of interest rate caps in securitization transactions. It accurately frames both firms as managing interest rate exposure through derivative instruments or sensitivity modeling, albeit in different contexts—AXP in core interest income and MS in structured finance via SPEs. The reasoning correctly synthesizes multi-hop information across two firms and strategies. (4) Contextual relevance is high, as the response directly addresses the relationship between interest rate sensitivity, repricing risk, and the use of caps in both firms’ strategies. Despite the incorrect number, the core conceptual comparison is sound and aligns with the ground truth. The answer would score higher if not for the unsupported quantitative claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 407,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the impact of a weaker U.S. dollar on MDLZ's consolidated earnings compare to the favorable currency effects experienced by Coca-Cola's Europe, Middle East and Africa segment, given both companies explicitly call out exchange rate fluctuations involving the euro and British pound?",
      "original_answer": "MDLZ states that a weaker U.S. dollar benefits its consolidated earnings and net assets, as many subsidiaries operate in non-dollar functional currencies. KO specifically notes that a weaker U.S. dollar compared to the euro and British pound had a favorable impact on its Europe, Middle East and Africa segment. Both companies explicitly identify these two currencies as key drivers of their respective foreign exchange impacts, showing a direct parallel in how they are affected by similar currency dynamics.",
      "llm_answer": "MDLZ notes that a weaker U.S. dollar “benefits our consolidated earnings and net assets” (MD&A, pages 63‑67).  Coca‑Cola reports that a weaker dollar relative to the euro and British pound provided a favorable currency effect for its Europe, Middle East & Africa segment, helping to offset a 16 % decline in that segment’s net operating revenues (MD&A, pages 47‑51, 119‑123).  Thus, MDLZ’s weaker dollar has a clear positive impact on earnings, whereas Coca‑Cola’s EMEA segment’s favorable currency effect only partially mitigated a net negative impact.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that a weaker U.S. dollar benefits MDLZ's consolidated earnings and that Coca-Cola's EMEA segment experienced favorable currency effects due to the euro and British pound. It accurately cites the relevant sections (MD&A pages) for both companies. However, the LLM introduces a claim not present in the original answer — that the favorable currency effect for Coca-Cola only 'partially mitigated a net negative impact' due to a 16% decline in net operating revenues. While this detail may be present in the filing, it goes beyond the scope of the original answer, which focused on the parallel between the two companies' exposure to the same currencies. This addition slightly distorts the comparison by implying Coca-Cola’s overall segment result was negative, which was not part of the ground truth comparison. (2) Quantitatively, the 16% decline is mentioned but not in the original answer; since the original did not include any numerical data, and the LLM pulled this figure from the source correctly (assuming accuracy in the filing), this does not count as a factual error but as an over-elaboration. No calculation errors are present. (3) The multi-hop reasoning is mostly sound — the model correctly links both companies’ exposure to the euro and British pound and connects currency movements to earnings impacts. However, the conclusion shifts from a direct parallel (as in the original) to a contrast in outcomes, weakening the qualitative accuracy. (4) The contextual relevance is high because the response addresses the core comparison and cites correct document locations. The correctness score is 7 because key facts and entities are accurate, but the interpretation adds a layer not supported by the ground truth, slightly misrepresenting the comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 493,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the voting power concentration in MA's dual-class share structure compare to V's, given the relationship between their respective Class A and Class B shares and the 15-vote weighting per Class B share?",
      "original_answer": "MA's dual-class structure includes 907 Class A shares and 7 Class B shares outstanding, with Class B shares carrying 15 votes each, resulting in a voting power concentration of approximately 10.4% for Class B shares. V has 125 Class B shares outstanding as of September 30, 2024, against 1,733 Class A shares, and if following the same 15-vote weighting per Class B share from the intermediary evidence, Class B would hold approximately 68.5% of the voting power despite representing just 6.7% of total shares. This indicates significantly more concentrated control at V compared to MA.",
      "llm_answer": "Mastercard’s 10‑K shows 7 Class B shares versus 907 Class A shares; with 15 votes per Class B share, the Class B shares account for roughly 10 % of total voting power (105 of 1,012 votes). Verizon’s 10‑K reports 370 Class B shares versus 1,733 Class A shares; with the same 15‑vote weighting, the Class B shares represent about 76 % of voting power (5,550 of 7,283 votes). Thus, Verizon’s dual‑class structure concentrates far more voting power in its Class B shares than Mastercard’s.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numeric inputs, particularly regarding the number of Class B shares for V (Verizon). The ground truth states V has 125 Class B shares, but the LLM claims 370, which is incorrect. This leads to a grossly inaccurate voting power calculation (76% vs. correct 68.5%). For MA (Mastercard), the LLM correctly identifies 7 Class B and 907 Class A shares, and the 15-vote weighting, leading to a roughly correct voting concentration (~10% vs. ground truth 10.4%). (2) Calculations: For MA, total votes = (907 × 1) + (7 × 15) = 907 + 105 = 1,012; Class B share = 105 / 1,012 ≈ 10.4% — LLM rounds to 10%, acceptable. For V, correct calculation: 125 Class B × 15 = 1,875 votes; 1,733 Class A × 1 = 1,733; total = 3,608; Class B % = 1,875 / 3,608 ≈ 51.9% — wait, this contradicts the original answer. Rechecking: Original answer claims 68.5% for V with 125 Class B and 1,733 Class A. 125×15=1,875; 1,733×1=1,733; total votes=3,608; 1,875/3,608≈51.96%. But original answer says 68.5% — this suggests possible error in ground truth or missing context. However, per evaluation principle, we assume ground truth is correct based on knowledge graph. Alternatively, perhaps V’s Class A shares have no votes? But LLM assumes 1 vote per Class A. The LLM uses 370 Class B shares (wrong), calculates 370×15=5,550; 1,733×1=1,733; total=7,283; 5,550/7,283≈76% — math is correct but based on wrong input. (3) Multi-hop reasoning: LLM correctly applies the 15-vote weighting and compares voting concentration between two companies, satisfying the comparative structure of the question. However, it uses incorrect data for V, undermining the synthesis. (4) The contextual relevance is high — it addresses the comparison and mechanism of dual-class structures. But due to the critical error in V’s Class B share count and resulting miscalculation of voting power (76% vs. 68.5%), and the use of incorrect entity data (370 vs. 125), the quantitative accuracy is low. The conclusion that V has more concentrated control is correct, but the magnitude is exaggerated. Thus, partial credit for reasoning and directionally correct conclusion, but major factual and calculation flaws reduce correctness score to 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 601,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How do the financial risks associated with nuclear power plants at NEE compare to those at Southern Company, particularly in terms of potential exposure from decommissioning costs exceeding available reserves?",
      "original_answer": "NEE and FPL face potential financial risks from decommissioning costs of their nuclear facilities possibly exceeding the available decommissioning funds. Similarly, Southern Company's subsidiaries Alabama Power and Georgia Power also face exposure if decommissioning costs exceed available reserves or insurance coverage. In both cases, the companies acknowledge that the financial impact could be material if the costs surpass the accumulated funds, which are subject to uncertainties in estimation and long-term planning.",
      "llm_answer": "Both NEE and Southern Company recognize that the cost of decommissioning their nuclear plants could exceed the reserves set aside in decommissioning funds. NEE’s risk disclosure (pages 28‑32) notes that decommissioning costs could surpass the amount available in its decommissioning funds, while Southern Company’s risk statement (pages 27‑31) adds that such costs could also exceed both decommissioning trusts and external insurance coverage, potentially exposing the company to additional liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that both NEE (and its subsidiary FPL, implied through context) and Southern Company face financial risks if decommissioning costs exceed available reserves. The mention of 'decommissioning funds' for NEE and both 'decommissioning trusts and external insurance coverage' for Southern Company aligns with the original answer, which notes exposure beyond reserves or insurance. (2) There are no numeric values, dates, or calculations in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes risk disclosures from both companies, noting similarities in exposure while accurately reflecting that Southern Company’s risk includes potential shortfalls beyond both trusts and insurance. The only minor omission is not explicitly naming Alabama Power and Georgia Power as Southern Company’s subsidiaries, but this does not detract from the core accuracy. (4) The answer is highly relevant, directly addressing the comparative financial risks related to decommissioning cost overruns. Wording differs slightly but meaning is preserved. A score of 9 is justified due to high factual fidelity with only slight lack of entity specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 373,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How does the $9.9 billion valuation of UPS's pension plan investments in real estate funds compare to the valuation approaches used by General Dynamics for its Level 3 assets, given that both companies rely on valuation models through real estate or private equity fund investments?",
      "original_answer": "UPS valued its $9.9 billion in pension plan investments in real estate funds using net asset value (NAV) as a practical expedient, based on audited and unaudited financial reports from fund managers, with adjustments for investment activity between reporting dates. These real estate funds rely on valuation models, as stated in the second chunk, which notes that real estate funds use NAV based on such models and periodic appraisals. General Dynamics, on the other hand, disclosed that its Level 3 assets include direct private equity investments that are measured using unobservable inputs—essentially internal or fund-level valuation models. Thus, while both companies depend on valuation models for real estate or private equity fund investments, UPS relies on NAV with manager reporting and adjustments, whereas GD directly uses unobservable inputs for its Level 3 private equity holdings.",
      "llm_answer": "UPS values its pension‑plan real‑estate fund holdings at **$9.9 billion** using a net‑asset‑value (NAV) model that relies on audited and unaudited fund reports and adjustments for interim activity. In contrast, General Dynamics classifies its private‑equity holdings as **Level 3 assets** and values them with valuation models that use unobservable inputs—an approach that is broader and more model‑driven, and not tied to a single NAV figure. Both companies therefore rely on valuation models, but UPS’s method is a specific NAV calculation for real‑estate funds, while GD’s Level 3 approach applies to a wider range of private‑equity investments and relies on more complex, unobservable inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $9.9 billion valuation for UPS is correctly stated, and the characterization of General Dynamics' Level 3 assets is consistent with the original. No calculations were required, and all financial figures are precise. (2) The LLM correctly identifies that UPS uses NAV based on fund manager reports (audited and unaudited) with adjustments for interim activity, which matches the ground truth. It also accurately notes that General Dynamics uses unobservable inputs for its Level 3 private equity investments, reflecting internal or fund-level models. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (UPS and General Dynamics), two types of investments (real estate funds vs. private equity), and two valuation approaches (NAV as a practical expedient vs. Level 3 unobservable inputs). (4) The only minor shortcoming is that the LLM does not explicitly mention that UPS’s NAV approach itself relies on valuation models and periodic appraisals (as noted in the ground truth), which slightly weakens the qualitative depth. However, stating that UPS uses a 'NAV model' implies this, so the semantic meaning remains largely equivalent. Overall, the answer is factually correct, well-structured, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 379,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "Given PepsiCo's 30% beverage revenue exposure in the Africa and Middle East region and Target's vendor arrangements where they only pay for merchandise after guest sale, what potential impact could a supply disruption in this region have on Target's inventory turnover and cash flow timing for beverage SKUs?",
      "original_answer": "A supply disruption in the Africa and Middle East region, which accounts for 30% of PepsiCo's beverage revenue, could delay product availability at Target. Since Target only pays vendors after merchandise is sold to guests, this delay could reduce inventory turnover for beverage SKUs during the disruption period. This would temporarily lower cash flow generation from beverage sales, as Target recognizes revenue only upon guest purchase and does not pay vendors until then.",
      "llm_answer": "A disruption in PepsiCo’s AMESA region—where roughly 30 % of its beverage revenue originates (PEP 10‑K, p. 71‑75)—would cut the flow of PepsiCo beverage SKUs to Target. Because Target only pays vendors after a guest purchase (TGT 10‑K, p. 47‑51), a shortage would slow inventory turnover (more days of inventory or stock‑outs) and lengthen the cash‑conversion cycle, as both customer receipts and vendor payments would be delayed until the disrupted SKUs eventually sell.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 30% beverage revenue exposure in the Africa and Middle East region (AMESA) is correctly cited, and no other numerical values require verification. The reference to PepsiCo’s 10-K pages 71–75 and Target’s 10-K pages 47–51 adds sourcing precision, though not required, and does not detract. (2) The reasoning correctly synthesizes two key facts: PepsiCo’s regional revenue dependency and Target’s pay-after-sale vendor model. It logically infers that a supply disruption would reduce inventory turnover due to stock-outs or slower replenishment. (3) The impact on cash flow timing is accurately described as a delay in both customer receipts and vendor payments, which is consistent with Target’s revenue recognition and payment policy. The mention of a lengthened cash-conversion cycle is a slightly more advanced interpretation but is semantically equivalent and correct. (4) The only minor gap is that the original answer emphasizes the temporary reduction in cash flow *generation from beverage sales*, while the LLM focuses on timing delays in receipts and payments. This is a nuance in emphasis, not in factual inaccuracy. All entities (PepsiCo, Target, AMESA, beverage SKUs, inventory turnover) are correct. The multi-hop logic—linking PepsiCo’s supply risk to Target’s operational model—is sound. Thus, the answer is factually complete and semantically equivalent, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 409,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How have LLY and AMGN responded differently to payer-driven pricing pressures on their high-cost biologics, particularly in light of access restrictions affecting Repatha and insulin products?",
      "original_answer": "LLY faces increasing public and private payer scrutiny on pricing, especially for insulin, with proposed legislation enabling government price negotiation and restrictive reimbursement policies like the Alzheimer’s Monoclonal Antibody NCD, which could materially affect revenue. In contrast, AMGN has responded to payer restrictions on Repatha—such as formulary exclusions, step therapy requirements, and copay accumulator programs—by reducing both net and list prices, discontinuing higher-priced NDCs in 2019, and directly partnering with payers to align on health outcomes. While LLY emphasizes regulatory and legislative uncertainty, AMGN has taken active pricing and partnership strategies to mitigate payer-imposed access barriers.",
      "llm_answer": "Eli Lilly has tackled payer‑driven pricing on its insulin portfolio by cutting net prices, expanding rebates and discounts to payers and adjusting list prices to keep the drugs on formulary and improve affordability (see LLY 10‑K, pp. 27‑31).  Amgen, in contrast, has responded to Repatha access restrictions by lowering its net price, offering larger rebates to PBMs and Medicare‑Part D plans, and issuing new NDCs that reduce the list price for Medicare patients (see AMGN 10‑K, pp. 39‑43).  These moves illustrate each company’s strategy to blunt payer cost‑control pressures while preserving market access for their high‑cost biologics.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of both companies' responses to payer-driven pricing pressures and correctly identifies that both LLY and AMGN have adjusted pricing and rebate strategies to maintain access. It accurately references insulin for LLY and Repatha for AMGN, and notes the use of rebates, discounts, and list price adjustments—elements aligned with the ground truth. However, there are significant qualitative inaccuracies in the portrayal of LLY’s strategy: the original answer emphasizes that LLY has not taken active pricing actions like AMGN but instead faces regulatory and legislative uncertainty, including government price negotiation risks and restrictive policies like the Alzheimer’s Monoclonal Antibody NCD. The LLM incorrectly states that LLY has cut net prices and adjusted list prices, which contradicts the ground truth where no such proactive pricing actions are attributed to LLY—instead, the focus is on external pressures. In contrast, the AMGN portion is more accurate: lowering net price, discontinuing higher-priced NDCs (rephrased as issuing lower-priced NDCs), and partnering with payers are correctly reflected, though the specific 2019 action and direct payer partnerships are omitted. There are no explicit numbers, dates, or calculations in either answer, so quantitative accuracy is not penalized. The reasoning is partially sound but fails the multi-hop synthesis by misrepresenting LLY’s response as proactive rather than reactive. Contextually, the answer is relevant and addresses the core question about differing responses. Thus, the correctness score is reduced due to a key factual mischaracterization of LLY’s strategy, even though the structure and intent of the comparison are valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 473,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How do BAC and SCHW's approaches to meeting capital buffer requirements compare under the current regulatory framework where the Countercyclical Capital Buffer remains at zero?",
      "original_answer": "BAC applies a Stress Capital Buffer of 2.5% under the Standardized approach as of December 31, 2023, while SCHW's subsidiary CSB maintains a Capital Conservation Buffer of 2.5%. Both institutions benefit from the Federal Reserve's current setting of the Countercyclical Capital Buffer at zero, which reduces their overall capital requirements. However, BAC's capital strategy incorporates a G-SIB surcharge of 2.5% alongside its buffer requirements, whereas SCHW structures its capital to meet minimum ratios of 7.0%, 8.5%, and 10.5% for Common Equity Tier 1, Tier 1, and Total Risk-Based Capital respectively, inclusive of buffers.",
      "llm_answer": "Bank of America meets its capital‑buffer requirement under the Basel III Advanced approach, which requires a 5.5 % CET‑1 buffer (SCB 2.5 % + G‑SIB surcharge 3.0 % + zero CCyB).  \nCharles Schwab meets its buffer requirement under the Standardized approach, which requires an 8.4 % CET‑1 buffer (SCB 5.4 % + G‑SIB surcharge 3.0 % + zero CCyB).  \nThus, while both banks rely on the SCB and G‑SIB surcharge and have a zero countercyclical buffer, BAC’s Advanced framework allows a lower overall buffer than Schwab’s Standardized framework.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors, despite addressing the general topic of capital buffer requirements for BAC and SCHW. (1) Quantitative inaccuracies: The LLM incorrectly states that Bank of America (BAC) uses a 2.5% Stress Capital Buffer (SCB) under the 'Advanced approach'—the ground truth confirms BAC does apply a 2.5% SCB, but under the Standardized approach, not Advanced. More critically, the LLM invents a 3.0% G-SIB surcharge for BAC, while the ground truth specifies 2.5%. For SCHW, the LLM falsely claims a 5.4% SCB and a 3.0% G-SIB surcharge; in reality, SCHW’s subsidiary CSB maintains a 2.5% Capital Conservation Buffer (not SCB), and SCHW is not subject to a G-SIB surcharge at all, as it is not a Global Systemically Important Bank. The claimed 8.4% CET1 buffer for SCHW is therefore entirely fabricated. (2) Calculations are based on incorrect inputs and thus invalid. (3) Multi-hop reasoning fails: the model incorrectly assumes both firms use SCB and G-SIB surcharges, when only BAC does; SCHW instead meets minimum capital ratios (7.0%, 8.5%, 10.5%) inclusive of buffers, with no G-SIB surcharge. (4) The conclusion that BAC has a lower buffer due to its regulatory framework is unsupported and misleading, as the premise is factually wrong. While the answer correctly notes the zero Countercyclical Capital Buffer, this is the only accurate point. Overall, the answer misrepresents key regulatory frameworks, capital components, and firm-specific requirements, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 424,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How does Southern Company's investment in solar facilities, which are connected to power purchase agreements (PPAs), compare with Duke Energy's reliance on PPAs in terms of renewable energy facility financing strategies and tax credit utilization timelines?",
      "original_answer": "Southern Company has approximately $1.2 billion of unutilized federal ITCs and PTCs as of December 31, 2021, which are expected to be fully utilized by 2024, and uses tax equity partnerships for solar and wind projects where the tax partner captures most of the federal tax benefits. These solar facilities are connected to PPAs that are accounted for as operating leases with remaining terms of up to 25 years. In contrast, Duke Energy negotiates PPAs as part of its commercial renewables strategy and enters into tax equity arrangements to finance renewable assets eligible for tax credits. Duke's PPAs significantly impact the economic performance of its renewable facilities, and Duke is the primary beneficiary of these VIEs due to its control over siting, PPA negotiation, and operations. The connection between Southern Company's solar investments and PPAs, and Duke's PPA-driven renewable financing, reveals differing approaches to leveraging long-term contracts and tax incentives in renewable energy development.",
      "llm_answer": "Southern Company’s solar portfolio is financed through long‑term PPAs and tax‑equity partnerships that capture federal ITCs and PTCs; the company has $1.2 B of unutilized ITCs and $0.8 B of PTCs, expected to be fully used by 2024 under the 30%→26%→22%→10% ITC schedule (Southern Company, pp. 95‑99, 266‑270). Duke Energy likewise relies on PPAs for its renewable projects and uses tax‑equity arrangements to secure the same federal credits, but the 10‑K excerpts (Duke Energy, pp. 200‑204) do not specify a distinct utilization timetable; the company’s strategy mirrors Southern’s in structure but the credit‑use timeline is not explicitly outlined.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Southern Company's $1.2 billion in unutilized ITCs and the 2024 utilization timeline, which matches the ground truth. However, it introduces a specific $0.8 billion figure for PTCs that is not present in the original answer—this number is unsupported and incorrect based on the provided ground truth, which only states 'approximately $1.2 billion of unutilized federal ITCs and PTCs' collectively. This misrepresents the data and constitutes a significant quantitative error. (2) The ITC phase-down schedule (30%→26%→22%→10%) is not mentioned in the original answer and appears to be external knowledge added by the model; while factually plausible, it was not part of the ground truth and does not directly support the comparison asked. (3) On qualitative accuracy, the model correctly identifies both companies' use of tax equity partnerships and PPAs as central to their renewable financing strategies. It accurately notes that Southern uses operating lease accounting for its PPA-connected solar facilities and that Duke Energy relies on PPAs and tax equity, but fails to mention the key differentiating point from the ground truth: that Duke is the primary beneficiary of VIEs due to control over siting, PPA negotiation, and operations—a critical element in the comparison of strategic control. (4) Contextually, the response is highly relevant, addressing both companies’ financing mechanisms and tax credit usage. However, the incorrect split of ITC/PTC amounts and the omission of Duke’s VIE control and Southern’s lease accounting details reduce factual completeness and accuracy. The model synthesizes multi-hop elements (PPAs, tax equity, credit utilization) but with partial fidelity. Thus, while the structure and intent are sound, the quantitative inaccuracy lowers the overall correctness score to 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 505,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How might the automatic conversion of Class B shares to Class A shares upon transfer at Google, combined with Comcast's non-dilutable Class B voting structure, influence investor sentiment toward Meta's dual-class governance model that grants disproportionate voting control to its founder?",
      "original_answer": "Google's Class B shares automatically convert to Class A shares upon transfer, reducing long-term concentration of voting power. In contrast, Comcast's Class B shares retain 33 1/3% of voting power and are non-dilutable, preserving control. Meta's governance risks highlight concerns that its dual-class structure could make Class A stock less attractive to investors. When considering these three elements together, the contrast in how voting power is preserved or diluted across these companies may shape investor perceptions of governance fairness and control concentration, particularly in Meta's case where founder control remains strong despite lower ownership percentages.",
      "llm_answer": "Google’s 10‑K (pp. 79‑83) explains that its Class B shares automatically convert to Class A upon sale or transfer, shrinking the pool of high‑voting shares over time and potentially easing concerns that a dual‑class structure can entrench control.  By contrast, Comcast’s 10‑K (pp. 89‑93) shows that its Class B shares carry 15 votes each and that their aggregate voting power is non‑dilutable, illustrating how high‑voting shares can remain protected.  These opposing mechanisms suggest that investors may view Meta’s dual‑class model (pp. 48‑52) with heightened scrutiny—balancing the possibility that automatic conversion could dilute founder control against the risk that non‑dilutable voting rights could entrench it.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Google's automatic conversion of Class B to Class A shares upon transfer, which reduces long-term voting power concentration, and contrasts this with Comcast's non-dilutable Class B structure that preserves voting control. It then ties these points to investor scrutiny of Meta's dual-class model—matching the core reasoning in the original answer. (2) Quantitatively, the LLM states Comcast's Class B shares carry '15 votes each', which is not in the ground truth; the original answer cites '33 1/3% of voting power' as non-dilutable but does not specify per-share votes. This is a minor discrepancy—while 15 votes per share may be factually correct in Comcast's actual filings, it was not in the provided ground truth and introduces a detail not confirmed by the reference, slightly reducing quantitative accuracy. All other structural descriptions are correct. (3) The multi-hop reasoning is sound: the model synthesizes governance mechanisms across Google, Comcast, and Meta, and evaluates their potential influence on investor sentiment regarding founder control and governance fairness. It correctly infers that contrasting models (self-diluting vs. protected voting rights) shape perceptions of Meta’s structure. (4) The answer is contextually excellent—directly addressing investor sentiment and governance implications. Wording differs but meaning is semantically equivalent. One minor point: the original emphasizes Meta's 'disproportionate voting control' and 'lower ownership percentages', which the LLM implies but does not explicitly state; this slight omission prevents a perfect 10. Overall, the answer is factually strong, well-reasoned, and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 478,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "Given CVS's launch of Cordavis to co-produce biosimilars with pharmaceutical manufacturers, and UnitedHealth's (UNH) $12.5 billion in rebates receivable from those same manufacturers, how might the increased market availability of lower-cost biosimilars impact UNH's rebate structure and revenue recognition timing, considering rebates are based on product utilization and contract terms?",
      "original_answer": "CVS launched Cordavis to work directly with pharmaceutical manufacturers to commercialize and/or co-produce high-quality biosimilar products, aiming to increase market access and reduce costs. This initiative could increase the utilization of biosimilars, which are typically less expensive than branded biologics. UnitedHealth (UNH) has $12.5 billion in rebates receivable from pharmaceutical manufacturers as of December 31, 2024, which are accrued monthly based on utilization, historical data, and contract terms. Since rebates are influenced by the volume and type of products used, a shift toward greater biosimilar adoption could reduce the rebate amounts negotiated by manufacturers, especially if biosimilars are priced lower and displace branded drugs. Additionally, changes in utilization patterns may affect the timing and predictability of rebate collections for UNH, as lower-cost biosimilars may alter the dynamics of rebate accruals and payment cycles outlined in manufacturer contracts.",
      "llm_answer": "Cordavis is expected to broaden biosimilar access, which will shift a larger share of biologic prescriptions toward lower‑cost alternatives.  UnitedHealth’s PBM contracts accrue rebates on a monthly basis and bill manufacturers quarterly, so a higher biosimilar mix could change the rebate percentages under those contracts—potentially raising the $12.5 billion receivable if manufacturers offer higher rebates to capture market share, or lowering it if the lower price reduces the rebate base.  The altered utilization pattern would also shift the timing of accruals and revenue recognition, as rebates would be earned and recorded in the periods when biosimilar volumes increase.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its reasoning and accurately reflects the key elements of the question. Quantitatively, it correctly references the $12.5 billion rebate receivable from UNH without introducing any incorrect numbers, satisfying quantitative accuracy. The entity identification (CVS's Cordavis, UnitedHealth/UNH, pharmaceutical manufacturers) and context (PBM contracts, rebate accruals) are appropriate and relevant. However, the qualitative accuracy is slightly reduced because the LLM introduces ambiguity by suggesting that higher biosimilar adoption could *increase* the $12.5 billion receivable if manufacturers offer higher rebates to gain market share. This contradicts the ground truth, which emphasizes that lower-priced biosimilars typically result in a smaller rebate base (since rebates are often a percentage of list price), leading to *lower* overall rebate amounts when branded biologics are displaced. While it's plausible manufacturers might offer higher rebate *rates*, the ground truth does not support the idea that total rebate dollars would likely increase; the dominant effect would be a reduction due to lower pricing. Additionally, the LLM correctly identifies that utilization shifts affect timing of accruals and revenue recognition, aligning with the original answer’s point about altered dynamics in rebate accruals and payment cycles. The multi-hop synthesis—linking CVS’s Cordavis initiative to biosimilar availability, then to utilization changes, and finally to UNH’s rebate structure and revenue timing—is logically structured and mostly sound, though the speculative upside in rebate value weakens the reasoning. Overall, the answer is contextually relevant and factually grounded but contains a significant qualitative misstep in rebate directionality.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 488,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How might the SEC's Regulation Best Interest, which requires broker-dealers to act in the best interest of retail consumers, influence Goldman Sachs' compliance costs and competitive positioning against Morgan Stanley, given their differing approaches to consumer protection regulations and retail client expansion?",
      "original_answer": "Goldman Sachs faces increased compliance costs due to consumer protection regulations like Regulation Best Interest, which applies to its consumer-oriented activities, including transaction banking and retail client services. The MET_10k_2024.pdf evidence shows that Regulation Best Interest imposes conduct standards on broker-dealers when recommending securities, including variable insurance products, and that state-level extensions could allow private litigation, increasing legal exposure. Meanwhile, Morgan Stanley's 2024 10-K acknowledges intense competition in the U.S. and globally, particularly from firms offering similar products and services to retail and institutional clients, and notes that some competitors may operate under less stringent regulatory regimes. This suggests that while both firms are subject to Regulation Best Interest, Morgan Stanley may have a more established retail client infrastructure, giving it a competitive edge in adapting to the regulation with lower incremental costs compared to Goldman Sachs, which is expanding in this space and facing higher compliance investments.",
      "llm_answer": "Goldman Sachs, which runs a sizable consumer‑credit and retail‑brokerage business, acknowledges that the SEC’s Regulation Best Interest will raise its compliance and potential litigation costs (“…Regulation Best Interest requires broker‑dealers to act in the best interest of retail consumers…; as a result it may become more costly to provide and distribute our products and services” [GS 10‑K, pp. 59‑63]).  Because the firm’s retail platform is larger than Morgan Stanley’s (whose wealth‑management arm serves “individual investors and small‑to‑medium‑sized businesses” but has a smaller consumer‑credit footprint), the higher regulatory burden could both strain GS’s costs and, at the same time, strengthen its competitive positioning by signalling stronger consumer‑protection standards that attract retail clients—an advantage Morgan Stanley may not enjoy to the same degree.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in entity and strategic positioning. It incorrectly claims that Goldman Sachs has a 'larger retail platform than Morgan Stanley,' which contradicts the ground truth stating that Morgan Stanley has a more established retail client infrastructure, giving it a competitive edge. This misrepresents a core element of the comparative analysis. Additionally, the LLM suggests that higher regulatory costs could strengthen Goldman Sachs' competitive positioning by attracting clients due to stronger consumer-protection signaling—an inference not supported in the original answer or evidence. The ground truth emphasizes that Goldman faces higher compliance costs as a firm expanding into retail, while Morgan Stanley benefits from existing infrastructure and potentially lower incremental costs. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable; no errors in this regard. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the comparative regulatory and structural dynamics between the two firms. It draws an incorrect conclusion about relative retail scale and competitive advantage, undermining the logical chain. While it correctly identifies that Regulation Best Interest increases compliance and litigation risk for Goldman Sachs, it misapplies the competitive implication. (4) Correctness and qualitative accuracy are low due to the key misrepresentation of the firms' retail footprints and competitive positioning. Contextual relevance is moderate because the answer addresses the regulation, compliance costs, and competition, but with incorrect comparative logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 472,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does the voting power distribution tied to CMCSA's Class A and Class B common stock structure compare with GOOGL's approach to Class B common stock in terms of concentrated control, given that CMCSA's Class B stock carries 15 votes per share and GOOGL's Class B stock carries 10 votes per share?",
      "original_answer": "CMCSA's Class A and Class B common stock structure allocates 66 2/3% of the combined voting power to Class A shares held broadly, while the Class B shares, which carry 15 votes per share and are entirely owned by Brian L. Roberts, control the remaining 33 1/3% of voting power. In contrast, GOOGL's Class B common stock carries 10 votes per share, and although the company also maintains a dual-class structure, the voting power distribution is not explicitly quantified in the evidence provided. However, GOOGL's Class B shares can be converted to Class A shares upon sale or transfer, which could potentially dilute concentrated control over time—unlike CMCSA’s Class B shares, which are non-dilutable.",
      "llm_answer": "Comcast’s Class B shares are heavily weighted (15 votes each) and are held by a single shareholder (Brian L. Roberts), giving that holder roughly one‑third (33 %) of the company’s voting power. Alphabet’s Class B shares carry 10 votes each and are concentrated in the Page family, which controls about 80 % of voting power. Thus, Comcast’s structure concentrates voting power less than Alphabet’s, but each Class B share carries a higher voting weight.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) Quantitatively, it incorrectly states that Alphabet's (GOOGL) Class B shareholders control 'about 80%' of voting power, which is not supported by the ground truth; the original answer explicitly states that GOOGL's voting power distribution is not quantified in the evidence provided. This is a major fabrication. (2) The claim that GOOGL's Class B shares are 'concentrated in the Page family' introduces specific entity ownership not present in the original evidence, which only notes that GOOGL's Class B shares can be converted to Class A upon sale or transfer. (3) While the LLM correctly notes CMCSA's Class B shares carry 15 votes per share and are held entirely by Brian L. Roberts with ~33% voting power, it misrepresents the comparative control structure: the ground truth emphasizes that CMCSA’s Class B control is non-dilutable, whereas GOOGL’s structure allows conversion that could dilute control—this critical distinction is omitted. (4) The reasoning is flawed in concluding that 'Comcast’s structure concentrates voting power less than Alphabet’s' because the 80% figure is invented; without verified data on GOOGL's actual distribution, no such comparison can be validly drawn. (5) The answer fails to mention the key differentiator in durability of control (non-dilutable vs. potentially dilutable), which is central to the original answer’s qualitative insight. While the LLM captures the higher per-share vote weight at CMCSA, the core comparative analysis is based on incorrect data, leading to a misleading conclusion. Wording flexibility is allowed, but invented statistics and ownership details violate factual integrity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 469,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does the increase in illicit trade prevalence in Turkey, which negatively impacted PM's cigarette volume growth, compare to PG's exposure to Turkey's foreign exchange volatility, and what does this reveal about the dual operational risks each company faces in the same market?",
      "original_answer": "PM reported that Turkey's cigarette market grew by 8.2%, primarily due to the easing of pandemic restrictions and increased tourism, but this growth was partially offset by a higher estimated prevalence of illicit trade. This illicit trade directly impacts PM's market dynamics by reducing legitimate sales volume and potentially eroding brand loyalty. Meanwhile, PG disclosed that Turkey is one of several countries where it faces significant foreign exchange exposure, with currency fluctuations having historically impacted its net sales, costs, and earnings. Given Turkey's economic instability, PG's exposure includes both transaction and translation risks that affect margins and cash flows. Together, these facts highlight that while PM is grappling with illicit trade undermining its cigarette sales in Turkey, PG is simultaneously facing financial risks from the country's volatile currency, illustrating how different types of market-specific risks—operational and financial—can concurrently challenge multinational corporations in the same geopolitical environment.",
      "llm_answer": "PM’s 10‑K (p. 38‑42) reports that the rise in illicit trade in Turkey has eroded cigarette volume growth, whereas PG’s 10‑K (p. 21‑25) shows that Turkey’s foreign‑exchange volatility has negatively impacted net sales and earnings. This contrast illustrates that PM is confronting a demand‑side operational risk from illicit trade, while PG is dealing with a financial‑risk from currency swings, underscoring the dual operational challenges both companies face in the same market.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies the key risks each company faces in Turkey, aligning well with the ground truth. (1) There are no numeric inaccuracies—while the LLM does not repeat the specific 8.2% market growth figure mentioned in the original answer, it does not introduce any incorrect numbers, and the absence of this percentage does not constitute a factual error but rather a minor omission. All other qualitative assertions about illicit trade affecting PM and FX volatility affecting PG are supported. (2) The answer correctly attributes the information to the respective 10-Ks (with plausible page ranges), and the entities (PM, PG, Turkey, illicit trade, FX volatility) are accurately identified. (3) The multi-hop reasoning is sound: it synthesizes risks across two companies in the same market and contrasts operational (demand-side) vs. financial (currency) risks, which is the central insight of the original answer. (4) The LLM conveys semantic equivalence by highlighting the dual operational challenges despite different risk types, though it provides less contextual depth (e.g., no mention of tourism, pandemic easing, transaction vs. translation risks, or impacts on costs and margins). This reduced detail affects completeness and qualitative richness but not factual correctness. Thus, the answer is contextually relevant and quantitatively accurate, with strong reasoning, meriting high scores but not perfect due to omitted contextual nuances present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 422,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does JPMorgan's approach to identifying and managing transition risk compare to Bank of America's exposure to reputational risk in the context of their climate-related commitments, particularly given JPM's Firmwide Climate Risk Framework and BAC's $1.5 trillion sustainable finance goal?",
      "original_answer": "JPMorgan addresses transition risk through its Firmwide Climate Risk Framework, which includes setting policies, developing metrics and stress testing mechanisms, and establishing a climate risk data strategy to assess financial impacts. This structured approach is designed to integrate climate risk considerations across its business lines. In contrast, Bank of America identifies reputational risk as a potential consequence of failing to meet its climate-related commitments, such as its $1.5 trillion sustainable finance goal, which includes $1 trillion dedicated to supporting the transition to a low-carbon economy. While both institutions recognize climate risk broadly, JPMorgan emphasizes proactive identification and scenario-based analysis of transition risks, whereas BAC focuses on reputational risk mitigation tied to its public climate goals and stakeholder expectations.",
      "llm_answer": "JPMorgan’s firm‑wide Climate Risk Framework (p. 146‑150) embeds transition‑risk identification, measurement, scenario analysis and stress testing into its existing risk‑management and governance structure, allowing the bank to proactively monitor and mitigate the financial impacts of a low‑carbon transition. In contrast, Bank of America’s $1.5 trillion sustainable‑finance goal (p. 81‑85) creates a reputational‑risk exposure that the bank manages through monitoring, mitigation and governance processes, with the risk that failure to meet those climate targets could damage its public perception. Thus, JPMorgan focuses on systematic transition‑risk management, while BAC’s approach centers on mitigating reputational fallout from its climate‑commitment objectives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: JPMorgan's Firmwide Climate Risk Framework is accurately described as embedding transition-risk identification, measurement, scenario analysis, and stress testing into its risk management structure. Bank of America's $1.5 trillion sustainable finance goal is correctly cited, along with its reputational risk exposure from failing to meet public climate commitments. (2) Quantitative accuracy is perfect: the $1.5 trillion figure is correctly stated, and no other numbers (e.g., years, percentages) are misreported. Format variations (e.g., $1.5 trillion vs $1.5T) are acceptable and do not affect accuracy. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two institutions, linking JPMorgan’s proactive, structured risk management approach to transition risks with BAC’s focus on reputational risk stemming from public climate goals. The contrast in focus—systematic risk management vs. reputational mitigation—is logically drawn and supported by the original answer. (4) Minor deduction in qualitative accuracy due to the absence of BAC’s additional detail about $1 trillion of the $1.5 trillion being dedicated to low-carbon transition support, which adds nuance to its commitment. While not critical to the core comparison, its omission slightly reduces completeness. Otherwise, the reasoning, entity identification (JPM, BAC), and contextual relevance are excellent, directly addressing the comparative climate risk approach as framed in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 436,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the timing of Microsoft's revenue recognition for hardware sales, which combines hardware and software as a single performance obligation, align with Cisco's average loan receivable terms for financing hardware purchases, and what is Cisco's total credit loss allowance for these financing arrangements as of July 29, 2023?",
      "original_answer": "Microsoft recognizes revenue for hardware sales at the point in time when ownership is transferred to resellers or end customers, treating the hardware and software as a single performance obligation. Cisco offers loan receivables with average terms of one to three years to finance hardware purchases. As of July 29, 2023, Cisco's total credit loss allowance for financing arrangements, including loan and lease receivables, was $72 million.",
      "llm_answer": "Microsoft recognizes hardware‑software bundle revenue at the point in time when ownership is transferred to a reseller or end customer. Cisco’s financing loan receivables for hardware have an average term of one to three years, so the revenue is recorded immediately while the financing extends over a multi‑year period. Cisco’s total credit‑loss allowance for these financing arrangements as of July 29 2023 was $72 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: Microsoft recognizes revenue for hardware-software bundles at the point of ownership transfer, which aligns with the original answer. Cisco's loan receivables for hardware financing have average terms of one to three years, correctly stated. The credit loss allowance as of July 29, 2023, is accurately reported as $72 million. (2) Quantitative accuracy is perfect: the date (July 29, 2023) and dollar amount ($72 million) match exactly, with acceptable formatting (space instead of slash in date, $72 million vs $72M). (3) Multi-hop reasoning is sound: the answer correctly synthesizes information across Microsoft's revenue recognition policy and Cisco's financing terms and credit loss allowance, even noting the timing contrast between immediate revenue recognition and multi-year financing. (4) Entity accuracy is complete—Microsoft and Cisco are correctly attributed with their respective financial policies and metrics. The answer is concise, factually precise, and fully addresses all parts of the multi-part, cross-company question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 328,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How might potential delays in FAA certification of Gulfstream's G700 aircraft impact FedEx's compliance costs under ICAO's 2028 production cutoff for non-compliant aircraft, given FedEx's reliance on fuel-efficient fleets to manage CORSIA obligations?",
      "original_answer": "Delays in FAA certification of Gulfstream's G700 aircraft could limit FedEx’s ability to acquire newer, more fuel-efficient aircraft before the 2028 cutoff date for non-compliant models, potentially increasing FedEx’s CORSIA compliance costs. FedEx noted in its 2023 10-K that its CORSIA-related expenses depend on factors including the fuel efficiency of its fleet and the availability of qualifying sustainable aviation fuels. Gulfstream’s 2023 inventory ramp-up for the G700 was explicitly tied to FAA certification timing, meaning a delay could slow the introduction of next-generation aircraft into FedEx’s fleet. This would prolong the use of older, less-efficient aircraft, increasing the company’s carbon offset or allowance purchase obligations under CORSIA and ETS, especially as free allowances are phased out by 2026.",
      "llm_answer": "Potential FAA certification delays for Gulfstream’s G700 would postpone its entry into service, forcing FedEx to rely on older, less‑fuel‑efficient aircraft that will not meet ICAO’s January 1, 2028 production‑cutoff standards.  This would raise FedEx’s CORSIA compliance costs, as the company’s strategy to manage emissions hinges on operating a fuel‑efficient fleet and older aircraft would increase emissions and the need for offsets or allowances (FedEx 10‑K, pp. 16‑20).  Gulfstream’s 10‑K notes that the G700 is still awaiting FAA certification and will only be delivered after certification (GD 10‑K, pp. 69‑73).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: FAA certification delays for the G700 could postpone its entry into service, affecting FedEx's ability to meet ICAO's 2028 production cutoff; this would force reliance on older, less fuel-efficient aircraft, increasing CORSIA compliance costs. The answer correctly cites FedEx’s 10-K (pp. 16–20) and Gulfstream’s 10-K (pp. 69–73) as sources, consistent with the knowledge graph. (2) Quantitative accuracy is perfect: the 2028 cutoff date is correctly stated as January 1, 2028, matching ICAO standards, and no numerical errors are present. Format and precision are appropriate. (3) Multi-hop reasoning is sound: the model correctly links FAA certification timing → G700 delivery delays → slower fleet modernization → continued use of non-compliant aircraft → higher emissions → increased need for offsets/allowances under CORSIA. It appropriately references both FedEx’s emissions strategy and Gulfstream’s certification dependency. (4) The only minor shortcoming is the omission of the detail about free allowances being phased out by 2026 (mentioned in the original answer), which adds nuance to the rising cost trajectory under ETS. While not critical, this contextual element strengthens the original answer’s depth. Otherwise, the LLM response is semantically equivalent, well-structured, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 396,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the voting power distribution tied to Class A and Class B common stock at CMCSA compare to the voting rights structure of Class A and Class B common stock at GOOGL, particularly in terms of the per-share voting ratio?",
      "original_answer": "At CMCSA, Class A common stockholders hold 66 2/3% of the combined voting power, with each share of Class A common stock receiving a variable number of votes depending on the outstanding shares, while each share of Class B common stock has 15 votes and collectively holds 33 1/3% of the voting power. In contrast, at GOOGL, each share of Class A common stock has 1 vote, and each share of Class B common stock has 10 votes, though the specific ownership percentages of each class are not disclosed. This indicates that CMCSA's structure grants significantly more voting weight to Class B shares compared to GOOGL's 10:1 ratio.",
      "llm_answer": "At Comcast, each Class A share carries one vote and each Class B share carries ten votes (a 1:10 voting ratio), with the Class B shares representing roughly one‑third of the combined voting power and being non‑dilutable. Alphabet’s GOOGL likewise gives Class A shares one vote and Class B shares ten votes per share, so the per‑share voting ratios are identical across the two companies.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that at CMCSA (Comcast), each Class A share carries one vote and each Class B share carries ten votes (1:10 ratio), which contradicts the ground truth: at CMCSA, Class B shares have 15 votes per share, and Class A votes are variable depending on outstanding shares, with Class A holding 66 2/3% and Class B 33 1/3% of total voting power. The LLM falsely claims a 1:10 ratio at CMCSA, when in fact it is not fixed and heavily favors Class B (15:variable). In contrast, the LLM correctly states that GOOGL (Alphabet) has a 1:10 voting ratio (Class A: 1 vote, Class B: 10 votes). (2) Quantitative accuracy is low: the 10 votes for Class B at CMCSA is wrong (should be 15), and the per-share voting ratio is misrepresented as identical (1:10) when CMCSA’s structure is fundamentally different and more skewed. The ground truth emphasizes that CMCSA gives *significantly more* weight to Class B than GOOGL, but the LLM claims the ratios are identical, which is false. (3) Multi-hop reasoning fails: the question asks for a comparison of voting power distribution and per-share voting ratios. The LLM incorrectly synthesizes the two structures as equivalent, missing the key distinction that CMCSA’s Class B has 15 votes vs GOOGL’s 10, and that CMCSA’s Class A voting power is not fixed at 1 vote per share. The answer omits the variable vote mechanism and the exact 66 2/3% vs 33 1/3% split, which are central to the correct analysis. (4) Contextual relevance is high because the answer addresses the right companies and the right topic (voting rights structure), but factual and quantitative errors severely undermine correctness. The conclusion that the ratios are identical is directly contradicted by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 491,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to GOOGL's dual-class structure, particularly in terms of the relative influence of holders of Class B shares?",
      "original_answer": "At CMCSA, holders of Class B common stock (owned entirely by Brian L. Roberts) have 15 votes per share and represent 33 1/3% of the combined voting power, while Class A common stockholders hold 66 2/3% of the voting power. In contrast, at GOOGL, Class B common stockholders have 10 votes per share, and upon conversion, these shares convert to Class A common stock, which has only one vote per share. This means that while both companies use a dual-class structure to concentrate voting power among certain shareholders, CMCSA’s Class B shares carry more per-share voting weight (15 votes vs. 10 votes) and are non-dilutable, giving the holder a fixed minority voting control compared to GOOGL’s structure, which allows for more fluidity through conversion.",
      "llm_answer": "At CMCSA, each Class B share carries 10 votes and together those shares represent 33.3 % of the company’s combined voting power (the single holder, Brian Roberts, thus controls a third of all votes)【CMCSA_10k_2023.pdf: pages 1‑5】. Alphabet’s dual‑class structure likewise awards 10 votes per Class B share, but because those shares are held by founders and early investors, they command a larger share of the overall voting power and therefore wield even greater influence relative to the broader shareholder base【GOOGL_10k_2023.pdf: pages 79‑83】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states that CMCSA Class B shares carry 10 votes per share, but the ground truth specifies 15 votes per share. This is a critical error in quantitative accuracy. Additionally, while it correctly notes that CMCSA Class B shares represent approximately 33.3% of voting power, it fails to mention that Class A holds 66 2/3%, weakening completeness. For GOOGL, the LLM correctly identifies 10 votes per Class B share but incorrectly implies that Class B holders have greater influence than at CMCSA, which contradicts the ground truth—CMCSA’s Class B shares have higher per-share voting power (15 vs 10). The LLM also omits the key point about conversion: GOOGL’s Class B shares convert to single-vote Class A shares, a crucial structural difference affecting long-term influence. (2) Number verification: '10 votes' for CMCSA Class B is wrong (should be 15); '33.3%' voting power is approximately correct (matches 33 1/3%). GOOGL's '10 votes' is correct. However, the comparative claim about influence is unsupported and misleading. (3) Multi-hop reasoning is partially present—comparing two companies’ dual-class structures—but flawed due to incorrect data and missing synthesis points like non-dilutability and conversion mechanics. (4) Correctness score is 4 due to major quantitative errors and incomplete comparison; qualitative accuracy is 5 because some structure is recognized but reasoning is flawed; contextual relevance is high as the response addresses the right topic and companies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 430,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the FDA approval timeline for BMY's Zeposia in ulcerative colitis compare with the regulatory milestone achieved by MRK for Welireg in von Hippel-Lindau disease, and what were the respective impacts on each company's 2021 oncology and immunology portfolios?",
      "original_answer": "BMY received FDA approval for Zeposia in May 2021 for the treatment of moderately to severely active ulcerative colitis (UC), based on the Phase III True North trial, which demonstrated its efficacy and led to expanded market access in immunology. In contrast, MRK received FDA approval for Welireg (belzutifan) in August 2021 for the treatment of von Hippel-Lindau (VHL) disease, marking a key oncology milestone. The approval of Zeposia contributed to BMY's immunology pipeline growth, while Welireg's approval led to a $50 million milestone payment to former Peloton shareholders and positioned MRK more strongly in the oncology space with a novel HIF-2α inhibitor.",
      "llm_answer": "BMY’s Zeposia received FDA approval for ulcerative colitis in May 2021, whereas Merck’s Welireg was approved for von Hippel‑Lindau disease in August 2021 – a three‑month gap. The Zeposia approval added a new biologic to BMY’s 2021 immunology lineup, while Welireg’s approval expanded Merck’s 2021 oncology portfolio with a targeted therapy for a rare cancer【BMY_10k_2022.pdf pages 91‑95】【MRK_10k_2022.pdf pages 99‑103】【MRK_10k_2022.pdf pages 50‑54】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: BMY's Zeposia was approved in May 2021 for ulcerative colitis, and MRK's Welireg was approved in August 2021 for von Hippel-Lindau disease — a three-month difference, correctly noted. These dates match the original answer exactly. (2) There are no numerical errors; the timeline comparison is quantitatively sound. While the original mentions a $50 million milestone payment to former Peloton shareholders related to Welireg, this detail is omitted in the LLM response, which slightly reduces completeness but does not affect core factual correctness. (3) The multi-hop reasoning is solid: the LLM correctly identifies both approvals, their respective therapeutic areas (immunology vs. oncology), and the strategic impact on each company’s portfolio — Zeposia expanding BMY’s immunology offerings and Welireg strengthening MRK’s oncology presence with a novel targeted therapy. (4) Semantic equivalence is maintained: though the LLM uses 'biologic' (Zeposia is actually an S1P receptor modulator, not a biologic — a minor inaccuracy), and doesn't mention the True North trial or the HIF-2α mechanism, the overall impact description is contextually appropriate. The citations reference correct documents, enhancing credibility. The omission of the milestone payment and mechanistic detail prevents a perfect 10, but the answer remains factually strong and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 403,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the vesting period structure for restricted stock at EMR compare to the vesting requirements in the multiemployer pension plans that UPS contributes to, given the differences in funding risk and benefit delivery mechanisms?",
      "original_answer": "EMR applies cliff vesting periods ranging from three to ten years for restricted stock awards, with compensation expense recognized ratably over these periods. In contrast, UPS contributes to multiemployer pension plans where vesting periods are defined by collective bargaining agreements and are tied to retirement, death, or termination benefits. These plans are subject to shared funding risks, where assets contributed by one employer may be used to fund benefits for employees of other employers, and UPS may face additional liabilities such as withdrawal liability or surcharge contributions if plans enter critical status. This highlights a fundamental difference in both the structure and risk exposure of vesting mechanisms between EMR’s equity-based compensation and UPS’s pension obligations.",
      "llm_answer": "EMR’s restricted‑stock awards vest on a cliff schedule—restricted stock vests after 3‑10 years of service, while RSUs vest after a 3‑year cliff (EMR, pp. 70‑74). UPS’s multiemployer pension plans, governed by collective‑bargaining agreements, set vesting periods that are typically longer and are shared among multiple employers, with benefits delivered by the plan and funding risk spread across participants (UPS, pp. 108‑112). Thus, EMR’s vesting is a company‑level equity incentive with a relatively short, fixed cliff, whereas UPS’s vesting is part of a broader, multi‑employer arrangement that carries shared funding risk and longer vesting timelines.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies EMR's cliff vesting periods for restricted stock as 3–10 years and specifies that RSUs have a 3-year cliff, which aligns with the ground truth that EMR uses cliff vesting over 3–10 years with ratable expense recognition. The mention of RSUs (not in the original answer) adds detail but does not contradict; however, the original answer focuses on restricted stock broadly. For UPS, the LLM correctly states that vesting is governed by collective bargaining agreements and involves shared funding risk across employers, accurately reflecting the multiemployer structure. However, it omits key elements from the ground truth: the explicit link between vesting and events like retirement, death, or termination, and the specific risks such as withdrawal liability or surcharge contributions when plans are in critical status. (2) Quantitatively, all timeframes (3–10 years, 3-year cliff) are accurate and consistent with the ground truth. No calculations are required, and number formats are appropriate. (3) The multi-hop reasoning is sound—comparing EMR’s equity-based vesting to UPS’s pension plan vesting—and correctly contrasts company-level incentives vs. multi-employer risk sharing. The synthesis across two different companies and compensation mechanisms is logically structured and relevant. (4) The answer is contextually excellent, directly addressing the comparison of vesting structures and risk mechanisms. The score is 8 because while core facts and comparisons are correct, there are minor omissions in detailing UPS’s specific liabilities and the exact nature of benefit triggers, which are part of the full risk picture in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 465,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does NFLX's exposure to data privacy risks under the Communications Act compare to CMCSA's regulatory obligations under the same Act, particularly in terms of potential financial penalties and operational constraints related to handling personal information?",
      "original_answer": "NFLX faces potential financial penalties and reputational damage due to unauthorized data breaches involving member personal information, including billing data, which could result in material costs and regulatory fines without insurance coverage. CMCSA, being subject to the Communications Act, must comply with privacy and data protection restrictions that govern the collection, use, and disclosure of personal information, which could lead to legal consequences if violated. Both companies are exposed to regulatory scrutiny and potential penalties under the Communications Act, though NFLX lacks insurance to mitigate such risks, whereas CMCSA’s obligations are framed within a broader regulatory compliance framework that includes audits and potential changes in law.",
      "llm_answer": "On pages 11‑15 of NFLX’s 10‑K, the company highlights privacy risks under GDPR, CPRA and other data‑protection laws, noting that non‑compliance could trigger investigations, claims and significant penalties, but it does not explicitly cite the Communications Act. In contrast, CMCSA’s 10‑K (pages 15‑19, 25‑29) expressly references the Communications Act and the Video Privacy Protection Act, stating that violations can lead to administrative enforcement, fines, civil and criminal liability, and operational restrictions on collecting, using, disclosing and retaining personal information. Thus, CMCSA faces clearer, Act‑based penalties and operational constraints, whereas NFLX’s exposure is framed more generally under broader privacy statutes without a specific Communications Act reference.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of substance, though it diverges slightly in emphasis. (1) It accurately identifies that CMCSA is explicitly subject to the Communications Act and the Video Privacy Protection Act, with clear regulatory obligations, including administrative enforcement, fines, and operational constraints—this matches the original answer’s point about CMCSA’s compliance framework. It also correctly notes that NFLX discusses privacy risks under GDPR, CPRA, and other laws but does not explicitly reference the Communications Act, which is consistent with the ground truth that NFLX’s exposure is framed more broadly and lacks specific Act-based obligations. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from both companies’ 10-Ks, compares their regulatory exposures, and draws a valid contrast in how each company frames its risk. However, the LLM omits a key point from the ground truth: that NFLX lacks insurance coverage to mitigate data breach costs, which is a material difference in risk management. This omission prevents a higher score. (4) The answer is contextually relevant and well-structured, directly addressing the comparison of financial penalties and operational constraints. While the LLM emphasizes statutory specificity rather than insurance coverage or reputational damage, it still captures the core distinction: CMCSA has clearer, Act-based obligations, while NFLX faces general privacy risks without explicit Communications Act linkage. Thus, the answer is factually accurate and relevant but slightly less complete than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 485,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the commercialization of Platform 5 nicotine pouches in Sweden by PM compare to CCEP's role as a bottler for KO in the same market, particularly in terms of their respective market entry strategies and product dependencies?",
      "original_answer": "Coca-Cola Europacific Partners (CCEP) serves as a key bottler for The Coca-Cola Company (KO) in Sweden, handling the distribution of Coca-Cola trademark beverages under contractual agreements that require CCEP to purchase concentrates from KO. In 2021, KO's five largest bottlers, including CCEP, represented 41% of KO’s total worldwide unit case volume. Meanwhile, Philip Morris International (PM) launched its Platform 5 nicotine pouch product in Sweden in January 2022 under the Shiro brand, following the acquisition of AG Snus. This launch represents a direct market entry strategy by PM, contrasting with CCEP’s role as a contracted third-party distributor for KO, where product supply is dependent on KO’s concentrate pricing and availability. Both companies operate in Sweden, but PM’s strategy involves direct product innovation and brand acquisition, while CCEP relies on KO for product inputs and brand authorization.",
      "llm_answer": "PM entered Sweden by launching a single product category—Platform 5 nicotine pouches—using a reformulated Shiro brand in January 2022, relying on its own manufacturing and distribution of that product【PM_10k_2022】【Platform 5 covers Modern Oral Nicotine Pouches, which consist of white pre‑portioned pouches…In 2021, PMI acquired AG Snus…Commercialization of Platform 5 product in Sweden in January 2022…】. In contrast, CCEP operates as an established bottler for Coca‑Cola in Sweden, distributing a broad range of Coca‑Cola beverages under a long‑term bottling agreement and depending on Coca‑Cola’s concentrate supply and brand licensing rather than a single product launch【KO_10k_2022】【Coca‑Cola Europacific Partners plc (‘CCEP’), which has bottling and distribution operations in … Sweden; Our concentrate operations typically generate net operating revenues by selling concentrates…to authorized bottling operations…】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: PM launched Platform 5 nicotine pouches in Sweden in January 2022 under the Shiro brand following the acquisition of AG Snus, and CCEP serves as a bottler for KO in Sweden under a long-term agreement. The dates (January 2022) and company roles are correctly identified. (2) Quantitative accuracy is perfect: no numerical errors, and while the ground truth mentions that CCEP and four other bottlers represented 41% of KO’s global unit case volume in 2021, this specific figure is not included in the LLM answer—but its omission does not distort the factual narrative, as the focus is on the structural relationship rather than the statistic. (3) Multi-hop reasoning is sound: the model correctly contrasts PM’s direct market entry via product innovation and acquisition with CCEP’s dependent role as a third-party distributor reliant on KO’s concentrates and brand licensing. The synthesis across PM and KO filings is appropriate and logically presented. (4) Semantic equivalence is strong: though the LLM does not repeat the 41% statistic, it captures the core strategic contrast—direct innovation vs. contracted distribution—and correctly identifies product dependencies and market entry modes. The answer is contextually complete and relevant, with only a minor omission of a supporting quantitative detail preventing a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 396,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the 8% decline in UNH's Medicare Part D enrollment from 2023 to 2024 interact with the IRA's manufacturer discount requirements and reinsurance shifts to assess CVS's financial exposure under its Medicare Advantage contracts?",
      "original_answer": "The 8% decline in UNH's Medicare Part D enrollment from 3,315,000 in 2023 to 3,050,000 in 2024 suggests a reduction in the number of Part D beneficiaries served by UNH, which may reflect broader market adjustments under the IRA's redesign of Medicare Part D. The IRA introduced significant changes, including capping beneficiary out-of-pocket costs and reducing Federal reinsurance in the catastrophic phase starting January 1, 2025, which shifts more financial responsibility to Part D plans and manufacturers through required manufacturer discounts. For CVS, this creates a dual exposure: first, as a provider of Medicare Advantage plans, it must manage the financial risk associated with the reduced reinsurance and increased member cost-sharing volatility; second, the IRA's rebate mechanism, which Amgen began accruing for in 2022, introduces further pricing pressures that may impact the pharmacy benefit manager's (PBM) drug acquisition costs and rebate negotiations. Thus, the enrollment decline at UNH, combined with the IRA's structural changes and Amgen's experience with manufacturer discounts, collectively signal a complex risk environment for CVS under its Medicare contracts.",
      "llm_answer": "UNH reported an 8 % drop in Medicare Part D stand‑alone enrollment (3,050 in 2024 versus 3,315 in 2023) (UNH 10‑K, pp. 29‑33).  The IRA now forces manufacturers to accept set prices for Part D drugs and, from 2025, cuts federal reinsurance in the catastrophic phase, shifting more cost to Part D plans and manufacturers and raising the need for manufacturer discounts (UNH 10‑K, pp. 30‑32).  Because CVS’s Medicare Advantage contracts bundle Part D benefits, the combination of a smaller enrollment base and the IRA‑driven discount and reinsurance shifts is likely to compress margins on those contracts, increasing CVS’s financial exposure (CVS 10‑K, pp. 38‑42).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the 8% decline in UNH's Medicare Part D enrollment and links it to IRA provisions affecting manufacturer discounts and reinsurance shifts. It appropriately connects these changes to CVS's financial exposure through its Medicare Advantage contracts that include Part D benefits. However, there is a critical error in the numeric values: the LLM states enrollment dropped from '3,315 in 2023 to 3,050 in 2024', which is off by a factor of 1,000 (should be 3,315,000 and 3,050,000). This is a significant quantitative inaccuracy, though the percentage decline (~8%) is approximately correct. 2) The calculation of the percentage drop is roughly accurate (using 3,315,000 → 3,050,000 yields ~8.0%, so the percentage is correct), but the raw numbers are presented with missing 'thousands' units, likely a formatting or transcription error. This undermines quantitative accuracy despite correct relative change. 3) The reasoning is sound: the LLM correctly synthesizes information across UNH and CVS 10-Ks, recognizes the IRA’s impact on manufacturer discounts and reduced federal reinsurance starting in 2025, and logically infers increased financial risk for CVS due to margin compression in Medicare Advantage plans. It captures the multi-hop chain: UNH enrollment trend → industry-wide Part D changes under IRA → financial risk shift to plans and manufacturers → implications for CVS as a Medicare Advantage provider with integrated PBM and plan operations. 4) The mention of Amgen’s rebate accruals in the original answer adds a supporting example of manufacturer-level impact, which the LLM omits. While not strictly necessary, it weakens completeness slightly. However, the core logic and synthesis remain intact. Overall, the answer is factually mostly correct in direction and reasoning but marred by a significant numerical inaccuracy in scale, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 515,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How does Southern Company's use of cost recovery mechanisms for environmental remediation at its natural gas utilities compare to Duke Energy's financial exposure from environmental remediation liabilities, given the differences in their regulatory and liability frameworks?",
      "original_answer": "Southern Company utilizes cost recovery mechanisms approved by state regulatory agencies to recover environmental remediation costs at its natural gas distribution utilities, allowing it to pass on prudently-incurred expenses—including those related to infrastructure replacement and environmental cleanup—to customers through regulated rates. In contrast, Duke Energy faces environmental remediation liabilities at various current and former sites, with $X million (hypothetical placeholder based on typical reporting) in reserves for probable and estimable costs, but without guaranteed regulatory recovery, meaning these costs are often expensed directly as operational expenses unless recovery is deemed probable. While Southern Company benefits from structured cost recovery riders, Duke Energy must manage uncertain future costs without assured cost pass-through, leading to greater financial exposure.",
      "llm_answer": "Southern Company’s natural‑gas utilities recover environmental‑remediation costs through state PSC‑approved cost‑recovery mechanisms that are built into their regulated rates, allowing the utilities to recover such expenses directly from customers. In contrast, Duke Energy records environmental‑remediation liabilities as reserves—$73 million for the parent company (plus $24 million for Carolinas, $19 million for Progress, etc.)—and notes that additional costs could arise, reflecting a federal‑state‑local liability framework where remediation costs are not automatically recoverable and must be provisioned for in the financial statements.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core contrast between Southern Company's cost recovery mechanisms and Duke Energy's financial exposure through reserves. It accurately describes Southern Company’s use of state PSC-approved recovery mechanisms allowing pass-through to rates, and Duke Energy’s recognition of environmental liabilities as reserves without guaranteed recovery. However, the original answer uses a placeholder '$X million' to indicate a hypothetical or generalized reserve amount due to variability in reporting, while the LLM answer provides specific figures—$73M (parent), $24M (Carolinas), $19M (Progress)—which are not present in the ground truth and may not be accurate or consistently reported across filings. These numbers, while plausible, introduce false precision and are not verifiable from the provided ground truth, reducing quantitative accuracy. (2) The numbers cited in the LLM answer do not match the placeholder format in the original, and there is no indication that these exact figures were in the knowledge graph; thus, they represent an over-specification error. The sum of these values ($116M total) is not requested or evaluated here, but their presence implies a level of detail not supported by the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes regulatory frameworks (state cost recovery vs. uncertain liability provisioning) across two companies and draws a valid comparison in terms of financial exposure. The reasoning about Duke Energy’s lack of automatic recovery and need to expense costs unless probable aligns with the original. (4) The contextual relevance is perfect—the answer directly addresses the comparison asked, including regulatory and liability frameworks. Qualitative accuracy is high due to correct entity identification (Southern Company, Duke Energy), accurate terminology (reserves, cost recovery, PSC), and logical structure. The correctness score is 8 because the core factual and conceptual content is correct, but the inclusion of unsupported specific dollar amounts prevents a 9–10 score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 567,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "What is the combined total of securities remaining available for future issuance under equity compensation plans approved by security holders for Caterpillar and Johnson & Johnson, and how does this compare to 3M's total available securities under similar plans?",
      "original_answer": "The combined total of securities remaining available for future issuance under equity compensation plans approved by security holders for Caterpillar (40,873,176) and Johnson & Johnson (111,042,139) is 151,915,315. This is significantly higher than 3M's total of 39,563,000 available securities under the same category.",
      "llm_answer": "Caterpillar and Johnson & Johnson together have 151,915,315 securities remaining available for future issuance under equity‑compensation plans approved by security holders (40,873,176 + 111,042,139)【Caterpillar pages 125‑129】【Johnson & Johnson pages 119‑123】.  \n3M’s equity‑compensation plans approved by security holders have only 21,316 such securities remaining available for future issuance【3M pages 114‑118】.  \nThus, the combined total for Caterpillar and Johnson & Johnson is roughly 7,200 times larger than 3M’s total.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Caterpillar's and Johnson & Johnson's available securities (40,873,176 and 111,042,139) and calculates their sum accurately as 151,915,315, which matches the ground truth. However, it provides an incorrect value for 3M's available securities—stating only 21,316 instead of the correct 39,563,000. This is a major factual error. (2) The calculation of the combined total is correct, but the comparison is severely flawed due to the incorrect 3M number. The claim that the combined total is 'roughly 7,200 times larger' than 3M’s total is based on this wrong figure (151,915,315 ÷ 21,316 ≈ 7,127), whereas the actual ratio is about 3.84 (151,915,315 ÷ 39,563,000 ≈ 3.84). (3) The multi-hop reasoning is partially sound—information is synthesized across three companies and equity compensation plans are correctly identified—but the final comparison fails due to the erroneous 3M data. (4) The contextual relevance is high because the structure and intent align with the question, but the quantitative inaccuracy in a core fact (3M's securities) severely undermines the correctness. The qualitative reasoning is weakened by the incorrect conclusion stemming from bad input data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 345,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How do Merck's Januvia and Janumet U.S. market exclusivity expiration timelines (May 2026) and IRA-imposed pricing constraints compare to Pfizer's regulatory exclusivity strategy, and what does this indicate about their respective post-2025 revenue protection mechanisms?",
      "original_answer": "Merck’s Januvia and Janumet are set to lose U.S. market exclusivity in May 2026 due to patent settlements and court rulings, with Janumet XR following in July 2026. Despite this, the IRA mandates government price-setting for Januvia starting in 2026 and for Janumet/Janumet XR in 2027, adding pricing pressure. In contrast, Pfizer relies on both patent rights and concurrent regulatory exclusivity periods upon drug approval to protect revenue beyond patent terms. This indicates that Merck is managing near-term exclusivity erosion through price adjustments and rebate reductions, while Pfizer’s strategy emphasizes regulatory exclusivity as a parallel shield alongside patents, suggesting divergent approaches to post-2025 revenue sustainability.",
      "llm_answer": "Merck’s Januvia and Janumet will retain U.S. market exclusivity until May 2026, but the Inflation‑Reduction‑Act (IRA) program will impose a government‑set price on Januvia effective Jan 1 2026 and on Janumet effective Jan 1 2027, effectively capping revenue once exclusivity ends【Merck 10‑K, p. 58‑60】.  By contrast, Pfizer’s strategy relies on regulatory exclusivity that can last up to 12 years for biologics (and 5 years for chemical products, plus orphan‑drug and pediatric‑study exclusivities)【Pfizer 10‑K, p. 12‑13】, giving it a longer post‑2025 revenue‑protection window.  Thus, while Merck faces an earlier loss of exclusivity coupled with price constraints, Pfizer’s extended regulatory exclusivity provides a more robust mechanism to shield revenue beyond 2025.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the core comparison between Merck and Pfizer's exclusivity strategies and correctly identifies the general timeline and impact of the IRA. However, there are key factual inaccuracies in dates: the original answer states that Januvia and Janumet lose exclusivity in May 2026 (with Janumet XR in July 2026), while the LLM claims IRA-imposed pricing starts January 1, 2026 for Januvia and January 1, 2027 for Janumet—this contradicts the ground truth, which specifies IRA price-setting begins in 2026 for Januvia and 2027 for Janumet/Janumet XR, but does not specify January 1. More critically, the exclusivity expiration (May 2026) and IRA price-setting (starting 2026) are conflated as if they occur simultaneously, but the LLM incorrectly implies the IRA pricing starts *before* exclusivity ends for Januvia (Jan 2026 vs May 2026), which distorts the revenue impact timeline.\n\n2) Quantitative accuracy is partially compromised: while the 12-year biologics exclusivity and 5-year chemical exclusivity for Pfizer are correctly cited, the specific dates for Merck’s exclusivity and IRA implementation are misaligned. The original answer does not specify exact months for IRA pricing start, so asserting 'January 1' introduces false precision. Additionally, the LLM omits mention of Janumet XR’s July 2026 exclusivity, a detail present in the ground truth and relevant to completeness.\n\n3) The multi-hop reasoning is sound in structure—comparing Merck’s patent-driven exclusivity erosion with IRA pricing to Pfizer’s regulatory exclusivity buffer—but the synthesis is weakened by incorrect temporal sequencing. The conclusion that Pfizer has a 'more robust' mechanism is reasonable, but the argument is based on a slightly distorted timeline.\n\n4) Despite these issues, the answer remains contextually relevant and conveys the essential contrast in post-2025 revenue protection strategies. The use of citations (10-K pages) adds credibility, though they are not evaluable here. The answer is qualitatively strong in framing the strategic divergence, earning high marks for reasoning and relevance, but loses points for factual precision in dates and over-specificity not supported by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 593,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the credit event risk associated with MS's investments in CLNs, which embed credit protection sold to issuers, compare to BAC's use of credit derivatives to mitigate commercial credit exposure, particularly in terms of how each firm manages counterparty risk through derivative instruments?",
      "original_answer": "Morgan Stanley (MS) invests in CLNs and CDOs, which are hybrid instruments containing embedded derivatives in which credit protection has been sold to the issuer of the note. If there is a credit event of a reference entity underlying the instrument, the principal balance of the note may not be repaid in full to the firm, indicating a direct exposure to counterparty risk. This contrasts with Bank of America (BAC), which actively purchases credit protection to cover both funded and unfunded portions of certain credit exposures as part of its commercial credit risk management strategy. BAC also uses credit derivatives to hedge risk, with changes in fair value recorded in other income. Both firms utilize credit derivatives, but MS assumes risk by investing in instruments where it has sold protection, while BAC mitigates risk by purchasing protection.",
      "llm_answer": "MS’s CLNs are hybrid notes that embed credit protection sold to the issuer; the firm’s credit‑event risk is therefore tied to the issuer’s default, which could leave the principal unpaid.  MS limits this counterparty risk by setting aggregate credit‑risk limits, monitoring correlation and credit exposure, and using collateral and netting arrangements to recover the underlying obligation when a credit event occurs.  By contrast, BAC uses CDS and other credit‑derivative contracts to hedge its commercial‑credit portfolio, and it manages counterparty risk through collateral posting, bilateral downgrade agreements that trigger additional collateral or termination payments when a counterparty’s rating falls, and strict monitoring of credit‑rating changes to keep exposure within set limits.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that MS invests in CLNs where it has effectively sold credit protection, exposing it to credit event risk if the reference entity defaults, potentially resulting in non-repayment of principal. It contrasts this with BAC, which uses credit derivatives (e.g., CDS) to hedge commercial credit exposure by purchasing protection—this core distinction in risk assumption vs. risk mitigation is accurately captured. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable in terms of calculations or figures; however, the absence of any incorrect numbers supports a score of 10. (3) The multi-hop reasoning is sound: the model synthesizes information about two firms (MS and BAC), their use of credit derivatives, and their counterparty risk management strategies. The LLM adds slightly more operational detail (e.g., bilateral downgrade agreements, collateral posting) than the original answer, which is consistent with plausible risk management practices and does not contradict the ground truth. (4) The only minor shortcoming is that the original answer explicitly states that BAC records changes in fair value in other income, a detail omitted in the LLM response. While not critical to the core comparison, it is a small completeness gap. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 410,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How does the indemnification structure established by 3M in connection with Solventum's spin-off compare to RTX's indemnification arrangements for its financial guarantees, particularly regarding the transfer of liability and the recognition of potential losses?",
      "original_answer": "3M transferred certain liabilities to Solventum as part of the spin-off, including those related to the Bair Hugger and Federal False Claims Act/Qui Tam Litigation, with Solventum assuming indemnification and defense obligations. 3M records liabilities for legal proceedings when probable and estimable, and discloses possible losses when not accrued. Similarly, RTX is subject to indemnification for certain liabilities under its financial guarantees, which could affect its financial exposure. Both companies recognize indemnification rights or obligations as part of their liability management, but 3M explicitly transferred liability to a spun-off entity, whereas RTX retains exposure subject to third-party indemnification terms. This distinction affects how each company accounts for contingent liabilities and insurance receivables under ASC 450 and ASC 610-30.",
      "llm_answer": "3M’s spin‑off indemnification structure transfers most Solventum‑related liabilities to the new company, with Solventum indemnifying and defending 3M for those actions while 3M retains certain liabilities (e.g., PFAS) and records potential losses only for those retained items (see MMM_10k_2024.pdf pages 82‑86). In contrast, RTX’s financial‑guarantee indemnification arrangements keep the liability on RTX’s books but shift the risk to the guarantee holder, with RTX recognizing potential losses as contingent liabilities and accruing for probable losses (see RTX_10k_2024.pdf pages 100‑104).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core distinctions between 3M's and RTX's indemnification structures. (1) It correctly identifies that 3M transferred liabilities to Solventum, with Solventum assuming indemnification and defense obligations, while 3M retains certain liabilities (e.g., PFAS), aligning with the ground truth's mention of Bair Hugger and False Claims Act litigation being transferred. The note about 3M recording losses only for retained items matches the ground truth's statement on accruing liabilities when probable and estimable. (2) For RTX, the LLM correctly states that liability remains on RTX’s books under financial guarantees, with potential losses recognized as contingent and accrued if probable—consistent with the ground truth’s reference to indemnification affecting financial exposure and ASC 450. (3) The multi-hop reasoning is sound: the model synthesizes across two companies and their respective 10-K disclosures, comparing liability transfer versus retention and accounting treatment. (4) Minor omission: the LLM does not explicitly name the specific litigation transferred (Bair Hugger, FCA/Qui Tam) or reference ASC 610-30, which the ground truth includes for 3M’s spin-off accounting. However, the semantic meaning and key comparative insight—that 3M transferred liability via spin-off while RTX retains exposure under third-party indemnifications—are preserved. All referenced document citations (page numbers, file names) are plausible and contextually appropriate. No numerical inaccuracies; no calculations required. Wording differs slightly but meaning is equivalent. Thus, high scores across all categories with a minor deduction in qualitative accuracy for missing specific litigation names and accounting standard references.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 483,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does the geographic revenue distribution of AMD in Taiwan compare to the potential supply chain risk NVIDIA faces through its foundry partners operating in the same region, given the geopolitical tensions mentioned in both companies' filings?",
      "original_answer": "AMD reported $1,841 million in sales to external customers from Taiwan in 2023, highlighting the region's significance in its revenue distribution. Meanwhile, NVIDIA explicitly states that its foundry partners—critical to its chipset supply—are primarily located in Taiwan, and a significant or prolonged geopolitical conflict involving China and Taiwan could severely limit or prevent NVIDIA from receiving chipset supply. This indicates that while Taiwan is a notable market for AMD's sales, it represents a core supply chain vulnerability for NVIDIA due to its dependency on foundry partners operating in the region.",
      "llm_answer": "AMD’s 2023 revenue from Taiwan was $1.841 billion, about 8 % of its $22.68 billion total sales (AMD, 10‑K, p. 73).  NVIDIA, by contrast, relies on Taiwan‑based foundry partners such as TSMC for chip manufacturing and warns that geopolitical tensions between China and Taiwan could disrupt that supply chain (NVDA, 10‑K, p. 18‑19).  Thus, while AMD’s Taiwan revenue is a modest portion of its business, NVIDIA faces a more pronounced supply‑chain risk from the same region’s geopolitical uncertainties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: AMD's $1.841 billion in revenue from Taiwan (equivalent to $1,841 million) and the total sales of $22.68 billion are accurately cited, and the 8% calculation is approximately correct (1.841 / 22.68 ≈ 8.11%). The formatting variation ($1.841 billion vs $1,841 million) is acceptable. (2) The answer correctly identifies NVIDIA’s reliance on Taiwan-based foundries like TSMC and the associated supply chain risk due to geopolitical tensions, as stated in its 10-K. (3) The multi-hop reasoning is sound: it synthesizes AMD’s revenue exposure (market-side) with NVIDIA’s supply-side dependency, contrasting the nature and severity of each company’s exposure to Taiwan. (4) The only minor shortcoming is that the original answer emphasizes more strongly that Taiwan is a 'core supply chain vulnerability' for NVIDIA, while the LLM slightly softens this to 'more pronounced supply-chain risk'—still accurate but slightly less forceful in conveying the severity. Otherwise, all entities (AMD, NVIDIA, TSMC, Taiwan), years (2023), and financial metrics are correct. The answer is contextually complete and directly addresses the comparative geographic and risk exposure question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 358,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does NEER's 15-year weighted average contract term for repowered wind facilities influence long-term revenue predictability, and how might this structural advantage compare to Southern Power's reliance on power sales agreements where specific contract terms are not disclosed?",
      "original_answer": "NEER benefits from a 15-year weighted average remaining contract term on its power sales agreements tied to repowered wind facilities, which enhances revenue predictability by locking in long-term pricing and output commitments. In contrast, Southern Power discloses its reliance on power sales agreements but does not specify contract durations, limiting visibility into its own revenue stability. This difference suggests NEER may have a more transparent and structured approach to securing long-term cash flows from renewable assets, which could influence investor confidence and financial planning strategies.",
      "llm_answer": "NEER’s 15‑year weighted‑average remaining term for repowered wind facilities locks in revenue for the life of those assets, giving the company a stable, long‑term earnings stream that reduces volatility (NEER: weighted‑average remaining contract term of approximately 15 years). In contrast, Southern Power’s long‑term PPAs—while also contract‑based—do not disclose specific terms, so revenue predictability is less transparent and more exposed to market and operational variability, potentially leading to greater earnings uncertainty (Southern Power: long‑term PPAs without capacity revenue, terms not disclosed).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies NEER's 15-year weighted-average remaining contract term for repowered wind facilities and accurately contrasts it with Southern Power's lack of disclosed contract terms. All factual elements—NEER’s 15-year term and Southern Power’s non-disclosure—are consistent with the ground truth. (2) Quantitative accuracy is perfect: the 15-year figure is correctly cited, and no other numerical claims are made that contradict or misrepresent the data. Format is consistent and precise. (3) The multi-hop reasoning is sound: the model synthesizes information about NEER’s disclosed contract duration and its implications for revenue stability, then contrasts it with Southern Power’s opacity in contract terms, correctly inferring reduced transparency and higher uncertainty. The conclusion about earnings predictability and stability aligns with the original answer’s logic. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'investor confidence' or 'financial planning strategies,' which are part of the original answer’s qualitative insight. While the implications for predictability are well-covered, this omission slightly reduces qualitative completeness. However, the core reasoning and factual content are equivalent. Thus, the answer is highly accurate, contextually appropriate, and correctly reasoned with only a small gap in full conceptual coverage.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 398,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does RTX's revenue recognition practices under FAR guidelines for U.S. government fixed-price contracts compare to Honeywell's exposure to contract termination risks under the same regulatory framework?",
      "original_answer": "RTX recognizes revenue in excess of billings under U.S. government fixed-price contracts due to performance-based or progress payments that typically cover only 80-90% of costs incurred, creating contract assets. These practices are governed by the FAR, which outlines allowable costs and payment structures. Honeywell, also subject to the FAR, faces unique risks such as the U.S. government's right to terminate contracts for convenience, which could impact its contract assets or liabilities similarly structured. Both companies are bound by the same FAR-regulated payment and cost frameworks, but Honeywell's risk profile includes potential contract termination that could disrupt revenue already recognized under FAR-compliant accounting practices.",
      "llm_answer": "RTX recognizes revenue from U.S. government fixed‑price contracts over time using a percentage‑of‑completion method based on costs incurred versus total estimated costs, and records contract assets when revenue exceeds billings (RTX 10‑K, pp. 77‑81). Honeywell, under the same FAR framework, highlights that U.S. government contracts carry termination rights—either for convenience or due to non‑performance—posing a risk of abrupt revenue loss and the need for adjustments or refunds (Honeywell 10‑K, pp. 33‑37). Thus, RTX’s FAR‑compliant revenue recognition focuses on progressive performance measurement, whereas Honeywell’s primary concern is the contractual termination risk that can cut revenue streams.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: RTX uses a percentage-of-completion method under FAR for fixed-price contracts, recognizing revenue in excess of billings, creating contract assets—consistent with the 80-90% cost coverage mentioned in the original answer. Honeywell’s exposure to termination for convenience or cause is accurately described, with appropriate risk implications. (2) No specific numbers (e.g., percentages, dollar amounts) are misstated; the LLM correctly avoids inventing figures and accurately reflects the qualitative financial mechanics. Format and content are consistent with the ground truth, allowing for semantic variation. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes RTX’s revenue recognition practices and Honeywell’s termination risks under the same FAR framework, contrasting their respective exposures while acknowledging shared regulatory context. (4) The only minor gap is that the LLM does not explicitly state that both companies face similar contract asset/liability structures under FAR, which the original answer emphasizes to link the two firms’ risk and accounting outcomes. However, this is implied through context. Wording differs but meaning is substantively equivalent. All sources are appropriately attributed to 10-K pages, enhancing credibility. No irrelevant or extraneous information is included.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 396,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does the absence of voting rights associated with Alphabet's Class C Capital Stock compare to Comcast's relinquishment of voting rights in Hulu, particularly in terms of governance control and financial outcomes?",
      "original_answer": "Alphabet's Class C Capital Stock has no voting rights except as required by law, which allows the company to maintain control through higher-vote Class A and Class B shares while repurchasing non-voting shares to optimize capital structure. In 2024, Alphabet had $44.7 billion remaining available for Class A and Class C share repurchases. In contrast, Comcast relinquished substantially all voting rights in Hulu in 2019, giving Disney full operational control, and exercised a put option in 2023 to sell its interest for a minimum equity value of $9.2 billion. This resulted in a $8.6 billion payment from Disney (net of $557 million for prior capital calls) and a recorded investment value of $883 million as of December 31, 2024. Both companies strategically managed voting rights to influence governance and financial returns, albeit through different mechanisms and outcomes.",
      "llm_answer": "Alphabet’s Class C capital stock has no voting rights, so holders cannot influence Alphabet’s governance, yet they still receive the same economic benefits as other classes—dividends and share‑repurchase proceeds. Comcast’s surrender of voting rights in Hulu removed its board seats and operational control, but the company realized an $8.6 billion cash payment (plus a tax gain) when Disney exercised the put option, turning the investment into a cash‑generating asset while ending its control. Thus, Alphabet’s non‑voting shares are a passive equity position with ongoing financial returns, whereas Comcast’s relinquishment was a strategic divestiture that produced a large cash inflow and ended its governance role.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core contrast between Alphabet's structural use of non-voting shares and Comcast's strategic divestiture of voting rights in Hulu. It accurately describes the governance and financial implications for both companies. However, it omits key quantitative details from the ground truth: Alphabet's $44.7 billion share repurchase authorization in 2024 and the $883 million recorded investment value of Comcast's Hulu stake as of December 31, 2024. The $8.6 billion payment from Disney is correctly stated, but the LLM does not mention the $557 million adjustment for prior capital calls, which affects the full financial picture. (2) The LLM correctly states the $8.6 billion cash payment to Comcast but fails to specify that this was net of $557 million for prior capital calls, and it omits the $44.7 billion repurchase capacity for Alphabet shares. These omissions reduce quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance control (voting rights) and financial outcomes across two different corporate structures and events. It draws a valid qualitative distinction between Alphabet’s ongoing capital structure strategy and Comcast’s exit transaction. (4) The answer is contextually excellent—directly addressing governance control and financial outcomes as asked. The reasoning is strong and semantically aligned with the ground truth, but the missing financial figures prevent a top score in correctness and quantitative accuracy. Hence, correctness is 8 (core facts right, minor omissions), quantitative accuracy 7 (missing or incomplete numbers), qualitative accuracy 9 (strong logic and entity use), and contextual relevance 10 (fully on-topic and responsive).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 481,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "Given LLY's ongoing challenges scaling production of incretin products while relying on third-party manufacturers, and TMO's $26.92 billion in remaining performance obligations—many tied to contract manufacturing over 3-5 year durations—how might shared vulnerabilities in quality assurance and supply chain execution affect both companies' ability to fulfill long-term commitments?",
      "original_answer": "LLY is experiencing intermittent supply delays for incretin products like Mounjaro and Zepbound, with tight supply expected to persist until additional manufacturing capacity becomes operational 'in the next several years.' These production constraints are tied to reliance on third-party manufacturers, which face quality assurance risks that could lead to regulatory actions, product recalls, or delays in approvals. Meanwhile, TMO has $26.92 billion in remaining performance obligations, with a significant portion linked to contract manufacturing agreements that typically span 3-5 years. If third-party manufacturers fail to maintain quality standards or encounter capacity limitations—as AMD also highlights in its 10-K—both companies could face fulfillment risks: LLY may struggle to meet patient demand amid supply volatility, while TMO could face delays or defaults on long-term manufacturing contracts, impacting revenue recognition and customer relationships.",
      "llm_answer": "LLY’s 2023 10‑K (pp. 43‑47) highlights intermittent delays and expected ongoing supply constraints for its incretin products as it scales production and relies on third‑party manufacturers. TMO’s 2023 10‑K (pp. 47‑51) shows $26.92 billion of remaining performance obligations, roughly half of which are tied to contract‑manufacturing agreements lasting 3–5 years. Because both firms depend on external manufacturing, shared vulnerabilities in quality assurance or supply‑chain execution could delay or reduce product availability, jeopardizing revenue recognition and the ability to meet long‑term contractual commitments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: LLY's supply constraints due to third-party manufacturing are accurately described, including reference to intermittent delays and scaling challenges. TMO's $26.92 billion in remaining performance obligations is correctly cited, and the detail that about half are tied to 3–5 year contract manufacturing agreements matches the source context. (2) Quantitative accuracy is perfect: the dollar amount ($26.92 billion) is exact, timeframes (3–5 years) match, and no calculations were required. Format is consistent and clear. (3) Multi-hop reasoning is sound: the model correctly synthesizes risks across LLY and TMO by identifying shared reliance on third-party manufacturers and linking this to quality assurance and supply chain vulnerabilities that could impact both patient supply and contractual fulfillment. It appropriately connects these risks to financial and operational consequences like revenue recognition and long-term commitments. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the forward-looking duration of LLY's capacity expansion ('in the next several years') or reference the parallel risk highlighted in AMD’s 10-K as supporting evidence, which slightly reduces completeness in qualitative synthesis. However, the core reasoning and factual content remain robust and contextually appropriate. Wording differs but semantic meaning is equivalent. Overall, this is a strong, factually correct response with only negligible omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 434,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What was the total cumulative impairment charge recognized by NextEra Energy Resources on its investment in XPLR as of December 31, 2024, and how does this compare to the carrying value of the investment before the 2024 impairment?",
      "original_answer": "As of December 31, 2024, NextEra Energy Resources had recognized a cumulative impairment charge of $2.0 billion on its investment in XPLR, combining the $1.2 billion impairment from September 30, 2023, and the $0.8 billion impairment from December 31, 2024. The carrying value of the investment before the 2024 impairment was approximately $2.6 billion, which was then written down to $1.8 billion after the 2024 impairment.",
      "llm_answer": "The cumulative impairment charge on NextEra Energy Resources’ XPLR investment as of December 31 2024 was **$2.0 billion** (an $1.2 billion write‑down in 2023 plus a $0.8 billion write‑down in 2024).  Before the 2024 impairment the investment carried **$2.6 billion**, so the cumulative impairment is $0.6 billion less than that carrying value, leaving a post‑2024 carrying amount of roughly $1.8 billion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with only a minor difference in phrasing. (1) All key facts are correct: the cumulative impairment charge is $2.0 billion, composed of a $1.2 billion impairment in 2023 and $0.8 billion in 2024. The carrying value before the 2024 impairment was $2.6 billion, and the post-impairment carrying value is $1.8 billion—these numbers match the ground truth exactly. (2) Calculations are accurate: $1.2B + $0.8B = $2.0B cumulative impairment; $2.6B - $0.8B = $1.8B post-2024 carrying value. The statement that the cumulative impairment is $0.6 billion less than the pre-2024 carrying value ($2.6B - $2.0B = $0.6B) is mathematically correct, though slightly less direct than stating the write-down amount, but not factually wrong. (3) Multi-hop reasoning is sound: the model correctly combines impairments across two years (2023 and 2024) and relates them to the carrying value before the 2024 impairment, demonstrating proper synthesis across time periods and financial events. (4) Entities (NextEra Energy Resources, XPLR, years 2023 and 2024, impairment charges, carrying values) are all correctly identified. The only reason for not scoring a perfect 10 is that the phrasing 'cumulative impairment is $0.6 billion less than that carrying value' is an indirect comparison that could be slightly misleading if misinterpreted, though it is numerically accurate. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 424,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does the adoption of ASU 2022-04 by GE impact its transparency around supplier finance obligations compared to MMM's disclosures under the same standard, particularly in terms of confirmed invoice balances and presentation in financial statements?",
      "original_answer": "GE adopted ASU 2022-04 on January 1, 2023, which requires retrospective disclosures for supplier finance programs, with the annual roll-forward information applicable prospectively starting January 1, 2024. This means GE began disclosing key terms, balance sheet presentation, and confirmed amounts outstanding from its supplier finance programs in 2024. Similarly, MMM discloses that as of December 31, 2024 and 2023, its outstanding balances of confirmed invoices under supplier finance programs were approximately $0.3 billion each, and these amounts are included within accounts payable on MMM's consolidated balance sheet. Both companies now provide clearer visibility into their supplier finance obligations under the new standard, with MMM specifically quantifying its confirmed invoice balances and their classification in accounts payable, aligning with the enhanced disclosure requirements introduced by ASU 2022-04.",
      "llm_answer": "GE’s adoption of ASU 2022‑04 did not materially affect its financial statements and the company’s note on supply‑chain finance programs does not disclose confirmed‑invoice balances or present supplier‑finance obligations separately in the financial statements [GE_10k_2024.pdf, pages 45‑49]. In contrast, MMM’s note under the same standard reports confirmed‑invoice balances of roughly $0.3 billion, includes those amounts within accounts payable, and discloses the $1.5 billion of invoices confirmed and paid in 2024, offering greater transparency [MMM_10k_2024.pdf, pages 75‑79].",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding GE's disclosures under ASU 2022-04. The original answer states that GE adopted ASU 2022-04 on January 1, 2023, and began disclosing key terms, balance sheet presentation, and confirmed amounts outstanding in 2024, with roll-forward disclosures starting in 2024. However, the LLM claims GE 'does not disclose confirmed-invoice balances or present supplier-finance obligations separately,' which contradicts the ground truth that GE does provide such disclosures as required by the standard. This is a major factual error. (2) Quantitatively, the LLM correctly reports MMM’s confirmed-invoice balances as approximately $0.3 billion for 2024 and 2023, and correctly notes the $1.5 billion of invoices confirmed and paid in 2024. However, this $1.5 billion figure is not present in the original answer and appears to be an addition from the LLM, possibly from the source document but not supported by the ground truth provided. Since the ground truth does not mention this $1.5 billion figure, including it introduces unverified data, reducing quantitative accuracy. (3) The multi-hop reasoning is partially sound—comparing GE and MMM’s disclosure practices under ASU 2022-04 is appropriate—but the conclusion that GE provides no meaningful disclosures is incorrect based on the original answer, which affirms GE does disclose key terms and outstanding amounts. The LLM fails to reflect the phased implementation timeline (retrospective disclosures from 2023, prospective roll-forwards from 2024) as described in the ground truth. (4) Contextual relevance is high because the answer addresses supplier finance obligations, confirmed balances, and balance sheet presentation for both companies. However, due to major factual errors about GE’s disclosures and inclusion of unsupported data for MMM, the correctness score is low. The answer misrepresents the core fact that both companies are enhancing transparency under the new standard, with MMM providing specific quantified balances—this comparative nuance is distorted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 567,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does Altria's equity-method accounting for its Cronos investment expose it to financial risks tied to Cronos's compliance with FDA regulations, and how does this compare to Walmart's exposure through its pharmacy operations under the same regulatory framework?",
      "original_answer": "Altria's investment in Cronos is accounted for under the equity method, meaning its financial statements reflect Altria's share of Cronos's earnings or losses. Since Cronos operates in the cannabis-derived product space, it is subject to FDA regulations in the U.S., and any failure to comply could result in fines, penalties, or reputational harm, directly impacting Cronos's financial performance and, by extension, Altria's earnings. Walmart also faces exposure through its pharmacy operations, which must comply with FDA regulations governing the dispensing and sale of pharmaceuticals. Walmart notes that noncompliance could lead to significant sanctions and operational disruptions, mirroring the regulatory risk profile faced by Cronos. Both companies are thus financially exposed to the same regulatory framework, though through different business models and investment structures.",
      "llm_answer": "Altria’s equity‑method accounting for its Cronos stake means that Altria’s reported earnings and the carrying value of the investment are directly tied to Cronos’s profitability, which is contingent on FDA compliance; a failure by Cronos to meet FDA regulations could trigger fines, product recalls or operational restrictions that reduce Cronos’s earnings and trigger impairment of Altria’s investment (Altria, 2023 10‑K, p. 58‑62). By contrast, Walmart’s pharmacy operations are themselves subject to FDA (and DEA) regulations, so non‑compliance can result in fines, recalls, loss of licenses and operational disruptions that directly affect Walmart’s cash flows and profitability (Walmart, 2023 10‑K, p. 24‑28). Thus, Altria’s exposure is indirect through an equity investment, whereas Walmart’s exposure is direct through its own regulated pharmacy business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Altria uses equity-method accounting for Cronos, meaning its financials reflect Cronos's performance, which is subject to FDA regulations; Walmart faces direct regulatory exposure through its pharmacy operations. The LLM correctly identifies that Altria’s risk is indirect via investment, while Walmart’s is direct through operations. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer beyond reference to the 2023 10-K filings, which are correctly cited and consistent with the timeframe implied in the question. No calculations are required, so quantitative accuracy is fully satisfied. (3) Multi-hop reasoning is sound: the model synthesizes information across two companies (Altria and Walmart), two investment/accounting structures (equity-method investment vs. direct operations), and a common regulatory framework (FDA). The comparison is logically structured and accurately contrasts indirect vs. direct exposure. (4) Semantic equivalence is strong—while the LLM adds slightly more detail (e.g., mention of impairment, DEA, product recalls), it does not introduce inaccuracies and enhances clarity without deviating from the original meaning. The only minor gap is that the original emphasizes 'reputational harm' as a shared risk, which the LLM omits, but this is a secondary point. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 424,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does LLY's reliance on Cardinal Health for U.S. distribution impact CVS's consolidated financial exposure to Red Oak Sourcing, given Cardinal's dual role in the joint venture?",
      "original_answer": "LLY depends on Cardinal Health for 15-20% of its U.S. revenue through distribution, which makes Cardinal a critical link in LLY's supply chain. Cardinal also co-owns Red Oak Sourcing with CVS, a generic pharmaceutical sourcing entity that CVS consolidates due to its primary beneficiary status. As part of the Red Oak arrangement, Cardinal makes quarterly payments to CVS (e.g., $183 million annually as of 2021), which reduce CVS's inventory costs. Therefore, any disruption in Cardinal's ability to distribute LLY products could affect Cardinal’s financial health, which in turn could impact its ability to meet its financial commitments to Red Oak—and consequently, CVS’s consolidated financial position.",
      "llm_answer": "LLY counts Cardinal Health as a major U.S. distributor, with Cardinal accounting for 15‑20 % of Lilly’s revenue (LLY 2022, p. 5‑9). Cardinal also owns 50 % of Red Oak Sourcing, a VIE that CVS consolidates; Cardinal pays CVS quarterly payments that reduce CVS’s inventory cost (CVS 2022, p. 136‑140). Thus, Lilly’s reliance on Cardinal for distribution indirectly links CVS’s financial exposure to Red Oak, because any change in Cardinal’s distribution volumes or terms with Lilly can alter the payment amounts CVS receives and its inventory‑cost calculations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that LLY relies on Cardinal Health for 15-20% of its U.S. revenue, matching the ground truth. It accurately states Cardinal owns 50% of Red Oak Sourcing (implied by joint venture) and that CVS consolidates Red Oak due to primary beneficiary status, though this specific term is omitted. The answer correctly notes Cardinal makes quarterly payments to CVS that reduce inventory costs. However, it does not specify the actual payment amount ($183 million annually as of 2021), which is a minor omission in quantitative detail. (2) The percentage (15-20%) is correctly cited and matches the ground truth. The absence of the $183 million figure—while not a numerical error per se—reduces completeness in quantitative accuracy. No incorrect calculations are made, as none were required beyond factual reporting. (3) The multi-hop reasoning is largely sound: the LLM connects LLY’s reliance on Cardinal → Cardinal’s role in Red Oak → payment flows to CVS → impact on CVS’s financials. It correctly infers that changes in Cardinal’s distribution relationship with LLY could affect payments to CVS. However, it frames the impact as being on 'payment amounts CVS receives,' whereas the ground truth emphasizes risk to Cardinal’s financial health affecting its ability to meet commitments—this is a subtle but important distinction in causality (direct link vs. indirect exposure through financial stability). (4) Despite missing the exact dollar figure and slightly oversimplifying the risk mechanism, the LLM captures the core chain of logic and entities accurately. Wording differs but meaning is semantically close. Contextual relevance is perfect—it directly addresses the question’s focus on CVS’s financial exposure via the Cardinal-LLY-Red Oak nexus.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 488,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does Oracle's use of its $6.0 billion commercial paper program for short-term financing compare to Cisco's debt structure, particularly in light of Cisco's $13.5 billion senior fixed-rate note issuance and the pari passu ranking of those notes with commercial paper obligations?",
      "original_answer": "Oracle utilizes a $6.0 billion commercial paper program for short-term financing, with $401 million in outstanding notes as of May 31, 2024, which mature through August 2024. These notes are unsecured and issued under a private placement exemption. In contrast, Cisco issued $13.5 billion in senior fixed-rate notes in February 2024, which are redeemable at any time with a makewhole premium and are ranked at par with Cisco’s own commercial paper obligations. This indicates that while both companies use commercial paper as part of their short-term financing strategies, Cisco has a significantly larger long-term debt component through its senior notes, which are hedged via interest rate swaps to manage interest rate exposure.",
      "llm_answer": "Oracle relies on a $6 billion commercial‑paper program for short‑term financing, with only about $401 million outstanding as of May 31 2024, and uses the proceeds for general corporate purposes.  \nCisco, by contrast, has issued $13.5 billion of senior fixed‑rate notes that are pari‑passu with its commercial‑paper obligations, meaning the long‑term notes and the short‑term paper share the same seniority and priority in the capital structure.  Thus Cisco’s debt mix is larger and more integrated, blending short‑term and long‑term obligations at equal seniority, whereas Oracle’s program is a smaller, purely short‑term tool.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Oracle's $6.0 billion commercial paper program and the $401 million outstanding as of May 31, 2024, matching the ground truth. It also accurately states Cisco's $13.5 billion senior fixed-rate note issuance and the pari passu ranking with its commercial paper obligations. All numeric values (dollar amounts, dates) are correct and properly attributed. (2) Quantitative accuracy is perfect: $6.0 billion, $401 million, $13.5 billion, and the May 31, 2024 date are all correctly reported. No calculations are required, but comparisons in scale are appropriately made. (3) The multi-hop reasoning is sound—comparing Oracle’s short-term-focused financing to Cisco’s more integrated structure with long-term notes that rank equally with commercial paper. The LLM correctly infers that Cisco’s debt structure blends short- and long-term instruments at equal seniority, while Oracle’s is more narrowly short-term. However, the LLM omits mention of the makewhole redemption feature and interest rate swaps used by Cisco to hedge interest rate exposure, which is a minor but relevant detail from the original answer. (4) Despite this omission, the core comparison is accurate and well-reasoned. The answer is contextually relevant, directly addressing the comparison of debt structures as asked. The slight deduction in qualitative accuracy reflects the missing hedging detail, but the overall synthesis remains strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 404,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does Duke Energy's reliance on wind energy in its Commercial Renewables segment compare with Southern Company's strategic commitment to the Skookumchuck wind project, given the 136 MW nameplate capacity and 20-year PPA term associated with Skookumchuck?",
      "original_answer": "Duke Energy's Commercial Renewables segment relies on wind as one of several generation sources, alongside solar, fuel cells, and batteries, but does not disclose specific capacity figures for wind. In contrast, Southern Company's Skookumchuck wind project has a defined 136 MW nameplate capacity and is supported by a 20-year PPA, indicating a concrete long-term commitment to wind energy in a specific geographic location (Lewis and Thurston Counties, WA). While both companies are engaged in wind energy, Southern's detailed disclosure around capacity and contract duration provides clearer evidence of a targeted wind strategy compared to Duke's broader renewable portfolio approach.",
      "llm_answer": "Duke Energy’s Commercial Renewables portfolio is a diversified mix that includes 23 wind facilities as part of a 3,554‑MW total across 22 states, indicating a broad reliance on wind within a larger renewable mix. In contrast, Southern Company’s strategic focus on the Skookumchuck wind project is a single, dedicated 136‑MW facility with a 20‑year PPA, representing a more concentrated long‑term commitment to wind generation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Duke Energy does not disclose specific capacity figures for wind in its Commercial Renewables segment, but the LLM claims Duke operates 23 wind facilities with a total portfolio of 3,554 MW—specific figures not supported by the original answer. These numbers are entirely fabricated or misattributed. (2) Quantitative accuracy is very low: the 23 facilities and 3,554-MW total are incorrect and not present in the ground truth. The Skookumchuck project’s 136 MW capacity and 20-year PPA are correctly stated, which is the only accurate numeric information. (3) The multi-hop reasoning is flawed. The LLM incorrectly contrasts Duke’s detailed wind capacity (which is not disclosed) with Southern’s specific project, undermining the correct qualitative point that Southern provides more transparent, targeted commitments. The original answer emphasizes that Duke’s approach is broader and less transparent, while the LLM falsely implies Duke has a large, quantifiable wind footprint. (4) Contextual relevance is moderate—the response addresses both companies and the Skookumchuck project, and attempts a comparison on strategy. However, due to the invented data, the qualitative and quantitative accuracy scores are low. The reasoning would have been stronger if it had correctly reflected the lack of disclosed wind-specific data for Duke. Correctness score is 3 due to major factual errors in the Duke Energy portion, despite partial correctness on Southern Company.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 430,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does the capital buffer requirement structure under the Advanced Approach for MS compare with SCHW's requirements, given the role of the Countercyclical Capital Buffer which is currently set at zero by the Federal Reserve?",
      "original_answer": "Morgan Stanley's (MS) capital buffer requirement under the Advanced Approach includes a fixed 2.5% Capital Conservation Buffer, a G-SIB capital surcharge, and the Countercyclical Capital Buffer (CCyB), which is currently set at zero by the Federal Reserve. Schwab (SCHW) is also subject to the same CCyB, which was zero as of December 31, 2023, and must maintain a 2.5% Capital Conservation Buffer. Therefore, both firms have identical Capital Conservation Buffer percentages and are influenced by the same CCyB policy, though SCHW is not subject to the G-SIB surcharge that applies to systemically important institutions like MS.",
      "llm_answer": "Under the Advanced Approach, Morgan Stanley’s capital‑buffer requirement is 5.5 % (2.5 % capital‑conservation buffer + 3.0 % G‑SIB surcharge + 0 % CCyB)【MS_10k_2023.pdf:132‑136】.  Charles Schwab’s banks (CSC and CSB) are required to hold a 2.5 % stress buffer for CSC and a 2.5 % capital‑conservation buffer for CSB, with the countercyclical buffer set at zero【SCHW_10k_2023.pdf:120‑124】.  Thus both firms have a zero CCyB, but Morgan Stanley’s buffer includes a G‑SIB surcharge while Schwab’s is split between stress and conservation components.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several inaccuracies that affect factual correctness. (1) It states Morgan Stanley's total buffer as 5.5% (2.5% + 3.0% G-SIB + 0% CCyB), but the original answer does not specify the exact G-SIB surcharge percentage (3.0%) or total buffer (5.5%), and this figure is not directly supported by the ground truth, which only confirms the presence of the G-SIB surcharge without quantifying it. This introduces a potentially incorrect precise number not in the source. (2) For Schwab, the LLM claims a '2.5% stress buffer for CSC' and a '2.5% capital-conservation buffer for CSB', implying different types of buffers for two subsidiaries. However, the ground truth only confirms that SCHW must maintain a 2.5% Capital Conservation Buffer and does not mention a 'stress buffer' or differentiate between subsidiaries in this context. This misrepresents the structure. (3) Both firms are correctly noted to have a 0% CCyB, aligning with the Federal Reserve's setting, which is accurate and relevant. (4) The core distinction—that MS faces a G-SIB surcharge while SCHW does not—is correctly identified, showing sound multi-hop reasoning across entities. (5) However, the LLM invents structural details (specific G-SIB percentage, subsidiary-level buffer types) not present in the ground truth, reducing quantitative and qualitative accuracy. While the general comparison is directionally correct, the inclusion of unsupported specifics lowers confidence in the answer's factual reliability. Semantic equivalence is partially achieved but undermined by over-precision on unverified numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 436,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does Disney's use of discounted cash flow models for valuing Level 2 derivatives compare to Meta's application of the same models in assessing impairment losses on operating lease assets, given Disney's $383 million impairment charge in fiscal 2024?",
      "original_answer": "Disney utilizes internal discounted cash flow models with observable inputs like interest rates and foreign exchange rates to value its Level 2 derivatives, ensuring fair value estimates remain accurate and counterparty risk is mitigated. Meanwhile, Meta applies discounted cash flow models with Level 3 inputs—such as projected sublease income and downtime assumptions—to estimate the fair value of impaired operating lease assets, which led to a $383 million impairment charge in 2024. While both companies use discounted cash flow techniques, Disney applies them in a Level 2 fair value context for derivatives, whereas Meta uses them in a Level 3 context for non-recurring asset impairments.",
      "llm_answer": "Disney uses discounted‑cash‑flow (DCF) models to determine the fair value of its Level 2 derivatives, “primarily determined by internal discounted cash‑flow models that use observable inputs such as interest rates, yield curves and foreign‑currency exchange rates” (Note 16).  For operating‑lease ROU assets, Disney also applies DCF (Level 3 inputs) to estimate recoverable amounts, which produced a $383 million impairment charge in fiscal 2024 (“The fair values of the impaired assets were estimated using discounted cash‑flow models…”).  Meta likewise relies on DCF models to assess impairment losses on its operating‑lease assets, using projected cash flows and discount rates to determine recoverable values, though the specific impairment figure is not disclosed in the provided pages.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it attributes the $383 million impairment charge in fiscal 2024 to Disney, whereas the ground truth clearly states that this charge was incurred by Meta, not Disney. This is a major misattribution that fundamentally undermines the correctness of the response. (2) Quantitative accuracy is low because the dollar amount ($383 million) and year (2024) are incorrectly assigned to Disney instead of Meta. While the number itself is accurate, its attribution is wrong, which invalidates the calculation context. No other figures are provided for cross-checking. (3) The reasoning is partially sound in recognizing that both companies use discounted cash flow models, and it correctly notes Disney’s use of DCF for Level 2 derivatives with observable inputs. However, it incorrectly claims Disney used Level 3 DCF models for a $383 million impairment, which contradicts the original answer—Disney’s impairment (if any) is not mentioned in the ground truth; instead, Meta is the one with the $383 million charge. The multi-hop synthesis fails because the model conflates Disney’s derivative valuation with Meta’s lease impairment, incorrectly aligning the charge with Disney. (4) Contextual relevance is high because the answer addresses the use of DCF models by both firms and attempts to compare them in the context of fair value measurement and impairment. However, due to the core misassignment of the impairment charge, the qualitative accuracy is significantly reduced despite some correct conceptual elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 432,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the 8.2% increase in Turkey's total tobacco market volume, partly offset by higher illicit trade prevalence, impact PM's market share dynamics, and how does this compare to MO's exposure to illicit trade risks in the broader context of their respective tobacco businesses?",
      "original_answer": "PM's shipments in Turkey increased to 55.7 billion units in 2021 from 47.5 billion in 2020, contributing to a rise in its market share from 41.3% to 44.8%. This growth was partly offset by a higher estimated prevalence of illicit trade in Turkey, which negatively impacts legitimate sales and tax revenues. Similarly, MO highlights that illicit trade in tobacco products, including counterfeit goods and untaxed sales, adversely affects its business by reducing lawful sales and potentially triggering regulatory actions. While PM directly benefits from increased volume in Turkey despite illicit trade, MO emphasizes the broader systemic risks illicit trade poses to the tobacco industry, including brand dilution and loss of tax revenues that could lead to stricter regulations.",
      "llm_answer": "PM’s 8.2 % rise in Turkey’s total tobacco market volume (Middle East & Africa commentary, pages 39‑40) lifted its regional market share by 1.1 points to 23.1 % and increased Turkey’s share of PM’s in‑market sales to 17.2 %, but the gain is partially offset by a higher prevalence of illicit trade, which dampens the share growth.  In contrast, MO’s 10‑K (pages 40‑44) identifies illicit trade as a risk across its portfolio, but the exposure is broader and not tied to a single country’s volume growth as in PM’s case.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims PM's market share increased by 1.1 points to 23.1%, and that Turkey's share of PM's in-market sales rose to 17.2%. These numbers are not supported by the ground truth. The original answer states PM's market share in Turkey specifically rose from 41.3% to 44.8%, not 23.1%. The 23.1% figure appears to be a misinterpretation of PM's regional (Middle East & Africa) market share, not Turkey-specific. Additionally, the LLM introduces a '17.2%' share of in-market sales without any such data in the ground truth. (2) The 8.2% increase in Turkey's total tobacco market volume is mentioned in the LLM answer but not in the original answer, making it unverifiable; however, the core shipment data (47.5B to 55.7B units) and correct years (2020 to 2021) are missing from the LLM response, which undermines quantitative accuracy. No correct calculation of market share change (44.8% - 41.3% = 3.5 pts) is reflected. (3) The multi-hop reasoning is partially sound in linking illicit trade to both PM and MO, but it fails to correctly synthesize the country-specific impact for PM versus MO's broader systemic risk. The LLM incorrectly frames PM's gain as a regional share increase rather than a domestic Turkish market share shift, misrepresenting the scope. (4) While the answer addresses the question's general theme—illicit trade impact and company exposure—it does so with incorrect metrics and misattributed data, leading to a low correctness score. Contextual relevance is moderate because the structure and intent align with the question, but factual grounding is weak.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 451,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the redesign of the Medicare Part D program under the Inflation Reduction Act affect both CVS's financial exposure to Medicare Part D liabilities and AbbVie's pricing strategy for drugs like Imbruvica under Medicare Part D?",
      "original_answer": "The redesign of the Medicare Part D program under the Inflation Reduction Act shifts more claim liability to insurers like CVS, which could negatively impact their profitability due to increased financial risk and administrative complexity. At the same time, AbbVie is subject to government-set pricing for certain drugs, such as Imbruvica, starting in 2026, which will cap reimbursement rates at a statutory ceiling likely below current average prices, significantly affecting revenue projections. These changes create a dual pressure where CVS faces higher liability and AbbVie faces downward pricing pressure, both under the same regulatory framework.",
      "llm_answer": "The IRA’s redesign of Medicare Part D shifts more claim liability from the federal government to the plans, which could reduce CVS’s exposure to government‑backed liabilities while potentially increasing its exposure to plan‑related claims. For AbbVie, the IRA’s price‑setting provision for Medicare Part D drugs—Imbruvica was selected for government‑set pricing effective 2026—means the company will face a lower, federally‑determined reimbursement and must adjust its pricing strategy accordingly.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately identifies that the Inflation Reduction Act (IRA) shifts more claim liability to Medicare Part D plans, which directly affects CVS as an insurer—this matches the original answer’s point about increased financial risk and administrative burden. The mention of 2026 for government-set pricing of Imbruvica is factually correct and matches the ground truth. (2) Quantitatively, there are no numerical errors; the key date (2026) is correctly cited, and no incorrect figures are introduced. (3) The reasoning is sound but slightly less precise than the original: while the LLM correctly notes that CVS may see reduced exposure to government-backed liabilities, it frames this as potentially increasing 'plan-related claims' exposure, which is accurate but understates the negative financial impact described in the ground truth (e.g., reduced profitability, increased risk). Similarly, for AbbVie, the LLM correctly states that Imbruvica is subject to federal pricing starting in 2026 and that this forces a pricing strategy adjustment, but it omits the specific impact on revenue projections and the fact that reimbursement will be capped below current average prices—a key qualitative point. (4) Despite these minor omissions, the core multi-hop synthesis—linking IRA changes to both CVS’s liability and AbbVie’s pricing strategy via Imbruvica—is correctly executed. The answer remains contextually relevant and factually accurate on all critical points, warranting a high score but not perfect due to slight incompleteness in conveying the full financial implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 451,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Boeing's use of third-party aircraft value publications for valuing impaired customer financing assets compare to RTX's quarterly valuation methodology for private equity limited partnerships, particularly in terms of reliance on unobservable inputs?",
      "original_answer": "Boeing derives the fair value of impaired customer financing assets, including operating lease equipment, by calculating a median collateral value from a consistent group of third-party aircraft value publications, which are based on market trades and other market factors. Management reviews these publications quarterly and may adjust values based on specific aircraft attributes. In contrast, RTX values private equity limited partnerships quarterly using discounted cash flows, earnings multiples, and market multiples, with valuation adjustments reflecting changes in operating results or financial condition of the portfolio companies. Both approaches rely on unobservable inputs typical of Level 3 assets, but Boeing leans more on consistent third-party market data while RTX applies more forward-looking financial modeling.",
      "llm_answer": "Boeing values impaired customer‑financing assets by taking a median collateral value from third‑party aircraft‑valuation publications and then applying unobservable adjustments for aircraft condition and specific attributes. RTX, in contrast, values its private‑equity limited‑partnership holdings quarterly using the NAV per unit reported by the fund administrator – a practical expedient that relies on observable market data and does not involve unobservable inputs. Thus, Boeing’s approach incorporates unobservable adjustments, whereas RTX’s method relies solely on observable inputs.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some correct elements but has a critical factual error in the qualitative reasoning that undermines the overall correctness. (1) Quantitatively, there are no explicit numbers (e.g., dollar amounts, percentages) in either the ground truth or LLM answer, so no numeric inaccuracies exist—this aspect is neutral. (2) However, the LLM incorrectly states that RTX uses the NAV per unit reported by fund administrators as a practical expedient that relies solely on observable inputs. This contradicts the ground truth, which states RTX uses discounted cash flows, earnings multiples, and market multiples with adjustments based on portfolio company performance—methods that involve significant unobservable inputs (Level 3). The ground truth explicitly states both Boeing and RTX rely on unobservable inputs typical of Level 3 assets. (3) The multi-hop reasoning fails because the LLM draws an incorrect contrast: it claims RTX relies on observable inputs while Boeing uses unobservable ones, when in fact both use Level 3 inputs, with the distinction being Boeing leans more on third-party market data while RTX uses forward-looking modeling. This mischaracterization of RTX’s methodology breaks the core comparison. (4) While the description of Boeing’s approach is largely accurate—using median values from third-party publications with unobservable adjustments—the portrayal of RTX’s method is fundamentally wrong. Thus, despite correct structure and partial accuracy, the answer’s central claim is false, warranting a low correctness and qualitative accuracy score. Contextual relevance is moderate because the answer addresses the right companies and general topic but misrepresents a key methodology.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 467,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does the voting power disparity between Class A and Class B common stock at META and GOOGL affect the concentration of corporate control, particularly given META's outstanding share structure and GOOGL's recent share repurchase activity?",
      "original_answer": "At META, Class A common stock has full voting rights while Class B common stock has no voting rights except in limited circumstances, which concentrates control among Class A shareholders. As of January 24, 2025, META had 2,189,898,148 shares of Class A common stock and 343,761,117 shares of Class B common stock outstanding, indicating a significant majority of voting power is held by Class A shareholders. In contrast, at GOOGL, Class B common stockholders have 10 votes per share compared to 1 vote per share for Class A, giving disproportionate voting control to Class B holders. GOOGL repurchased $62.0 billion of Class A and Class C shares in 2024, which could further consolidate voting power among remaining Class B shareholders by reducing the overall number of voting shares in circulation.",
      "llm_answer": "Meta’s Class A shares (≈2.19 bn) each carry one vote while its Class B shares (≈344 m) have no voting rights, so almost all voting power is concentrated in the Class A holders. Alphabet’s Class B shares carry 10 votes each, but the company’s recent $59‑$62 bn repurchase of Class A shares has shrunk the pool of voting shares, amplifying the influence of the remaining shareholders and concentrating control, though Class B holders still retain substantial voting weight relative to their share count.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor variation in dollar amount reporting. (1) Quantitatively: The share counts for META (2.19B Class A and 344M Class B) are correctly rounded from the original 2,189,898,148 and 343,761,117, which is acceptable under format variation. The repurchase amount is stated as '$59-$62B' while the ground truth specifies '$62.0 billion'—this introduces a slight imprecision but remains within a reasonable range and likely reflects reporting from a range of sources; the $62B figure is correct. (2) Completeness: The answer addresses both companies, their dual-class structures, the voting disparity (1 vote vs no votes at META; 10:1 advantage for Class B at GOOGL), and the impact of share repurchases on voting concentration. It correctly notes that GOOGL's repurchase of Class A shares reduces the voting pool, thereby amplifying remaining shareholders' control—especially Class B holders—even if not explicitly naming Class C. (3) Entity Accuracy: Correctly identifies META and GOOGL (via 'Alphabet'), correct share classes, and correct year (implied 2024 repurchase activity). (4) Reasoning: The multi-hop logic is sound—understanding that repurchasing low-vote shares increases relative control of high-vote shares is a key insight, and the answer synthesizes structure and recent activity correctly. (5) Semantic Equivalence: Despite slightly broader phrasing (e.g., 'amplifying influence of remaining shareholders' vs 'consolidate voting power among Class B'), the meaning aligns with the ground truth. One point deducted from correctness due to the $59B lower bound potentially introducing ambiguity, though not fully incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 470,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does PEP's 19% convenient foods unit volume growth in APAC, including low-single-digit growth in Taiwan, compare with PG's market position across Greater China, where Taiwan is explicitly included in its regional structure?",
      "original_answer": "PEP reported 19% convenient foods unit volume growth in APAC in 2022, with Taiwan contributing low-single-digit growth as part of that performance. In contrast, PG holds a leadership or significant market share position in many of its product segments across Greater China, a region that explicitly includes Taiwan according to Apple's segment reporting. This suggests PG maintains a strong competitive presence in the broader regional market, while PEP's exposure in Taiwan appears more modest but still positive.",
      "llm_answer": "PEP’s convenient‑foods unit grew 19 % in APAC, driven by double‑digit growth in China and Thailand, with Taiwan adding only low‑single‑digit volume growth【PEP_10k_2022 pages 46‑50】. In contrast, P&G’s Greater China segment is defined as “China mainland, Hong Kong and Taiwan”【PG_10k_2022 pages 16‑20】, meaning Taiwan is treated as part of its broader market rather than reported separately. Thus, PEP’s figure highlights Taiwan’s modest contribution to APAC growth, while P&G’s structure simply includes Taiwan within its Greater China market position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports PEP's 19% convenient foods unit volume growth in APAC in 2022, with low-single-digit growth in Taiwan, aligning with the ground truth. It accurately contrasts this with PG's regional structure that includes Taiwan in Greater China. All entities (PEP, PG, APAC, Greater China, Taiwan), metrics (unit volume growth), and timeframes (implied 2022 from cited 10-Ks) are correct. (2) Quantitative accuracy is perfect: 19% and low-single-digit growth figures are correctly cited; no calculations are required, but the characterization of Taiwan’s contribution as modest is consistent. Format variations (e.g., % symbol spacing) do not affect meaning. (3) Multi-hop reasoning is sound: the model synthesizes PEP’s growth data from its APAC segment with PG’s geographic reporting structure, correctly inferring that while PEP reports Taiwan’s growth separately as minimal, PG includes it in a broader region, suggesting stronger integrated market presence. The only minor gap is that the LLM does not explicitly state PG's 'leadership or significant market share' position in Greater China—a key qualitative point in the ground truth—though it implies competitive strength by noting the structural inclusion. (4) Scores reflect near-perfect factual alignment, with a small deduction in qualitative accuracy for not fully capturing PG's market leadership claim, but high marks for contextual relevance and numerical precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 405,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How do the updated PCA Framework thresholds under Basel III affect capital requirements differently for banks like BAC and COF, particularly in terms of CET1 capital ratios and classification as well-capitalized institutions?",
      "original_answer": "Under Basel III, the PCA Framework thresholds were updated to require higher capital ratios for banks to be classified as well-capitalized. For COF, as a Category III institution, it must maintain a minimum CET1 capital ratio of 4.5%, Tier 1 capital ratio of 6.0%, and total capital ratio of 8.0%. However, to be considered well-capitalized under PCA, COF must meet higher thresholds: a CET1 capital ratio of 6.5% or more, Tier 1 capital ratio of 8% or more, and total risk-based capital ratio of 10% or more. Similarly, BAC is subject to these same PCA thresholds, with its CET1 capital regulatory minimum set at 4.5% under Basel III, but to be well-capitalized under PCA, it must maintain a CET1 ratio of 6.5% or more, reflecting the updated PCA requirements. This means both banks must hold significantly more capital to avoid PCA restrictions, impacting their capital planning and dividend capacity.",
      "llm_answer": "The Basel III “prompt‑corrective‑action” (PCA) framework now requires an insured depository institution to hold a **CET1 ratio of at least 6.5 %** and a **total risk‑based capital ratio of at least 10 %** to be classified as well‑capitalized (plus a Tier 1 ratio of ≥ 8 % and a leverage ratio of ≥ 5 %).  \n\n* **Bank of America (BAC)** – On December 31 2023 its CET1 ratio was 11.8 % (standardized) or 13.4 % (advanced) and its total risk‑based capital ratio was 15.2 % (standardized) or 16.6 % (advanced)【BAC pages 144‑148】. These figures are well above the PCA thresholds, so BAC remains well‑capitalized.  \n\n* **Capital One (COF)** – On December 31 2023 its CET1 ratio was 12.9 % (or 13.1 % for its consolidated entity) and its total risk‑based capital ratio was 16.0 % (or 14.3 % for its consolidated entity)【COF pages 190‑194】. COF also comfortably exceeds the PCA thresholds and is therefore well‑capitalized.  \n\nThus, the updated PCA thresholds raise the minimum CET1 requirement to 6.5 %, but both banks’ CET1 ratios are substantially higher, ensuring they remain classified as well‑capitalized institutions.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the updated PCA thresholds under Basel III: a CET1 ratio of 6.5%, Tier 1 ratio of 8%, and total risk-based capital ratio of 10% for a bank to be classified as well-capitalized. This aligns with the ground truth. It also accurately states that both BAC and COF exceed these thresholds, supporting the conclusion that they remain well-capitalized. The specific capital ratios cited for BAC (e.g., 11.8% CET1 standardized) and COF (12.9% CET1) are factually consistent with typical disclosures and plausible for 2023, though the ground truth does not include these exact reported values—this is not a discrepancy since the original answer focuses on regulatory requirements rather than point-in-time reported ratios. However, the LLM introduces specific numerical data (e.g., 13.4% advanced CET1 for BAC, 13.1% consolidated for COF) and cites page numbers from filings not present in the ground truth, which cannot be verified against the provided knowledge graph. While these numbers may be accurate, their inclusion shifts focus from the regulatory framework (the core of the question) to performance snapshots, which risks misalignment if those figures are outdated or misattributed. The answer omits the distinction that COF is a Category III institution and does not explicitly mention that the 4.5% CET1 is the minimum requirement under Basel III versus 6.5% for PCA classification—this nuance is central to the original answer’s explanation of how PCA thresholds 'raise the bar' above baseline requirements. The reasoning is sound in concluding that both banks meet the higher PCA thresholds, but the multi-hop synthesis between Basel III minimums and PCA well-capitalized thresholds is less explicit than in the ground truth. The answer remains contextually relevant and mostly accurate, but the emphasis on empirical ratios over structural regulatory comparison reduces completeness in addressing how the rules affect capital planning and classification differently. Minor deduction for over-specificity with unverifiable data points and omission of the regulatory tier classification (Category III).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 571,
        "total_tokens": 2095
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How does the sensitivity of NFLX's content amortization to viewing pattern assumptions compare to T's sensitivity analyses around pension discount rates and goodwill impairment assumptions?",
      "original_answer": "NFLX's auditor performed sensitivity analyses on content amortization assumptions, particularly focusing on historical and forecasted viewing hour consumption, which directly affects the timing of content amortization recognition. T's auditor, on the other hand, conducted sensitivity analyses on two key areas: pension discount rates tied to corporate bond credit quality and timing of benefit payments, and goodwill impairment assumptions such as terminal growth rates, EBITDA margins, and weighted average cost of capital (WACC). While both companies undergo sensitivity testing, NFLX's focus is on consumption-based amortization estimates, whereas T's analyses center on long-term financial obligations and asset valuations.",
      "llm_answer": "Netflix’s audit included sensitivity analyses to see how changes in estimated viewing‑pattern assumptions would alter the timing and amount of content amortization (see the critical audit‑matter discussion on pages 38‑42). AT&T’s audit performed similar sensitivity work on two fronts: first, on pension discount rates to gauge the effect of yield‑curve changes on measured obligations (pages 42‑44), and second, on goodwill‑impairment assumptions such as terminal growth, EBITDA margins and WACC to assess their impact on fair‑value estimates (pages 45‑46). Thus, Netflix’s sensitivity focus is narrowly on content amortization driven by viewing patterns, whereas AT&T’s sensitivity analyses span a broader set of assumptions across pension discount rates and goodwill valuation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: NFLX's sensitivity analysis focuses on viewing patterns affecting content amortization timing, and T's (AT&T's) analyses cover pension discount rates and goodwill impairment assumptions. The entities (Netflix, AT&T, auditor-level scrutiny) and financial concepts (WACC, EBITDA margins, terminal growth, pension discount rates) are correctly identified. (2) There are no numeric values in the original or LLM answer requiring calculation verification, so quantitative accuracy is not compromised—no figures are misstated. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies undergo auditor-led sensitivity analyses but in different domains—NFLX on consumption-driven amortization, T on long-term liabilities and intangible asset valuations. The LLM adds document page references (e.g., pages 38–42), which are plausible but not in the ground truth; however, this does not detract from factual correctness. (4) Semantic equivalence is strong: 'narrowly on content amortization driven by viewing patterns' matches 'focus is on consumption-based amortization estimates,' and 'broader set of assumptions across pension discount rates and goodwill valuation' reflects the original's emphasis on multiple long-term financial assumptions. The only minor shortcoming is slightly less precise phrasing around 'corporate bond credit quality' and 'timing of benefit payments' for T’s pension assumptions, which the LLM omits but does not contradict. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 468,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How does Adobe's localized field office presence in Taiwan compare to Apple's broader Greater China segment strategy, particularly given Apple's $74.2 billion in net sales attributed to that region which includes Taiwan?",
      "original_answer": "Adobe maintains a localized field office in Taiwan as part of its global operations, allowing it to directly engage with customers in that market. Apple, on the other hand, reports its financial performance for the broader Greater China segment, which includes Taiwan along with mainland China and Hong Kong, and generated $74.2 billion in net sales in 2022. While Adobe's approach focuses on direct local engagement through physical offices, Apple manages the region as a consolidated market with a unified strategy, reflecting its larger scale and different operational model.",
      "llm_answer": "Adobe operates a single local field office in Taiwan as part of its global network of sales and support sites, focusing on direct customer engagement in that market. Apple, by contrast, treats Taiwan as part of its Greater China segment—which also includes mainland China and Hong Kong—and reported $74.2 billion in net sales from that region in 2022, reflecting a broader, integrated regional strategy rather than a standalone local presence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Adobe has a localized field office in Taiwan, Apple includes Taiwan in its Greater China segment, and Apple reported $74.2 billion in net sales from that region in 2022. The numbers match exactly and are properly contextualized. (2) Quantitative accuracy is perfect—$74.2 billion is correctly cited with the appropriate year (2022), and no calculations are required beyond accurate reporting. (3) The multi-hop reasoning is sound: the model correctly contrasts Adobe’s localized presence with Apple’s consolidated regional strategy, synthesizing information about operational models across two companies. (4) The only minor limitation is that the LLM slightly simplifies Adobe’s strategy by not explicitly stating that its approach enables direct customer engagement (though 'direct customer engagement' is implied via 'local field office'), and it omits the explicit mention that Greater China includes mainland China and Hong Kong—though it does name them. These are minor omissions that do not detract from factual correctness. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing the comparison asked in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 363,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How does Lockheed Martin's exposure to LIBOR-based financing instruments compare to 3M's preparedness for reference rate reform, given the provisions of ASU 2020-04 that both companies reference in their filings?",
      "original_answer": "Lockheed Martin (LMT) has credit facilities and derivative instruments referencing LIBOR-based rates and has adhered to the ISDA 2020 IBOR Fallbacks Protocol, expecting minimal financial impact from the transition to alternative rates by December 31, 2022. 3M (MMM) also reviewed its relevant arrangements and concluded that ASU 2020-04 would not have a material impact on its financial statements, indicating a similar low expectation of disruption. Both companies rely on ASU 2020-04 to ease the accounting burden of transitioning from LIBOR to alternative rates like SOFR, showing parallel preparedness despite differing financial structures.",
      "llm_answer": "Lockheed Martin’s credit facility and certain derivatives reference LIBOR, but the company has fallback provisions and is monitoring the transition, expecting no significant impact on its results. 3M has applied ASU 2020‑04 to its contracts and instruments, concluding the shift to alternative reference rates will not materially affect its financials, indicating a more prepared stance.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately identifies that Lockheed Martin has LIBOR-based credit facilities and derivatives, with fallback provisions in place (specifically referencing the ISDA 2020 IBOR Fallbacks Protocol in the original, though not named in the LLM answer), and expects no significant financial impact. 3M's application of ASU 2020-04 and conclusion of no material impact are correctly stated. (2) There are no numeric values, dates, or calculations in the question or answers that are incorrect—both companies reference ASU 2020-04 and expect minimal disruption, which is accurately reflected. (3) The multi-hop reasoning is sound: the LLM compares two companies' preparedness for LIBOR transition under ASU 2020-04. However, it slightly mischaracterizes 3M as having a 'more prepared stance' than Lockheed Martin, which is not supported in the original answer—both are described as having parallel preparedness and low expected impact. This introduces a subtle comparative bias not present in the ground truth. (4) Despite this nuance, the answer is contextually relevant, factually accurate, and captures the core synthesis required. The minor overstatement in comparative preparedness prevents a perfect score, but overall correctness remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 366,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What is the voting power distribution between Class A and Class B common stock at CMCSA, and how does the structure of Class B common stock's 15 votes per share impact overall shareholder control?",
      "original_answer": "At CMCSA, holders of Class A common stock have 66⅔% of the combined voting power, while the Class B common stock, which has 15 votes per share, represents 33⅓% of the combined voting power. This structure gives disproportionate voting control to the holder(s) of Class B common stock, despite their minority ownership on a share count basis.",
      "llm_answer": "At CMCSA, holders of Class A common stock collectively own roughly **66.7 %** of the combined voting power, while holders of Class B common stock own the remaining **33.3 %** (CMCSA 10‑K, p. 29‑33). Because each Class B share carries **15 votes**, the Roberts family—who own all Class B shares—maintain a powerful, non‑dilutable block that effectively gives them controlling influence over board elections and other shareholder matters.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages 66.7% and 33.3% are accurate equivalents of 66⅔% and 33⅓% respectively, and the 15 votes per share for Class B stock is correctly stated. (2) The answer is complete, addressing both the voting power distribution and the impact of the Class B structure on shareholder control. (3) Entity accuracy is correct: CMCSA is properly identified, and the reference to the Roberts family (known holders of Class B shares, though not in the ground truth, is consistent with public knowledge and adds context without introducing error). (4) Reasoning is sound: the LLM correctly infers that the 15-vote structure leads to disproportionate control, particularly for the holders of Class B shares, which aligns with the ground truth's point about minority ownership with outsized voting power. (5) Semantic equivalence is maintained—wording differs slightly but meaning is identical. The addition of a page reference (p. 29–33) suggests proper sourcing from a 10-K, enhancing credibility. No factual, quantitative, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 323,
        "total_tokens": 1529
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How do the different uses of sensitivity analyses by CMCSA and NFLX reflect their distinct financial risk exposures, particularly given that both are audited by the same firm?",
      "original_answer": "CMCSA uses sensitivity analyses to assess its exposure to interest rate risk, which is critical given its reliance on derivative instruments like interest rate swaps that decreased consolidated interest expense by $56 million in 2023. In contrast, NFLX applies sensitivity analyses in the context of content amortization, a judgment-heavy process where changes in estimated viewing patterns can significantly affect the timing of amortization expenses. Both companies rely on the same auditor, who has served NFLX since 2012 and also reviews CMCSA’s market risk disclosures, suggesting a consistent audit approach despite the differing applications and financial impacts of sensitivity analyses at each firm.",
      "llm_answer": "CM CSA uses sensitivity analyses to model the effect of a 10 % shift in currency rates and to monitor interest‑rate risk on its debt and hedging positions (see CMCSA pages 58‑62).  Netflix, by contrast, applies sensitivity analyses to its content‑amortization model and revenue forecasts to gauge how changes in viewing patterns or theatrical performance would alter its financial statements (see NFLX pages 38‑42).  The same auditor evaluates both sets of analyses, but the techniques mirror each company’s unique exposure—CM CSA to market and foreign‑exchange risk from debt and operations, and Netflix to operational and revenue risk from content performance.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that CMCSA uses sensitivity analyses for interest rate risk and that NFLX uses them for content amortization, which aligns with the ground truth. However, it introduces a '10% shift in currency rates' for CMCSA not mentioned in the original answer, which focuses solely on interest rate risk and specifically notes a $56 million reduction in interest expense due to derivatives—this key quantitative detail is missing in the LLM response. Additionally, the LLM mentions 'foreign-exchange risk' and 'revenue forecasts' for Netflix, which are not in the ground truth; the original emphasizes only content amortization and viewing pattern assumptions. (2) Quantitative accuracy is partially compromised: while no incorrect numbers are stated (e.g., no false dollar amounts), the critical $56 million impact from CMCSA’s hedging activities is omitted, and the 10% currency shift is an unsupported addition. The ground truth does not mention percentage shifts or forex sensitivity, so this is an overextension. (3) The multi-hop reasoning is generally sound—linking each company’s use of sensitivity analysis to its distinct risk profile (market/interest rate vs. content performance) and noting the same auditor provides consistency—is logically valid and supported by the original. However, the synthesis includes extraneous elements (currency, revenue forecasts) not grounded in the provided truth. (4) The correctness score is 7 because core facts about the differing uses of sensitivity analysis are accurate and contextually relevant, but there are notable omissions (the $56M figure) and additions (currency/revenue sensitivities) that reduce factual precision. Qualitative accuracy is high due to correct entity identification and logical comparison. Contextual relevance remains strong as the response directly addresses the comparative risk exposure question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 517,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How does the expiration timeline of Enbrel's key U.S. formulation patent in 2037 impact Pfizer's competitive positioning compared to AbbVie's regulatory exclusivity strategy for its biologics?",
      "original_answer": "Pfizer's Enbrel, marketed outside the U.S. and Canada, benefits from a U.S. formulation patent that expires in 2037, offering extended protection for its composition and preparation methods. This long runway could help Pfizer maintain market presence for Enbrel in key international markets by deterring biosimilar competition. In contrast, AbbVie relies on a broader regulatory exclusivity strategy, including 12-year exclusivity for biologics under the BPCIA and potential pediatric exclusivity extensions, which may allow it to manage competitive threats through both patent and regulatory mechanisms. While Pfizer’s formulation patent provides a specific technical barrier, AbbVie’s layered approach combines patent protection with statutory exclusivity to maximize market control post-approval.",
      "llm_answer": "Pfizer’s Enbrel formulation patent is set to expire on 19 Oct 2037 (Pfizer 10‑K, p. 12), giving the company roughly 13 years of patent‑based protection beyond its 2024 launch and delaying biosimilar entry.  AbbVie, by contrast, relies on the 12‑year regulatory exclusivity granted under the Biologics Price Competition and Innovation Act for its biologics (AbbVie 10‑K, pp. 7‑11), which will end about a decade after launch and may be extended only by a 180‑day pediatric‑study period.  Consequently, Pfizer enjoys a longer exclusive window for Enbrel, strengthening its competitive position relative to AbbVie’s biologics that face biosimilar competition sooner.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains several factual inaccuracies that reduce its correctness. First, it incorrectly states that Enbrel's patent expiration on October 19, 2037, provides '13 years of patent-based protection beyond its 2024 launch'—this is factually wrong because Enbrel was launched long before 2024 (it was approved in 1998); the 2024 date appears to be a misinterpretation of a forward-looking statement or risk factor in the 10-K, not a launch date. This invalidates the calculation of a '13-year protection beyond launch' and misrepresents the timeline. 2) The quantitative accuracy is compromised due to this incorrect time reference and unsupported calculation. While the 2037 expiration date aligns with the ground truth, the claim about '13 years beyond 2024' is erroneous and not present in the original answer. Additionally, the pediatric exclusivity is misrepresented as a '180-day' extension—while this is technically correct (6-month extension), the original answer frames it as 'potential pediatric exclusivity extensions' without specifying duration, so this detail is not incorrect per se but is overly precise without citation. 3) The qualitative reasoning is partially sound: the comparison between Pfizer’s formulation patent strategy and AbbVie’s reliance on BPCIA’s 12-year regulatory exclusivity is valid and reflects the multi-hop synthesis across both companies’ strategies. The LLM correctly identifies that Pfizer’s patent offers longer de facto protection than AbbVie’s statutory exclusivity period, which is a reasonable inference. However, it oversimplifies by suggesting Pfizer has a 'longer exclusive window' without acknowledging that AbbVie layers patents and regulatory exclusivity (as noted in the ground truth), thus missing a key nuance. 4) Contextual relevance is high—the answer addresses the core question about competitive positioning and correctly draws from 10-K disclosures (citing page numbers), showing appropriate sourcing. Despite the reasoning flaws, it attempts a meaningful cross-company comparison. Overall, the answer gets key elements right (patent expiration, BPCIA exclusivity) but fails in critical quantitative and contextual details, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 592,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How would a potential shift from 0.5-percentage-point to 0.1-percentage-point increments in the G-SIB surcharge proposal impact JPMorgan Chase's capital requirements under a resolution scenario where the Parent Company enters bankruptcy, given the loss-absorbing structure of its eligible long-term debt?",
      "original_answer": "The proposed shift from 0.5-percentage-point to 0.1-percentage-point increments in the G-SIB surcharge under the Federal Reserve's proposal would likely allow for more granular calibration of capital requirements for systemically important institutions like JPMorgan Chase. For JPM, this could mean a more tailored capital burden, which would interact with its 'single point of entry' resolution strategy where losses would first be imposed on equity holders and then on unsecured creditors, including holders of eligible long-term debt. If this surcharge adjustment is adopted, JPM may experience either a marginal increase or decrease in required capital depending on its G-SIB score, which would influence how much loss-absorbing capacity it must maintain under its current regulatory framework.",
      "llm_answer": "The move to 0.1‑percentage‑point increments would lower the G‑SIB surcharge applied to JPMorgan Chase’s risk‑based capital, thereby slightly reducing its regulatory capital requirement. In a resolution scenario where the Parent Company enters bankruptcy, the eligible long‑term debt would absorb losses first, but the surcharge would still be calculated on the remaining capital base; the smaller increments simply provide a more granular, modestly lower surcharge without changing the loss‑absorbing structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partial factual accuracy but introduces significant mischaracterizations. (1) Quantitatively, the answer incorrectly asserts that the shift to 0.1-percentage-point increments would 'lower' the G-SIB surcharge for JPMorgan Chase, which is not supported by the ground truth. The original answer states the change allows for more granular calibration, potentially resulting in either a marginal increase or decrease depending on JPM's G-SIB score—there is no definitive directional impact. This misstatement undermines the quantitative accuracy. (2) The answer correctly identifies the regulatory context (G-SIB surcharge, risk-based capital) and the resolution framework involving eligible long-term debt, but incorrectly implies that the smaller increments inherently lead to a 'modestly lower surcharge,' which is speculative and contradicts the neutral, conditional tone of the ground truth. (3) Multi-hop reasoning is partially sound: it connects the surcharge proposal to capital requirements and references the loss-absorbing role of long-term debt in resolution. However, it fails to accurately describe the interaction between the surcharge adjustment and JPM’s 'single point of entry' strategy as outlined in the original answer. (4) Contextual relevance is high—the response addresses the core elements of the question (regulatory change, capital requirements, resolution scenario), but the incorrect directional claim about the surcharge reduction reduces factual reliability. Overall, the answer is partially correct but contains a critical error in reasoning about the impact of the regulatory change.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 445,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does LMT's use of a discounted cash flow approach in valuing Level 3 fixed income investments compare to HON's application of the same method in testing goodwill and indefinite-lived intangible assets, particularly in terms of the sensitivity to projected cash flows and discount rates?",
      "original_answer": "LMT applies the discounted cash flow approach to certain Level 3 fixed income investments, relying on projected annuity payments and a discount rate applied to those payments. This valuation method is used when observable market inputs are unavailable, and it introduces sensitivity to changes in these projected cash flows and discount assumptions. Similarly, HON utilizes a discounted cash flow approach for testing goodwill and indefinite-lived intangible assets, incorporating strategic and annual operating plans adjusted for terminal value assumptions. HON also performs sensitivity analyses on key estimates, including expected growth rates, sales volumes, and discount rates, to assess the impact of changes in assumptions. Both companies depend on forward-looking financial projections and discounting techniques, making their valuations highly sensitive to shifts in economic conditions and internal performance expectations.",
      "llm_answer": "Lockheed Martin (LMT) applies a discounted‑cash‑flow (DCF) model to Level 3 fixed‑income holdings, with the valuation driven by projected annuity payments and the discount rate applied to those payments (LMT 10‑K, Note 1, pp. 86‑90). Honeywell (HON) uses a DCF approach for goodwill and indefinite‑lived intangibles, explicitly performing sensitivity analyses on key estimates—including growth rates, cash flows and the discount rate—and noting that changes in these assumptions could materially affect fair value (HON 10‑K, Note 12, pp. 45‑49). Thus, while both companies’ valuations hinge on projected cash flows and discount rates, HON’s disclosures emphasize the sensitivity of the fair‑value estimate to these inputs, whereas LMT’s disclosure merely identifies the inputs without an explicit sensitivity analysis.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that LMT uses a discounted cash flow (DCF) approach for Level 3 fixed income investments based on projected annuity payments and discount rates, and that HON applies DCF to goodwill and indefinite-lived intangible assets with sensitivity analyses on growth rates, cash flows, and discount rates. The answer accurately highlights a key distinction: HON explicitly performs and discloses sensitivity analyses, while LMT identifies the inputs but does not emphasize sensitivity testing. There are no numeric inaccuracies—though no specific numbers (e.g., rates or dollar values) are present in either answer, the qualitative descriptions of methods and disclosures are consistent with the ground truth. The multi-hop reasoning is sound, correctly synthesizing information across two companies and different applications of DCF. The only minor shortcoming is that the LLM answer slightly underrepresents the extent to which both companies rely on forward-looking projections and terminal value assumptions (mentioned in the original answer), but this does not detract significantly from the overall correctness. Wording differs but semantic meaning is equivalent. All entities (LMT, HON, Level 3 investments, goodwill, intangibles) are correctly identified and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 382,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does AT&T's use of discount rates tied to corporate bond credit quality in pension obligations compare to Netflix's reliance on forecasted viewing patterns in content amortization, given both are subject to auditor evaluation of significant assumptions?",
      "original_answer": "AT&T's pension obligations are sensitive to discount rates derived from corporate bonds' credit quality, which directly affects the measurement of $67,854 million in goodwill and postretirement liabilities. Netflix, on the other hand, relies on forecasted viewing patterns to amortize content assets, a process that is similarly judgmental and subject to auditor scrutiny. Both companies' financial statements depend heavily on significant assumptions—discount rates for AT&T and viewing forecasts for Netflix—that are evaluated by auditors using sensitivity analyses and comparisons to historical data. This highlights a parallel in how both firms manage subjectivity in long-term financial reporting, despite differing industries and asset types.",
      "llm_answer": "AT&T’s pension accounting uses discount rates derived from a yield curve built on high‑quality corporate bonds, so auditors must evaluate the credit quality of those bonds and how well their cash flows match the expected benefit payments. Netflix, in contrast, amortizes content based on estimated future viewing hours, requiring auditors to judge the reasonableness of those forecasts, test the underlying data, and perform sensitivity analyses. Both approaches involve subjective, judgment‑heavy assumptions that are subject to rigorous auditor scrutiny, but the former is rooted in market‑based bond yields while the latter depends on consumer‑viewing projections.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, no specific dollar amounts beyond $67,854 million in the original answer are mentioned in the LLM response, but this omission does not constitute a factual error—rather, a difference in detail emphasis. The LLM correctly avoids fabricating numbers and focuses on the conceptual framework, which is acceptable given the question does not explicitly require restating the dollar figure. All other financial concepts (discount rates, amortization methods) are accurately represented. (2) The LLM correctly identifies both companies—AT&T and Netflix—and their respective use of significant assumptions: AT&T’s discount rates tied to corporate bond credit quality and Netflix’s forecasted viewing patterns. These are correctly linked to auditor evaluation, including sensitivity analyses and reasonableness testing. (3) The multi-hop reasoning is sound: the model synthesizes how two different firms in different industries apply judgment-heavy assumptions in long-term asset/liability measurement, and how auditors assess them despite differing data sources (market-based vs. behavioral projections). The contrast is logically presented and parallels the original answer’s intent. (4) Semantically, the LLM conveys the same core message: both companies rely on significant, subjective assumptions subject to auditor scrutiny, even though the nature of the assumptions differs. The only minor shortcoming is the absence of the specific $67,854 million figure related to AT&T’s goodwill and postretirement liabilities, which was present in the original answer and adds concrete context. However, since the question does not explicitly ask for financial magnitudes, this omission reduces completeness slightly but not enough to undermine correctness. Overall, the response is factually accurate, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 525,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does the adoption timeline of ASU No. 2023-07 differ between MO and PM, and what specific changes did each company implement in their segment reporting as a result?",
      "original_answer": "MO adopted ASU No. 2023-07 in 2024 and began including expanded footnote disclosures in Note 17, with interim disclosure requirements set to appear in Q1 2025. PM adopted the ASU retrospectively for the year ended December 31, 2024, and updated its segment reporting by incorporating the former Swedish Match segment into its four existing geographical segments starting in January 2024.",
      "llm_answer": "Both MO and PM adopted ASU 2023‑07 for the year ended Dec 31 2024. MO added a new “Pharma” segment and expanded footnote disclosures to provide incremental segment information (MO 10‑K p. 61‑65), while PM merged the former Swedish Match results into its four existing geographic segments and updated footnote disclosures accordingly (PM 10‑K p. 84‑88).",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant errors in adoption timelines and segment changes. (1) Quantitatively, the answer incorrectly states that both MO and PM adopted ASU 2023-07 for the year ended December 31, 2024. However, the ground truth specifies that MO adopted the standard in 2024 with interim disclosures starting in Q1 2025, while PM adopted it retrospectively for the year ended December 31, 2024. The retrospective adoption by PM is correctly noted, but MO’s phased implementation (starting in 2024, with interim disclosures in 2025) is oversimplified and misleading. (2) Regarding segment reporting changes, the LLM incorrectly claims MO added a new 'Pharma' segment, which is not supported by the ground truth; instead, MO expanded footnote disclosures in Note 17. This is a major factual error. In contrast, PM’s integration of the Swedish Match segment into its four geographic segments starting January 2024 is accurately described. (3) The reasoning is partially sound in linking ASU adoption to segment reporting changes, but fails on multi-hop synthesis: it conflates MO’s actual disclosure enhancements with a non-existent structural segment change. (4) Contextually, the answer is relevant and cites appropriate sections of the 10-Ks, but the inclusion of false information (Pharma segment) undermines accuracy. Overall, core facts about PM are correct, but MO’s timeline and changes are significantly misrepresented, leading to a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 417,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does the inclusion of Pomalyst in the Inflation Reduction Act's (IRA) drug price negotiation program impact BMY's revenue outlook compared to PFE's exposure under the same IRA provisions, given both companies' reliance on Medicare Part D sales and regulatory exclusivity timelines?",
      "original_answer": "BMY faces potential revenue erosion for Pomalyst starting in 2027 due to its selection by HHS for government-set pricing under the IRA, which could accelerate prior to the expiry of its intellectual property protections. Similarly, PFE anticipates a net unfavorable revenue impact of approximately $1 billion in 2025 due to IRA-driven Medicare Part D redesign changes and faces additional IRA pricing pressures on products like Ibrance and Xtandi, which were selected for price negotiation effective 2027. Both companies are exposed to the IRA’s long-term financial implications, but BMY’s risk is specifically tied to Pomalyst’s regulatory exclusivity and market dynamics, while PFE’s exposure spans a broader portfolio affected by Part D redesign and inflation rebates.",
      "llm_answer": "Bristol‑Myers Squibb’s inclusion of Pomalyst in the IRA’s Medicare Part D price‑negotiation program means that, beginning in 2027, the drug will be subject to government‑set pricing after nine years from its FDA approval.  This is likely to reduce the revenue BMY derives from Medicare Part D sales of Pomalyst, potentially accelerating erosion of that revenue stream once the negotiated price takes effect.  The PFE 10‑K pages supplied do not identify any of Pfizer’s products that are currently selected for IRA negotiation, so a direct comparison of the revenue impact on Pfizer versus BMY cannot be drawn from the available information.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that BMY's Pomalyst is included in the IRA's price negotiation program and that government-set pricing will begin in 2027, which aligns with the ground truth. It also correctly notes the impact on Medicare Part D revenue and ties the timing to nine years post-FDA approval, which is consistent with IRA rules. However, the LLM incorrectly claims that the PFE 10-K does not identify any products selected for IRA negotiation, which contradicts the ground truth stating that PFE faces IRA pricing pressures on Ibrance and Xtandi (selected for negotiation effective 2027) and anticipates a $1 billion net unfavorable revenue impact in 2025 due to Part D redesign. This omission represents a significant failure in multi-hop reasoning and completeness, as the question explicitly asks for a comparison between BMY and PFE. The LLM also fails to mention PFE’s broader portfolio exposure, inflation rebates, or the $1B quantified impact in 2025—key elements in the original answer. While the information provided on BMY is largely accurate (supporting a moderate quantitative and qualitative score), the failure to accurately represent PFE’s exposure and draw the required comparison undermines the overall correctness. The contextual relevance remains high because the response addresses the core topic and mechanism of the IRA, but the lack of comparative analysis and key facts from PFE’s disclosures limits its accuracy and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 403,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does the exposure of MDLZ's Argentine operations, which contributed $401 million in 2021 net revenues, compare to KO's reliance on Arca Continental in Argentina, given that Arca Continental is one of KO's top bottlers and operates in northern Argentina?",
      "original_answer": "MDLZ's Argentine operations contributed $401 million in net revenues in 2021 and were subject to significant currency risk due to Argentina's highly inflationary status, resulting in a $13 million remeasurement loss in that year. Meanwhile, KO relies on Arca Continental, one of its top five bottlers, which operates in northern Argentina and contributes to KO's global unit case volume. Arca Continental is a key distribution partner in the region, and KO's bottler agreements require Arca to source concentrates exclusively from KO, making KO's exposure in Argentina indirect but strategically significant through this contractual relationship.",
      "llm_answer": "MDLZ’s Argentine operations generated $401 million in net revenues in 2021, representing about 1.4 % of its consolidated net revenues (MDLZ 10‑K, p. 90). Coca‑Cola’s exposure to Argentina is indirect, coming through its top bottler Arca Continental, which operates in northern Argentina (KO 10‑K, pp. 5‑9). The 10‑K does not disclose a specific revenue amount for Arca Continental’s Argentine operations, so MDLZ’s exposure is quantified while KO’s is not.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative aspects: MDLZ's $401 million in net revenues from Argentina in 2021 is correctly stated, and the 1.4% of consolidated revenue is a valid calculation (based on MDLZ's total net revenues of ~$28.6 billion in 2021, $401M / $28.6B ≈ 1.4%). The absence of a specific revenue figure for Arca Continental’s operations in Argentina is correctly noted, aligning with the ground truth that KO’s exposure is indirect and not quantified in disclosures. Entity accuracy is strong—MDLZ, KO, Arca Continental, and their respective roles are correctly identified. The reasoning correctly contrasts MDLZ’s direct operational exposure with KO’s indirect exposure via a bottling partner. However, the LLM omits key qualitative details present in the ground truth: (1) the $13 million remeasurement loss due to Argentina’s highly inflationary economy, which is a critical component of MDLZ’s risk exposure; and (2) the strategic significance of KO’s exclusive sourcing agreement with Arca Continental, which strengthens the indirect but binding relationship. These omissions reduce completeness and depth in multi-hop synthesis, particularly around risk implications and contractual dependencies. Despite this, the answer remains contextually relevant, directly addressing the comparison of exposure types (direct vs. indirect) and correctly identifying the availability (or lack) of financial data. Semantic equivalence is largely preserved, but the missing risk and contractual details prevent a top score in qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 428,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does BMY's engagement with the FDA's Fast Track Designation process inform the strategic value of LLY's acquisition of Prevail's PR006 gene therapy, given PR006's regulatory status and the CVR payment timeline tied to its approval?",
      "original_answer": "BMY's engagement with the FDA's Fast Track Designation process highlights the importance of expedited regulatory pathways in accelerating drug approvals and improving patient access to critical therapies. LLY acquired Prevail in 2021, including PR006, which was granted Fast Track Designation by the FDA for treating frontotemporal dementia with GRN mutations. The acquisition included a CVR entitling Prevail shareholders to up to an additional $4.00 per share (approximately $160 million total) upon the first regulatory approval of a Prevail product in specified countries by December 31, 2024. Given the Fast Track status of PR006, the likelihood of expedited approval may directly influence the timing and value of the CVR payout, thereby enhancing the strategic value of the acquisition if PR006 achieves regulatory approval within the stipulated timeline.",
      "llm_answer": "BMY’s 10‑K stresses that the FDA’s Fast‑Track designation is a key tool to accelerate development and approval of promising therapies (BMY_10k_2023, p.18). PR006, which LLY acquired through its purchase of Prevail, already holds Fast‑Track status and its contingent value right (CVR) will pay up to $4.00 per share only if regulatory approval occurs by Dec 31 2024 (BMY_10k_2023, p.20). Thus, BMY’s emphasis on Fast‑Track underscores the strategic value for LLY: the designation could expedite PR006’s approval, allowing LLY to capture the CVR payment before the deadline and maximize the acquisition’s value (LLY_10k_2023, p.68‑72).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: PR006 has Fast Track Designation, the CVR pays up to $4.00 per share (approximately $160 million total), and the deadline for approval to trigger the CVR is December 31, 2024. These numbers and dates match the original answer exactly. (2) Quantitative accuracy is perfect: dollar amounts, per-share payout, and deadline are all correctly stated. (3) The multi-hop reasoning is sound—linking BMY’s emphasis on Fast Track to the strategic value of LLY’s acquisition of Prevail via expedited approval potential and CVR timing. The synthesis across BMY’s regulatory strategy and LLY’s acquisition terms is logical and relevant. (4) Minor deduction in qualitative accuracy because the LLM cites 'BMY_10k_2023' as the source for PR006’s Fast Track status and CVR terms, which is factually inconsistent—those details should come from LLY’s or Prevail’s filings, not BMY’s. This misattribution could mislead about data provenance, though the facts themselves are correct. Otherwise, the answer is semantically equivalent, contextually relevant, and correctly emphasizes the strategic linkage between Fast Track status and CVR realization.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 350,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does V's increase in Class A common stock shares from 1,594 in 2023 to 1,733 in 2024 compare with MA's Class B-to-A conversion mechanism, especially considering MA's disclosure that only 7 shares of Class B common stock were outstanding in 2024, to assess the differing dynamics of shareholder structure evolution in both companies?",
      "original_answer": "V reported an increase in Class A common stock shares from 1,594 in 2023 to 1,733 in 2024, indicating an expansion in its Class A shareholder base. Meanwhile, MA disclosed that only 7 shares of Class B common stock were outstanding in 2024, showing minimal remaining shares eligible for conversion into Class A. This contrast highlights different dynamics in shareholder structure evolution: V is seeing organic growth or issuance in its Class A shares, while MA's structure is shaped by its conversion rules, which require Class B holders (typically principal or affiliate customers) to convert and then divest Class A shares, limiting long-term Class B retention.",
      "llm_answer": "V’s Class A common stock rose from 1,594 shares at September 30 2023 to 1,733 shares at September 30 2024 – a 139‑share increase driven by issuance and other corporate actions (see V_10k_2024, pp. 56‑60).  Mastercard’s Class B‑to‑A conversion mechanism, however, has had little effect on its shareholder structure in 2024, with only seven Class B shares outstanding and no reported conversions (see MA_10k_2024, pp. 66‑70, 90‑94).  Thus, V’s share count grew through active issuance, whereas MA’s structure remains largely unchanged because the conversion option is largely dormant and limited to a very small number of shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports V's Class A common stock increase from 1,594 shares in 2023 to 1,733 in 2024, a difference of 139 shares, which matches the ground truth. It also accurately states that MA had only 7 Class B shares outstanding in 2024, consistent with the original answer. These numbers are factually correct and properly attributed to the respective 10-K filings. (2) All quantitative elements are accurate: the starting and ending share counts for V, the implied increase of 139 shares, and the 7 remaining Class B shares at MA are all correct. No calculation errors are present. (3) The reasoning is sound and captures the multi-hop comparison: V’s growth is due to issuance and corporate actions, while MA’s minimal Class B shares indicate a largely inactive conversion mechanism. The LLM correctly infers that MA’s structure is stable due to the dormancy of conversions, aligning with the ground truth’s emphasis on conversion rules and divestment requirements. However, the LLM omits a specific mention of MA’s requirement for converted shares to be divested post-conversion, which is a minor but relevant detail in explaining why Class B retention is limited. (4) Despite this small omission, the answer is semantically equivalent in intent and meaning, correctly contrasting the two companies’ shareholder structure dynamics. The response is highly relevant, directly addressing the comparative evolution of shareholder structures as required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 413,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How might Saudi Arabia's data localization requirements, which Adobe identifies as a risk to its international operations, affect NVIDIA's ability to deploy its H100 and L40S chips in the country under U.S. export control regulations?",
      "original_answer": "Saudi Arabia's implementation of data localization requirements mandates that data be stored and processed within the country, which Adobe notes could adversely impact its international business operations. NVIDIA, which relies on Saudi Arabia as a market for its high-performance chips like the H100 and L40S, faces U.S. export licensing restrictions on these products to Saudi Arabia under updated Country Group D4 rules. Since these chips require U.S. government approval for export and NVIDIA has not received such licenses for restricted products, the combination of Saudi regulatory requirements and U.S. export controls could significantly limit NVIDIA's ability to serve Saudi customers with these advanced AI chips, potentially reducing its market access and revenue opportunities in the region.",
      "llm_answer": "Adobe’s 10‑K notes that Saudi Arabia’s data‑localisation laws – which require data to be collected, stored and processed within the country – are a risk to its global operations (see ADBE_10k_2024, pp. 28‑32).  NVIDIA’s 10‑K explains that U.S. export‑control rules now require a license for H100 and L40S chips shipped to Saudi Arabia (Country Group D5) (NVDA_10k_2024, pp. 25‑29).  The combination of a licensing requirement and the need to keep data local could add significant compliance hurdles, potentially limiting or delaying NVIDIA’s ability to deploy these chips in Saudi Arabia.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with only minor differences in detail. (1) All key facts are correct: Saudi data localization requirements are properly attributed to Adobe's 10-K, and U.S. export controls on NVIDIA's H100 and L40S chips to Saudi Arabia are correctly cited from NVIDIA's 10-K. The reference to Country Group D5 in the LLM answer slightly differs from the ground truth's mention of D4; however, this may reflect a document-specific classification nuance and does not materially undermine the correctness, as both indicate heightened export restrictions. (2) There are no numeric values requiring calculation, and all referenced regulatory and product details (H100, L40S, licensing requirements) are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across Adobe’s and NVIDIA’s 10-Ks to infer that data localization and export controls jointly create compliance hurdles. (4) The LLM answer captures the core implication—limited or delayed deployment of chips in Saudi Arabia—though it omits the explicit mention of market access and revenue impact present in the original. This omission slightly reduces completeness but does not affect the essential correctness. Overall, the response is highly accurate, contextually appropriate, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 376,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How do FedEx's and GE's disclosures regarding the discontinuation of LIBOR reflect differing applications of the accounting relief provided by ASU 2020-04, as extended by ASU 2022-06?",
      "original_answer": "FedEx notes that there has been 'no material effect' from reference rate reform on its financial condition as of May 31, 2024, but continues to monitor contracts for potential application of ASU 2022-06, which extended the optional expedients in ASU 2020-04 through December 31, 2024. In contrast, GE explicitly states that the overall impact of LIBOR reform under ASU 2020-04 on its financial statements is 'immaterial.' This suggests that while both companies applied the same accounting framework (ASU 2020-04, extended by ASU 2022-06), FedEx maintained a more cautious stance with ongoing monitoring, whereas GE concluded the transition had no significant financial impact.",
      "llm_answer": "FedEx’s note (pp. 91‑95) explicitly cites ASU 2020‑04 and the 2022‑06 extension, noting that the optional expedients and exceptions under the relief can be applied through December 31, 2024 and that the company is monitoring its LIBOR‑referenced contracts for potential use of the relief. In contrast, GE’s note (pp. 15‑19) only references the original ASU 2020‑04, states that the impact of LIBOR’s discontinuation is immaterial, and makes no mention of the 2022‑06 extension or ongoing monitoring, implying that it is not actively applying the extended relief. Thus, FedEx is proactively preparing to use the relief while GE is effectively treating the change as non‑material and not engaging the extended provisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: FedEx cites both ASU 2020-04 and ASU 2022-06, notes the extension through December 31, 2024, and states it is monitoring contracts for potential application of relief. GE states the impact is immaterial and does not reference ASU 2022-06 or ongoing monitoring. These points match the original answer. (2) Quantitative accuracy is perfect: the date 'December 31, 2024' is correctly cited, and no erroneous numbers are introduced. (3) The multi-hop reasoning is sound—comparing FedEx’s proactive, cautious approach with GE’s conclusion of immateriality demonstrates correct synthesis across both companies’ disclosures. The LLM infers GE’s lack of engagement with the extended relief based on absence of mention, which is reasonable given the context. (4) The only minor shortcoming is that the LLM slightly overreaches by stating GE is 'not actively applying the extended provisions'—while plausible, this is an inference not explicitly confirmed in the ground truth, which only says GE concluded the impact was immaterial. Thus, qualitative accuracy is slightly reduced, but overall the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 352,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How might geopolitical tensions involving Taiwan impact both Apple's and NVIDIA's supply chain operations, considering their reliance on manufacturing locations and foundry partners in the region?",
      "original_answer": "Apple's business is significantly impacted by geopolitical tensions involving Taiwan, as it relies heavily on outsourcing partners located in Taiwan for manufacturing critical components. A significant or prolonged conflict involving Taiwan could severely limit Apple's ability to manufacture and deliver products, creating delays and inefficiencies in its supply chain. Similarly, NVIDIA depends on foundry partners in Taiwan for chipset supply, and any disruption due to geopolitical tensions could severely limit or prevent NVIDIA from receiving this supply, which would have a material adverse impact on its business. Both companies face heightened risks due to their reliance on operations in a region with ongoing geopolitical instability.",
      "llm_answer": "Apple’s production is largely outsourced to partners in Taiwan, so heightened tensions could disrupt manufacturing, delay product launches and drive up costs (“Substantially all of the Company’s manufacturing is performed in whole or in part by outsourcing partners located primarily in China mainland, India, Japan, South Korea, Taiwan and Vietnam”). NVIDIA, which relies on Taiwan‑based foundries for wafer fabrication, faces a similar risk: geopolitical friction could constrain chip supply, delay deliveries and increase manufacturing expenses (“We depend on foundries to manufacture our semiconductor wafers… We have suppliers and foundries in Taiwan”).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies both Apple's and NVIDIA's reliance on manufacturing partners and foundries in Taiwan, respectively, and explains how geopolitical tensions could disrupt their supply chains, leading to delays, cost increases, and supply constraints. The quoted excerpts from company disclosures support the claims and enhance credibility. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers are involved). The reasoning is sound and reflects proper multi-hop synthesis: connecting Apple's outsourcing model and NVIDIA's foundry dependence to regional geopolitical risk. The only minor shortcoming is that the LLM slightly broadens Apple's manufacturing base to include other countries (e.g., China, India, Vietnam), which, while true, slightly dilutes the focus on Taiwan-specific risk emphasized in the original answer. However, it still correctly highlights Taiwan as a key location. All entities (Apple, NVIDIA, Taiwan, foundries, outsourcing partners) are accurately identified and contextually relevant. The answer fully addresses the question and maintains high qualitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 346,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What percentage of Broadcom's $24,156 million developed technology intangible asset from the VMware acquisition is specifically tied to VMware Cloud Foundation, and how does this compare to Oracle's net value of developed technology as a percentage of its total intangible assets?",
      "original_answer": "Of Broadcom's $24,156 million developed technology intangible asset from the VMware acquisition, a 'significant portion' is tied to VMware Cloud Foundation (VCF), though the exact percentage is not disclosed. Oracle's net value of developed technology was $1,276 million as of May 31, 2024, which represents approximately 18.4% of Oracle's total intangible assets of $6,890 million. While Broadcom emphasizes that a significant portion of its developed technology relates to VCF, Oracle's developed technology is a much smaller share of its overall intangible asset base, indicating differing strategic valuations of technology assets post-acquisition.",
      "llm_answer": "Broadcom’s $24,156 million of developed‑technology intangible assets from the VMware deal is about **19 %** tied to VMware Cloud Foundation (≈$4.63 billion of the $24.16 billion).  \nOracle’s developed‑technology intangible assets represent roughly **67 %** of its total intangible assets (≈$8.0 billion of $12.0 billion).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect on key points. The original answer states that the percentage of Broadcom's $24,156 million developed technology intangible asset tied to VMware Cloud Foundation (VCF) is not disclosed and only described as a 'significant portion.' However, the LLM falsely claims it is '19%' (≈$4.63 billion), which is not supported by the ground truth. This is a major factual error. Additionally, the LLM states Oracle’s developed technology is 67% of total intangibles (≈$8.0B of $12.0B), but the ground truth reports Oracle’s developed technology as $1,276 million and total intangibles as $6,890 million, resulting in ~18.4%, not 67%. The LLM also invents incorrect total intangible assets for Oracle ($12.0B vs $6.89B). (2) Calculations are entirely wrong: 19% of $24,156M is ~$4,589M, but this figure is fabricated. 67% of $12.0B is $8.0B, but Oracle’s actual developed tech value is $1.276B — less than 1/6 of that. The correct percentage is ~18.4%, as stated in the original. (3) Multi-hop reasoning fails: the model does not correctly synthesize the disclosed values for Oracle or acknowledge the lack of specific allocation for VCF within Broadcom’s intangibles. Instead, it invents precise numbers where none exist. (4) Scores are low because the answer fabricates critical numerical data, misrepresents both companies’ financials, and draws an invalid comparison. The only redeeming factor is that the answer attempts to address both parts of the question, hence minimal contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 424,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to the relative stockholder ownership structure at GOOGL, particularly in terms of non-affiliate market value and class-based control mechanisms?",
      "original_answer": "At CMCSA, holders of Class B common stock, of which there are only 3 record holders, maintain 33⅓% of the combined voting power of the company’s common stock, with each share carrying 15 votes. This concentrated voting power is designed to preserve control, as the Class B shares are non-dilutable under the company's articles of incorporation. In contrast, GOOGL disclosed that as of June 30, 2021, the aggregate market value of shares held by non-affiliates was approximately $1,451.1 billion, with 300,754,904 shares of Class A common stock outstanding. While GOOGL’s structure also includes differentiated voting rights, the non-affiliate ownership suggests a more dispersed market-based control mechanism compared to CMCSA’s concentrated Class B structure.",
      "llm_answer": "At CMCSA, Class B shares supply 33 ⅓ % of the company’s voting power—each share carries 15 votes and all 44.6 million shares are owned by Mr. Roberts, giving him decisive control, while the remaining 66 ⅔ % comes from Class A shares. Alphabet’s GOOGL reports a non‑affiliate market value of roughly $1.45 trillion and operates a dual‑class scheme: Class A shares vote one‑to‑one, Class C shares are non‑voting, and the concentrated Class B shares (10 votes each) held by founders provide the controlling stake, so control is similarly concentrated but the majority of shares are widely held non‑affiliates.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly around ownership details at CMCSA. The ground truth states there are 3 record holders of Class B shares, but the LLM incorrectly claims all 44.6 million shares are owned by Mr. Roberts alone—this specific detail is not supported in the original answer and introduces a significant factual error. Additionally, while the LLM correctly notes 33⅓% voting power and 15 votes per share for CMCSA Class B stock, it omits the critical fact that these shares are non-dilutable under the articles of incorporation, which is a key control mechanism. For GOOGL, the LLM correctly identifies the $1.45 trillion non-affiliate market value (approximating the $1,451.1 billion in the original), but incorrectly implies this figure is directly tied to 300,754,904 Class A shares without clarifying that this total includes both Class A and potentially other classes in public float calculations. The LLM also fails to mention the exact date (June 30, 2021) from the original. (2) Quantitative accuracy is partially correct: $1.45 trillion ≈ $1,451.1 billion is acceptable, but the claim of '44.6 million shares owned by Mr. Roberts' has no basis in the provided truth and appears fabricated. No calculation errors per se, but unsupported numbers reduce quantitative reliability. (3) Multi-hop reasoning is generally sound—the model compares voting structures across CMCSA and GOOGL, recognizing dual-class systems and contrasting concentrated vs. dispersed control. However, it misrepresents the nature of concentration at CMCSA by attributing control solely to one individual rather than a small group of 3 record holders, weakening the synthesis. (4) Despite these issues, the answer remains contextually relevant and captures the essence of the comparison: CMCSA has concentrated voting power via high-vote Class B shares, while GOOGL also has founder control via Class B but with broader non-affiliate ownership. The qualitative reasoning is mostly logical but undermined by incorrect specifics. Correctness score is 6 due to core conceptual accuracy but significant factual omissions and one major unsupported claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 585,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How does the difference in issued Class A and Class B common stock shares between CMCSA and META reflect on their respective equity structure concentration as disclosed in their 2024 filings?",
      "original_answer": "CMCSA disclosed that it issued 4,651,093,045 Class A common shares and 9,444,375 Class B common shares as of December 31, 2024, indicating a significantly higher proportion of Class A shares in its equity structure. META, on the other hand, reported 2,189,898,148 Class A common shares and 343,761,117 Class B common shares outstanding as of January 24, 2025, showing a much higher relative weighting of Class B shares. The evidence from Alphabet's filing clarifies that Class B shares carry 10 votes per share versus 1 vote for Class A, and that Class B shares automatically convert to Class A upon sale or transfer. This suggests META's equity structure maintains stronger voting rights concentration among fewer shareholders compared to CMCSA, where ownership appears more diffused due to the dominance of standard voting Class A shares.",
      "llm_answer": "CMCSA issued roughly 4.65‑4.84 billion Class A shares and only 9.44 million Class B shares, meaning the small pool of high‑voting shares is held by a limited group and the equity structure is highly concentrated [CMCSA pages 65‑69].  \nMeta, by contrast, had about 2.19 billion Class A shares and 343.76 million Class B shares outstanding, a much larger Class B base that dilutes concentration and indicates a more dispersed ownership structure [META pages 1‑5].",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual and logical errors in reasoning despite mostly accurate numbers. While the share counts for CMCSA and META are approximately correct (4.65 billion vs. 4,651,093,045 Class A and 9.44 million vs. 9,444,375 Class B for CMCSA; 2.19 billion vs. 2,189,898,148 and 343.76 million vs. 343,761,117 for META), the interpretation of equity concentration is completely reversed. The ground truth states that META has a more concentrated voting structure due to its Class B shares carrying 10 votes each and being held by insiders, whereas the LLM incorrectly claims that META's larger Class B base 'dilutes concentration' and indicates 'more dispersed ownership'—this is the opposite of the correct conclusion. (2) Quantitatively, the numbers are rounded but within acceptable range (e.g., 4.65 billion ≈ 4,651,093,045; 343.76 million ≈ 343,761,117), so numerical accuracy is high. However, the LLM introduces a false upper bound of '4.84 billion' for CMCSA with no support in the original answer. (3) The multi-hop reasoning fails critically: the model misinterprets the relationship between share class proportions and voting rights concentration. It ignores the key disclosure about Class B shares having superior voting rights and automatic conversion upon transfer, which is central to understanding control concentration. Instead, it assumes that a larger number of Class B shares implies less concentration, which contradicts standard corporate governance logic and the explicit conclusion in the ground truth. (4) Contextual relevance is moderate because the answer addresses the right companies, timeframes, and share classes, but the erroneous conclusion undermines the entire response. The citation of filing pages adds apparent credibility but does not compensate for the flawed logic. Thus, while the data input is mostly accurate, the qualitative reasoning is fundamentally incorrect, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 534,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How does the exposure of CVS's Oak Street Health business to Medicare reimbursement risks compare to AbbVie's exposure under the IRA's price-setting provisions, given the IRA's impact on the Medicare program?",
      "original_answer": "CVS's Oak Street Health business derives a significant portion of its revenue from Medicare or Medicare Advantage plans and is exposed to risks such as reductions in reimbursement rates and changes in Medicare program rules. The IRA introduces new financial pressures on Medicare-participating drug manufacturers like AbbVie by enabling government price-setting for certain Part B and Part D drugs starting in 2026 and 2028, respectively. AbbVie specifically faces exposure as Imbruvica has already been selected for price-setting under the IRA, with government-dictated prices set to take effect in 2026. This regulatory shift under the IRA compounds the existing Medicare-related risks faced by CVS's Oak Street Health, as both are tied to the same evolving Medicare framework, albeit through different mechanisms—direct reimbursement risk for CVS and mandated pricing for AbbVie.",
      "llm_answer": "CVS’s Oak Street Health is exposed to Medicare reimbursement risk because a large share of its revenue comes from Medicare and Medicare‑Advantage plans, and changes in Medicare rules or reductions in reimbursement rates could cut its earnings for primary‑care services.  \nAbbVie, by contrast, faces a direct price‑setting risk under the Inflation Reduction Act (IRA), which allows the CMS to set statutory ceiling prices for certain single‑source drugs reimbursed under Medicare Part B and Part D—potentially eroding AbbVie’s drug revenues more immediately and severely than the reimbursement‑rate risk faced by Oak Street Health.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core comparison between CVS's Oak Street Health and AbbVie regarding their respective exposures to Medicare-related risks under the IRA. (1) All factual elements are correct: Oak Street Health's reliance on Medicare/Medicare Advantage revenue and exposure to reimbursement rate changes is accurately described; AbbVie's exposure under the IRA via government price-setting for Part B and Part D drugs is correctly explained. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in the LLM answer that conflict with the ground truth. While the original answer specifies that Imbruvica was selected for price-setting and that prices take effect in 2026 (for Part B), the LLM omits this specific drug and exact year—but this is a minor omission, not an error. The LLM correctly identifies the mechanism (CMS setting prices for Part B/D drugs) and implies future impact without specifying 2026/2028. (3) The multi-hop reasoning is sound: the model correctly distinguishes between two different types of Medicare-related risk—reimbursement risk for a provider (CVS) vs. price-setting for a manufacturer (AbbVie)—and links both to the IRA’s impact on Medicare, showing synthesis across entities and mechanisms. (4) The answer is contextually relevant and directly addresses the comparative exposure question. The only reason for not scoring a 10 is the omission of Imbruvica and the specific 2026 implementation date, which are part of the ground truth and add precision, especially for AbbVie’s exposure. However, the absence does not distort the meaning or reduce the overall correctness significantly. Wording differences are semantically equivalent and acceptable.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 469,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How does Microsoft's inclusion of operating systems in its product revenue influence AMD's dependency on Microsoft's operating system support for its x86-based microprocessor and graphics products?",
      "original_answer": "Microsoft's product revenue includes operating systems, which are critical components for PC functionality. AMD relies on Microsoft to design and develop its operating systems to support AMD's x86-based microprocessors and graphics products. If Microsoft does not continue to support AMD's innovations through its operating systems, independent software vendors may avoid optimizing applications for AMD products, and customers may be less inclined to purchase PCs with AMD components, materially affecting AMD's business.",
      "llm_answer": "Microsoft’s 2022 10‑K shows that operating systems represent a substantial share of its product revenue (pages 60‑63), underscoring how central OS is to the PC ecosystem.  AMD’s own risk disclosures (pages 28‑30) note that its x86‑based microprocessors and graphics cards require Microsoft’s OS design, driver certification and ongoing support to function and be sold; thus, AMD’s business success is materially tied to Microsoft’s continued development and maintenance of its operating systems.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly identifies that Microsoft's operating systems are a significant part of its product revenue, referencing the 2022 10-K (pages 60–63), which is consistent with the original answer’s premise. While the original answer does not specify a dollar amount or percentage, the LLM appropriately avoids quantifying 'substantial share' numerically, so no inaccuracy is introduced. (2) There are no numerical values to verify, but the reference to fiscal year 2022 and page numbers is contextually appropriate and does not contradict the ground truth. (3) The multi-hop reasoning is sound: the LLM connects Microsoft’s OS revenue importance to its ecosystem influence, then cites AMD’s own risk disclosures (pages 28–30) to establish dependency—this synthesizes information across both companies’ filings logically. (4) The answer captures the core causal relationship: AMD depends on Microsoft’s OS support for functionality, market acceptance, and business success. The only minor shortcoming is that it does not explicitly mention the downstream effect on independent software vendors or customer purchasing behavior as in the original answer, which slightly reduces completeness in conveying the full chain of impact. However, the key point about material business dependence is preserved. Wording differs but semantic meaning is equivalent. All entities (Microsoft, AMD, x86 microprocessors, graphics products, OS support) are correct and appropriately contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 425,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does Cisco's network infrastructure for AI training and inference workloads compare to Broadcom's support for enterprise-scale AI and machine learning workloads through VMware Cloud Foundation, particularly in terms of enabling multicloud architectures and Kubernetes integration?",
      "original_answer": "Cisco provides high-density routers, switches, and high-performance optics to scale network infrastructure for AI training and inference workloads, aiming to simplify data center operations across multicloud environments. VMware Cloud Foundation (VCF), produced by Broadcom, enables enterprise-scale AI and machine learning workloads by offering native Kubernetes support, allowing both virtual machines and containerized workloads to run on a single platform. VCF also provides license portability, enabling customers to move environments between on-premises and cloud endpoints, aligning with Cisco's vision of policy and operational consistency across multicloud architectures. Broadcom values VCF through developed technology using the multi-period excess earnings method, reflecting its strategic role in supporting AI workloads.",
      "llm_answer": "Cisco’s AI‑training and inference infrastructure is built around high‑density routers, switches and high‑performance optics that deliver policy and operational consistency across multicloud architectures, but it does not explicitly feature Kubernetes integration (Cisco 10‑K, p.5). In contrast, Broadcom’s VMware Cloud Foundation is a private‑cloud platform that bundles compute, networking, storage, and security with native Kubernetes support, enabling enterprise‑scale AI and ML workloads to run on a single, license‑portable platform across on‑premises and cloud endpoints (Broadcom 10‑K, pp. 6‑7). Thus, Cisco focuses on the networking hardware and multicloud policy layer, while Broadcom provides a software‑defined, Kubernetes‑enabled environment that directly supports large‑scale AI workloads in multicloud settings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Cisco's role in providing high-density networking hardware (routers, switches, optics) for AI workloads and multicloud consistency is accurately described, as is Broadcom's VMware Cloud Foundation (VCF) offering native Kubernetes support, license portability, and support for enterprise-scale AI/ML workloads. The distinction between Cisco’s hardware/networking focus and Broadcom’s software-defined, platform-level approach is correctly synthesized. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—thus, quantitative accuracy is not applicable but assumed correct by absence of error. (3) The multi-hop reasoning across Cisco and Broadcom’s respective SEC filings is sound: the model correctly identifies that Cisco enables AI infrastructure through network scalability and operational consistency, while Broadcom (via VCF) supports AI workloads through integrated Kubernetes and hybrid cloud flexibility. The LLM correctly infers complementary roles without conflating the two. (4) The only minor omission is that the original answer mentions Broadcom values VCF using the multi-period excess earnings method—a detail absent in the LLM response. However, this does not impact the core comparison asked in the question about architecture and Kubernetes integration. Wording differs but semantic meaning and technical accuracy are preserved. Contextual relevance is perfect as all parts of the question are addressed: multicloud architectures, Kubernetes integration, AI workload support, and enterprise-scale capabilities.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 462,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does PayPal's use of pricing models for derivatives compare to Morgan Stanley's Level 3 valuation techniques, particularly in terms of reliance on unobservable inputs for fair value measurement?",
      "original_answer": "PayPal primarily uses Level 2 inputs for its derivatives, incorporating observable data such as currency rates, interest rate yield curves, option volatility, and equity prices in its pricing models, and did not have any Level 3 assets or liabilities as of December 31, 2024. In contrast, Morgan Stanley utilizes Level 3 classifications when unobservable inputs are significant, particularly for non-exchange-traded investments and certain secured financings where market liquidity is limited or unavailable. This indicates that Morgan Stanley has a greater reliance on internally derived assumptions for fair value measurement compared to PayPal, which avoids Level 3 classifications entirely.",
      "llm_answer": "PayPal’s derivatives are priced with models that rely on observable market inputs—currency rates, yield curves, volatility and equity prices—and the company reports no Level‑3 fair‑value items, indicating no reliance on unobservable inputs (PayPal 10‑K, pp. 91‑95).  \nMorgan Stanley, by contrast, classifies many of its derivatives as Level‑3 when significant inputs are unobservable (e.g., illiquid interest‑rate swaps), meaning its fair‑value measurement depends more heavily on subjective, unobservable assumptions (Morgan Stanley 10‑K, pp. 96‑100).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that PayPal uses observable inputs (currency rates, yield curves, volatility, equity prices) for its derivatives pricing and reports no Level 3 assets or liabilities, aligning with the original answer's claim that PayPal avoids Level 3 classifications entirely as of December 31, 2024. (2) No specific numerical values (e.g., dollar amounts, percentages) are required in this comparison; the absence of Level 3 items is a qualitative fact correctly conveyed. (3) The multi-hop reasoning is sound: the model correctly contrasts PayPal’s reliance on Level 2 inputs with Morgan Stanley’s use of Level 3 classifications when unobservable inputs are significant, particularly citing illiquid instruments like certain interest-rate swaps as examples. (4) The entities—PayPal and Morgan Stanley—are correctly identified, along with the relevant valuation techniques (Level 2 vs Level 3) and the conceptual distinction based on observability of inputs. The answer fully addresses the comparative aspect of the question regarding reliance on unobservable inputs. Minor differences in wording (e.g., 'illiquid interest-rate swaps' as an example not in the original but consistent with it) do not affect factual accuracy. All components of the question are addressed with precise, correct information and logical synthesis across the two companies’ 10-K disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 403,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "Given that META's Class B common stockholders have limited voting rights on specific corporate actions, and CMCSA's Class A common stock is the primary voting share class, how might the ownership structure of 343,761,117 outstanding Class B shares at META affect the potential for shareholder-driven governance changes compared to CMCSA's 3,778,302,017 outstanding Class A shares?",
      "original_answer": "META's Class B common stockholders, of which there are 343,761,117 outstanding shares, possess limited voting rights, only applicable in specific corporate actions such as exiting the core payments business or certain mergers. This restricts their ability to influence broader governance decisions, which are largely controlled by Class A shareholders. In contrast, CMCSA's 3,778,302,017 outstanding Class A shares carry full voting rights, enabling more direct shareholder influence over corporate governance. As a result, shareholder activism or governance overhauls would face a higher threshold for success at META due to the constrained voting power of its Class B holders, compared to the more broadly distributed and influential Class A shareholder base at CMCSA.",
      "llm_answer": "META’s 343 million Class B shares carry only limited voting rights – shareholders can vote only on a narrow set of matters and their votes are weighted by a conversion rate (see the 10‑K note on Class B voting rights).  In contrast, Comcast’s 3.78 billion Class A shares are the primary voting class and provide a large, fully voting base that can more readily influence governance decisions (see the 10‑K disclosure of Class A voting status and share count).  Thus, the ownership structure at META limits shareholder‑driven governance change, whereas Comcast’s larger, fully voting share pool gives shareholders greater potential to effect such changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: META has 343,761,117 Class B shares with limited voting rights, and CMCSA has 3,778,302,017 Class A shares as the primary voting class. The LLM correctly rounds these to '343 million' and '3.78 billion', which is acceptable under format variation rules. (2) Quantitative accuracy is perfect—no calculation errors, and the numbers match the original answer exactly when accounting for rounding. (3) The reasoning correctly synthesizes the multi-hop elements: it contrasts META's restricted voting structure (Class B limited to narrow corporate actions) with CMCSA's broad shareholder influence via fully voting Class A shares. It logically concludes that shareholder-driven governance changes are more difficult at META than at CMCSA. (4) Minor deduction in qualitative accuracy because the LLM references a 'conversion rate' and cites '10-K note' without confirming that detail from the source data—this nuance isn't in the ground truth and slightly overreaches, though it may be contextually plausible. Otherwise, the answer is semantically equivalent, complete, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 338,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "What percentage of KO's non-U.S. unit case volume is attributable to sparkling soft drinks in territories where CCEP operates, and how does this compare to PM's operational presence in Portugal, one of CCEP's key markets?",
      "original_answer": "KO's non-U.S. unit case volume is 71% attributable to sparkling soft drinks in territories where CCEP operates, including Portugal. Meanwhile, PM has a manufacturing facility in Portugal, which is among its largest facilities producing over 30 billion units (cigarettes and heated tobacco units combined). This highlights KO's significant reliance on CCEP for sparkling beverage distribution in key international markets, while PM maintains a direct production footprint in one of those same strategic locations.",
      "llm_answer": "KO’s sparkling soft drinks represent **71 % of its non‑U.S. unit‑case volume**—a share that includes the territories where CCEP operates. In contrast, Philip Morris International’s presence in **Portugal, one of CCEP’s key markets, is a single manufacturing facility located there**.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key percentage—71% of KO's non-U.S. unit case volume attributable to sparkling soft drinks in CCEP-operated territories—which matches the ground truth exactly. This satisfies the primary quantitative requirement. However, the LLM omits the specific detail about PM's manufacturing output in Portugal (over 30 billion units of cigarettes and heated tobacco), which is a significant part of the comparison. While it correctly notes PM has a manufacturing facility in Portugal, it fails to convey the scale of operations, weakening the comparative analysis. (2) All numbers presented (71%) are accurate and correctly formatted. No calculation errors. (3) The multi-hop reasoning is partially sound: the model connects KO’s volume share to CCEP’s operational territories and correctly situates Portugal as a shared market. However, it does not fully synthesize the contrast between KO’s distribution reliance on CCEP and PM’s direct production footprint with quantified output, which is central to the ground truth’s insight. (4) Scores reflect high factual accuracy on core numbers, but a moderate deduction for missing key qualitative context in the comparison, particularly PM’s production scale in Portugal. The answer remains contextually relevant and mostly complete, but lacks depth in the comparative analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 379,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "Given Cisco's reduced credit loss allowance for loan receivables from $103 million in 2022 to $53 million in 2023, how might this change impact their ability to finance technical support services, which are explicitly included in their loan receivables portfolio?",
      "original_answer": "Cisco's credit loss allowance for loan receivables decreased by 48.5% from $103 million in 2022 to $53 million in 2023. Since Cisco explicitly states that loan receivables include financing arrangements for technical support services, this reduction in credit loss allowance suggests improved credit quality or lower risk in these financing arrangements. A smaller allowance could indicate Cisco is more confident in the creditworthiness of customers receiving technical support financing, potentially enabling Cisco to expand financing options for technical support services with reduced financial risk. This could lead to more competitive financing terms for customers seeking technical support services.",
      "llm_answer": "Cisco’s allowance for credit loss on loan receivables fell from $103 million in 2022 to $53 million in 2023—a $50 million reduction that signals improved credit quality and lower expected defaults. Because loan receivables include financing for hardware, software and technical‑support services, the lower reserve frees up capital and improves cash flow, enabling Cisco to extend or expand financing for technical support or offer more favorable terms to customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the reduction in Cisco's credit loss allowance from $103 million in 2022 to $53 million in 2023, accurately stating a $50 million decrease. While the original answer includes the percentage decrease (48.5%), the LLM omits this specific figure but still conveys the magnitude and direction of change correctly. All entities (Cisco, loan receivables, technical support services, years) are accurate. 2) Quantitatively, the numbers are correct: $103M to $53M is indeed a $50M reduction. The percentage (48.5%) is missing but not misrepresented. No calculation errors. 3) The reasoning is sound: the LLM correctly links the reduced allowance to improved credit quality, connects loan receivables to financing for technical support services (as stated in the ground truth), and infers that lower risk could enable expanded or more favorable financing terms. This demonstrates proper multi-hop synthesis between the allowance change and its implication for service financing. 4) The answer is semantically equivalent to the ground truth in intent and factual content, though slightly less detailed in expressing the confidence aspect ('more confident in creditworthiness'). However, 'improved credit quality' captures the core idea. The omission of the exact percentage drop is minor and does not affect overall correctness. Contextual relevance is perfect—directly addresses the impact on financing technical support services.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 401,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How does AT&T's Series B Preferred Stock structure, which grants limited voting rights only on specific merger-related matters, compare to Netflix's universal voting rights for common stockholders in terms of corporate governance influence?",
      "original_answer": "AT&T's Series B Preferred Stockholders have no voting rights except on specific merger-related matters where they can vote as a single class with each holder casting votes equal to the number of shares held. This contrasts with Netflix, where each share of common stock provides one vote on all matters to be voted upon by stockholders, giving common stockholders broader governance influence. AT&T's structure limits Series B Preferred Stockholders' influence to defined corporate actions, whereas Netflix's model ensures universal voting participation for common stockholders.",
      "llm_answer": "AT&T’s Series B preferred stock gives holders no voting rights except on a narrow set of merger‑related matters, so their influence on day‑to‑day governance is limited to those specific events (T_10k_2023, pp. 100‑104).  \nNetflix’s common stockholders, by contrast, enjoy universal voting rights—one vote per share on all matters to be voted on by the company (NFLX_10k_2023, pp. 59‑63).  \nAccordingly, AT&T’s preferred holders have far less corporate‑governance influence than Netflix’s common shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It accurately states that AT&T’s Series B Preferred Stockholders have no voting rights except on specific merger-related matters, while Netflix common stockholders have one vote per share on all matters. These facts align with the original answer. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages, or dates), so quantitative accuracy is not compromised; all referenced document citations (T_10k_2023, NFLX_10k_2023) are contextually appropriate and correctly attributed. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance structures across two different companies (AT&T and Netflix) and contrasts their voting rights frameworks to draw a valid conclusion about relative corporate governance influence. (4) The only minor limitation is that the LLM answer does not explicitly mention that AT&T preferred holders vote 'as a single class' or that their voting power is 'equal to the number of shares held'—details present in the ground truth—which slightly reduces completeness in qualitative nuance. However, this does not affect the core correctness. Overall, the response is highly accurate, relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 356,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How does PayPal's risk of technological disruption from emerging payment methods like BNPL and cryptocurrency compare with Visa's strategic positioning as both partner and competitor to these alternative payment providers?",
      "original_answer": "PayPal faces significant risk from rapid technological changes, particularly in payment methods like BNPL and cryptocurrency, which could render its current offerings obsolete if not adopted timely. Visa, on the other hand, strategically partners with these alternative payment providers while also competing with them, leveraging its global network and security advantages to maintain relevance. This dual role allows Visa to adapt to the evolving payments landscape, whereas PayPal must invest heavily to keep pace or risk losing market share to these emerging platforms.",
      "llm_answer": "PayPal’s 10‑K lists BNPL and cryptocurrency as emerging technologies that could erode its transaction volumes or trigger regulatory scrutiny, labeling them a direct risk to its core payment business (see pages 16–19).  By contrast, Visa’s filing frames BNPL and crypto platforms as both partners and competitors, actively engaging with fintechs through programs such as Fintech Fast Track and the Visa Fintech Partner Connect while still competing for transaction volume on its network (see pages 14–18).  Thus, PayPal faces a more immediate disruption risk, whereas Visa mitigates it by integrating and competing with the same alternative payment providers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that PayPal faces significant risk from BNPL and cryptocurrency as emerging technologies that could erode transaction volumes or bring regulatory scrutiny, citing specific pages (16–19) from its 10-K—consistent with the original answer’s emphasis on disruption risk. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable; however, the LLM correctly references filing page numbers, which aligns with source-based expectations. (3) The multi-hop reasoning is sound: it contrasts PayPal’s vulnerability with Visa’s dual role as both partner and competitor, citing Visa’s Fintech Fast Track and Visa Fintech Partner Connect programs (pages 14–18), demonstrating synthesis across both companies’ filings. (4) The LLM captures the core strategic distinction: PayPal must react to disruption, while Visa proactively integrates and competes with alternative payment providers. The only minor shortcoming is that it doesn’t explicitly mention Visa’s 'global network and security advantages' as a reason for its stronger positioning, which slightly reduces qualitative completeness. However, the omission does not undermine the central, correct conclusion about strategic positioning. Overall, the answer is highly relevant, factually correct, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 395,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does the voting power per share of Netflix's common stock compare to the voting rights associated with Alphabet's Class A Common Stock, given both companies' disclosed equity structures?",
      "original_answer": "Netflix's common stock grants one vote per share, as stated in its 2023 10-K filing. Similarly, Alphabet's Class A Common Stock also provides one vote per share, as outlined in its 2023 10-K filing. This indicates that both companies offer equivalent voting power per share for their respective common stockholders, despite Alphabet having multiple stock classes with differing voting rights, such as Class B shares with 10 votes per share.",
      "llm_answer": "Netflix’s common stock is entitled to **one vote per share** (see NFLX 10‑K, pages 59‑63). Alphabet’s Class A common stock likewise carries **one vote per share** (see GOOGL 10‑K, pages 79‑83). Thus, the voting power per share is identical for both companies’ common equity.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Both Netflix and Alphabet are accurately described as granting one vote per share for their common stock, matching the original answer. (2) There are no numerical values requiring calculation, but the 'one vote per share' metric is correctly reported for both companies, with appropriate citations to their respective 10-K filings (pages may vary slightly but are within acceptable range). (3) The multi-hop reasoning—comparing voting rights across two companies using their disclosed equity structures—is sound and correctly synthesized from both filings. (4) The answer addresses all parts of the question: it identifies the voting power per share for both Netflix common stock and Alphabet Class A Common Stock, and concludes the equivalence in voting rights, despite Alphabet's multi-class structure (which is implicitly acknowledged by specifying Class A). Wording differs slightly from the original but conveys the same factual content with no omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 302,
        "total_tokens": 1491
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does the use of the parametric delta-gamma approximation technique by PM under normal market conditions compare with MDLZ's application of the same method, particularly in terms of their respective VAR estimates and risk exposure assumptions?",
      "original_answer": "Both PM and MDLZ utilize the parametric delta-gamma approximation technique in their VAR models under normal market conditions, with a 95% confidence interval and a one-day holding period. PM observed interest rate and forward currency rate movements primarily over the preceding quarter to determine interrelationships and calculate risk for their portfolio. MDLZ similarly observed interest rate, currency exchange, and commodity price movements over the prior quarter for VAR calculations at year-end. However, MDLZ specifically notes that the values of currency and commodity options do not change on a one-to-one basis with the underlying assets and were valued accordingly, while PM focuses on interrelationships between movements in interest rates and currencies. Both companies use VAR to estimate maximum potential one-day losses, but MDLZ provides specific disclosure of their VAR amounts at year-end, while PM focuses on the methodology and assumptions without disclosing a specific VAR figure.",
      "llm_answer": "PM’s 10‑K (pp. 79‑83) reports a one‑day VAR of $284 million (combined) at 12/31/23, derived with a parametric delta‑gamma model that covers interest‑rate, foreign‑currency, equity and commodity derivatives and excludes only anticipated transactions and net foreign‑currency positions. MDLZ’s 10‑K (pp. 62‑66) uses the same technique but reports separate fair‑value impacts – $119 million for interest rates and $14 million and $21 million pre‑tax‑earnings impacts for currency and commodity exposures – totalling roughly $154 million, and it does not include equity exposures or a combined portfolio figure. Both exclude anticipated transactions, foreign‑currency trade payables/receivables and net foreign‑investment positions, but PM’s VAR aggregates all derivative exposures while MDLZ’s is broken into distinct categories.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) Quantitative Accuracy: The LLM claims PM reported a one-day VAR of $284 million at 12/31/23, but the original answer states PM does *not* disclose a specific VAR figure—this is a major error. Similarly, the LLM attributes specific dollar amounts to MDLZ ($119M, $14M, $21M) and implies a total of $154M, but the ground truth does not mention these figures; instead, it says MDLZ discloses VAR amounts at year-end without specifying them in the provided answer. These numbers are fabricated or misattributed. (2) Completeness: The question asks for a comparison of the *use* of the parametric delta-gamma method, including VAR estimates and risk exposure assumptions. The LLM introduces equity derivatives for PM and claims MDLZ excludes equity exposures—but the original answer does not mention equity at all, so this is an unsupported addition. (3) Entity Accuracy: While PM and MDLZ are correctly identified, the fiscal year (12/31/23) and specific page numbers (pp. 79–83, 62–66) are not in the ground truth and cannot be verified, suggesting hallucination. (4) Reasoning: The multi-hop synthesis is flawed—instead of comparing methodological similarities (e.g., both use prior quarter data, same confidence interval and holding period), the LLM invents numerical comparisons that aren't supported. It incorrectly frames MDLZ’s disclosures as additive components of VAR when the original answer emphasizes MDLZ’s qualitative note about non-linear option valuation. (5) Semantic Equivalence: The LLM answer is structurally plausible but factually divergent. It focuses on unreported numbers and false contrasts rather than the actual similarities in methodology and differences in disclosure practices. The core claim—that PM provides no specific VAR figure while MDLZ does—is reversed in the LLM response, which falsely assigns a number to PM and breaks down MDLZ’s exposure numerically. Thus, despite addressing the general topic, the answer fails on key facts and calculations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 555,
        "total_tokens": 2038
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does Capital One's exposure to the Market Risk Rule, which adjusts capital ratios based on trading book risks, compare with JPMorgan Chase's regulatory capital requirements under Basel III, particularly in relation to their respective trading asset thresholds and VaR methodologies?",
      "original_answer": "Capital One (COF) is subject to the Market Risk Rule due to its trading assets and liabilities exceeding $1 billion or 10% of total assets, requiring adjustments to its risk-based capital ratios. This rule supplements the Basel III Capital Rules, which are also central to JPMorgan Chase's (JPM) regulatory capital framework. JPM calculates Regulatory VaR under Basel III with a 99% confidence level and a ten-business-day holding period, applying it to 'covered' positions. In contrast, COF’s capital adequacy is evaluated under Basel III standardized and proposed Expanded Risk-Based Approaches, with the latter phasing in by 2028. These differences highlight how both firms manage market risk capital requirements, with JPM using a more granular internal VaR model while COF must comply with both current and evolving Basel III standards.",
      "llm_answer": "Capital One is subject to the Market Risk Rule because its aggregate trading assets and liabilities equal at least 10 % of total assets or $1 billion, so it must adjust its risk‑based capital ratios to reflect market‑risk exposure in its trading book (COF 10‑K, pp. 84‑88).  JPMorgan Chase, which also meets the same 10 %/ $1 billion threshold, calculates its Basel III market‑risk capital through a defined VaR framework: a 10‑business‑day, 99 % confidence “regulatory VaR” applied to covered positions (with a 1‑day, 95 % confidence “risk‑management VaR” for internal use) (JPM 10‑K, pp. 143‑147).  Thus, Capital One’s exposure is governed by a threshold‑based rule that requires a capital adjustment, whereas JPMorgan’s Basel III requirements rely on a specific VaR methodology to determine the market‑risk capital charge.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Capital One's exposure to the Market Risk Rule due to the $1 billion or 10% threshold is accurately stated, as is JPMorgan Chase's use of a 99% confidence level and 10-business-day holding period for regulatory VaR. These quantitative thresholds match the original answer exactly. (2) Quantitative accuracy is perfect: percentages (10%, 99%, 95%), dollar threshold ($1 billion), and holding periods (10-day, 1-day) are all correctly reported. (3) The multi-hop reasoning is sound—comparing Capital One’s threshold-based compliance with JPMorgan’s internal VaR model under Basel III demonstrates proper synthesis across both firms’ 10-K disclosures. (4) The only minor omission is that the original answer notes Capital One will be transitioning to the 'Expanded Risk-Based Approaches' under Basel III by 2028, which the LLM answer does not mention. While this adds forward-looking context, it does not undermine the core factual correctness of the response. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9 for correctness and qualitative accuracy due to this slight incompleteness, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 358,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does Cisco's credit loss allowance for loan receivables tied to technical support services compare to Salesforce's reliance on third-party technical support providers, given both companies' exposure to service delivery risks?",
      "original_answer": "Cisco reported a $53 million credit loss allowance for loan receivables as of July 29, 2023, which includes financing arrangements specifically related to technical support services provided to customers. This indicates a financial risk exposure tied directly to service delivery outcomes. Meanwhile, Salesforce acknowledges its reliance on third parties to deliver technical support services to customers, stating that dissatisfaction with third-party service quality could harm its business and revenue recognition. While Cisco directly finances its technical support services and bears credit risk, Salesforce's risk manifests through potential third-party service failures affecting customer satisfaction and retention.",
      "llm_answer": "Cisco’s 10‑K shows a $50 million allowance for credit losses on loan receivables that include financing tied to technical‑support and advanced services (see Note 9, pages 80‑86). Salesforce’s 10‑K, by contrast, notes that it relies on third‑party technical‑support providers to deliver services, exposing it to service‑delivery risk but does not disclose a specific credit‑loss allowance (see pages 17‑21). Thus, Cisco quantifies its exposure with a $50 million buffer, while Salesforce’s risk is operational and not expressed as a credit‑loss figure.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Cisco's credit loss allowance and its connection to technical support financing, and accurately notes Salesforce's reliance on third-party providers and associated service delivery risks. However, the dollar amount reported for Cisco is $50 million, while the ground truth specifies $53 million as of July 29, 2023. This $3 million discrepancy affects quantitative accuracy. (2) The numbers are mostly correct but not fully precise—$50M vs $53M is a material difference in financial reporting context, especially when citing exact allowances. The date (July 29, 2023) is not mentioned in the LLM answer, which slightly reduces completeness. (3) The multi-hop reasoning is sound: the model correctly contrasts Cisco’s direct financial risk (credit loss allowance) with Salesforce’s operational risk (third-party reliance), synthesizing information across both companies’ 10-Ks. The conclusion that Cisco quantifies its risk while Salesforce does not express it as a credit-loss figure is logically valid and well-supported. (4) Despite the minor numerical inaccuracy, the answer captures the core contrast in risk exposure types and sources. The explanation is semantically close to the original and highly relevant, with strong qualitative reasoning and entity accuracy (Cisco, Salesforce, technical support, credit loss, third-party providers).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 388,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How does the governance risk associated with META's dual-class structure, particularly its impact on investor confidence in Class A common stock, contrast with CMCSA's equity structure that includes Class B common stock but lacks a conversion mechanism tied to governance restrictions?",
      "original_answer": "CMCSA's equity structure includes 9,444,375 issued and outstanding shares of Class B common stock as of 2023, but unlike META, there is no indication that CMCSA ties governance rights or stock conversion to special investor restrictions. In contrast, META's dual-class structure grants Class B stockholders, including Mr. Zuckerberg, disproportionate control over corporate decisions, such as requiring a majority of Class B stock approval for any change in control until those shares represent less than 35% of combined voting power. META also notes that its status as a 'controlled company' could make its Class A common stock less attractive to some investors due to reduced corporate governance protections. This implies that while both companies have Class B shares, META's structural governance risks tied to its dual-class system are more pronounced and explicitly linked to investor sentiment toward Class A shares, unlike CMCSA where the Class B shares do not appear to carry similar governance-linked conversion or control features.",
      "llm_answer": "META’s dual‑class structure concentrates voting power in the hands of the CEO and other holders of its Class B shares (ten votes per share versus one for Class A), which can erode investor confidence in Class A common stock and may depress its price (META 10‑K, pp. 48‑52). In contrast, Comcast’s equity structure includes a separate Class B common‑stock class but does not provide a conversion mechanism or governance‑linked restrictions, so the governance risk is less pronounced and investors in Class A shares face a more conventional voting structure (CMCSA 10‑K, pp. 67‑71).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core contrast between META's and CMCSA's equity structures as described in the ground truth. (1) All factual elements are correct: META’s dual-class structure with 10:1 voting rights for Class B shares, concentration of control with the CEO (Zuckerberg), and the resulting potential erosion of investor confidence in Class A shares are accurately represented and align with the ground truth. The reference to META’s 'controlled company' status and its implications are correctly implied, even if not explicitly stated. For CMCSA, the LLM correctly notes the existence of Class B shares but absence of governance-linked conversion mechanisms, which matches the ground truth assertion that no such restrictions exist. (2) There are no numeric inaccuracies. While the ground truth includes a specific figure (9,444,375 Class B shares for CMCSA), the LLM answer does not mention this number. However, the omission of this specific quantitative detail does not impair the qualitative correctness of the comparison, as the question primarily focuses on governance mechanisms, not share counts. The LLM is not penalized for omitting a non-critical number. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (META and CMCSA), compares their dual-class structures, and draws a valid conclusion about relative governance risk. It correctly identifies that META’s structure has explicit governance implications affecting investor sentiment, while CMCSA’s does not. (4) The answer is contextually relevant and directly addresses the contrast in governance risk as it pertains to investor confidence and structural design. The only minor shortcoming is the lack of explicit mention of the 35% voting power threshold for META’s control provisions, which is a nuanced but not central detail. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth in substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 535,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How does AIG's valuation of RMBS using discounted cash flow models compare to MS's use of discounted cash flow in fair value estimation, particularly in terms of reliance on unobservable inputs?",
      "original_answer": "AIG values its RMBS portfolio using discounted cash flow models that rely heavily on unobservable inputs such as constant prepayment rate (ranging from 4.10% to 9.26%) and loss severity (ranging from 40.81% to 76.72%). Similarly, MS identifies discounted cash flow as a key valuation technique in estimating fair value for financial instruments and goodwill impairment testing, particularly for Level 3 assets which rely on significant unobservable inputs. MS notes that Level 3 assets represented 0.9% of total assets as of December 31, 2024, indicating a smaller but still material reliance on unobservable assumptions in their fair value measurements.",
      "llm_answer": "AIG’s RMBS valuation is performed with discounted‑cash‑flow models that rely on significant unobservable inputs—such as constant pre‑payment rates, loss severity and default rates (AIG_10k_2024.pdf, pp. 124‑125).  By contrast, Morgan Stanley’s fair‑value estimation also uses discounted‑cash‑flow techniques but depends mainly on observable market data, with only minimal use of unobservable inputs (MS_10k_2024.pdf, pp. 40‑44).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitatively, the original answer states that MS's Level 3 assets—which rely on significant unobservable inputs—represented 0.9% of total assets as of December 31, 2024, indicating a material but limited reliance on unobservable inputs. However, the LLM incorrectly claims that Morgan Stanley 'depends mainly on observable market data, with only minimal use of unobservable inputs,' which contradicts the ground truth that MS explicitly uses significant unobservable inputs for Level 3 assets and includes discounted cash flow models in fair value estimation and goodwill impairment testing. (2) The LLM omits key quantitative ranges from AIG's valuation (e.g., CPR from 4.10% to 9.26%, loss severity from 40.81% to 76.72%) and fails to mention MS's 0.9% Level 3 asset figure, which is central to assessing the degree of reliance on unobservable inputs. (3) Qualitatively, the reasoning is flawed: the comparison suggests a strong contrast between AIG and MS, whereas the ground truth shows both firms use DCF models with significant unobservable inputs—AIG for RMBS, MS for Level 3 assets and goodwill testing—making the reliance more similar than different. The LLM fails this multi-hop synthesis by incorrectly characterizing MS's approach. (4) Contextual relevance is moderate because the answer addresses the right topic (DCF use and input observability) and cites correct document sources, but the core conclusion about MS's minimal use of unobservables is factually wrong. Thus, despite correct entity identification (AIG, MS, RMBS, DCF), the answer misrepresents key facts and comparisons, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 468,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does the change in Cisco's allowance for credit losses on loan receivables tied to hardware financing compare to Microsoft's revenue recognition approach for hardware that is similarly interdependent with software, and what does this reveal about their respective financial exposures to integrated hardware-software offerings?",
      "original_answer": "Cisco's allowance for credit losses on loan receivables tied to hardware financing decreased from $103 million in fiscal year 2022 to $53 million in fiscal year 2023, indicating a reduction in expected defaults on financing extended for hardware sales. These loan receivables are explicitly tied to the sale of Cisco's hardware and third-party products. Meanwhile, Microsoft recognizes hardware revenue at the point of sale only when it is transferred to resellers or end customers, especially in cases where the hardware is highly interdependent with the operating system and cannot function without it, similar to Cisco's financing structure for integrated offerings. This reveals that while Cisco manages credit risk exposure through allowances on multi-year financing arrangements, Microsoft's financial exposure is more closely tied to point-of-sale recognition, with less direct credit risk but greater dependency on the performance of integrated software-hardware systems post-sale.",
      "llm_answer": "Cisco’s allowance for credit losses on loan receivables tied to hardware financing fell from **$53 million to $50 million** (a $3 million reduction), indicating a modest improvement in expected credit losses on its customer‑financed hardware. Microsoft, by contrast, treats hardware and its interdependent software license as a **single performance obligation** and recognizes revenue **at the point of ownership transfer**. The difference shows Cisco’s integrated hardware‑software offering carries a measurable credit‑risk exposure from financing arrangements, whereas Microsoft’s model exposes it mainly to revenue‑recognition timing rather than to financing‑related credit losses.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. According to the ground truth, Cisco's allowance for credit losses decreased from $103 million in fiscal year 2022 to $53 million in fiscal year 2023—a $50 million reduction. The LLM incorrectly states the change was from $53 million to $50 million (a $3 million reduction), which misrepresents both the starting and ending values and the magnitude of the change. This is a critical error in financial data reporting. (2) While the LLM correctly identifies Microsoft's revenue recognition at the point of ownership transfer and the concept of a single performance obligation for interdependent hardware-software bundles, it omits the explicit comparison to Cisco’s financing model being tied to third-party products and multi-year arrangements. The qualitative insight about Cisco bearing credit risk while Microsoft avoids direct financing risk is partially correct and well-reasoned. (3) The multi-hop reasoning is partially sound—linking Cisco’s allowance changes to credit risk exposure and contrasting it with Microsoft’s point-of-sale recognition shows understanding of financial implications. However, the flawed numbers undermine the validity of the comparison. (4) The contextual relevance is high because the answer addresses the core contrast in financial exposure models. Scores reflect major quantitative inaccuracy (3/10), moderate qualitative accuracy due to correct conceptual framework but incomplete synthesis (6/10), and strong relevance to the question’s intent (8/10). Correctness score is 4 due to the severe numerical error despite some correct reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 458,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does AIG's $75 million loss from embedded derivatives in 2024 compare to MS's credit risk exposure through CDOs that contain similar hybrid instruments with embedded derivatives, given both firms' involvement in structured credit products?",
      "original_answer": "AIG reported a $75 million loss from embedded derivatives in 2024, indicating significant credit-related losses from these structured instruments. MS disclosed involvement in CDOs and CLNs that are classified as hybrid instruments containing embedded derivatives, where credit protection has been sold to the issuer. If a credit event occurs on the underlying reference entity, the principal balance of the note may not be repaid in full to the Firm. This parallels AIG’s exposure, as both firms face direct credit risk tied to the performance of reference entities in structured products, with MS’s CDOs posing similar potential for principal loss under credit events as seen in AIG’s realized loss.",
      "llm_answer": "AIG reported a $75 million loss from embedded derivatives in 2024 (see the “Derivatives not designated as hedging instruments” table on pages 142‑146).  The MS 10‑K pages supplied do not disclose a specific dollar amount for its credit‑risk exposure through CDOs that contain similar hybrid instruments with embedded derivatives, so a direct dollar‑to‑dollar comparison cannot be made from the information provided.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in stating AIG's $75 million loss from embedded derivatives in 2024 and correctly notes that MS's 10-K does not disclose a specific dollar amount for its credit risk exposure through CDOs with hybrid instruments. The quantitative accuracy is perfect—no incorrect numbers or misstatements of disclosed figures. However, the qualitative accuracy is lower because the LLM fails to fully address the comparative aspect of the question beyond the lack of a dollar figure. The original answer draws a meaningful parallel between AIG’s realized loss and MS’s structural exposure through CDOs and CLNs, where both firms face principal loss risk upon credit events due to selling credit protection via embedded derivatives. This conceptual synthesis across firms and instruments—a key multi-hop requirement—is missing in the LLM response. Instead, the LLM stops at the absence of a quantifiable number, which, while honest, omits the qualitative comparison grounded in similar risk profiles and instrument structures. The response is contextually relevant and accurately reflects the limitations of the data but falls short in delivering the deeper, reasoning-based comparison implied by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 343,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How does the duration of Disney's foreign exchange cash flow hedges for forecasted transactions compare to Google's hedge maturity periods, given both companies' use of option contracts to manage foreign currency exposure?",
      "original_answer": "Disney hedges its forecasted foreign currency transactions for periods generally not to exceed four years, while Google's foreign currency cash flow hedges have maturities of 24 months or less. Both companies use option contracts as part of their cash flow hedging strategies, with Disney reporting $9.9 billion in net foreign exchange cash flow hedges as of September 28, 2024, and Google holding $731 million in net accumulated gains on foreign currency cash flow hedges as of December 31, 2024.",
      "llm_answer": "Disney’s policy allows cash‑flow hedges of forecasted foreign‑currency transactions for periods “generally not to exceed four years” (DIS 10‑K, pp. 119‑123). In contrast, Google’s hedges are structured with much shorter maturities – typically up to 12 months (GOOGL 10‑K, pp. 68‑72). Thus, Disney’s hedges can be longer‑term than Google’s.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Disney hedges for periods generally not exceeding four years, which matches the ground truth. However, it states Google's hedge maturities are 'up to 12 months,' while the ground truth specifies '24 months or less.' This is a significant quantitative inaccuracy, as 12 months is half the actual maximum maturity period reported. Additionally, the LLM omits key financial figures provided in the original answer: Disney’s $9.9 billion in net foreign exchange cash flow hedges as of September 28, 2024, and Google’s $731 million in net accumulated gains as of December 31, 2024. These omissions reduce completeness and quantitative accuracy. (2) The numbers cited for hedge durations are partially correct—Disney’s 4-year cap is accurate, but Google’s 12-month figure is incorrect versus the 24-month maximum in the ground truth. The dollar amounts and dates are entirely missing, which are critical quantitative elements. (3) The multi-hop reasoning is sound in comparing the two companies’ hedging durations and recognizing that both use option contracts (implied in the context), but the failure to accurately report Google’s maturity period and omit financial values weakens the synthesis. (4) The answer is contextually relevant and well-structured, addressing the core comparison of hedge durations. Due to mostly correct reasoning and entity identification but with key numerical inaccuracies and omissions, the correctness score is 7—core facts are partially right, but significant details are wrong or missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 430,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the expected impact of the Global Minimum Tax on QCOM's fiscal year 2025 tax liabilities compare to INTC's exposure under the Pillar Two Model Rules, given the differing geographic distribution of their operations?",
      "original_answer": "QCOM expects minimal impact from the Global Minimum Tax starting in fiscal year 2025, as it does not operate materially in jurisdictions with tax rates below the 15% Pillar Two minimum. In contrast, INTC, which has a significant portion of its income taxed in non-US jurisdictions, is still evaluating the impacts of Pillar Two, particularly as several jurisdictions like the EU plan to adopt components starting in 2024. Both companies monitor Pillar Two developments closely, but INTC faces more immediate uncertainty due to its broader international tax footprint and ongoing legislative adoptions in key markets.",
      "llm_answer": "QCOM expects the OECD’s 15 % global minimum tax to have **no material effect on its FY 2025 tax provision** because its operations are concentrated in the U.S. and China and it has no significant presence in jurisdictions with rates below the Pillar Two threshold【QCOM_10k_2023.pdf, pages 44‑45】.  \nIn contrast, Intel acknowledges that it is **evaluating the impact of Pillar Two Model Rules in the non‑U.S. jurisdictions where it operates**, reflecting a more geographically diverse footprint that could expose it to the minimum‑tax regime【INTC_10k_2023.pdf, pages 42‑45】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core factual content of the ground truth. QCOM's expected minimal impact is accurately stated as 'no material effect' in FY 2025 due to lack of operations in low-tax jurisdictions, and INTC's ongoing evaluation is correctly attributed to its broader international footprint. The geographic reasoning (U.S. and China for QCOM; non-U.S. jurisdictions for INTC) aligns with the original. (2) There are no numeric values (e.g., percentages, dollar amounts) in the question or ground truth beyond the 15% minimum rate, which the LLM correctly includes. All dates (FY 2025, Pillar Two implementation starting 2024 in EU) are contextually accurate and consistent with the source material. (3) The multi-hop reasoning is sound: the model synthesizes information from both QCOM and INTC 10-K filings, compares their exposure based on geographic operations, and draws a valid contrast in uncertainty levels. The only minor omission is that the original mentions EU adoption starting in 2024 as a source of INTC's uncertainty, which the LLM does not explicitly reference, slightly reducing completeness. (4) The answer is semantically equivalent to the ground truth, with precise entity identification (QCOM, INTC, Pillar Two, OECD, FY 2025), correct financial terminology, and strong contextual relevance. The citation of specific 10-K pages adds credibility. The qualitative score is 9 due to the slight lack of detail on EU adoption timing, but overall accuracy and reasoning are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 423,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the difference in voting power ratios between Alphabet's Class B to Class A conversion structure and Comcast's non-dilutable Class B voting rights affect the degree of founder control in corporate governance decisions?",
      "original_answer": "Alphabet maintains a 10:1 voting power ratio between Class B and Class A shares, with Class B shares converting automatically to Class A upon sale or transfer, which allows for dynamic founder control that can diminish with share transfers. In contrast, Comcast's Class B shares hold 33⅓% of voting power that is non-dilutable and convertible share-for-share into Class A, preserving a fixed level of control for Class B holders regardless of share issuance. This means Alphabet's structure allows for more fluid founder influence depending on shareholding behavior, while Comcast's design guarantees a minimum level of voting control that cannot be diluted, offering stronger long-term governance insulation for its Class B shareholders.",
      "llm_answer": "Alphabet’s dual‑class structure gives each Class B share 10 votes versus one for Class A, and because Class B shares can be converted into Class A shares, the founder can retain a majority of voting power (currently >50 %) as long as Class B holdings stay above ~9 % of total shares (Alphabet 10‑K, pp. 79‑83). Comcast’s Class B shares carry 15 votes each but are capped at a fixed 33.3 % of total voting power that cannot be diluted by new issuances or conversion (Comcast 10‑K, pp. 89‑93), limiting founder influence to roughly one‑third of corporate decisions. Thus, Alphabet’s conversion‑enabled structure allows the founder to potentially control all governance matters, whereas Comcast’s non‑dilutable 33 % cap restricts founder control to a fixed minority stake.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general contrast between Alphabet's and Comcast's dual-class structures and correctly identifies the core governance implications. However, there are significant quantitative inaccuracies that undermine factual correctness. First, the claim that Comcast's Class B shares carry '15 votes each' is incorrect — the ground truth does not specify a per-share vote count, but rather that Class B holds a fixed 33⅓% of total voting power regardless of share count, which is non-dilutable. The LLM incorrectly infers a 15:1 ratio, which is not supported by the original answer or typical public disclosures. Second, the assertion that Alphabet founders need only ~9% of total shares to maintain majority control, while plausible, is not present in the ground truth and introduces unsupported specificity. The original answer emphasizes the 10:1 voting ratio and automatic conversion upon transfer, but does not quantify a threshold like 9%. On qualitative grounds, the LLM correctly notes that Alphabet’s structure allows dynamic control that can diminish with share transfers, and that Comcast’s structure caps influence at one-third, preserving a non-dilutable floor. The reasoning around conversion mechanics and governance implications is logically sound and contextually relevant. However, the introduction of incorrect vote ratios and unverified thresholds reduces quantitative accuracy. The answer synthesizes multi-hop concepts (conversion rules, dilution protection, founder control) appropriately but bases conclusions on flawed numerical premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 430,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the indemnification agreement between PM USA and PMI affect Altria's (MO) financial exposure to tobacco-related litigation liabilities compared to PM's retained obligations through RBH deconsolidation?",
      "original_answer": "Under the Distribution Agreement, PMI indemnifies Altria and PM USA for liabilities related to tobacco products manufactured by PMI or contract manufactured by PM USA, while PM USA indemnifies PMI for liabilities related to its own manufactured products, excluding those made for PMI. Altria has not recorded a liability for this indemnification as its fair value is considered insignificant. Meanwhile, PM retains obligations tied to the deconsolidation of RBH, which involved reclassifications from accumulated other comprehensive losses. This structure limits Altria's direct financial exposure to PMI-related litigation, while PM faces ongoing impacts from RBH-related reclassifications.",
      "llm_answer": "Under the distribution agreement, PMI indemnifies Altria and PM USA for liabilities arising from PMI‑manufactured tobacco products, so Altria has no related liability recorded on its consolidated balance sheet (fair‑value insignificant)【PM_10k_2022, pp. 110‑114】. Thus, Altria’s exposure to tobacco‑related litigation is effectively transferred to PMI. In contrast, PMI’s retained obligations through the RBH deconsolidation—such as the $194 million trust‑account deposit for the Létourneau/Blais judgment—remain on PMI’s books (though not consolidated) and represent a separate liability that PMI must cover, independent of Altria’s exposure【MO_10k_2022, pp. 106‑110】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error regarding the $194 million trust-account deposit for the Létourneau/Blais judgment, which is not mentioned in the original answer and incorrectly attributed to PMI’s RBH deconsolidation. The original answer states that RBH deconsolidation involved reclassifications from accumulated other comprehensive losses, not specific cash deposits or litigation payments. This misrepresents a key financial obligation and introduces a number not supported by the ground truth. (2) Quantitatively, the $194 million figure is incorrect in this context—no such amount appears in the original answer, and there is no verification that this number is accurate in relation to RBH or the Létourneau/Blais case within the provided knowledge base. The original answer does not include any dollar amounts, so introducing one without basis reduces quantitative accuracy. (3) Qualitatively, the LLM correctly identifies the indemnification structure: PMI indemnifies Altria and PM USA for liabilities related to PMI-manufactured products, and Altria has not recorded a liability due to insignificant fair value. It also correctly notes that PM USA indemnifies PMI for its own products. However, it conflates PMI’s indemnification obligations with PM’s (Philip Morris USA) retained obligations from RBH deconsolidation, which are structurally separate. The original answer clarifies that RBH-related impacts are on PM (not PMI) and relate to AOCI reclassifications, not direct litigation liabilities. The LLM incorrectly shifts focus to PMI’s non-consolidated liabilities, misaligning entities and financial impacts. (4) Contextually, the answer is well-structured and relevant, citing appropriate sections of the 10-Ks and addressing the core comparison between indemnification and retained obligations. Despite the reasoning flaws and incorrect number, it attempts proper multi-hop synthesis across indemnification and deconsolidation concepts. Hence, correctness is partially compromised by major factual and entity-level errors, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 565,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How does the decline in Cisco's allowance for credit losses on loan receivables from $103 million in 2022 to $53 million in 2023 impact the financing of technical support services, and how does this compare to Adobe's approach in funding its technical support offerings?",
      "original_answer": "Cisco's allowance for credit losses on loan receivables decreased significantly from $103 million in 2022 to $53 million in 2023, indicating a reduced financial risk in their financing arrangements tied to hardware, software, and services—including technical support. This decline may suggest either improved credit quality of borrowers or a strategic reduction in financing extended for such services. Cisco offers financing, including loans and leases, for the sale of its products and services, which explicitly include technical support and advanced services. In contrast, Adobe funds its technical support through subscription entitlements and annual fee-based maintenance programs, providing customers with technical support, product help, and upgrades over 1- to 3-year terms. Unlike Cisco, Adobe does not rely on loan receivables but integrates support funding directly into its subscription and maintenance models.",
      "llm_answer": "Cisco’s allowance for credit losses on loan receivables fell from $103 million in 2022 to $53 million in 2023 (allowance table, pages 82–83), reflecting improved credit quality of customers financing its hardware, software and technical‑support services (loan‑receivable note, pages 80–81). The lower allowance reduces the reserve needed for potential defaults, freeing capital that can be used to finance or support its technical‑support offerings. Adobe, by contrast, funds its technical support through subscription and maintenance fees built into its product pricing, so support costs are covered directly by revenue from its SaaS and perpetual‑license models (technical support section, pages 15–16).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the decline in Cisco's allowance for credit losses from $103 million in 2022 to $53 million in 2023 is accurately reported, with no calculation errors. (2) The reasoning is sound: the reduction in allowance is correctly interpreted as reflecting improved credit quality, which reduces reserves and frees capital—this logically connects to how Cisco finances technical support via loan receivables. (3) The comparison to Adobe is accurate: Adobe funds technical support through subscription and maintenance fees embedded in SaaS and perpetual-license models, which matches the original answer’s claim about subscription entitlements and annual fee-based programs. (4) Minor omission: the LLM does not explicitly mention that Cisco’s financing includes leases (only loans), and the original answer specifies 1- to 3-year terms for Adobe’s programs, which adds slight contextual detail missing in the LLM response. However, these are minor gaps that do not affect core factual correctness. The LLM correctly synthesizes multi-hop information across Cisco’s credit loss allowance and financing model and contrasts it with Adobe’s revenue-integrated support funding. Wording differs but semantic meaning is equivalent. Thus, high scores across all dimensions with a 9 in correctness due to slight incompleteness in detailing financing mechanisms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 402,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How does the involvement of Citibank, N.A. as administrative agent in Caterpillar's 2022 5-Year Credit Facility compare with its role in Boeing's similarly named 2019 Five-Year Credit Agreement, particularly in terms of the amendment timelines and the syndication structure?",
      "original_answer": "Citibank, N.A. served as the administrative agent in both Caterpillar's 2022 5-Year Credit Facility and Boeing's 2019 Five-Year Credit Agreement. In Caterpillar's case, Amendment No. 1 to the 5-Year Facility was dated August 31, 2023, indicating a modification within one year of the original agreement. For Boeing, Amendment No. 1 to its Five-Year Credit Agreement occurred on August 25, 2022, nearly three years after the initial agreement on October 30, 2019. Additionally, Boeing's syndication structure included JPMorgan Chase Bank, N.A. as syndication agent and joint lead arranger alongside Citibank, N.A., while Caterpillar's syndication involved Citibank, N.A. and MUFG Bank, Ltd. in agent roles without a comparable dual lead arranger structure.",
      "llm_answer": "Citibank, N.A. is the administrative agent for both facilities, but the timing of their amendments differs: Caterpillar’s 2022 5‑Year Credit Facility was amended in 2023 (via a 2023 364‑day facility addendum and a local‑currency addendum), whereas Boeing’s 2019 Five‑Year Credit Agreement was amended in 2022 (Amendment No. 1 dated August 25 2022). In terms of syndication, Caterpillar’s facility is syndicated by Citibank and its affiliates (Citibank Europe and MUFG Bank) without a separate syndication agent, while Boeing’s agreement lists JPMorgan Chase Bank, N.A. as the syndication agent and joint lead arranger, with Citibank serving as the administrative agent and joint lead arranger.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all dates and entities are correct: Caterpillar's amendment timing is correctly noted as occurring in 2023 (specifically August 31, 2023, per ground truth), and Boeing's Amendment No. 1 is accurately dated August 25, 2022. The original agreement dates (2022 for Caterpillar, 2019 for Boeing) are correctly implied. (2) The syndication structures are accurately contrasted: Boeing’s inclusion of JPMorgan Chase Bank, N.A. as syndication agent and joint lead arranger is correctly identified, while Caterpillar’s facility correctly notes Citibank, N.A. and MUFG Bank, Ltd. in agent roles without a syndication agent. The mention of 'affiliates' (e.g., Citibank Europe) adds detail not in the ground truth but does not contradict it. (3) The multi-hop reasoning is sound—comparing amendment timelines and syndication roles across two companies and agreements is correctly executed. (4) Minor deduction in qualitative accuracy because the LLM references a '2023 364-day facility addendum and a local-currency addendum' for Caterpillar, which, while possibly true, is not in the ground truth and slightly misrepresents the nature of Amendment No. 1 (which is simply dated August 31, 2023, without specification of addenda). This introduces unverified detail, but does not invalidate the core correctness. Overall, the answer is factually aligned, contextually relevant, and semantically equivalent to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 418,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact both NVIDIA's and Qualcomm's supply chain reliability, given their shared dependency on foundry partners in the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan could severely disrupt both NVIDIA's and Qualcomm's supply chains, as both companies rely heavily on foundry partners located in Taiwan for critical semiconductor manufacturing. NVIDIA has explicitly stated that challenges in estimating demand could be exacerbated by geopolitical tensions involving Taiwan and China, which are significant to their revenue and supply continuity. Similarly, Qualcomm depends on consistent chipset supply from foundry partners in Taiwan, and a conflict could severely limit or prevent them from receiving these components, directly impacting their ability to manufacture and deliver products. Both companies face the risk of supply constraints, production delays, and potential revenue loss due to the geographic concentration of their manufacturing dependencies in a geopolitically sensitive region.",
      "llm_answer": "A prolonged conflict in Taiwan could shut down or restrict the operations of the foundries that manufacture NVIDIA’s GPUs and Qualcomm’s processors, leading to shortages, longer lead times and higher costs for both firms.  Both companies flag this as a material risk in their 10‑K filings, noting that a conflict could “severely limit or prevent us from receiving chipset supply from Taiwan” (NVDA 2023 p. 15‑19) and that their key foundry partners are “primarily located in Taiwan and Korea” (QCOM 2023 p. 33‑37).  Such disruptions would impair their ability to meet customer demand and could materially affect revenue and margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the core risk: a prolonged conflict in Taiwan could disrupt foundry operations, impacting both NVIDIA and Qualcomm due to their reliance on Taiwanese semiconductor manufacturing. The key factual elements—supply chain disruptions, shortages, lead time extensions, cost increases, and revenue/margin impacts—are all present and correct. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not compromised; the citations to 10-K pages (e.g., NVDA 2023 p. 15–19, QCOM 2023 p. 33–37) are plausible and contextually appropriate, though exact page numbers are not verifiable without access to filings, but such referencing is acceptable as long as it doesn't fabricate content. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies depend on foundries in Taiwan, face material supply risks, and have disclosed these risks in their filings. It connects geopolitical risk to operational and financial outcomes across two firms, satisfying the multi-hop requirement. (4) The only minor shortcoming is that the LLM slightly mischaracterizes Qualcomm’s foundry location by including Korea as a primary location—while Qualcomm may use Korean foundries (e.g., Samsung), the original answer emphasizes Taiwan as the critical node for both firms, and the geopolitical risk is specifically tied to Taiwan. This does not invalidate the answer but introduces a small inaccuracy in emphasis. Otherwise, the answer is semantically equivalent, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 458,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does Boeing's indemnification risk exposure from U.S. government contracts compare with 3M's indemnification liabilities transferred to Solventum following the spin-off, particularly in relation to their respective legal proceedings and liability assumptions?",
      "original_answer": "Boeing discloses indemnification risks tied to U.S. government contracts where pension cost allocations under CAS may affect contract profitability. Meanwhile, 3M transferred indemnification obligations related to historical legal proceedings—such as the Bair Hugger and Federal False Claims Act litigation—to Solventum as part of the April 1, 2024 spin-off. Both companies face potential liabilities from legal proceedings, but Boeing's exposure is tied to contract cost allocations and uninsurable risks from defense and aerospace products, whereas 3M's transferred liabilities are now the responsibility of Solventum, which must indemnify and defend claims previously held by 3M.",
      "llm_answer": "Boeing’s indemnification exposure is tied to its U.S. government contracts, where the company may be required to indemnify the government or receive indemnification under those contracts and faces a broad range of potential litigation and regulatory inquiries that could trigger such obligations. In contrast, 3M’s indemnification liabilities transferred to Solventum are narrowly focused on specific litigation matters (Bair Hugger and Federal False Claims Act/Qui Tam cases) that Solventum has assumed and will indemnify and defend 3M, with the legal proceedings ongoing and the liability assumption that Solventum will cover those claims. Thus, Boeing’s risk is broader and linked to government contract obligations, while 3M’s is limited to particular post‑spin‑off litigation that Solventum now bears.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Boeing's indemnification risk is correctly tied to U.S. government contracts involving pension cost allocations under CAS and broader litigation/regulatory exposure, while 3M's liabilities related to Bair Hugger and Federal False Claims Act litigation were transferred to Solventum in the spin-off. The LLM correctly identifies that Solventum now assumes responsibility to indemnify and defend 3M for those specific legal proceedings. (2) There are no numeric values, dates, or calculations in the question or answers that require verification; the April 1, 2024 spin-off date is implied in the context but not stated in the LLM answer—this is a minor omission but not critical as the focus is on the transfer of liability, not the exact date. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across Boeing’s government contract risks and 3M’s corporate spin-off structure, contrasting the nature and scope of indemnification exposure. (4) The LLM captures the key distinction: Boeing’s exposure is prospective, broad, and tied to contract performance and uninsurable risks in aerospace/defense, whereas 3M’s relevant liabilities are historical and now reside with Solventum. The only minor shortcoming is slightly less detail on Boeing’s CAS-related pension allocation impact on contract profitability compared to the original, but the core reasoning and factual accuracy remain intact. Wording differs but semantic equivalence is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 432,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does the voting power structure of CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, influence the governance risks associated with META's Class A common stock, particularly in light of META's controlled company status and dual-class structure?",
      "original_answer": "CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, holds 33⅓% of the combined voting power, with each share carrying 15 votes. This concentrated voting power allows the holder significant influence over corporate decisions. Similarly, META's governance structure gives its Class B common stockholders, including Mark Zuckerberg, outsized voting control, with the dual-class structure requiring a majority of Class B votes for any change in control until they fall below 35% of voting power. This setup increases governance risks for Class A shareholders, as it limits their influence and could deter investors, mirroring the concerns raised in META's 10-K about its 'controlled company' status making Class A shares less attractive.",
      "llm_answer": "CMCSA’s Class B common stock is wholly owned by Brian L. Roberts and carries 15 votes per share, accounting for roughly one‑third of the company’s combined voting power (66 ⅓ % for Class A and 33 ⅓ % for Class B)【CMCSA_10k_2023, page 31‑32】.  This concentration of voting rights illustrates the governance risk that arises when a single shareholder can dominate corporate decisions, a risk that META faces as a controlled company with a dual‑class structure that similarly concentrates voting power in a small group of shareholders, thereby limiting minority influence【META_10k_2023, pages 48‑52】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: CMCSA's Class B stock has 15 votes per share and holds 33⅓% of voting power, while Class A holds 66⅔%, totaling 100%—this matches the original answer. The citation references are appropriate and support the claims. (2) The answer correctly identifies the governance risk associated with concentrated voting power in both CMCSA and META, drawing a valid parallel between Brian L. Roberts’ control and Mark Zuckerberg’s outsized influence via META’s dual-class structure. (3) The multi-hop reasoning is sound: it connects CMCSA’s ownership structure to META’s controlled company status, explaining how such structures limit minority shareholder influence and increase governance risks. (4) The only minor omission is that the LLM does not explicitly mention the 35% threshold in META’s voting structure beyond which control could change—a detail included in the original answer—but this does not undermine the core correctness. The synthesis across companies and governance themes is strong, and the answer remains semantically equivalent in meaning. Wording differences are acceptable and do not affect factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 345,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does Coca-Cola's reliance on Arca Continental for beverage distribution in northern Argentina intersect with Procter & Gamble's foreign exchange risk exposure in the same country?",
      "original_answer": "Coca-Cola relies on Arca Continental for beverage distribution in northern Argentina, which accounts for a portion of its 17% worldwide unit case volume through bottling partners. Arca Continental's operations in northern Argentina expose Coca-Cola indirectly to macroeconomic risks in the country. Meanwhile, Procter & Gamble directly cites Argentina as one of the countries with significant exchange rate fluctuations that have historically impacted its financials, noting foreign exchange volatility in Argentina has significantly affected its net sales, costs, and earnings. This creates a shared exposure point where both companies face risks tied to Argentina’s economic environment, with Coca-Cola exposed through its supply chain dependency and P&G through direct market operations.",
      "llm_answer": "Coca‑Cola’s sales in northern Argentina are delivered through its bottling partner Arca Continental, which operates distribution there (see the 10‑K bottling‑partner list).  Procter & Gamble notes that Argentina is one of the countries with significant exchange‑rate volatility, exposing the company to both translation and transaction foreign‑exchange risk.  Thus, both firms are exposed to the Argentine peso—Coca‑Cola indirectly via Arca Continental’s operations and P&G directly through its own Argentine activities—making the currency a common risk factor in that market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core intersection between Coca-Cola and Procter & Gamble in Argentina. (1) All entities are correct: Coca-Cola, Arca Continental, and Procter & Gamble are accurately identified with their respective exposures. (2) There are no numeric inaccuracies—while the original answer mentions Coca-Cola's 17% worldwide unit case volume through bottling partners, the LLM answer omits this specific figure but does not contradict it; the omission is minor and does not affect the correctness of the risk exposure logic. (3) The multi-hop reasoning is sound: the model correctly synthesizes that Coca-Cola faces indirect exposure via Arca Continental’s operations in northern Argentina, while P&G faces direct foreign exchange risk due to Argentina’s volatile peso, creating a shared risk factor. (4) Semantic equivalence is maintained—the LLM captures the essence of shared currency risk in Argentina, even without repeating the 17% statistic. The answer is concise, relevant, and correctly identifies the nature of both companies’ exposures. The only minor shortcoming is the omission of the 17% volume context, which adds depth but is not critical to the main point of intersection on foreign exchange risk. Hence, a high score is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 357,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How might the expiration of Alimta's patent protection impact Eli Lilly's oncology revenue stream compared to Amgen's exposure to patent-related risks for its biologics, given the differing regulatory frameworks governing small molecule drugs and biologics?",
      "original_answer": "The expiration of Alimta's patent protection is expected to result in a rapid and severe decline in Eli Lilly's revenue from the product due to the entry of generic competitors in the U.S. and other jurisdictions. This is typical for small molecule drugs like Alimta, where loss of exclusivity often leads to immediate and significant revenue erosion. In contrast, Amgen, which relies heavily on patent protection for its biologics, faces a different regulatory landscape where biosimilars may not enter the market as quickly due to manufacturing complexities and regulatory uncertainties, such as the FDA's stance on 'umbrella exclusivity'. However, Amgen still faces increasing biosimilar competition in the U.S., Europe, and elsewhere, which has had and could increasingly have a material adverse effect on its product sales. Thus, while both companies are exposed to patent-related risks, the speed and severity of revenue impact differ due to the nature of their product portfolios and the regulatory frameworks governing them.",
      "llm_answer": "Lilly’s 10‑K risk factors (pp. 23‑27) warn that the loss of patent protection for Alimta will trigger generic entry under the Hatch‑Waxman framework, leading to a rapid and severe decline in its oncology revenue.  In contrast, Amgen’s 10‑K risk factors (pp. 44‑48) note that its biologic products are protected by the BPCIA’s 12‑year exclusivity and a more protracted biosimilar approval pathway, so while patent litigation and biosimilar risk exist, the erosion of revenue is typically slower and less certain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Alimta's patent expiration will lead to rapid revenue decline for Eli Lilly due to generic entry under the Hatch-Waxman Act, which governs small molecule drugs—this matches the original answer's emphasis on immediate and significant revenue erosion. (2) For Amgen, the LLM correctly notes the 12-year exclusivity under the BPCIA and the more complex, slower biosimilar approval process, resulting in slower and less certain revenue erosion—this reflects the original answer's point about manufacturing complexities and regulatory uncertainties, including the FDA's stance on exclusivity (e.g., 'umbrella exclusivity' implied in 'protracted pathway'). (3) The multi-hop reasoning is sound: the model synthesizes information across two companies (Lilly and Amgen), two regulatory frameworks (Hatch-Waxman vs. BPCIA), and two drug types (small molecules vs. biologics), correctly contrasting the speed and severity of revenue impact. (4) All entities (Alimta, Eli Lilly, Amgen, Hatch-Waxman, BPCIA) are accurate, and no numeric values are incorrect—though none are explicitly stated (e.g., '12-year exclusivity' is correct and consistent with BPCIA). The only minor limitation is that the LLM does not explicitly mention 'material adverse effect' or Amgen’s exposure in multiple regions (U.S., Europe), slightly reducing completeness versus the original, but the core contrast in regulatory and commercial dynamics is preserved. Wording differs but semantic meaning is equivalent. Quantitative accuracy is perfect as no calculations or numbers are misstated.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 451,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does the impact of the OECD's Pillar Two Model Rules on Intel's non-US tax benefits compare to Microsoft's exposure under the global minimum tax, given the differences in their international tax strategies?",
      "original_answer": "Intel's tax benefits have increased due to a higher proportion of income taxed in non-US jurisdictions, and the company is actively evaluating the impact of Pillar Two Model Rules, which may begin in 2024 in several jurisdictions where Intel operates. In contrast, Microsoft acknowledges the global minimum tax as part of its broader regulatory exposure but does not expect a material increase in tax costs due to limited operations in jurisdictions below the 15% minimum rate. This suggests that while both companies are subject to Pillar Two, their exposure differs based on geographic tax strategy and operational footprint.",
      "llm_answer": "Intel expects the Pillar Two rules to have only a modest effect on its non‑US tax benefits, noting that it has few operations in jurisdictions with rates below the 15 % minimum and is still evaluating the legislation (INTC_10k_2023, pages 44‑46). In contrast, Microsoft’s broader international footprint exposes it to a higher potential tax cost under the global minimum tax, and it acknowledges that changes to the global tax framework could materially affect its tax position (MSFT_10k_2023, pages 28‑32). Thus, Intel’s impact is expected to be limited, while Microsoft faces a more significant exposure due to its diversified tax strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual reversal: it incorrectly states that Intel has few operations in low-rate jurisdictions and expects only a modest impact, while the ground truth indicates Intel's tax benefits have increased due to a higher proportion of income in non-US jurisdictions and it is still evaluating Pillar Two's impact—implying potentially significant exposure. Conversely, the LLM claims Microsoft faces higher exposure due to its broad footprint, but the ground truth states Microsoft does *not* expect a material increase in tax costs due to limited operations in sub-15% jurisdictions—directly contradicting the LLM's assertion. (2) Quantitatively, the 15% minimum rate is correctly cited, and no incorrect numbers or calculations are present; thus, quantitative accuracy is high. (3) The multi-hop reasoning is flawed: the model reverses the exposure levels between Intel and Microsoft. It incorrectly infers that Intel has limited exposure and Microsoft has significant exposure, when the ground truth shows the opposite in terms of expected material impact. This undermines the core comparison the question asks for. (4) Contextual relevance is fair—the answer addresses Pillar Two, both companies, and their international strategies—but the reversed logic on exposure severely limits factual correctness. The citations to 10-K pages suggest plausible sourcing, but the interpretation is inverted, leading to a partially correct but fundamentally misleading conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 418,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does KO's 2024 transfer of $523 million in surplus international pension assets to general assets affect its exposure to limited partnerships compared to PEP's continued use of limited partnerships in its pension investment strategy?",
      "original_answer": "KO's transfer of $523 million in surplus international pension assets to general assets in 2024 reduced its exposure to limited partnerships, as these assets were previously part of its pension plan investments, which include vehicles like limited partnerships (as seen in NEE's pension strategy). Meanwhile, PEP continues to maintain exposure to limited partnerships through its pension investments, as explicitly stated in its 2024 10-K, where it holds investments in limited partnerships and private credit funds valued based on net asset value. This indicates a strategic divergence: KO reduced its pension-linked alternative investments, while PEP maintains them as part of its diversified pension fund strategy.",
      "llm_answer": "KO’s 2024 transfer of $523 million of surplus international pension assets to its general assets removed those assets from the pension trust portfolio, which had been invested in limited‑partnership vehicles (the plan assets “h includes investments in limited partnerships and private credit funds”【Pension Plan Valuations】).  By moving the assets out of the pension trust, KO’s exposure to limited partnerships is effectively reduced, whereas PEP’s pension strategy continues to rely on limited partnerships, keeping its exposure unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information in the ground truth. (1) Quantitatively, all key facts are correct: the $523 million amount and the year 2024 are accurately reported, with no calculation errors. (2) The entity identification is correct—KO and PEP are properly referenced, and the focus on pension assets and limited partnerships aligns with the question. (3) The reasoning is sound: the LLM correctly infers that transferring surplus pension assets out of the pension trust reduces KO’s exposure to limited partnerships, especially since such vehicles were part of the pension plan (citing the general structure seen in pension disclosures). It also correctly contrasts this with PEP’s ongoing use of limited partnerships. (4) The only minor shortcoming is that the LLM does not explicitly mention that PEP’s continued exposure is documented in its 2024 10-K or that the valuation is based on net asset value, which adds slight contextual depth in the original answer. However, the omission does not affect the factual correctness or the multi-hop synthesis. The LLM uses a placeholder citation ['Pension Plan Valuations'] which lacks specificity but doesn't introduce inaccuracy. Overall, the answer is semantically equivalent and contextually appropriate, with excellent multi-hop reasoning linking asset transfer to reduced exposure and contrasting strategies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 386,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does the $17.3 billion increase in PFE's income from continuing operations in 2021 compared to 2020 relate to the role of patent rights in determining market exclusivity periods, especially when considering LLY's reliance on 12-year U.S. biologic data protection to safeguard revenue post-patent expiration?",
      "original_answer": "The $17.3 billion increase in PFE's income from continuing operations in 2021 compared to 2020 was partly due to factors like lower asset impairment charges and higher net gains on equity securities. However, PFE acknowledges that patent expirations could materially affect revenues, as patent rights are a key determinant of market exclusivity in the pharmaceutical industry. According to evidence, market exclusivity for pharmaceuticals is largely determined by patent rights and regulatory data protection. In the U.S., biologics benefit from a 12-year data protection period under the BPCIA, which LLY explicitly references as a critical mechanism to retain market exclusivity and protect revenues even after compound patents expire. This implies that while PFE's short-term financial performance saw a significant boost, the long-term sustainability of such gains for patented products will depend on both patent strength and complementary regulatory exclusivity mechanisms like those LLY relies on for its biologics.",
      "llm_answer": "Pfizer’s $17.3 billion rise in income from continuing operations in 2021 was largely driven by higher revenues and the continued benefit of its patent portfolio and regulatory exclusivities, which protect market share and pricing (see PFE 10‑K, pp. 34‑38).  Lilly’s 10‑K (pp. 8‑12) notes that its biologics benefit from a 12‑year U.S. data‑protection period, a regulatory exclusivity that extends revenue protection beyond the life of a patent.  Together, these examples illustrate how patent rights and data‑protection periods are central to sustaining revenue streams after product launch.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $17.3 billion increase in PFE's income from continuing operations in 2021 as stated in the ground truth, and accurately references the 12-year U.S. biologic data protection period relevant to LLY. These key numbers and durations are factually correct, earning full marks for quantitative accuracy. (2) However, the LLM misattributes the cause of PFE’s income increase. The ground truth specifies that the $17.3 billion rise was partly due to lower asset impairment charges and higher net gains on equity securities—non-operational, non-revenue factors—whereas the LLM incorrectly states it was 'largely driven by higher revenues and the continued benefit of its patent portfolio and regulatory exclusivities.' This is a significant qualitative error, as it misrepresents the primary drivers behind PFE’s financial performance. (3) The multi-hop reasoning is partially sound: the model correctly connects PFE’s financial performance to broader pharmaceutical market exclusivity mechanisms and appropriately cites LLY’s reliance on 12-year data protection as a post-patent revenue safeguard. This shows valid cross-company synthesis. However, the failure to accurately represent PFE’s actual reasons for the income increase weakens the logical chain. (4) The answer remains contextually relevant, addressing both PFE’s financial change and LLY’s regulatory protection strategy, and conveys a broadly accurate picture of how exclusivity mechanisms support revenue. Due to the factual inaccuracy in explaining PFE’s income jump, the correctness and qualitative accuracy scores are reduced, though not severely, as the core conceptual link between patents, data protection, and revenue sustainability is still appropriately emphasized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 483,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How does the revenue-sharing arrangement between ESPN and Hulu, as reflected in Disney's 2024 financials, relate to the $8.6 billion payment Comcast received in late 2023 following the partial exit of its Hulu stake?",
      "original_answer": "Disney's ESPN receives fees from Hulu for the right to air its networks, as noted in the elimination section of Disney's 2024 financials. This relationship is central to Hulu's content costs and revenue model. In late 2023, Comcast exercised a put option, requiring Disney to buy its 33% stake in Hulu for $8.6 billion, which included a $9.2 billion minimum equity value less $557 million for prior capital calls. This payment reflects the financial value derived from Comcast’s stake in Hulu, which is partially driven by revenue streams like those from ESPN content licensing fees. Thus, the revenue-sharing mechanism between ESPN and Hulu underpins part of the valuation that led to the $8.6 billion payment to Comcast.",
      "llm_answer": "Disney’s 2024 financials show that Hulu pays Disney a recurring fee for the right to air ESPN programming, recorded as an “elimination” of inter‑segment revenue (the Hulu‑to‑ESPN fee). The $8.6 billion Comcast received in late 2023 was a one‑time cash proceeds from Disney buying back Comcast’s stake in Hulu, a capital transaction that is separate from the ongoing revenue‑sharing fee. Thus, the fee arrangement continues as an operating stream after the sale, while the $8.6 billion payment was a standalone transaction unrelated to that fee.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several correct elements but misses key aspects of the multi-hop reasoning required, leading to a partially incorrect conclusion. (1) Quantitatively, the $8.6 billion figure and the characterization of the payment as a buyback of Comcast’s stake in late 2023 are accurate, and the mention of inter-segment eliminations aligns with Disney’s reporting practices. However, the LLM omits the critical detail from the ground truth that the $8.6 billion was derived from a $9.2 billion minimum equity value minus $557 million for prior capital calls—a specific calculation that adds depth to the valuation rationale. (2) The entity identification (Disney, ESPN, Hulu, Comcast) and years (2023, 2024) are correct, and the financial concepts (inter-segment revenue elimination, capital transaction) are appropriately used. (3) The reasoning is flawed in asserting that the $8.6 billion payment was 'unrelated' to the revenue-sharing fee. The ground truth explicitly links the two by stating that the revenue-sharing mechanism (e.g., ESPN licensing fees) contributes to Hulu’s overall valuation, which in turn influenced the $8.6 billion payment. By treating them as entirely separate, the LLM fails the multi-hop synthesis: it does not connect how ongoing operating revenues (like ESPN fees) affect the enterprise value of Hulu, thereby impacting the price Disney paid. (4) While the answer is contextually relevant and correctly describes both the revenue-sharing arrangement and the buyback, it undercuts the causal relationship emphasized in the original answer. Thus, the correctness score is 5 due to significant conceptual inaccuracy in the relationship between the two financial events, despite factual accuracy in isolated components.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 475,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How do KO's and MDLZ's respective uses of financial assumptions differ in terms of the instruments they apply them to and the time periods over which the associated costs are recognized?",
      "original_answer": "KO uses the Black-Scholes-Merton option-pricing model to estimate the fair value of stock option awards, which are expensed on a straight-line basis over a typical four-year vesting period. This approach incorporates weighted-average assumptions such as volatility and expected term. In contrast, MDLZ applies weighted-average assumptions to determine net periodic postretirement healthcare costs, which are measured annually and reflect actuarial estimates for long-term obligations. The key differences are that KO applies these assumptions to equity-based compensation instruments with a fixed four-year expense recognition period, while MDLZ applies them to postretirement benefit liabilities that are recalculated annually based on updated actuarial estimates.",
      "llm_answer": "KO applies its financial‑assumption framework to a broader set of equity‑based instruments—stock options, performance share units, restricted stock, and unvested compensation cost—recognizing expense over weighted‑average vesting periods of roughly four years for options and restricted stock, three years for performance units, and 1.7 years for unvested compensation cost (KO, pp. 93‑97). By contrast, MDLZ’s assumptions are applied mainly to stock options and performance share units, with expense recognized over weighted‑average vesting periods of about four years for options and three years for performance units (MDLZ, pp. 105‑109).",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains partially correct quantitative details about vesting periods (e.g., four-year and three-year periods for stock options and performance units) and correctly identifies that both KO and MDLZ use financial assumptions for equity-based compensation. However, it fundamentally misrepresents the core distinction highlighted in the original answer. The ground truth emphasizes that KO applies assumptions to equity instruments (like stock options) using the Black-Scholes model with straight-line expensing over a four-year vesting period, while MDLZ applies weighted-average assumptions to *postretirement healthcare costs*—a liability-driven, actuarially estimated obligation recalculated annually. The LLM incorrectly frames MDLZ’s use of assumptions as being primarily for stock options and performance units, which contradicts the original answer’s key point that MDLZ applies these assumptions to postretirement benefits, not equity awards. This is a critical error in entity and instrument identification, undermining the multi-hop comparison. While some numbers (e.g., 4-year vesting) are accurate and contextually relevant to equity compensation, they fail to address the actual contrast in financial instruments (equity vs. postretirement liabilities) and timeframes (fixed vesting vs. annual actuarial recalculation). Thus, despite some correct details, the reasoning and synthesis are flawed, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 400,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How might the expiration timeline of specific patent protections for Enbrel impact Pfizer's international revenue from the drug, given AbbVie's broader strategy around patent term restoration and regulatory exclusivity?",
      "original_answer": "The expiration timeline for Enbrel's U.S. patents begins in 2028 (fusion protein composition) and extends to 2037 for formulation methods, which could delay biosimilar competition internationally. However, AbbVie's strategy of seeking patent term restoration and leveraging regulatory exclusivity under the Hatch-Waxman Act—where patent extensions can add up to five years—may further extend protection in key markets. Pfizer, which markets Enbrel outside the U.S. and Canada, could see prolonged exclusivity in certain regions, potentially extending beyond 2028, thereby preserving revenue streams if biosimilar challenges are delayed or unsuccessful.",
      "llm_answer": "Enbrel’s key U.S. patents expire between 2028 and 2037 (e.g., composition patents 11/22/2028, DNA‑encoding patents 4/24/2029, formulation patents 10/19/2037)【AbbV_10k_2024, p.10】, so biosimilar competition could begin after 2028. AbbVie’s strategy of pursuing Hatch‑Waxman patent‑term restoration and leveraging regulatory exclusivity could extend protection beyond those dates, delaying biosimilar entry and thereby shielding Pfizer’s international revenue from the drug【AbbV_10k_2024, p.8】. If AbbVie fails to secure such extensions, Pfizer could see earlier erosion of its international sales, which totaled $24.9 billion in 2024【PFE_10k_2024, p.8】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the patent expiration dates (2028–2037) are correctly specified with precise dates (11/22/2028, 4/24/2029, 10/19/2037), which fall within the range mentioned in the original answer (2028–2037). These dates are cited from AbbVie’s 2024 10-K, supporting their accuracy. The $24.9 billion international sales figure for Pfizer in 2024 is correctly attributed to PFE_10k_2024, though this number appears inflated—Enbrel’s global sales were significantly lower in recent years, suggesting a possible data error or misattribution (e.g., confusion with total revenue). However, since the original answer does not provide a sales figure, this does not contradict the ground truth but introduces a potentially inaccurate number. (2) The answer addresses all parts of the question: Enbrel’s patent timeline, AbbVie’s strategy (patent term restoration, Hatch-Waxman, regulatory exclusivity), and the impact on Pfizer’s international revenue. (3) Entities are correct: AbbVie (patent holder), Pfizer (ex-U.S./Canada marketer), Enbrel, Hatch-Waxman Act. (4) Reasoning is sound: the LLM correctly infers that AbbVie’s patent strategy could delay biosimilar entry internationally, thus protecting Pfizer’s revenue, and acknowledges the risk if extensions fail. The multi-hop synthesis—linking U.S. patent expirations, AbbVie’s legal strategies, and Pfizer’s international commercial interest—is logically coherent and contextually appropriate. The only minor issue is the unverified $24.9B sales figure, which slightly undermines quantitative accuracy but does not distort the core conclusion. Overall, the answer is factually strong, well-sourced, and semantically equivalent to the ground truth in intent and substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 486,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How does MET's stress testing approach, which factors in early policyholder withdrawal scenarios, influence its reliance on global funding sources like commercial paper compared to COF's liquidity framework that emphasizes diversified funding sources and liquidity reserves?",
      "original_answer": "MET's stress testing includes scenarios of early policyholder withdrawal, which directly impacts its reliance on global funding sources like commercial paper to meet liquidity needs under stress conditions. MET adjusts asset mix and maturities based on rolling 12-month forecasts and relies on alternatives such as commercial paper and credit facilities when anticipated liquidity is exceeded. Similarly, COF's Liquidity Framework emphasizes diversified funding sources and maintains a liquidity reserve of cash, high-quality unencumbered securities, and committed credit lines to withstand systemic and idiosyncratic liquidity events. Both companies use stress testing to inform their funding strategies, but MET's exposure to policyholder behavior introduces a unique risk factor that directly affects its funding source selection, aligning with AIG's defined liquidity stress scenarios that impact funding sources.",
      "llm_answer": "MET’s liquidity policy (pages 121‑125) explicitly models early policy‑holder withdrawals; when those stress tests show a cash gap, the company can tap global funding sources—including commercial paper—to bridge the shortfall.  In contrast, COF’s Liquidity Framework (pages 94‑98) relies on a diversified funding mix—deposit gathering, committed credit lines, and a sizable reserve of cash and high‑quality securities—so it can absorb shocks without depending heavily on any single source such as commercial paper.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core contrast between MET's and COF's liquidity strategies as described in the ground truth. (1) It correctly identifies that MET's stress testing includes early policyholder withdrawals and that this can trigger reliance on global funding sources like commercial paper—directly aligning with the original answer. It also accurately describes COF’s diversified funding mix and liquidity reserve, noting its reduced dependence on any single source such as commercial paper. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, the absence of incorrect numbers supports a perfect score. (3) The multi-hop reasoning is sound: the model correctly links MET’s stress testing to its funding behavior and contrasts it with COF’s framework, synthesizing information across two companies and their respective liquidity approaches. The only minor omission is that the LLM answer does not mention AIG’s defined liquidity stress scenarios, which the original answer references as a point of alignment—this contextual nuance is absent but does not undermine the core correctness. (4) The answer is semantically equivalent to the original in all key aspects: entity names (MET, COF), financial instruments (commercial paper, credit lines, securities), and causal logic (stress test outcomes → funding response). Wording differs slightly but meaning is preserved. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to this slight incompleteness, while remaining fully contextually relevant and quantitatively sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 445,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How does the adoption of ASU 2022-04 impact the comparability of supplier finance obligation disclosures between CAT and GE, particularly regarding the roll-forward requirements that GE began applying in 2024?",
      "original_answer": "GE adopted ASU 2022-04 on January 1, 2023, and began applying the annual roll-forward disclosure requirement prospectively starting January 1, 2024 (GE_10k_2024.pdf:page_47). This aligns with CL's explanation that ASU 2022-04 mandates disclosures including key terms, balance sheet presentation, and a roll-forward of confirmed obligations (CL_10k_2024.pdf:page_57). CAT, in its 2024 10-K (CAT_10k_2024.pdf:page_111), provides a roll-forward of its supplier finance obligations, showing $830 million outstanding at year-end 2024. The adoption of ASU 2022-04 enhances comparability between CAT and GE by standardizing how supplier finance obligations are disclosed, particularly with the new roll-forward requirement that GE implemented in 2024.",
      "llm_answer": "The adoption of ASU 2022‑04 by GE requires an annual roll‑forward of supplier‑finance obligations, a disclosure that GE began applying in 2024.  GE’s 10‑K shows a roll‑forward table (beginning balance, invoices confirmed, invoices paid, ending balance) that was not previously required, whereas CAT’s 10‑K (pages 109‑113) does not provide a roll‑forward table for its supplier‑finance program, limiting direct comparability of the two companies’ disclosures.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in a critical aspect—contrary to the claim that CAT does not provide a roll-forward table, the ground truth states that CAT's 2024 10-K (CAT_10k_2024.pdf:page_111) does include a roll-forward of supplier finance obligations, including the $830 million year-end 2024 balance. The LLM incorrectly asserts that CAT lacks this disclosure, which directly contradicts the original answer and undermines the conclusion about limited comparability. (2) Quantitative accuracy is low because while GE’s adoption timeline (2023 effective, 2024 roll-forward) is correctly implied, the LLM fails to mention CAT’s $830 million disclosed obligation, a key quantitative data point. No calculations are involved, but the omission of a material number reduces accuracy. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize information across CAT and GE filings. It incorrectly concludes that disclosures are not comparable due to CAT’s lack of roll-forward, when in fact both companies now provide roll-forwards post-ASU 2022-04, enhancing comparability—the opposite of the LLM’s conclusion. (4) Contextual relevance is moderate because the answer addresses the right topic (ASU 2022-04, roll-forwards, GE and CAT disclosures) and references appropriate documents, but the core factual error leads to an incorrect assessment of comparability. The reasoning is structured appropriately but built on a false premise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 406,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How does the valuation methodology for MDLZ's Level 1 financial assets, which include exchange-traded commodity futures, differ from PEP's treatment of exchange-traded commodity futures, particularly in terms of fair value determination and daily settlement practices?",
      "original_answer": "MDLZ determines the fair value of its Level 1 financial assets, including exchange-traded commodity futures, based on quoted market prices on commodity exchanges. In contrast, PEP notes that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in their fair value hierarchy tables. While MDLZ relies directly on observable exchange prices for valuation, PEP's daily cash settlement approach for these instruments results in their exclusion from balance sheet reporting, highlighting distinct operational and accounting treatments despite both companies engaging with the same class of financial instruments.",
      "llm_answer": "MDLZ values its Level 1 assets – which include exchange‑traded commodity futures – at quoted market prices on commodity exchanges and explicitly notes that those futures are cash‑settled daily and therefore omitted from the fair‑value table【MDLZ_10k_2023.pdf:94-98】.  \nPEP also values its Level 1 commodity futures at quoted market prices on commodity exchanges【PEP_10k_2023.pdf:104-108】, but its disclosure does not mention daily cash settlement or exclusion from the table, implying the futures are reported in the table and settled on the exchange’s standard schedule.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in its description of MDLZ's treatment of exchange-traded commodity futures. Contrary to the LLM's claim, MDLZ does *not* state that its exchange-traded commodity futures are 'cash-settled daily and therefore omitted from the fair-value table.' In fact, MDLZ *does* include these instruments in its Level 1 fair value hierarchy table, valuing them based on quoted market prices. The LLM incorrectly attributes PEP's actual treatment (exclusion due to daily cash settlement) to MDLZ, which is the opposite of the ground truth. (2) There are no explicit numerical values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not heavily applicable; however, the logical 'quantitative' structure—classification within fair value hierarchy and inclusion/exclusion from tables—is misrepresented, particularly for MDLZ. (3) The multi-hop reasoning fails because the LLM incorrectly synthesizes the disclosures: it flips the key differentiating point between MDLZ and PEP. The ground truth states that MDLZ *includes* exchange-traded futures in Level 1 using exchange prices, while PEP *excludes* them due to daily cash settlement. The LLM says MDLZ *excludes* them due to daily settlement—which is false—and implies PEP *includes* them—which contradicts PEP's actual disclosure. This reversal of the core distinction invalidates the comparison. (4) Contextual relevance is moderate because the answer addresses the right topic (fair value determination of commodity futures) and cites correct document sections, but the substance of the comparison is fundamentally flawed. The answer misattributes accounting treatments, leading to an incorrect conclusion about how the two companies differ.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 489,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How does the voting rights structure between Class A and Class B common stock at CMCSA compare with META's dual-class share structure?",
      "original_answer": "At CMCSA, Class A common stockholders hold 66 2/3% of the combined voting power, while Class B common stockholders collectively hold 33 1/3%, with each share of Class B having 15 votes. In contrast, META also maintains a dual-class share structure, with Class B common stock possessing superior voting rights, although the exact vote ratio per share is not disclosed in the evidence. META had 343,761,117 shares of Class B common stock outstanding as of January 24, 2025.",
      "llm_answer": "CMCSA’s dual‑class structure gives each Class B share 15 votes (≈33 % of total voting power) versus one vote for each Class A share (CMCSA_10k_2024, p. 32). Meta’s dual‑class structure gives each Class B share 10 votes (≈61 % of total voting power) versus one vote for each Class A share (META_10k_2024, p. 3). Thus, CMCSA’s B shares are less powerful per share than Meta’s B shares, but still hold a significant portion of voting power.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors, particularly in the quantitative details about META's voting structure. (1) For CMCSA, the LLM correctly states that Class B shares have 15 votes per share and that Class A holds approximately 66.67% of voting power (Class B ~33.33%), which aligns with the ground truth. However, the LLM incorrectly claims that each Class A share has one vote — this is not confirmed in the original answer and introduces unsupported detail. (2) For META, the LLM asserts that Class B shares have 10 votes per share and hold ~61% of voting power, which directly contradicts the ground truth stating that the 'exact vote ratio per share is not disclosed.' This is a major factual error. Additionally, the LLM fabricates a specific voting percentage (61%) and vote ratio (10:1), which are not present or verifiable in the evidence. (3) The multi-hop reasoning is flawed because the comparison hinges on incorrect data — claiming CMCSA’s B shares are 'less powerful' than Meta’s due to 15 vs 10 votes reverses the actual implication (if 15 > 10, then CMCSA shares would be more powerful per share, not less). (4) The contextual relevance is fair because the answer attempts a direct comparison between dual-class structures of CMCSA and META, addressing the core intent of the question, but the incorrect numbers and reasoning undermine the validity. Overall, the answer is partially relevant but factually inaccurate on key quantitative and qualitative points.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 409,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How do AIG's and MetLife's exposures to CLOs differ in terms of their credit loss evaluation methodologies and unrealized loss recognition, given that both hold these instruments within structured products portfolios?",
      "original_answer": "AIG evaluates credit losses on CLOs by estimating future cash flows based on delinquency rates, default expectations, loss severity timing, and structural features like credit enhancement, with unrealized losses split between credit-related impairments and non-credit fair value changes recorded in OCI. MetLife, while also holding CLOs as part of structured products within AFS fixed maturity securities, limits its involvement to passive investment in trusts without substantial equity and does not appear to disclose the same level of detailed cash flow modeling for credit loss evaluation, instead focusing on maximum exposure to loss being limited to carrying amounts. AIG explicitly accounts for credit impairments under CECL with reversibility features, whereas MetLife emphasizes its passive investor status and lack of active management involvement in CLO structures.",
      "llm_answer": "AIG evaluates CLOs under the CECL framework, applying a detailed set of inputs—current delinquency, expected default rates, loss severity, pre‑payment speeds and credit‑enhancement structure—to estimate recoverable cash flows and record an allowance for credit losses that is reversed only if conditions improve (AIG, 2024, pp. 128‑130).  The difference between fair value and amortized cost that is not credit‑related is reported as unrealized appreciation/depreciation in OCI (AIG, 2024, p. 130).  MetLife, by contrast, does not disclose a separate credit‑loss allowance for CLOs; its structured‑product exposure (primarily FVO securities and unit‑linked investments) is reflected in net unrealized gains or losses reported within net investment income, with no distinct credit‑loss methodology disclosed (MetLife, 2024, pp. 81‑82).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies AIG's use of CECL for CLO credit loss evaluation, incorporating detailed cash flow modeling inputs such as delinquency rates, default expectations, loss severity, prepayment speeds, and credit enhancement—consistent with the original answer's emphasis on structural features and future cash flow estimation. It accurately notes that non-credit-related fair value changes are recorded in OCI, which matches the ground truth. (2) For MetLife, the LLM correctly observes the lack of disclosed detailed credit loss methodology for CLOs and emphasizes its passive investment role, which is semantically equivalent to the original answer’s point about not disclosing the same level of modeling and limiting exposure to carrying amounts. The statement that MetLife does not disclose a separate credit-loss allowance and reports unrealized gains/losses in net investment income (under FVO and unit-linked investments) is consistent with the ground truth’s focus on AFS classification and lack of active management involvement. (3) Multi-hop reasoning is sound: the model synthesizes differences in accounting frameworks (CECL vs. no disclosed allowance), recognition of unrealized losses (OCI vs. net investment income), and strategic positioning (active modeling vs. passive investment). (4) Minor deduction in qualitative accuracy due to slightly narrower framing—original answer highlights MetLife’s emphasis on 'maximum exposure to loss being limited to carrying amounts,' which adds context about risk limitation not explicitly mentioned in the LLM response. However, this does not undermine the core correctness. No numeric inaccuracies; all references to pages and years (2024) are consistent and plausible. Semantic equivalence is strong, with appropriate flexibility in wording.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 507,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How does the Inflation Reduction Act's redesign of Medicare Part D affect CVS's ability to forecast medical cost trends and BMY's rebate accruals for the same program?",
      "original_answer": "The Inflation Reduction Act (IRA) redesigns Medicare Part D by reducing federal reinsurance in the catastrophic phase and shifting more costs to manufacturers like BMY starting in 2025, which increases their rebate obligations. This directly impacts BMY’s gross-to-net U.S. rebate accruals for Medicare Part D, as they must account for these new liabilities in their financial reporting. For CVS, the IRA’s changes to Medicare Part D contribute to the uncertainty in forecasting health care and benefit costs, especially as new cost-sharing obligations for manufacturers may alter utilization patterns and overall program dynamics. These shifts make it more challenging for CVS to predict medical cost trends and manage profitability in their Medicare-insured products.",
      "llm_answer": "The IRA’s redesign of Medicare Part D caps beneficiary out‑of‑pocket costs and cuts federal reinsurance, shifting a larger share of drug costs to manufacturers and plans. For CVS, this shift makes forecasting medical‑cost trends more uncertain because the cost burden is changing and the pricing environment is more volatile (see the risk‑factor discussion on forecasting medical costs and the IRA’s Medicare Part D redesign in CVS 10‑K, pp. 38‑42). For BMY, the redesign increases the need for manufacturer rebates and imposes penalties for price hikes, so the company’s Medicare Part D rebate accruals become larger and involve more judgment and assumptions (see the Gross‑to‑Net U.S. rebate accruals discussion and the critical audit matter on GTN U.S. rebate accruals in BMY 10‑K, pp. 123‑127).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the key provisions of the Inflation Reduction Act (IRA) affecting Medicare Part D: reduced federal reinsurance and increased cost shifting to manufacturers and plans. The impact on BMY’s rebate accruals and CVS’s forecasting challenges is accurately described. (2) There are no specific numeric values (e.g., dollar amounts, percentages, years like 2025) in the LLM answer, but the ground truth mentions 2025 as the start date for manufacturer cost shifts. The LLM omits this specific year, which is a minor gap, but does not introduce any incorrect numbers—thus quantitative accuracy remains high. (3) The multi-hop reasoning is sound: it connects the IRA’s structural changes to increased uncertainty for CVS in forecasting medical costs and to greater judgment in BMY’s gross-to-net rebate accruals. The references to 10-K sections (e.g., pp. 38–42 for CVS, 123–127 for BMY) add contextual support and suggest correct entity and document alignment. (4) The answer is contextually excellent—directly addresses both parts of the question, uses correct entities (CVS, BMY, Medicare Part D, IRA), and accurately reflects the causal chain from policy change to financial impact. The only minor shortcoming is the omission of the 2025 effective date for the manufacturer cost shift mentioned in the ground truth, which slightly affects completeness but not overall correctness. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 436,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How does JPMorgan Chase's exposure to Stress Capital Buffer requirements influence its capital distribution constraints compared to Charles Schwab's obligations under the Capital Conservation Buffer, given the composition of their respective regulatory buffer requirements?",
      "original_answer": "JPMorgan Chase is subject to a Stress Capital Buffer (SCB) as part of its regulatory capital requirements, which could increase based on stress loss estimates from the Federal Reserve’s Comprehensive Capital Analysis and Review. This buffer, along with the GSIB surcharge and countercyclical buffer (CCyB), contributes to JPMorgan’s total capital buffer requirement. On the other hand, Charles Schwab’s banking subsidiary, Charles Schwab Bank (CSB), is required to maintain a Capital Conservation Buffer (CCB) of 2.5%, which imposes restrictions on capital distributions if not met. According to regulatory definitions, the CCB is a fixed component of capital buffer requirements, whereas JPMorgan’s SCB is dynamic and tied to stress testing outcomes. Therefore, JPMorgan faces a more variable and forward-looking capital constraint tied to macroeconomic stress scenarios, while Schwab faces a static buffer requirement that acts as a floor to avoid distribution limitations.",
      "llm_answer": "JPMorgan Chase’s regulatory buffer includes a 5.4 % Stress Capital Buffer (SCB) plus a 3.0 % G‑SIB surcharge, raising its total buffer requirement to 8.4 % of risk‑based capital (see JPMorgan table, p. 23).  \nCharles Schwab’s buffer consists of a 2.5 % Capital Conservation Buffer plus the same 3.0 % G‑SIB surcharge, giving a total of 5.5 % (see Schwab table, p. 23).  \nBecause JPMorgan must hold a higher buffer—an additional, stress‑based component that can rise further in stressed scenarios—its ability to distribute capital (dividends, buy‑backs) is more constrained than Schwab’s, whose lower, fixed buffer allows slightly greater distribution flexibility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. It states that JPMorgan Chase has a 5.4% Stress Capital Buffer (SCB) and a 3.0% G-SIB surcharge, totaling 8.4%, and that Charles Schwab has a 2.5% Capital Conservation Buffer (CCB) plus a 3.0% G-SIB surcharge, totaling 5.5%. However, the ground truth does not provide specific numerical values for JPMorgan’s SCB or confirm that Charles Schwab is subject to a G-SIB surcharge. In fact, Charles Schwab is not designated as a Global Systemically Important Bank (G-SIB), so applying a 3.0% G-SIB surcharge to Schwab is factually incorrect. This invalidates the core quantitative comparison. (2) The calculations (5.4% + 3.0% = 8.4%, 2.5% + 3.0% = 5.5%) are mathematically correct but based on incorrect premises. The ground truth emphasizes that the SCB is dynamic and stress-tested, not a fixed 5.4%, and does not state Schwab’s total buffer includes a G-SIB surcharge. (3) The reasoning partially captures the qualitative distinction: JPMorgan’s SCB is dynamic and stress-based, leading to more variable capital constraints, while Schwab’s CCB is fixed at 2.5%. This conceptual contrast is correctly identified, showing some multi-hop understanding. However, the erroneous inclusion of a G-SIB surcharge for Schwab undermines the synthesis. (4) The contextual relevance is high because the answer addresses the core question about capital distribution constraints and buffer composition. However, due to major quantitative errors and incorrect entity attributions (applying G-SIB surcharge to Schwab), the correctness score is low. The qualitative accuracy is moderate because the conceptual framework is partially sound, but entity and numerical inaccuracies reduce reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 481,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How do General Dynamics and Raytheon Technologies differ in their financial exposure to state and local income taxes on U.S. government contracts regulated by the FAR, especially considering GD's exclusion of these taxes from its tax provision and RTX's FAR-governed cost allowability and pricing mechanisms?",
      "original_answer": "General Dynamics excludes state and local income taxes allocable to U.S. government contracts from its tax provision, instead recognizing them in operating costs and expenses. This treatment is governed by the Federal Acquisition Regulation (FAR), which dictates how costs are allocated and allowed on government contracts. Raytheon Technologies, also subject to the FAR, structures its pricing under these contracts based on allowable costs, including mechanisms like performance-based payments and progress payments that influence revenue recognition patterns. The difference in financial exposure stems from GD directly expensing these taxes while RTX incorporates them into broader cost considerations under FAR-regulated pricing frameworks.",
      "llm_answer": "General Dynamics excludes state and local income taxes that are allocable to U.S. government contracts from its income‑tax provision, treating them as operating costs in the income statement (GD 10‑K, p. 18).  Raytheon Technologies, by contrast, treats those taxes as allowable costs under the FAR and recovers them through contract pricing, so they are reflected in the cost‑allowability and pricing calculations rather than as a separate tax expense (RTX 10‑K, pp. 77‑81).  Thus, GD’s tax provision is lower for government contracts, while RTX’s exposure is embedded in the cost base and recoverable via pricing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: General Dynamics excludes state and local income taxes on U.S. government contracts from its tax provision and instead treats them as operating costs, while Raytheon Technologies includes these taxes as allowable costs under FAR, recovering them through contract pricing mechanisms. The LLM correctly identifies the financial statement impact—GD lowers its tax provision, whereas RTX embeds the cost in pricing and cost allowability. (2) There are no numeric values in the question or answer requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; all references to financial treatments are consistent with the original. (3) Multi-hop reasoning is sound: the model synthesizes information across two companies (GD and RTX), connects their differing treatments to the FAR framework, and explains how each company’s approach affects financial exposure. The citation of specific 10-K pages (p. 18 for GD, pp. 77–81 for RTX) adds precision, though not required for correctness. (4) The only reason for not scoring a perfect 10 is minor: the original answer emphasizes RTX’s use of performance-based and progress payments influencing revenue recognition, which the LLM omits. While this detail is contextual and not central to the core comparison, its absence slightly reduces completeness in the qualitative dimension. However, the LLM captures the essential distinction in cost treatment and financial exposure, maintaining semantic equivalence on the main point. Thus, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 460,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does the voting power distribution in META's dual-class structure, including the dividend initiation on Class B shares, compare with GOOGL's structure where Class B shares automatically convert to Class A upon transfer?",
      "original_answer": "META’s Class B common stock is entitled to a non-dilutable 33 1/3% aggregate voting power, with each share receiving 15 votes, and it now receives the same $0.50 per share quarterly dividend as Class A stock following META’s initiation of dividends in 2024. Class B shares can convert share-for-share into Class A common stock, subject to restrictions. In contrast, GOOGL’s Class B shares are entitled to 10 votes per share and automatically convert to Class A shares upon sale or transfer, ensuring a more fluid transition between voting tiers. Both companies maintain dual-class systems to preserve founder control, but the structural mechanics and dividend treatment differ significantly.",
      "llm_answer": "Meta’s dual‑class structure gives holders of Class A common stock 66 ⅓ % of the company’s voting power and holders of Class B common stock 33 ⅓ %, with each Class B share entitled to 15 votes.  On February 1 2024 Meta announced its first cash dividend of $0.50 per share, declared equally for both Class A and Class B shares.  Alphabet’s structure differs in that Class B shares carry 10 votes per share but automatically convert to Class A upon sale or transfer, so voting power is ultimately consolidated into Class A shares after the conversion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: META's Class B shares have 33 1/3% voting power with 15 votes per share, Class A holds the remaining 66 1/3%, the $0.50 quarterly dividend initiated on February 1, 2024, applies equally to both classes, and GOOGL’s Class B shares carry 10 votes and convert to Class A upon transfer. These match the ground truth exactly. (2) Quantitative accuracy is perfect: percentages (33 1/3%, 66 1/3%), vote counts (15 and 10 votes), dividend amount ($0.50), and date (February 1, 2024) are all correct and precisely stated. Format variations (e.g., 66 ⅓ vs 66 ⅓ %) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound—LLM correctly synthesizes information across META and GOOGL, comparing voting power distribution, dividend treatment, and conversion mechanics. It captures the core contrast: META maintains permanent dual-class structure with dividend parity, while GOOGL enforces automatic conversion upon transfer. The only minor omission is that the ground truth explicitly notes Class B to Class A conversion in META is 'subject to restrictions,' which the LLM does not mention, slightly weakening completeness. (4) Contextual relevance is excellent—the response directly addresses the comparative structure, dividend policy, and transfer/conversion rules as asked. Overall, the answer is factually complete and accurate with only a small detail missing on conversion restrictions, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 421,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does the use of a 95% confidence interval in the VaR model under normal market conditions impact the one-day loss estimation methodology for both Philip Morris's derivative instruments and Mondelez's currency and commodity exposures, given their shared reliance on the parametric delta-gamma approximation technique?",
      "original_answer": "Both Philip Morris (PM) and Mondelez (MDLZ) rely on the parametric delta-gamma approximation technique within their Value at Risk (VaR) models, which operate under the assumption of normal market conditions and a 95% confidence interval. This methodology estimates the potential one-day loss by observing interest rate and currency movements—PM excludes anticipated transactions and hedges in its calculation, while MDLZ includes currency and commodity instruments, explicitly noting the non-linear response of options in the computation. The shared modeling assumption limits both firms' risk assessments to typical market behavior, potentially underestimating losses during periods of market stress.",
      "llm_answer": "Both companies use a VaR model that assumes normal market conditions, a one‑day holding period, and a 95 % confidence interval, and both rely on a parametric delta‑gamma approximation to capture the nonlinear effects of their derivative portfolios. The 95 % confidence interval means the one‑day loss estimate represents the loss that would be exceeded only 5 % of the time, providing a conservative, tail‑risk measure. For Philip Morris the VaR reflects potential fair‑value loss of interest‑rate and currency derivatives, while for Mondelez it reflects potential pre‑tax earnings loss from currency and commodity derivatives, but both use the same statistical framework to estimate the maximum daily loss.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key elements are correct: both companies use a 95% confidence interval, a one-day holding period, and the parametric delta-gamma approximation under normal market conditions—these match the original answer exactly. The interpretation of the 95% confidence interval as a loss exceeded only 5% of the time is statistically sound. (2) The LLM correctly identifies that Philip Morris assesses fair-value loss on interest-rate and currency derivatives, while Mondelez evaluates pre-tax earnings impact from currency and commodity derivatives, which reflects the entity-specific nuances in risk exposure and reporting. (3) The multi-hop reasoning is strong: the model synthesizes shared methodology (VaR with delta-gamma) across two firms while differentiating their application (fair value vs. earnings impact, inclusion of commodities). (4) One minor omission: the original answer notes that PM excludes anticipated transactions and hedges, and MDLZ explicitly accounts for the non-linear response of options—details not mentioned in the LLM response. While this slightly reduces completeness, the core technical and comparative insights are preserved. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with only minor depth differences.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 384,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How do the embedded derivatives within CDOs referenced by Morgan Stanley compare in risk exposure to Bank of America's structured liabilities that also contain embedded derivatives, particularly in the context of credit events impacting their market-making activities?",
      "original_answer": "Morgan Stanley's involvement with CDOs includes hybrid instruments containing embedded derivatives where credit protection has been sold to the issuer of the note, exposing the firm to risk in the event of a credit event on the reference entity, which could result in the principal balance of the note not being repaid in full. Similarly, Bank of America's structured liabilities also contain embedded derivatives that are part of their market-making activities, and these derivatives are typically offset by gains or losses on hedging instruments. Both firms face credit risk tied to these derivatives, though the specific impact on Morgan Stanley is tied to the performance of the CDOs' underlying reference entities, while Bank of America's exposure is more broadly tied to the performance of their structured liabilities and the effectiveness of their hedging strategies.",
      "llm_answer": "Morgan Stanley’s embedded derivatives in its CDOs expose the firm to credit events that can reduce the principal balance of the notes and alter the value of the collateral it receives, thereby potentially affecting its market‑making activities (see pages 125‑129). Bank of America’s structured liabilities also contain embedded derivatives, but the firm’s exposure is limited to the non‑recourse nature of those liabilities and the collateralized nature of the derivatives, which can mitigate direct loss (see pages 162‑166). Thus, while both entities face credit‑event risk that can impact market‑making, Morgan Stanley’s exposure is more directly tied to collateral value changes, whereas Bank of America’s exposure is more constrained by the non‑recourse, collateral‑backed structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the original answer in terms of core facts and reasoning. (1) Both Morgan Stanley and Bank of America are accurately identified as having structured products with embedded derivatives impacting their market-making activities. The key risk for Morgan Stanley—credit events leading to reduced principal repayment due to exposure to reference entities in CDOs—is correctly described, though the LLM emphasizes 'collateral value changes' more than the original, which focuses on failure of full principal repayment. This is a subtle shift but not factually incorrect. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable; however, the absence of fabricated numbers and correct use of qualitative financial concepts earns full marks. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both firms have embedded derivatives in structured products, identifies differing risk mitigation mechanisms (non-recourse, collateral-backed structures at Bank of America), and links these to market-making impact. The original emphasizes hedging offsets for Bank of America, while the LLM highlights structural protections—these are complementary perspectives, though not perfectly aligned. (4) Contextual relevance is high, as the response directly addresses the comparative risk exposure question and ties both firms' structures to credit event impacts. The slight deviation in emphasis—collateral value (LLM) vs. hedging effectiveness (original)—prevents a perfect score, but the overall semantic meaning and factual basis remain consistent. Minor differences in framing do not undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 462,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How does the global minimum tax under the OECD's Pillar Two model rules impact Salesforce's effective tax rate compared to Microsoft's projected tax liability, given the uncertainty around implementation timelines and jurisdictional adoption?",
      "original_answer": "Salesforce notes that global tax developments, including the OECD's Pillar Two model rules introducing a 15% global minimum tax, may have a material impact on its business, cash flows, or financial results. Microsoft, which currently operates with an effective tax rate of 19% (down to 18% in fiscal 2024), expects Pillar Two to apply to its operations starting in fiscal 2025 but does not currently estimate a material impact to its consolidated financial statements. However, uncertainty remains as to the final Pillar Two model rules and their adoption across jurisdictions, which could affect both companies differently depending on their global footprint and tax planning strategies.",
      "llm_answer": "Salesforce’s effective tax rate is not expected to be materially affected by the Pillar Two minimum tax because it has no significant operations in jurisdictions with rates below the 15 % threshold, and the company expects no material increase in global tax costs (Salesforce, 2023, pp. 27‑31). In contrast, Microsoft anticipates a projected tax liability under Pillar Two that could raise its tax expense, but the exact impact remains uncertain as the rules are still being adopted and implementation timelines vary across jurisdictions (Microsoft, 2023, pp. 45‑49).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but includes significant inaccuracies in both quantitative and qualitative aspects. (1) Quantitatively, the LLM incorrectly states that Salesforce has 'no significant operations in jurisdictions with rates below the 15% threshold' and 'expects no material increase in global tax costs,' which contradicts the original answer stating that Salesforce explicitly acknowledges a *potential material impact* due to Pillar Two. The original answer does not provide Salesforce's current effective tax rate or assert that it will be unaffected—this is a misrepresentation. For Microsoft, the LLM claims a 'projected tax liability under Pillar Two that could raise its tax expense,' but the original answer states Microsoft *does not currently estimate a material impact* to its financial statements, despite expecting Pillar Two to apply starting fiscal 2025. The LLM overstates the expected impact on Microsoft. (2) The original answer cites Microsoft’s effective tax rate as 19% (down to 18% in FY2024), but the LLM omits these specific figures, reducing quantitative accuracy. (3) In terms of reasoning, the LLM fails to correctly synthesize the multi-hop comparison: while both companies face uncertainty due to implementation timelines and jurisdictional adoption, the original answer emphasizes that Microsoft sees no current material impact, whereas Salesforce flags potential material risk—this contrast is misrepresented in the LLM response. (4) Contextually, the answer is relevant and addresses the core question about comparative impacts of Pillar Two, but the factual misstatements about both companies’ exposures undermine correctness. Semantic equivalence is not achieved due to these key factual divergences.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 478,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How does Boeing's Five-Year Credit Agreement, which involves JPMorgan Chase Bank, N.A. as syndication agent, compare with Honeywell's credit agreement with JPMorgan Chase Bank, N.A. in terms of syndication structure and key banking partners?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, includes JPMorgan Chase Bank, N.A. as syndication agent alongside Citibank, N.A. as administrative agent, with both also serving as joint lead arrangers and joint book managers. Honeywell's Amended and Restated Five-Year Credit Agreement, dated March 20, 2023, also features JPMorgan Chase Bank, N.A., along with Wells Fargo Bank, National Association, as syndication agents, with Bank of America, N.A. serving as administrative and swing line agent. Both agreements involve JPMorgan Chase Bank, N.A. in a syndication role, but differ in the lead arranger structure and partner institutions involved.",
      "llm_answer": "Boeing’s 2023 Five‑Year Credit Agreement is a two‑bank structure: Citibank, N.A. serves as the administrative agent and joint lead arranger/book manager, while JPMorgan Chase Bank, N.A. is the sole syndication agent.  Honeywell’s credit agreement, by contrast, is a three‑bank arrangement in which Bank of America, N.A. is the administrative (and swing‑line) agent, and JPMorgan Chase Bank, N.A. together with Wells Fargo Bank, N.A. act as syndication agents.  Thus, Boeing relies on Citibank and JPMorgan, whereas Honeywell adds Wells Fargo and assigns a separate swing‑line role to Bank of America.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key banks and their roles in both Boeing's and Honeywell's credit agreements, capturing the core comparison in syndication structure and key partners. However, it contains a critical error in stating that Boeing's agreement is from 2023, while the ground truth specifies it was dated October 30, 2019. This incorrect date undermines quantitative accuracy. The rest of the entity roles are mostly accurate: Citibank, N.A. as administrative agent and joint lead arranger/book manager for Boeing, and JPMorgan Chase Bank, N.A. as syndication agent are correct. For Honeywell, the roles of Bank of America, N.A. as administrative and swing line agent, and JPMorgan and Wells Fargo as co-syndication agents are correctly stated. (2) The only numeric/date discrepancy is the Boeing agreement year (2023 vs. 2019), which is a significant factual error. No financial figures are involved, so no calculation errors exist. (3) The multi-hop reasoning is sound—comparing syndication structures and key banking partners across two companies and agreements. The synthesis correctly highlights that both involve JPMorgan but differ in the number and roles of other banks. The conclusion that Boeing uses a two-bank structure (Citibank and JPMorgan) while Honeywell uses three (with Wells Fargo added) is logically derived and semantically aligned with the ground truth. (4) Correctness score is 7 because the core factual content about roles and structure is accurate, but the incorrect date reduces confidence in the source data. Quantitative accuracy is 6 due to the wrong year. Qualitative accuracy is 8 because reasoning and entity identification are strong despite the date error. Contextual relevance is 10—answer directly addresses the question with appropriate focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 493,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How does the absence of the Countercyclical Capital Buffer requirement impact the total capital buffer requirements for both Bank of America and Morgan Stanley under the Advanced Approaches framework, given their respective G-SIB surcharges of 2.5% and inclusion of the 2.5% Capital Conservation Buffer?",
      "original_answer": "For Bank of America, the absence of the Countercyclical Capital Buffer (CCyB) means its total Common Equity Tier 1 (CET1) capital buffer requirement under the Advanced Approaches framework is the sum of its G-SIB surcharge of 2.5% and the 2.5% Capital Conservation Buffer, totaling 5.0%. Similarly, Morgan Stanley’s CET1 capital buffer requirement under the same framework is also the sum of its G-SIB surcharge (which is not quantified in the provided data but assumed to be included), the 2.5% Capital Conservation Buffer, and the zero CCyB. Therefore, the absence of CCyB directly reduces the total CET1 buffer requirement for both banks by the amount the CCyB would have otherwise contributed.",
      "llm_answer": "Because the countercyclical capital buffer (CCyB) is zero, the Advanced‑Approaches buffer requirement is simply the sum of the 2.5 % capital‑conservation buffer and the G‑SIB surcharge.  Thus Bank of America’s buffer is 2.5 % + 3.0 % = 5.5 %, while Morgan Stanley’s is 2.5 % + 2.5 % = 5.0 %.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the G-SIB surcharge for Bank of America, stating it as 3.0% instead of 2.5% as per the ground truth. This leads to an incorrect total buffer of 5.5% instead of 5.0%. For Morgan Stanley, the calculation (2.5% + 2.5% = 5.0%) is numerically correct and aligns with the ground truth, assuming its G-SIB surcharge is 2.5%. However, the original answer notes that Morgan Stanley's G-SIB surcharge is not quantified in the data but assumed to be included, so the LLM's use of 2.5% is an unsupported assumption. (2) The calculation logic—summing G-SIB surcharge and Capital Conservation Buffer while correctly treating CCyB as zero—is sound and matches the required reasoning. However, the incorrect input value for Bank of America invalidates its result. (3) The multi-hop reasoning is partially correct: the model understands that total CET1 buffer = G-SIB + CCB + CCyB (with CCyB = 0), which is the correct synthesis across regulatory components. But it fails to accurately reflect the G-SIB surcharge for Bank of America, undermining the correctness. (4) The contextual relevance is high because the answer addresses the framework, the buffers involved, and the impact of CCyB absence. However, due to the significant numerical error affecting one of the two banks and an unsupported assumption for the other, the overall correctness score is reduced to 4. Quantitative accuracy is low (3) due to the wrong percentage and total for Bank of America. Qualitative accuracy is moderate (5) because the reasoning structure is valid but based on incorrect or unverified inputs.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 447,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What was NVIDIA's effective tax rate in fiscal year 2022, and how does it compare to Apple's operating income margin in the Greater China region during the same period?",
      "original_answer": "NVIDIA's effective tax rate in fiscal year 2022 was 1.9%, significantly lower than the U.S. federal statutory rate of 21%, due in part to income earned in jurisdictions like Hong Kong that have lower tax rates. Meanwhile, Apple reported $31,153 million in operating income from $74,200 million in net sales in the Greater China region during fiscal year 2022, resulting in an operating income margin of approximately 42%. These metrics reflect different financial impacts from operating in the region, with NVIDIA benefiting from lower tax rates and Apple demonstrating strong profitability from its sales in the same market.",
      "llm_answer": "NVIDIA’s effective tax rate in fiscal year 2022 was **1.9%**【NVDA page 52】.  \nApple’s operating‑income margin in the Greater China region for the same year was roughly **42%** (operating income $31.2 bn on net sales $74.2 bn)【AAPL page 52】, which is substantially higher than NVIDIA’s tax rate.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: NVIDIA's effective tax rate is correctly stated as 1.9%, and Apple's operating income margin in Greater China is accurately calculated from $31.2 billion operating income on $74.2 billion net sales, resulting in approximately 42% (31.2 / 74.2 ≈ 0.4198 or 42%). The dollar amounts match the ground truth ($31,153 million ≈ $31.2 billion; $74,200 million = $74.2 billion), with acceptable rounding. (2) The answer is complete, addressing both parts of the multi-part question: NVIDIA’s tax rate and Apple’s operating margin in Greater China for fiscal year 2022. (3) Entity accuracy is correct—NVIDIA (NVDA), Apple (AAPL), fiscal year 2022, and the financial metrics (effective tax rate, operating income margin) are all properly identified. (4) The reasoning is sound: the model correctly synthesizes data from two different companies and regions, and the comparison—while simplified—is logically valid and contextually appropriate. The inclusion of citation markers (e.g., 【NVDA page 52】) adds source transparency. (5) The semantic meaning is equivalent to the original answer, conveying the same core insight: NVIDIA’s low tax rate versus Apple’s high profitability in Greater China. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 377,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How do BA's and UPS's uses of pricing models for valuing Level 2 assets differ based on the observable inputs they emphasize in their 2024 filings?",
      "original_answer": "BA values its fixed income investments categorized as Level 2 using pricing models that incorporate inputs such as benchmark yields, swap curves, and inter-dealer broker rates. These models are primarily income-based and rely on structured cash flow analysis and rating agency data. In contrast, UPS applies pricing models to value its Level 2 derivatives—mainly over-the-counter instruments—using market observable inputs like yield curves, foreign currency exchange rates, and investment forward prices. While both companies rely on observable market data for Level 2 classifications, BA emphasizes credit and yield-related inputs for fixed income instruments, whereas UPS focuses on currency and interest rate dynamics for its derivative positions.",
      "llm_answer": "Boeing’s 2024 10‑K notes that Level 2 fair‑value estimates for its fixed‑income holdings are derived from pricing models that use reported trades, broker quotes, benchmark yields and base spreads—i.e., credit‑spread and bond‑market inputs (BA_10k_2024, pp. 100‑104). UPS, in contrast, characterizes Level 2 valuations for its over‑the‑counter derivatives as relying on observable interest‑rate curves, foreign‑currency exchange rates and investment‑forward prices, reflecting a focus on rate and currency market data (UPS_10k_2024, pp. 135‑139).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Boeing (BA) uses pricing models for Level 2 fixed-income assets with inputs like benchmark yields, credit spreads, broker quotes, and reported trades—consistent with income-based models and credit/yield focus. UPS uses observable inputs such as interest rate curves, foreign exchange rates, and investment forward prices for its OTC derivatives, aligning with its focus on currency and interest rate dynamics. (2) There are no numerical values (e.g., dollar amounts, percentages, dates) in the question or answers, so quantitative accuracy is not compromised; all references to inputs are non-numeric and correctly reported. (3) The multi-hop reasoning is sound—correctly contrasting BA’s fixed-income valuation approach with UPS’s derivative valuation by emphasizing different observable inputs, synthesizing across two companies and their respective 2024 filings. (4) The LLM slightly omits mention of swap curves and rating agency data for BA, and does not explicitly reference 'structured cash flow analysis' or 'rating agency data' as in the original, but captures the essential distinction in input emphasis (credit/yield vs. currency/rate). Wording differs but semantic meaning and analytical contrast are preserved. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to minor omissions, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 415,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How does the voting power disparity between Class A and Class B common stock at GOOGL compare to the uniform voting rights structure at NFLX, particularly in light of GOOGL's $62.2 billion share repurchase program in 2023?",
      "original_answer": "GOOGL's Class A common stockholders have 1 vote per share, while Class B common stockholders have 10 votes per share, creating a significant disparity in voting power. This contrasts sharply with NFLX, where each share of common stock carries exactly one vote, ensuring equal voting rights across all shareholders. Additionally, GOOGL's 2023 share repurchase program, which retired $62.2 billion worth of shares, primarily targeted Class A and Class C shares, potentially influencing the overall voting balance by reducing the number of shares that convert from Class B to Class A upon transfer, thereby preserving the voting control of existing Class B holders.",
      "llm_answer": "Alphabet’s 2023 10‑K states that each Class A share has one vote while each Class B share has ten votes (Note 11, p. 79‑80), and that the company repurchased $62.2 billion of Class A and Class C shares in 2023 (p. 81).  The buy‑back therefore reduces the number of one‑vote shares, slightly increasing the relative voting power of the ten‑vote Class B holders, but the ten‑to‑one disparity remains unchanged.  By contrast, Netflix’s 2023 10‑K reports that all common shares carry one vote each (p. 59), giving it a uniform voting structure with no disparity between share classes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GOOGL's Class A has 1 vote/share, Class B has 10 votes/share; NFLX has uniform 1 vote/share; and GOOGL's 2023 share repurchase was $62.2 billion targeting Class A and Class C shares. These numbers match the original answer exactly, with acceptable formatting ($62.2 billion). (2) Quantitative accuracy is perfect—no calculation errors, and all figures are correctly cited. (3) The reasoning is sound: the repurchase of Class A and C shares (which are 1-vote) reduces their outstanding count, thereby increasing the relative voting power of Class B holders, even though the formal 10:1 ratio remains unchanged. This subtle but important point is correctly captured. (4) The comparison to NFLX’s uniform voting structure is accurately presented. The only minor shortcoming is that the LLM does not explicitly mention the mechanism of Class B shares converting to Class A upon transfer—a nuance in the original answer that explains why reducing Class A supply indirectly preserves Class B control. However, the core insight about relative voting power shift is present. Overall, the answer is factually complete, logically sound, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 351,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does ACN's classification of U.S. government debt securities as Level 2 assets affect comparability with AVGO's investment disclosures, given that such securities are typically categorized as Level 1 based on active market pricing?",
      "original_answer": "ACN classified its U.S. government debt securities as Level 2 assets totaling $9,765 million, which contrasts with AVGO's disclosures where Level 1 securities are described as being valued based on quoted prices in active markets. This is notable because the UPS evidence indicates that U.S. government debt securities are generally categorized as Level 1 due to quoted prices in active markets. AVGO’s disclosures explicitly differentiate Level 1 and Level 2 securities based on valuation methodology, suggesting that ACN’s choice to classify these assets as Level 2 could reduce transparency and comparability in investment valuation practices between the two firms.",
      "llm_answer": "ACN’s 10‑K lists U.S. government debt securities as Level 2 assets, meaning they are valued with observable inputs such as yield curves rather than quoted market prices. AVGO, in its own disclosures, treats the same securities as Level 1 and values them at active‑market prices. This difference in valuation hierarchy introduces higher model risk and less transparency for ACN, making its fair‑value figures less directly comparable to AVGO’s quoted‑price basis.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately identifies that ACN classifies U.S. government debt securities as Level 2 assets and contrasts this with AVGO's classification of similar securities as Level 1, based on active market pricing. There are no explicit dollar amounts mentioned in the LLM answer (e.g., $9,765 million), which is a minor omission affecting completeness but not overall correctness. (2) Quantitative accuracy is high—while the specific value of $9,765 million from ACN is missing, no incorrect numbers are presented, and the absence does not distort the comparison. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across ACN and AVGO disclosures, recognizes the divergence in fair value hierarchy treatment, and infers implications for comparability and transparency. It correctly notes that Level 1 relies on quoted prices in active markets (AVGO) versus Level 2’s reliance on observable inputs (ACN), which is logically consistent with accounting standards. (4) The answer could have strengthened its argument by referencing the UPS evidence (as in the original answer) that U.S. government debt securities are typically Level 1, which would reinforce the anomaly in ACN’s classification. However, the core reasoning and conclusion about reduced comparability and increased model risk are valid and contextually appropriate. Thus, the answer is factually correct and relevant, with only minor omissions in supporting detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 418,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does Colgate-Palmolive's adoption timeline for ASU 2022-04, which mandates detailed disclosures on supplier finance obligations, compare to Target's implementation of similar disclosures, particularly regarding the confirmed amount outstanding at year-end?",
      "original_answer": "Colgate-Palmolive adopted ASU 2022-04 beginning January 1, 2023, with the roll-forward information disclosure effective January 1, 2024. Target discloses its confirmed obligations outstanding under supplier finance programs within Accounts Payable on its Consolidated Statements of Financial Position, with early payment options available to vendors up to 120 days from the invoice date. While Colgate-Palmolive references Note 15 for program details, Target explicitly outlines the structure of its arrangements and vendor discretion in electing early payments, though exact confirmed amounts are not quantified in the provided excerpt.",
      "llm_answer": "Colgate‑Palmolive adopted ASU 2022‑04 for its supplier‑finance disclosures on January 1 , 2023 (with roll‑forward information effective January 1 , 2024) and reported a confirmed amount outstanding of $3.666 billion at year‑end (December 31 , 2024). The Target 10‑K pages provided do not contain comparable supplier‑finance‑program disclosures or a confirmed‑amount figure, so a direct comparison of adoption timing or year‑end amounts cannot be made.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that Colgate-Palmolive adopted ASU 2022-04 on January 1, 2023, with roll-forward disclosures effective January 1, 2024, it incorrectly claims a confirmed amount outstanding of $3.666 billion at year-end 2024. The ground truth does not provide any specific quantified amount for Colgate-Palmolive’s year-end obligations, only that details are referenced in Note 15. This number is therefore fabricated or hallucinated. (2) Regarding Target, the LLM states that no comparable disclosures or confirmed amounts are present in the provided 10-K pages, which contradicts the ground truth: Target does disclose its supplier finance obligations as part of Accounts Payable and describes the program structure, including early payment options up to 120 days, even if exact amounts are not quantified. The LLM incorrectly concludes that no comparison can be made, when in fact the original answer allows for a qualitative comparison of disclosure practices. (3) The multi-hop reasoning is flawed: the model fails to synthesize the correct comparison — that both companies implement ASU 2022-04-related disclosures but with differing levels of detail (Colgate referencing Note 15 without explicit year-end figures in the ground truth, Target describing program mechanics but not quantifying confirmed obligations). Instead, it falsely asserts a precise figure for Colgate and denies any Target disclosure, breaking the chain of accurate cross-entity analysis. (4) Despite these issues, the answer is contextually relevant and attempts to address both companies and the ASU adoption timeline. The adoption dates are correctly cited, showing partial understanding. However, the hallucinated dollar amount severely undermines factual correctness, warranting a low quantitative accuracy score. Qualitative accuracy is moderate due to correct entity and timeline identification but flawed reasoning. Contextual relevance is fair as the structure aligns with the question, even if facts are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 558,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does BlackRock's exposure to operational risks through third-party technology partners like Microsoft compare to Mastercard's approach in managing similar reputational risks stemming from their own operational resilience strategies?",
      "original_answer": "BlackRock discloses that its reliance on key technology partners like Microsoft for hosting Aladdin on Azure introduces operational and execution risks, including infrastructure reliability, software security, and regulatory oversight, which could lead to reputational harm or legal liability if not managed properly. Operational risk is explicitly defined in the COF evidence as having the potential to result in reputational impact due to internal process failures, system issues, or external events. Mastercard identifies 'Reputational Impact' as a named risk factor in its 10-K and structures its risk management framework around it, listing 'Operational Resilience' as a core component of its reputational risk mitigation strategy. This suggests that while both firms recognize the reputational consequences of operational failures, BlackRock's risk is heightened by its dependency on external cloud providers, whereas Mastercard integrates operational resilience directly into its brand protection framework.",
      "llm_answer": "BlackRock’s operational‑risk exposure is largely external: it relies on Microsoft Azure to host its Aladdin platform, which introduces risks of infrastructure reliability, security, regulatory oversight and potential global cloud failures (BlackRock, “Key technology partnerships may expose BlackRock to increased regulatory oversight…”, p. 28).  By contrast, Mastercard treats operational resilience as an internal risk, embedding it in its governance and risk‑management framework to protect its brand and maintain service continuity, thereby managing reputational risk through proactive operational‑resilience controls (Mastercard, risk‑highlight table: “Information Security and Operational Resilience” and “Brand, Reputational Impact and Environmental, Social and Governance”, p. 26).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BlackRock's reliance on Microsoft Azure for Aladdin is accurately described, including the associated operational risks (infrastructure reliability, security, regulatory oversight). Mastercard's integration of operational resilience into its risk management framework as a means to protect reputation is also correctly portrayed. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the absence of any incorrect numbers or miscalculations supports a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (BlackRock and Mastercard), contrasting external dependency (third-party cloud risk) with internal resilience strategy. The use of specific risk categories from each firm’s 10-K (e.g., 'Information Security and Operational Resilience', 'Brand, Reputational Impact...') adds precision. (4) The only minor shortcoming is that the LLM does not explicitly state that both firms recognize reputational consequences from operational failures—a key point of comparison in the original answer—though this is implied. Otherwise, the answer is contextually rich, semantically equivalent, and directly addresses the comparative aspect of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 394,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How significant was Cardinal Health as a customer for BMY in 2021, and what role does Cardinal play in CVS's generic pharmaceutical sourcing strategy through Red Oak Sourcing, LLC?",
      "original_answer": "Cardinal Health represented 20% of BMY's revenue in 2021, making it a significant customer relationship. CVS partners with Cardinal through Red Oak Sourcing, LLC, where both companies hold 50% ownership and jointly negotiate generic pharmaceutical supply contracts. This strategic arrangement enables CVS and Cardinal to leverage combined sourcing capabilities, though it does not involve inventory ownership by Red Oak. The shared sourcing venture highlights Cardinal's dual role as both a key BMY customer and a strategic partner in CVS's supply chain infrastructure.",
      "llm_answer": "Cardinal Health was BMY’s largest customer in 2021, accounting for roughly 6.2 % of BMY’s net product sales (BMY 10‑K, pp. 105‑109). Through Red Oak Sourcing, LLC, Cardinal and CVS jointly own the generic‑pharmaceutical sourcing platform; Cardinal contributes its sourcing and supply‑chain expertise to negotiate and secure generic contracts for both companies (CVS 10‑K, pp. 16‑20).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the percentage of BMY's revenue attributed to Cardinal Health. The ground truth states that Cardinal Health represented 20% of BMY's revenue in 2021, whereas the LLM claims it was 'roughly 6.2%,' which is significantly off and undermines the core of the answer. This error likely stems from misreading or misquoting the BMY 10-K, as 6.2% does not align with the verified data. (2) The quantitative accuracy is severely compromised due to this incorrect percentage. Even though the format '6.2%' is valid, the value itself is wrong, and no correct calculation or reference to 20% is present. (3) On qualitative aspects, the LLM correctly identifies the structure of Red Oak Sourcing, LLC as a 50/50 joint venture between CVS and Cardinal Health for generic pharmaceutical sourcing, and notes that Cardinal contributes sourcing expertise—this aligns with the ground truth. However, it omits key details such as the fact that Red Oak does not own inventory and fails to emphasize Cardinal’s dual role as both a major customer of BMY and a strategic partner in CVS’s supply chain. The multi-hop reasoning is partially sound—linking Cardinal’s role across BMY and CVS—but weakened by the revenue miscalibration. (4) Contextual relevance is fair because the answer addresses both parts of the question: Cardinal’s significance to BMY and its role in CVS’s sourcing strategy. Despite incorrect numbers, the general direction of the response remains on-topic. However, the magnitude of the numerical error drastically reduces overall correctness, warranting a low score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 446,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How does the voting power of Class B common stockholders at META compare to that of NFLX common stockholders, given that META Class B shares are restricted to specific voting scenarios and each share carries a multiplier based on the conversion rate?",
      "original_answer": "META's Class B common stockholders have restricted voting rights, only applicable in specific scenarios such as exiting the core payments business, a merger, or certain amendments to the certificate of incorporation. In these cases, each Class B share's voting power is multiplied by the applicable conversion rate in effect on the record date. In contrast, NFLX common stockholders receive one vote per share on all matters requiring stockholder approval. This means that while META Class B shareholders have conditional voting rights with variable influence based on the conversion rate, NFLX shareholders have consistent, unconditional voting power proportional to their shareholding.",
      "llm_answer": "Meta’s Class B common shareholders can vote only on a narrow set of matters (e.g., exit of the core payments business, certain mergers or amendments to the certificate of incorporation) and, when they do vote, each share’s votes are multiplied by the conversion rate in effect on the record date【META_10k_2023.pdf pages 55‑59】. In contrast, Netflix has a single class of common stock and every share carries one vote on all matters to be voted upon by the company’s stockholders【NFLX_10k_2023.pdf pages 59‑63】. Thus, Meta’s Class B holders have substantially restricted voting power compared with Netflix’s common shareholders, who enjoy full, one‑vote‑per‑share rights on all issues.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that Meta's Class B shareholders have restricted voting rights limited to specific scenarios such as exiting the core payments business, mergers, or amendments to the certificate of incorporation, and that each share's voting power is multiplied by the conversion rate during those events. This matches the original answer's description of conditional voting with variable influence. (2) It accurately contrasts this with NFLX, stating that Netflix has a single class of common stock with one vote per share on all matters, which aligns with the ground truth's assertion of unconditional, proportional voting rights. (3) The multi-hop reasoning—comparing voting structures across two companies (Meta and Netflix) using information from their respective 10-K filings—is sound and well-synthesized. The citations (e.g., page ranges from the 10-Ks) further support the accuracy. (4) There are no numerical inaccuracies; although no specific numbers (like conversion rates) are provided, none are required—the answer correctly describes the structural mechanism without misrepresenting any data. Wording differs slightly but preserves full meaning. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 367,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How does the automatic conversion of Class B shares upon transfer at GOOGL contrast with META's structural protections that require Class B approval for change-of-control transactions, and what role does Mastercard's mandatory post-conversion Class A stock transfer mechanism play in evaluating dual-class governance frameworks?",
      "original_answer": "META requires that any change-of-control transaction must be approved by a majority of its outstanding Class B common stock voting as a separate class until those shares represent less than 35% of combined voting power. In contrast, GOOGL's Class B shares automatically convert to Class A shares upon sale or transfer, effectively limiting concentrated voting control over time. Mastercard's framework mandates that converted Class B shares become Class A shares that must be sold or transferred, creating a structural mechanism that prevents long-term retention of higher-vote shares. This contrast reveals different approaches to dual-class governance: META entrenches control through voting rights preservation, while GOOGL and Mastercard implement mechanisms that eventually dilute concentrated voting power through mandatory conversion and divestiture.",
      "llm_answer": "GOOGL’s charter automatically converts any transferred Class B shares to Class A shares (GOOGL 10‑K, pp. 79‑83), so that over time the concentrated voting power of Class B holders erodes.  By contrast, Meta’s bylaws require that any transaction that would change the company’s control must be approved by a majority of the outstanding Class B shareholders (META 10‑K, pp. 48‑52), giving those holders a veto over control changes.  Mastercard’s post‑conversion rule obligates Class B holders to sell or otherwise transfer any Class A shares they receive, preventing the accumulation of voting power and serving as a key metric when evaluating dual‑class governance structures (MA 10‑K, pp. 97‑101).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GOOGL's Class B shares automatically convert to Class A upon transfer, META requires Class B approval for change-of-control transactions, and Mastercard mandates post-conversion divestiture of Class A shares. These points are correctly attributed to the respective 10-K filings with accurate page ranges. (2) There are no numeric values (e.g., percentages, dollar amounts, dates) in either the question or answers that require verification—thus, quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the LLM correctly contrasts GOOGL’s erosion of voting power via automatic conversion, META’s entrenchment via veto rights, and Mastercard’s structural divestiture mechanism. The synthesis across three companies and governance models is logically coherent. (4) The only minor shortcoming is that the LLM does not explicitly mention the 35% voting power threshold for META’s Class B veto right, which is present in the ground truth. While this detail is important for completeness, its omission does not undermine the core correctness of the comparison. The LLM still captures the essential contrast in governance philosophies. Therefore, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 385,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How do MRK's pediatric market exclusivity opportunities compare with AMGN's regulatory exclusivity risks given recent changes to data protection periods for biologics?",
      "original_answer": "MRK benefits from six-month pediatric market exclusivity extensions that can apply to products like its high-risk adult COVID-19 treatment, potentially extending protection beyond patent expiration. In contrast, AMGN faces regulatory exclusivity risks as the FDA considers changes to biologic data exclusivity, including whether umbrella exclusivity applies, which could reduce the effective protection period for products like EPOGEN. These differences reflect MRK's proactive IP strategy versus AMGN's exposure to policy shifts in biologic exclusivity frameworks.",
      "llm_answer": "Merck’s 2022 10‑K notes that, if it completes the FDA‑approved pediatric studies, it can earn an extra six‑month market‑exclusivity period in the U.S. (and a similar six‑month extension tied to an SPC in the EU) for each new or existing indication (see MRK pages 16‑20).  By contrast, Amgen’s 10‑K highlights that the 12‑year data‑protection period for biologics—once the basis for a long‑term exclusivity shield—may be shortened or not applied to subsequent product changes, exposing the company to biosimilar competition earlier than previously expected (see AMGN pages 44‑48).  Thus, Merck has a clear, conditional benefit of up to six months of added exclusivity, whereas Amgen faces a regulatory risk that the biologics exclusivity window could be reduced, accelerating generic entry.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and time periods are correct: the six-month pediatric exclusivity extension for MRK and the 12-year biologic data protection period for AMGN are accurately cited, with proper context on potential shortening. These match the original answer’s emphasis on MRK’s six-month benefit and AMGN’s policy-related risks. (2) The answer is complete, addressing both companies’ regulatory exclusivity positions and the contrast between MRK’s proactive opportunity and AMGN’s exposure to policy changes. It correctly identifies the conditional nature of MRK’s exclusivity (upon completing pediatric studies) and AMGN’s risk due to potential changes in exclusivity application (e.g., for product modifications). (3) Entity accuracy is strong: MRK and AMGN are correctly attributed, and the regulatory frameworks (U.S. and EU SPC) are properly referenced. (4) The reasoning is sound and reflects multi-hop synthesis: it draws from MRK’s pediatric exclusivity mechanism and AMGN’s biologics data protection risks, comparing strategic advantage versus regulatory vulnerability. The only minor gap is that the original answer specifically mentions MRK’s high-risk adult COVID-19 treatment and AMGN’s EPOGEN as examples, which the LLM omits. While not critical to the core comparison, including those product-level details would have made the answer fully equivalent. Overall, the LLM captures the essential contrast and mechanisms accurately, with only slight loss in specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 428,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How do MA's and V's dual-class stock structures differ in terms of voting power distribution and control concentration mechanisms, particularly regarding the balance between Class A and Class B shares?",
      "original_answer": "MA's dual-class structure grants Class B common stock 15 votes per share, with all outstanding shares held by Mr. Brian L. Roberts, representing 33⅓% of the combined voting power, while Class A common stockholders collectively hold 66⅔% of the voting power. In contrast, V's structure ties Class B common stock transferability and convertibility to the resolution of U.S. covered litigation, with conversion rates for Class B shares into Class A shares subject to adjustments based on follow-on offerings or litigation outcomes. Additionally, V's Class C common stock has no transfer restrictions, and its exchange program allows for partial release of restrictions on Class B shares, further differentiating its control mechanisms from MA's more static voting power allocation.",
      "llm_answer": "Mastercard’s dual‑class structure consists of a large block of 925 million Class A shares and a very small block of 7 million Class B shares that are not publicly traded, implying that the minority Class B holders likely carry disproportionate voting power relative to their size, although the filing does not specify the exact voting ratio [MA pages 1‑5]. In contrast, Visa keeps its Class B common stock highly restricted and largely non‑voting—Class B holders can vote only on a narrow set of matters (e.g., exit from core business, mergers, or amendments affecting Class B/C) and the shares are convertible into Class A only after litigation resolution, concentrating voting control in the Class A shares [V pages 87‑91].",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. For MA, it incorrectly states there are 925 million Class A shares and 7 million Class B shares, which is not supported by the ground truth; more critically, it fails to specify the actual voting ratio of 15 votes per Class B share and the precise voting power distribution (33⅓% for Class B held by Mr. Brian L. Roberts, 66⅔% for Class A). Instead, it vaguely refers to 'disproportionate voting power' without quantifying it. For V, it incorrectly claims Class B shares are 'largely non-voting' and can vote only on a narrow set of matters—this contradicts the ground truth, which emphasizes transferability and convertibility restrictions tied to litigation, not limited voting rights. It also omits the existence and role of Class C shares, which have no transfer restrictions and are part of V's control mechanism. (2) Quantitative accuracy is very low: the share counts (925M, 7M) are fabricated or misattributed, and the critical percentages (33⅓%, 66⅔%) and 15:1 voting ratio for MA are missing. No correct numerical data from the ground truth is accurately reproduced. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize the distinct control mechanisms—MA’s static high-vote-per-share structure vs. V’s dynamic, litigation-contingent conversion and exchange program. It mischaracterizes V’s structure around voting limitations rather than transfer/conversion conditions, missing the core differentiating mechanism. (4) Contextual relevance is moderate because the answer addresses dual-class structures and attempts a comparison between MA and V, but the substantive content is largely incorrect or missing, undermining usefulness. The citations to page numbers do not compensate for factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 489,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does RTX's financial exposure to FAR-regulated U.S. government fixed-price contracts compare to LMT's risk profile under similar contracts, particularly in terms of revenue recognized in excess of billings and potential liabilities from government audits?",
      "original_answer": "RTX reports that under U.S. government fixed-price contracts, they typically receive performance-based or progress payments, which often result in revenue recognized in excess of billings, presented as Contract assets on their Consolidated Balance Sheet. This indicates a financial exposure tied to delayed cash receipt despite early revenue recognition. The FAR regulates these payment structures and cost-allowability, directly shaping RTX's financial reporting and risk. Similarly, LMT, which is also heavily dependent on U.S. government contracts, faces potential liabilities from government audits and investigations, including the risk of debarment or suspension from future contracts, which could have a material adverse effect given their 'dependence on contracts with the U.S. Government.' While RTX's exposure is primarily balance sheet-related (e.g., contract assets), LMT's risk is more compliance and enforcement-oriented, with potential financial penalties or operational restrictions stemming from FAR-regulated audits. Both companies are therefore financially and operationally impacted by the FAR’s regulatory framework, but through different risk mechanisms.",
      "llm_answer": "RTX’s fixed‑price U.S. government contracts generate contract assets that represent revenue recognized in excess of billings, and the company notes that FAR and CAS audits can create potential liabilities (RTX, pp. 77‑81). Lockheed Martin’s 10‑K likewise highlights audit exposure and contract assets/liabilities under FAR‑regulated contracts, though the specific amounts are not disclosed in the excerpt (LMT, pp. 107‑111). Thus, both firms face comparable audit risks, with RTX’s exposure quantified through contract assets and Lockheed Martin’s exposure described qualitatively.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies key elements from both RTX and LMT disclosures. It accurately notes that RTX reports contract assets due to revenue recognized in excess of billings under fixed-price government contracts, and that both companies face audit risks under FAR. The mention of FAR and CAS audits creating potential liabilities for RTX is supported by the source (pp. 77–81), and LMT’s exposure to audits and contract assets/liabilities is also correctly cited (pp. 107–111). There are no numeric inaccuracies, so quantitative accuracy is high. However, the LLM answer falls short in fully capturing the qualitative distinction emphasized in the ground truth: that RTX’s primary exposure is balance sheet-related (contract assets), while LMT’s risk is more compliance-driven, including material risks like debarment or suspension from contracts. The LLM describes the risks as 'comparable' and frames LMT’s exposure as 'qualitatively described,' which understates the severity and operational nature of LMT’s potential liabilities. This omission reduces the depth of multi-hop synthesis—while both companies are discussed, the contrast in risk mechanisms (financial reporting vs. enforcement) is not clearly articulated. Thus, while the answer is contextually relevant and factually sound, it lacks the nuanced comparative analysis present in the original answer, leading to a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 401,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does the voting power distribution between Class A and Class B common stock at META compare to GOOGL's structure, given the specific voting rights tied to each share class?",
      "original_answer": "At META, Class B common stockholders hold 33 1/3% of the combined voting power, with each Class B share carrying 15 votes, while Class A shares (publicly traded) hold the remaining 66 2/3% of voting power. In contrast, at GOOGL, Class B shares carry 10 votes per share and Class A shares carry 1 vote per share, though the equity note does not specify the exact percentage split between the two classes. This indicates that both companies use dual-class structures to concentrate voting control, but META's structure gives significantly more per-share voting power to Class B shares compared to GOOGL.",
      "llm_answer": "Meta’s common‑stock structure gives each Class A share one vote, while each Class B share carries ten votes—so Class B shares have ten‑times the voting power of Class A shares. Alphabet (GOOGL) is the opposite: its Class A shares also have one vote each, but its Class C shares have no voting rights at all, meaning only Class A shares vote at Alphabet.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors. (1) It incorrectly states that Meta's Class B shares have 10 votes per share; the ground truth is 15 votes per Class B share. (2) It falsely claims that Meta's Class A shares have 1 vote each, implying Class B has 10x the power, but the actual voting power distribution is 66 2/3% for Class A and 33 1/3% for Class B due to share count and vote weighting—this distribution is misrepresented. (3) Regarding GOOGL, the LLM incorrectly states that only Class A shares vote and that Class C shares have no voting rights, which is true, but it omits that GOOGL does have Class B shares (with 10 votes per share) held by insiders, and incorrectly frames the structure as 'opposite' to Meta’s when both use dual-class structures to concentrate control. (4) The answer fails to mention that the exact percentage split of voting power at GOOGL is unspecified in the source, which the ground truth correctly notes. (5) Multi-hop reasoning is flawed: the comparison between Meta and GOOGL misrepresents both companies’ capital structures and voting distributions. While the answer addresses the general topic of voting rights, the core quantitative and qualitative details are incorrect, leading to a misleading comparison. Minor contextual relevance is retained because it discusses share classes and voting rights in both companies, but the factual inaccuracies severely undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 396,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "Given BMY's reliance on regulatory data protection for key products like Opdivo, how does the expiration of such protections create a precedent for increased Paragraph IV ANDA challenges that could directly impact JNJ's litigation exposure for drugs like Stelara facing similar patent cliffs in the coming years?",
      "original_answer": "BMY's 2022 10-K highlights that when market exclusivity expires, there are often 'substantial and rapid declines' in sales of the original product, and that ANDAs with Paragraph IV certifications are frequently filed after four years of a five-year regulatory data protection period. AbbVie's filing demonstrates how such Paragraph IV challenges directly lead to increased patent litigation exposure, with companies filing Abbreviated New Drug Applications seeking to market generic forms of branded drugs before patent expiration. JNJ's 2022 10-K specifically cites patent litigation as a material risk, noting the company faces litigation related to its major products and that adverse judgments could significantly impact financial performance. Stelara, which generated over $8 billion in 2022, is a prime target for such challenges once exclusivity periods lapse, mirroring the pathway seen in BMY's and AbbVie's experiences.",
      "llm_answer": "BMY’s Opdivo is protected by 12‑year regulatory data exclusivity, and when that period lapses generic competitors can file ANDAs with Paragraph IV certifications—an approach detailed on BMY pages 6‑10.  This sets a precedent that JNJ’s Stelara, which is approaching patent cliffs and similar exclusivity losses, could face a surge of Paragraph IV challenges, thereby heightening JNJ’s litigation exposure (JNJ 10‑K, pages 3‑7).  AbbVie’s own risk factors note a growing number of generic and biosimilar filings, underscoring the broader industry trend (ABBV 10‑K, pages 30‑34).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omissions compared to the ground truth. It incorrectly states that Opdivo has a '12-year regulatory data exclusivity' period, which is not supported by the original answer or typical U.S. exclusivity rules for small-molecule drugs (which usually have 5 years); biologics have 12 years under the BPCIA, but Opdivo is not explicitly confirmed as a biologic in the provided context. The original answer references a five-year data protection period with Paragraph IV filings often occurring after four years—this timing nuance is missing in the LLM response. Additionally, the LLM cites 'BMY pages 6-10' and 'JNJ pages 3-7' without verifying if those page numbers are accurate or relevant, introducing unverified specifics. (2) There are no explicit dollar amounts or dates in the LLM answer that contradict the ground truth, but it omits key quantitative facts from the original answer—specifically, Stelara’s $8 billion in 2022 sales, which is a critical data point justifying its attractiveness to generic challengers. The absence of this figure weakens the quantitative foundation of the argument. (3) The multi-hop reasoning is partially sound: the LLM correctly infers that expiration of data protection leads to Paragraph IV ANDA filings, which increases litigation risk, and connects this pattern from BMY to JNJ’s Stelara. It also appropriately references AbbVie as an illustrative case. However, it fails to fully synthesize the causal chain described in the original—particularly the direct link between exclusivity expiration, rapid sales decline, and the strategic timing of Paragraph IV filings. The original emphasizes that BMY’s own 10-K warns of 'substantial and rapid declines' post-exclusivity, a key motivator for generics to challenge patents early, which the LLM omits. (4) Despite these gaps, the LLM answer remains contextually relevant and captures the core conceptual pathway: loss of exclusivity → Paragraph IV challenges → increased litigation exposure. It correctly identifies the precedent-setting behavior across firms and applies it to JNJ. Thus, while the reasoning is directionally correct and relevant, the factual inaccuracies (especially the 12-year claim) and missing key financial data reduce its correctness score to a 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 619,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does the structure of META's dual-class stock system, which requires Class B approval for change-of-control transactions until their voting power drops below 35%, compare with GOOGL's dual-class voting framework where Class B shares carry 10 votes each but automatically convert to Class A upon transfer?",
      "original_answer": "META's dual-class structure requires a separate Class B majority vote for any change-of-control transaction until Class B shares fall below 35% of total voting power, providing concentrated control to its primary stockholder. In contrast, GOOGL allows Class B shares to carry 10 votes each but mandates automatic conversion to Class A voting rights upon sale or transfer, limiting long-term entrenchment while still preserving enhanced voting power during ownership retention. Both structures concentrate control, but META's framework offers more enduring governance insulation due to its non-automatic nature and threshold-based trigger.",
      "llm_answer": "META’s dual‑class structure gives Mr. Zuckerberg’s Class B holders 10 votes each and requires that any change‑of‑control transaction be approved by a majority of the Class B voting class as long as those shares represent at least 35 % of the combined voting power. Alphabet’s dual‑class framework also grants Class B shares 10 votes each, but the shares automatically convert to Class A upon sale or transfer, so the voting advantage is lost whenever the shares change hands and no separate Class B approval is needed for a change of control.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential differences between META's and GOOGL's dual-class structures with correct quantitative details. (1) All numbers and percentages are correct: the 35% threshold for Class B voting power and the 10 votes per share for both companies are accurately stated. (2) The explanation correctly identifies that META requires a separate majority vote of Class B shares for change-of-control transactions until their voting power drops below 35%, which aligns with the ground truth. It also correctly notes that GOOGL’s Class B shares carry 10 votes but automatically convert to Class A upon transfer, eliminating the enhanced voting power. (3) The multi-hop reasoning is sound—comparing two distinct dual-class frameworks across companies and explaining how each affects control and transferability. The only minor omission is that the LLM does not explicitly state that GOOGL does not require separate Class B approval for change-of-control transactions (implied but not directly stated), and it doesn’t use the term 'entrenchment' or comment on the relative durability of control as in the original answer. However, the core factual and structural comparison is complete and accurate. (4) Wording differs slightly but maintains semantic equivalence. Thus, the answer earns a 9/10 for correctness due to slight incompleteness in qualitative nuance, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 402,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "UPS chose not to apply the practical expedients under ASU 2020-04 for its transition to SOFR in 2023 - how does this approach contrast with how MMM likely managed its hedging relationships affected by reference rate reform, given the optional relief available through December 31, 2024?",
      "original_answer": "UPS explicitly stated it did not elect to apply the practical expedients provided under ASU 2020-04 when transitioning its affected debt instruments to SOFR in 2023. In contrast, MMM's detailed disclosures of hedging relationships suggest it may have utilized the optional relief under the same standard, particularly since ASU 2022-06 extended the sunset date to December 31, 2024, allowing companies to apply the expedients to contracts modified through that date. MMM's reporting includes extensive hedging activity data, such as $152 million reclassified from accumulated other comprehensive income into income in 2023 for foreign currency contracts, which implies active management of hedging relationships—potentially benefiting from the optional relief provided by ASU 2020-04 as extended.",
      "llm_answer": "UPS elected not to use the optional expedients under ASU 2020‑04 for its 2023 transition to SOFR, treating the change as a standard contract modification (UPS 10‑K, pp. 72‑76).  By contrast, MMM’s LIBOR‑based interest‑rate swaps and other hedging relationships were likely covered by the optional relief, allowing the company to continue using the old reference rate under the guidance until the sunset date of December 31 2024 (MMM 10‑K, pp. 74‑78).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately states that UPS did not apply the practical expedients under ASU 2020-04 for its 2023 SOFR transition, which matches the original answer. It also correctly contrasts this with MMM's likely use of the optional relief, citing the extended sunset date of December 31, 2024, under ASU 2022-06. (2) There are no numeric values in the LLM answer, so quantitative accuracy is not compromised—no incorrect figures or miscalculations. (3) The reasoning is sound: the model correctly infers that MMM likely used the relief based on the availability of the extension and the nature of its hedging activities, though it omits the specific supporting evidence from the ground truth (e.g., MMM’s reclassification of $152 million from AOCI in 2023, which strengthens the inference). This omission reduces completeness and slightly weakens the multi-hop synthesis, but the core logic remains valid. (4) The answer is contextually relevant and directly addresses the contrast between UPS and MMM. The use of document citations (e.g., 10-K page ranges) adds precision. The main shortcoming is the lack of specific hedging activity data that would fully substantiate the claim about MMM, making the conclusion plausible but less robust than the original. Hence, correctness and qualitative accuracy are high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 385,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does the daily cash-settlement of exchange-traded commodity futures impact MDLZ's valuation methodology for Level 1 financial assets, given PEP's similar exposure to these instruments?",
      "original_answer": "MDLZ values its Level 1 financial assets, which include exchange-traded commodity futures, based on quoted market prices from commodity exchanges. These instruments are marked-to-market daily, as noted in PEP's disclosure that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in the balance sheet table as of year-end. This daily cash-settlement mechanism directly supports MDLZ's use of quoted market prices for fair value measurement, as both companies are exposed to the same class of instruments that are subject to daily valuation adjustments through cash settlement.",
      "llm_answer": "MDLZ classifies exchange‑traded commodity futures as Level 1 assets and values them at the quoted market price on commodity exchanges【MDLZ_10k_2022.pdf:110】. Because these futures are cash‑settled daily, the fair value is updated each day to reflect the current market price, and unrealized gains or losses are recognized immediately【MDLZ_10k_2022.pdf:114】. PEP holds a similar mix of exchange‑traded commodity futures (total notional $1.6 billion in 2021) and applies the same Level 1 valuation approach, so its fair‑value measurement is likewise driven by daily market prices【PEP_10k_2022.pdf:107】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that MDLZ classifies exchange-traded commodity futures as Level 1 assets valued at quoted market prices, and explains the daily cash-settlement mechanism that drives daily fair value updates and immediate recognition of gains/losses—consistent with the original answer's emphasis on daily mark-to-market valuation. It also correctly references PEP’s similar exposure and valuation approach. (2) The only minor quantitative deviation is the inclusion of a specific notional amount ($1.6 billion in 2021) for PEP’s futures, which is not present in the original answer. However, this detail does not contradict the ground truth and may be factually correct based on PEP’s filing; it simply adds granularity not required by the question. No calculation errors or incorrect numbers are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across MDLZ and PEP filings to explain how daily cash settlement impacts valuation methodology for Level 1 assets, drawing a valid parallel between the two companies. (4) The answer is contextually fully relevant, addressing all parts of the question—MDLZ’s valuation methodology, the role of daily cash settlement, and PEP’s similar exposure. The slight addition of a notional value from PEP’s filing does not detract from accuracy but may slightly exceed the scope. Overall, the semantic meaning and factual content match the ground truth closely, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 425,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does the voting power distribution tied to CMCSA's Class A and Class B common stock structure compare to GOOGL's approach, given that GOOGL also maintains a multi-tier voting rights system with Class B common stock?",
      "original_answer": "CMCSA's Class A common stockholders hold 66 2/3% of the combined voting power, while the Class B common stockholders (beneficially owned entirely by Brian L. Roberts) hold 33 1/3% of the voting power, with each Class B share carrying 15 votes. In contrast, GOOGL's Class B common stockholders have 10 votes per share, while Class A common stockholders have 1 vote per share, and Class C capital stock has no voting rights. This indicates that CMCSA concentrates more voting power in Class B shares relative to GOOGL, where Class B shares have a lower per-share vote weight but still serve to maintain control for certain key stakeholders.",
      "llm_answer": "CMCSA’s Class B shares carry 15 votes each and represent 33 ⅓ % of the company’s combined voting power, while its Class A shares hold the remaining 66 ⅔ % (page 32). Alphabet’s Class B shares, by contrast, carry 10 votes each, giving them a smaller share of voting power relative to the total shares but still a significant influence (Note 11, page 80). Both firms use a multi‑tier system to concentrate control in a minority of shares, but CMCSA’s higher vote multiplier and larger proportion of voting power for its Class B shares create a more pronounced concentration of control than Alphabet’s structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that CMCSA's Class B shares carry 15 votes per share and hold 33 1/3% of voting power, while Class A holds 66 2/3%, matching the ground truth exactly. For GOOGL (Alphabet), it accurately notes that Class B shares have 10 votes per share, and correctly contrasts this with CMCSA’s higher vote multiplier. The only minor omission is that the LLM does not explicitly mention GOOGL’s Class C shares having no voting rights, which is included in the original answer and adds completeness to the structural comparison. (2) All numeric values—percentages (33 1/3%, 66 2/3%), vote weights (15 vs. 10 votes per share)—are factually correct and precisely aligned with the ground truth. No calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes voting power distribution across two companies (CMCSA and GOOGL), compares their dual-class structures, and draws a valid conclusion about the relative concentration of control. It correctly infers that CMCSA’s structure leads to a more pronounced control concentration due to higher per-share voting power and proportional allocation. (4) Scores reflect near-perfect factual accuracy (quantitative accuracy = 10), excellent reasoning with only a small gap in completeness (qualitative accuracy = 9), full relevance to the question (contextual relevance = 10), and an overall correctness score of 9 due to the omission of Class C’s non-voting status in GOOGL, which slightly reduces completeness but does not undermine the core comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 428,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does BAC's market-making gains related to embedded derivatives compare to MS's involvement in CLNs structured as hybrid instruments with embedded derivatives, given the shared exposure to credit event risks in structured notes?",
      "original_answer": "BAC reports that its net gains (losses) in market-making activities relate to embedded derivatives in structured liabilities and are typically offset by gains (losses) on derivatives and securities used to hedge these liabilities. MS, on the other hand, structures CLNs as hybrid instruments containing embedded derivatives, where the Firm sells credit protection and faces risk of principal loss upon a credit event in the reference entity. Both firms demonstrate exposure to credit-linked derivatives, but BAC actively hedges these exposures while MS retains risk through structured note design.",
      "llm_answer": "BAC’s 2024 market‑making activity generated a net gain of **$4.2 billion** (see the “Market making” table on pages 162‑166).  That gain is largely offset by losses on embedded‑derivative positions in structured liabilities that hedge the same assets, so the net exposure to credit‑event risk is modest.  In contrast, MS’s 2024 10‑K (pages 125‑129) notes that it has invested in **credit‑linked notes (CLNs)**—hybrid instruments that embed credit‑derivative protection sold to the note issuer.  Because the principal balance of a CLN can fall short if a credit event occurs, MS’s exposure is a direct credit‑event risk rather than a hedged market‑making position.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in quantitative details: it claims BAC's 2024 market-making generated a net gain of $4.2 billion and that this is offset by losses on hedges, but the original answer (ground truth) does not provide any specific dollar amounts or mention 2024 data. There is no support in the ground truth for any numerical figure, so the inclusion of $4.2 billion is fabricated. Similarly, the LLM references MS's 2024 10-K and specific page numbers (125–129), which are not present in the original answer and cannot be verified from the provided context. (2) Quantitative accuracy is low because the numbers and document locations are incorrect or unsupported. The original answer makes no mention of fiscal year 2024, dollar figures, or page ranges, so these are hallucinations. (3) Qualitatively, the reasoning is mostly sound: the LLM correctly identifies that BAC hedges its exposure to embedded derivatives in structured liabilities, while MS structures CLNs as hybrid instruments where it sells credit protection and faces principal loss upon a credit event. This aligns with the core contrast in risk management strategy between hedging (BAC) vs. risk retention (MS). The multi-hop synthesis—comparing how two firms handle embedded derivatives in structured notes with credit-event risk—is conceptually accurate and relevant. (4) Contextual relevance is high because the response directly addresses the comparative structure of the question and focuses on credit-event risk exposure in CLNs and embedded derivatives. However, the correctness score is reduced to 6 due to the serious issue of introducing specific numbers and document citations not present in the ground truth, which undermines factual reliability despite correct conceptual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 486,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How does the implementation of the OECD's Pillar Two Model Rules, which Salesforce (CRM) identifies as a global tax development, potentially affect Intel's (INTC) effective tax rate given Intel's exposure to non-US jurisdictions and ongoing evaluation of Pillar Two impacts?",
      "original_answer": "Salesforce (CRM) identifies the OECD's Pillar Two Model Rules, which introduce a global minimum tax of 15%, as a material global tax development that could impact multinational businesses. Intel (INTC), which reports that a higher proportion of its income is taxed in non-US jurisdictions, is actively evaluating the impact of Pillar Two, particularly as several non-US jurisdictions, including EU Member States, have enacted or plan to enact legislation aligning with the rules starting in 2024. Since Intel's effective tax rate has been influenced by its geographic income distribution and non-US tax regimes, the implementation of Pillar Two could constrain its ability to benefit from lower tax jurisdictions, thereby increasing its effective tax rate or reducing future tax benefits.",
      "llm_answer": "Intel’s effective tax rate could rise if the OECD’s Pillar Two minimum‑tax rule is adopted in the non‑US jurisdictions where it operates, because the 15 % global minimum would add to its tax expense.  However, Intel currently has no material operations in jurisdictions with rates below the Pillar Two minimum, so the impact is expected to be limited; the company is monitoring the legislation and evaluating how any new rules might affect its tax planning.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but has significant factual and reasoning discrepancies compared to the ground truth. (1) Quantitatively, the 15% global minimum tax rate is correctly cited, and the reference to 2024 implementation in non-US jurisdictions (implied in the original answer) is contextually accurate. However, the LLM incorrectly asserts that Intel has 'no material operations in jurisdictions with rates below the Pillar Two minimum,' which contradicts the original answer stating that Intel earns a 'higher proportion of its income in non-US jurisdictions' where Pillar Two could constrain tax benefits—implying exposure to lower-tax jurisdictions. (2) The original answer emphasizes that Intel is actively evaluating the impact due to its geographic income distribution, while the LLM downplays the impact as 'limited,' which misrepresents the potential significance. (3) Multi-hop reasoning is partially sound—linking Salesforce’s identification of Pillar Two as a material tax development to Intel’s exposure—but fails in synthesis: the LLM does not acknowledge that Salesforce flagged the issue while Intel is assessing it, missing a key cross-company linkage. (4) The conclusion that the impact is 'expected to be limited' is speculative and not supported in the original answer, which states the rules could 'increase its effective tax rate or reduce future tax benefits'—a more cautious and accurate framing. While the LLM captures the general direction of the impact (potential rate increase), it omits critical context about Intel’s geographic tax exposure and the active risk assessment, leading to an incomplete and somewhat misleading answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 456,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How does RTX's revenue recognition timing under FAR-regulated U.S. government fixed-price contracts compare to BA's exposure to termination risk in their U.S. government contracts, and what implications does this have for cash flow predictability?",
      "original_answer": "RTX recognizes revenue in excess of billings on U.S. government fixed-price contracts due to retained customer payments until contract completion, typically receiving performance-based payments (PBPs) or progress payments covering 80-90% of costs incurred. This creates contract assets on their balance sheet. In contrast, BA faces risks of contract termination at the convenience of the U.S. government, which could limit payments to work completed and allowable termination costs, or even result in liability for re-procurement costs if terminated for default. The FAR regulations that govern both companies' U.S. government contracts allow for interim payments but expose contractors to different financial risks—RTX to cash flow timing mismatches, and BA to potential revenue reversals or liabilities—making BA's cash flow more unpredictable despite similar regulatory frameworks.",
      "llm_answer": "RTX’s FAR‑regulated U.S. government fixed‑price contracts are recognized over time on a percentage‑of‑completion basis, often creating contract assets when revenue exceeds billings (RTX, 2022, p. 78). Boeing, by contrast, has a significant exposure to termination risk—contracts can be terminated for convenience or default, potentially eliminating future revenue and incurring costs (Boeing, 2022, p. 7). Consequently, RTX’s systematic revenue recognition yields more predictable cash‑flow timing, while Boeing’s termination risk introduces greater volatility and uncertainty in its cash flows.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies RTX's revenue recognition method (percentage-of-completion, revenue exceeding billings) and Boeing's (BA) exposure to termination risk in U.S. government contracts. It accurately contrasts the two companies' risks—RTX's timing mismatch (contract assets) vs. Boeing's potential loss of future revenue and incurred costs. The core facts align with the ground truth. However, the LLM omits specific details about interim payment mechanisms (e.g., performance-based payments covering 80-90% of costs) and the distinction between termination for convenience (limited payments) vs. default (potential liability for re-procurement costs), which are present in the original answer and add nuance to BA's risk profile. (2) There are no explicit numbers (percentages, dollar amounts, dates) in the LLM answer that contradict the ground truth. The reference to 'RTX, 2022, p. 78' and 'Boeing, 2022, p. 7' appears consistent with plausible sourcing, though the ground truth does not specify page numbers—this is acceptable as long as the factual content is correct. No calculations are involved, so quantitative accuracy is high. (3) The multi-hop reasoning is sound: the model correctly synthesizes RTX's revenue timing and Boeing's termination risk under FAR regulations and draws a logical conclusion about cash flow predictability. It correctly infers that RTX’s systematic recognition leads to more predictable cash flows, while Boeing’s exposure introduces volatility. However, it does not fully elaborate on how both operate under similar regulatory frameworks (FAR), which the original answer uses to highlight the contrast in outcomes despite common rules. (4) The answer is contextually highly relevant, directly addressing the comparison and its implications for cash flow predictability. The omission of some granular risk distinctions slightly reduces completeness and qualitative accuracy, but the overall meaning and conclusion are semantically equivalent to the ground truth. Hence, correctness is high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 557,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How does the $119 million in floating rate notes with put provisions due in 2025 disclosed by MMM compare to GE's $315 million investment in fixed and floating rate notes containing similar 2025 put options, considering both companies' exposure to near-term debt obligations?",
      "original_answer": "MMM discloses $119 million in floating rate notes with put provisions due in 2025, which are classified as current portion of long-term debt. GE holds $315 million in fixed and floating rate notes that also contain put options exercisable in 2025, despite contractual maturities occurring after 2025. Both companies are exposed to near-term liquidity risks tied to these put options, though GE’s exposure is more than 2.5 times larger than MMM’s. This indicates a significant potential cash outflow in 2025 for both companies depending on whether the put options are exercised.",
      "llm_answer": "MMM’s $119 million of floating‑rate notes with put provisions due in 2025 is a modest portion of its $1.9 billion current‑portion long‑term debt. In contrast, GE’s $315 million investment in fixed‑ and floating‑rate notes that carry 2025 put options sits within its $2.04 billion current‑portion borrowings. Thus GE holds a larger absolute and relative near‑term debt exposure with put options than MMM.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all key numbers are accurate: MMM's $119 million and GE's $315 million are correctly reported, and the years (2025) and instrument types (floating/fixed rate notes with put provisions) match. The LLM adds contextual detail not in the original—current portion of long-term debt values ($1.9B for MMM, $2.04B for GE)—which are plausible and enhance analysis, though not present in the ground truth; however, this does not contradict it. (2) The comparison correctly identifies that GE has a larger absolute and relative exposure, which is consistent with the ground truth stating GE’s exposure is 'more than 2.5 times larger.' The LLM supports this with relative context (current debt portions), strengthening the reasoning. (3) Multi-hop reasoning is sound: the model synthesizes data across two companies, correctly identifies the nature of put options impacting near-term liquidity, and compares both absolute and relative exposures. (4) Minor deduction in correctness and qualitative accuracy because the original emphasizes the contractual maturities occurring *after* 2025 despite put options in 2025—a nuance the LLM omits. This is a relevant detail about off-balance-sheet timing risk. However, the core facts, numbers, and conclusion about greater near-term exposure for GE remain valid. Wording differs but semantic meaning is equivalent. No calculation errors. Contextual relevance is perfect—directly addresses the comparison of near-term debt obligations via put provisions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 430,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How does the valuation methodology for exchange-traded commodity futures used by PEP compare to MDLZ's treatment of Level 1 financial assets, given both companies' reliance on daily market pricing for fair value determination?",
      "original_answer": "PEP excludes exchange-traded commodity futures from its fair value table because they are cash-settled daily, while MDLZ explicitly includes exchange-traded commodity futures as Level 1 financial assets, valued based on quoted market prices on commodity exchanges. Both companies rely on daily market pricing for fair value determination, but PEP focuses on the daily cash settlement mechanism as the reason for exclusion, whereas MDLZ emphasizes quoted market prices as the basis for Level 1 classification.",
      "llm_answer": "Both firms value exchange‑traded commodity futures at observable market prices that are updated daily. PEP notes that its futures are cash‑settled each day and, because of that, are not shown in the derivative table (PEP, pp. 108‑109). MDLZ, by contrast, explicitly classifies these instruments as Level 1 assets and values them at quoted prices on commodity exchanges (MDLZ, pp. 93‑95). Thus, the valuation logic is essentially the same—daily market pricing—though MDLZ’s disclosure makes the Level 1 classification explicit while PEP simply omits the instruments from the table.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: PEP excludes exchange-traded commodity futures from its fair value table due to daily cash settlement (citing p. 108-109), and MDLZ includes them as Level 1 assets valued at quoted market prices (citing pp. 93-95). These details align with the original answer. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a problematic way; the absence of numbers does not detract from correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (PEP and MDLZ), compares their differing disclosure treatments, and identifies that both rely on daily market pricing despite different reporting approaches. The reasoning correctly highlights that the valuation basis (daily market pricing) is the same, but the presentation differs—MDLZ explicitly classifies as Level 1, while PEP omits due to settlement mechanics. (4) The only minor shortcoming is that the LLM answer does not explicitly state that PEP's exclusion is *because* they are cash-settled daily—though it implies it by saying 'because of that, are not shown in the derivative table.' The original answer makes the causal link slightly clearer. However, this is a nuance in phrasing, not a factual error. Overall, the answer is semantically equivalent, contextually relevant, and demonstrates strong qualitative and quantitative fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 423,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does Apple's revenue from the Greater China region, which includes Taiwan, compare to Intel's revenue specifically from Taiwan operations in 2022?",
      "original_answer": "Apple generated $74,200 million in net sales from the Greater China region in 2022, which includes Taiwan among other markets. In contrast, Intel reported $13,461 million in net revenue specifically from Taiwan operations during the same period. This indicates that Apple's revenue exposure through the Greater China segment, which encompasses Taiwan, is significantly higher than Intel's direct revenue from Taiwan.",
      "llm_answer": "Apple’s 2022 revenue from the Greater China region (which includes Taiwan) was **$74.2 billion**. The Intel 10‑K pages provided do not disclose a separate figure for revenue generated by its Taiwan operations, so a direct numerical comparison cannot be made from the supplied information.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states Apple's 2022 revenue from the Greater China region as $74.2 billion (equivalent to $74,200 million in the ground truth), so the quantitative value is accurate with acceptable format variation. However, it incorrectly claims that Intel's 10-K does not disclose revenue from Taiwan operations, when in fact the ground truth states Intel reported $13,461 million specifically from Taiwan in 2022. This is a critical factual error. (2) The number for Apple is correct; $74.2 billion = $74,200 million. The omission or denial of Intel's disclosed Taiwan revenue is factually incorrect and undermines the comparison. (3) The reasoning fails on a key multi-hop requirement: the model must synthesize Apple’s regional revenue (Greater China, including Taiwan) with Intel’s country-specific revenue (Taiwan). The LLM breaks down here by asserting lack of data, when the ground truth confirms Intel’s figure is available. This suggests either a failure in information retrieval or synthesis. (4) The correctness score is 4 due to one correct number but a major omission that prevents the core comparison. Quantitative accuracy is high (9) because the Apple figure is correct. Qualitative accuracy is low (3) due to flawed reasoning and failure to acknowledge available Intel data. Contextual relevance is moderate (6) as the answer addresses the right companies and region but fails to deliver the comparative insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 400,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the combined net property, plant, and equipment investment in the Americas by MMM compare to GD's revenue contribution from South America over the same geographic footprint, given that the Americas segment includes South America as part of its geographic definition?",
      "original_answer": "MMM reported $5,864 million in net property, plant, and equipment for the Americas in 2021, which includes South America. GD, in the same year, generated $234 million in revenue specifically from South America. This indicates that while GD's revenue from South America is relatively small, MMM has a significantly larger asset base tied to the broader Americas region, which encompasses South America.",
      "llm_answer": "The pages provided do not contain the figures needed for a direct comparison.  The 10‑K excerpts supplied do not list MMM’s (3M’s) net property, plant and equipment for the Americas segment, nor do they give General Dynamics’ revenue from South America.  Consequently, a quantitative comparison cannot be made from the supplied material.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is completely incorrect in its assertion that the data is not available. The original answer (ground truth) explicitly states that MMM reported $5,864 million in net property, plant, and equipment for the Americas in 2021, and GD generated $234 million in revenue from South America in the same year. These figures are specific, quantifiable, and directly responsive to the question. (2) The LLM failed to report any numbers, thus scoring minimally on quantitative accuracy—no values were provided or even attempted. (3) The multi-hop reasoning required—comparing MMM’s asset investment in the Americas (which includes South America) to GD’s South America-specific revenue—was not performed because the LLM incorrectly claimed data absence. This reflects a failure in both entity identification and cross-company synthesis. (4) The response is irrelevant to the actual content of the original answer, which does provide the necessary data. The LLM’s claim of missing information contradicts the ground truth, making the response factually wrong and contextually irrelevant. Hence, all scores are near the minimum.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 324,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the use of sensitivity analyses by NFLX's auditor in evaluating content amortization assumptions compare to CMCSA's application of sensitivity analyses in managing interest rate risk exposure?",
      "original_answer": "NFLX's auditor performed sensitivity analyses to evaluate how changes in assumptions about viewing patterns could affect content amortization timing, which directly impacts financial reporting accuracy. In contrast, CMCSA uses sensitivity analyses as part of its interest rate risk management strategy to assess the potential impact of interest rate fluctuations on its debt portfolio, with derivative instruments reducing interest expense by $56 million in 2023. While both companies apply sensitivity analyses, NFLX uses it for accounting policy judgment, whereas CMCSA applies it for financial risk management.",
      "llm_answer": "Netflix’s auditor applies sensitivity analyses to the assumptions used in estimating future viewing patterns, testing how changes in those assumptions would alter the amount and timing of content amortization. Comcast, by contrast, uses sensitivity analyses as part of its interest‑rate risk management to gauge how shifts in rates would affect the value of its debt and interest‑rate derivatives and the resulting interest expense. Thus, Netflix’s analysis focuses on accounting‑estimate uncertainty, while Comcast’s focuses on market‑risk exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: NFLX's auditor uses sensitivity analyses on viewing pattern assumptions affecting content amortization timing, and CMCSA uses sensitivity analyses for interest rate risk management related to debt and derivatives. The distinction between accounting-estimate uncertainty (NFLX) and market-risk exposure (CMCSA) is correctly identified. (2) Quantitative accuracy is perfect—while the LLM answer does not mention the $56 million reduction in interest expense by derivatives in 2023, this omission does not impair the correctness of the comparison being asked. The question focuses on the *use* of sensitivity analyses, not specific dollar impacts, so this detail, while present in the original, is contextual rather than essential. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies, two distinct financial processes (amortization assumptions vs. interest rate risk), and two applications of sensitivity analysis. (4) Semantic equivalence is strong—wording differs but meaning aligns closely with the original. The only minor shortcoming is the omission of the $56M figure, which prevents a perfect 10, but since it doesn’t alter the conceptual comparison, a 9 is justified.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 374,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does PEP's use of exchange-traded commodity futures to manage risk compare with COST's disclosure regarding the absence of Level 1 financial liabilities, given that both companies report under the same fair value hierarchy framework?",
      "original_answer": "PEP actively uses exchange-traded commodity futures, which are cash-settled daily and excluded from the balance sheet as of December 25, 2021, to manage market risk, particularly in relation to deferred compensation liabilities. These instruments fall under Level 1 of the fair value hierarchy, which includes instruments valued using quoted market prices. In contrast, COST explicitly states that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a different risk management approach with no direct use of such derivatives. This contrast highlights differing strategies in managing financial risk exposure under the same fair value reporting framework.",
      "llm_answer": "PEP uses exchange‑traded commodity futures—Level 1 instruments—to hedge commodity‑price risk, though they are excluded from the fair‑value table because they are cash‑settled daily (PEP, pp. 105‑109).  In contrast, COST reports that it has no Level 1 financial liabilities, indicating all of its liabilities are classified at Level 2 or higher (COST, pp. 49‑53).  Thus, while PEP’s risk‑management strategy relies on Level 1 derivatives, COST’s liabilities fall outside that level within the same fair‑value hierarchy framework.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core contrast between PEP and COST regarding their use of Level 1 instruments under the fair value hierarchy. (1) It correctly states that PEP uses exchange-traded commodity futures, which are Level 1 instruments, to manage risk, and that these are excluded from the fair value table due to daily cash settlement—consistent with the ground truth referencing their exclusion as of December 25, 2021. (2) It accurately notes that COST reports no Level 1 financial liabilities, aligning with the original answer’s statement that COST held no Level 1 or Level 3 financial assets or liabilities as of August 28, 2022. (3) The reasoning correctly synthesizes information across both companies and connects their disclosures within the same fair value hierarchy framework, showing sound multi-hop logic. However, the LLM slightly oversimplifies COST’s position by not mentioning the absence of Level 1 *assets* as well, and more importantly, fails to note that COST has no Level 1 instruments *at all* (assets or liabilities), which strengthens the contrast. The ground truth emphasizes that COST holds *no Level 1 financial assets or liabilities*, making its risk management approach distinct from PEP’s active use of Level 1 derivatives. The LLM’s focus only on liabilities is a minor but notable omission in completeness. (4) Quantitative accuracy is high—no specific numbers are incorrect, and dates, while not explicitly repeated, are contextually implied via document references (pp. 105–109 for PEP, pp. 49–53 for COST). Wording differences are acceptable under semantic equivalence, but the partial omission of COST’s full disclosure reduces qualitative accuracy slightly. Contextual relevance is perfect—the response directly addresses the comparative risk management and fair value hierarchy question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 500,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the expiration timeline of U.S. patent protections for Enbrel, as detailed in Amgen's 2024 10-K, impact Merck's competitive positioning and Pfizer's international production strategy for the drug, especially considering Merck's stated exposure to biosimilar competition and pricing pressures?",
      "original_answer": "The U.S. patent protections for Enbrel expire in three key phases: fusion protein composition in November 2028, DNA encoding in April 2029, and formulations in October 2037. This staggered expiration timeline creates a gradual risk of biosimilar entry in the U.S., which could indirectly affect global pricing dynamics. Merck, which depends heavily on patent protection to maintain sales and profitability, faces intensified risk of generic competition following these expirations, compounding existing pricing pressures from government programs like the 340B Drug Discount Program. Meanwhile, Pfizer produces Enbrel outside the U.S. and Canada, meaning it will likely face competitive pressure from biosimilars in those international markets sooner than in the U.S., aligning with its broader specialty care portfolio strategy. Thus, the expiration of Enbrel’s U.S. patents affects Merck’s competitive positioning by increasing biosimilar risk and influences Pfizer’s international production strategy by accelerating exposure to generic competition outside the U.S.",
      "llm_answer": "Amgen’s 2024 10‑K shows that U.S. patents protecting Enbrel expire between 2028 and 2037, with the first expiry in November 2028 (Amgen 10‑K, p. 9‑13). That timeline signals that U.S. biosimilar entry will likely begin after 2028, tightening Merck’s competitive position—Merck’s 10‑K notes that it is exposed to biosimilar competition and pricing pressures (Merck 10‑K, p. 31‑35). Pfizer’s 10‑K indicates that it markets Enbrel outside the U.S. and Canada, so its international production strategy is less directly affected by U.S. patent expirations but will need to monitor potential biosimilar competition in those markets (Pfizer 10‑K, p. 8‑12).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the staggered expiration timeline of Enbrel's U.S. patents between 2028 and 2037, aligning with the ground truth's three-phase expiration (2028, 2029, 2037). However, it omits the specific April 2029 expiration for DNA encoding and the October 2037 formulation patent, instead generalizing the range. This partial omission affects completeness. (2) Quantitatively, the key dates are mostly accurate—November 2028 is correctly cited—but the absence of the intermediate April 2029 and precise October 2037 dates reduces precision. No calculations are involved, so numerical accuracy is otherwise sound. (3) The reasoning correctly links Amgen’s patent expirations to Merck’s competitive exposure and biosimilar risk, citing Merck’s 10-K on pricing pressures. It also correctly notes Pfizer’s international role and reduced direct exposure to U.S. patent expirations. However, it fails to fully synthesize the multi-hop connection that Pfizer’s international production means earlier biosimilar competition abroad—while mentioned, the causal link to strategy is underdeveloped compared to the ground truth. (4) Contextually, the answer remains highly relevant, citing appropriate 10-K sections and addressing all entities (Amgen, Merck, Pfizer) and their strategic positions. The omission of specific patent types and incomplete explanation of Pfizer’s strategic exposure prevent a higher score. Overall, core facts are correct but with notable gaps in detail and synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 417,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How does the $90 of unfunded commitments in private equity funds disclosed by EMR compare to the $2.7 billion of unfunded commitments to private equity and other limited partnerships reported by UPS, given both companies measure these investments at NAV?",
      "original_answer": "EMR reports $90 of unfunded commitments in private equity funds as of September 30, 2024, while UPS reports a significantly larger amount of $2.7 billion in unfunded commitments to private equity, private debt, and real estate limited partnerships as of December 31, 2024. Both companies disclose these commitments in the context of investments measured at NAV, indicating similar accounting treatment for these alternative assets despite the large difference in scale.",
      "llm_answer": "EMR reports only **$90 million** of unfunded commitments to private‑equity funds (measured at NAV) as of September 30, 2024, whereas UPS reports **$2.7 billion** of unfunded commitments to private‑equity and other limited partnerships (also measured at NAV) for the same period. The EMR figure is therefore negligible—roughly 0.003 % of UPS’s commitments, or about 30,000 times smaller—highlighting a vastly smaller private‑equity exposure for EMR compared with UPS.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies EMR and UPS as the companies involved, the metric (unfunded commitments), and the accounting treatment (measured at NAV). It also accurately notes the $2.7 billion figure for UPS and the $90 amount for EMR. However, it incorrectly states EMR's amount as '$90 million' instead of '$90' (i.e., $90, not $90 million), which is a critical quantitative error. The ground truth specifies $90 (likely a typo or minimal amount, but still materially different from $90 million). This misstatement leads to a flawed comparison: claiming EMR’s commitment is 0.003% of UPS’s implies $90 million vs $2.7 billion, but if EMR is only $90, the correct percentage would be approximately 0.0000033% — over 1,000 times smaller than stated. 2) The date for EMR (September 30, 2024) is correct; UPS’s is December 31, 2024 — the LLM incorrectly says 'for the same period', which is false. This affects temporal accuracy. 3) The reasoning correctly synthesizes that both companies use NAV measurement and draws a valid qualitative conclusion about relative exposure, despite the numerical inaccuracies. The multi-hop logic (comparing scale across firms with similar accounting) is sound in intent. 4) The answer is contextually relevant and addresses the core comparison question. However, due to the significant numerical misrepresentation (off by a factor of one million) and incorrect alignment of reporting periods, the quantitative accuracy is low. Despite this, the overall structure and intent of the answer align with the ground truth, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 436,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "What percentage of PepsiCo's APAC segment revenue in 2024 came from beverages, and how does this compare to Mondelēz's total beverage revenue in 2024?",
      "original_answer": "In 2024, 23% of PepsiCo's APAC segment revenue came from beverages. Given that PepsiCo's APAC revenue was $10 million in 2024, this translates to $2.3 million from beverages. In comparison, Mondelēz reported total beverage revenue of $1,096 million in 2024, which is significantly higher than PepsiCo's beverage revenue in the APAC region.",
      "llm_answer": "PepsiCo’s APAC segment revenue was 23 % beverage‑driven in 2024 (the “Disaggregation of Net Revenue” table shows 23 % of APAC’s net revenue coming from beverages). The MDLZ 10‑K excerpt provided does not disclose a figure for Mondelēz’s total beverage revenue in 2024, so a direct numerical comparison cannot be made from the supplied pages.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that 23% of PepsiCo's APAC segment revenue came from beverages in 2024, which matches the ground truth. However, it fails to provide the calculated beverage revenue amount ($2.3 million) based on the given APAC revenue of $10 million, missing a key quantitative synthesis. More critically, the LLM incorrectly states that Mondelēz’s total beverage revenue in 2024 is not disclosed in the provided data, while the ground truth explicitly states it was $1,096 million. This is a major factual omission or misrepresentation, as the comparison hinges on this figure. (2) The percentage (23%) is accurate, but the absence of the $2.3 million calculation and the erroneous claim about missing Mondelēz data undermine quantitative accuracy. The $1,096 million figure for Mondelēz is absent from the LLM answer, which should have been included if present in the source material. (3) The reasoning is partially sound in identifying the PepsiCo beverage percentage, but fails in the multi-hop comparison: it does not synthesize PepsiCo's regional beverage revenue with Mondelēz's global beverage revenue, and incorrectly asserts lack of data, suggesting a failure in information retrieval or integration. (4) The answer is contextually relevant and addresses the structure of the question, but the missing comparison and incorrect claim about data availability significantly reduce its correctness. The answer should have either included the $1,096 million figure or acknowledged it if available in the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 427,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How does the volume of Capital One's (COF) delinquent loans as of December 31, 2023, influence the availability of reperforming loans that MetLife (MET) can purchase for its residential mortgage loan portfolio?",
      "original_answer": "Capital One reported total delinquent loans of $623 million as of December 31, 2023, which contributes to the pool of potentially reperforming loans. MetLife purchases reperforming loans that have returned to performing status after being delinquent for at least 12 months. The availability of such loans is directly influenced by the volume and characteristics of initial delinquencies, like those disclosed by Capital One, as these form the source pool for future reperforming loan opportunities.",
      "llm_answer": "Capital One reported $2.237 billion of delinquent loans as of December 31 2023 (Table 3.8). Because reperforming loans are those that were delinquent but have since returned to performing status, a large delinquent pool means fewer loans have re‑entered performance, thereby constraining the supply of reperforming loans that MetLife can acquire for its residential mortgage portfolio. MetLife’s RMBS holdings include $2.622 billion of reperforming loans, illustrating that the availability of such loans is limited by the volume of delinquent loans in the market.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states Capital One's delinquent loans were $623 million as of December 31, 2023, but the LLM incorrectly reports $2.237 billion, which is more than triple the correct amount. This major quantitative error undermines the entire response. (2) The LLM cites 'Table 3.8' as a source, which is not part of the provided context and appears fabricated. Additionally, the claim that MetLife holds $2.622 billion in reperforming loans is unsupported by the original answer and introduces unverified data. (3) The reasoning is flawed: the LLM argues that a larger delinquent loan pool leads to fewer reperforming loans and thus constrains supply, but this misrepresents the relationship. The original answer explains that delinquent loans form the source pool for future reperforming loans—so higher delinquencies today can increase the future availability of reperforming loans after they return to performing status. The LLM incorrectly frames the relationship as inverse rather than sequential or contributive. (4) While the LLM correctly identifies the conceptual link between delinquent and reperforming loans and mentions MetLife’s interest in such assets, the severe numerical inaccuracies and flawed logic result in a low correctness score. Contextual relevance is moderate because the answer addresses the right companies and general topic, but with incorrect data and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 405,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How does the exposure of UNP's pension plan to limited partnerships investing in real estate compare with UPS's unfunded commitments to similar structures, given both companies' reliance on NAV-based valuations for these illiquid assets?",
      "original_answer": "UNP's pension plan holds interests in limited partnerships that primarily invest in privately-held companies and reports these using NAV-based valuations, while UPS has unfunded commitments totaling approximately $3.3 billion to limited partnerships focused on private equity, private debt, and real estate funds. Both companies rely on NAV as a practical expedient for valuing these illiquid investments, with UPS specifically noting the limited redemption provisions until the end of the partnership terms, typically 10 to 15 years from inception. This indicates that both firms face similar challenges in liquidity and valuation transparency for these alternative investments.",
      "llm_answer": "UNP’s pension plan has roughly **$5 million** in future commitments to real‑estate limited partnerships, whereas UPS reports about **$3.3 billion** in unfunded commitments to private‑equity, private‑debt and real‑estate limited partnerships. Both companies value these illiquid holdings on a NAV basis, but UPS’s exposure is vastly larger than UNP’s.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in stating that UNP’s pension plan has $5 million in future commitments to real-estate limited partnerships. The ground truth does not specify any dollar amount for UNP’s unfunded commitments—only that UNP holds interests in limited partnerships (primarily in private companies) valued at NAV. Thus, the $5 million figure is unsupported and likely incorrect. In contrast, the $3.3 billion unfunded commitment for UPS is accurate and correctly attributed. (2) Quantitative accuracy is severely compromised due to the fabricated $5 million figure for UNP. While the $3.3 billion for UPS matches the original answer, the comparison is misleading because UNP’s actual exposure level is not disclosed. (3) The reasoning partially captures the multi-hop element by correctly identifying that both companies use NAV-based valuations for illiquid assets and noting UPS’s large unfunded commitments with limited liquidity. However, it fails to accurately represent UNP’s position—there is no mention in the ground truth about UNP having only $5 million in commitments, nor is there a breakdown of UNP’s exposure specifically to real estate (UNP’s focus is on private companies, not necessarily real estate). The synthesis is therefore flawed. (4) Contextual relevance is moderate because the answer addresses valuation methods (NAV), asset illiquidity, and compares exposures, which are all relevant. However, the incorrect number undermines the core comparison. Correctness and quantitative accuracy are low due to the invented figure; qualitative accuracy is limited by incomplete and misaligned entity mapping.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 455,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How does AMD's reliance on third-party manufacturers for 7 nm and smaller node production impact its exposure to quality control risks compared to Cisco's approach of maintaining quality control through automated testing and ISO 9001-certified processes?",
      "original_answer": "AMD's reliance on third-party manufacturers like TSMC for 7 nm and smaller node production exposes it to risks related to manufacturing yields, delivery schedules, and quality assurance, as these manufacturers are responsible for implementing leading-edge process technologies and maintaining acceptable yields. In contrast, Cisco maintains quality control internally through automated testing equipment, burn-in procedures, and ISO 9001-certified manufacturing processes, which are designed to ensure product reliability and reduce variability. This difference suggests that AMD has less direct control over quality assurance in its supply chain compared to Cisco, which integrates quality control directly into its manufacturing procedures.",
      "llm_answer": "AMD’s reliance on third‑party foundries—especially TSMC for its 7 nm and smaller nodes—means it has limited control over yield, quality assurance, and process improvements, so any defects or yield losses at the foundry directly expose AMD to product quality and supply disruptions (AMD 10‑K, pp. 22‑27). In contrast, Cisco’s manufacturing uses automated testing, burn‑in, and comprehensive inspection and statistical process controls that are ISO 9001‑certified, giving it a structured in‑house quality framework that mitigates external quality‑control risks (Cisco 10‑K, pp. 7‑11).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: AMD relies on third-party manufacturers like TSMC for 7 nm and smaller nodes, which exposes it to yield and quality control risks; Cisco uses automated testing, burn-in, and ISO 9001-certified processes for internal quality control. These points align with the original answer. (2) There are no numeric values (e.g., percentages, dollar amounts, dates) in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from AMD’s and Cisco’s respective 10-K filings to compare their quality control strategies and supply chain dependencies. It identifies the key contrast—AMD’s externalized manufacturing vs. Cisco’s internalized, standardized quality processes. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'delivery schedules' or 'variability reduction' as in the original, but it captures the essence of supply disruptions and quality assurance. Wording differs slightly (e.g., 'comprehensive inspection and statistical process controls' vs. 'automated testing equipment'), but the semantic meaning and factual content are equivalent. Thus, the answer is factually complete and contextually appropriate, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 389,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How does Comcast's lack of voting rights in Atairos compare to Alphabet's structure of Class C Capital Stock, which also carries no voting rights, particularly in terms of how each company manages governance influence versus financial exposure?",
      "original_answer": "Comcast does not have voting rights or the power to direct the activities of Atairos, which is classified as a VIE, and therefore does not consolidate it, limiting its governance influence while still being exposed to financial risk up to its investment balance and remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. In contrast, Alphabet issues Class C Capital Stock, which carries no voting rights except as required by law, but the company actively manages these shares through large-scale repurchases—$62.0 billion in 2024—allowing it to maintain governance control through Class A and B shares while offering different voting structures to investors. Both entities separate voting rights from certain stakeholders, but Alphabet retains control through its dual-class share structure, whereas Comcast has no such governance influence over Atairos despite significant financial exposure.",
      "llm_answer": "Comcast’s Atairos investment is a VIE in which it holds no voting rights, so it has no governance influence over Atairos’ operations and its exposure is limited to the $5.1 billion investment balance and the $1.4 billion unfunded capital commitment (CMCSA 10‑K, Atairos section). Alphabet’s Class C capital stock also carries no voting rights, so shareholders have no governance power, but they retain full economic exposure to Alphabet’s equity—including dividends and share‑repurchase activity (GOOGL 10‑K, Class C Capital Stock). Thus, while both structures deny voting influence, Comcast’s exposure is confined to a VIE investment, whereas Alphabet’s shareholders face the broader financial risks and rewards of owning equity in the company.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains a key factual discrepancy in the investment balance amount. The ground truth states Comcast's financial exposure includes its investment balance and a $1.4 billion unfunded capital commitment as of December 31, 2024, but does not specify the investment balance as $5.1 billion—this figure is not present in the original answer and appears to be an addition or inference not supported by the provided ground truth, making it potentially inaccurate. The $1.4 billion unfunded commitment is correctly reported. The qualitative analysis correctly identifies both Comcast's lack of governance over Atairos due to its VIE status and Alphabet's use of non-voting Class C shares, but misses a critical comparative point: Alphabet actively manages governance via repurchases and maintains control through Class A and B shares, which the LLM answer only partially captures by mentioning repurchases ($62.0 billion in 2024 per ground truth) without linking this to strategic governance retention. The LLM notes economic exposure for Alphabet shareholders but omits that Alphabet itself—unlike Comcast—retains full operational and governance control despite issuing non-voting stock. This weakens the multi-hop synthesis comparing how each company manages governance versus financial exposure. The reasoning is sound in structure and addresses the core contrast, but lacks depth in explaining how Alphabet’s dual-class structure enables control, which is central to the original answer. Contextually, the response is highly relevant and well-structured, accurately using terms like VIE and correctly framing the separation of voting rights. Number formats are consistent and acceptable. Overall, core facts are correct except for the unsupported $5.1 billion figure, and the analysis, while logical, lacks full completeness in comparative governance mechanisms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 509,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How does Coca-Cola HBC's distribution footprint in Austria compare with Philip Morris's market presence in the same country, based on their respective operational disclosures?",
      "original_answer": "Coca-Cola HBC, as a key bottler for The Coca-Cola Company, operates in Austria and contributes to 41% of Coca-Cola’s total worldwide unit case volume through its five largest bottlers. Meanwhile, Philip Morris reports a market share of at least 15% in Austria, as part of its presence across approximately 100 markets globally. Both companies maintain a direct or dedicated distribution presence in Austria, with Coca-Cola HBC managing bottling and distribution of beverages, and Philip Morris leveraging its exclusive zonified and direct distribution strategies to maintain its competitive market position.",
      "llm_answer": "Coca‑Cola HBC AG operates a dedicated bottling and distribution facility in Austria as part of its network of bottling partners. In contrast, Philip Morris International reports a market share of at least 15 % in Austria but does not disclose a specific bottling operation there, indicating its presence is measured by sales volume rather than a local bottling footprint.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all numbers are accurate: Philip Morris's market share of at least 15% in Austria is correctly reported. The absence of a specific bottling operation for Philip Morris is consistent with the original answer, which notes its presence is based on sales and distribution, not production. (2) The LLM correctly identifies Coca-Cola HBC’s operational presence in Austria through its bottling and distribution network, which is factually sound. However, it omits the contextual detail from the ground truth that Coca-Cola HBC contributes to 41% of Coca-Cola’s total worldwide unit case volume through its five largest bottlers—a key element in the multi-hop comparison of distribution footprint scale. (3) The reasoning is sound in contrasting Coca-Cola HBC’s physical bottling infrastructure with Philip Morris’s sales-based market presence, but the synthesis is slightly less complete due to the missing 41% figure, which provides important context about Coca-Cola HBC’s global significance. (4) Despite this omission, the answer remains factually accurate, relevant, and correctly interprets the nature of each company’s presence in Austria. Wording differs but meaning is semantically aligned. Hence, high scores across the board with a minor deduction in correctness and qualitative accuracy for incompleteness in multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 393,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How does the deterioration in BAC's commercial real estate credit quality, particularly in office properties, influence MET's use of the Bornhuetter-Ferguson Method and its annual updates to unpaid claims assumptions for Protection Life and Health products?",
      "original_answer": "BAC experienced a deterioration in commercial credit quality during 2023, especially in the commercial real estate office property type, due to stagnant office space demand and evolving employment models (BAC chunk). MET updates its unpaid claims assumptions annually to reflect emerging trends in claim experience, including macroeconomic conditions (MET chunk). MET uses the Bornhuetter-Ferguson Method to estimate unpaid claims for Protection Life and Health products, relying on historical claims data and expected loss ratios, which are sensitive to economic shifts (Hop2 chunk). Therefore, a worsening macroeconomic environment—such as declining commercial real estate values and increased defaults in office properties—could affect MET’s claims estimation by altering expected loss ratios, particularly for long-duration Protection Health claims or experience-rated contracts where adverse claim experience is passed to sponsors (MET chunk). This creates a multi-hop chain where BAC's credit quality trends serve as an early indicator of macroeconomic deterioration that MET must incorporate into its actuarial models.",
      "llm_answer": "The decline in BAC’s commercial‑real‑estate credit quality—especially the rise in non‑performing office‑property loans—signals broader economic stress that could alter claim patterns for insurers.  MET therefore relies on the Bornhuetter‑Ferguson method, which blends expected loss ratios with experience‑derived factors, and it revises its unpaid‑claims assumptions each year to incorporate any emerging trends in claim experience that may be driven by such credit deterioration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and captures the core multi-hop reasoning chain between BAC's commercial real estate credit deterioration and MET's use of the Bornhuetter-Ferguson method. It correctly identifies that BAC's declining credit quality in office properties reflects broader economic stress (linked to stagnant demand and evolving work models, per ground truth), which in turn can influence claim patterns for insurers like MET. The answer accurately states that MET uses the Bornhuetter-Ferguson method, which blends expected loss ratios with experience-based data, and that it updates unpaid claims assumptions annually to reflect emerging trends—including those driven by macroeconomic shifts such as credit deterioration. While the LLM omits specific mention of 'Protection Life and Health products' and the mechanism of 'experience-rated contracts where adverse claim experience is passed to sponsors,' it still conveys the essential causal pathway and actuarial sensitivity. There are no numerical inaccuracies (quantitative accuracy is perfect, though no specific numbers appear), and all entities (BAC, MET, Bornhuetter-Ferguson method) are correctly identified and logically connected. The reasoning is sound and semantically equivalent to the ground truth, with only minor omissions in detail preventing a perfect 10. Contextual relevance is excellent, directly addressing the question's focus on how BAC's credit trends influence MET's actuarial practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 407,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How does the voting rights structure of Netflix's common stock compare to Meta's, considering the influence of Class A Common Stock in both companies' governance frameworks?",
      "original_answer": "Netflix's common stockholders are entitled to one vote per share, creating a uniform voting rights structure. In contrast, Meta's Class A Common Stock also provides one vote per share, but Meta has a multi-tiered stock structure that includes Class B Common Stock with 10 votes per share, giving certain shareholders disproportionate voting power. This difference means that while both companies grant one vote per share for Class A Common Stock, Meta's governance framework allows for greater concentration of control through its Class B shares.",
      "llm_answer": "Netflix’s common stock is a single‑class structure – each share carries one vote on all shareholder matters (see “Voting Rights” in the NFLX 10‑K). Meta, by contrast, uses a dual‑class scheme: Class A shares (the public class) also have one vote per share, but Class B shares carry ten votes per share, so the majority of voting power is concentrated in the Class B holders and limits the influence of Class A shareholders (see the Meta 10‑K disclosure of Class A and Class B common stock).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It accurately states that Netflix has a single class of common stock with one vote per share, while Meta has a dual-class structure where Class A shares have one vote and Class B shares have ten votes per share—this matches the original answer exactly in substance. (2) All quantitative elements are correct: 'one vote per share' for Netflix and Meta's Class A, 'ten votes per share' for Meta's Class B—no calculations are required, but the comparison of voting power is accurately represented. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance structures across two different companies (Netflix and Meta) from their respective 10-K disclosures, identifying both the surface-level similarity (Class A = one vote) and the key structural difference (Meta’s Class B enables control concentration). (4) The answer is fully relevant, directly addressing the comparative voting rights structure and influence of Class A stock in both firms. Minor wording differences (e.g., 'dual-class scheme' vs 'multi-tiered stock structure') do not affect meaning and are semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 336,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How does the fair value treatment of exchange-traded commodity futures under Level 1 financial liabilities differ between PEP and MDLZ, given that both companies cash-settle these instruments and include them in their respective liability portfolios?",
      "original_answer": "PEP explicitly states that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in the fair value hierarchy table as of December 25, 2021. In contrast, MDLZ includes exchange-traded commodity futures in its Level 1 financial liabilities, with fair value determined based on quoted market prices on commodity exchanges. Both companies treat these futures as part of their Level 1 liabilities, but PEP excludes them from reported tables due to daily cash settlement, whereas MDLZ continues to report them based on market pricing as of the balance sheet date.",
      "llm_answer": "Both companies classify exchange‑traded commodity futures as Level 1 liabilities and value them at quoted market prices.  PepsiCo, however, excludes these cash‑settled futures from its fair‑value table, noting they are not included because they are settled daily.  Mondelez, in contrast, includes the same Level 1 commodity futures in its fair‑value schedule, presenting their fair value alongside other Level 1 liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the key distinction between PEP and MDLZ regarding the treatment of exchange-traded commodity futures in their fair value hierarchy disclosures. (1) All entities—PEP (PepsiCo) and MDLZ (Mondelez)—are correctly identified, and the classification of these instruments as Level 1 liabilities due to quoted market prices is accurate. (2) There are no numeric values (e.g., dollar amounts, dates) in the original or LLM answer that require verification; thus, quantitative accuracy is not compromised. The absence of the specific date 'December 25, 2021' in the LLM answer does not detract from correctness, as the focus is on the conceptual reporting difference rather than time-specific data. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies use Level 1 valuation due to market pricing but differ in reporting—PEP excludes daily cash-settled futures from its fair value table, while MDLZ includes them. This aligns with the ground truth. (4) The LLM answer is semantically equivalent to the original, though slightly less detailed in phrasing (e.g., 'fair value schedule' vs 'fair value hierarchy table'). However, the core informational content and comparative insight are preserved. The answer is fully contextually relevant and directly addresses the question. A score of 9 is given because the LLM omits the explicit mention of the balance sheet date context present in the original, which may be relevant for audit or reporting precision, but this does not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 432,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How do the cost-sharing arrangements between Merck and Gilead for the development of HIV treatments combining islatravir and lenacapavir compare to Pfizer's cost-reduction initiatives, and what implications might this have on each company's financial exposure in long-acting HIV therapies?",
      "original_answer": "Merck and Gilead share global development and commercialization costs for HIV treatments combining islatravir and lenacapavir at a 60/40 split (Gilead/Merck), with equal revenue sharing until certain thresholds are met ($2.0 billion for oral and $3.5 billion for injectable combinations), after which Gilead's revenue share increases. In contrast, Pfizer's 2024 filing highlights enterprise-wide cost realignment and manufacturing optimization programs aimed at reducing costs and improving productivity. These initiatives carry risks such as potential disruption of ongoing business, including impacts on the delivery of their pipeline, which could include HIV-related R&D. While Merck and Gilead are jointly investing in a high-potential, long-acting HIV therapy with shared financial exposure, Pfizer is focusing on internal cost controls that may affect its ability to invest in or compete with such collaborative models. This contrast suggests differing strategic approaches to managing financial exposure in the evolving HIV treatment landscape.",
      "llm_answer": "Merck and Gilead’s collaboration on the islatravir/lenacapavir long‑acting HIV candidates is structured so that Gilead bears roughly 60 % of global development and commercialization costs while Merck covers the remaining 40 % (GILD 2024 10‑K, pp. 72‑77). In contrast, Pfizer’s 2024 10‑K (pp. 28‑32) describes internal cost‑reduction initiatives—an enterprise‑wide cost realignment program and a manufacturing optimization program—rather than a shared‑cost partnership. Consequently, Merck and Gilead mitigate their R&D exposure through the 60/40 split, whereas Pfizer’s initiatives lower overall operating costs but leave its long‑acting HIV R&D expenses largely in‑house, potentially leaving it with higher individual financial exposure if such programs are pursued.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers and percentages are correct: the 60/40 cost split (Gilead/Merck) is accurately reported, and the distinction between Merck-Gilead's shared-cost model and Pfizer's internal initiatives is factually sound. The LLM correctly identifies the source documents (GILD 2024 10-K, Pfizer 2024 10-K) and page ranges, which supports verifiability. (2) The answer correctly captures the core financial arrangement—cost sharing at 60/40—though it omits the revenue-sharing thresholds ($2.0B oral, $3.5B injectable) and the detail that revenue sharing shifts in Gilead’s favor after those thresholds. This is a minor but notable omission affecting completeness. (3) The reasoning is strong: it correctly contrasts a collaborative, risk-sharing model (Merck/Gilead) with Pfizer’s internal cost controls, and infers that Pfizer may face higher individual financial exposure. This reflects valid multi-hop synthesis across two companies’ strategies. (4) Contextual relevance is excellent—the answer directly addresses the comparison of cost-sharing vs. cost-reduction and implications for financial exposure in long-acting HIV therapies. The omission of revenue-sharing dynamics prevents a perfect score, but the core financial exposure analysis remains substantively correct. Wording differs from the original but maintains semantic equivalence on key points.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 399,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does FDX's exposure to LIBOR-related hedging adjustments under ASU 2022-06 compare to UPS's use of hedging relationships, particularly in light of ASU 2022-06's extended sunset date through 2024?",
      "original_answer": "FDX has stated that reference rate reform, including ASU 2022-06, has had no material effect on its financial condition or results of operations as of May 31, 2024, though it continues to monitor contracts for potential application of the standard. ASU 2022-06 extends the sunset date for optional expedients and exceptions related to reference rate reform—including LIBOR transitions—to December 31, 2024. UPS, which designates derivative instruments in hedging relationships, including cash flow and fair value hedges, may benefit from the extended relief under ASU 2022-06 to manage LIBOR-related contracts through 2024 without significant accounting disruptions. Therefore, while FDX has not seen material impacts, UPS could be actively leveraging the extended ASU 2022-06 provisions in its hedging strategies.",
      "llm_answer": "FedEx has already moved all of its LIBOR‑referenced contracts and hedges to the alternative reference rate SOFR, and the company reports no material impact from ASU 2022‑06’s LIBOR‑related adjustments (FedEx notes that the optional relief can be applied through 31‑Dec‑2024 but that it has transitioned its debt and contracts to SOFR and will continue to monitor for any impact in 2024).  UPS, by contrast, discloses that it uses derivative instruments as hedges to manage interest‑rate and currency exposure, but the 10‑K does not identify any LIBOR‑based hedges; thus the ASU’s extended sunset date through 2024 would only affect UPS if it had remaining LIBOR‑linked hedges, which it does not appear to have.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several correct elements but diverges significantly from the ground truth in key aspects, leading to a partially correct assessment. (1) Quantitatively, the LLM correctly identifies the ASU 2022-06 sunset date as December 31, 2024, which matches the ground truth and is critical to the question. This earns high marks for quantitative accuracy. (2) However, the qualitative analysis is flawed: the LLM claims FDX has fully transitioned all LIBOR-referenced contracts to SOFR and reports no material impact, which aligns broadly with FDX’s position of no material effect. But the LLM incorrectly implies UPS has no LIBOR-based hedges and therefore would not benefit from the extended relief—this contradicts the ground truth, which states that UPS *may benefit* from the extended provisions due to its active use of hedging relationships, including cash flow and fair value hedges that could be LIBOR-related. The ground truth does not assert that UPS has no LIBOR hedges, only that it uses hedging strategies that could leverage ASU 2022-06 relief. (3) The multi-hop reasoning is unsound: the LLM fails to synthesize that ASU 2022-06’s extension allows companies like UPS, which actively use hedging, to continue applying relief through 2024—even if specific LIBOR exposure isn’t disclosed. The conclusion that UPS would not be affected because it 'does not appear to have' LIBOR hedges is speculative and not supported in the original answer. (4) Contextually, the answer addresses both companies and the ASU 2022-06 sunset, so relevance is moderate, but the incorrect inference about UPS undermines the core comparison. While wording flexibility is allowed, the LLM’s assertion contradicts the nuanced, evidence-based contrast in the ground truth: FDX has no material impact, while UPS could be actively leveraging the relief. Thus, the correctness score is reduced to 5 due to significant factual misrepresentation in the comparative analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 528,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does the dual-class stock structure's impact on investor protections at META compare to the voting power differential in GOOGL's Class B common stock, especially given that Class B shares automatically convert to Class A upon sale or transfer?",
      "original_answer": "META's dual-class structure allows its controlling stockholder to maintain decision-making power even if they own significantly less than a majority of shares, which could make Class A common stock less attractive to investors due to reduced governance protections. In contrast, GOOGL's Class B common stock provides 10 votes per share compared to 1 vote per share for Class A, but these Class B shares automatically convert to Class A upon sale or transfer, potentially limiting long-term control by insiders. This conversion mechanism in GOOGL may offer more eventual governance balance compared to META's structure, where Class B shares can maintain control for extended periods unless their voting power drops below 35% of the combined voting power.",
      "llm_answer": "At META, the dual‑class structure concentrates voting power in the hands of the CEO and other Class B holders (10 votes per share versus one for Class A), giving them a majority of the combined voting power as long as Class B shares represent at least 9.1 % of outstanding shares—this concentration limits investors’ ability to influence corporate matters and weakens their protections. In contrast, Google’s Class B shares also carry a 10‑to‑1 voting advantage, but they automatically convert to Class A upon sale or transfer, so the concentration of voting power is less permanent and can diminish over time, although long‑term holders of Class B shares still enjoy a significant voting edge.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core differences between META's and GOOGL's dual-class structures. (1) It correctly identifies that both companies have a 10-to-1 voting ratio for Class B shares and that GOOGL's Class B shares convert to Class A upon sale or transfer, limiting long-term control—this matches the ground truth. It also accurately notes that META's structure allows outsized control with minimal economic ownership, weakening investor protections. (2) The quantitative claim that Class B holders at META maintain majority voting power with as little as 9.1% ownership is factually correct and consistent with public filings, though this specific percentage is not in the original answer; however, it is a valid derived figure based on the 10:1 voting ratio and capital structure, so its inclusion enhances precision without contradicting the ground truth. The original answer references the 35% combined voting power threshold for conversion, which the LLM omits, representing a minor gap in completeness. (3) The multi-hop reasoning is sound: the model correctly synthesizes how voting rights, transfer restrictions, and conversion mechanisms affect long-term control and investor protections across both firms. (4) The answer is contextually excellent, directly addressing the comparison of investor protections and voting power dynamics. The only reason for not scoring a 10 is the omission of META's 35% combined voting power threshold, which is a notable detail in the original answer affecting long-term structural durability. Overall, the LLM provides a semantically equivalent, well-reasoned, and factually accurate response with only minor omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 459,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does KO's use of option contracts to hedge forecasted transactions compare to MDLZ's disclosure of gains and losses on forecasted transactions in terms of financial impact and hedging strategy?",
      "original_answer": "KO utilizes option contracts as part of its broader hedging strategy to mitigate foreign currency exchange rate risk, commodity price risk, and interest rate risk, with the goal of reducing earnings volatility from market fluctuations. These contracts are designated as cash flow hedges, and the unrealized gains or losses are deferred in AOCI until the forecasted transactions occur. In contrast, MDLZ disclosed that in 2024, it recognized $106 million in gains on forecasted transactions through cost of sales, and $17 million through interest and other expense, net, indicating the financial impact of these hedging activities on specific income statement line items. While KO emphasizes a structured hedging approach with clear accounting treatment for deferred gains/losses, MDLZ provides more granular disclosure on the realized financial outcomes of its hedging activities on forecasted transactions.",
      "llm_answer": "KO uses option contracts as cash‑flow hedges for forecasted foreign‑currency transactions, with net gains of $472 million reclassified to earnings in 2024 and a net deferred gain of $99 million in AOCI, effectively offsetting the value changes of those forecasted transactions. In contrast, MDLZ’s 10‑K discloses gains and losses on forecasted transactions directly in earnings, reflecting the impact of currency and commodity price movements on its forecasted purchases and sales, though the excerpt does not provide specific dollar amounts. Thus, KO’s strategy actively employs derivatives to manage forecasted‑transaction risk, whereas MDLZ’s disclosure indicates a more passive recognition of market‑driven gains/losses on forecasted transactions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. It claims KO had 'net gains of $472 million reclassified to earnings in 2024' and a 'net deferred gain of $99 million in AOCI', but these figures are not present in the original answer (ground truth) and contradict the disclosed MDLZ figures instead. The original answer states that MDLZ recognized $106 million in gains through cost of sales and $17 million through interest and other expense, totaling $123 million in realized gains — not $472 million. The LLM incorrectly attributes these (non-existent) numbers to KO, which severely undermines factual correctness. (2) There are no verifiable sources in the provided context for KO’s $472M reclassification or $99M AOCI balance; the ground truth only confirms KO’s use of options as cash flow hedges with deferral in AOCI, but without specific numbers. Thus, the quantitative accuracy is low due to fabrication of precise figures not supported by the truth. (3) The qualitative reasoning partially captures the contrast: KO uses structured derivative hedges (options) designated as cash flow hedges with AOCI deferral, while MDLZ discloses realized gains on forecasted transactions in earnings. However, the LLM mischaracterizes MDLZ’s approach as 'passive recognition' — a subjective and unsupported interpretation not in the original answer. The original emphasizes MDLZ’s granular disclosure of financial impact, not passivity. (4) Contextually, the response addresses the comparative question about hedging strategy and financial impact, correctly identifying KO’s active use of derivatives versus MDLZ’s disclosure practices. But due to invented numbers and flawed reasoning about MDLZ’s strategy, the overall correctness is significantly compromised. Minor point: both mention forecasted transactions and income statement impacts, preserving some relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 516,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does the valuation approach for TMO's fixed income funds, which are reported as 'not subject to leveling', contrast with BMY's classification of fixed income funds under Level 2 in the fair value hierarchy, and what does this indicate about their respective reliance on observable market data for pension asset valuation?",
      "original_answer": "TMO reports its fixed income funds as 'not subject to leveling,' indicating that these assets are valued outside the standard fair value hierarchy and likely measured using methods other than quoted market prices or observable inputs. In contrast, BMY classifies its fixed income funds under Level 2, which means their valuation relies on observable market data, such as quoted prices for similar instruments or in nonactive markets. This contrast suggests that BMY's pension assets have a more structured and market-based valuation methodology for fixed income funds, while TMO's approach implies less direct reliance on standardized market inputs for these assets.",
      "llm_answer": "TMO’s fixed‑income pension plan assets appear in the “not subject to leveling” column of its fair‑value hierarchy table (fixed‑income funds $739 m), meaning they are measured at NAV using a practical expedient and are not included in the hierarchy, so they rely only minimally on observable market data.  \nBMS, by contrast, classifies its fixed‑income funds as Level 2 assets—valued with observable inputs such as quoted prices for similar securities—indicating a higher reliance on observable market data for pension asset valuation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the dollar amount ($739M) for TMO's fixed-income funds is correctly stated, and while the original answer does not include this figure, its presence in the LLM response adds precision without introducing error. No calculations are required, and all numeric references are accurate. (2) Entity accuracy is strong: TMO and BMY (referred to as BMS in the LLM answer) are correctly identified; however, 'BMS' is a minor error—Bristol-Myers Squibb is abbreviated as BMY, not BMS (which typically refers to Bristol Myers Squibb post-merger but can cause confusion with other firms). This does not impact understanding but is a slight inaccuracy. (3) The reasoning is sound: the LLM correctly interprets 'not subject to leveling' as indicating measurement at NAV under a practical expedient, outside the fair value hierarchy, and contrasts it with Level 2 classification based on observable inputs. This reflects proper multi-hop synthesis between the two companies' valuation approaches. (4) Semantically, the LLM conveys the same core message as the original: BMY/BMS relies more on observable market data due to Level 2 classification, while TMO’s approach implies less reliance on standardized market inputs. The explanation of NAV as a practical expedient adds useful context not in the original but is factually correct. Only the company ticker discrepancy prevents a perfect score, hence correctness_score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 413,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How does the structure of AbbVie's debt agreements with U.S. Bank National Association compare to Abbott Laboratories' use of Abbott Ireland Financing DAC as an issuer, particularly in terms of trustee roles and note issuance timelines?",
      "original_answer": "AbbVie has multiple Supplemental Indentures with U.S. Bank National Association serving as trustee, transfer agent, and registrar, with key agreements dated September 26, 2019 (Supplemental Indenture No. 6), November 21, 2019 (Supplemental Indenture No. 7), and May 14, 2020 (Supplemental Indenture No. 8 and 9). These agreements involve the issuance of various notes and are supported by Agency Agreements with Elavon Financial Services DAC. Similarly, Abbott Ireland Financing DAC, as issuer, has entered into Indentures with U.S. Bank National Association as trustee, including the September 27, 2018 Indenture and the November 19, 2019 Second Supplemental Indenture, under which specific notes such as the 1.500% Note due 2026 and the 0.100% Note due 2024 were issued. Both companies rely on U.S. Bank National Association in a trustee capacity, but AbbVie’s structure includes more frequent use of Elavon Financial Services DAC as a paying agent, while Abbott Ireland Financing DAC directly issues notes under its own entity name with Abbott Laboratories as guarantor.",
      "llm_answer": "AbbVie’s 2023 10‑K does not disclose the details of its debt agreements with U.S. Bank National Association, so the trustee role and the dates on which the notes were issued are not specified in the supplied pages.  By contrast, Abbott Laboratories’ debt structure uses Abbott Ireland Financing DAC as the issuer, with U.S. Bank National Association serving as trustee; the indenture was dated September 27 2018 and the related notes (1.500 % due 2026, 0.100 % due 2024, 0.375 % due 2027) were issued in 2018–2019.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual information but fails to accurately represent the full structure of AbbVie's debt agreements, incorrectly claiming that the 2023 10-K does not disclose details, when in fact the ground truth includes specific Supplemental Indentures with U.S. Bank National Association dated September 26, 2019, November 21, 2019, and May 14, 2020. These dates and agreement numbers are missing from the LLM response, indicating a failure in multi-hop retrieval or synthesis. (2) Quantitatively, the Abbott Ireland Financing DAC details are mostly correct: the September 27, 2018 Indenture date is accurate, and the note maturities (1.500% due 2026, 0.100% due 2024) match the ground truth. However, the LLM adds a 0.375% note due 2027 not mentioned in the original answer, introducing an unsupported fact. The AbbVie-related dates and agreement numbers are entirely omitted, which are critical to answering the comparison question. (3) The reasoning is flawed: the LLM asserts lack of disclosure for AbbVie without justification, failing to recognize that the knowledge graph contains explicit data on AbbVie’s Supplemental Indentures. It also misses the key comparative insight that both entities use U.S. Bank National Association as trustee, and fails to mention Elavon Financial Services DAC’s role in AbbVie’s structure, which is a distinguishing feature in the ground truth. (4) The contextual relevance is moderate because it attempts to compare trustee roles and issuance timelines, but due to significant omissions and one fabricated note series, the answer is misleading. The correctness score is low due to major factual gaps and an unsupported addition, despite partial accuracy on Abbott’s side.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 475,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How does NVDA's dependency on foundries for advanced process node manufacturing at 7nm and smaller compare to AMD's reliance on larger wafers for competitive IC production, given both companies' exposure to TSMC's fabrication capabilities?",
      "original_answer": "NVDA depends on foundries like TSMC to manufacture its semiconductor wafers using advanced process node technologies such as 7nm and smaller, which are critical for producing high-performance GPUs and meeting customer demand. NVDA faces risks including supply shortages, yield issues, and delays if TSMC cannot scale production or implement new technologies effectively. Similarly, AMD relies on TSMC to produce wafers with competitive performance attributes, and specifically mentions the importance of transitioning to advanced manufacturing process technologies and increased wafer sizes to maintain cost efficiency and product competitiveness. Both companies are exposed to risks if TSMC fails to deliver sufficient quantities of 7nm or smaller wafers, which could increase per-unit costs, delay product launches, and harm customer relationships. This shared dependency on TSMC for leading-edge wafer production highlights a critical supply chain vulnerability affecting both NVDA and AMD.",
      "llm_answer": "NVDA’s advanced‑node portfolio (7 nm and below) is almost entirely built on TSMC’s foundry capacity – “we rely on TSMC for the production of all wafers for micro‑processor and GPU products at 7 nm or smaller nodes” – so any TSMC constraint directly limits NVDA’s supply and product performance.  AMD, by contrast, uses larger‑wafer nodes for its competitive ICs, giving it a slightly broader supply base, but it still relies on TSMC for its most advanced products and remains exposed to the same capacity and technology risks.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and context. (1) It accurately identifies that NVDA relies exclusively on TSMC for 7nm and smaller node manufacturing, which matches the original answer's assertion about NVDA's dependency on TSMC for advanced nodes. The quote-like statement, while not a direct citation, reflects actual disclosures made by NVDA in its filings. (2) There are no numerical values requiring calculation (e.g., percentages, dollar amounts, dates), so quantitative accuracy is not compromised—no errors in numbers or metrics. (3) The comparison to AMD is mostly accurate: AMD does rely on TSMC for advanced nodes, and while the LLM mentions 'larger-wafer nodes' as a contrast, this slightly mischaracterizes AMD’s strategy. The original answer clarifies that AMD emphasizes both advanced process nodes *and* increased wafer sizes for cost efficiency, not a shift to larger wafers *instead* of advanced nodes. The LLM implies a structural difference in supply chain strategy (larger wafers = broader supply base), which is not fully supported—AMD remains highly dependent on TSMC for leading-edge nodes like 7nm and below, just like NVDA. This is a minor but notable gap in reasoning. (4) Despite this nuance, the core multi-hop synthesis—that both companies are heavily exposed to TSMC’s capacity and technology execution—is correctly conveyed. The answer is contextually relevant, directly addressing the comparative dependency and shared risk. Thus, the correctness and qualitative accuracy scores are high but not perfect due to the slight misrepresentation of AMD’s reliance on TSMC and the interpretation of 'larger wafers' as a mitigating factor in supply chain risk.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 474,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "Given Philip Morris's ongoing regulatory challenges in Thailand stemming from the WTO panel decision on customs valuation of cigarette imports, and Colgate-Palmolive's manufacturing presence in Thailand, how might the unresolved customs and tax compliance issues in Thailand impact Colgate-Palmolive's operational costs or regulatory risk exposure in the country?",
      "original_answer": "The WTO panel decision found that Thailand lacked grounds to challenge the customs valuation of Philip Morris's cigarette imports and obligated Thailand to revise its customs and tax practices. However, Thailand has not fully complied, and the dispute remains unresolved due to the inoperability of the WTO Appellate Body. This regulatory inertia indicates a persistent risk of non-aligned customs enforcement in Thailand. Colgate-Palmolive operates manufacturing and warehousing facilities in Thailand, a country where customs and tax measures have proven resistant to international rulings. If Thailand continues to apply inconsistent or non-compliant customs valuation practices, Colgate-Palmolive may face increased scrutiny, higher import duties, or regulatory uncertainty affecting its cost structure and compliance burden in the country.",
      "llm_answer": "Unresolved customs and tax compliance issues in Thailand—highlighted by the WTO panel decision (PM 10‑K, pp. 66‑70)—could raise import duties or compliance costs for all importers, including Colgate‑Palmolive.  With manufacturing operations in Thailand (CL 10‑K, pp. 23‑27), the company may face higher operational costs and heightened regulatory risk exposure if Thai authorities enforce stricter customs‑valuation or tax measures, potentially leading to additional compliance expenses or fines.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies the WTO panel decision and its implications for customs and tax compliance in Thailand, referencing Philip Morris's 10-K (pp. 66–70) and Colgate-Palmolive's manufacturing presence in Thailand (CL 10-K, pp. 23–27), which aligns with the original answer. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: it connects the unresolved WTO dispute affecting Philip Morris to broader regulatory risks in Thailand and correctly infers that Colgate-Palmolive, as a manufacturer in the same jurisdiction, could face higher import duties, compliance costs, or regulatory scrutiny. The only minor omission is not explicitly mentioning the inoperability of the WTO Appellate Body as a reason for non-compliance, which slightly reduces completeness in qualitative terms, but the core causal chain is preserved. (4) The answer is highly contextually relevant, directly addressing how customs and tax issues in Thailand could impact Colgate-Palmolive’s operational costs and regulatory risk. Wording differs but meaning matches. Overall, this is a strong, correct response with only negligible detail missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 374,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How does the $265,000 decline in UNH's Medicare Part D enrollment from 2023 to 2024 relate to the IRA's redesign of Medicare Part D and Pfizer's projected $1 billion revenue loss in 2025 under the same program?",
      "original_answer": "The $265,000 decline in UnitedHealth's (UNH) Medicare Part D enrollment from 2023 to 2024 reflects a reduction in the number of beneficiaries in this program, which aligns with broader structural changes introduced by the Inflation Reduction Act (IRA). The IRA's redesign of Medicare Part D, effective in 2025, includes a $2,000 annual out-of-pocket cap for beneficiaries and a new Manufacturer Discount Program requiring 10% and 20% discounts in different coverage phases. These changes increase financial pressure on manufacturers like Pfizer (PFE), which projects a $1 billion revenue loss in 2025 due to IRA-related adjustments. The enrollment decline at UNH may indicate reduced attractiveness of Part D plans to beneficiaries or shifting market dynamics, which, when combined with the IRA's pricing pressures, could contribute to reduced revenue for manufacturers like Pfizer.",
      "llm_answer": "The $265,000 drop in UnitedHealth’s Medicare Part D stand‑alone enrollment (3,050 k in 2024 vs. 3,315 k in 2023, an 8 % decline) is an early sign of the IRA’s Part D redesign, which caps beneficiary out‑of‑pocket costs and reduces federal reinsurance, shifting more cost burden to plans and manufacturers and discouraging enrollment.  The same redesign is projected to hit drug makers hard – Pfizer’s 2024 10‑K forecasts a roughly $1 billion revenue loss in 2025 under the new Medicare Part D rules, underscoring the broader industry impact of the IRA’s changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct and aligns closely with the ground truth. It accurately reports the $265,000 decline in UNH's Medicare Part D enrollment (3,315k to 3,050k), correctly calculates the 8% decline, and links it to the IRA's redesign. It also correctly states Pfizer's projected $1 billion revenue loss in 2025 due to IRA changes. All entities (UNH, PFE, IRA, Medicare Part D), years (2023–2025), and financial figures are accurate.\n\n2) Quantitative accuracy is excellent: the enrollment numbers (3,315k in 2023 and 3,050k in 2024) yield a 265k (not $265,000) decline—this is a critical error in unit labeling. The original answer says '$265,000 decline', which is incorrect (should be 265,000 enrollees), but the LLM repeats this as '265,000 drop' and correctly interprets it as a person count (given the context of enrollment and 'k' units). However, the LLM correctly uses '265,000' as a count (not dollars), so despite the original answer's erroneous '$', the LLM interprets it correctly in context. Thus, the number is substantively correct.\n\n3) The multi-hop reasoning is sound: the LLM connects UNH's enrollment drop to the IRA's structural changes (out-of-pocket cap, reduced reinsurance), explains the increased cost burden on plans and manufacturers, and ties this to Pfizer’s projected $1B revenue loss. It correctly infers that these changes may discourage enrollment and impact manufacturer revenues, matching the causal chain in the ground truth.\n\n4) The only minor issue is a slight conflation of 'stand-alone' enrollment (which the LLM specifies) versus general Part D enrollment (the original answer does not specify), but this adds precision rather than inaccuracy. The LLM also cites the 2024 10-K for Pfizer’s projection, which is plausible but not confirmed in the ground truth—this is a minor addition but not incorrect. Overall, the answer is semantically equivalent, factually accurate, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 533,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does Lockheed Martin's $4,863 million investment in private equity funds, which are valued using the NAV practical expedient, compare to FedEx's application of the same accounting policy for equity securities without readily determinable fair values?",
      "original_answer": "Lockheed Martin reports $4,863 million in private equity fund investments valued under the NAV practical expedient, which relies on unobservable inputs in valuation models of underlying securities and typically has terms between 8 and 12 years. FedEx also applies the NAV practical expedient to equity securities without readily determinable fair values, though it notes that for these investments, adjustments to cost are made only for observable price changes and impairments. While Lockheed Martin’s NAV-based private equity investments are part of a broader portfolio including real estate and hedge funds, FedEx specifically highlights immaterial annual and cumulative impairment adjustments under the measurement alternative for such equity securities.",
      "llm_answer": "Lockheed Martin reported $4,863 million in private‑equity funds that are measured at NAV under the practical expedient, whereas FedEx reported only $37 million in equity securities that are measured at NAV for the same reason.  Thus Lockheed Martin’s NAV‑measured investment is roughly 130‑times larger, and the policy is applied to different asset classes—private‑equity vehicles for Lockheed Martin’s post‑retirement plan assets versus a small subset of equity securities in FedEx’s investment portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error: it claims FedEx reported $37 million in NAV-measured equity securities, which is not supported by the original answer (ground truth). The ground truth does not provide any specific dollar amount for FedEx’s investments valued under the NAV practical expedient—only qualitative information about its accounting policy and immaterial impairments. This invalidates the core quantitative comparison. (2) The calculation that Lockheed Martin’s investment is '130-times larger' is therefore entirely incorrect, as it is based on a fabricated number for FedEx. The original answer makes no such comparison and does not state FedEx’s NAV-based investment value. (3) While the LLM correctly identifies that Lockheed Martin uses the NAV practical expedient for private equity funds with unobservable inputs and long-term horizons, and that FedEx applies the same expedient to equity securities without readily determinable fair values, it misrepresents the scope and nature of the comparison. The original answer emphasizes differences in accounting treatment (e.g., FedEx adjusts only for observable price changes and impairments, with immaterial adjustments), which the LLM omits. (4) The LLM introduces new, unsupported details—such as linking Lockheed’s investments to 'post-retirement plan assets' and claiming FedEx has a 'small subset'—that are not in the original answer. These additions reflect overinterpretation or hallucination. While the response attempts multi-hop reasoning by comparing scale and asset class, the reasoning collapses due to incorrect data. The contextual relevance is moderate because it addresses the right topic and policy, but the factual foundation is flawed, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 484,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does the voting power dilution mechanism in CMCSA's Class B to Class A common stock conversion compare with GOOGL's dual-class structure, particularly in light of GOOGL's $62.0 billion share repurchase in 2024 targeting Class A and Class C shares?",
      "original_answer": "GOOGL's 2024 share repurchase of $62.0 billion focused on Class A and Class C shares, which could indirectly impact ownership concentration by reducing the number of shares outstanding, while maintaining the dual-class voting structure where Class B shares retain 10 votes per share. In contrast, CMCSA's Class B common stock is convertible share-for-share into Class A common stock and holds 33⅓% of the total voting power, which is non-dilutable under their articles of incorporation. This means CMCSA's Class B stock maintains a fixed voting influence regardless of conversions or new issuances, whereas GOOGL's repurchase strategy may influence the economic value of shares without altering the 10:1 voting rights disparity between Class B and Class A shares.",
      "llm_answer": "CM CSA’s Class B shares carry 15 votes each and are convertible share‑for‑share into Class A shares that have only one vote; when B shares convert, the aggregate voting power of B holders is diluted. Alphabet’s dual‑class structure gives Class A shares one vote and Class C shares no voting rights, and the $62 billion 2024 repurchase of Class A and Class C shares simply reduces the number of shares outstanding without changing the voting‑rights ratio—Class A shares keep one vote each and Class C shares remain non‑voting.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. It incorrectly states that CMCSA's Class B shares carry '15 votes each'—the ground truth indicates that CMCSA's Class B stock holds 33⅓% of total voting power on a non-dilutable basis, not a per-share vote count like 15 votes. There is no evidence in the ground truth that CMCSA Class B shares have 15 votes per share. Additionally, the claim that 'when B shares convert, the aggregate voting power of B holders is diluted' directly contradicts the ground truth, which states that CMCSA's Class B voting power is 'non-dilutable under their articles of incorporation'—meaning it is specifically designed to avoid dilution. For GOOGL, the LLM correctly identifies the 2024 $62 billion repurchase and that it covers Class A and Class C shares, and that Class C shares are non-voting. However, it fails to mention that GOOGL’s Class B shares carry 10 votes per share (not discussed), and incorrectly implies that Class A has only one vote without contrasting it to Class B’s superior voting rights. (2) Quantitative accuracy is low: while the $62 billion figure is correct, the description of voting rights lacks accurate numerical representation—e.g., missing 10:1 voting ratio for GOOGL’s Class B vs Class A, and completely fabricating a '15 votes' claim for CMCSA with no basis. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize the key contrast—CMCSA’s fixed voting power (non-dilutable) vs GOOGL’s structural voting disparity maintained through share repurchases that reduce float without altering voting ratios. Instead, it invents a dilution mechanism in CMCSA that contradicts the ground truth. (4) Contextual relevance is moderate because the answer addresses dual-class structures and repurchases, but due to major factual errors in both entities’ governance mechanics, the comparison is misleading. The core insight—that CMCSA protects voting power contractually while GOOGL uses repurchases to affect ownership concentration without changing voting ratios—is entirely missed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 558,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does the revenue exposure of CVS through its 50% ownership in Red Oak Sourcing, LLC—which negotiates generic pharmaceutical supply contracts with Cardinal Health, Inc., compare to LLY's reliance on Cardinal Health as a top-three distributor accounting for 15–20% of its consolidated revenue?",
      "original_answer": "CVS has a 50% ownership stake in Red Oak Sourcing, LLC, which serves as a joint venture with Cardinal Health, Inc. to negotiate generic pharmaceutical supply contracts for both companies, though Red Oak does not hold inventory. Meanwhile, LLY relies on Cardinal Health, Inc. as one of only three U.S. wholesale distributors each accounting for 15–20% of LLY’s consolidated revenue, alongside McKesson and AmerisourceBergen. This means Cardinal plays a dual role—both as a strategic sourcing partner to CVS via Red Oak and as a critical distribution channel for LLY’s pharmaceutical products in the U.S. market.",
      "llm_answer": "CVS’s 50 % stake in Red Oak Sourcing is limited to sourcing and negotiating generic contracts; Red Oak does not own inventory or generate sales revenue for either party, so CVS’s revenue exposure to Cardinal is indirect and minimal【Generic Sourcing Venture】.  In contrast, Lilly’s top‑three distributor Cardinal accounts for 15–20 % of Lilly’s consolidated revenue, representing a substantial direct revenue reliance【Distribution Section】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core distinction in revenue exposure between CVS and LLY with respect to Cardinal Health. (1) Quantitatively, all percentages (15–20%) and ownership stake (50%) are correct. There are no calculations required beyond accurate representation of these values, which are properly cited. (2) The answer correctly identifies that Red Oak Sourcing does not generate revenue or hold inventory, thus CVS’s exposure is indirect and minimal—this aligns with the ground truth. It also accurately states that Cardinal Health is one of LLY’s top three distributors, accounting for 15–20% of consolidated revenue, matching the original answer. (3) The multi-hop reasoning is sound: it synthesizes information across CVS’s joint venture structure (Red Oak) and LLY’s distribution dependency, correctly contrasting indirect sourcing influence (CVS) vs. direct revenue channel (LLY). (4) While the LLM omits mention of McKesson and AmerisourceBergen as the other two distributors (a minor completeness gap), this does not detract from the central comparison. The semantic meaning and key insights are preserved, with clear, concise, and relevant reasoning. The use of footnotes (【Generic Sourcing Venture】 and 【Distribution Section】) suggests source tagging, which does not affect accuracy. Overall, the answer is highly accurate, contextually appropriate, and correctly emphasizes the contrast in business relationships with Cardinal Health.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 405,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "What is the difference in voting rights per share between Class B common stock disclosed by UPS and the common stock voting rights at Honeywell as of 2024?",
      "original_answer": "UPS's Class B common stock has 10 votes per share, while Honeywell's common stock has 1 vote per share, resulting in a 9-vote difference per share in favor of UPS's Class B shares.",
      "llm_answer": "UPS’s Class B common stock is entitled to **10 votes per share** (UPS 10‑K, Note 11, pages 67‑71).  \nHoneywell’s common stock carries **1 vote per share** (Honeywell 10‑K, Note 18, pages 94‑98).  \n\nThus, UPS Class B shares have **9 more voting rights per share** than Honeywell’s common shares as of 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the voting rights per share are accurately reported: UPS Class B common stock has 10 votes per share, and Honeywell common stock has 1 vote per share. The difference of 9 votes per share is correctly calculated. (2) The answer is complete, addressing both companies' voting rights and computing the difference as required by the question. (3) Entity accuracy is correct—UPS and Honeywell are properly identified, and the information is attributed to the correct filings (10-K) and note numbers (Note 11 and Note 18), with appropriate page ranges. (4) The multi-hop reasoning is sound: the model correctly synthesizes data from two separate companies and filings, compares the voting rights, and draws the correct conclusion. (5) The semantic meaning is equivalent to the original answer, with clear, precise wording and proper emphasis on key facts. Minor formatting differences (e.g., use of bold, em dash) do not affect accuracy. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1123,
        "completion_tokens": 304,
        "total_tokens": 1428
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "How does the maturity of AMGN's 3.625% 2024 Notes, which triggered the termination of $1.4 billion in associated interest rate swap contracts, compare with ABBV's use of interest rate swap contracts as cash flow hedges in 2024?",
      "original_answer": "AMGN's 3.625% 2024 Notes matured in 2024, which led to the termination of $1.4 billion in interest rate swap contracts that were hedging this fixed-rate debt. In contrast, ABBV did not have any active interest rate swap contracts designated as cash flow hedges in 2024, as the amount reported for that year was $0, compared to $6 million in 2022. This indicates a difference in hedging strategy between the two companies with respect to interest rate exposure on debt instruments.",
      "llm_answer": "AMGN’s 3.625 % 2024 notes were due in 2024, and the repayment of those notes caused the company to terminate the $1.4 billion of interest‑rate swap contracts that had been linked to them【AMGN_10k_2024.pdf:147-151】.  In contrast, AbbVie’s interest‑rate swaps in 2024 were not used as cash‑flow hedges but were designated as fair‑value hedges for debt maturing from 2025 through 2051 (e.g., 3.125 % 2025, 2.60 % 2026, 2.45 % 2030, 2.30 % 2031, 5.25 % 2033, 4.663 % 2051)【ABBV_10k_2024.pdf:80-84】.  Thus, AMGN’s swap termination was tied to a 2024 maturity, whereas AbbVie’s swaps are tied to longer‑dated debt and are used for fair‑value rather than cash‑flow hedging.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that AMGN's 3.625% 2024 Notes matured in 2024 and triggered the termination of $1.4 billion in interest rate swaps, which matches the ground truth. This part is factually accurate and well-supported by the citation. However, the LLM's claim about ABBV’s interest rate swaps being designated as fair-value hedges for specific debt tranches (e.g., 3.125% 2025, etc.) contradicts the ground truth, which states that ABBV had $0 in cash flow hedges in 2024 and does not mention fair-value hedges at all. The original answer emphasizes the absence of cash flow hedges, while the LLM shifts focus to fair-value hedges, which were not part of the question or the ground truth. (2) Quantitatively, all numbers are correct: $1.4 billion and 2024 maturity for AMGN; no incorrect figures are introduced for ABBV. However, the LLM introduces new data (specific coupon rates and maturities) not present in the ground truth, which may be from the source but are irrelevant to the question about cash flow hedges. (3) The multi-hop reasoning is partially flawed: while the model correctly links AMGN’s note maturity to swap termination, it fails to accurately contrast ABBV’s lack of cash flow hedges in 2024. Instead, it misdirects by discussing fair-value hedges, which changes the nature of the comparison. The core of the question is about cash flow hedges, and the LLM does not confirm their absence in ABBV as required. (4) The contextual relevance is high because the response addresses the maturity and hedging relationship, but the qualitative accuracy is reduced due to incorrect characterization of ABBV’s hedging activities. The correctness score is 6 due to significant error in the ABBV portion despite correct AMGN facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 480,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "How did the adoption of ASU 2022-02 impact Capital One's reporting of financial difficulty modifications compared to JPMorgan's prior TDR disclosures, particularly in terms of modification types and their financial effects?",
      "original_answer": "The adoption of ASU 2022-02 eliminated the TDR framework and introduced FDMs, changing how Capital One reports loan modifications. Capital One noted that the types of modifications offered—such as interest rate reductions, term extensions, and principal reductions—remained the same, but they are now categorized and reported differently under FDMs. For JPMorgan, prior to the change, TDRs included similar modifications but were assessed under concession criteria. After the adoption, JPMorgan reported $136 million in FDMs for 2023, primarily involving term extensions and interest rate reductions that extended loan lives by 20 years and reduced the weighted-average rate from 7.21% to 4.44%. This shift reflects a more standardized reporting approach under ASU 2022-02, removing the previous TDR distinctions while maintaining the same types of borrower support.",
      "llm_answer": "Capital One’s adoption of ASU 2022‑02 re‑classified all loan concessions that were previously reported as “troubled‑debt restructurings” (TDRs) into “financial‑difficulty modifications” (FDMs) and required the firm to disclose each modification’s performance on a rolling 12‑month basis.  The types of concessions (interest‑rate reductions, term extensions, principal reductions, or combinations thereof) remained the same, but the new guidance eliminated the concession‑based definition of a TDR and produced a detailed table of amounts and weighted‑average interest‑rate reductions (e.g., $687 million in credit‑card rate cuts, $970 million in commercial‑banking term extensions, 19.32% rate cut for domestic cards) that was not shown in JPMorgan’s earlier TDR disclosures.  By contrast, JPMorgan’s prior TDR reporting aggregated modifications under the old framework and summarized financial effects mainly as charge‑offs and principal forgiveness amounts, without the granular breakdown of modification types and financial metrics that Capital One now provides.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in quantitative details, despite capturing some qualitative aspects of the ASU 2022-02 transition. (1) Quantitative Accuracy: The dollar amounts cited—$687 million in credit-card rate cuts and $970 million in commercial-banking term extensions—and the 19.32% rate cut for domestic cards are not present in the ground truth and contradict the only specific number provided: JPMorgan’s $136 million in FDMs for 2023. These figures appear fabricated or misattributed. The ground truth does not mention Capital One disclosing such granular data, nor does it state that JPMorgan’s prior disclosures lacked breakdowns—this comparative claim is unsupported. (2) Completeness: The answer addresses the shift from TDRs to FDMs and notes that modification types (rate reductions, term extensions, etc.) remained consistent, which aligns with the original answer. It also touches on differences in disclosure practices, fulfilling part of the comparative aspect. (3) Entity Accuracy: Correctly identifies Capital One and JPMorgan, ASU 2022-02, TDRs, and FDMs, and correctly characterizes the nature of modifications. However, it misattributes specific disclosures to Capital One that are not in the ground truth. (4) Reasoning: The multi-hop reasoning is partially sound—the model attempts to compare Capital One’s current reporting under ASU 2022-02 with JPMorgan’s prior TDR disclosures—but the logic is undermined by incorrect data. The claim that Capital One now provides more granular disclosures than JPMorgan did is speculative and not supported by the ground truth, which states JPMorgan reported $136M in FDMs with specific rate and term changes. (5) Semantic Equivalence: While the structural understanding of the accounting change is reasonable, the inclusion of false quantitative details severely compromises factual correctness. The ground truth emphasizes standardization post-ASU 2022-02, whereas the LLM implies divergent disclosure practices, misrepresenting the conclusion. Thus, despite relevant context and correct terminology, the answer is materially incorrect due to invented metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 574,
        "total_tokens": 2076
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How does the alignment of interest rate swap maturities with debt exposure differ between GD's hedging strategy and UPS's economic hedge approach, and what does this reveal about their respective risk management priorities?",
      "original_answer": "GD's hedging strategy involves interest rate swap contracts with a dollar-weighted two-year average maturity that generally matches the duration of the activities at risk, indicating a focus on closely aligning hedge instruments with underlying exposure timelines. In contrast, UPS uses interest rate swaps as economic hedges for portions of its outstanding debt but does not specify a maturity alignment, instead emphasizing the use of offsetting positions to terminate existing swaps and eliminate market valuation effects. This reveals that GD prioritizes duration-matching to manage interest rate risk over time, while UPS focuses on dynamic risk mitigation through offsetting transactions, reflecting different approaches to managing financial exposure.",
      "llm_answer": "GD’s interest‑rate swaps are structured so that their dollar‑weighted average maturity matches the duration of the debt they hedge, reflecting a cash‑flow‑matching approach (GD_10k_2022, p. 81). UPS, by contrast, uses interest‑rate swaps as an economic hedge to offset the overall economic impact of its debt, with swap maturities that are not tied to the debt’s maturity profile (UPS_10k_2022, p. 136). This contrast shows GD prioritizes precise cash‑flow protection, while UPS focuses on broader economic exposure management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: GD's swaps have a dollar-weighted average maturity that matches the duration of the hedged debt, reflecting a cash-flow-matching strategy, while UPS uses swaps as economic hedges without tying maturities to debt profiles. These points align with the original answer’s emphasis on GD’s duration-matching versus UPS’s lack of specified maturity alignment. (2) There are no numeric values (e.g., exact durations, dollar amounts) in either answer, so quantitative accuracy is not compromised—both correctly describe the structural relationship without introducing false figures. (3) The multi-hop reasoning is sound: the model correctly synthesizes contrasting hedging philosophies from two different 10-K filings (GD_10k_2022 and UPS_10k_2022), compares their strategies, and infers differing risk management priorities—precise cash-flow protection for GD versus broader economic exposure management for UPS. This matches the original answer’s conclusion, though it omits the detail about UPS using offsetting positions to terminate swaps and eliminate market valuation effects, which slightly reduces completeness. (4) Despite this minor omission, the semantic meaning and analytical insight are equivalent. The LLM captures the essential contrast in risk management priorities. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 423,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How might Alphabet's share repurchase activity in 2023, which focused on Class A and Class C shares, impact the relative voting power of its undiluted Class B shares, and how does this compare to the non-dilutable 33 1/3% voting power structure of Class B shares at Comcast?",
      "original_answer": "Alphabet's 2023 share repurchase of $62.2 billion in Class A and Class C shares likely increased the relative voting power of its undiluted Class B shares, which are held by insiders and carry 10 votes per share. This mirrors the structure at Comcast, where Class B shares, held entirely by Brian L. Roberts, maintain a non-dilutable 33 1/3% of combined voting power despite having 15 votes per share. Both companies use dual-class structures to protect long-term strategic control, but Alphabet's repurchase activity may have amplified the concentration of voting power further by reducing the number of publicly traded shares.",
      "llm_answer": "Alphabet’s 2023 repurchase of $62.2 billion of Class A and Class C shares reduced the total number of voting shares, thereby increasing the proportion of voting power held by its undiluted Class B shares (10 votes per share) even though their absolute voting rights remain unchanged (GOOGL_10k_2023, pp. 79–81). In contrast, Comcast’s Class B shares are structured to represent a fixed, non‑dilutable 33 ⅓ % of the company’s combined voting power (CMCSA_10k_2023, p. 33).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Alphabet's $62.2 billion share repurchase in 2023 targeted Class A and Class C shares, which have 1 vote per share, while Class B shares carry 10 votes and are undiluted. The reduction in outstanding voting shares increases the relative voting power of Class B shares, a point correctly conveyed. The Comcast comparison accurately notes that its Class B shares hold a fixed 33 1/3% voting power, which is non-dilutable, as stated in the original. (2) Quantitative accuracy is perfect: the $62.2 billion figure is correct, and the 33 1/3% voting stake at Comcast is precisely reported. Format variations (e.g., '33 1/3%' vs '33 ⅓ %') are acceptable and semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across Alphabet and Comcast, linking share repurchases to voting power concentration and contrasting dynamic amplification (Alphabet) with structural fixity (Comcast). (4) The only minor shortcoming is the lack of explicit mention that both companies use dual-class structures to protect insider control, which adds contextual depth in the original. However, this does not detract from the core factual accuracy. The answer is concise, relevant, and fully addresses both parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 375,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How does the structure of Robert Iger's Rule 10b5-1 trading plan at DIS, including the number of shares and termination date, compare to Peggy Alford's plan at META, given both are governed by the same regulatory framework?",
      "original_answer": "Robert Iger's trading plan at DIS involves the potential sale of up to 372,412 shares of Disney common stock, with a termination date of December 17, 2024. Peggy Alford's plan at META provides for the sale of up to $1.2 million worth of META Class A common stock, with a termination date of November 15, 2025. Both plans were adopted under Rule 10b5-1(c), which provides an affirmative defense for insider trading activities conducted under a prearranged plan. The comparison shows that while Iger's plan focuses on a fixed number of shares tied to expiring options, Alford’s plan is value-based and has a longer duration.",
      "llm_answer": "Robert Iger’s Disney plan is a fixed‑share arrangement—up to **372,412 shares** of common stock—scheduled to terminate on **December 17, 2024**. In contrast, Meta’s Peggy Alford plan is a dollar‑value arrangement—up to **$1.2 million** worth of Class A shares—set to expire on **November 15, 2025**. Both plans are Rule 10b5‑1 trading arrangements, but Iger’s is shorter in duration and quantified by shares, whereas Alford’s is longer and quantified by dollar value.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: The numbers—372,412 shares for Robert Iger, $1.2 million for Peggy Alford—and the dates—December 17, 2024, and November 15, 2025—are all accurately reported. Format variations (e.g., $1.2 million vs $1.2M) are acceptable and semantically equivalent. (2) Completeness: The answer addresses all parts of the question—structure (fixed shares vs. dollar value), number of shares/amount, termination dates, and the fact both are Rule 10b5-1 plans. (3) Entity accuracy: Correctly identifies Robert Iger at DIS (Disney) and Peggy Alford at META (Meta), with correct stock class (Class A for META). (4) Reasoning: The multi-hop comparison is sound—correctly contrasts share-based vs. value-based plans, duration differences, and regulatory framework (Rule 10b5-1). The synthesis across two executives, companies, and plan structures is accurate and well-articulated. (5) Semantic equivalence: While slightly more concise, the LLM conveys the same key information as the original answer, including the nature of each plan and their comparative features. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 337,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How does the vesting timeline for equity awards at CL compare with PM's RSU vesting schedule, and what does this imply about the timing of compensation expense recognition for each company?",
      "original_answer": "CL issues stock options that generally vest ratably over three years, with a contractual term of eight years post-2019. In contrast, PM grants RSU awards that typically vest on the third anniversary of the grant date. For CL, this means compensation expense is recognized evenly over the three-year vesting period. For PM, the fair value of RSU awards is amortized to expense over the restriction period, which is typically three years after the award date, or earlier upon death, disability, or reaching age 58. As of December 31, 2023, PM had $160 million of total unrecognized compensation costs related to non-vested RSUs, expected to be recognized over a weighted-average period of approximately seventeen months. This indicates that while both companies align on a three-year vesting horizon, PM's structure allows for more accelerated expense recognition based on specific triggering events.",
      "llm_answer": "CL’s equity awards (stock options, time‑vested restricted‑stock units and performance‑based RSUs) all vest over a typical three‑year service period – options ratably over three years, time‑vested RSUs at the end of a three‑year restriction period, and performance‑based RSUs at the end of a three‑year performance cycle. PMI’s RSUs likewise vest on the third anniversary of the grant date, i.e., a three‑year period. As a result, both companies amortize the fair value of these awards over the vesting period, recognizing compensation expense ratably—CL over weighted‑average periods of roughly 1.4–1.6 years for unvested awards, and PMI over a weighted‑average period of about 17 months for unvested RSUs.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that both CL and PM have a three-year vesting horizon for equity awards and that compensation expense is amortized over this period. It accurately notes PM's weighted-average unrecognized expense period of 17 months (matching the ground truth of 'approximately seventeen months'). However, it incorrectly states that CL recognizes expense over a weighted-average period of 1.4–1.6 years for unvested awards, which is not mentioned in the original answer and introduces unsupported data. The original answer states CL recognizes expense evenly over the three-year vesting period, with no such weighted-average figure provided. (2) Quantitatively, the $160 million unrecognized cost and 17-month weighted-average period for PM are correctly cited (implied from 'approximately seventeen months'). The 1.4–1.6 year range for CL is fabricated and incorrect. (3) The multi-hop reasoning is mostly sound—comparing vesting schedules and linking them to expense recognition—but fails to mention PM's accelerated vesting upon death, disability, or reaching age 58, a key differentiator in expense timing. This omission reduces completeness and qualitative accuracy. (4) The answer is contextually relevant and captures the core comparison, but the introduction of incorrect CL metrics and missing acceleration clauses in PM's plan prevent a higher score. Semantic equivalence is mostly preserved except for the erroneous CL expense period.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 407,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How do regulatory restrictions on product differentiation, such as flavor bans and standardized packaging, impact the ability of both PM and MO to maintain brand equity and pricing power in key international and U.S. markets?",
      "original_answer": "Regulatory restrictions on product differentiation, such as flavor bans and standardized packaging, significantly impair both PM and MO's ability to maintain brand equity and pricing power. PM faces specific risks from the EU's ban on characterizing flavors in cigarettes and roll-your-own tobacco, menthol bans in Turkey and Brazil, and potential future restrictions on slim cigarettes and flavor capsules. These limitations reduce PM’s ability to differentiate products, especially in international markets where they estimate illicit trade accounts for 8% of EU cigarette consumption, further eroding legitimate brand value and pricing control. Similarly, MO faces flavor bans in six U.S. states and the District of Columbia, including California’s broad restriction on menthol, mint, and wintergreen, which is currently delayed due to a referendum. These bans, along with proposed nicotine caps in Massachusetts, constrain MO’s ability to market differentiated products and maintain premium pricing. Both companies are also restricted in advertising and branding through global FCTC guidelines and domestic regulations like the State Settlement Agreements, which prohibit youth-targeted marketing and outdoor advertising, further limiting brand equity development and pricing flexibility.",
      "llm_answer": "Regulatory limits on product differentiation – such as EU and U.S. menthol/characterizing‑flavor bans and plain or standardized packaging – strip PM and MO of the branding, flavor, and packaging cues that underpin premium pricing and brand equity (see PM risk factors pp. 14‑18, 40‑44 and MO’s discussion of regulatory constraints pp. 38‑42).  These rules force the companies to compete on price and limited product attributes, eroding pricing power, encouraging down‑trading and illicit trade in key markets, and compelling a shift toward reduced‑risk products and new marketing strategies to preserve profitability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically aligned with the ground truth, though slightly less detailed in specific examples. (1) All factual claims are correct: flavor bans and standardized packaging do impair brand equity and pricing power for both PM and MO, and the answer correctly identifies key regulatory environments (EU, U.S.) and their impacts. (2) There are no numeric inaccuracies—while the LLM does not include the 8% illicit trade figure from the EU mentioned in the original, it does not contradict it or introduce incorrect numbers, so quantitative accuracy remains high. (3) The multi-hop reasoning is sound: the model correctly synthesizes how regulatory constraints limit branding and product differentiation, leading to reduced pricing power and increased illicit trade, and connects this to strategic shifts toward reduced-risk products. However, it omits specific country-level examples (e.g., menthol bans in Turkey, Brazil, California, Massachusetts nicotine cap proposals) and references to FCTC and State Settlement Agreements, which weakens completeness. (4) Despite these omissions, the core logic and context are preserved, and the answer directly addresses the question’s focus on brand equity and pricing power. The reference to PM and MO risk factor pages suggests grounding in source material. Thus, while the answer is concise and correct in substance, it lacks some granular detail from the original, justifying a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 408,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How does AIG's exposure to structured securities containing RMBS, as measured by their accounting treatment for credit losses and yield adjustments, compare to BAC's valuation risks associated with RMBS holdings under fluctuating prepayment speeds and default rates?",
      "original_answer": "AIG accounts for structured securities, including RMBS, by recalculating effective yields based on actual payments and updated prepayment expectations, adjusting amortized cost accordingly with a corresponding impact on net investment income. For non-high credit quality structured securities, AIG bases yields on expected cash flows that factor in credit losses and prepayments, and recognizes changes in expected cash flows through an allowance for credit losses. Meanwhile, BAC notes that a significant increase in default rates or loss severities would materially lower the fair value of RMBS long positions, while changes in prepayment speeds would have differential impacts depending on instrument seniority. This shows that while AIG focuses on yield and credit loss adjustments tied to expected cash flows, BAC emphasizes sensitivity to default and prepayment volatility in RMBS valuation.",
      "llm_answer": "AIG’s RMBS exposure is quantified by a $35 million allowance for credit losses and by prospectively adjusting yields when expected cash‑flow changes cannot be captured by that allowance, providing a systematic credit‑loss provision and yield‑adjustment framework. In contrast, Bank of America’s RMBS holdings carry valuation risk that is driven directly by market‑driven fluctuations in prepayment speeds and default rates, which can materially alter fair values. Thus, AIG’s accounting approach explicitly provisions for credit losses and adjusts yields, whereas BAC’s risk is more exposed to the volatility of prepayment and default dynamics that affect fair value.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces a specific dollar amount—$35 million allowance for credit losses—that is not present in the original answer (ground truth). The ground truth does not provide any quantitative figure for AIG’s allowance, only describing the accounting methodology. This is a significant factual inaccuracy, as there is no support for this number in the provided truth. All other qualitative descriptions are generally aligned with the ground truth. (2) The $35 million figure cannot be verified and appears fabricated or hallucinated, failing the quantitative accuracy check. No other numbers are present in either answer, so this is the sole quantitative point of comparison and it is incorrect. (3) The multi-hop reasoning is partially sound: the model correctly identifies that AIG adjusts yields based on expected cash flows and maintains an allowance for credit losses on lower-quality securities, and contrasts this with BAC’s exposure to fair value volatility from prepayment and default rate changes. This reflects a correct synthesis of the different risk emphases—AIG on accounting adjustments, BAC on market valuation sensitivity. However, the inclusion of the unsupported $35M figure undermines confidence in the reasoning process, suggesting potential data contamination or hallucination. (4) The correctness score is 6 due to the core conceptual comparison being accurate, but the introduction of a false quantitative claim significantly reduces factual reliability. Quantitative accuracy is low (4) due to the incorrect dollar amount. Qualitative accuracy is 7 because the conceptual framework and contrast are well-reasoned and semantically aligned with the original. Contextual relevance is high (9) as the response directly addresses the comparison asked, with only a minor deviation due to the erroneous number.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 502,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Broadcom's valuation methodology for its developed technology in cybersecurity, which includes cloud security solutions, compare to Cisco's revenue recognition approach for its Cloud Security product category?",
      "original_answer": "Broadcom valued its developed technology in cybersecurity, including cloud security solutions, using the multiperiod excess earnings method under the income approach, which considers the present value of projected cash flows less charges for contributions from other assets. The economic useful life was determined based on the technology cycle and forecast cash flows. In contrast, Cisco recognizes revenue for its Cloud Security product ratably over the contract term as a single distinct performance obligation satisfied over time, particularly for SaaS arrangements. This highlights a difference in financial treatment—Broadcom focused on asset valuation through projected earnings, while Cisco emphasizes revenue recognition aligned with service delivery timelines.",
      "llm_answer": "Broadcom values its developed cybersecurity technology—including cloud‑security solutions—using a multiperiod excess‑earnings method under the income approach, estimating the present value of projected cash flows less contributions from other assets (AVGO 10‑K, pp. 98‑99). Cisco, by contrast, applies ASC 606 to its Cloud Security product category, recognizing revenue when control of the product or service is transferred and, for SaaS‑type arrangements, ratably over the contract term (CSCO 10‑K, pp. 73‑77). Thus, Broadcom’s method is an intangible‑asset valuation for balance‑sheet reporting, whereas Cisco’s is a revenue‑recognition policy for operating performance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Broadcom uses the multiperiod excess earnings method under the income approach to value its developed cybersecurity technology, including cloud security, based on present value of projected cash flows less contributions from other assets. Cisco recognizes revenue for its Cloud Security product category ratably over the contract term under ASC 606, particularly for SaaS arrangements. (2) There are no numeric values requiring calculation in this question, but the references to accounting methods and reporting standards (ASC 606) are correctly cited with appropriate context. (3) The multi-hop reasoning is sound—correctly synthesizing Broadcom’s asset valuation methodology (from its 10-K, pp. 98–99) with Cisco’s revenue recognition policy (from its 10-K, pp. 73–77), two distinct financial treatments across different companies and reporting frameworks. (4) The answer clearly distinguishes between Broadcom’s balance-sheet-focused intangible asset valuation and Cisco’s income-statement-oriented revenue recognition, capturing the core contrast in financial treatment as required by the question. Minor enhancements like citation of specific accounting standards (ASC 606) and document page numbers improve precision without deviating from the original meaning. All entities (Broadcom/AVGO, Cisco/CSCO, cybersecurity technology, cloud security, SaaS) are accurately identified and correctly contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 422,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does the voting power disparity between Class A and Class B common stock at META compare to GOOGL's dual-class structure, particularly in relation to the number of shares outstanding and the potential influence of high-vote shares on corporate governance decisions?",
      "original_answer": "At META, Class A common stock has 2,189,898,148 shares outstanding with one vote per share, while Class B common stock has 343,761,117 shares outstanding, each with voting rights only in specified circumstances and tied to the conversion rate. This creates a concentrated voting structure where Class B shares can exert significant influence during specific corporate events. Similarly, GOOGL's Class B common stock has 10 votes per share, giving disproportionate voting power to holders of this class, although the rights of Class A and Class B are otherwise identical. Both companies use dual-class structures to maintain control with certain stakeholders, but META's Class B shares only gain enhanced voting rights under defined conditions, whereas GOOGL's Class B shares have consistently higher voting power. This difference affects how corporate governance decisions are influenced at each company.",
      "llm_answer": "At Meta, Class B shares carry ten votes each, so the 343.8 million Class B shares generate roughly 3.44 billion votes versus 2.19 billion votes for the 2.19 billion Class A shares—high‑vote shares hold about 60 % of the voting power while representing only ~15 % of the shares (META 10‑K, p. 1‑5). Alphabet’s dual‑class structure gives Class C shares no votes; with roughly 1.5 billion Class A and 1.5 billion Class C shares outstanding (GOOGL 10‑K, p. 80‑84), voting power is concentrated entirely in the 50 % of shares that are Class A, so the share‑to‑vote disparity is less extreme than Meta’s.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) It incorrectly states that Meta's Class B shares have ten votes each, which is false: according to the ground truth, Meta's Class B shares only have enhanced voting rights under specified circumstances and are tied to conversion rates, not a fixed 10-vote structure. This leads to an incorrect calculation of voting power (3.44 billion votes for Class B), which is not supported by the original data. (2) The claim that Class B shares represent ~15% of total shares is roughly accurate (343.8M out of ~2.53B total shares), but the derived 60% voting power is invalid due to the false vote-per-share assumption. (3) Regarding GOOGL, the LLM incorrectly refers to Class C shares having no votes and compares Class A and Class C, while the ground truth discusses Class B shares having 10 votes per share. Alphabet’s actual dual-class structure includes Class B shares (not mentioned in LLM answer) held by insiders with 10 votes each; Class A (GOOGL) have one vote, and Class C (GOOG) have none. The LLM misidentifies the high-vote class and fails to mention Class B entirely, leading to a flawed comparison. (4) The conclusion that GOOGL's disparity is 'less extreme' than Meta’s is unsupported because the LLM misunderstands both structures. The original answer correctly highlights that GOOGL’s high-vote shares have consistent 10x voting power, while Meta’s Class B only gain influence in specific circumstances—this key governance distinction is missing in the LLM response. (5) Despite these errors, the answer attempts relevant multi-hop reasoning by comparing share counts, voting power concentration, and governance implications, showing contextual awareness. However, due to fundamental errors in entity identification (wrong share classes), vote allocation, and calculations, the overall correctness is low. Minor formatting variations (e.g., 343.8 million vs 343,761,117) are acceptable, but core facts about voting rights are not.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 542,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Coca-Cola FEMSA's bottling operations in Argentina impact both KO's net sales to equity method investees and CL's organic sales growth in Latin America, considering KO's contractual pricing model with its bottlers?",
      "original_answer": "Coca-Cola FEMSA's operations in Argentina contribute to KO's $14,471 million in net sales to equity method investees in 2021 through the incidence-based concentrate pricing model, where bottler pricing and package mix directly affect the concentrate prices charged by KO. As Coca-Cola FEMSA bottles in Argentina (federal capital of Buenos Aires and surrounding areas), this relationship supports KO's financial dependency on equity method investees. Meanwhile, CL reported a 7.0% net sales increase in Latin America in 2021, with Argentina being one of the key growth drivers. Specifically, CL's Oral Care, Personal Care, and Home Care segments in Argentina benefited from favorable market conditions that also likely supported Coca-Cola FEMSA's operations, creating parallel growth effects across both companies' financial performance in the region.",
      "llm_answer": "Coca‑Cola FEMSA’s bottling operations in Argentina generate sales that are recorded as part of KO’s net sales to equity‑method investees, because Coca‑Cola FEMSA is an equity‑method investee and its Argentina operations contribute to those sales (page 6, page 87). KO’s incidence‑based concentrate pricing model sets the price of concentrates sold to the bottler, which influences the revenue generated in Argentina and therefore the net sales to equity‑method investees (page 8). For CL, the growth in Argentina is reflected in its Latin America segment’s organic sales growth, which rose 8.0% in 2021, driven in part by volume and price gains in that market (page 38).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the relationship between Coca-Cola FEMSA's operations in Argentina and KO's net sales to equity method investees, as well as the role of KO's incidence-based pricing model. It also correctly links CL's Latin America organic sales growth to Argentina. However, there is a critical error in the quantitative claim: the LLM states CL's Latin America organic sales growth was 8.0% in 2021, while the ground truth reports 7.0%. This discrepancy affects the factual accuracy of a core metric. Additionally, the LLM omits KO's specific net sales figure of $14,471 million to equity method investees in 2021, which is a key data point in the original answer. (2) The 8.0% vs 7.0% error is significant and unexplained; no calculation is involved, but the number is directly contradicted by the ground truth. The absence of the $14,471 million figure further reduces quantitative accuracy. (3) The multi-hop reasoning is partially sound: the model correctly connects Coca-Cola FEMSA (bottler) → KO (concentrate sales) and Argentina → CL's regional growth. However, it fails to fully synthesize how favorable market conditions in Argentina benefited both CL's consumer segments and Coca-Cola FEMSA’s operations in parallel, which is a nuanced but important part of the original answer. (4) Despite missing key numbers and having one incorrect percentage, the LLM captures the general causal链条 and entity relationships, showing strong qualitative understanding and contextual relevance. The answer is on-topic and logically structured, but the numerical inaccuracies prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 446,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Abbott's investment in private equity funds, which are valued using NAV as a practical expedient, compare to Merck's use of NAV for measuring similar alternative investments, considering the typical redemption restrictions associated with these fund types?",
      "original_answer": "Abbott holds investments in private equity funds valued at NAV, with $555 million in unfunded commitments as of December 31, 2023, and these funds cannot be redeemed but will make distributions through liquidation over periods ranging from 2024 to 2033. These private equity funds are subject to NAV valuation practices consistent with those described in UPS's 10-K, where private equity funds typically have redemption restrictions until the end of the partnership term (10–15 years) and are valued at NAV adjusted for known cash flows. Merck similarly discloses NAV-based valuations for alternative investments, reporting $382 million in NAV-based assets in 2023, including private real estate and equity funds. Both companies rely on NAV as a practical expedient for illiquid alternative investments, but Abbott faces longer liquidation timelines and greater unfunded commitments compared to Merck's disclosed NAV-based portfolio.",
      "llm_answer": "Abbott’s private‑equity holdings are valued at NAV as a practical expedient and are non‑redeemable; the company can receive distributions only through liquidation over a 2024‑2033 period (Abbott, pp. 69‑73).  Merck likewise values its alternative investments at NAV, and those funds also have limited liquidity—typically requiring a lock‑up or long liquidation period—so both firms face comparable redemption restrictions for these illiquid assets.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both Abbott and Merck use NAV as a practical expedient for valuing private equity and alternative investments, and that these investments are non-redeemable with distributions occurring through liquidation. It accurately notes Abbott's 2024–2033 liquidation period and references redemption restrictions consistent with illiquid fund structures. However, it omits key quantitative details from the ground truth: Abbott’s $555 million in unfunded commitments and Merck’s $382 million in NAV-based assets as of 2023. These figures are central to the comparative aspect of the question and their absence significantly reduces quantitative completeness. (2) While the time range (2024–2033) is correctly stated for Abbott, no dollar amounts are mentioned, making the comparison between Abbott and Merck incomplete. The LLM does not quantify or contrast the scale of unfunded commitments or NAV-based holdings, which is a core part of the original answer. (3) The multi-hop reasoning is partially sound—linking Abbott’s and Merck’s use of NAV and recognizing the shared illiquidity characteristics—but fails to synthesize the comparative dimension (Abbott having greater unfunded commitments and longer liquidation timelines). The reference to 'comparable redemption restrictions' is reasonable but oversimplifies the original point that Abbott faces *longer* liquidation timelines. (4) The contextual relevance is high because the answer addresses valuation method, liquidity constraints, and timeframes. Qualitative accuracy is strong in terminology and conceptual understanding, but quantitative accuracy is reduced due to missing financial figures essential to the comparison. Hence, correctness is scored at 7—core facts are right, but significant data omissions limit completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 498,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does BlackRock's management of Separate Account Assets, which are legally segregated and not subject to general creditor claims, impact AIG's reporting of equal and offsetting Separate Account Liabilities tied directly to contract holder account balances?",
      "original_answer": "BlackRock discloses that its Separate Account Assets, which include equity securities, debt securities, money market funds, and derivatives, are legally segregated and not subject to general claims of creditors. These assets are held to fund individual and group pension contracts and are offset by equal and offsetting liabilities on BlackRock’s consolidated statements of financial condition. AIG reports Separate Account Liabilities that directly reflect the contract holder's account balance in these assets, and they are required to be equal and offsetting to the total Separate Account Assets. Therefore, any changes in the valuation or composition of BlackRock's Separate Account Assets would directly influence AIG’s liability reporting, as AIG must mirror these asset values in its liabilities to reflect the contract holders' beneficial interest.",
      "llm_answer": "BlackRock’s separate‑account assets are held in a wholly‑owned life‑insurance subsidiary and are legally segregated, so they are not exposed to BlackRock’s general creditors (BlackRock 10‑K, pp. 78‑82). Because the assets and the corresponding liabilities are matched and recorded as separate‑account assets and liabilities, AIG reports its separate‑account liabilities as equal and offsetting to the contract‑holder account balances, reflecting that the assets and liabilities are protected from other claims and are not impacted by BlackRock’s general creditor exposure (AIG 10‑K, pp. 230‑235).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies the key relationship between BlackRock's separate account assets and AIG's reporting of offsetting liabilities. It correctly states that BlackRock’s separate account assets are legally segregated and not subject to general creditor claims, and that AIG reports equal and offsetting liabilities tied to contract holder balances. There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is not applicable in a numerical sense—however, the absence of incorrect numbers supports a score of 10. The answer is contextually relevant and addresses the structural and accounting relationship appropriately. However, it misses a critical element of the original answer: the direct impact of changes in valuation or composition of BlackRock’s assets on AIG’s liability reporting. The original answer emphasizes that AIG must *mirror* changes in asset values, making the liability dynamic and directly tied to asset performance—this causal, ongoing linkage is underemphasized in the LLM response. Additionally, the LLM introduces a detail not in the ground truth—that BlackRock’s separate account assets are held in a 'wholly-owned life-insurance subsidiary'—which may be accurate but is not part of the verified knowledge graph and distracts from the broader asset categories (equity, debt, derivatives, etc.) mentioned in the original. While the reasoning is generally sound, it lacks full multi-hop synthesis: it does not explicitly connect how changes in BlackRock’s asset valuation propagate to AIG’s financial statements. Thus, while the qualitative reasoning is mostly correct, it is incomplete, warranting a 7. Contextual relevance remains high as the answer stays focused on the accounting and legal structure central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 500,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How does AbbVie's revenue recognition for Imbruvica sales in the U.S. reflect its cost-sharing arrangement with Janssen Biotech, and how does this compare to Johnson & Johnson's global commercialization strategy for the same drug?",
      "original_answer": "AbbVie recognizes 100% of Imbruvica sales in the U.S. as net revenue, while Janssen's share of profits is deducted as part of cost of products sold, indicating a co-exclusive commercialization model where AbbVie acts as the principal. Both companies share pre-tax profits and losses equally, with Janssen covering approximately 60% of development costs and AbbVie 40%. Meanwhile, Johnson & Johnson, through its subsidiary Janssen, holds exclusive rights to commercialize Imbruvica outside the U.S. and also shares pre-tax profits equally with AbbVie. This global division of commercial rights and cost-sharing creates a dual-market strategy where Janssen leverages its international infrastructure to drive global expansion of Imbruvica, while AbbVie leads in the domestic market.",
      "llm_answer": "AbbVie records U.S. Imbruvica sales in its net‑revenues, but the cost of goods sold includes Janssen’s 60 % share of collaboration profits, reflecting the 60/40 cost‑sharing arrangement (AbbVie 10‑K, pp. 66‑70). In contrast, Johnson & Johnson’s 10‑K (pp. 6‑10) shows that Imbruvica is sold outside the U.S. under the same collaboration, with AbbVie responsible for U.S. sales and J&J responsible for international commercialization, and the two companies share profits equally on global sales.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core structure of the cost-sharing and commercialization arrangement between AbbVie and Janssen/Johnson & Johnson but contains a critical error in the quantitative description of the profit and cost-sharing mechanics. It states that 'cost of goods sold includes Janssen’s 60% share of collaboration profits' and refers to a '60/40 cost-sharing arrangement', which misrepresents the ground truth. The original answer clarifies that Janssen covers ~60% of development costs and AbbVie 40%, not that profits are split 60/40. Profits and losses are shared equally (50/50), a key distinction the LLM misses. This is a significant quantitative inaccuracy. (2) The LLM incorrectly implies the 60/40 split applies to profits or revenue recognition, when it applies only to development cost contributions. The equal pre-tax profit/loss sharing is mentioned in the ground truth but misrepresented in the LLM answer. (3) The reasoning is partially sound: the LLM correctly identifies AbbVie as recording U.S. sales and J&J (via Janssen) handling international commercialization, and correctly notes equal profit sharing globally. It synthesizes information across both companies' 10-Ks, showing multi-hop capability. However, the conflation of cost contributions with profit splits undermines the accuracy. (4) Despite the numerical error, the answer addresses both parts of the question—U.S. revenue recognition and global commercialization strategy—and uses correct entities (AbbVie, Janssen, Johnson & Johnson) and appropriate context. Wording is concise and largely aligned with the original, but the misstatement of the 60/40 split as applying to profits (rather than development costs) reduces correctness. Hence, a score of 7 is justified: core facts are present, but a major quantitative inaccuracy prevents a higher rating.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 504,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact both NVIDIA's supply chain execution and Apple's manufacturing operations, considering NVIDIA's dependency on foundry partners in Taiwan and Apple's reliance on manufacturing in the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan could severely disrupt NVIDIA's supply chain execution due to its dependency on foundry partners in the region, particularly for advanced GPU manufacturing. This could lead to production delays, inventory shortages, and an inability to meet customer demand, which NVIDIA has previously warned could damage customer relationships and reduce revenue. Similarly, Apple relies heavily on manufacturing operations in Taiwan, as part of its broader supply chain concentrated in the region. A disruption in Taiwan would likely delay product manufacturing and delivery, increase costs, and potentially force Apple to restructure its supply chain, which it has noted could be expensive and time-consuming. Both companies would face significant operational and financial risks due to their shared exposure to Taiwan's geopolitical stability.",
      "llm_answer": "NVDA’s risk factor (page 18) warns that a prolonged conflict in Taiwan could “severely limit or prevent us from receiving chipset supply from Taiwan,” leading to shortages, longer lead times and higher costs. Apple’s risk factor (page 8) notes that its manufacturing and supply chain are heavily concentrated in China, Taiwan and Vietnam, so a similar conflict could disrupt production, delay product launches and raise manufacturing costs, potentially impacting product availability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with high quantitative and contextual accuracy. (1) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not compromised. (2) The LLM correctly identifies both NVIDIA (NVDA) and Apple, their respective risk factors, and the relevant pages (18 and 8), demonstrating strong entity accuracy. It accurately reflects NVIDIA’s dependency on chipset supply from Taiwan and Apple’s concentration in manufacturing across China, Taiwan, and Vietnam. (3) The multi-hop reasoning is sound: it synthesizes information from both companies’ risk disclosures to address the shared exposure to Taiwan’s geopolitical stability. The LLM captures the core risks—supply chain disruption, production delays, increased costs, and product availability issues—consistent with the original answer. (4) Minor deduction in qualitative accuracy (9/10) because the LLM does not explicitly mention broader consequences highlighted in the ground truth, such as damage to customer relationships, revenue reduction for NVIDIA, or the expense and difficulty of supply chain restructuring for Apple. However, these are implied in 'higher costs' and 'disrupt production.' Wording differences are acceptable under semantic equivalence. Contextual relevance is perfect as all content directly addresses the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 398,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How does the use of pricing models for Level 2 fixed income investments by LMT compare to HON's use of pricing models for corporate bonds and government securities in terms of observable market data inputs and risk adjustments?",
      "original_answer": "LMT values its Level 2 fixed income investments using pricing models that rely on verifiable observable market data such as interest rates, yield curves, and credit spreads, or through bids from brokers and quoted prices of similar securities. In contrast, HON uses pricing models for corporate bonds, mortgage/asset-backed securities, and government securities that also incorporate observable inputs but may include unobservable adjustments for risks like credit and liquidity. This indicates that while both companies use pricing models involving market data, HON's valuations may involve more subjective risk-based adjustments not always present in LMT's Level 2 valuations.",
      "llm_answer": "LMT’s Level 2 fixed‑income valuations are built on pricing models that use verifiable observable market data – such as interest‑rate and yield‑curve levels, credit‑spreads, broker/dealer bids and quoted prices of comparable securities. HON’s corporate‑bond and government‑security models also rely on observable inputs (broker/dealer bids and quoted prices of similar securities), but the models explicitly incorporate adjustments for credit and liquidity risk that may not be directly observable. In short, both use observable market data, but HON’s approach adds explicit risk‑adjustments beyond the observable inputs used by LMT.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) All factual elements are correct: LMT uses observable market data such as interest rates, yield curves, credit spreads, broker bids, and prices of comparable securities for Level 2 fixed income investments. HON also uses observable inputs but adds unobservable risk adjustments for credit and liquidity in its pricing models for corporate bonds and government securities. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense—however, the absence of any incorrect figures supports a score of 10. (3) The multi-hop reasoning is sound: the model correctly identifies and contrasts the valuation approaches of two companies (LMT and HON) across different but related asset classes, synthesizing information about input observability and risk adjustments. (4) The only minor shortcoming is that the LLM omits HON’s use of mortgage/asset-backed securities mentioned in the original answer, slightly reducing completeness. However, this does not detract from the central comparison about observable inputs and risk adjustments. Overall, the answer is semantically equivalent, well-structured, and contextually precise, warranting a high correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 373,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did the unfavorable foreign currency exchange rate impact from a stronger U.S. dollar affect Coca-Cola's (KO) Europe, Middle East and Africa segment in 2024, and how does this compare to the exposure risk described by Mondelez (MDLZ) under similar macroeconomic conditions?",
      "original_answer": "Coca-Cola (KO) reported that fluctuations in foreign currency exchange rates unfavorably impacted consolidated operating income by 11% in 2024, with a stronger U.S. dollar affecting several segments including Europe, Middle East and Africa. While the euro and British pound provided some offsetting benefit, the segment was still significantly affected by the stronger dollar. Mondelez (MDLZ) similarly noted that a stronger U.S. dollar relative to other functional currencies adversely affects its consolidated earnings and net assets, as the company translates non-U.S. dollar financials into U.S. dollars for reporting. Although KO quantified the impact (11% unfavorable), MDLZ emphasized the inherent unpredictability and volatility introduced by such currency movements, despite active hedging strategies.",
      "llm_answer": "In 2024, a stronger U.S. dollar caused a 15 % adverse impact on operating income for Coca‑Cola’s Europe, Middle East & Africa segment, a hit that was partially offset by favorable pricing initiatives.  Mondelez, by contrast, describes its foreign‑currency exposure as primarily arising from translating non‑U.S. subsidiaries’ financial statements into U.S. dollars, noting that macroeconomic factors such as inflation and currency swings can affect its consolidated results and that hedging mitigates but does not eliminate this risk.  Thus, while KO’s segment faced a specific 15 % operating‑income hit, MDLZ highlights a broader, translation‑based risk that is influenced by similar macroeconomic conditions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the quantitative impact on Coca-Cola's Europe, Middle East and Africa segment. The ground truth states that foreign exchange rates unfavorably impacted *consolidated operating income* by 11% in 2024, with the EMEA segment being affected among others, but does not specify a 15% adverse impact *on the EMEA segment specifically*. The LLM incorrectly attributes a 15% hit directly to the EMEA segment, which is not supported by the original answer. This misrepresentation of the magnitude and scope of the impact undermines factual accuracy. (2) The number '15%' is incorrect and contradicts the ground truth '11%' for consolidated impact; no source in the original answer supports 15% or assigns a specific percentage to the EMEA segment alone. The date (2024) and company tickers (KO, MDLZ) are correct. (3) The qualitative reasoning is partially sound: the LLM correctly identifies that a stronger U.S. dollar negatively affects both companies due to translation of non-U.S. dollar financials, and notes that Mondelez emphasizes unpredictability and hedging limitations. It also correctly contrasts KO’s quantification of impact with MDLZ’s more general risk description. However, it fails to mention that KO noted some offsetting benefit from the euro and British pound, and incorrectly isolates the EMEA segment impact. (4) Contextual relevance is high—the response addresses both parts of the multi-hop question (KO’s impact and MDLZ’s exposure) and draws a relevant comparison. However, due to the major quantitative inaccuracy and incomplete synthesis (missing offsetting factors), the overall correctness score is reduced to 4, with low quantitative accuracy (3), moderate qualitative accuracy (6), and high contextual relevance (8).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 491,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How does the $365 million in long-lived assets that AVGO reported in Taiwan for fiscal 2024 compare to the risk QCOM highlighted regarding its reliance on foundry partners in Taiwan for chipset supply, particularly in the context of geopolitical tensions involving China and Taiwan?",
      "original_answer": "AVGO reported $365 million in long-lived assets in Taiwan for fiscal 2024, indicating a significant operational presence in the region. Meanwhile, QCOM explicitly stated that its business depends on receiving consistent and reliable chipset supply from foundry partners in Taiwan, and a significant or prolonged geopolitical conflict involving China and Taiwan could severely limit or prevent this supply, materially impacting QCOM’s business. This highlights that both companies have substantial exposure to Taiwan, but while AVGO’s exposure is reflected in its asset base, QCOM’s risk is operational and supply chain-dependent, making them vulnerable to the same regional geopolitical tensions in different ways.",
      "llm_answer": "AVGO’s FY‑2024 balance sheet lists $365 million of long‑lived assets in Taiwan, a modest share of its $2.5 billion total long‑lived assets (AVGO, 10‑K, p. 91).  By contrast, Qualcomm’s 2023 10‑K warns that its heavy reliance on Taiwan‑based foundry partners for chipset supply exposes it to a material risk if geopolitical tensions with China disrupt that supply chain, potentially causing a significant adverse impact on its business (QCOM, 10‑K, pp. 33‑37).  Thus, while AVGO’s Taiwan footprint is a tangible but relatively small asset base, Qualcomm faces a larger supply‑chain vulnerability tied to the same geopolitical environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AVGO's $365 million in long-lived assets in Taiwan for fiscal 2024 and QCOM's supply chain risk related to Taiwan-based foundries. All numeric values are accurate: $365 million and $2.5 billion totals are consistent with the context (minor formatting: $365 million vs $365 million is acceptable). The fiscal year (2024 for AVGO, 2023 for QCOM) is correctly attributed, noting that QCOM’s 10-K referenced is for 2023, which aligns with the timing of disclosures relative to AVGO’s 2024 report. (2) Quantitative accuracy is perfect—no calculations were required beyond relative size assessment ('modest share'), which is reasonably supported. The $2.5 billion total long-lived assets figure is not in the ground truth but is plausible and does not contradict it; its inclusion adds context without introducing error. (3) The multi-hop reasoning is sound: the model correctly synthesizes AVGO’s asset exposure (balance sheet risk) with QCOM’s operational/supply chain risk, contrasting the nature of their Taiwan exposure in the context of geopolitical tensions involving China and Taiwan. The conclusion that AVGO has a tangible but smaller asset footprint while QCOM faces larger supply-chain vulnerability is logically derived and semantically equivalent to the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly state that both companies are exposed to the same regional geopolitical risk 'in different ways'—a nuance present in the original—but this is implied in the contrast drawn. Thus, qualitative accuracy is slightly reduced but not significantly. Contextual relevance is perfect: all information directly addresses the comparative risk question. Overall, the answer is factually correct, well-reasoned, and complete with only slight omission of phrasing around shared regional risk.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 507,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How does Apple's reliance on manufacturing operations in Taiwan for a majority of its product assembly impact its exposure to regional geopolitical risks compared to Microsoft's business operations in Greater China through its regional center in Singapore?",
      "original_answer": "Apple's reliance on manufacturing in Taiwan for a significant portion of its product assembly increases its exposure to regional geopolitical risks, particularly given that Taiwan is included in Apple's Greater China segment, which is subject to trade policies and disputes that could result in tariffs, sanctions, and other business restrictions. Microsoft operates in Greater China through its regional operations center in Singapore, which supports logistics and vendor management across the region. However, unlike Apple, Microsoft's operations are not heavily dependent on localized manufacturing, reducing its exposure to supply chain disruptions tied to geopolitical tensions. Apple's outsourced manufacturing in Asia, including Taiwan, makes it more vulnerable to interruptions from tariffs, export controls, and public health crises, while Microsoft's regional center in Singapore primarily supports administrative and logistics functions, which can be more easily adapted or relocated if necessary.",
      "llm_answer": "Apple’s supply chain is heavily concentrated in Taiwan, where most of its product assembly occurs (see Apple’s risk‑factor discussion on pages 7‑11 and 38‑42).  This concentration increases its exposure to U.S.–China tensions, trade restrictions and the possibility of conflict involving Taiwan, which can disrupt manufacturing and supply‑chain operations.  By contrast, Microsoft’s Greater China activities are supported through a regional center in Singapore (pages 14‑18), dispersing its presence across multiple jurisdictions and reducing reliance on a single manufacturing hub, thereby mitigating direct exposure to Taiwan‑specific geopolitical events while still facing broader regulatory and political risks in China.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Apple's reliance on Taiwan for product assembly increases its exposure to geopolitical risks, particularly within the context of U.S.-China tensions and Taiwan's inclusion in the Greater China segment. Microsoft’s operations in Greater China are managed through a regional center in Singapore, which supports logistics and vendor management without heavy dependence on localized manufacturing. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across Apple’s supply chain risk and Microsoft’s operational structure, contrasting their exposure levels based on manufacturing dependency vs. administrative/logistical support functions. (4) The LLM omits a minor detail—Microsoft’s center supports 'administrative and logistics functions' that are 'more easily adapted or relocated'—but captures the core idea of reduced vulnerability due to lack of manufacturing concentration. Wording differs slightly (e.g., 'dispersing its presence across multiple jurisdictions') but conveys the same qualitative risk distinction. No entity errors; both companies, regions, and operational models are correctly identified. The answer fully addresses the comparative geopolitical risk exposure as required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 411,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did Nebraska's 2023 corporate tax rate reduction impact Union Pacific's deferred tax expense in relation to Boeing's exposure to federal appropriations delays as disclosed in their respective 10-K filings?",
      "original_answer": "Nebraska's 2023 corporate tax rate reduction contributed to a $114 million reduction in Union Pacific's deferred tax expense, as disclosed in their 2024 10-K filing. In contrast, Boeing highlighted in its 2024 10-K that delays in U.S. government appropriations, such as continuing resolutions or government shutdowns, could disrupt operations, delay new programs, and negatively impact revenue. While Union Pacific benefited from state-level tax legislation, Boeing faces regulatory and funding risks tied to federal legislation, which could impair its ability to execute contracts or deliver commercial airplanes.",
      "llm_answer": "Nebraska’s 2023 corporate‑tax‑rate cut lowered Union Pacific’s deferred‑tax expense by $114 million, a benefit noted in its 10‑K.  Boeing’s 10‑K, by contrast, warns that delays in U.S. federal appropriations could hurt its business, highlighting a cash‑flow and revenue risk rather than a tax‑expense reduction.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core information from the ground truth. (1) Quantitatively, the $114 million reduction in Union Pacific's deferred tax expense due to Nebraska's 2023 tax rate cut is correctly stated, matching the original answer. The fiscal year context (2024 10-K referencing 2023 events) is implied correctly. (2) The contrast with Boeing is appropriately framed: while Union Pacific experienced a tax benefit, Boeing faces operational and revenue risks from federal appropriations delays, as disclosed in its 10-K. The LLM correctly identifies this as a cash-flow and revenue risk rather than a tax-related impact. (3) Multi-hop reasoning is sound—information from two separate 10-K filings (Union Pacific and Boeing) is correctly synthesized to contrast state-level tax benefits versus federal funding risks. (4) Minor qualitative difference: the original answer provides more detail on Boeing’s specific risks (e.g., disruptions to operations, delays in new programs, impact on commercial airplane delivery), which the LLM summarizes more succinctly as 'hurt its business' and 'cash-flow and revenue risk.' While not incorrect, this omits some contextual depth. However, the semantic meaning and key contrast are preserved. No factual errors; wording is concise but accurate. Hence, high scores across all dimensions with a slight deduction in qualitative accuracy for reduced detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 392,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How might the expiration timelines of specific Enbrel-related patents in the U.S. influence MRK's strategic focus on maintaining patent protection for its own products, given the competitive dynamics in the biopharmaceutical industry?",
      "original_answer": "The expiration timelines for Enbrel-related patents in the U.S.—including the Fusion protein and pharmaceutical compositions patent expiring on 11/22/2028, the DNA encoding fusion protein and methods of making fusion protein patent on 4/24/2029, and the formulations and methods of preparing formulations patent on 10/19/2037—suggest a phased decline in AMGN's exclusivity for this product. This gradual patent erosion likely reinforces MRK's emphasis on actively protecting its own patents, as outlined in its 2024 10-K, where it states that loss of patent protection typically leads to generic substitutes and reduced sales. MRK acknowledges that political and regulatory pressures to encourage early approval of generics could further exacerbate this risk, making robust patent defense a strategic imperative to maintain market position and profitability in the face of increasing biosimilar competition.",
      "llm_answer": "Enbrel’s U.S. patents expire in a staggered window—11/22/2028, 4/24/2029 and 10/19/2037—after which biosimilar competitors can enter and erode sales.  This timeline illustrates the sharp loss of exclusivity that can occur in the biopharma market, prompting Merck to intensify its patent strategy—filing new patents, pursuing supplemental protection certificates and new indications—to extend exclusivity for its own products and pre‑empt generic entry.  In a highly competitive industry where rivals quickly fill gaps, the Enbrel expiration schedule serves as a benchmark for Merck’s focus on safeguarding revenue streams through robust intellectual‑property protection.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All dates—11/22/2028, 4/24/2029, and 10/19/2037—are correctly stated and match the original answer, satisfying quantitative accuracy. (2) The entity 'Enbrel' is correctly attributed to AMGN (implied via context), and MRK (Merck) is accurately referenced in terms of strategic response. (3) The reasoning correctly interprets the staggered patent expirations as a competitive threat that prompts proactive IP strategies, such as filing new patents and pursuing extended protections—consistent with Merck’s stated concerns in its 10-K about generic substitution and revenue loss post-patent expiry. (4) While the LLM does not explicitly cite MRK’s 2024 10-K or mention political/regulatory pressures (a minor omission), it captures the core strategic implication: that Enbrel’s phased exclusivity loss serves as a benchmark for Merck’s focus on IP protection. The answer demonstrates strong multi-hop reasoning by linking competitor patent expirations to Merck’s strategic behavior. Wording differs but semantic meaning and factual content are equivalent. One point deducted from correctness and qualitative accuracy for missing explicit reference to regulatory pressures and the source document, which are part of the full context in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 368,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has AMD's revenue from operations in Taiwan compared to Apple's revenue contribution from Taiwan (as part of Greater China) in 2022, and what does this suggest about their relative market presence in the region?",
      "original_answer": "In 2022, AMD reported $2,091 million in revenue from operations in Taiwan. Apple, on the other hand, reported $74,200 million in net sales from the Greater China region, which includes Taiwan, China mainland, and Hong Kong. Since Taiwan is only a subset of Apple's Greater China segment, and no specific breakdown is provided for Taiwan's contribution within that region, we cannot directly compare the absolute revenue from Taiwan between the two companies. However, AMD's $2,091 million in Taiwan revenue represents a significant portion of its regional operations, whereas Apple's revenue in the broader Greater China region dwarfs AMD's exposure. This suggests that while Taiwan is a meaningful market for AMD, Apple's market presence and revenue scale in the broader Greater China region, including Taiwan, is substantially larger.",
      "llm_answer": "AMD’s revenue from operations in Taiwan in 2022 was roughly **$2.1 billion** (the 2021 figure of $2,091 million is the closest available data for the 2022 period). In contrast, Apple’s revenue contribution from Taiwan—within its Greater China segment—was **$74.2 billion** in 2022. The stark difference shows that Apple’s market presence in the region is far larger than AMD’s.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Apple's revenue contribution from Taiwan was $74.2 billion, but the ground truth clarifies that Apple reported $74.2 billion in net sales from the entire Greater China region (including mainland China, Hong Kong, and Taiwan), not just Taiwan. This is a critical error that misrepresents Apple's revenue exposure specifically from Taiwan. Additionally, the LLM claims AMD's 2022 revenue from Taiwan was $2.1 billion based on 2021 data, but the ground truth confirms that AMD's $2,091 million (i.e., $2.091 billion) figure is for 2022, not 2021—so the citation of 2021 data is incorrect. (2) While the numeric values for AMD ($2,091 million ≈ $2.1 billion) and Apple ($74,200 million = $74.2 billion) are correctly interpreted in magnitude and format, their attribution is flawed: Apple’s $74.2 billion is not attributable solely to Taiwan, which the LLM falsely implies. Thus, the quantitative accuracy is partially correct but misapplied. (3) The reasoning fails on a key multi-hop aspect: the model does not recognize that Apple’s revenue is reported at the aggregated Greater China level and cannot be directly compared to AMD’s Taiwan-specific revenue without a breakdown. The original answer correctly highlights this limitation, but the LLM overlooks it, leading to an invalid comparison. This undermines the qualitative accuracy and logical soundness. (4) The answer is contextually relevant—it addresses the question about relative market presence and attempts a comparison—but due to the fundamental error in equating Apple’s Greater China revenue with Taiwan-specific revenue, the conclusion is misleading. Hence, while the structure and intent are appropriate, the factual and logical flaws severely reduce correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 496,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How does Alphabet's repurchase of Class C shares, which carry no voting rights, enable different capital allocation flexibility compared to Netflix's share repurchase strategy under its uniform voting rights structure?",
      "original_answer": "Alphabet's repurchase of Class C shares, which carry no voting rights, allows the company to return capital to shareholders while preserving insider control through the retention of higher-vote Class A and B shares. In 2023, Alphabet repurchased $62.2 billion of Class A and Class C shares, with an additional $36.3 billion remaining available under the repurchase authorization. In contrast, Netflix's capital stock carries uniform voting rights — one vote per share — meaning any significant share repurchase could potentially dilute voting control among existing shareholders. This structural difference implies that Netflix may need to be more cautious in its repurchase activity to avoid unintended shifts in governance, unlike Alphabet which can execute larger buybacks without affecting its core governance structure.",
      "llm_answer": "Alphabet can buy back its Class C shares— which carry no voting rights—without affecting the company’s voting power or board control, giving it the flexibility to return capital to shareholders while preserving its governance structure (GOOGL 10‑K, pp. 79‑83).  By contrast, Netflix’s shares all have equal voting rights, so any share‑repurchase reduces the total voting pool and can alter the relative voting power of remaining shareholders, constraining the firm’s ability to adjust capital structure without impacting governance (NFLX 10‑K, pp. 59‑63).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core distinction between Alphabet's and Netflix's share repurchase strategies with correct reasoning. (1) All factual elements are correct: Alphabet's repurchase of non-voting Class C shares preserves voting control, while Netflix's uniform voting structure means buybacks affect the relative voting power of remaining shareholders. The explanation correctly identifies the governance implications of each structure. (2) There are no numeric inaccuracies; the LLM answer does not include specific dollar amounts but this is not a deficiency because the original question did not explicitly ask for them, and the ground truth includes figures ($62.2B repurchased, $36.3B remaining) that were omitted in the LLM response. However, since the LLM answer focuses on the structural and governance contrast rather than quantitative details, and the question emphasizes 'flexibility' rather than specific amounts, the omission does not undermine correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across Alphabet’s dual-class structure and Netflix’s uniform voting rights, drawing a valid comparative conclusion about capital allocation flexibility and governance impact. (4) Semantic equivalence is maintained—wording differs but meaning matches the ground truth. The LLM could have been slightly more complete by referencing the scale of Alphabet’s repurchase program to reinforce flexibility, but the core logic and qualitative accuracy remain strong. Hence, a score of 9 is appropriate for correctness and qualitative accuracy, with full marks for quantitative accuracy (no incorrect numbers) and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 463,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How does MET's exposure to non-agency pass-through mortgage-backed securities with $1,699 million in NQM and Alt-A loans compare to AIG's liquidity risk from mortgage assets, particularly in light of MET's $1,294 million in unrealized losses on pass-through securities versus AIG's concerns about valuing illiquid mortgage-related investments?",
      "original_answer": "MET holds $12,567 million in pass-through mortgage-backed securities, including $1,699 million in NQM and Alt-A loans categorized under non-agency RMBS, with $1,294 million in unrealized losses in 2024. These pass-through securities are directly secured by pools of mortgage loans, including lower-quality segments like NQM and Alt-A that carry elevated credit risk. AIG, meanwhile, faces liquidity risk from its mortgage and loan portfolio, particularly due to its holdings of less liquid assets like private equity, hedge funds, mortgage loans, and real estate. AIG explicitly warns that adverse market conditions or valuation volatility in these assets could lead to material losses if sold in stressed environments. Thus, while MET's exposure is more specifically defined and marked-to-market with known unrealized losses, AIG's risk lies in the uncertain valuation and potential illiquidity of its broader mortgage-linked investments, which could realize even greater losses under unfavorable market conditions.",
      "llm_answer": "MET’s non‑agency pass‑through RMBS portfolio contains **$1.699 billion of NQM/Alt‑A loans** (see the RMBS “Risk profile” table on pages 85‑90) and has recorded **$1.294 billion of unrealized losses on pass‑through securities** (the “Net Unrealized Gains (Losses)” line for pass‑through securities). In contrast, AIG’s 10‑K risk discussion (pages 18‑22) focuses on a broader liquidity concern: its mortgage‑related holdings—including residential and commercial mortgage‑backed securities—are illiquid and difficult to value, with rapid market changes potentially impairing liquidity and forcing sales at prices below carrying value. Thus, MET’s exposure is quantified by a specific unrealized‑loss figure, whereas AIG’s risk is expressed as a general liquidity and valuation uncertainty surrounding its mortgage assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: MET's $1.699 billion (i.e., $1,699 million) in NQM/Alt-A loans and $1.294 billion ($1,294 million) in unrealized losses are correctly reported, with acceptable format variation (billion vs. million). The years and entities (MET and AIG) are accurate. (2) Quantitative accuracy is perfect—no calculation errors, and the numbers align exactly with the original answer. (3) The reasoning correctly synthesizes multi-hop information: it contrasts MET’s specific, marked-to-market exposure in non-agency RMBS with AIG’s broader liquidity and valuation concerns around illiquid mortgage assets. The LLM captures the core distinction: MET has quantified unrealized losses, while AIG faces uncertain valuation and forced sale risks. (4) The only minor shortcoming is slight incompleteness—while the original answer notes MET’s total pass-through securities ($12,567 million), the LLM omits this contextual total, which helps frame the proportion of NQM/Alt-A loans. However, since the question did not explicitly ask for total exposure, this omission does not undermine the correctness. The LLM answer remains semantically equivalent in addressing the comparison of risk profiles. Thus, the answer is factually sound, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 373,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the revenue contribution from beverage operations in the Asia Pacific region compare between Coca-Cola (KO) and PepsiCo (PEP) in 2021, based on their regional and product segment reporting?",
      "original_answer": "In 2021, Coca-Cola (KO) generated $4,682 million in third-party beverage revenue from its Asia Pacific (APAC) operations. PepsiCo (PEP) reported that 20% of its total revenue in the APAC region came from beverage operations, though the exact dollar amount is not disclosed. This indicates that while KO's APAC beverage revenue is directly quantifiable for 2021, PEP's APAC beverage revenue would require further calculation based on total regional revenue to determine the precise figure.",
      "llm_answer": "In 2021 Coca‑Cola’s Asia Pacific segment generated **$5.291 billion** in beverage revenue (KO_10‑K 2022, pp. 122‑126). PepsiCo’s APAC net revenue was **$4.615 billion**, of which 20 % was beverage sales, yielding roughly **$923 million** (PEP_10‑K 2022, pp. 71‑75). Thus Coca‑Cola’s Asia Pacific beverage contribution was about five‑to‑six times larger than PepsiCo’s.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Coca-Cola's 2021 APAC beverage revenue was $4,682 million, but the LLM reports $5.291 billion, which is incorrect. For PepsiCo, the ground truth states that 20% of APAC revenue came from beverages but does not disclose the total APAC revenue or the exact beverage dollar amount. However, the LLM claims PepsiCo’s total APAC net revenue was $4.615 billion and calculates beverage revenue as $923 million (20% of $4.615B), which is not supported by the original answer or the knowledge graph. These numbers appear to be fabricated or misextracted. (2) Calculations: While 20% of $4.615B does equal ~$923M, this data is not present in the ground truth, making the entire quantitative chain invalid. The comparison that Coca-Cola’s APAC beverage revenue was 'five-to-six times larger' is therefore based on incorrect inputs and is misleading. (3) Multi-hop reasoning: The model attempts synthesis by combining regional revenue and percentage breakdowns, but it uses incorrect base figures. The original answer explicitly states that PEP's exact dollar amount is not disclosed, so deriving one represents a failure in reasoning fidelity. (4) Despite these major errors, the answer is contextually relevant—addressing the right companies, region, year, and product segment—and follows a logical structure. Hence, contextual relevance is high, but correctness and quantitative accuracy are severely compromised due to incorrect data extraction and unsupported calculations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 431,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How does Gilead's revenue-sharing structure with Merck for long-acting HIV products compare to Merck's royalty obligations to BMS and Ono for Keytruda sales, and what implications does this have for Merck's profitability from both partnerships?",
      "original_answer": "Gilead and Merck share global product revenues equally for long-acting HIV products until $2.0 billion (oral) or $3.5 billion (injectable) in net sales are surpassed, after which Gilead's share increases to 65%. Meanwhile, Merck pays BMS and Ono royalties of 6.5% through 2023 and 2.5% from 2024–2026 on global Keytruda sales, with BMS receiving 75% of those payments. In 2023, Merck recorded $212 million in alliance revenue from its collaboration with BMS on Reblozyl, which includes a 20–24% sales royalty. These structures indicate that Merck both shares in revenue from joint development (with Gilead) and pays significant royalties (to BMS and Ono), which directly affects its net profitability from these partnerships depending on the scale of product sales.",
      "llm_answer": "Gilead’s collaboration with Merck is a revenue‑sharing model in which Merck receives 50 % of global sales of the long‑acting HIV products until the oral combination exceeds $2 B and the injectable exceeds $3.5 B in a calendar year, after which Merck’s share rises to 65 % on the incremental revenue. By contrast, Merck’s Keytruda license obliges it to pay 6.5 % of global sales (through 2023) and 2.5 % thereafter to BMS and Ono (split 75/25), an expense that reduces its profitability. Thus, Merck stands to gain upside from the Gilead partnership if sales hit the thresholds, while it incurs a predictable royalty cost that erodes profit from Keytruda sales.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the revenue-sharing structure between Gilead and Merck for long-acting HIV products, including the $2.0B (oral) and $3.5B (injectable) thresholds and the shift to 65% for Gilead (though incorrectly stated as Merck’s share increasing to 65%, when it is Gilead’s). This is a critical error in entity attribution. The royalty rates Merck pays to BMS and Ono—6.5% through 2023 and 2.5% from 2024–2026—are accurately reported, as is the 75/25 split in favor of BMS. However, the LLM omits the $212 million in 2023 alliance revenue from Reblozyl and its associated 20–24% royalty, which is part of the original answer and relevant to Merck’s income stream. (2) Quantitative accuracy is mostly correct: thresholds and percentages match the ground truth, but the misattribution of the 65% share to Merck instead of Gilead is a significant factual error. The LLM says 'Merck’s share rises to 65%', which is incorrect—after the threshold, Gilead gets 65%, meaning Merck’s share drops to 35%. This reverses the financial implication. (3) The reasoning is logically structured and synthesizes the two partnerships appropriately, drawing a valid contrast between Merck as a revenue sharer (with Gilead) and a royalty payer (to BMS/Ono). However, due to the flipped revenue share, the conclusion about Merck gaining upside is misleading—Merck actually gets a smaller share after thresholds, so the upside is limited. (4) Contextual relevance is excellent: the answer directly addresses the comparison and profitability implications. Despite the key error in revenue share direction and omission of Reblozyl details, the core framework is sound, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 467,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How does BAC's investment in CDOs, which contain embedded credit default swaps that transfer risk through tranche structures, compare to AIG's $75 million loss from embedded derivatives in 2024, considering the role of credit events in triggering losses for both institutions?",
      "original_answer": "BAC invests in CDOs, which are hybrid instruments containing embedded derivatives where credit protection has been sold to the issuer. These structures pass credit event losses from junior tranches to more senior ones, exposing investors like BAC to cascading risk. AIG, in turn, reported a $75 million loss from embedded derivatives in 2024, which includes similar instruments like credit default swaps tied to reference entities. A credit event in the underlying reference entity would directly impact both BAC’s CDO value and AIG’s derivative exposure, linking their financial risks through the same type of structured credit mechanism.",
      "llm_answer": "BAC’s 2024 10‑K notes that its “Other Credit Contracts” include CDOs that embed credit‑default swaps, which transfer credit risk through tranche structures; a credit event on a reference entity can trigger losses on the note’s principal balance (BAC, pp. 126‑130).  AIG reported a $75 million loss in 2024 from embedded derivatives, also triggered by credit events on the underlying reference entities (AIG, pp. 142‑146).  Thus, both institutions face losses when credit events occur, but BAC’s exposure is structured through tranche‑based CDOs as part of its investment portfolio, while AIG’s loss is a realized figure from embedded derivatives in its insurance contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BAC's investment in CDOs with embedded credit default swaps that transfer risk via tranches is accurately described, and AIG's $75 million loss from embedded derivatives in 2024 is correctly stated. The role of credit events in triggering losses for both institutions is properly identified. (2) Quantitative accuracy is perfect: the $75 million figure and the year 2024 match the original answer exactly; no calculations were required. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across BAC and AIG, linking their exposures through credit events and embedded derivatives, while distinguishing BAC’s portfolio-based CDO exposure from AIG’s insurance-related derivative losses. (4) The only minor shortcoming is a slight lack of detail on how losses cascade from junior to senior tranches in CDOs—mentioned in the original but only implied in the LLM answer—hence a 9 instead of 10 on qualitative accuracy. Otherwise, the answer is semantically equivalent, contextually precise, and factually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 322,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "What specific roles does Citibank, N.A. hold in both 3M's May 2023 Five-Year Credit Agreement and Caterpillar's September 2022 credit facilities, and how do these roles differ in terms of administrative responsibilities across the two agreements?",
      "original_answer": "In 3M’s May 2023 Five-Year Credit Agreement, Citibank, N.A. serves as an administrative agent and joint lead arranger alongside JPMorgan Chase Bank, N.A., with responsibilities including coordination of the lending group and oversight of borrowing procedures. In Caterpillar’s September 2022 credit facilities, Citibank, N.A. acts as the Agent for both the 3-Year and 5-Year Facilities, and also as the Local Currency Agent through Citibank Europe plc, UK Branch, and Japan Local Currency Agent in coordination with MUFG Bank, Ltd. These roles differ in that Citibank holds multiple layered responsibilities in Caterpillar’s structure, including cross-border coordination, while at 3M it shares leadership with another bank without such international scope.",
      "llm_answer": "Citibank, N.A. is the **administrative agent** in both 3M’s May 2023 Five‑Year Credit Agreement (see Exhibit 10.29) and in Caterpillar’s September 2022 credit facilities (see the credit‑agreement exhibit incorporated in the 2022 10‑K).  In 3M’s agreement Citibank also acts as a **joint lead arranger and joint book manager**, giving it broader responsibilities such as arranging the loan and managing the book, whereas in Caterpillar’s facility it is limited to the administrative‑agent role—primarily record‑keeping and borrower communications.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in identifying Citibank, N.A. as an administrative agent in both the 3M and Caterpillar agreements, and correctly references the May 2023 and September 2022 timeframes. However, it contains significant factual inaccuracies in the qualitative roles. According to the ground truth, in Caterpillar’s September 2022 credit facilities, Citibank, N.A. is not limited to just the administrative agent role—it also serves as the Agent for both the 3-Year and 5-Year Facilities, and there are additional layered roles involving Citibank Europe plc (as Local Currency Agent) and coordination with MUFG Bank, Ltd. for Japan Local Currency Agent duties. The LLM incorrectly claims Citibank has a more limited role at Caterpillar, when in fact its responsibilities are more extensive and internationally layered compared to 3M. Conversely, in the 3M agreement, while the LLM correctly notes joint lead arranger and joint book manager roles, it fails to mention that JPMorgan Chase Bank, N.A. is the co-agent, which is a key part of the shared leadership structure. Most critically, the LLM misrepresents the comparative aspect of administrative responsibilities: it claims Citibank has broader responsibilities at 3M, whereas the ground truth states the opposite—Caterpillar’s structure involves more complex, multi-jurisdictional coordination. Quantitatively, there are no numerical errors (dates and roles are referenced correctly in part), so quantitative accuracy is high. Contextually, the answer addresses the question’s structure and cites exhibits, so relevance is strong. However, due to major errors in entity roles and flawed comparative reasoning, the overall correctness is significantly compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 470,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How does the use of option contracts by KO to hedge foreign currency exposure compare with PEP's foreign exchange risk management strategy, given the impact of these instruments on their respective foreign currency liabilities?",
      "original_answer": "KO uses option contracts as part of its derivative strategy to hedge foreign currency exchange rate risk, aiming to mitigate the impact of currency fluctuations on its financial performance. These contracts are designated as cash flow hedges and affect KO's foreign currency liabilities by deferring gains and losses in AOCI until the hedged transactions occur. Similarly, PEP actively manages foreign exchange risk through derivatives, including option and forward contracts, which are also used to hedge forecasted transactions and firm commitments. PEP reported that foreign exchange movements unfavorably impacted net revenue by 1.5 percentage points in 2024, highlighting the importance of these hedges. Both companies rely on option contracts to manage foreign currency liabilities, but KO specifically emphasizes the deferral of mark-to-market impacts in AOCI, while PEP focuses on offsetting exposure from its significant international operations (44% of revenue).",
      "llm_answer": "KO uses option contracts as part of a cash‑flow hedging program for forecasted foreign‑currency transactions, with a notional amount of $9.9 billion in 2024. The gains and losses on these contracts are deferred in AOCI and reclassified into earnings (a $472 million gain in 2024), effectively offsetting fluctuations in its foreign‑currency liabilities. In contrast, PepsiCo’s strategy blends hedged and non‑hedged contracts; the $3.4 billion of non‑designated foreign‑exchange contracts produced a net loss of $135 million on foreign‑currency liabilities and contracts in 2024, indicating a net adverse impact on its foreign‑currency exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in quantitative details not present in the original answer. The original answer does not mention specific notional amounts ($9.9 billion for KO or implied $3.4 billion for PEP), nor does it report a $472 million gain for KO or a $135 million loss for PEP. These figures are fabricated or hallucinated, severely undermining quantitative accuracy. The original answer states that PEP reported a 1.5 percentage point unfavorable impact on net revenue due to FX movements in 2024, but does not attribute this to non-designated contracts or report a net loss of $135 million—information absent from the ground truth. While the LLM correctly identifies that KO uses option contracts as cash flow hedges with AOCI deferral, and that PEP uses derivatives including options, it misrepresents PEP’s strategy as blending hedged and non-hedged contracts with adverse impacts, which is not stated in the original. The original emphasizes both companies use similar instruments (options and forwards) for similar purposes, with differences in emphasis (AOCI deferral for KO, offsetting exposure from international operations for PEP), but the LLM frames PEP’s approach as less effective due to net losses, introducing a comparative judgment not supported by the ground truth. The reasoning is partially sound in structure—comparing hedging instruments and their impact on foreign currency liabilities—but flawed due to invented data. Contextual relevance is high as the response addresses the core topic of FX risk management and liability impacts. However, the hallucinated numbers and mischaracterization of PEP’s strategy reduce correctness significantly. Semantic equivalence fails on key financial metrics, though some qualitative elements (KO’s AOCI deferral) are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 491,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 183,
      "question": "How does the use of discounted cash flow models by GE in assessing goodwill impairment risk compare with LMT's application of DCF in valuing Level 3 fixed income investments, particularly in terms of sensitivity to discount rate assumptions and projected cash flow estimates?",
      "original_answer": "GE uses a discounted cash flow (DCF) approach as part of its annual goodwill impairment testing, relying on cash flow forecasts, terminal value assumptions, and discount rates to estimate fair value. The company performs sensitivity analyses due to the material impact that changes in these assumptions could have on impairment determinations. Similarly, LMT applies DCF models to value certain Level 3 fixed income investments when observable market data is unavailable, using projected annuity payments and discount rates as key inputs. Both companies depend on forward-looking cash flow projections and discount rate assumptions, making their valuations sensitive to shifts in economic conditions or interest rate environments. However, GE’s DCF use is tied to internal strategic and operational planning, while LMT’s is externally focused on asset valuation within its pension fund investments.",
      "llm_answer": "GE’s goodwill impairment test (pages 15‑19) uses an internal discounted‑cash‑flow model based on strategic and operating forecasts and an “appropriate discount rate”; the company explicitly performs sensitivity analyses on those key estimates, so the impairment outcome is highly responsive to changes in both the discount rate and projected cash flows.  \nLockheed Martin’s Level 3 fixed‑income valuations (pages 87‑91) also rely on a discounted‑cash‑flow approach, with projected annuity payments and the discount rate as the principal inputs, but the filing does not describe formal sensitivity testing—though the valuation is inherently affected by those same inputs.  \nThus, both entities use DCF and are sensitive to discount‑rate and cash‑flow assumptions, yet GE explicitly quantifies that sensitivity while LMT’s approach acknowledges the inputs without detailing sensitivity analysis.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: GE uses DCF for goodwill impairment with sensitivity analysis on discount rates and cash flows; LMT uses DCF for Level 3 fixed income investments based on annuity payments and discount rates. The distinction that GE explicitly performs sensitivity analyses while LMT does not describe formal testing is correctly noted and consistent with the original answer’s implication about differing levels of disclosed rigor. (2) There are no numerical values in the question or answers requiring verification, so quantitative accuracy is not compromised—no figures are misstated. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (GE and LMT), two distinct applications of DCF (goodwill impairment vs. asset valuation), and compares them on sensitivity and input assumptions. It accurately identifies both commonalities (reliance on cash flows and discount rates) and differences (internal strategic use vs. external pension asset valuation; explicit vs. implicit sensitivity treatment). (4) The LLM slightly omits the point that LMT’s DCF is used in the context of pension fund investments, which adds contextual nuance, but this does not undermine the core accuracy. Wording differs from the original but maintains semantic equivalence. The answer is fully relevant and directly addresses the comparative aspect of the question. A score of 9 is justified due to minor omission of LMT's pension fund context; otherwise, it matches the ground truth in substance and insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 444,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How does the voting power distribution in CMCSA's Class A and Class B common stock compare to GOOGL's structure, given the repurchase activity and voting rights differences?",
      "original_answer": "In CMCSA, holders of Class A common stock collectively hold 66 2/3% of the combined voting power, while Class B common stock (held entirely by Brian L. Roberts) holds 33 1/3%, with each Class B share carrying 15 votes. In contrast, GOOGL's Class A shares carry 1 vote each, while Class B shares have 10 votes per share, giving disproportionate voting power to Class B holders in both companies. Additionally, GOOGL repurchased $62.2 billion of Class A and Class C shares in 2023, which could affect ownership concentration and voting dynamics, though CMCSA does not disclose such repurchase volumes for Class A shares directly.",
      "llm_answer": "CM CSA’s Class A shares vote one‑to‑one while Class B shares vote ten‑to‑one, giving Class A holders roughly 66 % of the company’s voting power and Class B holders about 34 %. Alphabet’s structure is similar—Class A shares vote one‑to‑one, Class B shares vote ten‑to‑one and Class C shares have no vote—but the voting power is far more concentrated in the privately held Class B shares. Both firms’ repurchase programs have mainly bought back Class A shares (Alphabet also bought non‑voting Class C shares), reducing the number of voting shares and slightly shifting the balance toward the higher‑voting Class B class, although GOOGL’s voting power remains dominated by the Class B shares.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains several factual inaccuracies, particularly in the voting rights structure of CMCSA. It states that CMCSA's Class B shares have a 10-to-1 voting ratio, but the ground truth specifies 15 votes per Class B share. It also incorrectly states that Class A holders have 'roughly 66%' and Class B 'about 34%', which oversimplifies and misrepresents the precise 66 2/3% and 33 1/3% split. While the GOOGL structure is mostly correct (1 vote for Class A, 10 for Class B, none for Class C), the repurchase amount of $62.2 billion in 2023 for GOOGL is omitted entirely. (2) Quantitative accuracy is low: the 15-vote Class B shares in CMCSA are misrepresented as 10-vote, and the exact fractional voting power distribution (66 2/3% vs 33 1/3%) is rounded and thus inaccurate. The $62.2 billion repurchase figure by GOOGL in 2023 is missing, a significant omission. (3) The reasoning is partially sound—LLM correctly identifies that repurchasing Class A shares can shift voting power toward higher-vote classes, and it draws a valid comparison in intent between the two companies' structures. However, it fails to mention that CMCSA's Class B is held entirely by Brian L. Roberts, a key point in understanding control, and conflates the voting ratios across companies. (4) Contextual relevance is high—the answer addresses voting power distribution, compares both companies, discusses repurchase effects, and touches on concentration. However, due to key numerical and structural inaccuracies, especially in CMCSA's voting mechanics, the correctness score is limited to 5. Minor wording flexibility is allowed, but core facts like vote ratios and ownership percentages must be precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 460,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How does the 8.2% increase in Turkey's total cigarette market, driven by increased in-bound tourism, impact PM's business performance in comparison to CL's operational footprint in the same country?",
      "original_answer": "The 8.2% growth in Turkey's total cigarette market, attributed to the easing of pandemic-related measures and increased in-bound tourism (particularly by Turkish expatriates), positively contributed to PM's net revenues and shipment volumes in the region. PM reported favorable volume/mix and pricing variances in Turkey, which were key contributors to its Middle East & Africa regional performance. Meanwhile, CL operates manufacturing and warehousing facilities in Turkey as part of its global Oral, Personal and Home Care product segment, indicating a significant operational presence in the country. Therefore, while PM benefits from increased consumer activity linked to tourism, CL maintains a physical and ongoing business infrastructure in Turkey, suggesting differing but regionally aligned exposure to the country's economic dynamics.",
      "llm_answer": "PM’s Turkey operations benefited from the 8.2 % rise in the country’s cigarette market, with a 17.2 % jump in shipment volume and a 1.1‑point lift in regional market share to 23.1 %—a clear boost driven by inbound tourism. In contrast, Coca‑Cola’s footprint in Turkey is limited to beverage bottling and distribution and is not tied to the cigarette market, so the market growth does not materially affect CL’s business there.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The 17.2% jump in shipment volume and 1.1-point market share increase to 23.1% for PM in Turkey are not present in the ground truth and are therefore incorrect. The original answer does not provide specific shipment growth or market share figures, so these numbers are fabricated. (2) Quantitative accuracy is very low because the LLM introduces precise but unsupported metrics (17.2%, 1.1-point lift, 23.1%) that do not appear in the ground truth. There is no verification that these numbers are accurate, and they misrepresent the extent of PM's performance. (3) The reasoning is flawed in the comparison with CL. The LLM incorrectly states that Coca-Cola's footprint in Turkey is limited to beverage bottling and distribution and implies it has no significant operations, while the ground truth highlights that CL (Colgate-Palmolive, not Coca-Cola) operates manufacturing and warehousing facilities in Turkey as part of its Oral, Personal and Home Care segment. The LLM confuses CL with Coca-Cola, a critical entity error. Additionally, the ticker 'CL' refers to Colgate-Palmolive, not Coca-Cola (which is KO), undermining the entire comparison. (4) Contextual relevance is moderate because the answer addresses Turkey's cigarette market growth and attempts to contrast PM and CL, but due to the entity misidentification and invented metrics, the synthesis is invalid. The core multi-hop requirement—comparing PM's market-driven benefit to CL's operational footprint—is completely undermined by the misrepresentation of CL as Coca-Cola and the lack of reference to manufacturing infrastructure. Thus, despite addressing the general topic, the answer fails on factual and logical grounds.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 479,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How might geopolitical tensions involving Taiwan impact both NVIDIA's ability to secure timely supply from its foundry partners and Qualcomm's operations in the region, given their shared dependency on Taiwanese manufacturing infrastructure?",
      "original_answer": "NVIDIA faces risks related to its dependency on foundry partners, particularly in Taiwan, where it relies on timely production capacity to meet customer demand. If geopolitical tensions involving Taiwan disrupt operations, NVIDIA may not be able to secure sufficient supply to fulfill orders on time, which could damage customer relationships and lead to revenue loss. Similarly, Qualcomm explicitly states that its business depends on receiving consistent chipset supply from foundry partners in Taiwan, and a significant or prolonged conflict involving Taiwan could severely limit or prevent this supply, materially impacting its business. Both companies are exposed to the same regional risk due to their reliance on Taiwanese manufacturing infrastructure, amplifying the cross-company impact of geopolitical instability in the region.",
      "llm_answer": "Geopolitical tensions around Taiwan could interrupt the supply chain that both companies rely on.  NVIDIA’s risk disclosures note that “geopolitical tensions…involving Taiwan and China…could have a material adverse impact on us” because its wafer‑fabrication and assembly partners are largely in Taiwan (NVDA, p. 15‑19).  Qualcomm similarly warns that its “key suppliers and their manufacturing foundries and assembly, test, and other facilities are primarily located in Taiwan and Korea,” so a conflict could delay or curtail chip and RF component production, leading to inventory shortages and shipment delays (QCOM, p. 10‑14, 33‑37).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) It correctly identifies the core risk both NVIDIA and Qualcomm face due to geopolitical tensions involving Taiwan, emphasizing their dependency on Taiwanese manufacturing infrastructure. The citations to specific page ranges (e.g., NVDA p. 15–19, QCOM p. 10–14, 33–37) are consistent with typical 10-K disclosure locations and support the claims, though exact page numbers are not part of the ground truth and are treated as reasonable approximations. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable in a traditional sense—however, the absence of incorrect numbers and the correct use of qualitative disclosures earn full marks. (3) The multi-hop reasoning is sound: the model correctly synthesizes risk disclosures from both companies, identifies their shared reliance on Taiwanese foundries, and explains the potential operational impact (supply delays, inventory shortages). The only minor shortcoming is that the LLM answer does not explicitly state that this shared dependency 'amplifies the cross-company impact' as in the original, slightly reducing qualitative completeness. (4) The answer is fully contextually relevant, directly addressing how geopolitical tensions could impact both companies’ supply chains through their common exposure to Taiwan-based manufacturing. Wording differs but semantic meaning is equivalent. Minor deduction from 10 to 9 in correctness and qualitative accuracy due to slightly less explicit emphasis on the *amplified cross-company* risk, but all key facts and logic are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 458,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How has the application of ASU 2020-04 impacted FDX's exposure to LIBOR-related contract modifications, and how does this compare to MMM's financial treatment of hedging relationships affected by reference rate reform?",
      "original_answer": "FDX has not experienced any material effect from reference rate reform, including ASU 2020-04, as of May 31, 2024, although it continues to monitor contracts that may be affected by LIBOR discontinuation. In contrast, MMM actively manages its hedging relationships, including those affected by reference rate changes, and reported $9 million in losses related to interest rate contracts in 2023, indicating active financial impact and accounting treatment under the ASU 2020-04 framework. This suggests that while FDX has not yet seen significant financial effects, MMM has recognized tangible impacts in its hedging activities tied to reference rate reform.",
      "llm_answer": "FedEx’s adoption of ASU 2020‑04 has reduced the operational and financial impacts of contract modifications that replace LIBOR, and the company reports that the guidance had no material effect on its consolidated financial statements【FedEx Note – ASU 2020‑04, pages 91‑95】. 3M accounts for its hedging relationships under ASC 815, with gains and losses recognized in other comprehensive income or income, and the reference‑rate reform may affect the hedging instrument but the company uses the optional expedients under ASU 2020‑04 to mitigate the impact, also reporting no material effect on its financial statements【MMM Note – Derivatives and Hedging, pages 74‑78】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that both FDX and MMM reported 'no material effect' from ASU 2020-04, which directly contradicts the ground truth. The original answer clearly states that MMM recognized a tangible financial impact—$9 million in losses related to interest rate contracts in 2023—indicating a material effect, while FDX had no material effect. The LLM answer omits this critical quantitative and qualitative difference, misrepresenting MMM's financial treatment. (2) Quantitatively, the LLM fails to mention the $9 million in losses reported by MMM in 2023, a key figure in the ground truth. This omission or inaccuracy severely undermines the quantitative accuracy. There are no calculations in the LLM answer, but the failure to report a specific, relevant dollar amount in a comparison question constitutes a major quantitative error. (3) The multi-hop reasoning is flawed: the question asks for a comparison between FDX's exposure and MMM's financial treatment under ASU 2020-04. The LLM incorrectly equates their treatments by claiming both had no material effect, when in fact MMM did have a material financial impact. This breaks the synthesis required across the two companies' disclosures. (4) Contextual relevance is high because the LLM addresses the correct companies, the correct accounting standard (ASU 2020-04), and the correct topic (LIBOR transition and hedging). However, the factual inaccuracy in portraying MMM’s financial impact severely reduces correctness and qualitative accuracy. The citations to note pages do not compensate for the substantive misrepresentation of the financial outcomes.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 450,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does the voting power distribution tied to CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, influence the governance structure compared to GOOGL's dual-class stock system where Class A and Class B shares have differential voting rights?",
      "original_answer": "CMCSA's Class B common stock, entirely owned by Brian L. Roberts, holds 33⅓% of the combined voting power with each share carrying 15 votes, creating a non-dilutable control mechanism. This contrasts with GOOGL's structure, where Class A shares (1 vote per share) and Class B shares (10 votes per share) allow insiders to maintain control while enabling broader public ownership. Both systems use dual-class structures to preserve founder/leadership control, but differ in the vote ratios and ownership concentration, with CMCSA's setup being more concentrated and structurally rigid due to the non-dilutable nature of Class B shares.",
      "llm_answer": "Comcast’s Class B shares—held entirely by Brian L. Roberts—carry 15 votes each and represent about one‑third (≈33 %) of the company’s total voting power, but the bylaws require that Class A and B votes be combined for most corporate actions, giving Roberts a sizable but not absolute influence. Alphabet’s dual‑class scheme gives Class B shares 10 votes per share while Class A shares have one vote, so the founders and early investors holding Class B shares can command a far larger voting bloc—often the majority of votes—despite a minority equity stake, thereby exerting stronger control over board elections and major decisions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core differences between CMCSA's and GOOGL's dual-class structures. (1) Quantitatively, it correctly states that CMCSA's Class B shares carry 15 votes and represent approximately one-third (33%) of total voting power, aligning with the ground truth's 33⅓%. It also accurately notes GOOGL's 10 votes per Class B share versus 1 vote for Class A. These numbers are factually correct, though the LLM omits the explicit term 'non-dilutable' which is a key structural feature in the original answer. (2) The answer correctly identifies Brian L. Roberts as the sole holder of CMCSA Class B stock and contrasts this with GOOGL’s broader insider-held Class B shares. However, it slightly mischaracterizes the extent of Roberts’ influence by calling it 'sizable but not absolute'—while technically true due to vote combination requirements, the ground truth emphasizes the structural rigidity and control preservation, which the LLM downplays. (3) The reasoning is sound in comparing the two governance models and highlighting how dual-class systems enable control retention, but the LLM misses the explicit comparison of ownership concentration and structural rigidity in CMCSA versus GOOGL. (4) Despite minor omissions in nuance and terminology (e.g., 'non-dilutable'), the answer remains contextually relevant, factually accurate on key metrics, and effectively addresses the comparative governance question. The omission of 'non-dilutable' prevents a top score, but core facts and synthesis are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 423,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does Amgen's remaining repatriation tax payment schedule under the 2017 Tax Act compare with Eli Lilly's cash payment obligations for the same tax provision as of December 31, 2023?",
      "original_answer": "Amgen has remaining scheduled repatriation tax payments under the 2017 Tax Act, which it is paying over an eight-year period beginning in 2018. Similarly, Eli Lilly made the election to pay the Toll Tax over the same eight-year period, with its future cash payments extending through 2025. Both companies are managing their obligations under the same regulatory framework introduced by the 2017 Tax Act, though the specific amounts differ based on their foreign earnings and individual tax calculations.",
      "llm_answer": "Amgen’s remaining 2017 Tax Act repatriation (Toll) tax payments total **$1.427 billion** as of December 31 2023, with **$634.2 million** scheduled for 2024 and **$792.8 million** for 2025. Eli Lilly’s cash payment obligations for the same tax provision are not disclosed in the pages provided, so a direct comparison cannot be made.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies and fails to align with the ground truth in key aspects. (1) The dollar amounts provided for Amgen ($1.427 billion total, with $634.2 million in 2024 and $792.8 million in 2025) are not present in the original answer and are factually unsupported by the ground truth, which does not specify any numerical payment amounts for either company. (2) The original answer states that both Amgen and Eli Lilly are paying their repatriation taxes over an eight-year period beginning in 2018, extending through 2025—this structural similarity is correctly identified in the LLM answer, but the detailed breakdown for Amgen appears fabricated or inferred beyond available data. (3) Regarding Eli Lilly, the LLM claims payment obligations are 'not disclosed,' which contradicts the original answer stating explicitly that Eli Lilly elected to pay over eight years through 2025—thus, the obligation schedule is known qualitatively even if exact dollar figures are not provided. (4) The reasoning is partially sound in recognizing the shared regulatory framework and time horizon, but the introduction of precise numbers for Amgen without grounding in the source data severely undermines factual correctness. (5) While the answer attempts a direct comparison, it incorrectly implies asymmetry in disclosure when the original answer emphasizes parallel structures. The contextual relevance is fair because it addresses the core topic and timeframe, but the false precision on numbers leads to a low quantitative accuracy score. Overall, the answer is partially correct in structure but fails on key factual elements, warranting a correctness score of 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 461,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 186,
      "question": "How does the risk of biosimilar competition following loss of exclusivity for Amgen's biologics compare to Bristol Myers Squibb's exposure, given the differing regulatory pathways and product portfolios in the U.S. and EU?",
      "original_answer": "Amgen's reliance on biologics such as 'Erbitux, Cyramza, Trulicity, Taltz, and Emgality' is at risk due to the potential entry of biosimilars, which could occur after 12 years of regulatory data protection in the U.S. However, litigation and expedited review processes like IPR could weaken patent protection and accelerate biosimilar entry. Similarly, Bristol Myers Squibb faces biosimilar threats to its biologics including 'Opdivo, Yervoy, Orencia, Reblozyl, and Empliciti,' with regulatory data protection lasting 12 years in the U.S., but also faces earlier generic competition in the EU under the '8+2+1' regime, where biosimilars can enter after 8 years of data exclusivity. Both companies are exposed to rapid revenue declines upon loss of exclusivity, but the timing and competitive intensity differ based on regional regulatory frameworks and the complexity of biosimilar development.",
      "llm_answer": "Amgen’s biologic portfolio faces a higher biosimilar threat because many products are approaching or have lost exclusivity, and the U.S. BPCIA permits biosimilar filings after 4 years while the EU 8+2+1 regime can accelerate entry—risk factors highlighted in its 2022 10‑K (pp. 121‑125). In contrast, BMS’s exposure is lower; its biologic line is smaller and many products enjoy longer exclusivity or patent protection, which mitigates biosimilar risk in both the U.S. and EU, as noted in its 2022 10‑K (pp. 7‑11).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and misrepresents key aspects of the ground truth. (1) Incorrect product portfolios: Amgen does not market 'Erbitux, Cyramza, Trulicity, Taltz, or Emgality'—these are products of other companies (e.g., Trulicity and Taltz are Eli Lilly; Erbitux is Eli Lilly/BMS; Cyramza is Lilly; Emgality is Lilly). Amgen’s key biologics include Enbrel, Neulasta, and others not mentioned. Similarly, BMS’s portfolio includes Opdivo, Yervoy, etc., but the LLM does not list them, instead vaguely referring to a 'smaller biologic line.' (2) Regulatory timelines: The LLM incorrectly states that the U.S. BPCIA allows biosimilar filings after 4 years—this is false. The BPCIA allows application submission after 4 years of approval, but biosimilar approval cannot occur until 12 years of data exclusivity expire. The ground truth correctly emphasizes the 12-year U.S. data protection. The EU '8+2+1' regime is correctly referenced in the LLM answer, but it is misapplied by implying it accelerates entry for Amgen, while in the ground truth it is BMS that faces earlier EU competition. (3) Mischaracterization of risk: The LLM claims Amgen has a 'higher biosimilar threat' and BMS has 'lower exposure' due to longer patent protection, but the ground truth states both face significant risks with differing timing due to regional frameworks—not a clear 'higher' or 'lower' exposure. The LLM introduces unsupported comparative judgments not in the original. (4) Source references: The LLM cites specific 10-K pages, but these are not verifiable here and may be fabricated. (5) Multi-hop reasoning: The model attempts to compare regulatory pathways and portfolios but fails due to incorrect entity mapping and regulatory timelines. While the answer addresses the general theme of biosimilar risk and regional differences, core factual errors in products, timelines, and comparative exposure reduce correctness. Quantitative accuracy is partially maintained (e.g., 8+2+1 mentioned), but the 4-year filing claim is wrong. Qualitative reasoning is flawed due to incorrect synthesis. Contextual relevance is fair as it engages with the regulatory and portfolio aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 589,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How does Medtronic's exposure to Medicaid reimbursement policies compare to AbbVie's pricing pressures under the IRA, particularly in relation to their respective product portfolios and revenue risks?",
      "original_answer": "Medtronic faces increased price sensitivity from Medicaid reimbursement limitations, which affects hospitals' purchasing behavior and creates a need for competitively priced medical devices. AbbVie, on the other hand, is directly impacted by the Inflation Reduction Act (IRA), which allows the U.S. Department of Health and Human Services to set government prices for certain drugs like Imbruvica (selected in 2023 for pricing starting in 2026) and Vraylar and Linzess (selected in 2025 for pricing starting in 2027), potentially accelerating revenue erosion before patent expiration. While both companies face healthcare cost-containment pressures, Medtronic’s Medicaid exposure affects device pricing strategies, whereas AbbVie must navigate IRA-driven government pricing that could apply to more high-revenue products in the future.",
      "llm_answer": "Medtronic’s exposure is tied to Medicaid reimbursement policies that can lower or deny coverage for its device portfolio (airway, respiratory, diabetes, etc.), potentially reducing demand and compressing margins (MDT_10k_2024, pp. 11‑15).  AbbVie faces pricing pressure from the Inflation Reduction Act, which can set statutory price ceilings for certain biologics and small‑molecule drugs reimbursed under Medicare Part B and D, cutting prices and rebates on high‑revenue products such as Humira, Skyrizi and Rinvoq before patent expiry (ABBV_10k_2024, pp. 17‑21).  Thus, Medtronic’s risk stems from Medicaid coverage decisions on devices, while AbbVie’s risk comes from federal price‑setting that can erode revenue on key biologic therapies.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies the distinct regulatory pressures facing Medtronic and AbbVie. It accurately states that Medtronic's exposure stems from Medicaid reimbursement policies affecting device demand and pricing, citing relevant therapeutic areas (airway, respiratory, diabetes), which aligns with the ground truth's emphasis on Medicaid-driven price sensitivity influencing hospital purchasing. For AbbVie, the LLM correctly identifies IRA-imposed pricing pressures, including federal price-setting for Medicare Part B and D drugs, and notes the risk to high-revenue products. However, it diverges from the ground truth by naming Humira, Skyrizi, and Rinvoq as examples—none of which are mentioned in the original answer. The ground truth specifically identifies Imbruvica (selected in 2023 for pricing from 2026), Vraylar, and Linzess (selected in 2025 for 2027 pricing) as the IRA-affected drugs. While the LLM captures the qualitative nature of the IRA risk, the incorrect product examples represent a factual inaccuracy in entity identification. There are no numerical values in either answer, so quantitative accuracy is scored as 10 by default. The reasoning is logically sound and synthesizes multi-hop information correctly—linking Medicaid policy to device pricing and IRA to drug pricing—and the answer is fully contextually relevant. The omission of the correct drug names and inclusion of unverified ones prevents a higher score, but the overall structure and conclusion remain substantially aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 434,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How does the $2.7 billion in unfunded commitments to private equity funds held by UPS compare to General Dynamics' use of NAV for valuing its Level 1 plan assets, given both companies rely on NAV as a practical expedient for alternative investments?",
      "original_answer": "UPS reports $2.7 billion in unfunded commitments to private equity and similar funds as of December 31, 2024, with contributions expected over 3 to 6 years. These investments are valued using NAV as a practical expedient due to the lack of readily determinable fair value. Similarly, General Dynamics (GD) uses NAV for its Level 1 plan assets, which include commingled equity and fixed-income funds valued using a unit price or NAV. Both companies rely on NAV for valuation, but UPS's private equity commitments carry longer redemption restrictions (10–15 year terms), whereas GD's NAV-based assets are generally redeemable monthly or quarterly. This suggests UPS has a less liquid exposure to NAV-based investments compared to GD.",
      "llm_answer": "UPS reports about **$2.7 billion of unfunded commitments** to private‑equity funds that will be contributed over the next 3–6 years (UPS 10‑K, Note to Consolidated Financial Statements). General Dynamics, by contrast, **uses NAV as a practical expedient to value its Level 1 plan assets**—a valuation method rather than a disclosed commitment amount (GD 10‑K, Note to Consolidated Financial Statements). Thus, while UPS has a concrete unfunded commitment figure, GD’s NAV approach is a valuation technique applied to its plan assets, illustrating a similar reliance on NAV but in a different context.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $2.7 billion unfunded commitments for UPS and accurately characterizes General Dynamics' use of NAV as a practical expedient for valuing Level 1 plan assets. All quantitative figures (dollar amounts, timeframes like 3–6 years) are factually correct and match the ground truth. (2) Quantitative accuracy is perfect: $2.7 billion is correctly cited, and the 3–6 year contribution period for UPS aligns with the original answer. No calculations were required, but the numbers are reported accurately. (3) The multi-hop reasoning is partially sound—both companies’ use of NAV is correctly noted, and the distinction between a funding commitment (UPS) and a valuation method (GD) is well articulated. However, the LLM omits a key comparative insight from the ground truth: the difference in liquidity and redemption terms (UPS’s 10–15 year restrictions vs. GD’s monthly/quarterly redeemability), which is central to the comparison. This missing element weakens the qualitative synthesis. (4) The answer is contextually relevant and clearly structured, but the absence of the liquidity contrast—a critical differentiator in how NAV is applied—prevents a higher score. While the core facts are correct, the incomplete comparison limits the depth of the multi-hop analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 367,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How does CMCSA's issuance of Class B Common Stock in 2024 influence its shareholder voting rights structure, and how does this compare to META's dual-class framework as disclosed in their respective filings?",
      "original_answer": "CMCSA issued 9,444,375 shares of Class B Common Stock in 2024, which, as per the governance structure outlined in V_10k_2024.pdf, carries no voting rights except in limited circumstances such as exiting the core payments business or specific merger scenarios. This creates a tiered voting rights system where Class A shareholders maintain full voting control. Similarly, META's filing reveals a dual-class structure with Class A and Class B common stock, where Class A stockholders have full voting rights while Class B stockholders generally do not, except in defined events like a merger. Both companies thus concentrate voting power among a subset of shareholders, reinforcing control while allowing for differentiated capital structures.",
      "llm_answer": "CMCSA’s 2024 issuance of 9.44 million Class B common shares (authorized 75 million) creates a class that is largely non‑voting—holders may vote only on a narrow set of matters and at a reduced rate, thereby diluting the voting power of the publicly traded Class A shares (CMCSA, pages 65‑69). In contrast, Meta’s dual‑class structure gives its 343 million Class B shares 10 votes per share while Class A shares have one vote each, concentrating control in the founders’ hands (META, pages 1‑5). Thus, CMCSA’s Class B shares are more restrictive in voting rights than Meta’s Class B shares, which carry significant voting power.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both quantitative and qualitative aspects. While it correctly identifies CMCSA's issuance of approximately 9.44 million Class B shares (matching the ground truth 9,444,375), it incorrectly characterizes META's dual-class structure. The claim that Meta's Class B shares have 10 votes per share and that there are 343 million such shares is unsupported by the ground truth, which states only that Class A has full voting rights and Class B has limited rights except in defined events like a merger—no vote ratios or specific share counts for META Class B are provided in the original answer. This misrepresents META’s structure entirely. (2) Quantitative accuracy is partially correct for CMCSA (9.44 million ≈ 9,444,375), but the 75 million authorized figure and 343 million Meta Class B shares are not in the ground truth and appear fabricated. No vote ratios (e.g., 10:1) were disclosed in the original data. (3) Multi-hop reasoning fails: the comparison incorrectly frames CMCSA’s Class B as less powerful than Meta’s, when both actually render Class B non-voting except in limited circumstances—thus the structures are more similar than different, contrary to the LLM’s conclusion. The synthesis across companies is flawed due to incorrect attribution of voting power to Meta’s Class B. (4) Contextual relevance is high as the response addresses shareholder voting rights and compares both companies’ frameworks. However, due to major factual and reasoning errors, especially regarding META’s structure, the correctness score is low. The answer contradicts the ground truth rather than aligning with it.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 459,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How might the IRA's Medicare price-setting provisions impact revenue erosion timelines for Amgen's products that rely on federal reimbursement, especially in light of AbbVie's experience with Imbruvica and Vraylar being selected for government pricing starting in 2026 and 2027?",
      "original_answer": "The IRA's Medicare price-setting provisions could accelerate revenue erosion for Amgen's products that depend on federal reimbursement by imposing government-determined prices as early as nine or thirteen years post-FDA approval, depending on whether the product is a small molecule or biologic. This mirrors AbbVie's experience where Imbruvica was selected for price setting in 2026 and Vraylar and Linzess in 2027, leading to potential revenue declines before patent expiration. Amgen, which also relies heavily on Medicare reimbursement, faces similar risk as these policies reduce pricing flexibility and increase downward pressure on profitability.",
      "llm_answer": "The IRA will impose mandatory Medicare price‑setting on 10 drugs in 2026, 15 in 2027, and 20 in 2029, potentially bringing Amgen’s federally reimbursed products into the same cycle (Amgen risk factors, pp. 33‑37). AbbVie’s experience—Imbruvica selected for 2026 pricing and Vraylar for 2027—shows that once a drug is chosen, the government sets a lower price that immediately cuts revenue, and the IRA’s inflation‑penalty and Part D redesign can further erode reimbursement. Thus, Amgen’s revenue erosion timeline could shift earlier, potentially beginning in 2026 for the first selected drugs, and accelerate before patent expiry or generic entry.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that the IRA imposes Medicare price-setting starting in 2026 (Imbruvica) and 2027 (Vraylar), consistent with the original answer. The mention of 10 drugs in 2026, 15 in 2027, and 20 in 2029 is contextually plausible and reflects known IRA implementation schedules, though the ground truth does not specify these exact numbers—this is a minor addition not contradicted by the source. (2) Quantitatively, all years (2026, 2027) and company-product pairings (AbbVie’s Imbruvica and Vraylar) are correct. The LLM infers that Amgen could face similar timelines starting in 2026, which is a reasonable extrapolation given the policy mechanism and AbbVie’s precedent. (3) The multi-hop reasoning is sound: it connects IRA provisions → AbbVie’s experience → implications for Amgen’s revenue erosion timeline. It correctly synthesizes that government price-setting leads to immediate revenue cuts and accelerates erosion before patent expiry, mirroring the original answer’s logic. (4) The answer is semantically equivalent, capturing the core risk: reduced pricing flexibility, earlier revenue decline, and parallel exposure due to federal reimbursement dependence. The only minor gap is the lack of explicit distinction between small molecule vs. biologic timelines (9 vs. 13 years post-approval), which is in the ground truth but not essential to the main conclusion. Overall, the answer is factually correct, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 422,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 190,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Colgate-Palmolive compare to the total remaining available securities disclosed by Procter & Gamble, based on their respective disclosures?",
      "original_answer": "Colgate-Palmolive reported 37,028,000 securities remaining available under equity compensation plans approved by security holders, while Procter & Gamble disclosed a total of 133,185,995 remaining available securities across both Stock Options/SARs and RSUs/PSUs under the same category of approved plans. This indicates PG has a significantly larger pool of available securities for future issuance compared to CL.",
      "llm_answer": "Colgate‑Palmolive reports **37,028 thousand** (≈ 37 million) securities remaining available for future issuance under equity‑compensation plans approved by security holders.  \nProcter & Gamble discloses **119 million** shares available for future issuance under its approved plans, which is roughly **3.2 times** the number reported by Colgate‑Palmolive.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Colgate-Palmolive's figure as 37,028,000 (rounded to 37 million), which matches the ground truth. However, it reports Procter & Gamble's total remaining available securities as 119 million, which is incorrect—the ground truth is 133,185,995. This is a significant numerical discrepancy of over 14 million shares. (2) The calculation of '3.2 times' is based on the incorrect P&G number (119M / 37M ≈ 3.2), whereas the correct ratio is approximately 133.2M / 37M ≈ 3.6, so the comparison magnitude is off. (3) The multi-hop reasoning is sound in structure—comparing securities available under shareholder-approved equity plans at two companies—but fails in execution due to the inaccurate P&G figure. It appears the model may have used outdated or incorrect data for P&G, possibly conflating it with a subset of awards or an older filing. (4) Despite the error in P&G's number, the answer is contextually relevant and correctly frames the comparison, with proper entity identification and metric understanding. The qualitative reasoning is logical, and the direction of the comparison (P&G > Colgate) is correct, but the quantitative inaccuracy significantly undermines the correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 347,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 190,
      "question": "How does the joint commercialization of BMY's biologics in Taiwan compare with MRK's strategic spin-off of its biosimilars business, given Taiwan's regulatory requirement for local clinical trial data for biologics registration?",
      "original_answer": "BMY jointly commercializes biologics like Opdivo and Yervoy in Taiwan with Ono, where BMS handles supply and both parties share development costs and profits. This suggests a collaborative, market-access-focused strategy in Taiwan, which requires local clinical trial data for biologics registration. In contrast, MRK spun off its biosimilars business into Organon, signaling a strategic retreat from the biosimilars segment, which faces increasing global competition and regulatory complexity, including in markets like Taiwan that require additional local data for registration. Thus, while BMY maintains a direct and collaborative presence in Taiwan's biologics market, MRK has opted to divest its biosimilars portfolio, potentially avoiding the added burden of meeting such regulatory requirements in markets requiring local trials.",
      "llm_answer": "BMS’s alliance with Ono in Taiwan is a direct, co‑commercialization partnership that requires the partners to generate local clinical‑trial data to satisfy Taiwan’s biologics‑registration rule (see BMS 10‑K, pp. 84‑88).  Merck’s 2021 spin‑off of its biosimilars segment into the independent company Organon & Co. (Merck 10‑K, pp. 1‑5) is a corporate restructuring that does not alter the regulatory requirement—Organon will still need to obtain local data for Taiwanese registration, but the spin‑off simply separates the biosimilars business from Merck’s core operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in its description of BMS's collaboration with Ono and Merck's 2021 spin-off of its biosimilars business into Organon, including correct references to the 10-K pages and the regulatory requirement for local clinical trial data in Taiwan. There are no numeric inaccuracies—dates and corporate actions (e.g., 2021 spin-off) are correct, earning a perfect quantitative accuracy score. However, the qualitative reasoning is flawed in a key aspect: the LLM claims that the spin-off 'does not alter the regulatory requirement—Organon will still need to obtain local data,' which misinterprets the strategic implication emphasized in the ground truth. The original answer highlights that MRK's spin-off represents a strategic retreat from the biosimilars segment, thereby avoiding the burden of meeting complex regulatory requirements like Taiwan's. In contrast, the LLM frames the spin-off as a neutral corporate restructuring that doesn't change regulatory obligations—an accurate statement in isolation—but fails to draw the correct strategic comparison: BMY maintains active market engagement requiring compliance with local trials, while MRK has exited the space entirely. This missing synthesis weakens the multi-hop reasoning, as the model does not contrast BMY's collaborative market-access strategy with MRK's divestiture as a strategic avoidance of such regulatory burdens. Thus, while contextually relevant and factually sound on surface details, the LLM misses the deeper strategic contrast, resulting in a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 430,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How does AAPL's 2022 revenue contribution from Taiwan, as part of its Greater China segment, compare to ADBE's operational presence in the same region?",
      "original_answer": "AAPL reported $74,200 million in net sales for its Greater China segment in 2022, which includes Taiwan among other regions. ADBE maintains a local field office in Taiwan as part of its global operations, indicating a direct market presence. While AAPL's exposure to Taiwan is embedded within its broader Greater China revenue, ADBE's operational footprint in Taiwan suggests a more targeted geographic strategy in the region.",
      "llm_answer": "Apple’s Greater China segment generated $74.2 billion in 2022 (Note 11, pages 50‑54), which includes Taiwan, but the company does not break out Taiwan‑specific revenue. In contrast, Adobe lists a local field office in Taiwan (pages 13‑17), indicating an operational presence but no revenue figure is disclosed for the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $74.2 billion figure for AAPL's Greater China segment in 2022 is correct and matches the $74,200 million in the original answer (equivalent values, different formatting). The mention of Note 11 and page numbers adds sourcing precision. (2) The LLM correctly notes that AAPL does not break out Taiwan-specific revenue, which is consistent with the original answer's implication that Taiwan's contribution is embedded within the broader segment. (3) For ADBE, the LLM accurately states the presence of a local field office in Taiwan, confirming operational presence, and correctly observes that no revenue figure is disclosed—this matches the original's claim about ADBE's targeted strategy. (4) The reasoning is sound: the LLM synthesizes information across two companies (AAPL and ADBE), correctly contrasts revenue reporting versus operational presence, and avoids making unsupported claims. The only minor shortcoming is that it doesn't explicitly frame the comparison as 'AAPL has significant revenue exposure (via Greater China) while ADBE has a direct operational footprint,' which would mirror the original's concluding insight. However, the information needed to draw that conclusion is fully present. Wording differs slightly but maintains semantic equivalence. All entities (AAPL, ADBE, Taiwan, 2022, Greater China) are correct. No factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 399,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How do CMCSA and META differ in terms of the voting control concentration between Class A and Class B common stockholders, and what implications does this have for shareholder influence in corporate governance decisions?",
      "original_answer": "CMCSA's Class A common stockholders hold 66 2/3% of the combined voting power, while Class B stockholders (led by Brian L. Roberts) hold 33 1/3%, with each Class B share carrying 15 votes. In contrast, META's Class B common stock, though not publicly traded, holds significant voting rights, but the specific voting power percentage is not disclosed. However, META's Class A shares are publicly traded under the ticker META, and as of December 31, 2023, there were only 23 stockholders of record for Class B shares, indicating concentrated control. This means CMCSA maintains a structured balance of voting power, while META's control is more opaque and concentrated among fewer Class B holders.",
      "llm_answer": "Comcast (CMCSA) reports that Class A shareholders hold 66.3 % of voting power, while the single Class B share—held by Mr. Roberts—holds 33.3 %, giving him a substantial voting stake. Meta Platforms does not disclose specific voting‑power percentages for its Class A and Class B shares in the provided pages, but the presence of 23 record holders of Class B stock suggests a more dispersed voting base. Consequently, CMCSA’s governance is more heavily influenced by a single shareholder, whereas Meta’s governance is likely more evenly distributed among a larger group of shareholders, reducing the potential for concentrated control.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that CMCSA's Class A holds 66.3% and Class B (held by Mr. Roberts) holds 33.3%, which is close but not exact—ground truth specifies 66 2/3% and 33 1/3%, respectively. More critically, it misrepresents the structure: CMCSA Class B is not a single share but a class of shares with 15 votes per share, and Brian L. Roberts leads the Class B holders, not holds the only share. This is a major error in entity and structural understanding. Regarding META, the LLM incorrectly infers that 23 record holders suggest a 'more dispersed voting base'—the ground truth interprets this as indicating concentrated control, which is correct because Class B holds superior voting rights and is not publicly traded. The LLM draws the opposite conclusion, reversing the implication. (2) Quantitatively, the percentages are approximately correct (66.3% vs 66 2/3% = 66.66...%), so minor rounding is acceptable, but the characterization of Class B as a single share is factually wrong. The 23 holders number is correctly cited, but misinterpreted. (3) The multi-hop reasoning fails: the model should have contrasted CMCSA's structured, disclosed dual-class system with META's opaque but highly concentrated control via non-public Class B shares. Instead, it incorrectly concludes that META has more distributed control, which contradicts the ground truth and fundamental corporate governance principles. (4) Contextual relevance is high—the answer addresses voting control and shareholder influence—but correctness and reasoning are severely compromised by key factual and interpretive errors, warranting a low correctness score despite some accurate data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 473,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How do LLY and MRK benefit differently from pediatric exclusivity provisions in the U.S. and EU regulatory frameworks?",
      "original_answer": "LLY benefits from pediatric exclusivity in the U.S. by receiving an additional six months of exclusivity added to data protection, orphan drug exclusivity, or non-expired patents. MRK, on the other hand, benefits in the U.S. through an additional six months of market exclusivity added to Orange Book-listed patents and regulatory data exclusivity, and in the EU through an additional six months added to the Supplementary Protection Certificate (SPC) term. This difference in application highlights how the U.S. framework ties pediatric exclusivity to both patents and data protection, while the EU framework applies it only to the SPC term.",
      "llm_answer": "LLY and MRK both receive an extra six‑month “pediatric exclusivity” period, but the way it is applied differs between the U.S. and the EU. In the U.S., the provision adds six months to the data‑exclusivity term for small‑molecule and biologic products (and to the patent term for Orange‑Book patents), giving each company an additional six months of market exclusivity after pediatric studies are completed. In the EU, the same six‑month extension is attached to the product’s Supplementary Protection Certificate (SPC) term rather than to data exclusivity. Thus, LLY’s pediatric exclusivity extends its data‑exclusivity period, whereas MRK’s pediatric exclusivity extends the SPC term in the EU, while both enjoy the U.S. data‑exclusivity extension.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the six-month pediatric exclusivity extension in both the U.S. and EU, which is quantitatively accurate and contextually relevant. However, it misattributes how LLY and MRK specifically benefit. The original answer specifies that LLY benefits in the U.S. through extensions to data protection, orphan drug exclusivity, or non-expired patents, while MRK benefits in the U.S. via Orange Book-listed patents and data exclusivity, and in the EU via SPC extension. The LLM incorrectly implies that LLY’s exclusivity extends only data exclusivity and that MRK’s applies only to SPC in the EU, failing to correctly differentiate the companies' experiences based on regulatory frameworks. It also incorrectly suggests that LLY does not benefit in the EU or that MRK does not receive U.S. data exclusivity, when the ground truth indicates MRK benefits in both regions. The reasoning is partially sound but contains key entity-specific inaccuracies, leading to flawed multi-hop synthesis. While the general regulatory mechanisms are described with semantic similarity, the company-specific application is reversed or oversimplified, reducing qualitative accuracy despite correct numbers and overall relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 345,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 192,
      "question": "How does the change in EMR's foreign currency liabilities from 2023 to 2024 compare with the scale of LMT's foreign currency hedge exposure, and what might this indicate about their respective foreign exchange risk management strategies?",
      "original_answer": "EMR's foreign currency liabilities decreased from $22 billion in 2023 to $20 billion in 2024, a $2 billion reduction, while LMT maintained $7.5 billion in outstanding foreign currency hedges at the end of 2024. This indicates that LMT is proactively hedging a significant portion of its foreign exchange exposure, whereas EMR appears to be reducing its overall foreign currency liability position rather than necessarily increasing hedging activity. The use of option contracts by LMT suggests a strategy focused on offsetting earnings volatility from exchange rate fluctuations, while EMR's declining liabilities may reflect either reduced international operations or a shift in risk management approach.",
      "llm_answer": "EMR’s foreign‑currency liabilities rose only modestly from 2023 to 2024 (≈ $0.2 billion), whereas Lockheed Martin’s foreign‑currency hedge exposure was $7.5 billion on December 31 2024【LMT_10k_2024.pdf: pages 50‑54】. The small change in EMR’s liabilities relative to LMT’s large hedge program suggests EMR has a comparatively limited FX exposure and a more modest hedging strategy, while LMT actively manages a substantial foreign‑exchange risk base.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. It states that EMR's foreign currency liabilities increased by approximately $0.2 billion from 2023 to 2024, but the ground truth shows a decrease from $22 billion to $20 billion—a $2 billion reduction. This is a significant quantitative inaccuracy that reverses the direction of change. Additionally, while the LMT hedge exposure of $7.5 billion in 2024 is correctly reported, the interpretation of EMR’s position is fundamentally flawed due to the incorrect trend. (2) The calculation and comparison are invalid because the core data about EMR is wrong. The claim of a 'modest rise' of $0.2 billion contradicts the actual $2 billion decline. No correct difference was computed. (3) The multi-hop reasoning fails because the model misrepresents EMR’s liability trend, leading to an incorrect conclusion about its FX risk strategy. The ground truth infers that EMR is reducing liabilities (possibly de-risking via balance sheet changes), whereas LMT uses active hedging (option contracts). The LLM incorrectly concludes EMR has 'limited FX exposure' and a 'modest hedging strategy' based on a false premise. It does not mention EMR’s liability reduction or the strategic implication of reducing exposure vs. hedging it. (4) The contextual relevance is moderate because the answer addresses the right companies and general topic (FX risk management), and correctly cites LMT’s $7.5 billion hedge. However, due to the critical error in EMR’s data, the comparison and resulting insights are invalid, severely undermining the answer’s correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 446,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 192,
      "question": "How does the $3.6 billion in dividends paid by AENB to AXP in 2023 relate to the leverage ratio requirements that both AENB and WFC are subject to under federal banking regulations?",
      "original_answer": "The $3.6 billion in dividends paid by AENB to AXP in 2023 is directly tied to AENB's compliance with leverage ratio requirements, as AENB must consider the impact of such distributions on its regulatory capital ratios. AENB, as a subsidiary bank of AXP, is subject to federal banking regulations that restrict dividend payments if they would cause the bank to fall short of required leverage ratios. Similarly, WFC, as a large bank holding company, is also subject to leverage and supplementary leverage ratio requirements under Basel III and FRB rules, which constrain its ability to make capital distributions like dividends. Therefore, both AENB and WFC must ensure that any dividend payments comply with these leverage constraints, making the $3.6 billion distribution by AENB a function of its ability to maintain required capital levels under the same type of regulatory framework that governs WFC.",
      "llm_answer": "The $3.6 billion of dividends that AENB paid to AXP in 2023 is a capital distribution that cuts into AENB’s Tier 1 capital—the numerator in its leverage ratio.  Under federal banking rules, both AENB and Wells Fargo must keep a minimum leverage ratio (Tier 1 capital divided by average total assets), a requirement that the FRB imposes on large bank‑holding companies and their insured depository institutions.  Consequently, the dividend payout must be factored into AENB’s capital planning to ensure the leverage ratio stays above the regulatory minimum, a constraint that applies equally to Wells Fargo.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers and dates are correct: the $3.6 billion dividend amount and the year 2023 are accurately stated, with no calculations required. (2) The answer correctly identifies the relevant entities: AENB, AXP, and WFC (Wells Fargo), and correctly associates them with federal banking regulations and leverage ratio requirements. (3) The reasoning is sound: it explains that the dividend reduces Tier 1 capital, which affects the leverage ratio (Tier 1 capital / average total assets), and notes that both AENB and WFC are subject to these rules. It correctly frames the dividend as a capital distribution that must be managed within regulatory constraints. (4) The only minor shortcoming is that it does not explicitly mention Basel III or the fact that AENB is a subsidiary of AXP, which adds contextual depth to the regulatory relationship—this slight omission prevents a perfect 10 on qualitative accuracy. However, the core multi-hop synthesis—linking AENB’s dividend, its impact on leverage ratio, and the parallel constraint on WFC—is logically and factually sound. The answer is fully contextually relevant and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 354,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does the geographic distribution of Microsoft's pre-tax income ($62.9B U.S. and $44.9B foreign in fiscal 2024) influence its exposure to the OECD's Pillar Two Model Rules, and how does this compare to Qualcomm's expected impact under the same Global Minimum Tax framework given their similar fiscal year 2025 implementation timeline?",
      "original_answer": "Microsoft's geographic distribution of pre-tax income shows significantly higher earnings in the U.S. ($62.9B) compared to foreign jurisdictions ($44.9B), which may reduce its exposure to the Pillar Two Model Rules since these rules target multinational enterprises with operations in low-tax jurisdictions. Microsoft notes it does not expect a material impact from Pillar Two. Similarly, Qualcomm acknowledges the global minimum tax framework will apply to them starting in fiscal 2025 and also states they do not expect a material impact on their financial statements, suggesting both companies anticipate minimal disruption from the same regulatory framework.",
      "llm_answer": "Microsoft’s 2024 pre‑tax income is roughly 58 % U.S. ($62.9 B) and 42 % foreign ($44.9 B).  Because the company has no material operations in jurisdictions with tax rates below the 15 % global minimum, the OECD Pillar Two rules are not expected to materially increase its tax costs.  The Qualcomm 10‑K pages referenced are not included in the material provided, so its anticipated impact under the same framework cannot be assessed from the supplied documents.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM correctly reports Microsoft's pre-tax income split ($62.9B U.S., $44.9B foreign) and accurately calculates the approximate percentages (58%/42%), which aligns with the ground truth. The statement that Microsoft does not expect a material impact from Pillar Two due to lack of material operations in low-tax jurisdictions is factually consistent with the original answer. However, the LLM fails to address Qualcomm's expected impact under Pillar Two, stating that the 10-K pages were not included—this is a critical omission because the original answer confirms Qualcomm also expects no material impact in fiscal 2025, which is a core part of the multi-hop comparison. 2) All numeric values and calculations are correct: $62.9B and $44.9B are accurately cited, and the implied total pre-tax income (~$107.8B) supports the 58%/42% split. 3) The reasoning for Microsoft’s limited exposure to Pillar Two is sound and reflects proper synthesis of geographic income distribution and tax policy implications. However, the model breaks down on the multi-hop requirement by not addressing Qualcomm’s position, despite the original answer confirming both companies anticipate minimal impact. This suggests either a data access failure or inability to synthesize cross-company information. 4) While the response is contextually relevant and well-structured, the failure to complete the comparative analysis significantly undermines completeness and qualitative accuracy. The answer should have mirrored the original by noting Qualcomm’s similar timeline and expected minimal impact, even if sourced from external knowledge. The correctness score is reduced due to this major gap in synthesis, though quantitative accuracy remains perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 470,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does WMT's $37.2 billion in unrecorded purchase obligations expose the company to financial risks that aren't captured by the VAR models used by peers like MDLZ?",
      "original_answer": "WMT has $37.2 billion in unrecorded purchase obligations as of January 31, 2025, which includes firm commitments for inventory, utility purchases, and capital expenditures. These obligations are legally binding but are not reflected on the balance sheet. However, according to DIS's 10-K filing, VAR models — like the one used by MDLZ — exclude forecasted transactions and firm commitments when estimating financial risk exposure. MDLZ's VAR model specifically uses a parametric delta-gamma approximation technique based on interest rate, currency, and commodity price movements to estimate potential one-day losses, but does not include firm commitments in its calculations. This means that while WMT has significant off-balance sheet obligations, companies using VAR models like MDLZ do not incorporate these types of commitments into their risk assessments, leaving WMT potentially more exposed to market volatility that isn't captured through standard VAR modeling practices.",
      "llm_answer": "Walmart’s $37.2 billion of unrecorded purchase obligations—binding contracts for inventory, capital expenditures, software, licenses and other services—represent a large contingent liability that could materialize into significant cash outflows. Because Walmart’s VAR model, like Mondelēz’s, excludes forecasted transactions, firm commitments and other non‑market‑sensitive obligations, the risk of these commitments is not reflected in the one‑day VAR estimate. Thus, the company faces liquidity and capital‑structure risk that is invisible to the VAR analysis used by peers such as MDLZ.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM correctly identifies Walmart's $37.2 billion in unrecorded purchase obligations, which matches the ground truth in amount and nature (inventory, capital expenditures, etc.). The figure is accurate and properly contextualized as off-balance sheet, legally binding commitments. 2) Quantitatively, the $37.2 billion figure is correct, and no calculations are required beyond accurate representation—this is handled properly. 3) However, the LLM incorrectly implies that Walmart uses a VAR model similar to Mondelēz (MDLZ), stating 'Walmart’s VAR model, like Mondelēz’s...'. The ground truth does not state that WMT uses a VAR model; rather, it contrasts WMT’s unrecorded obligations with the fact that MDLZ’s VAR model excludes firm commitments. This misattribution of a VAR model to WMT introduces a factual error in entity-metric linkage. Additionally, the ground truth cites DIS’s 10-K as the source for the claim about VAR models excluding firm commitments, which the LLM omits, weakening the multi-hop reasoning chain. 4) Despite this, the core insight—that unrecorded obligations represent a risk not captured by VAR models like MDLZ’s—is semantically preserved and relevant. The answer correctly links the exclusion of firm commitments from VAR models to incomplete risk visibility. Thus, while the central financial exposure point is valid and well-framed, the incorrect attribution of a VAR model to WMT and omission of DIS as a source reduce qualitative accuracy. Contextual relevance remains high as the response directly addresses the risk exposure question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 430,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does UNH's use of interest rate swaps to manage exposure to floating-rate liabilities compare with AMGN's use of similar instruments in relation to their respective $1.4 billion repayments of the 3.625% 2024 Notes?",
      "original_answer": "UNH uses interest rate swaps as part of its broader strategy to manage exposure to market interest rate fluctuations on both assets and liabilities, including $27 billion of floating-rate financial liabilities as of December 31, 2024. AMGN, on the other hand, specifically entered into interest rate swap contracts to convert fixed-rate coupons to floating-rate SOFR-based coupons, with $1.4 billion of such swaps maturing in 2024 in connection with the repayment of the 3.625% 2024 Notes. While both companies use interest rate swaps, UNH's application is broader in scope across its balance sheet, whereas AMGN's use is directly tied to specific debt instruments like the 3.625% 2024 Notes that were fully repaid in 2024.",
      "llm_answer": "UnitedHealth Group uses interest‑rate swaps as part of a broader strategy to match floating‑rate assets and liabilities—swaps are employed to offset the $27 billion of floating‑rate debt it holds (see pages 37–38 of the 10‑K).  Amgen, by contrast, tied its swap activity directly to the 3.625% 2024 Notes: a $1.4 billion notional of interest‑rate swaps matured in connection with the repayment of those notes (see pages 146–147).  Thus, UNH’s swaps are used to manage overall floating‑rate exposure, whereas Amgen’s swaps are specifically hedging the $1.4 billion repayment of the 3.625% 2024 Notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: UNH has $27 billion in floating-rate debt and uses swaps broadly to manage interest rate exposure; AMGN used $1.4 billion in interest rate swaps tied specifically to the 3.625% 2024 Notes, which matured and were repaid in 2024. (2) Quantitative accuracy is perfect: both dollar amounts ($27 billion and $1.4 billion), the interest rate (3.625%), and the year (2024) are correctly stated. Format variations (e.g., $1.4 billion vs $1.4 billion) are acceptable. (3) The multi-hop reasoning is sound—correctly contrasting UNH’s broad balance sheet-level use of swaps with AMGN’s instrument-specific hedging strategy tied to the note repayment. (4) The only minor shortcoming is that the LLM does not explicitly state that AMGN converted fixed-rate to floating-rate SOFR-based coupons, which is a detail present in the original answer. However, the essential point—that AMGN’s swaps were directly linked to the 3.625% 2024 Notes and matured with their repayment—is clearly conveyed. This omission slightly affects qualitative completeness but does not undermine the factual correctness or overall synthesis. Contextual relevance is excellent, directly addressing the comparative use of swaps in relation to the $1.4 billion repayment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 374,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 194,
      "question": "How does the potential acceleration of AMD's 3.924% Senior Notes Due 2032 in the event of an 'Event of Default' compare with Oracle's exposure to similar default-triggered obligations under their Revolving Credit Agreement, particularly in terms of debt repayment structure and maturity conditions?",
      "original_answer": "AMD's 3.924% Senior Notes Due 2032 could be accelerated upon an Event of Default, which would require AMD to repay $1.0 billion in aggregate principal issued in 2022, plus accrued interest. Oracle, under its Revolving Credit Agreement, also faces potential acceleration if an Event of Default occurs, with the full $6.0 billion facility becoming due unless terminated earlier. Unlike AMD's notes, which are unsecured senior obligations, Oracle's Revolving Facility allows borrowing, prepayment, and reborrowing until March 8, 2027, with interest rates tied to credit ratings. Both companies face significant financial obligations upon default, but Oracle's structure allows more flexibility in managing short-term liquidity.",
      "llm_answer": "AMD’s 3.924% Senior Notes are fixed‑maturity, general‑unsecured obligations due March 1, 2032, and an event of default “may result in the acceleration of the maturity” so the notes become immediately repayable. In contrast, Oracle’s $6 billion Revolving Credit Agreement is a revolving facility with a maturity of March 8, 2027; a default causes all outstanding borrowings to become due on that date rather than immediately. Thus, AMD’s default trigger leads to instant repayment of a specific debt instrument, whereas Oracle’s default trigger pushes all revolving debt to a single future maturity date.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AMD's 3.924% Senior Notes Due 2032 as unsecured obligations subject to acceleration upon an Event of Default, and Oracle's $6.0 billion Revolving Credit Agreement with a maturity date of March 8, 2027. However, it inaccurately states that Oracle's debt becomes due 'on that date' (i.e., March 8, 2027) upon default, whereas the ground truth indicates the full amount becomes due immediately upon default unless terminated earlier—similar to AMD's immediate repayment trigger. This misrepresents the timing of Oracle's repayment obligation. (2) Quantitatively, the LLM correctly reports the $6.0 billion facility size and the March 8, 2027 maturity date for Oracle, and correctly references the 2032 maturity for AMD's notes. However, it omits the $1.0 billion principal amount of AMD's notes issued in 2022, which is a key quantitative detail from the ground truth. (3) The reasoning correctly contrasts a fixed-maturity bond with a revolving credit facility, and highlights differences in repayment structure. However, the multi-hop synthesis is flawed in the conclusion about default-triggered timing: both instruments allow acceleration upon default, but the LLM incorrectly implies Oracle’s repayment is deferred to 2027 upon default, when in fact it becomes immediately due. This undermines the comparative analysis. (4) Despite this key error, the answer remains contextually relevant and captures the core contrast in debt structures—fixed vs. revolving—while accurately describing interest rate linkage to credit ratings (implied in Oracle's case). The omission of AMD's principal amount and the mischaracterization of Oracle's default consequence prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 471,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 195,
      "question": "How does the $31.0 billion of trust assets under reinsurance agreements at GE, which are subject to strict investment guidelines, compare to General Dynamics' $191 million in marketable securities held in trust as of December 31, 2021, in terms of investment policy and risk exposure?",
      "original_answer": "GE holds $31.0 billion in trust assets associated with reinsurance contracts and is subject to strict investment guidelines that include limitations on asset class concentration, issuer exposure, and duration variances, with a focus on diversification and credit quality while considering risk-based capital requirements. These trust assets are managed to support insurance liabilities and are reviewed periodically for asset allocation changes, including the potential inclusion of non-traditional asset classes. In contrast, General Dynamics held $191 million in marketable securities in trust as of December 31, 2021, governed by an investment policy that restricts purchases to investment-grade fixed-income securities with a maximum maturity of five years, indicating a more conservative and short-duration approach. This highlights a significant difference in scale and investment strategy between the two companies' trust asset management, with GE facing broader credit, interest rate, and reinvestment risks due to the larger and more diverse asset base.",
      "llm_answer": "GE’s $31 billion of trust assets under reinsurance agreements are managed under strict guidelines that limit concentration, single‑issuer exposure, and asset‑liability duration gaps, yet the policy still allows allocation to higher‑yielding non‑traditional assets (e.g., private equity, senior secured loans, infrastructure debt). This exposes GE’s trust portfolio to credit, interest‑rate, and equity risk. In contrast, General Dynamics’ $191 million of marketable securities held in trust are restricted to investment‑grade fixed‑income securities with maturities of five years or less, resulting in a much lower credit and duration risk profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GE's $31.0 billion in trust assets under reinsurance agreements and General Dynamics' $191 million in marketable securities as of December 31, 2021, are correctly stated. The dollar amounts match exactly, and the time reference for General Dynamics is accurate. (2) The investment policies are accurately described: GE’s strict guidelines include limitations on concentration, issuer exposure, and duration, with allowance for non-traditional assets like private equity and infrastructure debt—consistent with the original answer’s mention of potential inclusion of non-traditional asset classes. The LLM correctly identifies GE’s exposure to credit, interest rate, and equity risk due to broader asset allocation. For General Dynamics, the restriction to investment-grade fixed-income securities with maturities of five years or less is correctly reported, leading to lower risk—this matches the ground truth’s emphasis on a conservative, short-duration strategy. (3) Multi-hop reasoning is sound: the model successfully compares two different companies, financial instruments, investment policies, and risk profiles across distinct contexts (reinsurance trusts vs. corporate marketable securities). The synthesis of scale ($31B vs $191M) and risk implications is logically presented. (4) Minor deduction in qualitative accuracy: while the LLM captures the essence of GE’s policy, it does not explicitly mention periodic review for asset allocation changes or the focus on risk-based capital requirements, which are part of the original answer. However, these omissions do not undermine the core correctness. Wording differences are acceptable under semantic equivalence. Overall, the answer is factually correct, contextually appropriate, and demonstrates strong reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 507,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 195,
      "question": "How do the observable market data inputs used in Lockheed Martin's fixed income pricing models compare to the inputs used in PayPal's derivative valuations, given both institutions rely on Level 2 pricing methodologies?",
      "original_answer": "Lockheed Martin's fixed income investments categorized as Level 2 are valued using pricing models that incorporate verifiable observable market data such as interest rates, yield curves at commonly quoted intervals, and credit spreads. Similarly, PayPal values a majority of its derivative instruments using pricing models that consider observable inputs like currency rates, interest rate yield curves, option volatility, and equity prices. Both institutions rely on Level 2 methodologies, indicating a shared dependence on observable market factors to determine fair value, although applied to different asset classes—fixed income for Lockheed Martin and derivatives for PayPal.",
      "llm_answer": "Lockheed Martin’s Level‑2 fixed‑income models are built on observable market data such as interest‑rate curves, credit‑spreads and broker/dealer bids or quoted prices for comparable securities. PayPal’s Level‑2 derivative valuations, by contrast, use a broader set of observable inputs—including currency rates, interest‑rate curves, option volatilities and equity prices—to price its contracts. Both rely on Level‑2 pricing, but Lockheed Martin focuses on fixed‑income market data while PayPal incorporates a wider range of market inputs for its derivatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All entities—Lockheed Martin, PayPal, Level 2 pricing, fixed income, and derivatives—are correctly identified and appropriately contextualized. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in the question or ground truth, so quantitative accuracy is not applicable; however, the absence of numerical errors supports a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies use Level 2 inputs (observable market data) but apply them to different asset classes—Lockheed Martin to fixed income (using interest rate curves, credit spreads, broker/dealer quotes), PayPal to derivatives (using currency rates, interest rate curves, option volatility, equity prices). The LLM adds a minor detail—'broker/dealer bids or quoted prices for comparable securities'—which is consistent with Level 2 methodology and plausible for fixed income pricing, though not explicitly in the original answer; this does not detract from accuracy. (4) The answer captures the core comparison: shared reliance on observable inputs under Level 2, applied to different financial instruments. Wording differs slightly (e.g., 'broader set' vs. 'similarly'), but the reasoning and factual content align. One point deducted from qualitative accuracy due to slight overstatement of contrast ('broader set') not present in the neutral comparison of the original. Overall, the response is highly accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 430,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 196,
      "question": "How does the sensitivity of AVGO's fixed rate senior notes to interest rate changes compare to the impact of CSCO's interest rate swap on their fixed-rate debt, given both companies' exposure to market interest rate fluctuations?",
      "original_answer": "AVGO's $56.3 billion in fixed rate senior notes as of November 3, 2024, would see a $1.7 billion change in fair value with a 50 basis point interest rate shift, while CSCO has an interest rate swap with a notional amount of $0.5 billion that converts a portion of its fixed-rate debt to floating, offsetting changes in fair value due to interest rate movements. CSCO’s swap specifically hedges a senior note due in fiscal 2025, whereas AVGO uses treasury rate lock contracts to hedge anticipated future debt issuances, indicating differing hedging strategies despite both managing interest rate risk on fixed-rate debt.",
      "llm_answer": "Broadcom’s fixed‑rate senior notes are materially sensitive to market rates – a 50‑basis‑point move would shift their fair value by roughly $1.7 billion. In contrast, Cisco’s $0.5 billion notional interest‑rate swap is a fair‑value hedge that converts the fixed‑rate portion to floating, so the swap’s gain/loss offsets the fair‑value change of the hedged debt, effectively neutralizing that exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core comparison between AVGO's and CSCO's interest rate sensitivities and hedging strategies. (1) Quantitatively, all numbers are correct: AVGO's $1.7 billion fair value change from a 50 bps shift and CSCO's $0.5 billion notional swap are accurately reported. The original answer specifies AVGO has $56.3 billion in fixed-rate notes, which the LLM omits, but this does not affect the correctness of the sensitivity figure provided. (2) The explanation of CSCO’s swap as a fair-value hedge that offsets changes in the hedged debt’s fair value is factually sound and aligns with the ground truth. (3) The multi-hop reasoning is strong: the model correctly contrasts AVGO’s direct exposure (with sensitivity quantified) against CSCO’s offsetting hedge mechanism, even though the specific mention of AVGO’s treasury rate lock contracts (used for future debt issuance hedges) is omitted. (4) Despite this minor omission, the LLM conveys the essential contrast in hedging approaches and correctly identifies the functional impact: CSCO neutralizes exposure on the hedged portion, while AVGO remains exposed but manages risk differently. Wording differs but semantic meaning is equivalent. No irrelevant or incorrect information is introduced. Thus, the answer is fully contextually relevant and nearly complete, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 390,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 196,
      "question": "How does BMY's joint research and commercialization obligations with Pfizer under the Eliquis alliance compare to Pfizer's financial commitments in its collaboration with Beam for in vivo base editing programs, particularly in terms of upfront payments and potential milestone obligations?",
      "original_answer": "BMY and Pfizer share joint research and commercialization responsibilities under the Eliquis alliance, with Pfizer receiving co-exclusive license rights in exchange for an upfront payment and potential milestone payments, which are being amortized over BMY’s co-promotion obligation period. Separately, Pfizer paid Beam $300 million upfront upon entering their collaboration for in vivo base editing programs and may pay up to an additional $1.05 billion in development, regulatory, and commercial milestone payments across three targets, for a total potential deal value of $1.35 billion. This shows that Pfizer’s financial commitment to Beam could significantly exceed its initial payments under the Eliquis alliance, depending on development progress and milestone achievements.",
      "llm_answer": "BMY’s Eliquis alliance with Pfizer involves an upfront payment (the amount is not disclosed in the filing) and potential milestone payments tied to development, regulatory approval and sales milestones, which are recorded as deferred income and amortized over the exclusivity period. In contrast, Pfizer’s collaboration with Beam requires a $300 million upfront payment and could trigger up to $1.05 billion in development, regulatory and commercial milestone payments—making the total potential deal consideration $1.35 billion. Thus, while BMY’s upfront outlay is undisclosed, its milestone obligations are similar in nature but unspecified, whereas Pfizer’s Beam deal has a clearly defined $300 million upfront cost and a sizable, quantified milestone potential.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $300 million upfront payment, up to $1.05 billion in milestone payments, and total potential deal value of $1.35 billion are accurately reported. These match the original answer exactly, with acceptable formatting (e.g., $300 million vs $300 million). (2) The LLM correctly notes that BMY’s upfront payment from Pfizer under Eliquis is not disclosed, which is consistent with the ground truth stating it is being amortized but not specifying the amount. (3) The qualitative reasoning is sound: the comparison between the two collaborations correctly highlights that while Eliquis involves undisclosed financials (upfront and milestones), the Beam deal has clearly defined and substantial financial commitments from Pfizer. (4) The multi-hop synthesis across BMY-Pfizer (Eliquis) and Pfizer-Beam collaborations is accurate and relevant. The only minor shortcoming is that the LLM does not explicitly state that Pfizer made the upfront payment *to Beam* (though context implies it), and slightly underemphasizes that the Eliquis arrangement involves *joint* responsibilities and co-exclusive licensing, which the original answer clarifies. However, these omissions do not detract significantly from the overall correctness. Semantic equivalence is maintained, and the core financial comparison is precise and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 397,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How do Texas Instruments' accounting practices for lease extension and termination options compare with Cisco's treatment of similar provisions in their customer financing arrangements, particularly regarding the impact on long-term liabilities and revenue recognition?",
      "original_answer": "Texas Instruments accounts for lease extension and termination options by recognizing lease assets and liabilities based on the present value of lease payments when it is reasonably certain they will be exercised, using their incremental borrowing rate. This affects long-term liabilities on their balance sheet. Cisco, on the other hand, includes similar extension and termination provisions in its customer financing arrangements, which are primarily collateralized and affect the timing of revenue recognition. Cisco also defers revenue on arrangements involving guarantees until the risk is removed. Both companies incorporate these options into their financial reporting, but with different implications: TXN affects liability valuation, while CSCO affects revenue timing and credit exposure.",
      "llm_answer": "Texas Instruments records lease‑extension and termination options in the lease liability when it is reasonably certain that the option will be exercised, thereby increasing its long‑term liabilities and recognizing lease expense on a straight‑line basis over the lease term (TXN, pp. 33‑37). Cisco’s customer‑financing leases also contain similar options, but as a lessor the options affect the lease receivable and the timing of revenue—sales‑type leases generate revenue at commencement and operating leases are recognized ratably—without adding to long‑term liabilities (CSCO, pp. 50‑54). Thus, TI’s practice expands its liability balance, whereas Cisco’s practice primarily influences revenue timing rather than liability balance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Texas Instruments includes lease extension and termination options in its lease liability when it is reasonably certain they will be exercised, impacting long-term liabilities—consistent with TXN's use of incremental borrowing rate and present value of lease payments. The impact on liability valuation is accurately portrayed. (2) For Cisco, the LLM correctly distinguishes its role as a lessor in customer financing arrangements, noting that such options affect revenue timing and lease receivables rather than liabilities. It accurately reflects that sales-type leases recognize revenue at commencement and operating leases are recognized ratably, which matches CSCO’s revenue recognition policy. The deferral of revenue under guarantees (mentioned in ground truth) is not explicitly stated but is contextually covered by the focus on revenue timing. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies, different lease roles (lessee vs. lessor), and distinct financial statement impacts (liabilities vs. revenue). (4) Minor omission: the LLM does not mention collateralization or credit exposure (part of CSCO’s risk management), which slightly reduces completeness. However, the core financial implications for both companies are correctly captured. No numeric inaccuracies; all statements are qualitatively and contextually aligned with the original answer. Formatting references (e.g., page numbers) are plausible and consistent with source documentation style.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 442,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does Disney's 73% stake in National Geographic influence the content differentiation strategy on Disney+, and what implications does this have for subscriber acquisition costs relative to YouTube's content licensing model?",
      "original_answer": "Disney's 73% stake in National Geographic allows it to integrate National Geographic-branded programming directly into Disney+ as a top-level tile within the interface, providing exclusive access to content that is not subject to third-party licensing fees (chunk 1 and chunk 2). This vertical integration reduces dependency on external content providers and lowers long-term content acquisition costs. In contrast, YouTube, as a digital video service competitor, relies more heavily on licensed and third-party content, which may involve ongoing licensing expenditures (chunk 3). This structural advantage could give Disney+ a cost edge in subscriber acquisition by leveraging proprietary content like National Geographic to attract and retain users at a lower marginal cost than YouTube.",
      "llm_answer": "Disney’s 73 % ownership of National Geographic gives the company control over a large library of documentary and nature programming that is highlighted as a distinct “National Geographic” tile on Disney+, creating clear content differentiation from rivals. Because Disney can supply this content in‑house, it reduces the need to pay high third‑party licensing fees, thereby lowering subscriber‑acquisition costs. In contrast, YouTube’s model relies on licensing third‑party content to build its library, which can drive higher acquisition costs for subscribers. [Disney 10‑K, p.13] [Google 10‑K, p.6]",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 73% ownership stake is correctly stated, and no other numerical values (e.g., costs, subscriber numbers) are misstated—only qualitative financial implications are discussed, which match the original. Format variations (e.g., '73 %' vs '73%') are acceptable. (2) The answer addresses both parts of the multi-hop question: how Disney's stake enables content differentiation on Disney+ (via the dedicated National Geographic tile and exclusive content), and the cost implications relative to YouTube’s licensing model. (3) Entity accuracy is strong: Disney, National Geographic, Disney+, YouTube, and correct references to 10-K filings (Disney p.13, Google p.6) are properly cited. (4) Reasoning is sound—vertical integration reduces licensing costs, which lowers subscriber acquisition costs; contrast with YouTube’s reliance on third-party licensing is logically drawn. The only minor shortcoming is a slight lack of explicit mention that National Geographic content is integrated without third-party fees *because* of Disney’s controlling stake (though this is implied), and the original answer emphasizes the 'top-level tile' as a structural interface feature contributing to differentiation, which the LLM captures but could have phrased more precisely. Overall, the semantic meaning, factual accuracy, and multi-hop synthesis are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 396,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does the impact of regulatory exclusivity expiration timelines on BMY's biologic products compare to MRK's experience with Januvia family market exclusivity delays, considering the role of regulatory exclusivity in extending market protection beyond patent terms?",
      "original_answer": "BMY's biologic products, such as Opdivo and Yervoy, benefit from 12 years of regulatory exclusivity in the U.S., which prevents the FDA from approving biosimilars until 12 years after initial approval. This regulatory exclusivity can extend beyond patent terms and provide additional market protection. In contrast, MRK's Januvia family of products saw their key U.S. patent expire in January 2023, but due to favorable court rulings and settlement agreements on a later-expiring salt-form patent, MRK expects to maintain market exclusivity until May 2026 for Januvia and Janumet and July 2026 for Janumet XR. This shows that while BMY relies on the standard 12-year biologic exclusivity framework, MRK was able to extend market exclusivity for its chemical products through litigation and secondary patents, highlighting different strategies and outcomes tied to regulatory exclusivity mechanisms.",
      "llm_answer": "BMY’s biologic products enjoy a statutory 12‑year regulatory exclusivity that extends market protection beyond the life of any patents, with estimated minimum exclusivity dates in the mid‑2030s (e.g., Breyanzi 2033, Abecma 2036).  In contrast, Merck’s Januvia family has delayed loss of exclusivity through patent litigation and settlement agreements, keeping Januvia and Janumet protected in the U.S. until May 2026 and Janumet XR until July 2026, thereby extending market protection beyond the original patent term.  Both companies rely on exclusivity mechanisms that surpass patent life, but BMY’s is a fixed regulatory period while Merck’s is achieved via legal and settlement actions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in specificity. (1) Quantitatively, all dates and exclusivity periods are correct: MRK's Januvia and Janumet protected until May 2026, Janumet XR until July 2026 — matching the original answer. The 12-year U.S. regulatory exclusivity for BMY’s biologics is correctly stated. While the LLM cites Breyanzi (2033) and Abecma (2036) as examples not in the original, these are plausible and consistent with the 12-year framework; their inclusion adds detail without introducing error. (2) The original answer highlights Opdivo and Yervoy, while the LLM uses different BMY biologics — a difference in emphasis, not accuracy. (3) The reasoning correctly contrasts BMY’s reliance on statutory regulatory exclusivity with MRK’s use of litigation and settlement agreements to extend protection beyond the base patent term (Januvia’s 2023 patent expiry), capturing the multi-hop comparison between regulatory vs. legal strategies. (4) The LLM accurately synthesizes that both companies extend market protection beyond patents, but through different mechanisms — a key conceptual point. The answer is semantically equivalent, well-structured, and contextually complete. One point deducted from correctness due to slightly less representative product examples for BMY, though not factually wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 387,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does MetLife's issuance of 40,000 shares of Series F preferred stock, with redemption terms tied to a 'rating agency event,' intersect with AIG's exposure to financial risks from potential rating downgrades, particularly given AIG's acknowledgment that a downgrade could limit its ability to write new business and impair customer retention?",
      "original_answer": "MetLife has issued 40,000 shares of Series F preferred stock, which includes a redemption clause triggered by a 'rating agency event'—defined as a change in rating criteria that lowers equity credit assigned to such securities. This creates a financial contingency for MetLife should credit agencies revise their treatment of these instruments. Similarly, AIG acknowledges in its 10-K that a downgrade in its Insurer Financial Strength ratings could materially impair its ability to write new business and retain customers. Therefore, both companies face strategic and operational risks tied to rating agency actions, with MetLife facing potential redemption obligations and AIG facing direct business constraints due to a potential loss of creditworthiness.",
      "llm_answer": "MetLife’s 40,000‑share Series F preferred stock carries a redemption clause that can be triggered within 90 days of a “rating agency event” (pages 260‑266), meaning a downgrade could force early redemption and a cash outflow. AIG’s risk disclosures (pages 83‑87) note that a rating downgrade could limit its ability to write new business and impair customer retention, thereby affecting revenue and capital. Thus, both firms face financial exposure to rating‑agency actions: MetLife to a direct capital outflow from preferred‑stock redemption, and AIG to a loss of underwriting volume and customer base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: MetLife's issuance of 40,000 shares of Series F preferred stock is accurately stated. The mention of a redemption clause triggered by a 'rating agency event' is factually consistent, and while the LLM adds specificity (e.g., 'within 90 days'), this does not contradict the ground truth and may reflect actual filing details (e.g., from 10-K pages 260–266 cited). (2) The comparison to AIG is correctly grounded: AIG’s exposure to rating downgrades affecting new business and customer retention is accurately summarized, consistent with its 10-K disclosures (pages 83–87). (3) Multi-hop reasoning is sound—both companies are linked through exposure to rating agency actions, with distinct consequences: MetLife faces potential cash outflows from redemption, while AIG faces operational and revenue risks. This synthesis across two firms and their respective risks is logically and factually correct. (4) The only minor shortcoming is the LLM’s addition of a '90 days' timeframe, which, while likely accurate from the filing, is not present in the ground truth and introduces a detail not confirmed by the reference. However, this does not detract from correctness, as it doesn't contradict the core logic. Wording differs slightly (e.g., 'underwriting volume' vs 'write new business'), but semantic equivalence is maintained. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 417,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does the use of matrix pricing for U.S. Government Securities differ between LMT's portfolio as of December 31, 2021, and UPS's valuation methodology for similar assets, based on their respective Level 2 classifications?",
      "original_answer": "LMT reported $121 million in U.S. Government Securities as of December 31, 2021, which were classified under Level 2 inputs, indicating they were valued using matrix pricing or similar methods when broker quotes were unavailable. UPS also utilized matrix pricing for Level 2 marketable securities, including U.S. government debt, though the specific amount was not disclosed. Both companies rely on matrix pricing as a fallback when direct market data is not available, aligning with the broader accounting policy described by MO, which lists matrix pricing as a standard valuation technique for government securities when broker quotes are absent.",
      "llm_answer": "LMT’s Level 2 U.S. government securities are valued with matrix pricing when broker quotes are not available – the company treats these bonds as Level 2 and applies a model that uses observable inputs such as yield curves and indices (see the valuation‑methodology note for LMT). In contrast, UPS classifies most U.S. government debt as Level 1, valuing them with observable market quotes, and reserves matrix pricing for its Level 2 securities (asset‑backed securities, corporate bonds and municipal bonds) rather than for U.S. government securities.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in both entity-specific valuation methodologies and classifications, despite correctly identifying matrix pricing as a technique used in Level 2 valuations. (1) Quantitatively, the original answer states that LMT reported $121 million in U.S. Government Securities classified as Level 2 as of December 31, 2021—this specific figure is missing from the LLM response, reducing quantitative accuracy. (2) More critically, the LLM incorrectly claims that UPS classifies most U.S. government debt as Level 1 and does not use matrix pricing for such securities, which contradicts the ground truth stating that UPS *does* use matrix pricing for Level 2 marketable securities including U.S. government debt. This misrepresents UPS’s methodology and breaks the multi-hop comparison. (3) The reasoning is flawed: the LLM creates a false contrast between LMT and UPS, suggesting divergent practices, while the original answer emphasizes alignment in using matrix pricing for U.S. government securities when broker quotes are unavailable. (4) The mention of MO’s policy supporting matrix pricing as a standard technique is entirely omitted, weakening the synthesis. While the LLM correctly associates matrix pricing with Level 2 inputs and observable models, the core comparative conclusion is incorrect, warranting a low correctness and qualitative accuracy score. Contextual relevance is moderate as the response addresses the right topic and framework but draws wrong inferences.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 417,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does PM's use of market inputs for derivative valuations compare to MDLZ's approach for its real estate fund investments, given the differing levels of observability in their respective valuation models?",
      "original_answer": "PM values its derivative contracts using standard valuation models based on readily observable market inputs such as foreign exchange spot rates, interest rate differentials, and maturity dates. In contrast, MDLZ values its real estate fund investments using the present value of future cash flows, relying on unobservable inputs like projected operating performance and local market conditions. While PM's approach falls under Level 1 or 2 fair value measurements due to the use of observable data, MDLZ's real estate fund valuations are categorized as Level 3 due to the reliance on unobservable inputs that cannot be corroborated by market data.",
      "llm_answer": "PMI’s derivative contracts are valued with readily observable market inputs—spot rates, interest‑rate differentials, volatilities and futures prices—so the fair value is classified as Level 2. In contrast, MDLZ’s real‑estate funds are valued by investment managers using present‑value models that rely on appraisals, local market conditions and projected cash flows, inputs that are largely unobservable and are therefore classified as Level 3 fair value. Thus, PMI’s valuations are based on transparent, observable data, whereas MDLZ’s real‑estate valuations depend on more subjective, unobservable inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that PM (PMI) uses observable market inputs—spot rates, interest-rate differentials, volatilities, and futures prices—for valuing derivatives, leading to a Level 2 classification, which aligns with the original answer’s assertion of Level 1 or 2 (Level 1 is not explicitly supported here, but Level 2 is consistent). MDLZ’s real estate fund valuations are correctly described as using present-value models with unobservable inputs like appraisals, local market conditions, and projected cash flows, resulting in a Level 3 classification—this matches the ground truth exactly. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense, but all qualitative data points are factually correct. (3) The multi-hop reasoning is sound: the model correctly contrasts two different companies’ valuation approaches across different asset types (derivatives vs. real estate funds), links them to fair value hierarchy levels, and explains the basis in observability—this demonstrates proper synthesis across entities and concepts. (4) Minor difference: the original answer mentions 'maturity dates' as an input for PM, which the LLM omits, and the LLM adds 'volatilities' and 'futures prices' not in the original—these are plausible but not confirmed in the ground truth. Also, the original allows for Level 1 or 2, while LLM specifies Level 2; this is a slight narrowing but still within acceptable range given that derivatives using models with observable inputs typically fall into Level 2. Overall, the semantic meaning, factual content, and reasoning are substantially equivalent and correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 485,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does MetLife's repayment strategy for its junior subordinated debentures compare to AIG's obligations under the AIGLH-issued junior subordinated debentures, particularly in terms of liquidity constraints and deferral provisions?",
      "original_answer": "MetLife has provisions allowing it to defer interest payments on its junior subordinated debentures under certain conditions, which in turn triggers dividend stopper provisions. Additionally, MetLife is subject to replacement capital covenants that require it to raise specified replacement securities before repaying, redeeming, or purchasing the debentures. In contrast, AIG's obligations under the AIGLH-issued junior subordinated debentures include specific maturities such as $54 million of 8.5% debentures due in 2030, $142 million of 8.125% debentures due in 2046, and $31 million of 7.57% debentures due in 2045, all of which are guaranteed by AIG Parent. However, AIG does not guarantee any of the borrowings of AIGLH post-distribution of debentures, indicating a different liquidity risk profile compared to MetLife's structured repayment and deferral constraints.",
      "llm_answer": "MetLife’s junior‑subordinated debentures can have interest payments deferred at its option, but any elective deferral triggers dividend‑stopper provisions and the company is bound by replacement‑capital covenants that require cash proceeds from the sale of replacement securities before any repayment, redemption or purchase—effectively imposing liquidity constraints (MET_10‑K_2022, pp. 128‑132). In contrast, AIG’s AIGLH junior‑subordinated debentures are simply guaranteed by AIG Parent, carry fixed maturities and coupon rates, and the 10‑K does not disclose any deferral rights or liquidity‑related covenants, so AIG’s obligations are straightforward without such constraints (AIG_10‑K_2022, p. 288).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core differences between MetLife and AIG regarding deferral provisions and liquidity constraints. It accurately notes MetLife's deferral option, dividend stopper provisions, and replacement capital covenants, which impose liquidity constraints. For AIG, it correctly identifies that the AIGLH-issued debentures are guaranteed by AIG Parent and carry fixed maturities and coupons. However, the LLM omits specific quantitative details from the ground truth: the exact amounts ($54M, $142M, $31M) and maturities (2030, 2045, 2046) of the AIGLH debentures, as well as their respective interest rates (8.5%, 8.125%, 7.57%). These omissions reduce completeness but do not distort the overall comparison. (2) Quantitative accuracy is high—no incorrect numbers are presented, and the absence of numbers is not a factual error, though the missing specifics lower completeness. The LLM does not misstate any dollar amounts, dates, or percentages. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across MetLife and AIG filings, comparing deferral rights, covenants, and guarantee structures. It draws a valid qualitative contrast between MetLife’s structured constraints and AIG’s more straightforward obligations. (4) The answer is contextually relevant and well-structured, directly addressing the comparison in terms of liquidity and deferral. The omission of specific debenture details prevents a top score, but the reasoning and entity identification (MetLife, AIG, AIGLH, junior subordinated debentures) are accurate. Hence, correctness is 8 due to missing specifics, but qualitative and quantitative accuracy remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 465,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "How does NVIDIA's competitive positioning against Samsung in the SoC and GPU markets influence Intel's strategic challenges in scaling its IFS Foundry Services, particularly given Intel's historical manufacturing delays and competitive pressures?",
      "original_answer": "NVIDIA competes with Samsung in the SoC and GPU markets, which are critical to automotive, gaming, and accelerated computing applications. Samsung is also a key competitor to Intel's IFS Foundry Services, which Intel established as part of its IDM 2.0 strategy to become a major foundry provider. Intel highlights that IFS must compete with established players like Samsung on multiple fronts including time-to-market, process performance, and ecosystem support. However, Intel's history of manufacturing delays, such as the setbacks with its 10nm and Intel 4 (formerly 7nm) process technologies, creates a disadvantage compared to Samsung's mature foundry capabilities. These delays have already impacted Intel's product competitiveness and gross margins, and could hinder IFS's ability to attract customers in a market where timely access to advanced processes is critical. Therefore, NVIDIA's competitive pressure on Samsung indirectly affects Intel's ability to scale IFS, as Samsung remains a dual threat both in end-product markets and in the underlying manufacturing ecosystem.",
      "llm_answer": "NVIDIA’s rivalry with Samsung in both SoC and GPU segments underscores Samsung’s strong design‑and‑manufacturing capabilities (NVDA 10‑K, pp. 13‑17).  Intel’s IFS Foundry Services must compete for the same customers that Samsung serves, but its own historical delays—such as setbacks in 10 nm and Intel 4 nodes—have eroded confidence and limited its ability to deliver on time and at high yields (INTC 10‑K, pp. 52‑56).  These delays, coupled with Samsung’s proven SoC and GPU expertise, intensify the challenge of scaling IFS and winning market share against established foundries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: NVIDIA competes with Samsung in SoC and GPU markets; Samsung is a foundry competitor to Intel's IFS; Intel has faced manufacturing delays in 10nm and Intel 4 processes; these delays impact IFS's ability to scale. No numeric values (e.g., dates, percentages, dollar amounts) are present in either answer, so quantitative accuracy is not compromised. (2) The LLM correctly cites relevant sections of NVIDIA and Intel 10-K filings (pp. 13–17 and 52–56), supporting its claims with appropriate source references. (3) The multi-hop reasoning is sound: it connects NVIDIA’s competition with Samsung to Samsung’s broader foundry strength, then links that to Intel’s challenge in scaling IFS due to its own delays. The indirect pressure on Intel via Samsung’s dual role (as product competitor and foundry) is implied, though slightly less explicitly articulated than in the original answer. (4) The answer is semantically equivalent to the ground truth—wording differs but meaning is preserved. The only minor gap is that the LLM does not explicitly mention the impact on Intel’s gross margins or the IDM 2.0 strategy context, which slightly reduces completeness. However, the core strategic challenge is clearly conveyed. Thus, correctness is high but not perfect, warranting a 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 382,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "Given that Alphabet repurchased $62.0 billion in Class A and Class C shares in 2024, how does the difference in voting rights between Class A and Class B shares at both Alphabet and Comcast impact their respective share repurchase strategies, particularly in light of Comcast's concentrated ownership of Class B shares by a single individual?",
      "original_answer": "Alphabet's share repurchase strategy in 2024 focused on Class A and Class C shares, with $62.0 billion repurchased, while maintaining the balance between voting classes since Class B shares automatically convert to Class A upon sale. This preserves the concentrated voting power of Class B holders. Similarly, Comcast's Class B shares, which carry 15 votes per share and represent 33⅓% of the combined voting power, are entirely owned by Brian L. Roberts. This concentrated ownership influences Comcast's repurchase strategy, as repurchases of Class A shares increase the relative voting power of the Class B shares. Both companies manage their share structures to maintain governance control while returning capital to shareholders.",
      "llm_answer": "Alphabet’s repurchase program targets only Class A (one vote per share) and Class C (no voting rights) shares, deliberately avoiding its 10‑vote Class B shares that are held by controlling shareholders, so the buy‑backs do not dilute voting power (GOOGL, pp. 80‑84). Comcast likewise repurchases only Class A shares (one vote per share) and not its 15‑vote Class B shares, which are wholly owned by Mr. Roberts; this preserves the concentrated voting power of the single owner while still returning capital to the broader shareholder base (CMCSA, pp. 29‑33, 65‑69).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Alphabet repurchased $62.0 billion in Class A and C shares in 2024 (implied by context), and the strategy avoids Class B shares, which carry 10 votes and are held by controlling shareholders. The automatic conversion of Class B to Class A upon sale is omitted but not contradicted. Comcast's Class B shares carry 15 votes and are wholly owned by Brian L. Roberts (referred to correctly as Mr. Roberts), and repurchases are limited to Class A shares. (2) Quantitative accuracy is perfect: no incorrect numbers, percentages, or dollar amounts; the $62.0 billion figure is consistent with the question and original answer. (3) Multi-hop reasoning is sound: the model correctly synthesizes governance implications of share structures at both Alphabet and Comcast, linking repurchase strategies to voting power preservation. The only minor omission is that the original answer notes Class B shares at Alphabet convert to Class A upon sale—a mechanism reinforcing control—which the LLM answer does not mention, slightly reducing completeness. (4) Contextual relevance is excellent: the response directly addresses the impact of voting rights on repurchase strategies at both firms, aligns with the documents cited (GOOGL and CMCSA), and maintains focus on governance and capital return trade-offs. Wording differs but semantic meaning matches. Thus, a 9/10 correctness score reflects near-perfect accuracy with a minor gap in depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 425,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "How does Amgen's focus on NSCLC therapies compare with Bristol Myers Squibb's recent FDA approval of Opdivo Qvantig in terms of administration method and potential market expansion for adult solid tumor indications?",
      "original_answer": "Amgen's 2024 disclosures highlight its strategic focus on NSCLC therapies, indicating a strong commitment to oncology innovation. Meanwhile, Bristol Myers Squibb's FDA approval in December 2024 for Opdivo Qvantig enables subcutaneous administration for most previously approved adult solid tumor indications of Opdivo, either as monotherapy, maintenance therapy, or in combination with chemotherapy or cabozantinib. This administration route offers a more convenient alternative to traditional intravenous delivery, potentially expanding market access and improving patient adherence. The combination of Amgen’s ongoing NSCLC development and BMS’s subcutaneous innovation in Opdivo Qvantig reflects divergent strategies in addressing the same therapeutic area, with BMS leveraging delivery mechanism improvements to enhance market positioning in solid tumor oncology.",
      "llm_answer": "Amgen’s 2024 10‑K shows a focus on oral small‑molecule NSCLC agents—particularly its KRAS G12C inhibitor—which would be taken orally and target a mutation‑specific subset of NSCLC patients. In contrast, BMS’s 2024 10‑K notes that the FDA approval of Opdivo Qvantig provides a subcutaneous formulation of nivolumab that expands the adult solid‑tumor portfolio to most previously approved adult solid‑tumor Opdivo indications, broadening its market reach and convenience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Amgen's focus on oral small-molecule NSCLC therapies, specifically the KRAS G12C inhibitor, which is consistent with Amgen’s 2024 disclosures on targeted NSCLC innovation. This contrasts appropriately with BMS’s Opdivo Qvantig, approved by the FDA in December 2024 (implied in original answer), with the LLM correctly noting the subcutaneous administration method. (2) There are no explicit numerical values, percentages, or dates in the LLM answer, but the reference to 2024 is consistent with the original answer’s timeline, and no incorrect quantitative claims are made—thus quantitative accuracy is full. (3) The multi-hop reasoning is sound: the model synthesizes Amgen’s strategic focus (from its 10-K) with BMS’s regulatory advancement and correctly contrasts administration methods (oral vs. subcutaneous) and implications for market expansion. The LLM captures that Opdivo Qvantig extends to most previously approved adult solid tumor indications, which matches the original. (4) The only minor shortcoming is that the LLM does not explicitly mention the combination regimens (e.g., with chemotherapy or cabozantinib) or the potential impact on patient adherence and market access as emphasized in the original answer. While the broader market reach and convenience are noted, this slight omission in clinical context prevents a perfect 10 on qualitative accuracy. However, the core facts, entities, and reasoning are correct and relevant, making the answer semantically equivalent in intent and substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 440,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 201,
      "question": "Given CMCSA's non-dilutable 33 1/3% voting power protection for Class B shares and the conversion mechanism to Class A shares, how does this structure limit GOOGL's influence despite its stake in Class A common stock?",
      "original_answer": "CMCSA's capital structure protects 33 1/3% of the voting power through Class B shares, which cannot be diluted by additional issuances of common stock. Each Class B share converts on a 1:1 basis into Class A shares, but this conversion is subject to restrictions. Meanwhile, GOOGL holds a stake in Class A common stock, which carries voting rights that could otherwise influence corporate decisions. However, due to CMCSA's structural protections, even if all Class B shares were converted to Class A, the non-dilutable voting safeguard would still preserve the 33 1/3% voting control, limiting GOOGL’s ability to shift governance outcomes through its Class A stake alone.",
      "llm_answer": "Comcast’s charter gives each Class B share 15 votes and guarantees that the aggregate voting power of all Class B shares is 33 ⅓ % of the company’s total voting power (Note 12, pages 67‑71 and 89‑93).  Because that 33 ⅓ % cannot be diluted by new issuances of any other class of stock, Alphabet’s stake in the Class A shares is capped by the protected Class B block.  The share‑for‑share conversion of Class B to Class A is limited to the existing Class B shares and does not alter the overall voting‑power split, so Alphabet’s influence remains constrained despite its Class A holdings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key figures are correct: the 33 1/3% voting power protection for Class B shares is accurately stated, and the non-dilutable nature of this block is correctly emphasized. The reference to Note 12 and page numbers adds precision, though not required, and does not detract. (2) The answer correctly explains that GOOGL (referred to as Alphabet) holds Class A shares whose influence is structurally capped due to the protected voting power of Class B shares. (3) The reasoning accurately captures the multi-hop logic: even if Class B shares convert to Class A on a 1:1 basis, the voting structure preserves the 33 1/3% control block, thereby limiting external influence from Alphabet's Class A stake. (4) One minor omission: the LLM mentions '15 votes per Class B share'—a detail not present in the original answer and potentially extraneous or unverified by the ground truth—which could imply a different voting mechanism but does not contradict the core conclusion. However, since the primary focus is on the 33 1/3% protected voting power and its anti-dilution effect, this addition doesn't undermine correctness. Overall, the answer is factually sound, contextually relevant, and semantically equivalent to the original, with only slight over-specification in voting rights per share.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 381,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 201,
      "question": "How does the 13.2% increase in South Africa's total tobacco market volume, partly offset by higher illicit trade prevalence, affect both PEP's merger-related socioeconomic obligations and MO's illicit trade risk exposure in their respective international operations?",
      "original_answer": "The 13.2% increase in South Africa's total tobacco market volume, which was partly offset by higher illicit trade prevalence, directly impacts both companies through different mechanisms. For PEP, this market dynamic influences the scope and cost of their socioeconomic program obligations in South Africa, which are explicitly included in their merger and integration charges. For MO, the increased prevalence of illicit trade associated with this market growth contributes to the illicit trade risks outlined in their filings, which they state can lead to lost sales, brand dilution, and potential legal or regulatory actions against their distribution channels.",
      "llm_answer": "The 13.2 % rise in South Africa’s total tobacco market volume enlarges the scope of PepsiCo’s (PEP) merger‑related socioeconomic commitments under its Pioneer Foods acquisition, as the company must meet larger obligations to employees, agriculture, education and development programs in the country (PEP 10‑K, pp. 113‑117). At the same time, the higher prevalence of illicit trade that partly offsets this volume growth heightens Altria’s (MO) illicit‑trade risk exposure, potentially eroding legitimate sales and increasing regulatory scrutiny in its international operations (MO 10‑K, pp. 40‑44).",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical entity error: it incorrectly identifies PepsiCo (PEP) as the company with merger-related socioeconomic obligations in South Africa, and Altria (MO) as having international operations affected by illicit trade. In reality, PEP refers to Pioneer Holdings (Pioneer Foods), not PepsiCo, in this context, and MO refers to British American Tobacco (BAT) or Philip Morris International (PMI), not Altria. Altria (MO) has minimal international operations and does not operate in South Africa. The original answer correctly identifies PEP as Pioneer Foods and MO as a company with illicit trade risk exposure in international markets, but the LLM misattributes these to the wrong corporations. (2) Quantitatively, the 13.2% increase in South Africa's tobacco market volume is accurately reported, and no other numerical values require verification. There are no calculation errors. (3) The multi-hop reasoning is structurally sound—linking market volume growth to socioeconomic obligations and illicit trade to risk exposure—but it fails due to incorrect entity mapping. The LLM incorrectly pulls ticker symbols without verifying the correct corporate entities, undermining the entire analysis. (4) While the answer is well-structured and semantically plausible, the core entities are factually wrong, leading to a major factual deficiency. Correctness score is 4 due to partial factual accuracy on the market trend but severe error in company identification. Quantitative accuracy is 10 because the percentage is correct. Qualitative accuracy is low (3) due to incorrect reasoning based on wrong entities. Contextual relevance is moderate (6) as the framework matches the question but applies to incorrect firms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 477,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 203,
      "question": "How do the legal risks associated with securities litigation in Slack's IPO compare to Meta's exposure from its privacy-related lawsuits, particularly in terms of procedural outcomes and potential financial liabilities?",
      "original_answer": "Slack faced securities litigation related to its IPO, where a motion to dismiss was partially granted and partially denied in 2020, followed by a Ninth Circuit reversal in 2025 that led to the dismissal of the complaint with prejudice, significantly reducing its legal exposure. In contrast, Meta faced a $725 million settlement in a consumer privacy class action, which was approved in 2023, and continues to face ongoing litigation and regulatory scrutiny, including a $5.0 billion FTC penalty paid in 2020 and pending appeals in several state attorney general cases. Unlike Slack's litigation, which was ultimately dismissed, Meta's legal challenges have resulted in substantial financial liabilities and ongoing regulatory constraints.",
      "llm_answer": "Slack’s IPO securities litigation, detailed in Google’s 10‑K (pp. 7‑11), has moved through a series of motions and appeals, culminating in a 2025 Ninth Circuit order to dismiss the federal complaint with prejudice; no specific monetary damages have been disclosed. In contrast, Meta’s privacy‑related lawsuits (META 10‑K, pp. 110‑114) have already yielded substantial financial penalties—$5 billion to the FTC, a $725 million consumer‑privacy settlement, and a €798 million EU fine—along with ongoing appeals and potential additional liabilities. Thus, Slack’s case is largely procedural with no disclosed financial exposure, whereas Meta faces significant, already‑incurred monetary penalties and possible further costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Slack's IPO litigation was dismissed with prejudice in 2025 after a Ninth Circuit reversal, and no financial liability was disclosed—this matches the original answer. Meta's $5.0 billion FTC penalty (paid in 2020), $725 million consumer privacy settlement (approved in 2023), and ongoing litigation including state attorney general appeals are all accurately reported. The €798 million EU fine, while not in the original answer, is factually correct and contextually relevant, adding value without introducing error. (2) Quantitative accuracy is perfect: all dollar amounts, years, and procedural milestones match or are consistent with the ground truth. Format variations (e.g., $5 billion vs $5.0 billion) are acceptable. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across Slack and Meta, contrasting procedural outcomes (dismissal vs. settlements and ongoing liability) and financial exposure (none disclosed vs. substantial). The only minor shortcoming is that the original answer emphasizes the 2020 motion to dismiss (partially granted/denied), which the LLM omits, though it correctly captures the ultimate procedural outcome. (4) Contextual relevance is excellent—the response directly addresses both procedural outcomes and financial liabilities as required by the question. The reference to Google’s 10-K is erroneous (likely a hallucination), but the content about Slack is still factually correct, slightly affecting qualitative accuracy. Overall, the answer is semantically equivalent and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 451,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 203,
      "question": "How does the difference in vesting timelines for RSU awards between PM and WMT affect the recognition period of compensation costs, given PM's $160 million in unrecognized RSU costs and WMT's shift from 25% annual vesting to 8% quarterly vesting?",
      "original_answer": "PM has $160 million in unrecognized compensation costs from non-vested RSU awards, which are expected to be recognized over a weighted-average period of seventeen months, typically over three years or upon specific events like death, disability, or reaching age 58. This vesting schedule aligns with PM's policy where RSU awards generally vest on the third anniversary of the grant date. In contrast, WMT shifted its vesting schedule for RSU awards in fiscal 2023 to an 8% quarterly vesting rate over three years, down from a previous 25% annual vesting rate over four years. This change in WMT's vesting schedule accelerates the recognition of compensation costs earlier in the vesting period compared to PM’s structure. As a result, WMT’s updated vesting approach leads to a more evenly distributed cost recognition over the three-year period, whereas PM's cost recognition is more back-loaded due to its cliff-vesting structure tied to specific events or the three-year anniversary.",
      "llm_answer": "PMI’s RSU awards vest on the third anniversary of the grant, and the $160 million of un‑recognized RSU cost is amortized over a weighted‑average period of roughly 17 months (PMI, Note 10, p. 110‑111). Walmart’s plan now vests RSUs at 8 % each quarter over a three‑year period (down from 25 % annually over four years), shortening the vesting horizon and accelerating the recognition of compensation expense relative to the prior schedule (WMT, Note 4, p. 65‑66).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key quantitative facts: PM's $160 million in unrecognized RSU costs, the 17-month weighted-average recognition period, and the third-anniversary cliff vesting. It accurately states WMT's shift from 25% annual vesting over four years to 8% quarterly vesting over three years. All numbers, percentages, and dollar amounts match the ground truth exactly, with acceptable formatting (e.g., $160 million vs $160 million). (2) Quantitative accuracy is perfect—no calculation or numerical errors. The 8% quarterly over three years implies full vesting in 36 months (12 quarters × 8% = 96%, with final quarter completing 100%), which aligns with the shortened vesting horizon. The 17-month weighted average for PM is correctly cited. (3) The reasoning is sound and captures the core multi-hop comparison: PM’s back-loaded cost recognition due to cliff vesting versus WMT’s accelerated, more evenly distributed recognition under the new quarterly schedule. However, the LLM omits explicit mention that PM’s vesting can also occur upon specific events (death, disability, age 58), which adds nuance to the recognition period and is part of the ground truth. This is a minor omission affecting completeness but not the central conclusion. (4) Contextual relevance is excellent—the answer directly addresses the impact on compensation cost recognition periods for both companies. The qualitative accuracy is high but not perfect due to the missing detail on PM’s event-driven vesting triggers. Overall, the answer conveys the essential comparison accurately and succinctly, warranting a 9/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 452,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How does the $620 million unrecognized tax benefit risk at Boeing compare to Lockheed Martin's assessment of Pillar 2's impact, given the OECD's global minimum tax framework and differing implementation timelines across jurisdictions?",
      "original_answer": "Boeing identifies a $620 million risk in unrecognized tax benefits related to federal tax matters under audit, with Pillar 2's global minimum tax of 15% potentially applying to its worldwide operations, though it expects minimal impact due to lack of material operations in low-tax jurisdictions. Meanwhile, Lockheed Martin also anticipates no material impact from Pillar 2 on its effective tax rate or consolidated results, despite the framework's phased implementation starting in 2024 and 2025. This assessment is complicated by the OECD's Pillar 2 model rules, which, while providing a framework, allow for varied national adoption timelines and potential modifications to domestic tax incentives, as noted by General Electric's evidence.",
      "llm_answer": "Boeing’s 2023 10‑K notes that audit settlements could reduce its unrecognized tax‑benefit balance by as much as **$620 million** (page 73‑77).  In contrast, Lockheed Martin’s 2023 10‑K states that the OECD‑proposed Pillar 2 global minimum tax is not expected to materially raise its effective tax rate, though the impact will depend on how and when individual jurisdictions implement the rules (pages 34‑38).  Thus, Boeing faces a specific dollar‑level risk, whereas Lockheed Martin’s Pillar 2 assessment is a qualitative view that any effect will be modest and vary by jurisdictional timing.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies Boeing's $620 million unrecognized tax benefit risk and Lockheed Martin's qualitative assessment of Pillar 2, aligning with the ground truth on key factual points. The dollar amount is accurate, and the companies, context (OECD Pillar 2), and fiscal year (implied 2023 filings) are correct. The LLM accurately contrasts Boeing’s specific quantitative exposure with Lockheed Martin’s forward-looking, non-material impact assessment. However, the LLM omits a key element from the original answer: the reasoning behind both companies’ low expected impact—specifically, that Boeing and Lockheed Martin both anticipate minimal effect due to lack of material operations in low-tax jurisdictions, and the added complexity from varied national implementation timelines and potential changes to domestic incentives, as highlighted by General Electric’s evidence. While the LLM mentions jurisdictional timing, it does not fully synthesize the multi-hop element involving the broader OECD framework implications across firms. This omission reduces completeness and qualitative depth, but core facts and quantitative data remain fully accurate. Wording differences are acceptable under semantic equivalence, and source page references add precision without affecting correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 362,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How will the implementation of ASU No. 2023-07 impact the way PepsiCo reports its newly reorganized segments starting in Q1 2025, and how does this align with Altria's adoption timeline and disclosure requirements under the same standard?",
      "original_answer": "PepsiCo will recast its historical segment reporting beginning in Q1 2025 to reflect its new organizational structure, which includes combining FLNA and QFNA into PepsiCo Foods North America and reorganizing international food businesses into Latin America Foods, EMEA, and Other International Foods. This aligns with ASU No. 2023-07, which requires incremental disclosures of disaggregated expense information by reportable segment. Altria adopted the standard in 2024 and included expanded disclosures in Note 17, with interim requirements to be implemented starting Q1 2025. Thus, both companies are aligning with the new standard's timeline for retrospective application and enhanced reporting beginning in 2025.",
      "llm_answer": "PepsiCo will recast its historical segment reporting to reflect the new structure effective Q1 2025 and, under ASU 2023‑07, will disclose incremental segment information—including disaggregated expense data—on an annual and interim basis for the newly defined segments (e.g., PepsiCo Foods North America, Latin America Foods, EMEA, Other International Foods, International Beverages Franchise, and the EMEA bottling segment)【PEP_10k_2024, pages 5‑9】. Altria adopted ASU 2023‑07 for the year ended 12‑31‑2024 and will begin providing the required interim segment disclosures in its first‑quarter 2025 condensed statements, aligning its reporting timeline with PepsiCo’s implementation of the standard【MO_10k_2024, pages 61‑65】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PepsiCo will recast historical segment reporting starting Q1 2025 under ASU 2023-07, which mandates disaggregated expense disclosures by reportable segment. The new segments—PepsiCo Foods North America, Latin America Foods, EMEA, Other International Foods, International Beverages Franchise, and EMEA bottling segment—are accurately listed, consistent with the reorganization. Altria adopted the standard in 2024 and will begin interim disclosures in Q1 2025, matching the timeline in the original answer. (2) Quantitative accuracy is perfect: dates (Q1 2025, year ended 12-31-2024), adoption timelines, and reporting requirements are all factually correct. Format variations (e.g., '12-31-2024' vs '2024') are acceptable and semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across PepsiCo and Altria filings, linking their adoption timelines and disclosure requirements under ASU 2023-07. It correctly infers alignment in implementation timing despite different adoption years due to retrospective application and interim reporting starting in 2025. (4) The only minor shortcoming is that the LLM includes 'International Beverages Franchise' and 'EMEA bottling segment' as newly defined segments, which are not explicitly mentioned in the ground truth. While these may be accurate based on the source citation, they go slightly beyond the scope of the original answer, which focused on the core reorganization (FLNA + QFNA → PepsiCo Foods NA; international split). This does not make the answer incorrect but adds detail not confirmed in the ground truth, slightly reducing qualitative accuracy. Overall, the answer is factually sound, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 495,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How does the expiration timeline of Merck's MK-7962 (sotatercept) patent protection in the U.S. compare to Pfizer's broader patent strategy for biologics, especially considering potential extensions in both portfolios?",
      "original_answer": "Merck's MK-7962 (sotatercept) has a base U.S. patent expiration of 2027, with potential additional protection extending to 2037 if patent term extensions (PTEs) are granted. This reflects a strategy of relying on both initial and extended patent coverage for biologics. Pfizer also leverages PTEs and supplementary protection certificates (SPCs), particularly in Europe, to extend exclusivity beyond basic patent expirations. Both companies utilize regulatory exclusivity and patent filings to maximize product lifecycle management, though Pfizer explicitly notes variability in extension outcomes due to external factors.",
      "llm_answer": "Merck’s MK‑7962 compound patent is set to expire in 2027, but a method patent covering its use in pulmonary arterial hypertension is expected to last until 2037 (absent a PTE), with a potential five‑year patent‑term extension and six‑month pediatric exclusivity, plus 12 years of data exclusivity.  \nPfizer’s biologic portfolio is built around similar tools—PTEs up to five years, supplementary protection certificates, pediatric exclusivity and 12‑year data exclusivity—but many of its patents have already been extended (e.g., to 2028) and data exclusivity runs through 2033, giving it a potentially longer or overlapping protection window than Merck’s MK‑7962 timeline.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly impact correctness. First, it incorrectly states that Merck's method patent for MK-7962 (sotatercept) in pulmonary arterial hypertension lasts until 2037 'absent a PTE'—this contradicts the ground truth, which specifies that 2037 is the potential date *if* patent term extensions are granted, not without them. This misrepresents the nature and direction of the extension. Additionally, the claim of 'five-year patent-term extension and six-month pediatric exclusivity' is speculative and not supported in the original answer, which only mentions potential PTEs without specifying duration. The original answer does not mention pediatric exclusivity or data exclusivity for Merck’s compound, so adding these details introduces unsupported precision. For Pfizer, the LLM asserts specific extension outcomes (e.g., patents extended to 2028, data exclusivity to 2033), which are not present in the ground truth; the original answer only states that Pfizer uses PTEs and SPCs and notes variability in outcomes, without citing specific years. These invented dates reduce quantitative accuracy. While the LLM correctly identifies the strategic use of PTEs, SPCs, and exclusivity periods by both companies (showing sound qualitative reasoning and contextual relevance), the inclusion of fabricated numeric details and the misstatement of the 2037 date as a base rather than extended term constitute major factual errors. The multi-hop synthesis is partially correct—comparing patent strategies across firms—but built on incorrect data points, undermining overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 446,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 205,
      "question": "How do cost overruns under fixed-price contracts impact both Lockheed Martin's financial performance and GE's operational execution, given the sensitivity of these contracts to inflationary pressures and project complexity?",
      "original_answer": "Lockheed Martin reported cumulative reach-forward losses of $270 million and $280 million on two fixed-price contracts as of December 31, 2023, with potential for additional losses if cost overruns continue. These contracts are especially vulnerable to inflation, as noted in RTX's 10-K, which stated that rising material and labor costs can lead to losses on fixed-price contracts when overruns occur. Similarly, GE's operational execution is negatively impacted by cost overruns, particularly in large-scale projects such as those in its Power and Renewable Energy segments, where delays or technical issues can lead to contractual penalties and joint liability in consortiums. This highlights how both companies face significant financial and operational risks stemming from fixed-price contract structures under current economic and project execution conditions.",
      "llm_answer": "Lockheed Martin’s fixed‑price contracts are highly sensitive to inflation and project complexity; when actual costs exceed estimates the company records reach‑forward losses that erode profitability and margin (LMT, pp. 64‑66). For GE, cost overruns under similar contracts threaten operational execution, driving delays, penalties, liquidated damages and cash‑flow strain as the firm must meet performance obligations amid inflationary and complex project environments (GE, pp. 30‑34).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer correctly identifies the qualitative risks of cost overruns on fixed-price contracts for both Lockheed Martin and GE, including inflation sensitivity, project complexity, reach-forward losses, penalties, and cash-flow impacts. However, it fails to include the specific quantitative data from the ground truth: Lockheed Martin's $270 million and $280 million reach-forward losses as of December 31, 2023. These figures are critical for multi-hop accuracy and are entirely omitted. (2) Quantitative accuracy is low because the answer contains no dollar amounts or dates despite their presence in the original. While the LLM cites page numbers (e.g., LMT pp. 64–66, GE pp. 30–34), these do not compensate for missing financial figures. The ground truth specifies exact cumulative losses and a clear time reference (December 31, 2023), which are absent in the LLM response. (3) Qualitatively, the reasoning is sound: the model correctly links inflation and complexity to cost overruns, understands reach-forward losses as a financial consequence for Lockheed Martin, and connects operational execution risks (delays, penalties, joint liability) for GE. It also appropriately references segment-level risks in GE’s Power and Renewable Energy divisions, aligning with the original’s emphasis on large-scale projects. However, it misses the RTX 10-K reference that supports the inflation argument, weakening cross-entity synthesis. (4) Contextual relevance is high—the answer directly addresses both companies, contract types, financial and operational impacts, and macroeconomic conditions. Despite missing key numbers, the conceptual framework matches the question’s intent. The omission of specific figures, however, significantly undermines factual completeness and correctness, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 492,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 207,
      "question": "How does MDLZ's use of commodity futures for raw material price risk compare with COST's disclosure of Level 1 financial liabilities in terms of fair value measurement and derivative instrument exposure?",
      "original_answer": "MDLZ actively uses commodity futures to hedge against price risk for raw materials like cocoa, sugar, and wheat, with these instruments classified as Level 1 financial liabilities measured at fair value based on quoted market prices. In contrast, COST disclosed that it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis as of August 28, 2022, indicating no direct exposure to exchange-traded commodity futures like those used by MDLZ. This highlights a strategic difference in derivative usage and fair value exposure between the two companies.",
      "llm_answer": "MDLZ uses exchange‑traded commodity futures and options—Level 1 fair‑value instruments—to hedge the price risk of raw‑material purchases, with significant derivative exposure in commodity forwards, futures, and options that are recorded on a gross basis (MDLZ Note 10, “Commodity derivatives” and “Level 1 financial assets and liabilities” sections). In contrast, COST’s Level 1 financial liabilities are measured at fair value using quoted market prices, but the disclosure does not indicate any derivative exposure; the liabilities are likely debt instruments rather than hedging derivatives.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that MDLZ uses Level 1 commodity futures (exchange-traded) for hedging raw material price risk, with fair value based on quoted market prices, which aligns with the ground truth. It also correctly states that COST measures Level 1 financial liabilities at fair value using quoted prices. However, the LLM answer does not fully reflect the key point from the ground truth that COST disclosed *no* Level 1 or Level 3 financial assets or liabilities as of August 28, 2022. Instead, it assumes COST has Level 1 liabilities (likely debt), which contradicts the original answer and introduces inaccuracy. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—no errors in numbers or dates. (3) The multi-hop reasoning is partially sound: the model correctly contrasts MDLZ’s active derivative use with COST’s lack thereof, but fails to synthesize the critical disclosure that COST had *no* Level 1 liabilities at all, undermining the qualitative accuracy of the comparison. (4) The contextual relevance is high because the response addresses fair value measurement and derivative exposure for both companies, but the incorrect assumption about COST’s Level 1 liabilities reduces correctness and qualitative accuracy. A score of 7 is justified because core facts about MDLZ are correct and the conceptual framework is sound, but a significant omission in COST’s disclosure affects the overall accuracy of the comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 421,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 208,
      "question": "What is the total number of UPS Class A shares that are convertible into Class B shares, and how does this compare to the assets held in Lockheed Martin's nonqualified pension trust as of December 31, 2024?",
      "original_answer": "As of December 31, 2024, there were 4.6 billion UPS Class A shares that are fully convertible into Class B shares. Lockheed Martin reported $658 million in assets held in a separate trust for its nonqualified defined benefit pension plans as of the same date.",
      "llm_answer": "UPS has 121 million Class A shares that are fully convertible into Class B shares.  \nLockheed Martin’s nonqualified pension trust held $658 million in assets as of December 31 2024, a dollar amount that far exceeds the nominal count of convertible shares, though the two figures are not directly comparable.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error in the number of UPS Class A convertible shares. The ground truth states 4.6 billion, but the LLM reports 121 million, which is off by more than an order of magnitude. This is a critical quantitative error. However, the Lockheed Martin nonqualified pension trust asset figure of $658 million is correct and matches the ground truth. (2) The date 'December 31, 2024' is correctly used for both entities. The dollar amount for Lockheed Martin is accurate. However, the UPS share count is severely underreported—121 million vs. 4.6 billion—making the quantitative accuracy very low. (3) The multi-hop reasoning is partially sound in that the model attempts to compare two distinct financial figures from different companies, but the comparison is based on a false premise due to the incorrect UPS share number. The comment that the figures are not directly comparable is contextually appropriate, but does not excuse the factual inaccuracy. (4) The contextual relevance is high because the answer addresses both parts of the question and references the correct entities and time frame. However, the qualitative accuracy is reduced due to the failure in entity-specific data retrieval for UPS. The correctness score is low because the primary numerical fact (UPS convertible shares) is incorrect, which undermines the core of the multi-hop comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 390,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How does the sensitivity of AVGO's fixed rate senior notes to interest rate changes compare to CSCO's use of interest rate swaps in managing similar debt exposure, given the specific fair value impacts and hedging strategies outlined?",
      "original_answer": "AVGO's fixed rate senior notes are highly sensitive to interest rate changes, with a 50 basis point increase in rates causing a $1.7 billion decline in fair value as of November 3, 2024. In contrast, CSCO actively manages this risk using an interest rate swap with a $0.5 billion notional amount, which converts fixed interest payments on a portion of its senior notes to floating rates based on SOFR, thereby offsetting changes in the fair value of the hedged debt. This indicates that while AVGO faces significant exposure due to the size of its unhedged fixed-rate debt ($56.3 billion), CSCO employs targeted hedging strategies to mitigate similar risks on its smaller fixed-rate debt base.",
      "llm_answer": "AVGO’s fixed‑rate senior notes are highly sensitive to market rates – a 50‑basis‑point move in interest rates would shift their fair value by roughly $1.7 billion (2024) or $1.4 billion (2023) (Item 7A, pages 47‑51).  In contrast, Cisco uses a $0.5 billion notional interest‑rate swap as a fair‑value hedge of its fixed‑rate senior notes; the swap’s gain/loss offsets the fair‑value change of the underlying debt, effectively neutralizing the sensitivity to rate movements (Interest‑Rate Risk section, pages 87‑94).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key quantitative facts: AVGO's $1.7 billion fair value impact from a 50-basis-point rate increase as of 2024 is accurate and matches the ground truth. It also correctly states CSCO's $0.5 billion notional interest rate swap. The mention of a $1.4 billion impact for AVGO in 2023 is an additional detail not in the ground truth but does not contradict it and may reflect actual data from the filing; thus, it does not reduce accuracy. (2) Quantitative accuracy is perfect: all numbers (50 bps, $1.7B, $0.5B) are correct, properly attributed, and consistent with the original answer. Format variations (e.g., '50-basis-point move') are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly contrasts AVGO’s direct exposure due to unhedged fixed-rate debt with CSCO’s use of an interest rate swap as a fair-value hedge that offsets fair value changes. It captures the core conceptual difference—AVGO has significant sensitivity while CSCO mitigates it through hedging—even if it omits the explicit total size of AVGO’s debt ($56.3B) mentioned in the ground truth. This omission is minor and does not affect the correctness of the comparison. (4) The answer is contextually fully relevant, directly addressing the comparison of sensitivity and hedging strategies. The qualitative accuracy is slightly reduced only because the LLM does not explicitly mention the conversion to SOFR-based floating rates, a detail present in the original, but the functional effect (offsetting fair value changes) is accurately described. Overall, the answer conveys the same essential conclusion with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 462,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How do PM and MDLZ differ in their application of the parametric delta-gamma approximation technique within their VAR models to estimate one-day loss under normal market conditions?",
      "original_answer": "PM applies the parametric delta-gamma approximation technique by observing interest rate and forward currency rate movements primarily over the preceding quarter for determining VAR at year-end, and over each of the four preceding quarters for average, high, and low VAR amounts during the year. MDLZ also uses the parametric delta-gamma method but extends its parameter estimation to include commodity price movements, in addition to interest rates and currencies. Furthermore, MDLZ observes movements over the prior quarter for year-end VAR calculations and across each of the four prior quarters for average VAR amounts, similar to PM, but explicitly accounts for the non-linear behavior of currency and commodity options in its computation.",
      "llm_answer": "PM’s VAR model uses the parametric delta‑gamma approximation to estimate a one‑day loss for its interest‑rate‑sensitive and foreign‑currency‑sensitive derivatives, calibrating the delta‑gamma parameters from the preceding quarter’s market movements and applying a 95 % confidence interval with a one‑day horizon. MDLZ also employs the same technique, but it extends the analysis to commodity‑ and equity‑sensitive instruments and derives the delta‑gamma parameters from both the preceding quarter and the preceding four quarters for average, high, and low VAR estimates.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core differences between PM and MDLZ in their use of the parametric delta-gamma approximation technique within VAR models. Quantitatively, it correctly states that both companies use the preceding quarter for year-end VAR and the four prior quarters for average, high, and low VAR estimates, which aligns with the ground truth. It also accurately notes PM's focus on interest rate and foreign currency movements and MDLZ's extension to commodity- and equity-sensitive instruments. However, there is a minor inaccuracy: the ground truth specifies that MDLZ explicitly accounts for the non-linear behavior of currency and commodity options, a key qualitative nuance in how the delta-gamma method is applied, which the LLM omits. Additionally, while the LLM mentions a 95% confidence interval and one-day horizon, this detail is not present in the original answer and may be inferred but is not confirmed by the ground truth, introducing unverified information. The multi-hop reasoning is sound—correctly comparing two companies' modeling approaches across time periods and risk factors—but the omission of MDLZ's explicit treatment of non-linearity in options reduces completeness. Overall, the answer is factually strong, contextually relevant, and semantically close to the original, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 380,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How does Medtronic's emphasis on increasing global patient access to its therapies compare with Amgen's challenges in maintaining patient affordability under pressure from payers like Express Scripts, particularly in light of Express Scripts' role in negotiating deeper discounts that limit access to Amgen's products such as Repatha?",
      "original_answer": "Medtronic aims to expand global patient access to its therapies by leveraging its product pipeline and local presence, as stated in its 2024 10-K. In contrast, Amgen faces significant challenges in ensuring patient affordability for products like Repatha due to increasing payer pressure, particularly from large PBMs such as Express Scripts. Express Scripts, as part of the top six integrated health plans and PBMs controlling 94% of U.S. pharmacy prescriptions, utilizes Rebate Management Organizations to negotiate deeper discounts, which in turn leads to formulary restrictions and higher out-of-pocket costs for patients. This dynamic negatively affects Amgen's product sales and patient access, especially for Medicare patients who abandon prescriptions due to high co-pays, despite Amgen's efforts to lower the list price of Repatha. Therefore, while Medtronic's strategy positively impacts patient access, Amgen's ability to maintain access is constrained by the market power of entities like Express Scripts.",
      "llm_answer": "Medtronic stresses expanding global patient access, noting that “patients around the world deserve access to our life‑saving products” and that the company is using its local presence and scale to broaden adoption worldwide (MDT 10‑K, pp. 4‑8).  In contrast, Amgen is contending with payer consolidation – particularly PBMs such as Express Scripts that negotiate deeper rebates – which forces lower net prices and can limit patient affordability and access to products like Repatha (AMGN 10‑K, pp. 35‑39).  Thus, while Medtronic proactively seeks to increase access, Amgen must navigate payer‑driven price pressures that can curtail patient use.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core contrast between Medtronic's proactive strategy to expand global patient access and Amgen's challenges with payer-driven price pressures limiting access to Repatha. (1) All factual elements are correct: Medtronic’s emphasis on global access via local presence and scale is accurately attributed to its 10-K (pp. 4–8), and Amgen’s struggle with PBM-driven rebates, particularly from Express Scripts, is correctly cited from its 10-K (pp. 35–39). (2) There are no numeric values (e.g., percentages, dollar amounts) in either the ground truth or LLM answer that conflict; thus, quantitative accuracy is perfect. (3) The multi-hop reasoning—comparing Medtronic’s strategic focus with Amgen’s market access barriers due to payer power—is logically sound and synthesizes information across two companies and contexts. (4) The LLM omits a few contextual details present in the ground truth, such as the specific statistic that the top six PBMs control 94% of U.S. pharmacy prescriptions, and the point about Medicare patients abandoning prescriptions due to high co-pays despite list price reductions. While these are relevant nuances, their absence does not undermine the central argument or factual correctness. The answer remains semantically equivalent in intent and substance. Therefore, the correctness score is 9 due to minor omissions in supporting detail, but the answer is otherwise accurate, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 408,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 210,
      "question": "How does Alphabet's share repurchase strategy prioritize certain stock classes relative to their conversion rights, and what might this imply about potential voting control considerations given that Class A shares are also publicly traded by another major corporation?",
      "original_answer": "Alphabet repurchased $62.2 billion of Class A and Class C shares in 2023, with $36.3 billion remaining available under the repurchase authorization as of December 31, 2023. Notably, Class B common stock—which carries 10 votes per share—can be converted to Class A shares at the stockholder's option or automatically upon sale or transfer. The company has focused repurchases on Class A and Class C shares rather than Class B, preserving the weighted voting power associated with Class B shares. Meanwhile, Class A common stock is also publicly traded by Comcast Corporation (CMCSA), suggesting Class A shares may represent a broader market standard for voting equity that could be strategically maintained for governance purposes.",
      "llm_answer": "Alphabet’s repurchase program is limited to its publicly traded Class A and Class C shares and does not include Class B shares, which carry ten votes each and can be converted into Class A shares (Note 11, Share Repurchases). By excluding Class B shares, the company preserves the voting power of the concentrated Class B holders while reducing the overall share count through purchases of the lower‑voting or non‑voting classes (Note 11). Because Class A shares are publicly traded on the Nasdaq (GOOGL), large repurchases could consolidate ownership and shift voting influence among the remaining shareholders, potentially affecting control dynamics.",
      "correctness_score": 7,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Alphabet's repurchase strategy focusing on Class A and Class C shares while excluding Class B shares, and accurately explains the voting implications—preserving concentrated voting power in Class B shares, which carry 10 votes and can be converted to Class A. However, it omits all quantitative details from the original answer: the $62.2 billion repurchased in 2023 and the $36.3 billion remaining authorization as of December 31, 2023. These are key factual elements directly stated in the ground truth and missing in the LLM response. (2) No numeric values are present in the LLM answer, so there is a complete failure in quantitative accuracy despite the availability of precise figures in the source. The absence of dollar amounts and dates significantly reduces factual completeness. (3) The multi-hop reasoning is partially sound: the model correctly infers that excluding Class B from repurchases preserves voting control and understands conversion rights. It also recognizes the public trading of Class A shares (though it identifies GOOGL, not explicitly linking to another corporation). However, it fails to make the critical connection that Class A shares are also publicly traded by Comcast Corporation (CMCSA), which is a key part of the original answer and implies broader standardization of Class A as a governance structure across firms. This cross-company entity link is missing, weakening the synthesis. (4) Despite missing numbers and the Comcast comparison, the LLM captures the core governance logic and strategic rationale behind share repurchases and voting control. Wording is clear and relevant, and the reasoning around control dynamics is plausible. Hence, qualitative and contextual scores are high, but quantitative accuracy is low due to omitted figures, leading to a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 507,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 210,
      "question": "How might UnitedHealth Group's formulary restrictions on high-cost biologics, as demonstrated by Repatha's access challenges, impact Eli Lilly's ability to maintain revenue growth for its biologic therapies given their dependence on patient access?",
      "original_answer": "UnitedHealth Group, as one of the top six integrated health plans and PBMs controlling 94% of U.S. pharmacy prescriptions, has significant leverage to impose formulary restrictions and require prior authorization for high-cost biologics. This is exemplified by the access limitations placed on Repatha, which resulted in reduced patient affordability and use despite price reductions. Eli Lilly acknowledges that its revenue prospects for biologics are directly affected by patient access issues, including payer restrictions such as prior authorization and formulary exclusions. Given the concentration of payer power and the precedent set by Repatha’s access challenges, Eli Lilly’s ability to maintain revenue growth for its biologic therapies may be significantly constrained if similar restrictions are applied to its products.",
      "llm_answer": "UnitedHealth Group’s formulary restrictions on high‑cost biologics—illustrated by the Repatha access challenges described in Gilead’s 10‑K (p. 6–7)—can curtail patient access to Lilly’s biologic therapies.  Lilly’s 10‑K (p. 23–27) notes that revenue growth for its biologics is heavily dependent on payer coverage and patient access, so similar formulary limitations could dampen sales and slow revenue expansion.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and conveys the essential relationship between UnitedHealth Group's formulary restrictions and Eli Lilly's revenue growth risks. It correctly identifies that UnitedHealth (as part of the concentrated payer market) can limit access to high-cost biologics, using Repatha as an example, and links this to Eli Lilly’s dependence on patient access for revenue growth. The citation of Gilead’s 10-K for Repatha is incorrect—Repatha is a product of Amgen, not Gilead; this is a significant entity error. However, the broader point about payer restrictions impacting access is valid and supported by the ground truth. The LLM correctly cites Eli Lilly’s 10-K regarding its revenue dependence on payer coverage. While the answer captures the key multi-hop logic (payer power → formulary restrictions → reduced access → lower sales), it omits specific contextual details present in the ground truth, such as UnitedHealth being one of the top six PBMs controlling 94% of prescriptions and the mention of prior authorization and formulary exclusions as specific barriers. There are no numerical inaccuracies, hence perfect quantitative accuracy. The reasoning is sound but slightly less comprehensive than the original, leading to a slightly lower qualitative accuracy score. Contextual relevance is strong as it directly addresses the question’s focus on revenue impact due to access constraints.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 396,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 211,
      "question": "How does Oracle's use of its $3.0 billion commercial paper program compare with Cisco's treatment of its $9.0 billion in senior fixed-rate notes, particularly in light of their shared exposure to short-term debt financing mechanisms?",
      "original_answer": "Oracle maintains a $3.0 billion commercial paper program, which allows it to issue unsecured short-term promissory notes under a private placement exemption. As of May 31, 2022, Oracle had no outstanding commercial paper notes. Cisco, on the other hand, had $9.0 billion in principal amount of senior fixed-rate notes outstanding as of July 30, 2022, which rank at par with any commercial paper notes it may issue in the future under its short-term debt financing program. Cisco also uses interest rate swaps to convert fixed interest rates on $1.5 billion of these notes to floating rates based on LIBOR. This indicates that while Oracle actively manages short-term liquidity through a flexible commercial paper facility, Cisco has a larger, more structured long-term debt profile with embedded risk management through interest rate hedging.",
      "llm_answer": "Oracle’s 2022 10‑K (Note 12, pages 89‑93) shows that the company has a $3.0 billion commercial‑paper program that is a short‑term financing tool, but as of May 31 2022 it had no notes outstanding. By contrast, Cisco’s 2022 10‑K (Note 12, pages 55‑59, 88‑92) reports $9.0 billion of senior fixed‑rate notes that are long‑term debt and are currently outstanding, representing a larger debt exposure. Both firms therefore rely on short‑term debt mechanisms—Oracle through its commercial‑paper program and Cisco through its senior notes (along with other short‑term facilities)—to support liquidity, though the scale and current usage differ markedly.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: Oracle's $3.0 billion commercial paper program with no outstanding notes as of May 31, 2022, and Cisco's $9.0 billion in senior fixed-rate notes outstanding as of July 30, 2022 (LLM correctly notes the existence of the debt but does not specify the exact date, using 'currently outstanding' instead). These figures match the ground truth exactly. (2) Quantitative accuracy is perfect—dollar amounts, program sizes, and dates (where specified) are correct. The LLM cites the correct 10-K note (Note 12) and page ranges, enhancing credibility. (3) However, the qualitative accuracy is lower because the LLM omits a critical multi-hop element: Cisco’s use of interest rate swaps to convert $1.5 billion of fixed-rate debt to floating rates based on LIBOR. This is a key differentiator in how Cisco manages its debt risk, and its absence weakens the comparative analysis. Additionally, the LLM incorrectly implies that Cisco's senior fixed-rate notes are part of its short-term debt mechanism, when in fact they are long-term debt instruments—though they may rank pari passu with commercial paper. This mischaracterization affects reasoning accuracy. (4) Despite these issues, the answer remains contextually relevant and captures the core contrast: Oracle uses a short-term commercial paper program currently undrawn, while Cisco has a larger, active long-term debt position. The synthesis is partially correct but lacks depth in risk management practices and precise classification of debt instruments. Hence, correctness is reduced to 7 due to missing key qualitative details and minor conceptual inaccuracy in classifying Cisco’s notes as short-term mechanisms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 473,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 211,
      "question": "How does the extension of ASU 2022-06's optional hedging relief until 2024 impact FedEx's and Caterpillar's management of LIBOR-related interest rate risk in their respective derivative instruments?",
      "original_answer": "ASU 2022-06 extends the optional expedients and exceptions for accounting related to reference rate reform, including LIBOR, until December 31, 2024. FedEx, which references this ASU, continues to monitor its contracts and hedging relationships affected by LIBOR, though it has not yet experienced a material impact. Caterpillar, which actively uses interest rate contracts as part of its risk management strategy, benefits from the extended relief by maintaining flexibility in accounting for LIBOR-based hedging relationships without disruption. The extension allows both companies to continue transitioning away from LIBOR without immediate accounting complications, supporting consistent treatment of derivative instruments tied to legacy rates.",
      "llm_answer": "FedEx and Caterpillar both note that ASU 2022‑06 extends the optional relief for contracts and hedges that reference LIBOR through December 31 2024.  The extension lets each company continue to apply the existing accounting treatment to LIBOR‑based derivatives without having to modify or reclassify them, thereby reducing the operational and financial impact of the reference‑rate reform.  Consequently, both firms can maintain their current LIBOR‑related interest‑rate‑risk management strategies through 2024 while monitoring for any future changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: ASU 2022-06 extends optional hedging relief for LIBOR-related contracts and hedges until December 31, 2024—this date is correctly stated (quantitative accuracy = 10). (2) The answer addresses both FedEx and Caterpillar and explains how the extension allows them to maintain current accounting and risk management practices without disruption, which reflects the core of the original answer. (3) Entity accuracy is strong: correct ASU number, correct companies, correct context of derivative instruments and LIBOR transition. (4) Reasoning is sound: the LLM correctly synthesizes that the extension provides continuity in accounting treatment and reduces operational burden, enabling both firms to delay changes to their LIBOR-related hedging strategies. The only minor shortcoming is that the original answer adds slightly more nuance—FedEx has not experienced a material impact, while Caterpillar actively uses interest rate contracts and thus benefits more directly from the flexibility. This additional detail about Caterpillar’s active use and FedEx’s monitoring stance is omitted, slightly reducing qualitative accuracy. However, the LLM captures the essential multi-hop synthesis: ASU extension → continued accounting relief → sustained risk management approach for both firms. Semantic equivalence is maintained, and the response is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 405,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does Boeing's use of Citibank, N.A. as administrative agent in its Five-Year Credit Agreement compare with Caterpillar's engagement of Citibank in its multi-facility credit agreements in terms of syndication structure and amendment activity in 2022 and 2023?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, and amended on August 25, 2022, involved Citibank, N.A. as administrative agent alongside JPMorgan Chase Bank, N.A. as syndication agent, with both also serving as joint lead arrangers and joint book managers. Caterpillar, on the other hand, had Citibank, N.A. acting as agent in both its 3-Year and 5-Year Facilities dated September 1, 2022, with additional roles for Citibank Europe plc and MUFG Bank, Ltd. in local currency management. Both companies saw Citibank play a central role in structuring and managing credit facilities, but Caterpillar’s agreements included more complex international components, while Boeing’s amendment in 2022 was a singular update to its existing agreement.",
      "llm_answer": "Boeing’s Five‑Year Credit Agreement (Exhibit 10.2, pages 123‑127) names Citibank, N.A. as the administrative agent, JPMorgan Chase Bank, N.A. as the syndication agent, and lists both banks as joint lead arrangers and joint book managers; the agreement was amended in 2022 (Amendment No. 1, Exhibit 10.5) and re‑issued in 2023. In contrast, Caterpillar’s multi‑facility 364‑day credit agreements (Exhibit 10.39 and 10.41, pages 124‑128) list Citibank, N.A. as the primary agent with Citibank Europe PLC and MUFG Bank as local‑currency agents, and the 2022 facility was amended in 2023 (Japan Local Currency Addendum) while a new 2023 facility was also entered. Thus, Boeing’s structure involves a joint syndication arrangement between Citibank and JPMorgan, whereas Caterpillar’s arrangement relies on Citibank as the sole agent with additional local‑currency partners and features amendment activity only in 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains some inaccuracies and omissions that affect factual precision. (1) Correct elements: Boeing's use of Citibank, N.A. as administrative agent and JPMorgan Chase Bank, N.A. as syndication agent, along with joint roles, is accurately described. Caterpillar’s engagement of Citibank, N.A. as agent and the involvement of Citibank Europe plc and MUFG Bank, Ltd. for local currency management are also correctly identified. The mention of amendment activity in 2023 for Caterpillar aligns with the ground truth. (2) Quantitative/Date Issues: The LLM incorrectly states that Boeing’s agreement was 're-issued in 2023'—the ground truth only confirms an amendment on August 25, 2022, with no mention of a 2023 re-issuance. Additionally, the LLM refers to '364-day credit agreements' for Caterpillar, while the ground truth specifies 3-Year and 5-Year Facilities dated September 1, 2022—this misrepresents the facility types. The LLM also claims amendment activity for Caterpillar 'only in 2023', but the ground truth does not specify the timing of amendments beyond noting the 2022 facility, leaving open the possibility of earlier activity. (3) Multi-hop reasoning is partially sound: the comparison between Boeing’s joint syndication structure and Caterpillar’s more internationally distributed agent framework is valid and reflects synthesis across filings. However, the characterization of Caterpillar’s structure as having Citibank as the 'sole agent' is misleading—it is the primary agent, but the structure is more nuanced with multiple agents for different components. (4) The answer is contextually relevant and addresses the core aspects of syndication structure and amendment activity, but the errors in facility type, amendment timeline, and the unsupported claim of a 2023 re-issuance reduce quantitative and qualitative accuracy. Hence, a score of 7 is justified—core facts are correct, but with notable inaccuracies in details and some overstatement of certainty.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 539,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does the dual-class stock structure at META, which gives Class B shareholders disproportionate voting control, compare to CMCSA's dual-class framework in terms of potential impact on investor confidence, especially given CMCSA's Class B to Class A conversion mechanism?",
      "original_answer": "META's dual-class stock structure gives Class B shareholders, such as Mark Zuckerberg, disproportionate voting control, which could make its Class A common stock less attractive to some investors. This is due to reduced corporate governance protections and potential conflicts of interest. Similarly, CMCSA has a dual-class framework where Class B common stockholders hold 33⅓% of the voting power, and each share of Class B stock is convertible, share for share, into Class A stock. The conversion mechanism in CMCSA could allow for shifts in voting control, much like META's structure, though CMCSA's Class B shares currently represent a much smaller total quantity (9,444,375 issued and outstanding). This structural similarity may affect investor confidence in both companies, especially if control remains concentrated in a minority of shareholders.",
      "llm_answer": "Meta’s dual‑class structure concentrates voting power in its Class B shares (10 votes per share versus one for Class A), giving the CEO and other holders a majority of the combined voting power and potentially eroding investor confidence by limiting shareholder influence (Meta 10‑K, p. 48‑49). Comcast also has a dual‑class structure with 10 votes per Class B share, but its conversion mechanism allows Class B shares to convert to Class A shares over time, potentially diluting concentrated control and mitigating some investor concerns (CMCSA 10‑K, p. 89‑90).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the dual-class structures at both META and CMCSA and their potential impact on investor confidence, noting concentrated voting power and limited shareholder influence. It accurately references the disproportionate voting rights (10 votes per Class B share) for both companies, which aligns with the general structure described in the ground truth. However, it incorrectly states that CMCSA Class B shares have 10 votes each — the ground truth specifies that CMCSA Class B holds 33⅓% of total voting power, not that each share carries 10 votes. This is a significant quantitative inaccuracy. Additionally, the LLM mentions a conversion mechanism 'over time' diluting control, but the ground truth specifies that conversion is share-for-share and does not imply a time-based or automatic process. (2) The ground truth includes specific numbers: CMCSA has 9,444,375 Class B shares issued and outstanding — this detail is missing in the LLM answer, reducing completeness and quantitative accuracy. The 33⅓% voting power allocation is also omitted. (3) The multi-hop reasoning is partially sound: the model correctly compares both companies' dual-class systems and links them to investor confidence concerns. It recognizes the conversion mechanism in CMCSA as a differentiating factor, though it misrepresents its mechanics. (4) Despite missing key numbers and containing a critical vote-per-share error, the LLM captures the core qualitative comparison — structural concentration of control and its implications — and correctly cites 10-K page references. Wording differences are acceptable, but the vote-ratio inaccuracy lowers quantitative and overall correctness scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 468,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "What was The Coca-Cola Company's net sales to equity method investees in 2021, and which regions does Coca-Cola FEMSA specifically cover in its bottling and distribution operations?",
      "original_answer": "The Coca-Cola Company's net sales to equity method investees in 2021 were $14,471 million. Coca-Cola FEMSA operates in several countries including Mexico (central, southeast, and northeast), Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil (parts of São Paulo, Minas Gerais, Mato Grosso do Sul, Paraná, Santa Catarina, parts of Rio Grande do Sul, Goiás, and Rio de Janeiro), Argentina (Buenos Aires and surrounding areas), and Uruguay.",
      "llm_answer": "In 2021, Coca‑Cola’s net sales to equity‑method investees totaled **$14.471 billion**.  \nCoca‑Cola FEMSA’s bottling and distribution operations cover **Mexico (central, southeast and northeast), Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil (major parts of São Paulo, Minas Gerais, Mato Grosso do Sul, Paraná, Santa Catarina and portions of Rio Grande do Sul, Goiás and Rio de Janeiro), Argentina (Buenos Aires and surrounding areas), and Uruguay**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the net sales amount of $14,471 million is accurately reported as $14.471 billion—this is a correct format conversion (1 billion = 1,000 million), so $14,471 million = $14.471 billion. (2) The regions covered by Coca-Cola FEMSA are listed completely and accurately, including all specified countries and sub-regional details in Brazil and Argentina. Minor wording differences (e.g., 'major parts' vs 'parts', 'portions') do not affect factual accuracy and are semantically equivalent. (3) The answer correctly synthesizes multi-hop information: it identifies the correct financial metric (net sales to equity method investees) for The Coca-Cola Company in 2021 and separately details the geographic scope of Coca-Cola FEMSA’s operations, which requires pulling distinct data points from different parts of the 10-K. (4) All entities—The Coca-Cola Company, equity method investees, Coca-Cola FEMSA—are correctly identified, and the response addresses both sub-questions completely. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 320,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does the decline in Remicade sales due to biosimilar competition impact Merck's overall immunology segment revenue, and how does this compare to AbbVie's exposure to biosimilar pressures on biologics like Humira?",
      "original_answer": "Merck's Remicade sales declined by 9% in 2021 and 20% in 2020 due to biosimilar competition in Europe, where it lost market exclusivity in 2015. This decline directly affected its immunology segment, which includes Remicade and Simponi, both impacted by biosimilar pressures. In 2021, Remicade generated $299 million in international sales, contributing to the overall decline in the segment. AbbVie, on the other hand, faces similar biosimilar threats, particularly with Humira, which is now facing direct biosimilar competition in Europe and other countries. Unlike Merck, AbbVie continues to invest heavily in biologics infrastructure and emphasizes patent protection and regulatory exclusivity to delay biosimilar entry, particularly in the U.S. market.",
      "llm_answer": "Merck’s immunology segment revenue fell by roughly 3.8% in 2021 (from $1,168 m to $1,124 m) largely because Remicade sales dropped 9% to $299 m due to biosimilar competition (Merck 10‑K, p. 61). In contrast, AbbVie’s exposure to biosimilar pressure is concentrated on Humira, a major revenue driver, and the company has entered settlement and license agreements with biosimilar manufacturers, with U.S. licenses beginning in 2023 and European licenses in 2018—indicating a potentially larger erosion of its biologics revenue (AbbVie 10‑K, p. 12‑13).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct and aligns well with the ground truth. It accurately reports that Merck's Remicade sales declined by 9% in 2021 to $299 million due to biosimilar competition, consistent with the original answer. It also correctly notes the impact on the immunology segment, estimating a decline from $1,168 million to $1,124 million (a ~3.8% drop), which is a valid calculation based on the figures provided. These numbers are not explicitly stated in the ground truth, but they are logically derived and consistent with the narrative of declining immunology revenue due to Remicade’s performance. (2) All quantitative values—9% decline, $299 million in sales, and the implied segment revenue figures—are accurate or reasonably inferable from the context. The LLM correctly identifies AbbVie’s exposure via Humira and the timing of biosimilar licenses: European in 2018 and U.S. in 2023, which matches known public disclosures (e.g., AbbVie’s 10-K). (3) The multi-hop reasoning is sound: the model connects Remicade’s biosimilar-driven decline to Merck’s immunology segment performance and contrasts this with AbbVie’s strategic response to Humira biosimilars through licensing settlements. While the ground truth emphasizes AbbVie’s investment in infrastructure and patent protection, the LLM complements this by highlighting settlement agreements, which is a valid and relevant aspect of AbbVie’s strategy. (4) The only minor gap is that the LLM omits Merck’s 2020 20% decline and earlier loss of exclusivity in 2015, which adds historical context present in the original answer. However, since the question focuses on the impact and comparison, and the 2021 data is the most relevant, this omission does not undermine the core correctness. Overall, the answer is precise, contextually appropriate, and demonstrates strong synthesis across entities and filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 513,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How did Honeywell's investment in Garrett's Series B Preferred Stock, originally tied to indemnification agreements, impact its long-term receivables after the partial redemptions in late 2021, and what was the remaining present value of the unredeemed shares as of December 31, 2021?",
      "original_answer": "Honeywell received $375 million and 834.8 million shares of Garrett's Series B Preferred Stock as part of the resolution of indemnification and tax matters agreements following Garrett's emergence from bankruptcy. The Series B Preferred Stock was subject to mandatory redemptions, with the First Partial Redemption of $211 million completed on December 28, 2021, and a planned Second Partial Redemption of $200 million in early 2022. As of December 31, 2021, the present value of the remaining mandatory redemptions of the Series B Preferred Stock was $423 million, which was included in Honeywell’s long-term receivables and investments.",
      "llm_answer": "After Garrett’s partial redemptions in late 2021, Honeywell’s investment in Garrett’s Series B Preferred Stock—originally tied to indemnification agreements—was re‑classified as long‑term receivables with a carrying amount of **$423 million** (page 104).  The present value of the remaining unredeemed shares was **$207 million** as of December 31, 2021 (page 103).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numerical values. While it correctly identifies that Honeywell's investment was tied to indemnification agreements and that partial redemptions occurred in late 2021, it incorrectly states the present value of the remaining unredeemed shares as $207 million, whereas the ground truth is $423 million. Additionally, it claims the carrying amount in long-term receivables was $423 million (which matches the ground truth), but then contradicts itself by stating the present value of the remaining shares was $207 million—this is incorrect and inconsistent. (2) Quantitative accuracy is severely compromised: the First Partial Redemption was $211 million (correctly implied in context but not stated), the Second Partial Redemption was planned for $200 million, so the total original redemption obligation was $411 million; adding this to the $423 million present value of remaining redemptions gives a total present value of $834 million, aligning with the 834.8 million shares referenced. The LLM’s $207 million figure has no support in the ground truth and appears erroneous. (3) The multi-hop reasoning is partially sound—linking the indemnification agreement to the Series B Preferred Stock, its redemption, and impact on long-term receivables—but fails in synthesizing the correct financial impact as of December 31, 2021. The model references 'page 103' and 'page 104', suggesting document-based reasoning, but the numbers do not align with the verified data. (4) Contextual relevance is high—the answer addresses the right entities (Honeywell, Garrett, Series B Preferred Stock), time frame (December 31, 2021), and accounting treatment (long-term receivables). However, due to the critical error in the present value figure, the correctness and quantitative accuracy scores are low, as these numbers are central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 515,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How does the voting power distribution in CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, relate to the repurchase activity and voting structure of GOOGL's Class A and Class B common stock, given the interplay between their respective share classes and repurchase programs?",
      "original_answer": "In CMCSA, Class B common stock has 15 votes per share and represents 33 1/3% of the combined voting power, which is entirely owned by Brian L. Roberts. This structure ensures concentrated voting control despite broader share repurchases of Class A stock. Similarly, GOOGL’s Class A shares carry one vote each, while Class B shares have 10 votes per share, and the company repurchased $62.2 billion of Class A and Class C shares in 2023, with $36.3 billion remaining under the repurchase authorization. These repurchases primarily affect the float of lower-vote shares, preserving the relative control of insiders who hold Class B stock. Thus, both companies maintain dual-class structures that insulate control while using share repurchases to manage capital allocation.",
      "llm_answer": "Comcast’s single Class B share—held entirely by Brian L. Roberts—carries 15 votes per share and represents about 33 % of the company’s combined voting power, giving Roberts concentrated control. Alphabet’s voting structure gives Class A shares one vote each and Class B shares ten votes each, but its repurchase program targets only Class A and Class C shares, leaving the voting power of its higher‑vote Class B holders unchanged. Thus, while Comcast’s voting power is highly concentrated in one shareholder, Alphabet’s buy‑back activity does not alter the voting balance of its widely held Class B shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: CMCSA's Class B stock has 15 votes per share and represents 33 1/3% of voting power, entirely held by Brian L. Roberts; GOOGL’s Class A has 1 vote, Class B has 10 votes; repurchases target only Class A and C shares, preserving insider control. (2) Quantitative accuracy is perfect: while the LLM does not explicitly state the $62.2B repurchase amount or $36.3B remaining authorization from the original answer, these specific figures are not misrepresented—just omitted. The absence of dollar figures is a minor completeness gap but does not introduce inaccuracy. (3) Multi-hop reasoning is sound: the LLM correctly identifies the parallel between CMCSA and GOOGL in using dual-class structures to concentrate voting power and using repurchases of low-vote shares to preserve control without diluting insider influence. (4) Semantic equivalence is strong: the LLM captures the structural intent and economic effect of both companies’ share designs and repurchase strategies. The only minor shortcoming is the lack of specific repurchase dollar amounts, which slightly reduces completeness but not correctness. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 377,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How does the Value-at-Risk (VAR) calculation methodology under normal market conditions used by MDLZ compare to PM's approach, particularly in terms of the time horizon for observing interest rate and currency movements and the confidence interval applied?",
      "original_answer": "Both MDLZ and PM use a VAR model that assumes normal market conditions and applies a 95% confidence interval with a one-day holding period. However, MDLZ observes interest rate, currency exchange, and commodity price movements over the prior quarter for point-in-time VAR calculations and over each of the four prior quarters for average VAR amounts. Similarly, PM observes interest rate and forward currency rate movements primarily over the preceding quarter for point-in-time VAR and over each of the four preceding quarters for average, high, and low VAR amounts. This indicates a largely consistent methodology between the two companies, with both relying on quarterly historical data for risk estimation under normal market conditions.",
      "llm_answer": "MDLZ’s VAR model assumes normal market conditions, a 95 % confidence interval and a one‑day holding period.  It estimates the parameters for interest‑rate and currency movements from the prior quarter’s data for the December 31 VAR figures, and from each of the four preceding quarters for the average VAR amounts.  PMI’s approach is essentially identical – it also uses a 95 % confidence interval, a one‑day holding period, and derives its parameters from the preceding quarter’s interest‑rate and forward‑currency movements for the December 31 VAR and from each of the four preceding quarters for the average, high and low VAR figures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: both MDLZ and PM use a 95% confidence interval, a one-day holding period, and observe interest rate and currency movements over the prior quarter for point-in-time VAR (e.g., December 31) and over each of the four preceding quarters for average VAR amounts. PM also includes high and low VAR figures, which the LLM correctly notes. (2) Quantitative elements—95%, one-day holding period, prior quarter and four-quarter windows—are all accurately reported with no calculation or numeric errors. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes VAR methodology across two companies (MDLZ and PM) and compares their time horizons and confidence intervals, showing consistency in approach. (4) The only minor shortcoming is that the LLM refers to 'PMI' instead of 'PM', though PMI (Philip Morris International) is contextually accurate and commonly used; however, the original question and ground truth use 'PM', so this is a slight entity naming inconsistency. Otherwise, the answer is semantically equivalent, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 333,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does Apple's reliance on China Mainland for manufacturing, as a component of its Greater China segment, compare with Microsoft's operational footprint in Greater China, particularly in terms of regional support infrastructure and localized product offerings?",
      "original_answer": "Apple relies heavily on China Mainland for manufacturing, which is a key part of its Greater China segment that also includes Hong Kong and Taiwan. This reliance exposes Apple to risks such as trade tensions, tariffs, and supply chain disruptions. Microsoft operates in Greater China through its regional operations center in Singapore, which supports Japan, India, Greater China, and Asia-Pacific. Microsoft also localizes many of its products to reflect local languages and conventions, modifying user interfaces and translating text to better serve the region. Both companies are significantly engaged in Greater China, but Apple's exposure is more supply-chain intensive while Microsoft's is more focused on localized customer engagement and regional support infrastructure.",
      "llm_answer": "Apple’s Greater China segment is largely a sales and distribution region, but the company’s manufacturing is almost entirely outsourced to partners in China mainland (and other Asian countries) – the firm has no own factories there and relies on a small number of contract manufacturers for most of its hardware.  In contrast, Microsoft operates a dedicated regional center in Singapore that supports the Greater China market and actively localizes its software and services to local languages and conventions, giving it a more robust on‑ground support infrastructure and tailored product offerings in that region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly identifies Apple's reliance on China Mainland for manufacturing through contract manufacturers, noting the absence of owned factories—consistent with the original answer's emphasis on supply-chain intensity. It also accurately contrasts this with Microsoft's regional support infrastructure via its Singapore operations center, which supports Greater China among other regions. The localization of Microsoft's software and services to local languages and conventions is correctly highlighted. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable beyond the absence of errors—scored as 10. (3) The multi-hop reasoning is sound: the model synthesizes Apple’s manufacturing dependency with Microsoft’s regional operational model and product localization, correctly contrasting supply-chain exposure versus customer-facing infrastructure. The only minor omission is that the original answer explicitly names Hong Kong and Taiwan as part of Apple’s Greater China segment, which the LLM answer does not mention—this slightly reduces completeness but does not undermine the core accuracy. (4) The answer is highly contextually relevant, directly addressing the comparison of operational footprints, regional support, and product localization as requested. Wording differs but semantic equivalence is strong. A score of 9 is justified due to this minor omission; all key facts and reasoning are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 425,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does UPS's use of pricing models for foreign currency derivatives (classified as Level 2) contrast with GE's use of Level 3 valuation techniques in its insurance and pension liabilities, particularly regarding the role of unobservable inputs?",
      "original_answer": "UPS primarily uses pricing models with observable inputs like yield curves and exchange rates for its foreign currency derivatives, which are classified as Level 2 due to reliance on market-observable data. In contrast, GE employs Level 3 valuation techniques—such as discounted cash flow (DCF) methodologies—for certain insurance and pension liabilities, where significant unobservable assumptions are required. This distinction highlights that while UPS’s derivatives are grounded in active market data, GE’s long-duration insurance contracts and postretirement benefit obligations require internal modeling with assumptions not corroborated by market data, resulting in a higher degree of estimation uncertainty.",
      "llm_answer": "UPS’s foreign‑currency derivatives are priced with models that rely on observable market data—yield curves, spot and forward FX rates—so they are classified as Level 2. In contrast, GE’s insurance and pension liabilities are valued with Level 3 techniques that depend on significant unobservable inputs (actuarial mortality/morbidity assumptions, discount‑rate choices, and other internal estimates), making the valuation more subjective and heavily judgment‑based.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that UPS uses observable market inputs (yield curves, FX rates) for its foreign currency derivatives, justifying their Level 2 classification, while GE uses Level 3 techniques with significant unobservable inputs for insurance and pension liabilities. The specific examples of unobservable inputs—actuarial mortality/morbidity assumptions and discount-rate choices—are factually correct and align with typical Level 3 valuation practices. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense; however, the qualitative financial concepts are accurately represented, earning a perfect score here by default. (3) The multi-hop reasoning is sound: the model correctly contrasts two companies (UPS and GE), two financial instruments (derivatives vs. insurance/pension liabilities), and two levels of the fair value hierarchy (Level 2 vs. Level 3), synthesizing the distinction based on observability of inputs. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'discounted cash flow (DCF) methodologies' or 'long-duration contracts' as in the original, which adds slightly less context about why GE’s models require unobservable inputs. However, referencing 'internal estimates' and 'judgment-based' valuation effectively captures the essence. Overall, the answer is semantically equivalent, highly relevant, and factually correct with only slight omission of elaborative detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 444,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does Coca-Cola's reliance on Swire Beverages for distribution in Hong Kong compare to Colgate-Palmolive's operational performance in the same market, given both companies' reported activities in the region?",
      "original_answer": "Coca-Cola relies on Swire Beverages for distribution in Hong Kong, where Swire is one of Coca-Cola's top bottling partners, contributing to a significant portion of Coca-Cola’s non-U.S. unit case volume, which totaled 83% of worldwide volume in 2021. In the same region, Colgate-Palmolive reported $2,867 million in Asia Pacific net sales in 2021, with growth led by the Greater China region, particularly in Oral Care categories such as toothpaste and manual toothbrushes. While Coca-Cola’s distribution strategy in Hong Kong is managed through its bottler partner, Colgate-Palmolive directly manages its operations and achieved 3.0% organic sales growth in Asia Pacific, driven by volume increases and cost savings. This comparison highlights differing market strategies—Coca-Cola through a key bottling partner versus Colgate-Palmolive through direct brand growth—within the same geographic region.",
      "llm_answer": "Coca‑Cola’s Hong Kong distribution is handled by its bottler Swire Beverages, which operates the company’s bottling and distribution network in the territory.  In contrast, the Colgate‑Palmolive 10‑K pages supplied do not provide any specific operational data for Hong Kong, so a direct performance comparison cannot be drawn from the available information.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is partially correct in stating that Coca-Cola relies on Swire Beverages for distribution in Hong Kong, which aligns with the ground truth. However, it fails on multiple critical dimensions. (1) Quantitative Accuracy: The LLM claims no specific operational data for Colgate-Palmolive in Hong Kong is available, but the ground truth correctly reports Colgate-Palmolive's $2,867 million in Asia Pacific net sales in 2021, with growth driven by Greater China, which includes Hong Kong. The LLM incorrectly concludes that no comparison can be made due to lack of data, when in fact the 10-K does provide regional data that allows for a market-level comparison. (2) Completeness: The question asks for a comparison of Coca-Cola’s distribution reliance versus Colgate-Palmolive’s operational performance in the same market. The LLM omits all Colgate-Palmolive financial figures, growth metrics (3.0% organic sales growth), and product category performance (Oral Care), which are present in the ground truth and essential to answering the multi-hop question. (3) Entity Accuracy: While Coca-Cola and Swire Beverages are correctly identified, the LLM fails to reference Colgate-Palmolive’s actual reported metrics in the region, misrepresenting data availability. (4) Reasoning: The multi-hop synthesis is flawed—the model should have connected Coca-Cola’s partnership model in Hong Kong with Colgate-Palmolive’s direct operations and reported financials in Greater China/Asia Pacific. Instead, it defaults to a data-unavailable conclusion, indicating a failure in reasoning or retrieval. (5) Semantic Equivalence: The LLM answer does not convey the same information as the ground truth; it underreports available data and avoids the comparative analysis entirely. While the first sentence is factually correct, the rest is misleading. Hence, the correctness score is low due to major omissions and incorrect assessment of data availability.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 523,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does BAC's investment in CDOs, which contain embedded derivatives, compare to JPM's valuation methodology for similar structured notes with embedded derivatives, particularly in terms of risk exposure and modeling techniques?",
      "original_answer": "BAC invests in CDOs that are part of its broader involvement with VIEs, and while the Corporation does not consolidate these vehicles, it recognizes maximum loss exposure tied to the value of its investment balances. These CDOs are linked to embedded derivatives, as noted in the context of hybrid instruments where credit protection has been sold to the issuer, exposing the investor to credit events. JPM, on the other hand, explicitly discloses that structured notes with embedded derivatives are valued using discounted cash flow analyses and models such as Black-Scholes or simulation models, depending on the derivative features. JPM also adjusts valuations for its own credit risk (DVA), indicating a more detailed and model-driven approach to managing the risk of these instruments. This comparison highlights differing approaches to both risk exposure and valuation transparency in handling similar financial products.",
      "llm_answer": "BAC’s CDO holdings are treated as part of its variable‑interest‑entity (VIE) portfolio.  The bank reports a **maximum‑loss exposure** that captures the worst‑case loss if all assets in the VIEs—including the CDOs—became worthless, and it does not disclose a detailed embedded‑derivative valuation model in the 10‑K (BAC 10‑K, pp. 126‑130).  \n\nIn contrast, JPMorgan’s structured‑note valuation **explicitly models the embedded derivative** using discounted‑cash‑flow analysis with Black‑Scholes or simulation models and then applies a DVA adjustment for its own credit risk, providing a more granular, model‑based assessment of embedded‑derivative risk (JPM 10‑K, pp. 185‑189).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All factual elements are correct: BAC's CDO investments are linked to VIEs with maximum loss exposure disclosed, and the bank does not consolidate these entities or provide detailed valuation models for embedded derivatives. JPM's approach is correctly described as using discounted cash flow analysis with models like Black-Scholes or simulation techniques, along with DVA adjustments. (2) There are no numerical values in the question or answer requiring calculation, but all qualitative financial concepts (e.g., DVA, maximum loss exposure, embedded derivatives) are used correctly and consistently with the source material. (3) The multi-hop reasoning is sound—comparing BAC’s risk exposure framework to JPM’s more granular modeling approach across two different 10-K disclosures is logically synthesized and directly addresses the comparative aspect of the question. (4) The only minor shortcoming is a slight lack of explicit mention that BAC’s exposure arises through hybrid instruments where credit protection has been sold (a nuance in the original answer), but the core contrast in valuation transparency and modeling rigor is preserved. Wording differs slightly but maintains semantic equivalence. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 395,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 215,
      "question": "How does the voting structure of CMCSA's Class B Common Stock compare to NFLX's common stock voting rights, given the specific limitations outlined in CMCSA's disclosure?",
      "original_answer": "CMCSA's Class B Common Stock has limited voting rights, only allowing votes on specific matters such as exiting the core payments business, certain consolidation or merger transactions, or amendments to the certificate of incorporation, and votes are calculated by multiplying shares held by the applicable conversion rate. In contrast, NFLX grants one vote per share on all matters to be voted upon by stockholders, providing more generalized voting power. CMCSA's disclosure also indicates that Class B Common Stock was issued and outstanding as of 2023, reinforcing the structured governance framework in place.",
      "llm_answer": "CMCSA’s Class B common stock is largely non‑voting; the 10‑K discloses that holders of Class B (and C) shares have no right to vote on any matters except (i) an exit of the core payments business, (ii) a consolidation/merger/combination, or (iii) certain amendments to the certificate of incorporation, and they vote as a single class with Class A shares on those matters (CMCSA 10‑K, pp. 67‑71). In contrast, Netflix’s common stock carries full voting rights—each share entitles the holder to one vote on all matters (NFLX 10‑K, pp. 59‑63). Thus, CMCSA’s Class B shares are subject to significant voting restrictions, whereas Netflix’s common shares have unrestricted voting rights.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that CMCSA's Class B Common Stock has limited voting rights, specifying the exact exceptions: exit from the core payments business, consolidation/merger/combination, and certain charter amendments—matching the original answer's content. It also accurately contrasts this with NFLX's common stock, which grants one vote per share on all matters. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages, or share counts), so quantitative accuracy is not compromised; all referenced disclosures (e.g., page numbers in 10-Ks) are contextually appropriate and correctly attributed. (3) The multi-hop reasoning is sound: the model synthesizes governance structures from two different companies (CMCSA and NFLX) using their respective 10-K disclosures, correctly comparing the scope and limitations of voting rights. (4) The only minor shortcoming is that the LLM omits the detail about votes being calculated by multiplying shares held by the applicable conversion rate—a nuance present in the ground truth. Additionally, it does not mention that CMCSA’s Class B shares were still issued and outstanding as of 2023, which reinforces the ongoing governance structure. These omissions are minor and do not distort the overall meaning, hence the 9/10 on correctness and qualitative accuracy. The answer remains semantically equivalent in intent and factual substance, with excellent contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 419,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 215,
      "question": "How does the treatment of embedded derivatives within CDOs by Morgan Stanley compare to JPMorgan Chase's valuation methodology for similar instruments, given their respective involvement in structured note products?",
      "original_answer": "Morgan Stanley treats CDOs as hybrid instruments containing embedded derivatives, where credit protection has been sold to the issuer of the note, and if there is a credit event of a reference entity, the principal balance of the note may not be repaid in full. JPMorgan Chase, on the other hand, values structured notes using discounted cash flow analyses that consider the embedded derivative features through models like Black-Scholes or simulation models, with adjustments for the Firm's own credit risk (DVA). Both firms recognize the complexity and risk associated with these instruments, but differ in how they disclose and value the embedded derivatives within their portfolios.",
      "llm_answer": "Morgan Stanley treats the embedded derivative that sits inside a CDO as part of the CDO’s fair‑value measurement – the firm’s exposure is limited to the fair value of the assets it owns in the special purpose entity and the CDO is not consolidated unless it serves as servicer or collateral manager【Morgan Stanley 10‑K, p. 107‑108】. By contrast, JPMorgan Chase values structured notes that contain embedded derivatives using a discounted‑cash‑flow model that explicitly prices the embedded derivative (e.g., via Black‑Scholes or simulation models) and then adjusts the base valuation for its own credit risk (DVA)【JPMorgan Chase 10‑K, p. 185‑186】. Thus, Morgan Stanley integrates the embedded derivative into the CDO’s overall fair‑value assessment, whereas JPMorgan Chase models the embedded derivative separately as part of the structured note’s valuation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Morgan Stanley treats CDOs as hybrid instruments where the embedded derivative is part of the fair-value measurement and notes the limited exposure unless the firm acts as servicer or manager, which is consistent with the original answer’s emphasis on credit protection and non-consolidation. (2) For JPMorgan Chase, the LLM accurately describes the use of discounted cash flow models, explicit pricing of embedded derivatives via Black-Scholes or simulation models, and the inclusion of DVA (debt valuation adjustment) for its own credit risk—this matches the original answer’s description. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in valuation methodologies between the two firms, drawing from their respective 10-K disclosures. (4) While the wording differs, the semantic meaning is equivalent—Morgan Stanley integrates the derivative into overall fair value, while JPMorgan models it separately. The only minor omission is not explicitly mentioning the potential non-repayment of principal upon a credit event for Morgan Stanley’s CDOs, which slightly reduces completeness. However, this does not undermine the core accuracy. No numeric inaccuracies are present, and all entities, methodologies, and concepts are correctly identified and contrasted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 387,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 216,
      "question": "How does Abbott's exposure to intellectual property risks, particularly regarding patent enforcement, intersect with AbbVie's legal actions through its subsidiary Forest Laboratories Holdings Limited to protect the exclusivity of Vraylar, and what implications does this have for both companies' pharmaceutical revenue streams?",
      "original_answer": "Abbott faces significant risks related to the expiration or loss of intellectual property protection, which could reduce future revenues and operating income. In parallel, AbbVie's subsidiary Forest Laboratories Holdings Limited is actively involved in patent enforcement litigation concerning Vraylar (cariprazine), seeking to prevent generic competition from companies like Sun Pharmaceutical and Aurobindo Pharma. This litigation, initiated in the U.S. District Court for the District of Delaware in December 2019, aims to preserve market exclusivity for Vraylar, a key pharmaceutical product. If successful, the enforcement of these patents would protect AbbVie’s revenue from Vraylar. However, if generic versions are allowed to enter the market, both companies could face competitive pressure—Abbott due to its reliance on strong IP protections and AbbVie through reduced exclusivity for Vraylar—highlighting the interplay between IP enforcement and pharmaceutical revenue sustainability.",
      "llm_answer": "Abbott’s risk‑factor discussion (pages 10‑14) stresses that loss or invalidation of patents and litigation over intellectual property can materially reduce its pharmaceutical revenues. AbbVie’s 10‑K (pages 111‑115) notes that the company has pursued legal action through its subsidiary Forest Laboratories Holdings Limited to defend the exclusivity of Vraylar, thereby protecting its sales from generic competition. The intersection shows that both firms depend on robust IP enforcement to sustain revenue, but Abbott faces the risk of litigation that could erode its sales, while AbbVie’s proactive defense helps preserve its revenue stream—albeit at the cost of legal expenses and the risk of losing exclusivity if patents lapse.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Abbott's exposure to intellectual property risks, particularly patent loss and litigation, and AbbVie's legal actions through Forest Laboratories Holdings Limited to protect Vraylar's exclusivity. It accurately captures the core dynamic: both companies rely on IP protection, with Abbott facing risks from erosion and AbbVie actively defending its position. However, the LLM omits specific details present in the ground truth, such as the December 2019 filing date and the names of the generic challengers (Sun Pharmaceutical and Aurobindo Pharma), which are key elements of the multi-hop synthesis. (2) There are no numeric values, dates, or calculations in the LLM answer that contradict the ground truth; it avoids stating dates or specific court details, so there is no inaccuracy—only omission. The absence of incorrect numbers supports a full score in quantitative accuracy. (3) The reasoning is sound: the model correctly infers that Abbott is vulnerable to IP erosion while AbbVie is proactively litigating to maintain revenue, and that both are interconnected through the broader theme of IP-dependent revenue sustainability. The synthesis across the two companies’ risk profiles is logically coherent and contextually appropriate, though slightly less detailed than the ground truth. (4) The answer is highly contextually relevant, directly addressing the intersection of IP risks and legal actions and their implications for revenue. The omission of specific litigation timing and counterparties prevents a perfect score in correctness and qualitative accuracy, but the core factual and conceptual content is accurate and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 463,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 216,
      "question": "How does Citigroup's use of foreign currency forwards and cross-currency swaps in its net investment hedging strategy compare to Morgan Stanley's reliance on VaR models for managing market risk exposure in trading portfolios?",
      "original_answer": "Citigroup utilizes foreign currency forwards, cross-currency swaps, and options to hedge foreign exchange risk on equity investments in non-U.S.-dollar subsidiaries, recording changes in fair value in CTA within AOCI under ASC 815. In contrast, Morgan Stanley employs Value-at-Risk (VaR) models as a key risk management tool to estimate aggregate market risk exposure across trading portfolios, incorporating diversification and hedging effects, while acknowledging VaR's limitations in capturing extreme market events or liquidity constraints. Southern Company Gas, which connects the two entities, also uses weather derivative instruments and other risk management tools to mitigate weather-related revenue volatility in its gas marketing services segment, demonstrating a broader industry application of risk management frameworks.",
      "llm_answer": "Citigroup’s net‑investment hedge is a specific derivative strategy: it uses foreign‑currency forwards and cross‑currency swaps to offset the translation risk of its equity investments in non‑U.S. subsidiaries, with the fair‑value changes recorded in CTA within AOCI under ASC 815/830 (C_10k_2024, pp. 151‑155).  \nMorgan Stanley, by contrast, relies on a daily one‑day, 95 % VaR model that aggregates linear and non‑linear exposures across equity, commodity, interest‑rate, credit‑spread and FX risk to monitor and limit market‑risk exposure in its trading portfolios (MS_10k_2024, pp. 58‑62).  \nThus, Citigroup applies a direct, instrument‑based hedge to a single risk category, while Morgan Stanley uses a statistical risk‑measurement framework to manage a broader spectrum of market‑risk exposures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all details are correct: Citigroup's use of foreign currency forwards and cross-currency swaps for hedging equity investments in non-U.S.-dollar subsidiaries is accurately described, including the accounting treatment under ASC 815 (and reference to ASC 830, which governs foreign currency translation and complements ASC 815). Morgan Stanley's use of a one-day, 95% VaR model across multiple risk categories (equity, commodity, interest rate, credit spread, FX) is factually consistent with its 10-K disclosures. The cited page ranges (C_10k_2024 pp. 151–155; MS_10k_2024 pp. 58–62) are plausible and support the claims. (2) The LLM correctly identifies the core contrast: Citigroup employs specific derivative instruments for targeted FX risk hedging in net investments, while Morgan Stanley uses a statistical, aggregate risk measurement framework (VaR) for trading portfolios. This captures the essential difference in risk management philosophy—direct hedging vs. portfolio-level risk monitoring. (3) The only minor omission is the reference to Southern Company Gas in the original answer, which serves as a connecting entity and illustrates broader industry use of risk management tools (e.g., weather derivatives). While this adds contextual depth, it is not central to the Citigroup–Morgan Stanley comparison asked in the question. Thus, its absence does not undermine the correctness of the response. (4) The reasoning is sound, logically synthesizing information from two distinct financial institutions and contrasting their risk management approaches with appropriate financial terminology and regulatory context. The answer is semantically equivalent to the ground truth in all key aspects, with only the peripheral detail about Southern Company Gas missing. Therefore, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 538,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 217,
      "question": "How does Colgate-Palmolive's use of option contracts to hedge foreign exchange risk compare to Walmart's exposure through firm commitments, given the impact of these financial instruments on their respective cash flow stability?",
      "original_answer": "Colgate-Palmolive utilizes option contracts as part of its foreign exchange risk management strategy, hedging portions of its foreign currency purchases and firm commitments with contracts valued using observable market rates, aiming to minimize earnings volatility from currency fluctuations. These contracts, with a typical duration of no more than 12 months, are aligned with the company's policy of matching derivative terms to underlying exposures. In contrast, Walmart reports $37.2 billion in unrecorded purchase obligations as of January 31, 2025, including $15.9 billion due within one year, which includes firm commitments for inventory, utilities, and capital expenditures. These obligations are legally binding and expose Walmart to cash flow risks if market conditions change. The impact of Colgate's use of option contracts is to stabilize the U.S. dollar equivalent value of foreign currency transactions, while Walmart lacks such financial instrument protections on its firm commitments, leaving it more exposed to market volatility affecting its cash flow stability.",
      "llm_answer": "Colgate‑Palmolive uses option contracts as cash‑flow hedges of forecasted foreign‑currency transactions, with a notional amount of roughly $9.9 billion in 2024 (page 90).  Gains and losses on those contracts are deferred in AOCI and only recognized when the underlying transactions occur, which dampens earnings and cash‑flow volatility.  Walmart, by contrast, has firm‑commitment obligations of about $41 billion in 2024 (page 44) that are not hedged, leaving the company exposed to price and currency swings that can increase cash‑flow swings; thus Colgate’s hedging strategy provides more predictable cash‑flow stability than Walmart’s unhedged commitments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numbers. The ground truth states Walmart has $37.2 billion in unrecorded purchase obligations as of January 31, 2025, with $15.9 billion due within one year, but the LLM incorrectly reports $41 billion in 2024 without specifying the breakdown or correct amount. Additionally, the LLM claims Colgate-Palmolive has option contracts with a notional amount of $9.9 billion in 2024, which is not present in the original answer and lacks corroboration from the ground truth. These quantitative errors significantly affect accuracy. (2) The original answer does not provide a notional value for Colgate’s derivatives, nor does it state the $9.9 billion figure cited by the LLM, making this a fabrication or hallucination. The Walmart obligation amount is also misstated: $41 billion vs. the correct $37.2 billion, and the due-within-one-year component ($15.9B) is omitted entirely. (3) The qualitative reasoning is sound—LLM correctly identifies that Colgate uses option contracts to hedge foreign exchange risk and defer gains/losses through AOCI, thereby stabilizing cash flows, while Walmart has unhedged firm commitments that expose it to volatility. This reflects proper multi-hop synthesis of strategy differences and their impact on cash flow stability. (4) Contextual relevance is high—the response directly addresses the comparison of financial instruments and their impact on cash flow stability. However, due to significant quantitative inaccuracies, especially the unsupported $9.9B and $41B figures, the correctness score is limited to 6, reflecting partially correct information with major factual flaws in critical data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 466,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 217,
      "question": "How does the adoption timeline of ASU No. 2023-07 for segment reporting differ between TMO and CVS, and what specific disclosures were required by each company as a result of this new standard?",
      "original_answer": "TMO adopted ASU No. 2023-07 for its 2024 annual report and applied it retrospectively, resulting in increased disclosures in Note 11. CVS adopted the standard on January 1, 2024, for fiscal year reporting and is required to provide additional disclosures related to its reportable segments, including the CODM's title, how the CODM uses segment operating results, and alignment of interim reporting with annual requirements, as detailed in Note 19. Both companies applied the standard retrospectively to prior periods, but TMO implemented it specifically for the 2024 annual report while CVS also aligned it with interim reporting requirements starting after December 15, 2024.",
      "llm_answer": "TMO adopted ASU 2023‑07 effective for its 2024 annual report and all subsequent interim periods, applying the change retrospectively (see the “Recent Accounting Pronouncements” table on pages 42‑46). CVS made the same adoption effective for its 2024 annual report and interim periods thereafter, also applying it retrospectively (see the analogous table on pages 131‑135). Both companies now disclose, in their segment‑reporting notes, significant segment expenses and other items by reportable segment and provide details on the chief operating decision maker (title, position, and how CODM uses segment operating results to evaluate performance and allocate resources); TMO’s disclosures appear in Note 11, while CVS’s appear in its Segment‑Reporting note (Note 12).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both TMO and CVS adopted ASU No. 2023-07 for their 2024 annual reports and applied it retrospectively, which aligns with the ground truth. It also correctly notes that both companies enhanced segment reporting disclosures, including information about the CODM and segment performance evaluation, with TMO in Note 11 and CVS in its segment note (though LLM says Note 12 vs. ground truth Note 19—this is a factual discrepancy). However, the LLM incorrectly states that TMO adopted the standard for 'all subsequent interim periods' and implies a broader implementation than specified; the ground truth clarifies TMO applied it specifically for the 2024 annual report, while CVS explicitly aligned with interim reporting requirements after December 15, 2024. This distinction in adoption timelines—particularly CVS’s alignment with interim reporting—is missing in the LLM answer, leading to a partial misrepresentation of the timeline difference. (2) Quantitatively, the years (2024) and note numbers (Note 11 for TMO) are correct or close, though CVS’s note is misstated as Note 12 instead of Note 19, which affects entity accuracy. No calculations are involved, so numerical precision is not applicable beyond dates and note references. (3) The multi-hop reasoning is partially sound—LLM correctly synthesizes adoption timing and disclosure requirements across both companies but fails to highlight the key difference in interim reporting alignment emphasized in the ground truth. The synthesis is adequate but lacks precision in comparative analysis. (4) The answer is contextually relevant and covers both parts of the question—adoption timeline and required disclosures—but omits the nuanced difference in how each company implemented the standard regarding interim reporting, which is central to the question. Hence, correctness is reduced to 7 due to missing key differentiating detail and a minor error in note number for CVS.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 535,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "What was the impact of the Philippines' corporate income tax rate reduction on ACN's 2021 effective tax rate, and how does this compare to AMD's disclosure of tax reform effects in the same period?",
      "original_answer": "ACN benefited from the Philippines' corporate income tax rate reduction enacted in Q1 2021, which favorably impacted its 2021 effective tax rate of 21.8%, partially offsetting other unfavorable tax factors like GILTI-related foreign tax credit limitations. In contrast, AMD reported no impact from the Tax Reform Act in 2021, as shown by the $0 value in their tax provision table for that line item, indicating different exposure or geographic applicability of the reform.",
      "llm_answer": "ACN’s 2021 effective tax rate rose to 21.8% – a 0.1‑percentage‑point increase – and the reduction in the Philippines’ corporate income‑tax rate “partially offset” that rise, limiting the net increase. In contrast, AMD disclosed that the 2021 tax‑reform changes had no material effect on its effective tax rate, indicating a negligible impact.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error: it states that ACN's effective tax rate 'rose' to 21.8% with a 0.1-percentage-point increase, which contradicts the ground truth that does not mention any such increase or baseline comparison. The ground truth only reports the 21.8% rate and the favorable impact of the Philippines rate reduction, without stating a year-over-year change. This misrepresents the quantitative trend. The claim of a '0.1-percentage-point increase' is unsupported and incorrect. (2) The Philippines tax rate reduction's qualitative impact ('partially offset') is correctly described, and AMD's $0 impact is accurately reflected as 'no material effect.' However, the LLM invents a numerical change (0.1-point rise) not present in the original, undermining quantitative accuracy. (3) The multi-hop reasoning is partially sound: the model correctly contrasts ACN’s exposure to Philippine tax changes with AMD’s lack of exposure to U.S. tax reform. It synthesizes across two companies and tax events appropriately. However, the erroneous calculation claim weakens the reasoning. (4) Contextually, the answer is relevant and addresses both parts of the question—ACN’s tax rate impact and AMD’s disclosure. The core entities (ACN, AMD, 2021, effective tax rate, tax reform) are correct. The qualitative description of 'partially offset' and 'no material effect' aligns with the ground truth. However, the invented numerical change reduces correctness. Quantitative accuracy is scored low due to the false precision; qualitative and contextual scores are higher due to correct entity use and logical structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 451,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Honeywell's use of pricing models for valuing fixed income investments in its pension plans compare to 3M's valuation methodology, particularly in terms of reliance on observable versus unobservable inputs?",
      "original_answer": "Honeywell values its fixed income investments using pricing models, broker bids, or discounted cash flows, incorporating adjustments for credit and liquidity risks when necessary. 3M similarly uses pricing models that rely on observable inputs like interest rates and yield curves for Level 2 fixed income investments, while Level 3 investments depend on unobservable inputs such as projected annuity payments and discount rates. Both companies apply discounted cash flow techniques in certain cases and disclose the use of NAV practical expedients for certain fund types, though 3M explicitly categorizes its fixed income investments by valuation hierarchy levels, whereas Honeywell focuses on the nature of the valuation adjustments made.",
      "llm_answer": "Honeywell values corporate bonds, mortgage/asset‑backed securities and government securities in its pension plans by applying pricing models, broker bids, quoted prices or discounted‑cash‑flow calculations, and then adds adjustments for credit and liquidity risks that are not directly observable. 3M follows a similar scheme: U.S. government securities are priced at market close, while corporate bonds, asset‑backed securities and collateralized mortgage obligations are valued either at comparable‑security yields or via discounted‑cash‑flow models that use observable market yields, with additional adjustments for unobservable credit and liquidity risks.  Thus, both companies rely on observable market data for the core valuation but supplement it with unobservable risk adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that both Honeywell and 3M use pricing models, broker bids, and discounted cash flow techniques for valuing fixed income investments in their pension plans. It accurately notes the use of observable inputs (e.g., market yields, interest rates) as the core valuation basis and acknowledges the application of unobservable adjustments for credit and liquidity risks—consistent with the original answer. (2) There are no numerical values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not compromised; the response contains no erroneous figures. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Honeywell and 3M), compares their methodologies, and draws a valid conclusion about reliance on observable versus unobservable inputs. The LLM captures the nuanced point that while observable data forms the foundation, both firms apply unobservable adjustments—this reflects proper cross-document synthesis. (4) The only minor shortcoming is that the LLM omits 3M's explicit categorization of investments by valuation hierarchy levels (Level 2 vs Level 3), which is mentioned in the original answer and adds a layer of transparency not mirrored in Honeywell’s disclosures. This detail, while not central, is a small gap in completeness. However, the core comparison—methodologies, inputs, and adjustments—is accurately conveyed with strong semantic equivalence. Hence, a score of 9 is warranted for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 464,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does the voting power distribution tied to Class B common stock conversion mechanisms at CMCSA compare with the share repurchase strategy for Class A and Class C shares at GOOGL, given the differing impacts on equity structure and shareholder control?",
      "original_answer": "At CMCSA, Class B common stockholders control 33 1/3% of the voting power, which is non-dilutable and convertible share-for-share into Class A common stock, while the voting power of Class A shares depends on the total number of Class A and Class B shares outstanding. This structure ensures continued influence by Class B holders. In contrast, GOOGL has repurchased $62.2 billion of Class A and Class C shares in 2023, with an additional $36.3 billion remaining under the repurchase authorization. These repurchases reduce the number of outstanding shares, increasing the proportional ownership of remaining shareholders, including those holding Class B shares, which carry 10 votes per share. Since Class B shares automatically convert to Class A upon sale or transfer, these repurchases indirectly influence the balance of voting control by reducing the total pool of shares subject to Class A voting calculations. Thus, while CMCSA’s structure protects Class B voting power through fixed percentages and conversion rules, GOOGL’s equity control dynamics are shaped by aggressive repurchases that affect the relative ownership and voting influence of remaining shareholders.",
      "llm_answer": "CMCSA’s Class B shares carry ten votes each and may be converted share‑for‑share into Class A shares (which have one vote), so a holder can shift from a high‑voting position to a lower‑voting one, directly altering the balance of control between the two classes【CMCSA_10k_2023.pdf pages 1‑5, 89‑93】. Alphabet (GOOGL) has a two‑class structure in which only Class A shares vote; its share‑repurchase program buys back Class A and non‑voting Class C shares, shrinking the equity base but leaving voting power concentrated in the remaining Class A shares【GOOGL_10k_2023.pdf pages 79‑83】. Thus, CMCSA’s conversion mechanism can redistribute voting power, whereas GOOGL’s repurchases mainly affect capital structure and earnings per share without changing the voting‑power allocation among the surviving shareholders.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that CMCSA’s Class B shares carry ten votes each, which is false; the ground truth specifies that Class B shareholders collectively hold 33 1/3% of the voting power, not per-share vote multiples. This misrepresents the entire voting structure. Additionally, the LLM claims GOOGL’s Class A shares are the only voting shares, but in reality, GOOGL’s Class B shares carry 10 votes per share—this is a critical error. The answer also omits all quantitative details from the ground truth: the $62.2 billion repurchased and $36.3 billion remaining authorization under GOOGL’s program are not mentioned, failing the quantitative accuracy test. (2) No numbers from the ground truth are present in the LLM answer, and incorrect vote ratios are introduced. The absence of dollar figures and misrepresentation of voting rights severely undermine quantitative accuracy. (3) The reasoning is partially sound in contrasting conversion mechanisms (CMCSA) vs. repurchases (GOOGL), and it correctly identifies that repurchases shrink the equity base. However, it fails to recognize that GOOGL’s repurchases indirectly affect voting control by increasing the relative weight of remaining shares—including high-vote Class B shares—and that Class B shares convert to Class A upon transfer. The model misses the multi-hop insight that repurchases amplify the influence of entrenched insiders holding Class B shares. (4) While the answer addresses the general theme of equity control and structural mechanisms, the factual errors in vote allocation and missing financial figures result in a low correctness and quantitative accuracy score. Contextual relevance is higher because the framework of comparison (conversion vs. repurchase effects) is appropriate, even if the details are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 504,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Altria's exposure to FCTC-driven advertising restrictions, as outlined in its 2022 10-K, compare to Philip Morris International's experience with implemented advertising bans in markets like Australia and Russia, and what implications does this have for their respective international marketing strategies?",
      "original_answer": "Altria acknowledges in its 2022 10-K that while the U.S. is a signatory to the FCTC, it is not a party to the agreement, and therefore FCTC-driven advertising restrictions have limited direct regulatory impact in the U.S. However, the document notes that the FCTC has called for and influenced advertising bans globally. In contrast, Philip Morris International (PMI) reports that in markets like Australia and Russia, governments have already banned the display of tobacco products at the point of sale, which severely restricts visibility and marketing potential. These bans align with FCTC guidelines recommending the prohibition of all forms of communication with adult smokers. Given that Altria's primary market remains the U.S., where such bans are not yet widespread, its international marketing strategy is less constrained compared to PMI, which operates more heavily in FCTC-compliant markets where advertising and product visibility restrictions are already enforced. This divergence suggests that PMI must adapt more aggressively to restrictive advertising environments, while Altria faces more potential future risk if the U.S. adopts similar FCTC-aligned policies.",
      "llm_answer": "Altria’s 2022 10‑K explains that the United States is not a party to the WHO Framework Convention on Tobacco Control, so its exposure to FCTC‑driven advertising restrictions is limited; the company still faces local advertising limits in many overseas markets (see pages 37‑41). In contrast, PMI’s 10‑K notes that Australia and Russia have enacted full advertising bans that directly curb its marketing activities, forcing the company to shift its international strategy toward compliance‑focused, product‑centric promotion (see pages 40‑44). Consequently, PMI must navigate stricter regulatory constraints abroad, while Altria enjoys relatively greater flexibility but must still adapt to local advertising restrictions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that the U.S. is not a party to the FCTC, limiting Altria's exposure to FCTC-driven advertising restrictions—this matches the original answer's key point. It also accurately contrasts this with PMI’s experience in Australia and Russia, where full advertising bans are in place. The implication for PMI having to adapt its international marketing strategy is correctly inferred. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not applicable in a traditional sense; however, the cited page numbers (e.g., pages 37–41, 40–44) are plausible and consistent with 10-K formatting, though not verifiable from the knowledge graph—this does not detract from factual correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes Altria’s U.S.-centric regulatory environment with PMI’s international exposure to FCTC-aligned policies, drawing a valid strategic comparison. (4) The LLM omits a minor but relevant detail from the original answer: the FCTC’s call to prohibit 'all forms of communication with adult smokers' and the specific point-of-sale display bans. It also doesn’t explicitly note that Altria faces more future risk if the U.S. adopts FCTC policies. However, the core facts, entities (Altria, PMI, FCTC, Australia, Russia), years (2022 10-K), and strategic implications are correct and semantically equivalent. Wording differs slightly but meaning is preserved. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 465,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Goldman Sachs' competitive disadvantage to JPMorgan in cryptocurrency offerings, influenced by Dodd-Frank compliance burdens, compare with Morgan Stanley's exposure to regulatory risks in emerging markets that could impact its cross-border cryptocurrency-related financial activities?",
      "original_answer": "Goldman Sachs faces a competitive disadvantage compared to JPMorgan due to Dodd-Frank compliance burdens that restrict its ability to offer cryptocurrencies and digital assets, as stated in its 2024 10-K filing. JPMorgan, as a competitor, offers these products, giving it a strategic edge in evolving financial markets. Meanwhile, Morgan Stanley's 2024 10-K highlights exposure to regulatory risks in emerging markets, where uncertain and rapidly changing laws could hinder its ability to structure and enforce cryptocurrency-related transactions across borders. Both firms face regulatory constraints, but Goldman Sachs' limitations are self-imposed due to U.S. regulatory frameworks, while Morgan Stanley's risks stem from external geopolitical and legal environments in foreign jurisdictions.",
      "llm_answer": "Goldman Sachs notes that the Dodd‑Frank Act’s limits on proprietary trading and certain hedge‑fund investments constrain its ability to offer cryptocurrency products, leaving it at a competitive disadvantage versus JPMorgan, which is less restricted by those U.S. rules (GS 10‑K, Competition section, paragraphs on crypto and Dodd‑Frank).  By contrast, Morgan Stanley’s risk‑factor disclosures highlight that regulatory uncertainty in emerging‑market jurisdictions could restrict its cross‑border crypto‑related activities, as local rules may be inconsistent or evolve rapidly (MS 10‑K, Risk‑Factors section on regulatory developments).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Goldman Sachs' competitive disadvantage due to Dodd-Frank compliance burdens is accurately attributed to restrictions on proprietary trading and investments, which limit its cryptocurrency offerings compared to JPMorgan. This is correctly sourced to Goldman Sachs' 10-K. Morgan Stanley's exposure to regulatory risks in emerging markets affecting cross-border crypto activities is also accurately described and sourced. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different firms (Goldman Sachs and Morgan Stanley), identifies distinct regulatory challenges (U.S.-based structural constraints vs. foreign regulatory uncertainty), and contrasts them appropriately. The only minor shortcoming is that the LLM does not explicitly state that Goldman’s limitations are 'self-imposed' due to U.S. frameworks or that Morgan Stanley’s risks are 'external'—a nuance present in the original answer—but this conceptual distinction is implied through context. (4) The answer is fully relevant, directly addressing the comparative regulatory landscape affecting cryptocurrency activities at both firms. Wording differs slightly but maintains semantic equivalence. No irrelevant or extraneous information is included.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 414,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does the adoption of ASU 2022-04 impact the disclosure requirements for supplier finance obligations at both 3M and GE, particularly in terms of the roll-forward information introduced in 2024?",
      "original_answer": "The adoption of ASU 2022-04 requires companies like 3M and GE to disclose key terms, balance sheet presentation, and the confirmed amount outstanding under supplier finance programs. For 3M, this includes a $0.3 billion balance in confirmed invoices as of December 31, 2024, with $1.5 billion of invoices confirmed and paid during the year. GE adopted the standard on January 1, 2023, and in line with the ASU's phased requirements, began providing the annual roll-forward information in 2024. This roll-forward requirement, applicable prospectively from January 1, 2024, aligns both companies' disclosures to include changes in confirmed invoice balances over the reporting period, enhancing transparency in their accounts payable disclosures.",
      "llm_answer": "ASU 2022‑04 requires companies to disclose the key terms of supplier‑finance programs, the balance‑sheet presentation of related amounts, the confirmed amount outstanding at period end, and a roll‑forward of beginning and ending balances and invoice activity. 3M’s Note 15 (pp. 75‑79) now presents the $0.3 billion of confirmed‑invoice balances as of 12/31/2024, the $1.5 billion of invoices confirmed and paid in 2024, and the roll‑forward of those balances. GE’s supply‑chain‑finance note (pp. 45‑49) likewise includes the roll‑forward information for 2024, showing the starting balance, invoices confirmed, paid, and ending balance, thereby meeting the new disclosure requirement.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitative accuracy: The dollar amounts ($0.3 billion confirmed invoices at year-end, $1.5 billion confirmed and paid during 2024) are correctly reported and match the original answer. The time frame (2024) is accurate, and the adoption date for GE (January 1, 2023) is correctly implied by the context of 2024 disclosures. (2) Completeness: The answer addresses all parts of the question—disclosure requirements under ASU 2022-04, the impact on both 3M and GE, and the introduction of roll-forward information in 2024. It correctly notes that both companies now provide roll-forward disclosures in their 2024 filings. (3) Entity accuracy: Both companies (3M and GE) are correctly identified, along with the relevant financial disclosures and time periods. The references to specific notes (e.g., Note 15 for 3M, pp. 45–49 for GE) add precision and are consistent with typical 10-K structures. (4) Reasoning: The multi-hop synthesis is sound—linking the ASU’s requirements to the specific disclosures made by each company, and recognizing that the roll-forward is a new requirement effective prospectively in 2024. (5) Semantic equivalence: The LLM conveys the same information as the original answer, with slightly more detail (e.g., page numbers), but without introducing inaccuracies. Minor wording differences do not affect factual correctness. All key elements—transparency enhancement, balance sheet presentation, confirmed amounts, and roll-forward—are accurately reflected.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 429,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does MDT's geographic revenue concentration in 'Other Countries' expose it to similar regulatory and reimbursement challenges as those impacting AMGN's drug pricing strategies in international markets?",
      "original_answer": "MDT reports $32.251 billion in net sales from 'Total other countries, excluding Ireland' in fiscal 2024, which represents the majority of its revenue outside the U.S. This significant international exposure subjects MDT to regulatory environments where governments increasingly control healthcare costs through reimbursement and coverage limitations. As outlined in the DHR filing, these limitations include direct price controls, reference pricing, and mandatory licensing, which tie reimbursement to outcomes and constrain revenue potential. Similarly, AMGN notes that many countries outside the U.S. apply price controls, therapeutic-reference pricing, and volume caps, which limit both pricing and market access for its biologics. Both companies face parallel pressures from global payers seeking cost predictability and imposing narrower coverage criteria, despite operating in different healthcare sectors.",
      "llm_answer": "Medtronic’s “Other Countries” segment accounts for roughly 32 % of its 2024 net sales (≈$15.7 bn) (MDT_10k_2023, p. 103), meaning a large portion of revenue is earned in foreign markets that are governed by government‑sponsored health systems, price‑control mechanisms, and health‑technology‑assessment bodies (MDT_10k_2023, p. 105‑107).  These same regulatory and reimbursement forces that constrain Amgen’s international drug‑pricing strategy—government‑controlled pricing, reimbursement negotiations, and regulatory approvals—are also at play for Medtronic, exposing it to comparable risks in those markets (AMGN_10k_2023, p. 16‑20).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies. It states that MDT's 'Other Countries' segment accounts for roughly 32% of its 2024 net sales, approximately $15.7 billion. However, the ground truth reports $32.251 billion in net sales from 'Total other countries, excluding Ireland' in fiscal 2024, which is not 32% but actually the majority (over 50%) of MDT's total international revenue. The $15.7 billion figure and 32% percentage are both incorrect and not supported by the ground truth. This suggests a misinterpretation or miscalculation of the revenue split.\n\n2) Despite the numerical errors, the qualitative reasoning partially aligns with the ground truth. The LLM correctly identifies that both MDT and AMGN face regulatory and reimbursement challenges in international markets due to government price controls, health technology assessments, and reimbursement negotiations. It appropriately draws a parallel between the two companies’ exposure to similar systemic pressures abroad, even though they operate in different healthcare subsectors (devices vs. biologics).\n\n3) The multi-hop reasoning is conceptually sound—linking MDT’s geographic revenue concentration to regulatory risks and comparing them to AMGN’s drug pricing challenges—but is undermined by the incorrect financial data. The synthesis across companies (MDT and AMGN) and filings is relevant and addresses the core of the question, showing awareness of shared international market risks.\n\n4) Contextually, the answer is well-framed and relevant. It cites appropriate sections of the 10-Ks and uses correct terminology (e.g., price controls, reimbursement negotiations). However, the incorrect revenue figure and percentage severely impact factual reliability. While the direction of the argument is correct, the foundation is flawed due to inaccurate numbers. Minor formatting flexibility is allowed, but a 50% discrepancy in revenue magnitude cannot be overlooked.\n\nJustification: The correctness score is 5 due to major quantitative errors but partially correct reasoning and contextual relevance. Quantitative accuracy is low (4) because the dollar amount and percentage are both wrong. Qualitative accuracy is moderate (6) as the conceptual comparison is valid. Contextual relevance is high (8) because the answer addresses the right themes and mechanisms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 627,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does the combined capital buffer requirement above the minimum risk-based capital ratios for SCHW and JPM compare, considering their respective application of countercyclical and capital conservation buffers?",
      "original_answer": "SCHW is subject to a stress capital buffer of 2.5% and a capital conservation buffer of 2.5%, with the countercyclical capital buffer at 0%, resulting in a total buffer requirement of 5.0% above the minimum risk-based capital ratios. JPM, on the other hand, applies a fixed capital conservation buffer of 2.5% and a stress capital buffer (SCB) of 2.9%, with the countercyclical buffer also at 0%, leading to a total buffer requirement of 5.4% above the minimum. Therefore, JPM has a slightly higher combined buffer requirement than SCHW due to its higher SCB. This comparison reflects how both firms are subject to similar regulatory buffer frameworks, but with firm-specific SCB and CCyB determinations.",
      "llm_answer": "Schwab’s banking subsidiaries are required to hold a combined buffer of **5.0 %** above the regulatory minimum risk‑based capital ratios – 2.5 % stress buffer for CSC, 2.5 % capital‑conservation buffer for CSB, and no countercyclical buffer.  \nJPMorgan Chase must maintain a **9.4 %** buffer above the minimum – 4.0 % GSIB surcharge, 2.9 % SCB, 2.5 % capital‑conservation buffer, and 0 % countercyclical buffer – so its buffer requirement is substantially higher than Schwab’s.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in quantitative values and components. While SCHW's total buffer of 5.0% is correct (2.5% stress capital buffer + 2.5% capital conservation buffer, 0% countercyclical), JPM's total buffer is incorrectly stated as 9.4%. The ground truth specifies only the stress capital buffer (2.9%), capital conservation buffer (2.5%), and 0% countercyclical, totaling 5.4%. The LLM incorrectly adds a 4.0% GSIB surcharge, which was not mentioned in the original answer and is not part of the buffer requirement being compared. This leads to a major miscalculation. (2) The calculation for SCHW is accurate (2.5% + 2.5% = 5.0%), but for JPM, the LLM computes 4.0% + 2.9% + 2.5% = 9.4%, which is factually incorrect based on the provided ground truth. The GSIB surcharge is not part of the buffer components listed in the original answer and should not be included. (3) The multi-hop reasoning is partially sound—comparing SCHW and JPM’s buffer requirements—but fails in synthesis by introducing an extraneous component (GSIB surcharge) not present in the source. The conclusion that JPM has a higher buffer is correct (5.4% > 5.0%), but the magnitude and reasoning are flawed. (4) Correctness score is 4 due to partial accuracy on SCHW and the correct directional comparison, but major error in JPM’s buffer composition and total. Quantitative accuracy is low (3) due to incorrect numbers and inclusion of unsupported figures. Qualitative accuracy is moderate (5) as the structure and intent are reasonable, but reasoning is compromised. Contextual relevance is high (8) as the response addresses the right entities and question framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 461,
        "total_tokens": 1773
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 598,
    "successful_evaluations": 598,
    "failed_evaluations": 0,
    "average_correctness_score": 7.22,
    "average_quantitative_accuracy": 7.98,
    "average_qualitative_accuracy": 7.44,
    "average_contextual_relevance": 9.08,
    "score_distribution": {
      "excellent": 293,
      "good": 122,
      "fair": 120,
      "poor": 63
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-20b-reasoning",
    "experiment": "e2_page_window",
    "pattern": "qualitative_3hop_cross_company_type1",
    "total_questions": 600,
    "successful": 598,
    "failed": 2,
    "elapsed_seconds": 26271.41,
    "timestamp": "2026-02-02T22:58:17.150443"
  }
}